{
    "Clozapine is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment.": [
        [
            {
                "label": "Clozapine",
                "id": {
                    "PUBCHEM.COMPOUND:135398737": [
                        "clozapine",
                        "Clozapine",
                        "CloZAPine",
                        "CLOZAPINE",
                        "cloZAPine",
                        "clozapine",
                        "CLOZAPINE (SUN)",
                        "CLOZAPINE (MAYNE)",
                        "CLOZAPINE (SANDOZ)",
                        "Clozapine (substance)",
                        "clozapine (medication)",
                        "CLOZAPINE (GOLDEN STATE)",
                        "Clozapine-containing product",
                        "Product containing clozapine (medicinal product)",
                        "Leponex",
                        "Clozaril",
                        "Clozapin",
                        "Clozapin",
                        "Clozapin",
                        "Clozapina",
                        "Clozapina",
                        "clozapina",
                        "Clozapinum",
                        "clozapinum",
                        "Clozapinum",
                        "8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine",
                        "8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine",
                        "5H-Dibenzo(b,e)(1,4)diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)-"
                    ],
                    "UMLS:C3666182": [
                        "Clozapine",
                        "DRUG ASSAY CLOZAPINE",
                        "Drug assay clozapine",
                        "DRUG SCREEN QUANTITATIVE CLOZAPINE"
                    ],
                    "PUBCHEM.COMPOUND:135858214": [
                        "Clozapine-d8"
                    ],
                    "PUBCHEM.COMPOUND:136951475": [
                        "Clozapine-D4"
                    ],
                    "UMLS:C0796743": [
                        "cloZAPine Ql",
                        "cloZAPine SerPl Ql",
                        "cloZAPine:PrThr:Pt:Ser/Plas:Ord",
                        "cloZAPine [Presence] in Serum or Plasma",
                        "cloZAPine:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of severely ill patients with schizophrenia",
                "id": {}
            }
        ],
        [
            {
                "label": "severely ill patients with schizophrenia",
                "id": {}
            },
            {
                "label": "fail to respond adequately to",
                "id": {}
            },
            {
                "label": "standard antipsychotic treatment",
                "id": {}
            }
        ]
    ],
    "Clozapine is indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state": [
        [
            {
                "label": "Clozapine",
                "id": {
                    "PUBCHEM.COMPOUND:135398737": [
                        "clozapine",
                        "Clozapine",
                        "CloZAPine",
                        "CLOZAPINE",
                        "cloZAPine",
                        "clozapine",
                        "CLOZAPINE (SUN)",
                        "CLOZAPINE (MAYNE)",
                        "CLOZAPINE (SANDOZ)",
                        "Clozapine (substance)",
                        "clozapine (medication)",
                        "CLOZAPINE (GOLDEN STATE)",
                        "Clozapine-containing product",
                        "Product containing clozapine (medicinal product)",
                        "Leponex",
                        "Clozaril",
                        "Clozapin",
                        "Clozapin",
                        "Clozapin",
                        "Clozapina",
                        "Clozapina",
                        "clozapina",
                        "Clozapinum",
                        "clozapinum",
                        "Clozapinum",
                        "8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine",
                        "8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine",
                        "5H-Dibenzo(b,e)(1,4)diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)-"
                    ],
                    "UMLS:C3666182": [
                        "Clozapine",
                        "DRUG ASSAY CLOZAPINE",
                        "Drug assay clozapine",
                        "DRUG SCREEN QUANTITATIVE CLOZAPINE"
                    ],
                    "PUBCHEM.COMPOUND:135858214": [
                        "Clozapine-d8"
                    ],
                    "PUBCHEM.COMPOUND:136951475": [
                        "Clozapine-D4"
                    ],
                    "UMLS:C0796743": [
                        "cloZAPine Ql",
                        "cloZAPine SerPl Ql",
                        "cloZAPine:PrThr:Pt:Ser/Plas:Ord",
                        "cloZAPine [Presence] in Serum or Plasma",
                        "cloZAPine:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder",
                "id": {}
            }
        ],
        [
            {
                "label": "patients with schizophrenia or schizoaffective disorder",
                "id": {}
            },
            {
                "label": "are judged to be at",
                "id": {}
            },
            {
                "label": "chronic risk for re-experiencing suicidal behavior",
                "id": {}
            }
        ]
    ],
    "Amantadine hydrochloride capsules are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions.": [
        [
            {
                "label": "Amantadine hydrochloride capsules",
                "id": {
                    "UMLS:C4720215": [
                        "Amantadine Hydrochloride Capsules"
                    ]
                }
            },
            {
                "label": "are",
                "id": {
                    "NCIT:C13662": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1515984": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1551058": [
                        "Are",
                        "are unit of measure"
                    ],
                    "MONDO:0044742": [
                        "AREI",
                        "autosomal recessive epidermolytic ichthyosis"
                    ],
                    "MONDO:0017339": [
                        "AREI",
                        "Ichthyosis exfoliativa",
                        "ICHTHYOSIS EXFOLIATIVA",
                        "ichthyosis exfoliativa",
                        "Exfoliative ichthyosis",
                        "Ichthyosis Exfoliativa",
                        "exfoliative ichthyosis",
                        "ICHTHYOSIS BULLOSA OF SIEMENS-LIKE",
                        "autosomal recessive exfoliative ichthyosis",
                        "Autosomal recessive exfoliative ichthyosis",
                        "ICHTHYOSIS, EXFOLIATIVE, AUTOSOMAL RECESSIVE",
                        "ichthyosis congenital autosomal recessive exfoliative",
                        "Autosomal recessive exfoliative ichthyosis (disorder)",
                        "Autosomal recessive exfoliative ichthyosis (diagnosis)"
                    ]
                }
            },
            {
                "label": "also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions",
                "id": {}
            }
        ]
    ],
    "Amantadine hydrochloride capsules are indicated in the treatment of idiopathic Parkinson’s disease (Paralysis Agitans), postencephalitic parkinsonism and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication.": [
        [
            {
                "label": "Amantadine hydrochloride capsules",
                "id": {
                    "UMLS:C4720215": [
                        "Amantadine Hydrochloride Capsules"
                    ]
                }
            },
            {
                "label": "are indicated in",
                "id": {
                    "UMLS:C1548408": [
                        "The indicated time slot(s) is(are) blocked"
                    ],
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C0514907": [
                        "Provide input in areas of strength and development needs, as indicated"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4714006": [
                        "Activate the rapid response team if indicated by presence of trigger areas, per agency protocol"
                    ]
                }
            },
            {
                "label": "the treatment of idiopathic Parkinson’s disease (Paralysis Agitans)",
                "id": {}
            }
        ],
        [
            {
                "label": "Amantadine hydrochloride capsules",
                "id": {
                    "UMLS:C4720215": [
                        "Amantadine Hydrochloride Capsules"
                    ]
                }
            },
            {
                "label": "are indicated in",
                "id": {
                    "UMLS:C1548408": [
                        "The indicated time slot(s) is(are) blocked"
                    ],
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C0514907": [
                        "Provide input in areas of strength and development needs, as indicated"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4714006": [
                        "Activate the rapid response team if indicated by presence of trigger areas, per agency protocol"
                    ]
                }
            },
            {
                "label": "postencephalitic parkinsonism",
                "id": {
                    "MONDO:0001945": [
                        "postencephalitic Parkinsonism",
                        "postencephalitic parkinsonism",
                        "Postencephalitic parkinsonism",
                        "postencephalitic parkinsonism",
                        "Postencephalitic Parkinsonism",
                        "parkinsonism; postencephalitic",
                        "Parkinsonism, Postencephalitic",
                        "PARKINSONISM, POSTENCEPHALITIC",
                        "postencephalitic; parkinsonism",
                        "Postencephalitic parkinsonism (disorder)",
                        "Postencephalitic Economo Type Parkinsonism",
                        "Postencephalitic Economo-Type Parkinsonism",
                        "Parkinsonism, Postencephalitic Economo-Type",
                        "Economo-Type Parkinsonism, Postencephalitic",
                        "POSTENCEPH PARKINSONISM",
                        "PARKINSONISM POSTENCEPH",
                        "POSTENCEPH PARKINSON DIS",
                        "PARKINSON DIS POSTENCEPH",
                        "POST ENCEPH PARKINSON DIS",
                        "PARKINSON DIS POST ENCEPH",
                        "Parkinsonism post encephalitic",
                        "PARKINSONIAN SYNDROME POSTENCEP",
                        "postencephalitic Parkinson disease",
                        "postencephalitic Parkinson disease",
                        "Postencephalitic Parkinson Disease",
                        "Parkinson Disease, Postencephalitic",
                        "Post Encephalitic Parkinson Disease",
                        "ENCEPH LETHARGICA TYPE PARKINSONISM",
                        "Post-Encephalitic Parkinson Disease",
                        "postencephalitic Parkinson's disease",
                        "Parkinson Disease, Post Encephalitic",
                        "Parkinson Disease, Post-Encephalitic",
                        "Postencephalitic Parkinson's disease",
                        "POSTENCEPH ECONOMO TYPE PARKINSONISM",
                        "Postencephalitis Parkinsonian Syndrome",
                        "Parkinsonian Syndrome, Postencephalitis",
                        "Encephalitis Lethargica Type Parkinsonism",
                        "von Economo Encephalitis Type Parkinsonism",
                        "postencephalitic Parkinson's disease (diagnosis)"
                    ]
                }
            }
        ],
        [
            {
                "label": "Amantadine hydrochloride capsules",
                "id": {
                    "UMLS:C4720215": [
                        "Amantadine Hydrochloride Capsules"
                    ]
                }
            },
            {
                "label": "are indicated in",
                "id": {
                    "UMLS:C1548408": [
                        "The indicated time slot(s) is(are) blocked"
                    ],
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C0514907": [
                        "Provide input in areas of strength and development needs, as indicated"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4714006": [
                        "Activate the rapid response team if indicated by presence of trigger areas, per agency protocol"
                    ]
                }
            },
            {
                "label": "symptomatic parkinsonism",
                "id": {
                    "MONDO:0006966": [
                        "Symptomatic parkinsonism",
                        "Symptomatic Parkinsonism",
                        "Symptomatic parkinsonism",
                        "symptomatic parkinsonism",
                        "Parkinsonism, Symptomatic",
                        "Symptomatic parkinsonism (disorder)",
                        "PARKINSONISM SECOND",
                        "SECOND PARKINSONISM",
                        "PARKINSON DIS SECOND",
                        "Secondary parkinsonism",
                        "secondary parkinsonism",
                        "parkinsonism secondary",
                        "secondary parkinsonism",
                        "Secondary Parkinsonism",
                        "secondary Parkinsonism",
                        "secondary; parkinsonism",
                        "parkinsonism; secondary",
                        "Parkinsonism, secondary",
                        "Parkinsonism, Secondary",
                        "SYMPTOMATIC PARKINSON DIS",
                        "PARKINSON DIS SYMPTOMATIC",
                        "secondary Parkinson disease",
                        "Secondary Parkinson disease",
                        "Secondary Parkinson Disease",
                        "secondary Parkinson disease",
                        "Paralysis agitans, secondary",
                        "Parkinson Disease, Secondary",
                        "parkinson's disease secondary",
                        "Secondary Parkinson's disease",
                        "Symptomatic Parkinson Disease",
                        "Dis presnt prim with parkinson",
                        "Parkinson Disease, Symptomatic",
                        "Symptomatic Parkinson's disease",
                        "Secondary parkinsonism (disorder)",
                        "secondary Parkinsonism (diagnosis)",
                        "Secondary parkinsonism, unspecified",
                        "secondary parkinsonism, unspecified",
                        "secondary parkinsonism (disorder) [ambiguous]",
                        "disorder presenting primarily with parkinsonism",
                        "disorder presenting primarily with parkinsonism",
                        "Disorders presenting primarily with parkinsonism"
                    ],
                    "UMLS:C0242040": [
                        "PARKINSONISM, SECONDARY OR SYMPTOMATIC"
                    ]
                }
            }
        ],
        [
            {
                "label": "symptomatic parkinsonism",
                "id": {
                    "MONDO:0006966": [
                        "Symptomatic parkinsonism",
                        "Symptomatic Parkinsonism",
                        "Symptomatic parkinsonism",
                        "symptomatic parkinsonism",
                        "Parkinsonism, Symptomatic",
                        "Symptomatic parkinsonism (disorder)",
                        "PARKINSONISM SECOND",
                        "SECOND PARKINSONISM",
                        "PARKINSON DIS SECOND",
                        "Secondary parkinsonism",
                        "secondary parkinsonism",
                        "parkinsonism secondary",
                        "secondary parkinsonism",
                        "Secondary Parkinsonism",
                        "secondary Parkinsonism",
                        "secondary; parkinsonism",
                        "parkinsonism; secondary",
                        "Parkinsonism, secondary",
                        "Parkinsonism, Secondary",
                        "SYMPTOMATIC PARKINSON DIS",
                        "PARKINSON DIS SYMPTOMATIC",
                        "secondary Parkinson disease",
                        "Secondary Parkinson disease",
                        "Secondary Parkinson Disease",
                        "secondary Parkinson disease",
                        "Paralysis agitans, secondary",
                        "Parkinson Disease, Secondary",
                        "parkinson's disease secondary",
                        "Secondary Parkinson's disease",
                        "Symptomatic Parkinson Disease",
                        "Dis presnt prim with parkinson",
                        "Parkinson Disease, Symptomatic",
                        "Symptomatic Parkinson's disease",
                        "Secondary parkinsonism (disorder)",
                        "secondary Parkinsonism (diagnosis)",
                        "Secondary parkinsonism, unspecified",
                        "secondary parkinsonism, unspecified",
                        "secondary parkinsonism (disorder) [ambiguous]",
                        "disorder presenting primarily with parkinsonism",
                        "disorder presenting primarily with parkinsonism",
                        "Disorders presenting primarily with parkinsonism"
                    ],
                    "UMLS:C0242040": [
                        "PARKINSONISM, SECONDARY OR SYMPTOMATIC"
                    ]
                }
            },
            {
                "label": "may follow",
                "id": {
                    "UMLS:C4531950": [
                        "I am confident that I can follow through on medical treatments I may need to do at home"
                    ],
                    "UMLS:C4531949": [
                        "I am confident that I can follow through on medical treatments I may need to do at home [PAM]",
                        "I am confident that I can follow through on medical treatments I may need to do at home:Find:Pt:^Patient:Ord:PAM",
                        "I am confident that I can follow through on medical treatments I may need to do at home:Finding:To identify measures at a point in time:^Patient:Ordinal:PAM"
                    ],
                    "UMLS:C4714194": [
                        "Determine the patient's and family's perspectives, cultural backgrounds, and other factors that may affect the patient's willingness to follow prescribed diet"
                    ],
                    "UMLS:C5214567": [
                        "No antibodies to Francisella tularensis detected. Antibody response may be negative in samples collected too soon following infection/exposure. Repeat testing on a new sample if clinically indicated."
                    ]
                }
            },
            {
                "label": "injury to the nervous system by carbon monoxide intoxication",
                "id": {}
            }
        ]
    ],
    "It is indicated in those elderly patients believed to develop parkinsonism in association with cerebral arteriosclerosis.": [
        [
            {
                "label": "It",
                "id": {
                    "MGI:96598": [
                        "It"
                    ],
                    "PUBCHEM.COMPOUND:44298493": [
                        "IT",
                        "IT dipeptide",
                        "I-T",
                        "Ile-Thr",
                        "CHEMBL54609",
                        "I-T dipeptide",
                        "isoleucylthreonine",
                        "L-Isoleucyl-L-threonine",
                        "L-isoleucyl-L-threonine",
                        "isoleucine threonine dipeptide",
                        "(2S,3R)-2-{[(2S,3S)-2-amino-3-methylpentanoyl]amino}-3-hydroxybutanoic acid"
                    ],
                    "UMLS:C0677897": [
                        "IT",
                        "IT - Intrathecal route",
                        "intrathecal",
                        "Intrathecal",
                        "Intrathecal use",
                        "IntrathecalRoute",
                        "Intrathecal route",
                        "into the spinal space",
                        "Intrathecal route (qualifier value)",
                        "Intrathecal Route of Administration",
                        "Intrathecal Route of Drug Administration"
                    ],
                    "MONDO:0008558": [
                        "itp",
                        "ITP",
                        "ITP, NOS",
                        "ITP - Idiopat thrombocytop pur",
                        "ITP (immune thrombocytopenic purpura)",
                        "Idiopathic thrombocytopenic purpura (ITP)",
                        "ITP (idiopathic thrombocytopenic purpura)",
                        "idiopathic thrombocytopenic purpura (ITP)",
                        "ITP - Idiopathic thrombocytopenic purpura",
                        "AITP",
                        "AITP",
                        "Frank",
                        "Werlhof",
                        "WERLHOF DIS",
                        "WERLHOFS DIS",
                        "Werlhof Disease",
                        "WERLHOF DISEASE",
                        "Werlhofs Disease",
                        "Disease, Werlhof",
                        "werlhof's disease",
                        "Werlhof's Disease",
                        "Werlhof's disease",
                        "Werlhof's disease",
                        "werlhof's disease",
                        "Idiopathic purpura",
                        "Idiopathic purpura",
                        "Werlhof's syndrome",
                        "idiopathic purpura",
                        "idiopathic purpura",
                        "Disease, Werlhof's",
                        "purpura; idiopathic",
                        "idiopathic; purpura",
                        "Immune thrombocytopenia",
                        "Immune Thrombocytopenia",
                        "immune thrombocytopenia",
                        "Idiopathic purpura, NOS",
                        "Thrombocytopenia, Immune",
                        "Immune Thrombocytopenias",
                        "Immune thrombocyt purpra",
                        "Thrombocytopenias, Immune",
                        "Idiopathic Thrombocytopenia",
                        "Autoimmune Thrombocytopenia",
                        "idiopathic thrombocytopenia",
                        "Autoimmune Thrombocytopenias",
                        "Thrombocytopenia, Autoimmune",
                        "Thrombocytopenias, Autoimmune",
                        "Ideopath thrombocytopenic pur",
                        "ideopath thrombocytopenic pur",
                        "Idiopath thrombocytopen purpur",
                        "Autoimmune thrombocytopen purp",
                        "Immune thrombocytopenic purpur",
                        "Idiopath Thrombocytopenic Purp",
                        "immune purpura thrombocytopenic",
                        "thrombocytopenic purpura immune",
                        "Primary immune thrombocytopenia",
                        "Immune thrombocytopenic purpura",
                        "IMMUNE THROMBOCYTOPENIC PURPURA",
                        "immune thrombocytopenic purpura",
                        "Immune thrombocytopenic purpura",
                        "Primary Immune Thrombocytopenia",
                        "Immune Thrombocytopenic Purpura",
                        "immune thrombocytopenic purpura",
                        "primary thrombocytopenic purpura",
                        "primary thrombocytopenic purpura",
                        "Immune Thrombocytopenic Purpuras",
                        "Thrombocytopenic Purpura, Immune",
                        "Purpura, Immune Thrombocytopenic",
                        "Thrombocytopenic Purpuras, Immune",
                        "Purpuras, Immune Thrombocytopenic",
                        "IDIOPATHIC THROMBOCYTOPENIC PURPURA",
                        "idiopathic thrombocytopenic purpura",
                        "Idiopathic thrombocytopenia purpura",
                        "idiopathic thrombocytopenia purpura",
                        "Idiopathic Thrombocytopenic Purpura",
                        "autoimmune thrombocytopenic purpura",
                        "idiopathic thrombocytopenic purpura",
                        "thrombocytopenic purpura autoimmune",
                        "autoimmune thrombocytopenic purpura",
                        "Autoimmune thrombocytopenic purpura",
                        "Idiopathic Thrombocytopenia Purpura",
                        "Idiopathic thrombocytopenic purpura",
                        "Autoimmune Thrombocytopenic Purpura",
                        "THROMBOCYTOPENIC PURPURA, AUTOIMMUNE",
                        "Idiopathic Thrombocytopenic Purpuras",
                        "Autoimmune Thrombocytopenic Purpuras",
                        "Thrombocytopenic Purpura, Idiopathic",
                        "Purpura, Autoimmune Thrombocytopenic",
                        "thrombocytopenic purpura, autoimmune",
                        "Thrombocytopenic Purpura, Autoimmune",
                        "Purpura, Idiopathic Thrombocytopenic",
                        "thrombocytopenic; purpura, idiopathic",
                        "Purpuras, Autoimmune Thrombocytopenic",
                        "PURPURA, THROMBOCYTOPENIC, IDIOPATHIC",
                        "purpura; thrombocytopenic, idiopathic",
                        "Thrombocytopenic Purpuras, Idiopathic",
                        "Purpura, Thrombocytopenic, Idiopathic",
                        "Purpuras, Idiopathic Thrombocytopenic",
                        "Purpura, Thrombocytopenic, Autoimmune",
                        "Idiopathic thrombocytopenic purpura, NOS",
                        "immune thrombocytopenic purpura (diagnosis)",
                        "idiopathic thrombocytopenic purpura (diagnosis)"
                    ],
                    "MGI:3716200": [
                        "ita"
                    ]
                }
            },
            {
                "label": "is indicated in",
                "id": {
                    "UMLS:C1548409": [
                        "The indicated appointment is booked"
                    ],
                    "UMLS:C1548408": [
                        "The indicated time slot(s) is(are) blocked"
                    ],
                    "UMLS:C4489688": [
                        "No, and walking goal is clinically indicated"
                    ],
                    "UMLS:C4489223": [
                        "No, and walking goal is not clinically indicated"
                    ],
                    "UMLS:C1548417": [
                        "The indicated appointment has begun and is currently in progress"
                    ]
                }
            },
            {
                "label": "those elderly patients believed to develop parkinsonism in association with cerebral arteriosclerosis",
                "id": {}
            }
        ]
    ],
    "Selegiline capsules, USP are indicated as an adjunct in the management of Parkinsonian patients being treated with levodopa/carbidopa who exhibit deterioration in the quality of their response to this therapy.": [
        [
            {
                "label": "Selegiline capsules, USP",
                "id": {}
            },
            {
                "label": "are indicated as",
                "id": {
                    "UMLS:C0514907": [
                        "Provide input in areas of strength and development needs, as indicated"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4712573": [
                        "Assist physician with the provision of electroconvulsive therapy (ECT) treatments when they are indicated"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "an adjunct in the management of Parkinsonian patients",
                "id": {}
            }
        ],
        [
            {
                "label": "Parkinsonian patients",
                "id": {}
            },
            {
                "label": "being treated with",
                "id": {
                    "UMLS:C3840796": [
                        "Currently being treated and transferred in with treatment records from within system."
                    ]
                }
            },
            {
                "label": "levodopa/carbidopa",
                "id": {
                    "PUBCHEM.COMPOUND:441193": [
                        "Carbidopa-levodopa"
                    ],
                    "UMLS:C0353697": [
                        "levodopa carbidopa",
                        "carbidopa/levodopa",
                        "Carbidopa-Levodopa",
                        "Carbidopa Levodopa",
                        "Carbidopa/Levodopa",
                        "carbidopa levodopa",
                        "CARBIDOPA/LEVODOPA",
                        "carbidopa-levodopa",
                        "Carbidopa/ Levodopa",
                        "carbidopa + levodopa",
                        "carbidopa / levodopa",
                        "carbidopa - levodopa",
                        "levodopa with carbidopa",
                        "carbidopa + levodopa (medication)",
                        "carbidopa, levodopa drug combination",
                        "Carbidopa- and levodopa-containing product",
                        "Product containing carbidopa and levodopa (medicinal product)",
                        "co careldopa",
                        "Co-careldopa",
                        "co-careldopa"
                    ],
                    "UMLS:C1170124": [
                        "Carbidopa-Levodopa ER"
                    ],
                    "UMLS:C0939684": [
                        "Carbidopa-Levodopa CR"
                    ],
                    "PUBCHEM.COMPOUND:104778": [
                        "Carbidopa and levodopa",
                        "carbidopa, levodopa drug combination"
                    ]
                }
            }
        ],
        [
            {
                "label": "Parkinsonian patients",
                "id": {}
            },
            {
                "label": "exhibit",
                "id": {
                    "UMLS:C0015272": [
                        "Exhibit",
                        "exhibit",
                        "exhibits",
                        "exhibiting",
                        "Exhibits as Topic",
                        "Exhibits as Topics",
                        "Exhibitions as Topic",
                        "Topics, Exhibitions as"
                    ],
                    "UMLS:C0600649": [
                        "Exhibit",
                        "Exhibition",
                        "Exhibitions"
                    ],
                    "MONDO:0000983": [
                        "exhibitionism",
                        "Exhibitionist",
                        "Exhibitionism",
                        "exhibitionism",
                        "exhibitionist",
                        "Exhibitionisms",
                        "exhibitionists",
                        "Exhibitionism (disorder)",
                        "exhibitionism (diagnosis)",
                        "sexual; deviation, exhibitionism",
                        "deviation; sexual, exhibitionism",
                        "Flasher",
                        "flasher",
                        "flashers"
                    ],
                    "UMLS:C0681324": [
                        "fair, exhibit",
                        "exposition",
                        "expositions"
                    ],
                    "UMLS:C1821903": [
                        "Exhibits trust"
                    ]
                }
            },
            {
                "label": "deterioration in the quality of their response to this therapy",
                "id": {}
            }
        ]
    ],
    "Xyrem is indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy.": [
        [
            {
                "label": "Xyrem",
                "id": {
                    "UMLS:C1170735": [
                        "Xyrem",
                        "xyrem"
                    ],
                    "PUBCHEM.COMPOUND:10413": [
                        "Xyrem",
                        "Xyrem",
                        "ghb",
                        "GHB",
                        "GHB",
                        "GHB",
                        "Oxybate",
                        "OXYBATE",
                        "oxybate",
                        "4-Hydroxyacid",
                        "Oxy-N-butyrate",
                        "4-Hydroxybutyrate",
                        "4-Hydroxybutyrate",
                        "g-Hydroxybutyrate",
                        "4-hydroxybutyrate",
                        "g Hydroxybutyrate",
                        "Γ hydroxybutyrate",
                        "Γ-hydroxybutyrate",
                        "4-Hydroxybutanoate",
                        "4-Hydroxybutanoate",
                        "4-Hydroxy-butyrate",
                        "oxy-n-butyric acid",
                        "Oxy-N-butyric acid",
                        "4-Hydroxybutanoate",
                        "4-hydroxybutanoate",
                        "4-Hydroxyalkanoate",
                        "Hydroxybutyric acid",
                        "4-Hydroxy-butanoate",
                        "4-Hydroxycarboxylate",
                        "gamma Hydroxybutyrate",
                        "gamma-hydroxybutyrate",
                        "gamma-Hydroxybutyrate",
                        "Γ-hydroxybutyric acid",
                        "gamma-Hydroxybutyrate",
                        "g-Hydroxybutyric acid",
                        "3-Carboxypropoxy acid",
                        "gamma hydroxybutyrate",
                        "4-Hydroxybutyric acid",
                        "Γ hydroxybutyric acid",
                        "Gamma hydroxybutyrate",
                        "Gamma-hydroxybutyrate",
                        "4-hydroxybutyric acid",
                        "g Hydroxybutyric acid",
                        "gamma Hydroxybutyrate",
                        "3-carboxypropoxy acid",
                        "4-Hydroxyalkanoic acid",
                        "4-Hydroxybutanoic acid",
                        "4-hydroxy-butyric acid",
                        "4-hydroxybutanoic acid",
                        "gamma-Hydroxy butyrate",
                        "4-Hydroxy-butyric acid",
                        "4-Hydroxyalkanoic acid",
                        "4-Hydroxybutanoic acid",
                        "4-Hydroxybutanoic acid",
                        "4-Hydroxy-butanoic acid",
                        "4-Hydroxycarboxylic acid",
                        "4-Hydroxycarboxylic acid",
                        "4-Hydroxybutyrate sodium",
                        "Gamma Hydroxybutyric Acid",
                        "gamma-Hydroxybutyric acid",
                        "gamma-hydroxybutyric acid",
                        "Gamma Hydroxybutyric acid",
                        "gamma-Hydroxybutyric acid",
                        "&gamma;-hydroxybutyric acid",
                        "gamma-Hydroxybutyrate sodium",
                        "4-hydroxybutyrate (substance)",
                        "gamma-Hydroxy sodium butyrate",
                        "4-Hydroxybutyric acid monosodium salt"
                    ],
                    "UMLS:C3240387": [
                        "Xyrem Oral Product"
                    ],
                    "UMLS:C1169880": [
                        "Xyrem 0.5g/mL Solution",
                        "Xyrem, 500 mg/mL oral liquid",
                        "XYREM 0.5 GM in 1 mL Oral Solution",
                        "Xyrem 500 MG per 1 ML Oral Solution",
                        "Xyrem 0.5 GM per 1 ML Oral Solution",
                        "sodium oxybate 500 MG/ML Oral Solution [Xyrem]",
                        "Sodium Oxybate 500 MG/1 ML Oral Solution [XYREM]",
                        "SODIUM OXYBATE 0.5 g in 1 mL ORAL SOLUTION [Xyrem]"
                    ],
                    "UMLS:C3240386": [
                        "Xyrem Oral Liquid Product"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy",
                "id": {}
            }
        ]
    ],
    "OXYCODONE HCl EXTENDED-RELEASE TABLETS are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate in: adults and Opioid-tolerant pediatric patients 11 years of age and older who are already receiving and tolerate a minimum daily opioid dose of at least 20 mg oxycodone orally or its equivalent": [
        [
            {
                "label": "OXYCODONE HCl EXTENDED-RELEASE TABLETS",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment",
                "id": {}
            }
        ],
        [
            {
                "label": "OXYCODONE HCl EXTENDED-RELEASE TABLETS",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "which alternative treatment options are inadequate",
                "id": {}
            }
        ],
        [
            {
                "label": "OXYCODONE HCl EXTENDED-RELEASE TABLETS",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "adults",
                "id": {
                    "UBERON:0007023": [
                        "adults",
                        "Adult",
                        "adult",
                        "ADULT",
                        "Human, Adult",
                        "adult organism",
                        "Adult Human (21+)"
                    ],
                    "UMLS:C0001675": [
                        "adults",
                        "Adults",
                        "adult",
                        "Adult",
                        "21 year old",
                        "21 old year",
                        "Human, Adult",
                        "21+ years old",
                        "Adult (person)",
                        "Adult Human (21+)",
                        "adult human (21+)"
                    ],
                    "UMLS:C0220615": [
                        "adults aml",
                        "Adult AGL",
                        "adult AML",
                        "aml adult",
                        "Adult AML",
                        "adult ANLL",
                        "AML, adult",
                        "Adult ANLL",
                        "ANLL, adult",
                        "Acute Myeloid Leukemia (AML)",
                        "adult acute myeloid leukemia",
                        "Adult Acute Myeloid Leukemia",
                        "acute myeloid leukemia, adult",
                        "leukemia, adult acute myeloid",
                        "myeloid leukemia, adult acute",
                        "adult leukemia, acute myeloid",
                        "Adult Acute Myelocytic Leukemia",
                        "adult acute myelogenous leukemia",
                        "Adult Acute Myelogenous Leukemia",
                        "myelogenous leukemia, adult acute",
                        "Adult Acute Myeloblastic Leukemia",
                        "acute myelogenous leukemia, adult",
                        "Adult Acute Granulocytic Leukemia",
                        "leukemia, adult acute myelogenous",
                        "adult leukemia, acute myelogenous",
                        "adult acute nonlymphocytic leukemia",
                        "acute nonlymphocytic leukemia, adult",
                        "leukemia, adult acute nonlymphocytic",
                        "adult acute non-lymphocytic leukemia",
                        "nonlymphocytic leukemia, adult acute",
                        "adult leukemia, acute nonlymphocytic",
                        "Leukemia, acute myeloid (AML), adult",
                        "leukemia, adult acute non-lymphocytic",
                        "Adult Acute NonLymphoblastic Leukemia",
                        "adult acute nonlymphoblastic leukemia",
                        "acute non-lymphocytic leukemia, adult",
                        "non-lymphocytic leukemia, adult acute",
                        "adult leukemia, acute non-lymphocytic",
                        "adult leukemia, acute nonlymphoblastic",
                        "acute nonlymphoblastic leukemia, adult",
                        "adult acute non-lymphoblastic leukemia",
                        "leukemia, adult acute nonlymphoblastic",
                        "Adult Acute Non-Lymphoblastic Leukemia",
                        "nonlymphoblastic leukemia, adult acute",
                        "acute non-lymphoblastic leukemia, adult",
                        "leukemia, adult acute non-lymphoblastic",
                        "non-lymphoblastic leukemia, adult acute",
                        "adult leukemia, acute non-lymphoblastic"
                    ],
                    "UMLS:C0718275": [
                        "adults pain",
                        "adults pains",
                        "adult pain",
                        "pain adult",
                        "Adult Pain"
                    ],
                    "UMLS:C1171177": [
                        "adults care",
                        "adult care",
                        "Adult care",
                        "care adult",
                        "Adult health care",
                        "Adult care (regime/therapy)"
                    ]
                }
            }
        ],
        [
            {
                "label": "OXYCODONE HCl EXTENDED-RELEASE TABLETS",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "Opioid-tolerant pediatric patients 11 years of age and older",
                "id": {}
            }
        ],
        [
            {
                "label": "Opioid-tolerant pediatric patients 11 years of age and older",
                "id": {}
            },
            {
                "label": "are already receiving and tolerate",
                "id": {}
            },
            {
                "label": "a minimum daily opioid dose of at least 20 mg oxycodone orally or its equivalent",
                "id": {}
            }
        ]
    ],
    "EMGALITY is indicated for the treatment of episodic cluster headache in adults.": [
        [
            {
                "label": "EMGALITY",
                "id": {
                    "UMLS:C4731566": [
                        "Emgality",
                        "Emgality"
                    ],
                    "UMLS:C4762487": [
                        "Emgality Prefilled Pen"
                    ],
                    "UMLS:C4762488": [
                        "Emgality Prefilled Syringe"
                    ],
                    "UMLS:C4731569": [
                        "Emgality Injectable Product"
                    ],
                    "UMLS:C4724223": [
                        "Emgality 120mg/mL Prefilled Pen",
                        "Emgality 120 MG in 1 ML Auto-Injector",
                        "Emgality 120 MG per 1 ML Auto-Injector",
                        "Emgality Prefilled Pen, 120 mg/mL subcutaneous solution",
                        "1 ML galcanezumab-gnlm 120 MG/ML Auto-Injector [Emgality]",
                        "Galcanezumab-gnlm 120 MG/1 ML Subcutaneous Solution [EMGALITY]_#1",
                        "galcanezumab 120 mg in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [EMGALITY]"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of episodic cluster headache in adults",
                "id": {}
            }
        ]
    ],
    "EMGALITY is indicated for the preventive treatment of migraine in adults.": [
        [
            {
                "label": "EMGALITY",
                "id": {
                    "UMLS:C4731566": [
                        "Emgality",
                        "Emgality"
                    ],
                    "UMLS:C4762487": [
                        "Emgality Prefilled Pen"
                    ],
                    "UMLS:C4762488": [
                        "Emgality Prefilled Syringe"
                    ],
                    "UMLS:C4731569": [
                        "Emgality Injectable Product"
                    ],
                    "UMLS:C4724223": [
                        "Emgality 120mg/mL Prefilled Pen",
                        "Emgality 120 MG in 1 ML Auto-Injector",
                        "Emgality 120 MG per 1 ML Auto-Injector",
                        "Emgality Prefilled Pen, 120 mg/mL subcutaneous solution",
                        "1 ML galcanezumab-gnlm 120 MG/ML Auto-Injector [Emgality]",
                        "Galcanezumab-gnlm 120 MG/1 ML Subcutaneous Solution [EMGALITY]_#1",
                        "galcanezumab 120 mg in 1 mL SUBCUTANEOUS INJECTION, SOLUTION [EMGALITY]"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the preventive treatment of migraine in adults",
                "id": {}
            }
        ]
    ],
    "Clonidine hydrochloride injection is indicated in combination with opiates for the treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone.": [
        [
            {
                "label": "Clonidine hydrochloride injection",
                "id": {
                    "UMLS:C5222414": [
                        "Clonidine Hydrochloride Injection"
                    ],
                    "UMLS:C0520138": [
                        "Injection, clonidine hydrochloride, 1 mg",
                        "INJECTION, CLONIDINE HYDROCHLORIDE, 1 MG ADMINISTERED",
                        "Clonidine hydrochloride"
                    ],
                    "UMLS:C0872744": [
                        "10 ML clonidine hydrochloride 0.5 MG/ML Injection",
                        "10 ML cloNIDine hydrochloride 0.5 MG/ML Injection",
                        "Clonidine Hydrochloride 500mcg/1mL Solution for injection",
                        "CLONIDINE HYDROCHLORIDE 500 ug in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 0.5 mg in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 500 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "CLONIDINE HCL 500MCG/ML INJ",
                        "cloNIDine 500 mcg/mL injectable solution",
                        "cloNIDine HCl 5000 MCG in 10 ML Injection",
                        "cloNIDine HCl 5000 MCG per 10 ML Injection",
                        "clonidine HCl 5000 MCG per 10 ML Injection",
                        "clonidine HCl/PF@5,000 mcg/10 mL@EPIDURAL@VIAL (ML)",
                        "clonidine HCl/PF 5,000 mcg/10 mL EPIDURAL VIAL (ML)",
                        "Clonidine Hydrochloride 0.5 MG/1 ML Epidural Solution",
                        "CloNIDine Hydrochloride, 500 mcg/mL injectable solution"
                    ],
                    "UMLS:C0975738": [
                        "10 ML cloNIDine hydrochloride 0.1 MG/ML Injection",
                        "10 ML clonidine hydrochloride 0.1 MG/ML Injection",
                        "Clonidine Hydrochloride 100mcg/1mL Solution for injection",
                        "CLONIDINE HYDROCHLORIDE 100 ug in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 0.1 mg in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 100 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "CLONIDINE HCL 100MCG/ML INJ",
                        "cloNIDine 100 mcg/mL injectable solution",
                        "cloNIDine HCl 1000 MCG in 10 ML Injection",
                        "clonidine HCl 1000 MCG per 10 ML Injection",
                        "cloNIDine HCl 1000 MCG per 10 ML Injection",
                        "Clonidine Hydrochloride 0.1 MG/1 ML Epidural Solution",
                        "CloNIDine Hydrochloride, 100 mcg/mL injectable solution",
                        "clonidine HCl/PF@1,000 mcg/10 mL (100 mcg/mL)@EPIDURAL@VIAL (ML)",
                        "clonidine HCl/PF 1,000 mcg/10 mL (100 mcg/mL) EPIDURAL VIAL (ML)"
                    ],
                    "UMLS:C0787088": [
                        "Clonidine hydrochloride 150micrograms/1mL injection",
                        "Clonidine hydrochloride 150 microgram/mL solution for injection",
                        "Product containing precisely clonidine hydrochloride 150 microgram/1 milliliter conventional release solution for injection (clinical drug)",
                        "Clonidine HCl 150mcg/1mL inj",
                        "clonidine hydrochloride 0.015 % Injectable Solution",
                        "cloNIDine hydrochloride 0.015 % Injectable Solution",
                        "cloNIDine hydrochloride 0.15 MG/ML Injectable Solution",
                        "clonidine hydrochloride 0.15 MG/ML Injectable Solution"
                    ]
                }
            },
            {
                "label": "is indicated in combination with",
                "id": {}
            },
            {
                "label": "opiates",
                "id": {
                    "UMLS:C0376196": [
                        "Opiates",
                        "opiates",
                        "opiate",
                        "Opiate",
                        "Opium Derivatives",
                        "opium derivatives",
                        "Opioid receptor agonist-containing product",
                        "Product containing opioid receptor agonist (product)"
                    ],
                    "MESH:D053610": [
                        "Opiates",
                        "Alkaloid Opiates",
                        "Opiates, Alkaloid",
                        "Opiate",
                        "Opium alkaloid",
                        "opiate alkaloid",
                        "opium alkaloids",
                        "Opium Alkaloids",
                        "alkaloids opium",
                        "alkaloids opiate",
                        "Opiate Alkaloids",
                        "Alkaloids, Opiate",
                        "Opium alkaloid (substance)",
                        "Opium alkaloid-containing product",
                        "Product containing opium alkaloid (product)"
                    ],
                    "UMLS:C0242401": [
                        "opiates",
                        "Opiates",
                        "Opiates, NOS",
                        "drug screen opiates",
                        "drug screen opiates (lab test)",
                        "Opiate Assay",
                        "Opiate Measurement",
                        "Measurement of opiate"
                    ],
                    "UMLS:C0366105": [
                        "Opiates Ql",
                        "Opiates SerPl Ql",
                        "Opiates:PrThr:Pt:Ser/Plas:Ord",
                        "Opiates [Presence] in Serum or Plasma",
                        "Opiates:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ],
                    "UMLS:C0367914": [
                        "Opiates Ur",
                        "Opiates Nom (U)",
                        "Opiates:Prid:Pt:Urine:Nom",
                        "Opiates [Identifier] in Urine",
                        "Opiates:Presence or Identity:Point in time:Urine:Nominal",
                        "Opiates:Presence or Identity:To identify measures at a point in time:Urine:Nominal"
                    ]
                }
            }
        ],
        [
            {
                "label": "opiates",
                "id": {
                    "UMLS:C0376196": [
                        "Opiates",
                        "opiates",
                        "opiate",
                        "Opiate",
                        "Opium Derivatives",
                        "opium derivatives",
                        "Opioid receptor agonist-containing product",
                        "Product containing opioid receptor agonist (product)"
                    ],
                    "MESH:D053610": [
                        "Opiates",
                        "Alkaloid Opiates",
                        "Opiates, Alkaloid",
                        "Opiate",
                        "Opium alkaloid",
                        "opiate alkaloid",
                        "opium alkaloids",
                        "Opium Alkaloids",
                        "alkaloids opium",
                        "alkaloids opiate",
                        "Opiate Alkaloids",
                        "Alkaloids, Opiate",
                        "Opium alkaloid (substance)",
                        "Opium alkaloid-containing product",
                        "Product containing opium alkaloid (product)"
                    ],
                    "UMLS:C0242401": [
                        "opiates",
                        "Opiates",
                        "Opiates, NOS",
                        "drug screen opiates",
                        "drug screen opiates (lab test)",
                        "Opiate Assay",
                        "Opiate Measurement",
                        "Measurement of opiate"
                    ],
                    "UMLS:C0366105": [
                        "Opiates Ql",
                        "Opiates SerPl Ql",
                        "Opiates:PrThr:Pt:Ser/Plas:Ord",
                        "Opiates [Presence] in Serum or Plasma",
                        "Opiates:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ],
                    "UMLS:C0367914": [
                        "Opiates Ur",
                        "Opiates Nom (U)",
                        "Opiates:Prid:Pt:Urine:Nom",
                        "Opiates [Identifier] in Urine",
                        "Opiates:Presence or Identity:Point in time:Urine:Nominal",
                        "Opiates:Presence or Identity:To identify measures at a point in time:Urine:Nominal"
                    ]
                }
            },
            {
                "label": "for the treatment of",
                "id": {
                    "UMLS:C0018100": [
                        "Drugs for the treatment of gout",
                        "drug gout",
                        "gout drug",
                        "drugs gout",
                        "antigout agent",
                        "ANTIGOUT AGENTS",
                        "Antigout Agents",
                        "Agents, Antigout",
                        "Gout suppressants",
                        "gout suppressants",
                        "Gout Suppressants",
                        "suppressants gout",
                        "Suppressants, Gout",
                        "drugs gout treatment",
                        "ANTIGOUT PREPARATIONS",
                        "Drugs in the treatment of gout"
                    ],
                    "UMLS:C2030072": [
                        "heat therapy of forearm (treatment)",
                        "heat therapy of forearm"
                    ],
                    "UMLS:C0571129": [
                        "Drug for the treatment of gout allergy",
                        "Drug treatment of gout allergy"
                    ],
                    "UMLS:C2030119": [
                        "heat therapy of left forearm (treatment)",
                        "heat therapy of left forearm",
                        "heat applied to the left forearm"
                    ],
                    "UMLS:C2030020": [
                        "heat therapy of both forearms (treatment)",
                        "heat applied to both forearms",
                        "heat therapy of both forearms"
                    ]
                }
            },
            {
                "label": "severe pain in cancer patients",
                "id": {}
            }
        ],
        [
            {
                "label": "severe pain in cancer patients",
                "id": {}
            },
            {
                "label": "is not adequately relieved by",
                "id": {}
            },
            {
                "label": "opioid analgesics alone",
                "id": {}
            }
        ]
    ],
    "Epidural clonidine is more likely to be effective in patients with neuropathic pain than somatic or visceral pain.": [
        [
            {
                "label": "Epidural clonidine",
                "id": {
                    "UMLS:C0872744": [
                        "clonidine HCl/PF@5,000 mcg/10 mL@EPIDURAL@VIAL (ML)",
                        "clonidine HCl/PF 5,000 mcg/10 mL EPIDURAL VIAL (ML)",
                        "Clonidine Hydrochloride 0.5 MG/1 ML Epidural Solution",
                        "CLONIDINE HYDROCHLORIDE 500 ug in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 0.5 mg in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HCL 500MCG/ML INJ",
                        "cloNIDine 500 mcg/mL injectable solution",
                        "cloNIDine HCl 5000 MCG in 10 ML Injection",
                        "cloNIDine HCl 5000 MCG per 10 ML Injection",
                        "clonidine HCl 5000 MCG per 10 ML Injection",
                        "10 ML clonidine hydrochloride 0.5 MG/ML Injection",
                        "10 ML cloNIDine hydrochloride 0.5 MG/ML Injection",
                        "CloNIDine Hydrochloride, 500 mcg/mL injectable solution",
                        "Clonidine Hydrochloride 500mcg/1mL Solution for injection",
                        "CLONIDINE HYDROCHLORIDE 500 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION"
                    ],
                    "UMLS:C0975738": [
                        "Clonidine Hydrochloride 0.1 MG/1 ML Epidural Solution",
                        "clonidine HCl/PF@1,000 mcg/10 mL (100 mcg/mL)@EPIDURAL@VIAL (ML)",
                        "clonidine HCl/PF 1,000 mcg/10 mL (100 mcg/mL) EPIDURAL VIAL (ML)",
                        "CLONIDINE HYDROCHLORIDE 100 ug in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 0.1 mg in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HCL 100MCG/ML INJ",
                        "cloNIDine 100 mcg/mL injectable solution",
                        "cloNIDine HCl 1000 MCG in 10 ML Injection",
                        "clonidine HCl 1000 MCG per 10 ML Injection",
                        "cloNIDine HCl 1000 MCG per 10 ML Injection",
                        "10 ML cloNIDine hydrochloride 0.1 MG/ML Injection",
                        "10 ML clonidine hydrochloride 0.1 MG/ML Injection",
                        "CloNIDine Hydrochloride, 100 mcg/mL injectable solution",
                        "Clonidine Hydrochloride 100mcg/1mL Solution for injection",
                        "CLONIDINE HYDROCHLORIDE 100 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION"
                    ],
                    "UMLS:C0875858": [
                        "Clonidine Hydrochloride 0.5 MG/1 ML Epidural Solution [DURACLON]",
                        "10 ML Duraclon 0.5 MG/ML Injection",
                        "Duraclon 5000 MCG in 10 ML Injection",
                        "Duraclon 5000 MCG per 10 ML Injection",
                        "Duraclon 5000mcg/10mL Solution for Injection",
                        "10 ML cloNIDine hydrochloride 0.5 MG/ML Injection [Duraclon]",
                        "10 ML clonidine hydrochloride 0.5 MG/ML Injection [Duraclon]"
                    ],
                    "UMLS:C0714612": [
                        "Clonidine Hydrochloride 0.1 MG/1 ML Epidural Solution [DURACLON]",
                        "CLONIDINE HYDROCHLORIDE 0.1 mg in 1 mL EPIDURAL INJECTION, SOLUTION [Duraclon]",
                        "10 ML Duraclon 0.1 MG/ML Injection",
                        "Duraclon 1000 MCG in 10 ML Injection",
                        "Duraclon 1000 MCG per 10 ML Injection",
                        "Duraclon, 100 mcg/mL injectable solution",
                        "Duraclon 1000mcg/10mL Solution for Injection",
                        "10 ML clonidine hydrochloride 0.1 MG/ML Injection [Duraclon]",
                        "10 ML cloNIDine hydrochloride 0.1 MG/ML Injection [Duraclon]"
                    ]
                }
            },
            {
                "label": "is more likely to be effective in",
                "id": {}
            },
            {
                "label": "patients with neuropathic pain",
                "id": {}
            }
        ],
        [
            {
                "label": "Epidural clonidine",
                "id": {
                    "UMLS:C0872744": [
                        "clonidine HCl/PF@5,000 mcg/10 mL@EPIDURAL@VIAL (ML)",
                        "clonidine HCl/PF 5,000 mcg/10 mL EPIDURAL VIAL (ML)",
                        "Clonidine Hydrochloride 0.5 MG/1 ML Epidural Solution",
                        "CLONIDINE HYDROCHLORIDE 500 ug in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 0.5 mg in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HCL 500MCG/ML INJ",
                        "cloNIDine 500 mcg/mL injectable solution",
                        "cloNIDine HCl 5000 MCG in 10 ML Injection",
                        "cloNIDine HCl 5000 MCG per 10 ML Injection",
                        "clonidine HCl 5000 MCG per 10 ML Injection",
                        "10 ML clonidine hydrochloride 0.5 MG/ML Injection",
                        "10 ML cloNIDine hydrochloride 0.5 MG/ML Injection",
                        "CloNIDine Hydrochloride, 500 mcg/mL injectable solution",
                        "Clonidine Hydrochloride 500mcg/1mL Solution for injection",
                        "CLONIDINE HYDROCHLORIDE 500 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION"
                    ],
                    "UMLS:C0975738": [
                        "Clonidine Hydrochloride 0.1 MG/1 ML Epidural Solution",
                        "clonidine HCl/PF@1,000 mcg/10 mL (100 mcg/mL)@EPIDURAL@VIAL (ML)",
                        "clonidine HCl/PF 1,000 mcg/10 mL (100 mcg/mL) EPIDURAL VIAL (ML)",
                        "CLONIDINE HYDROCHLORIDE 100 ug in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 0.1 mg in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HCL 100MCG/ML INJ",
                        "cloNIDine 100 mcg/mL injectable solution",
                        "cloNIDine HCl 1000 MCG in 10 ML Injection",
                        "clonidine HCl 1000 MCG per 10 ML Injection",
                        "cloNIDine HCl 1000 MCG per 10 ML Injection",
                        "10 ML cloNIDine hydrochloride 0.1 MG/ML Injection",
                        "10 ML clonidine hydrochloride 0.1 MG/ML Injection",
                        "CloNIDine Hydrochloride, 100 mcg/mL injectable solution",
                        "Clonidine Hydrochloride 100mcg/1mL Solution for injection",
                        "CLONIDINE HYDROCHLORIDE 100 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION"
                    ],
                    "UMLS:C0875858": [
                        "Clonidine Hydrochloride 0.5 MG/1 ML Epidural Solution [DURACLON]",
                        "10 ML Duraclon 0.5 MG/ML Injection",
                        "Duraclon 5000 MCG in 10 ML Injection",
                        "Duraclon 5000 MCG per 10 ML Injection",
                        "Duraclon 5000mcg/10mL Solution for Injection",
                        "10 ML cloNIDine hydrochloride 0.5 MG/ML Injection [Duraclon]",
                        "10 ML clonidine hydrochloride 0.5 MG/ML Injection [Duraclon]"
                    ],
                    "UMLS:C0714612": [
                        "Clonidine Hydrochloride 0.1 MG/1 ML Epidural Solution [DURACLON]",
                        "CLONIDINE HYDROCHLORIDE 0.1 mg in 1 mL EPIDURAL INJECTION, SOLUTION [Duraclon]",
                        "10 ML Duraclon 0.1 MG/ML Injection",
                        "Duraclon 1000 MCG in 10 ML Injection",
                        "Duraclon 1000 MCG per 10 ML Injection",
                        "Duraclon, 100 mcg/mL injectable solution",
                        "Duraclon 1000mcg/10mL Solution for Injection",
                        "10 ML clonidine hydrochloride 0.1 MG/ML Injection [Duraclon]",
                        "10 ML cloNIDine hydrochloride 0.1 MG/ML Injection [Duraclon]"
                    ]
                }
            },
            {
                "label": "is more likely to be effective",
                "id": {}
            },
            {
                "label": "than somatic or visceral pain",
                "id": {}
            }
        ]
    ],
    "AIMOVIG is indicated for the preventive treatment of migraine in adults.": [
        [
            {
                "label": "AIMOVIG",
                "id": {
                    "UMLS:C4692294": [
                        "Aimovig",
                        "Aimovig"
                    ],
                    "UMLS:C4692297": [
                        "Aimovig Injectable Product"
                    ],
                    "UMLS:C4731353": [
                        "Aimovig SureClick Autoinjector"
                    ],
                    "UMLS:C4692295": [
                        "erenumab-aooe 70 MG/ML [Aimovig]"
                    ],
                    "UMLS:C4692302": [
                        "erenumab Auto-Injector [Aimovig]"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the preventive treatment of migraine in adults",
                "id": {}
            }
        ]
    ],
    "Gabapentin capsules, USP are indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy.": [
        [
            {
                "label": "Gabapentin capsules, USP",
                "id": {}
            },
            {
                "label": "are indicated as",
                "id": {
                    "UMLS:C0514907": [
                        "Provide input in areas of strength and development needs, as indicated"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4712573": [
                        "Assist physician with the provision of electroconvulsive therapy (ECT) treatments when they are indicated"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "adjunctive therapy in treatment of partial seizures with and without secondary generalization",
                "id": {}
            }
        ],
        [
            {
                "label": "Gabapentin capsules, USP",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "patients over 12 years of age with epilepsy",
                "id": {}
            }
        ]
    ],
    "Gabapentin capsules, USP are also indicated as adjunctive therapy in the treatment of partial seizures in pediatric patients age 3 to 12 years.": [
        [
            {
                "label": "Gabapentin capsules, USP",
                "id": {}
            },
            {
                "label": "are also indicated as",
                "id": {}
            },
            {
                "label": "adjunctive therapy in the treatment of partial seizures",
                "id": {}
            }
        ],
        [
            {
                "label": "Gabapentin capsules, USP",
                "id": {}
            },
            {
                "label": "are also indicated for",
                "id": {}
            },
            {
                "label": "pediatric patients age 3 to 12 years",
                "id": {}
            }
        ]
    ],
    "Tolcapone tablets, USP is indicated as an adjunct to levodopa and carbidopa for the treatment of the signs and symptoms of idiopathic Parkinson's disease": [
        [
            {
                "label": "Tolcapone tablets, USP",
                "id": {}
            },
            {
                "label": "is indicated as",
                "id": {
                    "UMLS:C4710292": [
                        "Assure that someone is oxygenating the patient and assisting with intubation, as indicated"
                    ],
                    "UMLS:C4713987": [
                        "Assure that the surgical site is marked with a permanent marker by the surgeon, as indicated"
                    ],
                    "UMLS:C4714380": [
                        "Perform targeted assessment of the system that is indicated by the history of present illness"
                    ],
                    "UMLS:C4711109": [
                        "Ensure that equipment is operational via trial run (i.e., assemble laryngoscope and check light bulb function), as indicated"
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ]
                }
            },
            {
                "label": "an adjunct to levodopa and carbidopa for the treatment of the signs and symptoms of idiopathic Parkinson's disease",
                "id": {}
            }
        ]
    ],
    "Because of the risk of potentially fatal, acute fulminant liver failure, tolcapone tablets, USP should ordinarily be used in patients with Parkinson's disease on l-dopa/carbidopa who are experiencing symptom fluctuations and are not responding satisfactorily to or are not appropriate candidates for other adjunctive therapies.": [
        [
            {
                "label": "tolcapone tablets, USP",
                "id": {}
            },
            {
                "label": "should ordinarily be used in",
                "id": {}
            },
            {
                "label": "patients with Parkinson's disease on l-dopa/carbidopa",
                "id": {}
            }
        ],
        [
            {
                "label": "patients with Parkinson's disease on l-dopa/carbidopa",
                "id": {}
            },
            {
                "label": "are experiencing",
                "id": {
                    "UMLS:C0514359": [
                        "Point out, if asked, that you are not experiencing the same stimuli"
                    ]
                }
            },
            {
                "label": "symptom fluctuations",
                "id": {
                    "UMLS:C1838633": [
                        "Diurnal fluctuations of symptoms"
                    ]
                }
            }
        ],
        [
            {
                "label": "patients with Parkinson's disease on l-dopa/carbidopa",
                "id": {}
            },
            {
                "label": "are not responding satisfactorily to",
                "id": {}
            },
            {
                "label": "other adjunctive therapies",
                "id": {}
            }
        ],
        [
            {
                "label": "patients with Parkinson's disease on l-dopa/carbidopa",
                "id": {}
            },
            {
                "label": "are not appropriate candidates for",
                "id": {}
            },
            {
                "label": "other adjunctive therapies",
                "id": {}
            }
        ]
    ],
    "Almotriptan tablets (almotriptan malate) are indicated for the acute treatment of migraine attacks in patients with a history of migraine with or without aura": [
        [
            {
                "label": "Almotriptan tablets (almotriptan malate)",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the acute treatment of migraine attacks",
                "id": {}
            }
        ],
        [
            {
                "label": "Almotriptan tablets (almotriptan malate)",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "patients with a history of migraine with or without aura",
                "id": {}
            }
        ]
    ],
    "Almotriptan tablets are indicated for the acute treatment of migraine headache pain in patients with a history of migraine attacks with or without aura usually lasting 4 hours or more (when untreated).": [
        [
            {
                "label": "Almotriptan tablets",
                "id": {
                    "UMLS:C1248746": [
                        "Almotriptan Tablets",
                        "almotriptan Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the acute treatment of migraine headache pain",
                "id": {}
            }
        ],
        [
            {
                "label": "patients",
                "id": {
                    "UMLS:C0030705": [
                        "Patients",
                        "patients",
                        "PT",
                        "patient",
                        "Patient",
                        "PATIENT",
                        "^Patient",
                        "*^patient",
                        "Patient (person)"
                    ],
                    "UMLS:C0029921": [
                        "out-patients",
                        "Out-patients",
                        "Out patients",
                        "outpatient",
                        "Outpatient",
                        "Outpatients",
                        "out-patient",
                        "outpatients",
                        "Out-patient",
                        "Outpatient (person)"
                    ],
                    "UMLS:C0150831": [
                        "patients sex",
                        "patient sex",
                        "Patient sex",
                        "Patient's Sex",
                        "Patient sex (observable entity)"
                    ],
                    "UMLS:C0030690": [
                        "fall patients",
                        "falls patients",
                        "patient fall",
                        "PATIENT FALL",
                        "falls patient"
                    ],
                    "UMLS:C0150904": [
                        "male patients",
                        "male patient",
                        "patient is male",
                        "Patient is male"
                    ]
                }
            },
            {
                "label": "with",
                "id": {
                    "FB:FBgn0004015": [
                        "with"
                    ],
                    "UMLS:C0332287": [
                        "With",
                        "With (attribute)",
                        "c",
                        "W",
                        "PL",
                        "Cum",
                        "Plus",
                        "Addition",
                        "In addition to"
                    ],
                    "UMLS:C1705690": [
                        "With",
                        "With - dosing instruction fragment",
                        "With - dosing instruction fragment (qualifier value)"
                    ],
                    "UMLS:C0332285": [
                        "Within",
                        "Of",
                        "In",
                        "in",
                        "Inside",
                        "Found in",
                        "Located in",
                        "Has setting",
                        "Has location",
                        "Arising from",
                        "In (attribute)"
                    ],
                    "UBERON:0017749": [
                        "withers"
                    ]
                }
            },
            {
                "label": "a history of migraine attacks with or without aura usually lasting 4 hours or more",
                "id": {}
            }
        ]
    ],
    "PRIALT (ziconotide) solution, intrathecal infusion is indicated for the management of severe chronic pain in adult patients for whom intrathecal therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies, or intrathecal morphine": [
        [
            {
                "label": "PRIALT (ziconotide) solution",
                "id": {
                    "UMLS:C1620461": [
                        "Ziconotide 25 MCG/1 ML Intrathecal Solution [PRIALT]",
                        "ziconotide acetate 25 ug in 1 mL INTRATHECAL INJECTION, SOLUTION [PRIALT]",
                        "prialt 500 MCG in 20 ML Injection",
                        "Prialt 500 MCG per 20 ML Injection",
                        "Prialt, 25 mcg/mL intrathecal solution",
                        "Prialt 500mcg/20mL Solution for Intrathecal Injection",
                        "20 ML ziconotide acetate 0.025 MG/ML Injection [Prialt]"
                    ],
                    "UMLS:C4048773": [
                        "Ziconotide 100 MCG/1 ML Intrathecal Solution [PRIALT]",
                        "Prialt, 100 mcg/mL intrathecal solution"
                    ],
                    "UMLS:C1612470": [
                        "Ziconotide 100 MCG/1 ML Intrathecal Solution [PRIALT]_#2",
                        "ziconotide acetate 100 ug in 1 mL INTRATHECAL INJECTION, SOLUTION [PRIALT]",
                        "ziconotide acetate 100 ug in 1 mL INTRATHECAL INJECTION, SOLUTION [Prialt]",
                        "prialt 500 MCG in 5 ML Injection",
                        "Prialt 500 MCG per 5 ML Injection",
                        "Prialt, 100 mcg/mL intrathecal solution_#2",
                        "Prialt 500mcg/5mL Solution for Intrathecal Injection",
                        "5 ML ziconotide acetate 0.1 MG/ML Injection [Prialt]"
                    ],
                    "UMLS:C4048772": [
                        "Ziconotide 100 MCG/1 ML Intrathecal Solution [PRIALT]_#1",
                        "ziconotide acetate 100 ug in 1 mL INTRATHECAL INJECTION, SOLUTION [PRIALT]",
                        "ziconotide acetate 100 ug in 1 mL INTRATHECAL INJECTION, SOLUTION [Prialt]",
                        "prialt 100 MCG in 1 ML Injection",
                        "Prialt 100 MCG per 1 ML Injection",
                        "Prialt, 100 mcg/mL intrathecal solution_#1",
                        "Prialt 100mcg/mL Solution for Intrathecal Injection",
                        "1 ML ziconotide acetate 0.1 MG/ML Injection [Prialt]"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the management of severe chronic pain in adult patients",
                "id": {}
            }
        ],
        [
            {
                "label": "intrathecal therapy",
                "id": {}
            },
            {
                "label": "is warranted for",
                "id": {}
            },
            {
                "label": "adult patients who are intolerant of or refractory to other treatments",
                "id": {}
            }
        ],
        [
            {
                "label": "Adult patients",
                "id": {
                    "UMLS:C1855413": [
                        "Nystagmus in adult patients"
                    ],
                    "UMLS:C1855412": [
                        "Impaired smooth pursuit in adult patients"
                    ],
                    "UMLS:C1855411": [
                        "Retinal degeneration in adult patients, progressive"
                    ],
                    "UMLS:C4746352": [
                        "Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5",
                        "Adit mdd dys rem 12 mnths"
                    ],
                    "UMLS:C5229138": [
                        "Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq- 9 or phq-9m score was not assessed or is greater than or equal to 5",
                        "Remis12m not phq-9 score <5"
                    ]
                }
            },
            {
                "label": "are intolerant of or refractory to",
                "id": {}
            },
            {
                "label": "systemic analgesics",
                "id": {
                    "UMLS:C0513438": [
                        "Monitor for therapeutic effects of topical anesthetics, oral protective pastes, and topical or systemic analgesics, as appropriate"
                    ]
                }
            }
        ],
        [
            {
                "label": "Adult patients",
                "id": {
                    "UMLS:C1855413": [
                        "Nystagmus in adult patients"
                    ],
                    "UMLS:C1855412": [
                        "Impaired smooth pursuit in adult patients"
                    ],
                    "UMLS:C1855411": [
                        "Retinal degeneration in adult patients, progressive"
                    ],
                    "UMLS:C4746352": [
                        "Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5",
                        "Adit mdd dys rem 12 mnths"
                    ],
                    "UMLS:C5229138": [
                        "Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq- 9 or phq-9m score was not assessed or is greater than or equal to 5",
                        "Remis12m not phq-9 score <5"
                    ]
                }
            },
            {
                "label": "are intolerant of or refractory to",
                "id": {}
            },
            {
                "label": "adjunctive therapies",
                "id": {}
            }
        ],
        [
            {
                "label": "Adult patients",
                "id": {
                    "UMLS:C1855413": [
                        "Nystagmus in adult patients"
                    ],
                    "UMLS:C1855412": [
                        "Impaired smooth pursuit in adult patients"
                    ],
                    "UMLS:C1855411": [
                        "Retinal degeneration in adult patients, progressive"
                    ],
                    "UMLS:C4746352": [
                        "Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5",
                        "Adit mdd dys rem 12 mnths"
                    ],
                    "UMLS:C5229138": [
                        "Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq- 9 or phq-9m score was not assessed or is greater than or equal to 5",
                        "Remis12m not phq-9 score <5"
                    ]
                }
            },
            {
                "label": "are intolerant of or refractory to",
                "id": {}
            },
            {
                "label": "intrathecal morphine",
                "id": {
                    "UMLS:C4047685": [
                        "Removal of intrathecal morphine pump",
                        "Removal of intrathecal morphine pump (procedure)"
                    ],
                    "UMLS:C0978736": [
                        "MORPHINE SULFATE 1 mg in 1 mL INTRATHECAL INJECTION, SOLUTION",
                        "10 ML MS 1 MG/ML Injection",
                        "MORPHINE SO4 1MG/ML (PF) INJ_#2",
                        "MORPHINE SO4 1MG/ML PF INJ AMP 10ML",
                        "MORPHINE SO4 1MG/ML (PF) INJ,AMP,10ML",
                        "MORPHINE SO4 1MG/ML INJ MIN-I-JET 10ML",
                        "10 ML morphine sulfate 1 MG/ML Injection",
                        "10 ML Morphine Sulfate 1 MG/ML Injection",
                        "morphine sulfate 10 MG in 10 ML Injection",
                        "morphine sulfate 10 MG per 10 ML Injection",
                        "morphine sulfate/PF 1 mg/mL INJECTION VIAL (ML)",
                        "morphine sulfate/PF@1 mg/mL@INJECTION@VIAL (ML)",
                        "Morphine Sulfate 1 MG/1 ML Injection Solution_#1",
                        "Morphine Sulfate 1mg/1mL Solution for injection_#1",
                        "MORPHINE SO4 1MG/ML INJ,MIN-I-JET 18G,STK-GUARD,10ML",
                        "MORPHINE SULFATE 1 mg in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "MORPHINE SULFATE 1 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "Morphine Sulfate, 1 mg/mL preservative-free injectable solution"
                    ],
                    "UMLS:C4048929": [
                        "Morphine Sulfate 2 mg in 1 mL INTRATHECAL INJECTION, SOLUTION",
                        "Morphine sulph 100mg/50mL syng",
                        "Morphine sulfate 100mg/50mL prefilled syringe",
                        "Morphine sulphate 100mg/50mL prefilled syringe",
                        "Morphine Sulfate, 2 mg/mL-D5% intravenous solution",
                        "Morphine Sulfate 2 mg in 1 mL INTRAMUSCULAR INJECTION",
                        "Morphine Sulfate, 2 mg/mL-NaCl 0.9% intravenous solution",
                        "Morphine Sulfate 2 mg in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "morphine sulfate/0.9% NaCl/PF 2 mg/mL INTRAVEN SYRINGE (ML)",
                        "Dextrose/Morphine Sulfate 5%-2 MG/1 ML Intravenous Solution",
                        "Morphine Sulfate 2 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "Morphine Sulfate 2 mg in 1 mL INTRAMUSCULAR INJECTION, SOLUTION",
                        "Morphine Sulfate/Sodium Chloride 2 MG/1 ML-0.9% Injection Solution",
                        "morphine sulfate in 0.9 % NaCl 2 mg/mL (1 mL) INTRAVEN SYRINGE (ML)",
                        "Morphine Sulfate/Sodium Chloride 2 MG/1 ML-0.9% Intravenous Solution",
                        "morphine sulfate in 0.9 % sodium chloride/PF 2 mg/mL INTRAVEN SYRINGE (ML)",
                        "morphine sulfate in 0.9 % sodium chloride/PF@2 mg/mL@INTRAVEN@SYRINGE (ML)",
                        "morphine sulfate in 0.9 % sodium chloride@2 mg/mL (1 mL)@INTRAVEN@SYRINGE (ML)",
                        "morphine sulfate in 0.9 % sodium chloride 2 mg/mL (1 mL) INTRAVEN SYRINGE (ML)",
                        "morphine sulfate/0.9% NaCl/PF 50 mg/25 mL (2 mg/mL) INTRAVEN PATIENT CONTROLLED ANALGESIA SYRINGE",
                        "morphine sulfate in 0.9 % NaCl 60 mg/30 mL (2 mg/mL) INTRAVEN PATIENT CONTROLLED ANALGESIA SYRINGE",
                        "morphine sulfate in 0.9 % sodium chloride 60 mg/30 mL (2 mg/mL) INTRAVEN PATIENT CONTROLLED ANALGESIA SYRINGE",
                        "morphine sulfate in 0.9 % sodium chloride@60 mg/30 mL (2 mg/mL)@INTRAVEN@PATIENT CONTROLLED ANALGESIA SYRINGE",
                        "morphine sulfate in 0.9 % sodium chloride/PF@50 mg/25 mL (2 mg/mL)@INTRAVEN@PATIENT CONTROLLED ANALGESIA SYRINGE",
                        "morphine sulfate in 0.9 % sodium chloride/PF 50 mg/25 mL (2 mg/mL) INTRAVEN PATIENT CONTROLLED ANALGESIA SYRINGE"
                    ],
                    "UMLS:C0709059": [
                        "MORPHINE SULFATE 1 mg in 1 mL INTRATHECAL INJECTION [Duramorph]",
                        "Duramorph 10 MG in 10 ML Injection",
                        "Duramorph 10 MG per 10 ML Injection",
                        "10 ML MS 1 MG/ML Injection [Duramorph]",
                        "Duramorph PF 10mg/10ml Solution for Injection",
                        "10 ML Morphine Sulfate 1 MG/ML Injection [Duramorph]",
                        "10 ML morphine sulfate 1 MG/ML Injection [Duramorph]",
                        "Morphine Sulfate 1 MG/1 ML Injection Solution [DURAMORPH]",
                        "Duramorph PF, 1 mg/mL preservative-free injectable solution",
                        "MORPHINE SULFATE 1 mg in 1 mL EPIDURAL INJECTION [Duramorph]",
                        "MORPHINE SULFATE 1 mg in 1 mL INTRAVENOUS INJECTION [Duramorph]"
                    ],
                    "UMLS:C3498081": [
                        "MORPHINE SULFATE 0.5 mg in 1 mL INTRATHECAL INJECTION, SOLUTION",
                        "10 ML Morphine Sulfate 0.5 MG/ML Prefilled Syringe",
                        "Morphine Sulfate, 0.5 mg/mL-NaCl 0.9% intravenous solution",
                        "morphine sulfate/0.9% NaCl/PF 0.5 mg/mL INTRAVEN SYRINGE (ML)",
                        "MORPHINE SULFATE 0.5 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "Morphine Sulfate/Sodium Chloride 0.5 MG/1 ML-0.9% Injection Solution",
                        "morphine sulfate in 0.9 % sodium chloride/PF 0.5 mg/mL INTRAVEN SYRINGE (ML)",
                        "morphine sulfate in 0.9 % sodium chloride/PF@0.5 mg/mL@INTRAVEN@SYRINGE (ML)"
                    ]
                }
            }
        ]
    ],
    "Bromocriptine mesylate tablets are indicated in the treatment of the signs and symptoms of idiopathic or postencephalitic Parkinson's disease.": [
        [
            {
                "label": "Bromocriptine mesylate tablets",
                "id": {
                    "UMLS:C4720022": [
                        "Bromocriptine Mesylate Tablets"
                    ]
                }
            },
            {
                "label": "are indicated in",
                "id": {
                    "UMLS:C1548408": [
                        "The indicated time slot(s) is(are) blocked"
                    ],
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C0514907": [
                        "Provide input in areas of strength and development needs, as indicated"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4714006": [
                        "Activate the rapid response team if indicated by presence of trigger areas, per agency protocol"
                    ]
                }
            },
            {
                "label": "the treatment of the signs and symptoms of idiopathic or postencephalitic Parkinson's disease",
                "id": {}
            }
        ]
    ],
    "As adjunctive treatment to levodopa (alone or with a peripheral decarboxylase inhibitor), bromocriptine mesylate therapy may provide additional therapeutic benefits in those patients who are currently maintained on optimal dosages of levodopa, those who are beginning to deteriorate (develop tolerance) to levodopa therapy, and those who are experiencing \"end of dose failure\" on levodopa therapy.": [
        [
            {
                "label": "As adjunctive treatment to levodopa (alone or with a peripheral decarboxylase inhibitor), bromocriptine mesylate therapy",
                "id": {}
            },
            {
                "label": "may provide",
                "id": {
                    "UMLS:C4713411": [
                        "Provide undisturbed time because patient may fall asleep"
                    ],
                    "UMLS:C4711171": [
                        "Provide head phones for private listening when music may disturb others"
                    ],
                    "UMLS:C0514768": [
                        "Provide factual information about sexual myths and misinformation that patient may verbalize"
                    ],
                    "UMLS:C4711326": [
                        "Provide opportunities for family to apply coping strategies that may work in the current situation"
                    ],
                    "UMLS:C5448054": [
                        "Comfortable Calling Healthcare Provider About Symptom that May be Related to Return of Breast Cancer"
                    ]
                }
            },
            {
                "label": "additional therapeutic benefits in those patients who are currently maintained on optimal dosages of levodopa",
                "id": {}
            }
        ],
        [
            {
                "label": "those who are beginning to deteriorate (develop tolerance) to levodopa therapy",
                "id": {}
            },
            {
                "label": "are experiencing",
                "id": {
                    "UMLS:C0514359": [
                        "Point out, if asked, that you are not experiencing the same stimuli"
                    ]
                }
            },
            {
                "label": "\"end of dose failure\" on levodopa therapy",
                "id": {}
            }
        ]
    ],
    "Bromocriptine mesylate therapy may permit a reduction of the maintenance dose of levodopa and, thus may ameliorate the occurrence and/or severity of adverse reactions associated with long-term levodopa therapy such as abnormal involuntary movements (e.g., dyskinesias) and the marked swings in motor function (\"on-off\" phenomenon).": [
        [
            {
                "label": "Bromocriptine mesylate therapy",
                "id": {}
            },
            {
                "label": "may permit",
                "id": {
                    "UMLS:C3628586": [
                        "Mayamaea permitis",
                        "Mayamaea atomus var. permitis",
                        "Mayamaea permitis (Hustedt) K.Bruder & L.K.Medlin 2008",
                        "Navicula permitis",
                        "Navicula atomus var. permitis",
                        "Navicula permitis Hustedt 1945"
                    ]
                }
            },
            {
                "label": "a reduction of the maintenance dose of levodopa",
                "id": {}
            }
        ],
        [
            {
                "label": "Bromocriptine mesylate therapy",
                "id": {}
            },
            {
                "label": "may ameliorate",
                "id": {}
            },
            {
                "label": "the occurrence and/or severity of adverse reactions associated with long-term levodopa therapy",
                "id": {}
            }
        ],
        [
            {
                "label": "long-term levodopa therapy",
                "id": {}
            },
            {
                "label": "such as",
                "id": {
                    "UMLS:C1881351": [
                        "Label as Such",
                        "L.A.S."
                    ],
                    "UMLS:C3843727": [
                        "Prescription pill such as Zyban®"
                    ],
                    "UMLS:C5452792": [
                        "Pests such as bugs, ants, or mice"
                    ],
                    "UMLS:C4534416": [
                        "Being around animals such as pets"
                    ],
                    "UMLS:C3641919": [
                        "Drinks Alcohol Such as Beer or Wine"
                    ]
                }
            },
            {
                "label": "abnormal involuntary movements (e.g., dyskinesias) and the marked swings in motor function (\"on-off\" phenomenon)",
                "id": {}
            }
        ]
    ],
    "Continued efficacy of bromocriptine mesylate therapy during treatment of more than two years has not been established.": [
        [
            {
                "label": "Continued efficacy of bromocriptine mesylate therapy during treatment of more than two years",
                "id": {}
            },
            {
                "label": "has not been",
                "id": {
                    "UMLS:C3841803": [
                        "Patient has not been assessed"
                    ],
                    "UMLS:C1548416": [
                        "Appointment has not yet been confirmed"
                    ],
                    "UMLS:C1548945": [
                        "Pending _ Consent has not yet been sought"
                    ],
                    "UMLS:C1548650": [
                        "Advanced Beneficiary Notice has not been signed"
                    ],
                    "UMLS:C5570997": [
                        "No, the quality of my life has not been affected"
                    ]
                }
            },
            {
                "label": "established",
                "id": {
                    "UMLS:C0443211": [
                        "ESTABLISHED",
                        "established",
                        "Established",
                        "Established (qualifier value)",
                        "establish",
                        "establishing"
                    ],
                    "UMLS:C1272684": [
                        "Established",
                        "accept",
                        "accepts",
                        "accepted",
                        "Accepted",
                        "accepting",
                        "Accepted (qualifier value)"
                    ],
                    "UMLS:C0022868": [
                        "Labor established",
                        "Labour established",
                        "labor finding established",
                        "Labor established (finding)",
                        "Labor established (physical finding)",
                        "labor onset",
                        "onset labor",
                        "Labor Onset",
                        "labour onset",
                        "Labor Onsets",
                        "Onset, Labor",
                        "Labor, onset",
                        "Onsets, Labor",
                        "onset of labor",
                        "Onset of labor",
                        "Onset of labour",
                        "onset of labour"
                    ],
                    "UMLS:C5671297": [
                        "Established Patient",
                        "Domiciliary, Rest Home (eg, Boarding Home), or Custodial Care Services - Established Patient"
                    ],
                    "UMLS:C5671298": [
                        "Established Patient",
                        "Home Services - Established Patient"
                    ]
                }
            }
        ]
    ],
    "Temazepam is indicated for the short-term treatment of insomnia (generally 7 to 10 days).": [
        [
            {
                "label": "Temazepam",
                "id": {
                    "PUBCHEM.COMPOUND:5391": [
                        "temazepam",
                        "TEMAZEPAM",
                        "Temazepam",
                        "Nu-temazepam",
                        "Nu temazepam",
                        "PMS-Temazepam",
                        "Gen temazepam",
                        "PMS Temazepam",
                        "apo-Temazepam",
                        "Gen-temazepam",
                        "apo Temazepam",
                        "(RS)-Temazepam",
                        "novo-Temazepam",
                        "novo Temazepam",
                        "Temazepam (substance)",
                        "temazepam (medication)",
                        "AHP brand OF temazepam",
                        "ICN brand OF temazepam",
                        "Orion brand OF temazepam",
                        "Sigma brand OF temazepam",
                        "Wyeth brand OF temazepam",
                        "Knoll brand OF temazepam",
                        "Norton brand OF temazepam",
                        "Apotex brand OF temazepam",
                        "Katwijk brand OF temazepam",
                        "Desitin brand OF temazepam",
                        "Nu-pharm brand OF temazepam",
                        "Genpharm brand OF temazepam",
                        "Pfizer brand 1 OF temazepam",
                        "Novartis brand OF temazepam",
                        "Pfizer brand 2 OF temazepam",
                        "Nu pharm brand OF temazepam",
                        "Temazepam-containing product",
                        "Scheffler brand OF temazepam",
                        "Novopharm brand OF temazepam",
                        "Genopharm brand OF temazepam",
                        "Alphapharm brand OF temazepam",
                        "Mallinckrodt brand OF temazepam",
                        "Pharmascience brand OF temazepam",
                        "CT Arzneimittel brand OF temazepam",
                        "CT-Arzneimittel brand OF temazepam",
                        "Product containing temazepam (medicinal product)",
                        "Tenox",
                        "Dasuen",
                        "Planum",
                        "Nortem",
                        "Temaze",
                        "Temtabs",
                        "Euhypnos",
                        "levanxol",
                        "Restoril",
                        "Nocturne",
                        "Normison",
                        "Signopam",
                        "Normitab",
                        "Remestan",
                        "Levanxol",
                        "levanxene",
                        "Oxydiazepam",
                        "Oxydiazepam",
                        "Pronervon T",
                        "Restoril (TN)",
                        "Norkotral tema",
                        "Methyloxazepam",
                        "Methyloxazepam",
                        "Temazep von CT",
                        "Tema, norkotral",
                        "Von CT, temazep",
                        "Hydroxydiazepam",
                        "Hydroxydiazepam",
                        "N-Methyloxazepam",
                        "3 Hydroxydiazepam",
                        "3-Hydroxydiazepam",
                        "3-Hydroxydiazepam",
                        "3 Hydroxydiazepam",
                        "2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-",
                        "10-chloro-4-hydroxy-6-methyl-2-phenyl-3,6-diazabicyclo[5.4.0]undeca-2,8,10,12-tetraen-5-one"
                    ],
                    "PUBCHEM.COMPOUND:137699845": [
                        "Temazepam-d8"
                    ],
                    "PUBCHEM.COMPOUND:76973559": [
                        "Temazepam-D5",
                        "TEMAZEPAM, (PHENYL D5)-"
                    ],
                    "PUBCHEM.COMPOUND:138402766": [
                        "Temazepam-d1"
                    ],
                    "UMLS:C0796771": [
                        "Temazepam Ql",
                        "Temazepam SerPl Ql",
                        "Temazepam:PrThr:Pt:Ser/Plas:Ord",
                        "Temazepam [Presence] in Serum or Plasma",
                        "Temazepam:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the short-term treatment of insomnia (generally 7 to 10 days)",
                "id": {}
            }
        ]
    ],
    "Lorazepam injection is indicated for the treatment of status epilepticus.": [
        [
            {
                "label": "Lorazepam injection",
                "id": {
                    "UMLS:C0498924": [
                        "Lorazepam injection",
                        "Injection, lorazepam, 2 mg",
                        "INJECTION, LORAZEPAM, 2 MG ADMINISTERED"
                    ],
                    "UMLS:C2092263": [
                        "Lorazepam Injection",
                        "lorazepam injection",
                        "Lorazepam Liquid Injection",
                        "lorazepam injection (medication)"
                    ],
                    "UMLS:C4049914": [
                        "LORazepam Injection",
                        "Lorazepam Injection",
                        "lorazepam Injection"
                    ],
                    "UMLS:C0774179": [
                        "Lorazepam 4mg/1mL injection",
                        "Lorazepam 4 mg/mL solution for injection",
                        "lorazepam 4 mg/mL INJECTION VIAL (ML)_#2",
                        "Lorazepam 4 MG/1 ML Injection Solution_#1",
                        "Lorazepam 4mg/1mL Solution for injection_#2",
                        "LORAZEPAM 4.0 mg in 1 mL INTRAVENOUS INJECTION",
                        "LORAZEPAM 4.0 mg in 1 mL INTRAMUSCULAR INJECTION",
                        "Lorazepam 4 MG/1 ML Injection Solution [LORAZEPAM NOVAPLUS]_#1",
                        "Product containing precisely lorazepam 4 milligram/1 milliliter conventional release solution for injection (clinical drug)",
                        "LORAZEPAM 4MG/ML INJ_#1",
                        "LORazepam 4 mg/mL injectable solution",
                        "lorazepam 4 MG/ML Injectable Solution",
                        "LORazepam 4 MG/ML Injectable Solution",
                        "Lorazepam 4 MG/ML Injectable Solution",
                        "Lorazepam, 4 mg/mL injectable solution_#2"
                    ],
                    "UMLS:C4051025": [
                        "lorazepam Injection [Ativan]",
                        "LORazepam Injection [Ativan]"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of status epilepticus",
                "id": {}
            }
        ]
    ],
    "Lorazepam injection is indicated in adult patients for preanesthetic medication, producing sedation (sleepiness or drowsiness), relief of anxiety, and a decreased ability to recall events related to the day of surgery.": [
        [
            {
                "label": "Lorazepam injection",
                "id": {
                    "UMLS:C0498924": [
                        "Lorazepam injection",
                        "Injection, lorazepam, 2 mg",
                        "INJECTION, LORAZEPAM, 2 MG ADMINISTERED"
                    ],
                    "UMLS:C2092263": [
                        "Lorazepam Injection",
                        "lorazepam injection",
                        "Lorazepam Liquid Injection",
                        "lorazepam injection (medication)"
                    ],
                    "UMLS:C4049914": [
                        "LORazepam Injection",
                        "Lorazepam Injection",
                        "lorazepam Injection"
                    ],
                    "UMLS:C0774179": [
                        "Lorazepam 4mg/1mL injection",
                        "Lorazepam 4 mg/mL solution for injection",
                        "lorazepam 4 mg/mL INJECTION VIAL (ML)_#2",
                        "Lorazepam 4 MG/1 ML Injection Solution_#1",
                        "Lorazepam 4mg/1mL Solution for injection_#2",
                        "LORAZEPAM 4.0 mg in 1 mL INTRAVENOUS INJECTION",
                        "LORAZEPAM 4.0 mg in 1 mL INTRAMUSCULAR INJECTION",
                        "Lorazepam 4 MG/1 ML Injection Solution [LORAZEPAM NOVAPLUS]_#1",
                        "Product containing precisely lorazepam 4 milligram/1 milliliter conventional release solution for injection (clinical drug)",
                        "LORAZEPAM 4MG/ML INJ_#1",
                        "LORazepam 4 mg/mL injectable solution",
                        "lorazepam 4 MG/ML Injectable Solution",
                        "LORazepam 4 MG/ML Injectable Solution",
                        "Lorazepam 4 MG/ML Injectable Solution",
                        "Lorazepam, 4 mg/mL injectable solution_#2"
                    ],
                    "UMLS:C4051025": [
                        "lorazepam Injection [Ativan]",
                        "LORazepam Injection [Ativan]"
                    ]
                }
            },
            {
                "label": "is indicated in",
                "id": {
                    "UMLS:C1548409": [
                        "The indicated appointment is booked"
                    ],
                    "UMLS:C1548408": [
                        "The indicated time slot(s) is(are) blocked"
                    ],
                    "UMLS:C4489688": [
                        "No, and walking goal is clinically indicated"
                    ],
                    "UMLS:C4489223": [
                        "No, and walking goal is not clinically indicated"
                    ],
                    "UMLS:C1548417": [
                        "The indicated appointment has begun and is currently in progress"
                    ]
                }
            },
            {
                "label": "adult patients",
                "id": {
                    "UMLS:C1855413": [
                        "Nystagmus in adult patients"
                    ],
                    "UMLS:C1855412": [
                        "Impaired smooth pursuit in adult patients"
                    ],
                    "UMLS:C1855411": [
                        "Retinal degeneration in adult patients, progressive"
                    ],
                    "UMLS:C4746352": [
                        "Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5",
                        "Adit mdd dys rem 12 mnths"
                    ],
                    "UMLS:C5229138": [
                        "Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq- 9 or phq-9m score was not assessed or is greater than or equal to 5",
                        "Remis12m not phq-9 score <5"
                    ]
                }
            }
        ],
        [
            {
                "label": "Lorazepam injection",
                "id": {
                    "UMLS:C0498924": [
                        "Lorazepam injection",
                        "Injection, lorazepam, 2 mg",
                        "INJECTION, LORAZEPAM, 2 MG ADMINISTERED"
                    ],
                    "UMLS:C2092263": [
                        "Lorazepam Injection",
                        "lorazepam injection",
                        "Lorazepam Liquid Injection",
                        "lorazepam injection (medication)"
                    ],
                    "UMLS:C4049914": [
                        "LORazepam Injection",
                        "Lorazepam Injection",
                        "lorazepam Injection"
                    ],
                    "UMLS:C0774179": [
                        "Lorazepam 4mg/1mL injection",
                        "Lorazepam 4 mg/mL solution for injection",
                        "lorazepam 4 mg/mL INJECTION VIAL (ML)_#2",
                        "Lorazepam 4 MG/1 ML Injection Solution_#1",
                        "Lorazepam 4mg/1mL Solution for injection_#2",
                        "LORAZEPAM 4.0 mg in 1 mL INTRAVENOUS INJECTION",
                        "LORAZEPAM 4.0 mg in 1 mL INTRAMUSCULAR INJECTION",
                        "Lorazepam 4 MG/1 ML Injection Solution [LORAZEPAM NOVAPLUS]_#1",
                        "Product containing precisely lorazepam 4 milligram/1 milliliter conventional release solution for injection (clinical drug)",
                        "LORAZEPAM 4MG/ML INJ_#1",
                        "LORazepam 4 mg/mL injectable solution",
                        "lorazepam 4 MG/ML Injectable Solution",
                        "LORazepam 4 MG/ML Injectable Solution",
                        "Lorazepam 4 MG/ML Injectable Solution",
                        "Lorazepam, 4 mg/mL injectable solution_#2"
                    ],
                    "UMLS:C4051025": [
                        "lorazepam Injection [Ativan]",
                        "LORazepam Injection [Ativan]"
                    ]
                }
            },
            {
                "label": "is for",
                "id": {
                    "CHEBI:140821": [
                        "iso-Forssman",
                        "i-Forssman",
                        "isogloboside iGb5Cer",
                        "alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer",
                        "N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide"
                    ],
                    "UMLS:C1552560": [
                        "is backup for"
                    ],
                    "PUBCHEM.COMPOUND:8052": [
                        "Isoamyl formate",
                        "Isoamyl formate",
                        "isoamyl formate",
                        "ISOAMYL FORMATE",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formic acid",
                        "Formate, isopentyl ester",
                        "Isopentyl alcohol, formate",
                        "Formic acid, isopentyl ester",
                        "Formic acid, isopentyl ester",
                        "Isoamyl methanoate",
                        "Isoamyl methanoate",
                        "Isopentyl methanoate",
                        "Isopentyl methanoate",
                        "3-methylbutyl formate",
                        "3-Methylbutyl formate",
                        "Isoamyl methanoic acid",
                        "Isopentyl methanoic acid",
                        "3-Methyl-1-butyl formate",
                        "3-Methylbutyl formic acid",
                        "1-Butanol, 3-methyl-, formate",
                        "3-Methyl-2-butenyl formic acid",
                        "1-Butanol, 3-methyl-, 1-formate"
                    ],
                    "UMLS:C2346508": [
                        "ISS for Myeloma",
                        "International Staging System for Myeloma"
                    ],
                    "UMLS:C1562189": [
                        "Is etiology for",
                        "is etiology for",
                        "Is aetiology for",
                        "Is etiology for (link assertion)"
                    ]
                }
            },
            {
                "label": "preanesthetic medication",
                "id": {
                    "UMLS:C0032924": [
                        "Preanesthetic Medication",
                        "preanesthetic medication",
                        "Preanesthetic medication",
                        "Preanesthetic Medications",
                        "Medication, Preanesthetic",
                        "Medications, Preanesthetic",
                        "Anesthetic premedication",
                        "Anaesthetic premedication",
                        "Premedication for anesthetic procedure",
                        "Premedication for anaesthetic procedure",
                        "Premedication for anesthetic procedure, NOS",
                        "Premedication for anaesthetic procedure, NOS",
                        "Premedication for anesthetic procedure (procedure)"
                    ],
                    "UMLS:C0508235": [
                        "Administer appropriate preanesthetic medications and fluids"
                    ]
                }
            }
        ],
        [
            {
                "label": "Lorazepam injection",
                "id": {
                    "UMLS:C0498924": [
                        "Lorazepam injection",
                        "Injection, lorazepam, 2 mg",
                        "INJECTION, LORAZEPAM, 2 MG ADMINISTERED"
                    ],
                    "UMLS:C2092263": [
                        "Lorazepam Injection",
                        "lorazepam injection",
                        "Lorazepam Liquid Injection",
                        "lorazepam injection (medication)"
                    ],
                    "UMLS:C4049914": [
                        "LORazepam Injection",
                        "Lorazepam Injection",
                        "lorazepam Injection"
                    ],
                    "UMLS:C0774179": [
                        "Lorazepam 4mg/1mL injection",
                        "Lorazepam 4 mg/mL solution for injection",
                        "lorazepam 4 mg/mL INJECTION VIAL (ML)_#2",
                        "Lorazepam 4 MG/1 ML Injection Solution_#1",
                        "Lorazepam 4mg/1mL Solution for injection_#2",
                        "LORAZEPAM 4.0 mg in 1 mL INTRAVENOUS INJECTION",
                        "LORAZEPAM 4.0 mg in 1 mL INTRAMUSCULAR INJECTION",
                        "Lorazepam 4 MG/1 ML Injection Solution [LORAZEPAM NOVAPLUS]_#1",
                        "Product containing precisely lorazepam 4 milligram/1 milliliter conventional release solution for injection (clinical drug)",
                        "LORAZEPAM 4MG/ML INJ_#1",
                        "LORazepam 4 mg/mL injectable solution",
                        "lorazepam 4 MG/ML Injectable Solution",
                        "LORazepam 4 MG/ML Injectable Solution",
                        "Lorazepam 4 MG/ML Injectable Solution",
                        "Lorazepam, 4 mg/mL injectable solution_#2"
                    ],
                    "UMLS:C4051025": [
                        "lorazepam Injection [Ativan]",
                        "LORazepam Injection [Ativan]"
                    ]
                }
            },
            {
                "label": "producing",
                "id": {
                    "HP:0031245": [
                        "Producing sputum",
                        "producing sputum",
                        "Wet cough",
                        "Wet Cough",
                        "Loose Cough",
                        "loose cough",
                        "Loose cough",
                        "Moist cough",
                        "chesty cough",
                        "Chesty cough",
                        "Bronchial cough",
                        "bronchial cough",
                        "cough productive",
                        "Cough;productive",
                        "cough; bronchial",
                        "Productive cough",
                        "productive cough",
                        "bronchial; cough",
                        "COUGH PRODUCTIVE",
                        "Productive Cough",
                        "coughs productive",
                        "COUGH, PRODUCTIVE",
                        "coughing up sputum",
                        "bronchial coughing",
                        "coughing productive",
                        "loose cough (symptom)",
                        "Productive cough (finding)",
                        "Cough with mucus production",
                        "coughing up sputum (symptom)"
                    ],
                    "UMLS:C1517690": [
                        "LH-Producing Cell",
                        "LH Producing Cells",
                        "LH-Producing Cells",
                        "LH Cell",
                        "LH Cells",
                        "LH-Secreting Cell",
                        "LH Secreting Cells",
                        "LH-Secreting Cells"
                    ],
                    "MONDO:0019960": [
                        "VIP-producing NET",
                        "VIP-Producing NET",
                        "VIP Producing Neoplasm",
                        "VIP producing neoplasm",
                        "VIP-producing neuroendocrine tumor",
                        "VIP-Producing Neuroendocrine Tumor",
                        "vasoactive intestinal peptide producing tumor",
                        "vasoactive intestinal peptide-producing tumor",
                        "Vasoactive Intestinal Peptide-Producing Tumor",
                        "Vasoactive Intestinal Peptide Producing Tumor",
                        "Vasoactive Intestinal Peptide Producing Neoplasm",
                        "vasoactive intestinal peptide producing neoplasm",
                        "Vipoma",
                        "VIPOMA",
                        "VIPoma",
                        "vipoma",
                        "VIPoma",
                        "vipomas",
                        "Vipomas",
                        "Vipoma, NOS",
                        "WDHA syndrome",
                        "WDHA syndrome",
                        "Pancreatic VIPoma",
                        "VIPoma, malignant",
                        "Vipoma, malignant",
                        "pancreatic vipoma",
                        "VIPoma, Pancreatic",
                        "Pancreatic VIPomas",
                        "pancreatic cholera",
                        "Pancreatic cholera",
                        "VIPomas, Pancreatic",
                        "VIP-secreting tumor",
                        "Diarrheogenic Tumor",
                        "VIP- secreting tumor",
                        "Tumor, Diarrheogenic",
                        "Diarrheogenic Tumors",
                        "VIP- Secreting tumor",
                        "VIP- Secreting Tumor",
                        "Tumors, Diarrheogenic",
                        "VIP- secreting neoplasm",
                        "VIP- Secreting Neoplasm",
                        "Verner-Morrison syndrome",
                        "VIP Secreting Tumor (VIPoma)",
                        "VIP-Secreting Tumor (VIPoma)",
                        "VIP-oma - VIP-secreting tumor",
                        "Tumor, VIP-Secreting (VIPoma)",
                        "VIP-Secreting Tumors (VIPoma)",
                        "Tumors, VIP-Secreting (VIPoma)",
                        "Diarrheogenic Islet Cell Tumor",
                        "Diarrheogenic islet cell tumor",
                        "VIP-oma - VIP-secreting tumour",
                        "Vasoact intes peptide-secr tum",
                        "Vipoma (morphologic abnormality)",
                        "Vasoactive Intestinal Peptide (VIP) Tumor",
                        "vasoactive intestinal peptide (VIP) tumor",
                        "Vasoactive intestinal peptide-secreting tumor",
                        "vasoactive intestinal peptide-secreting tumor",
                        "Vasoactive intestinal peptide-secreting tumor",
                        "Vasoactive intestinal peptide-secreting tumour",
                        "Vasoactive Intestinal Peptide Secreting Neoplasm",
                        "vasoactive intestinal peptide secreting neoplasm",
                        "Watery diarrhea-hypokalemia-achlorhydria syndrome",
                        "watery diarrhea-hypokalemia-achlorhydria syndrome",
                        "VIP-oma - Vasoactive intestinal peptide-secreting tumor",
                        "malignant vasoactive intestinal peptide-secreting tumor",
                        "malignant vasoactive intestinal peptide-secreting tumor",
                        "watery diarrhea, hypokalemia, and achlorhydria syndrome",
                        "VIP-oma - Vasoactive intestinal peptide-secreting tumour",
                        "Vasoactive intestinal peptide-secreting tumor (disorder)",
                        "vasoactive intestinal peptide-secreting tumor (diagnosis)"
                    ],
                    "UMLS:C5237049": [
                        "Insulin-Producing"
                    ],
                    "UMLS:C0003273": [
                        "IG PRODUCING CELLS",
                        "Antibody Producing Cell",
                        "Antibody-Producing Cell",
                        "Antibody Producing Cells",
                        "Antibody-Producing Cells",
                        "Cell, Antibody-Producing",
                        "Cells, Antibody-Producing",
                        "Immunoglobulin-Producing Cell",
                        "Cell, Immunoglobulin-Producing",
                        "Immunoglobulin Producing Cells",
                        "Immunoglobulin-Producing Cells",
                        "Cells, Immunoglobulin-Producing"
                    ]
                }
            },
            {
                "label": "sedation",
                "id": {
                    "UMLS:C5400562": [
                        "Sedation"
                    ],
                    "NCIT:C118302": [
                        "SEDATION",
                        "Sedation",
                        "sedation",
                        "under sedation",
                        "Under sedation",
                        "sedation [status]",
                        "sedate",
                        "sedated",
                        "Sedated",
                        "sedates",
                        "sedating",
                        "Sedated state",
                        "Sedated (finding)"
                    ],
                    "UMLS:C0344106": [
                        "Sedation",
                        "sedation",
                        "Sedation, NOS",
                        "Sedation procedure",
                        "sedation [procedure]",
                        "Sedation procedure, NOS",
                        "Sedative therapy",
                        "Administration of sedative",
                        "Administration of sedative (procedure)"
                    ],
                    "UMLS:C1301902": [
                        "MAC sedation",
                        "Monitored anesthesia care sedation",
                        "Monitored anaesthesia care sedation",
                        "Monitored anesthesia care (MAC) sedation",
                        "Monitored anaesthesia care (MAC) sedation",
                        "Monitored anesthesia care sedation (procedure)"
                    ],
                    "NCIT:C50850": [
                        "OVER SEDATION",
                        "over sedation",
                        "Oversedated",
                        "OVERSEDATION",
                        "Oversedation"
                    ]
                }
            }
        ],
        [
            {
                "label": "Lorazepam injection",
                "id": {
                    "UMLS:C0498924": [
                        "Lorazepam injection",
                        "Injection, lorazepam, 2 mg",
                        "INJECTION, LORAZEPAM, 2 MG ADMINISTERED"
                    ],
                    "UMLS:C2092263": [
                        "Lorazepam Injection",
                        "lorazepam injection",
                        "Lorazepam Liquid Injection",
                        "lorazepam injection (medication)"
                    ],
                    "UMLS:C4049914": [
                        "LORazepam Injection",
                        "Lorazepam Injection",
                        "lorazepam Injection"
                    ],
                    "UMLS:C0774179": [
                        "Lorazepam 4mg/1mL injection",
                        "Lorazepam 4 mg/mL solution for injection",
                        "lorazepam 4 mg/mL INJECTION VIAL (ML)_#2",
                        "Lorazepam 4 MG/1 ML Injection Solution_#1",
                        "Lorazepam 4mg/1mL Solution for injection_#2",
                        "LORAZEPAM 4.0 mg in 1 mL INTRAVENOUS INJECTION",
                        "LORAZEPAM 4.0 mg in 1 mL INTRAMUSCULAR INJECTION",
                        "Lorazepam 4 MG/1 ML Injection Solution [LORAZEPAM NOVAPLUS]_#1",
                        "Product containing precisely lorazepam 4 milligram/1 milliliter conventional release solution for injection (clinical drug)",
                        "LORAZEPAM 4MG/ML INJ_#1",
                        "LORazepam 4 mg/mL injectable solution",
                        "lorazepam 4 MG/ML Injectable Solution",
                        "LORazepam 4 MG/ML Injectable Solution",
                        "Lorazepam 4 MG/ML Injectable Solution",
                        "Lorazepam, 4 mg/mL injectable solution_#2"
                    ],
                    "UMLS:C4051025": [
                        "lorazepam Injection [Ativan]",
                        "LORazepam Injection [Ativan]"
                    ]
                }
            },
            {
                "label": "relief of",
                "id": {
                    "UMLS:C3469264": [
                        "skin care: relief of itching",
                        "skin care: relief of itching (treatment)"
                    ],
                    "UMLS:C4715375": [
                        "Relief of symptoms of illness"
                    ],
                    "UMLS:C0723011": [
                        "Relief brand of phenylephrine",
                        "Relief",
                        "Relief [name]"
                    ],
                    "UMLS:C0556545": [
                        "Provn of pressure relief equip",
                        "Provision of pressure relief equipment",
                        "Provision of pressure relief equipment (procedure)"
                    ],
                    "UMLS:C0686946": [
                        "Holiday relief care of patient",
                        "Holiday relief care of patient (regime/therapy)"
                    ]
                }
            },
            {
                "label": "anxiety",
                "id": {
                    "NCIT:C146778": [
                        "Anxiety",
                        "Anxiety, CTCAE_5",
                        "Anxiety, CTCAE 5.0"
                    ],
                    "NCIT:C55441": [
                        "Anxiety",
                        "Anxiety, CTCAE_3",
                        "Anxiety, CTCAE 3.0"
                    ],
                    "UMLS:C0860603": [
                        "anxiety",
                        "Anxiety",
                        "anxiety symptom",
                        "anxiety symptoms",
                        "symptoms anxiety",
                        "Anxiety symptoms",
                        "anxiety (symptom)",
                        "anxiety; complaint",
                        "Anxiety symptoms NOS"
                    ],
                    "MONDO:0011918": [
                        "ANXIETY",
                        "anxiety",
                        "Anxiety",
                        "RNDx anxiety",
                        "Anxiety disease",
                        "Anxiety disease",
                        "Reaction anxiety",
                        "REACTION ANXIETY",
                        "ANXIETY REACTION",
                        "Anxiety reaction",
                        "Anxiety Reaction",
                        "anxiety reaction",
                        "Anxiety (finding)",
                        "unfocused anxiety",
                        "RNDx anxiety (diagnosis)",
                        "anxiety-related personality traits",
                        "Angst",
                        "angst",
                        "anxious",
                        "Anxious",
                        "anxieties",
                        "Anxiousness",
                        "anxiousness",
                        "Feel anxious",
                        "harm avoidance",
                        "Feeling;anxious",
                        "Feeling anxious",
                        "feeling anxious",
                        "Anxious behavior",
                        "anxious; sensation",
                        "Excessive, persistent worry and fear"
                    ],
                    "MONDO:0005618": [
                        "anxiety",
                        "Anxiety",
                        "anxiety",
                        "anxiety",
                        "Anxiety NOS",
                        "ANXIETY DIS",
                        "anxiety state",
                        "anxiety state",
                        "anxiety disorder",
                        "Anxiety disorder",
                        "anxiety disorder",
                        "ANXIETY DISORDER",
                        "Disorder;anxiety",
                        "Anxiety Disorder",
                        "ANXIETY DISORDERS",
                        "Disorder, Anxiety",
                        "Anxiety disorders",
                        "anxiety disorders",
                        "Anxiety Disorders",
                        "Disorders, Anxiety",
                        "anxiety disorder nos",
                        "Anxiety disorder, NOS",
                        "9-81 ANXIETY DISORDERS",
                        "Anxiety disorder (disorder)",
                        "Unspecified anxiety disorder",
                        "anxiety disorder (diagnosis)",
                        "Anxiety disorder, unspecified"
                    ]
                }
            }
        ],
        [
            {
                "label": "Lorazepam injection",
                "id": {
                    "UMLS:C0498924": [
                        "Lorazepam injection",
                        "Injection, lorazepam, 2 mg",
                        "INJECTION, LORAZEPAM, 2 MG ADMINISTERED"
                    ],
                    "UMLS:C2092263": [
                        "Lorazepam Injection",
                        "lorazepam injection",
                        "Lorazepam Liquid Injection",
                        "lorazepam injection (medication)"
                    ],
                    "UMLS:C4049914": [
                        "LORazepam Injection",
                        "Lorazepam Injection",
                        "lorazepam Injection"
                    ],
                    "UMLS:C0774179": [
                        "Lorazepam 4mg/1mL injection",
                        "Lorazepam 4 mg/mL solution for injection",
                        "lorazepam 4 mg/mL INJECTION VIAL (ML)_#2",
                        "Lorazepam 4 MG/1 ML Injection Solution_#1",
                        "Lorazepam 4mg/1mL Solution for injection_#2",
                        "LORAZEPAM 4.0 mg in 1 mL INTRAVENOUS INJECTION",
                        "LORAZEPAM 4.0 mg in 1 mL INTRAMUSCULAR INJECTION",
                        "Lorazepam 4 MG/1 ML Injection Solution [LORAZEPAM NOVAPLUS]_#1",
                        "Product containing precisely lorazepam 4 milligram/1 milliliter conventional release solution for injection (clinical drug)",
                        "LORAZEPAM 4MG/ML INJ_#1",
                        "LORazepam 4 mg/mL injectable solution",
                        "lorazepam 4 MG/ML Injectable Solution",
                        "LORazepam 4 MG/ML Injectable Solution",
                        "Lorazepam 4 MG/ML Injectable Solution",
                        "Lorazepam, 4 mg/mL injectable solution_#2"
                    ],
                    "UMLS:C4051025": [
                        "lorazepam Injection [Ativan]",
                        "LORazepam Injection [Ativan]"
                    ]
                }
            },
            {
                "label": "a decreased ability to",
                "id": {
                    "UMLS:C3279726": [
                        "Decreased ability to run"
                    ],
                    "UMLS:C4049329": [
                        "Decreased ability to grasp"
                    ],
                    "HP:0000966": [
                        "Decreased ability to sweat",
                        "OLIGIDRIA",
                        "HYPHIDROSIS",
                        "Hyphidrosis",
                        "HYPOHIDROSIS",
                        "Hypohydrosis",
                        "Hypohidrosis",
                        "hypohidrosis",
                        "Sweating less",
                        "oligohidrosis",
                        "Oligohidrosis",
                        "Reduced sweating",
                        "Sweating decreased",
                        "Decreased sweating",
                        "SWEATING DECREASED",
                        "Sweating, decreased",
                        "Diminished sweating",
                        "Inadequate sweating",
                        "Hypohidrosis (disorder)",
                        "Diminished sweating (finding)",
                        "hypohidrosis (physical finding)"
                    ],
                    "UMLS:C2055429": [
                        "TMJ decreased ability to open",
                        "temporomandibular joint decreased ability to open",
                        "temporomandibular joint decreased ability to open (physical finding)"
                    ],
                    "HP:0003546": [
                        "Decreased ability to exercise",
                        "Exercise intolerance",
                        "EXERCISE INTOLERANCE",
                        "intolerance exercise",
                        "exercise intolerance",
                        "Inability to exercise",
                        "Low exercise endurance",
                        "Poor exercise tolerance",
                        "Impaired exercise tolerance",
                        "decreased exercise tolerance",
                        "Decreased Exercise Tolerance",
                        "Exercise tolerance decreased",
                        "DECREASED EXERCISE TOLERANCE",
                        "Decreased exercise tolerance",
                        "EXERCISE TOLERANCE DECREASED",
                        "Impaired exercise tolerance (finding)",
                        "decreased exercise tolerance (procedure)"
                    ]
                }
            },
            {
                "label": "recall events related to the day of surgery",
                "id": {}
            }
        ]
    ],
    "It is most useful in those patients who are anxious about their surgical procedure and who would prefer to have diminished recall of the events of the day of surgery": [
        [
            {
                "label": "It",
                "id": {
                    "MGI:96598": [
                        "It"
                    ],
                    "PUBCHEM.COMPOUND:44298493": [
                        "IT",
                        "IT dipeptide",
                        "I-T",
                        "Ile-Thr",
                        "CHEMBL54609",
                        "I-T dipeptide",
                        "isoleucylthreonine",
                        "L-Isoleucyl-L-threonine",
                        "L-isoleucyl-L-threonine",
                        "isoleucine threonine dipeptide",
                        "(2S,3R)-2-{[(2S,3S)-2-amino-3-methylpentanoyl]amino}-3-hydroxybutanoic acid"
                    ],
                    "UMLS:C0677897": [
                        "IT",
                        "IT - Intrathecal route",
                        "intrathecal",
                        "Intrathecal",
                        "Intrathecal use",
                        "IntrathecalRoute",
                        "Intrathecal route",
                        "into the spinal space",
                        "Intrathecal route (qualifier value)",
                        "Intrathecal Route of Administration",
                        "Intrathecal Route of Drug Administration"
                    ],
                    "MONDO:0008558": [
                        "itp",
                        "ITP",
                        "ITP, NOS",
                        "ITP - Idiopat thrombocytop pur",
                        "ITP (immune thrombocytopenic purpura)",
                        "Idiopathic thrombocytopenic purpura (ITP)",
                        "ITP (idiopathic thrombocytopenic purpura)",
                        "idiopathic thrombocytopenic purpura (ITP)",
                        "ITP - Idiopathic thrombocytopenic purpura",
                        "AITP",
                        "AITP",
                        "Frank",
                        "Werlhof",
                        "WERLHOF DIS",
                        "WERLHOFS DIS",
                        "Werlhof Disease",
                        "WERLHOF DISEASE",
                        "Werlhofs Disease",
                        "Disease, Werlhof",
                        "werlhof's disease",
                        "Werlhof's Disease",
                        "Werlhof's disease",
                        "Werlhof's disease",
                        "werlhof's disease",
                        "Idiopathic purpura",
                        "Idiopathic purpura",
                        "Werlhof's syndrome",
                        "idiopathic purpura",
                        "idiopathic purpura",
                        "Disease, Werlhof's",
                        "purpura; idiopathic",
                        "idiopathic; purpura",
                        "Immune thrombocytopenia",
                        "Immune Thrombocytopenia",
                        "immune thrombocytopenia",
                        "Idiopathic purpura, NOS",
                        "Thrombocytopenia, Immune",
                        "Immune Thrombocytopenias",
                        "Immune thrombocyt purpra",
                        "Thrombocytopenias, Immune",
                        "Idiopathic Thrombocytopenia",
                        "Autoimmune Thrombocytopenia",
                        "idiopathic thrombocytopenia",
                        "Autoimmune Thrombocytopenias",
                        "Thrombocytopenia, Autoimmune",
                        "Thrombocytopenias, Autoimmune",
                        "Ideopath thrombocytopenic pur",
                        "ideopath thrombocytopenic pur",
                        "Idiopath thrombocytopen purpur",
                        "Autoimmune thrombocytopen purp",
                        "Immune thrombocytopenic purpur",
                        "Idiopath Thrombocytopenic Purp",
                        "immune purpura thrombocytopenic",
                        "thrombocytopenic purpura immune",
                        "Primary immune thrombocytopenia",
                        "Immune thrombocytopenic purpura",
                        "IMMUNE THROMBOCYTOPENIC PURPURA",
                        "immune thrombocytopenic purpura",
                        "Immune thrombocytopenic purpura",
                        "Primary Immune Thrombocytopenia",
                        "Immune Thrombocytopenic Purpura",
                        "immune thrombocytopenic purpura",
                        "primary thrombocytopenic purpura",
                        "primary thrombocytopenic purpura",
                        "Immune Thrombocytopenic Purpuras",
                        "Thrombocytopenic Purpura, Immune",
                        "Purpura, Immune Thrombocytopenic",
                        "Thrombocytopenic Purpuras, Immune",
                        "Purpuras, Immune Thrombocytopenic",
                        "IDIOPATHIC THROMBOCYTOPENIC PURPURA",
                        "idiopathic thrombocytopenic purpura",
                        "Idiopathic thrombocytopenia purpura",
                        "idiopathic thrombocytopenia purpura",
                        "Idiopathic Thrombocytopenic Purpura",
                        "autoimmune thrombocytopenic purpura",
                        "idiopathic thrombocytopenic purpura",
                        "thrombocytopenic purpura autoimmune",
                        "autoimmune thrombocytopenic purpura",
                        "Autoimmune thrombocytopenic purpura",
                        "Idiopathic Thrombocytopenia Purpura",
                        "Idiopathic thrombocytopenic purpura",
                        "Autoimmune Thrombocytopenic Purpura",
                        "THROMBOCYTOPENIC PURPURA, AUTOIMMUNE",
                        "Idiopathic Thrombocytopenic Purpuras",
                        "Autoimmune Thrombocytopenic Purpuras",
                        "Thrombocytopenic Purpura, Idiopathic",
                        "Purpura, Autoimmune Thrombocytopenic",
                        "thrombocytopenic purpura, autoimmune",
                        "Thrombocytopenic Purpura, Autoimmune",
                        "Purpura, Idiopathic Thrombocytopenic",
                        "thrombocytopenic; purpura, idiopathic",
                        "Purpuras, Autoimmune Thrombocytopenic",
                        "PURPURA, THROMBOCYTOPENIC, IDIOPATHIC",
                        "purpura; thrombocytopenic, idiopathic",
                        "Thrombocytopenic Purpuras, Idiopathic",
                        "Purpura, Thrombocytopenic, Idiopathic",
                        "Purpuras, Idiopathic Thrombocytopenic",
                        "Purpura, Thrombocytopenic, Autoimmune",
                        "Idiopathic thrombocytopenic purpura, NOS",
                        "immune thrombocytopenic purpura (diagnosis)",
                        "idiopathic thrombocytopenic purpura (diagnosis)"
                    ],
                    "MGI:3716200": [
                        "ita"
                    ]
                }
            },
            {
                "label": "is useful in",
                "id": {}
            },
            {
                "label": "those patients",
                "id": {
                    "UMLS:C4713117": [
                        "Use a slide board to assist transfer to a chair or wheel chair for those patients with fair balance"
                    ],
                    "UMLS:C4710824": [
                        "Obtain a fasting blood glucose reading preprocedure and postprocedure for those patients who have insulin-dependent diabetes"
                    ],
                    "UMLS:C0547608": [
                        "Avoid exposing patient to persons with infectious diseases, including upper respiratory infections; or to those recently exposed or vaccinated; or to staff caring for infected patients."
                    ],
                    "UMLS:C4710266": [
                        "Target at risk patients (e.g., diabetics, smokers, elderly, hypertensive patients and those with elevated cholesterols levels) for comprehensive peripheral assessments and modification of risk factors"
                    ],
                    "UMLS:C5574463": [
                        "On date of encounter, patient is not able to participate in assessment or screening, including non-verbal patients, delirious, severely aphasic, severely developmentally delayed, severe visual or hearing impairment and for those patients, no knowledgeable informant available",
                        "Pt not able to participate"
                    ]
                }
            }
        ],
        [
            {
                "label": "patients",
                "id": {
                    "UMLS:C0030705": [
                        "Patients",
                        "patients",
                        "PT",
                        "patient",
                        "Patient",
                        "PATIENT",
                        "^Patient",
                        "*^patient",
                        "Patient (person)"
                    ],
                    "UMLS:C0029921": [
                        "out-patients",
                        "Out-patients",
                        "Out patients",
                        "outpatient",
                        "Outpatient",
                        "Outpatients",
                        "out-patient",
                        "outpatients",
                        "Out-patient",
                        "Outpatient (person)"
                    ],
                    "UMLS:C0150831": [
                        "patients sex",
                        "patient sex",
                        "Patient sex",
                        "Patient's Sex",
                        "Patient sex (observable entity)"
                    ],
                    "UMLS:C0030690": [
                        "fall patients",
                        "falls patients",
                        "patient fall",
                        "PATIENT FALL",
                        "falls patient"
                    ],
                    "UMLS:C0150904": [
                        "male patients",
                        "male patient",
                        "patient is male",
                        "Patient is male"
                    ]
                }
            },
            {
                "label": "are",
                "id": {
                    "NCIT:C13662": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1515984": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1551058": [
                        "Are",
                        "are unit of measure"
                    ],
                    "MONDO:0044742": [
                        "AREI",
                        "autosomal recessive epidermolytic ichthyosis"
                    ],
                    "MONDO:0017339": [
                        "AREI",
                        "Ichthyosis exfoliativa",
                        "ICHTHYOSIS EXFOLIATIVA",
                        "ichthyosis exfoliativa",
                        "Exfoliative ichthyosis",
                        "Ichthyosis Exfoliativa",
                        "exfoliative ichthyosis",
                        "ICHTHYOSIS BULLOSA OF SIEMENS-LIKE",
                        "autosomal recessive exfoliative ichthyosis",
                        "Autosomal recessive exfoliative ichthyosis",
                        "ICHTHYOSIS, EXFOLIATIVE, AUTOSOMAL RECESSIVE",
                        "ichthyosis congenital autosomal recessive exfoliative",
                        "Autosomal recessive exfoliative ichthyosis (disorder)",
                        "Autosomal recessive exfoliative ichthyosis (diagnosis)"
                    ]
                }
            },
            {
                "label": "anxious about their surgical procedure",
                "id": {}
            }
        ],
        [
            {
                "label": "patients",
                "id": {
                    "UMLS:C0030705": [
                        "Patients",
                        "patients",
                        "PT",
                        "patient",
                        "Patient",
                        "PATIENT",
                        "^Patient",
                        "*^patient",
                        "Patient (person)"
                    ],
                    "UMLS:C0029921": [
                        "out-patients",
                        "Out-patients",
                        "Out patients",
                        "outpatient",
                        "Outpatient",
                        "Outpatients",
                        "out-patient",
                        "outpatients",
                        "Out-patient",
                        "Outpatient (person)"
                    ],
                    "UMLS:C0150831": [
                        "patients sex",
                        "patient sex",
                        "Patient sex",
                        "Patient's Sex",
                        "Patient sex (observable entity)"
                    ],
                    "UMLS:C0030690": [
                        "fall patients",
                        "falls patients",
                        "patient fall",
                        "PATIENT FALL",
                        "falls patient"
                    ],
                    "UMLS:C0150904": [
                        "male patients",
                        "male patient",
                        "patient is male",
                        "Patient is male"
                    ]
                }
            },
            {
                "label": "would prefer to have",
                "id": {}
            },
            {
                "label": "diminished recall of the events of the day of surgery",
                "id": {}
            }
        ]
    ],
    "ABSTRAL® is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving, and who are tolerant to, around-the-clock opioid therapy for their underlying persistent cancer pain.": [
        [
            {
                "label": "ABSTRAL®",
                "id": {
                    "UMLS:C2961835": [
                        "Abstral"
                    ],
                    "PUBCHEM.COMPOUND:13810": [
                        "Abstral",
                        "Actiq",
                        "Oralet",
                        "Fentora",
                        "Lazanda",
                        "Onsolis",
                        "Leptanal",
                        "fentanyl citrate",
                        "FENTANYL CITRATE",
                        "Fentanyl citrate",
                        "phentanyl citrate",
                        "fentanyl monocitrate",
                        "fentanyl dihydrogen citrate",
                        "N-(1-phenethyl-4-piperidyl)propionanilide citrate",
                        "N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide citrate",
                        "N-(1-phenethyl-4-piperidyl)propionanilide dihydrogen citrate",
                        "N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide citrate",
                        "N-(1-phenethyl-4-piperidinyl)propionanilide dihydrogen citrate",
                        "N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide 2-hydroxypropane-1,2,3-tricarboxylate"
                    ],
                    "UMLS:C3220203": [
                        "Abstral Pill"
                    ],
                    "UMLS:C3220202": [
                        "Abstral Oral Product"
                    ],
                    "UMLS:C2961836": [
                        "fentaNYL 0.1 MG [Abstral]",
                        "fentanyl 0.1 MG [Abstral]"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the management of breakthrough pain in cancer patients 18 years of age and older",
                "id": {}
            }
        ],
        [
            {
                "label": "cancer patients 18 years of age and older",
                "id": {}
            },
            {
                "label": "are already receiving",
                "id": {
                    "UMLS:C4290509": [
                        "Categories Z40-Z53 are intended for use to indicate a reason for care. They may be used for patients who have already been treated for a disease or injury, but who are receiving aftercare or prophylactic care, or care to consolidate the treatment, or to deal with a residual state"
                    ]
                }
            },
            {
                "label": "around-the-clock opioid therapy",
                "id": {}
            }
        ],
        [
            {
                "label": "cancer patients 18 years of age and older",
                "id": {}
            },
            {
                "label": "are tolerant to",
                "id": {}
            },
            {
                "label": "around-the-clock opioid therapy",
                "id": {}
            }
        ],
        [
            {
                "label": "around-the-clock opioid therapy",
                "id": {}
            },
            {
                "label": "is for",
                "id": {
                    "CHEBI:140821": [
                        "iso-Forssman",
                        "i-Forssman",
                        "isogloboside iGb5Cer",
                        "alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer",
                        "N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide"
                    ],
                    "UMLS:C1552560": [
                        "is backup for"
                    ],
                    "PUBCHEM.COMPOUND:8052": [
                        "Isoamyl formate",
                        "Isoamyl formate",
                        "isoamyl formate",
                        "ISOAMYL FORMATE",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formic acid",
                        "Formate, isopentyl ester",
                        "Isopentyl alcohol, formate",
                        "Formic acid, isopentyl ester",
                        "Formic acid, isopentyl ester",
                        "Isoamyl methanoate",
                        "Isoamyl methanoate",
                        "Isopentyl methanoate",
                        "Isopentyl methanoate",
                        "3-methylbutyl formate",
                        "3-Methylbutyl formate",
                        "Isoamyl methanoic acid",
                        "Isopentyl methanoic acid",
                        "3-Methyl-1-butyl formate",
                        "3-Methylbutyl formic acid",
                        "1-Butanol, 3-methyl-, formate",
                        "3-Methyl-2-butenyl formic acid",
                        "1-Butanol, 3-methyl-, 1-formate"
                    ],
                    "UMLS:C2346508": [
                        "ISS for Myeloma",
                        "International Staging System for Myeloma"
                    ],
                    "UMLS:C1562189": [
                        "Is etiology for",
                        "is etiology for",
                        "Is aetiology for",
                        "Is etiology for (link assertion)"
                    ]
                }
            },
            {
                "label": "their underlying persistent cancer pain",
                "id": {}
            }
        ]
    ],
    "ABSTRAL® is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving, and who are tolerant to, around-the-clock opioid therapy for their underlying persistent cancer pain": [
        [
            {
                "label": "ABSTRAL®",
                "id": {
                    "UMLS:C2961835": [
                        "Abstral"
                    ],
                    "PUBCHEM.COMPOUND:13810": [
                        "Abstral",
                        "Actiq",
                        "Oralet",
                        "Fentora",
                        "Lazanda",
                        "Onsolis",
                        "Leptanal",
                        "fentanyl citrate",
                        "FENTANYL CITRATE",
                        "Fentanyl citrate",
                        "phentanyl citrate",
                        "fentanyl monocitrate",
                        "fentanyl dihydrogen citrate",
                        "N-(1-phenethyl-4-piperidyl)propionanilide citrate",
                        "N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide citrate",
                        "N-(1-phenethyl-4-piperidyl)propionanilide dihydrogen citrate",
                        "N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide citrate",
                        "N-(1-phenethyl-4-piperidinyl)propionanilide dihydrogen citrate",
                        "N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide 2-hydroxypropane-1,2,3-tricarboxylate"
                    ],
                    "UMLS:C3220203": [
                        "Abstral Pill"
                    ],
                    "UMLS:C3220202": [
                        "Abstral Oral Product"
                    ],
                    "UMLS:C2961836": [
                        "fentaNYL 0.1 MG [Abstral]",
                        "fentanyl 0.1 MG [Abstral]"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving, and who are tolerant to, around-the-clock opioid therapy for their underlying persistent cancer pain",
                "id": {}
            }
        ],
        [
            {
                "label": "cancer patients 18 years of age and older",
                "id": {}
            },
            {
                "label": "are already receiving, and who are tolerant to",
                "id": {}
            },
            {
                "label": "around-the-clock opioid therapy for their underlying persistent cancer pain",
                "id": {}
            }
        ]
    ],
    "Patients considered opioid tolerant are those who are taking around-the-clock medicine consisting of at least 60 mg of oral morphine per day, or at least 25 mcg per hour of transdermal fentanyl, or at least 30 mg of oral oxycodone per day, or at least 8 mg of oral hydromorphone per day, or at least 25 mg oral oxymorphone per day, or at least 60 mg oral hydrocodone per day or an equianalgesic dose of another opioid medication daily for a week or longer.": [
        [
            {
                "label": "Patients",
                "id": {
                    "UMLS:C0030705": [
                        "Patients",
                        "patients",
                        "PT",
                        "patient",
                        "Patient",
                        "PATIENT",
                        "^Patient",
                        "*^patient",
                        "Patient (person)"
                    ],
                    "UMLS:C0029921": [
                        "out-patients",
                        "Out-patients",
                        "Out patients",
                        "outpatient",
                        "Outpatient",
                        "Outpatients",
                        "out-patient",
                        "outpatients",
                        "Out-patient",
                        "Outpatient (person)"
                    ],
                    "UMLS:C0150831": [
                        "patients sex",
                        "patient sex",
                        "Patient sex",
                        "Patient's Sex",
                        "Patient sex (observable entity)"
                    ],
                    "UMLS:C0030690": [
                        "fall patients",
                        "falls patients",
                        "patient fall",
                        "PATIENT FALL",
                        "falls patient"
                    ],
                    "UMLS:C0150904": [
                        "male patients",
                        "male patient",
                        "patient is male",
                        "Patient is male"
                    ]
                }
            },
            {
                "label": "are considered",
                "id": {
                    "UMLS:C1301552": [
                        "Patient's value system, lifestyle, ethnicity, and culture are considered, respected, and incorporated in the perioperative plan of care",
                        "Perioperative plan of care consistent with patient value system, lifestyle, ethnicity, and culture",
                        "Perioperative plan of care consistent with patient value system, lifestyle, ethnicity, and culture (finding)"
                    ],
                    "UMLS:C4316215": [
                        "Documented history of renal failure or baseline serum creatinine >= 4.0 mg/dl; renal transplant recipients are not considered to have preoperative renal failure, unless, since transplantation the cr has been or is 4.0 or higher",
                        "Doc hx renal fail or cr+ >=4"
                    ]
                }
            },
            {
                "label": "opioid tolerant",
                "id": {
                    "UMLS:C4709628": [
                        "Assure appropriateness of opioid dosage (e.g., large doses acceptable in opioid-tolerant patients but not opioid-nave patients)"
                    ]
                }
            }
        ],
        [
            {
                "label": "Patients",
                "id": {
                    "UMLS:C0030705": [
                        "Patients",
                        "patients",
                        "PT",
                        "patient",
                        "Patient",
                        "PATIENT",
                        "^Patient",
                        "*^patient",
                        "Patient (person)"
                    ],
                    "UMLS:C0029921": [
                        "out-patients",
                        "Out-patients",
                        "Out patients",
                        "outpatient",
                        "Outpatient",
                        "Outpatients",
                        "out-patient",
                        "outpatients",
                        "Out-patient",
                        "Outpatient (person)"
                    ],
                    "UMLS:C0150831": [
                        "patients sex",
                        "patient sex",
                        "Patient sex",
                        "Patient's Sex",
                        "Patient sex (observable entity)"
                    ],
                    "UMLS:C0030690": [
                        "fall patients",
                        "falls patients",
                        "patient fall",
                        "PATIENT FALL",
                        "falls patient"
                    ],
                    "UMLS:C0150904": [
                        "male patients",
                        "male patient",
                        "patient is male",
                        "Patient is male"
                    ]
                }
            },
            {
                "label": "are taking",
                "id": {
                    "UMLS:C3176195": [
                        "Are you now taking insulin"
                    ],
                    "UMLS:C3176194": [
                        "Are you now taking insulin [PhenX]",
                        "Are you now taking insulin:Find:Pt:^Patient:Ord:PhenX",
                        "Are you now taking insulin:Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX",
                        "Taking insulin PhenX"
                    ],
                    "UMLS:C0946223": [
                        "Medications are taking over my life"
                    ],
                    "UMLS:C3176475": [
                        "Are you taking medicine for diabetes"
                    ],
                    "UMLS:C3166617": [
                        "What medication are you taking for diabetes"
                    ]
                }
            },
            {
                "label": "around-the-clock medicine",
                "id": {}
            }
        ],
        [
            {
                "label": "Patients",
                "id": {
                    "UMLS:C0030705": [
                        "Patients",
                        "patients",
                        "PT",
                        "patient",
                        "Patient",
                        "PATIENT",
                        "^Patient",
                        "*^patient",
                        "Patient (person)"
                    ],
                    "UMLS:C0029921": [
                        "out-patients",
                        "Out-patients",
                        "Out patients",
                        "outpatient",
                        "Outpatient",
                        "Outpatients",
                        "out-patient",
                        "outpatients",
                        "Out-patient",
                        "Outpatient (person)"
                    ],
                    "UMLS:C0150831": [
                        "patients sex",
                        "patient sex",
                        "Patient sex",
                        "Patient's Sex",
                        "Patient sex (observable entity)"
                    ],
                    "UMLS:C0030690": [
                        "fall patients",
                        "falls patients",
                        "patient fall",
                        "PATIENT FALL",
                        "falls patient"
                    ],
                    "UMLS:C0150904": [
                        "male patients",
                        "male patient",
                        "patient is male",
                        "Patient is male"
                    ]
                }
            },
            {
                "label": "are taking",
                "id": {
                    "UMLS:C3176195": [
                        "Are you now taking insulin"
                    ],
                    "UMLS:C3176194": [
                        "Are you now taking insulin [PhenX]",
                        "Are you now taking insulin:Find:Pt:^Patient:Ord:PhenX",
                        "Are you now taking insulin:Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX",
                        "Taking insulin PhenX"
                    ],
                    "UMLS:C0946223": [
                        "Medications are taking over my life"
                    ],
                    "UMLS:C3176475": [
                        "Are you taking medicine for diabetes"
                    ],
                    "UMLS:C3166617": [
                        "What medication are you taking for diabetes"
                    ]
                }
            },
            {
                "label": "at least 60 mg of oral morphine per day",
                "id": {}
            }
        ],
        [
            {
                "label": "Patients",
                "id": {
                    "UMLS:C0030705": [
                        "Patients",
                        "patients",
                        "PT",
                        "patient",
                        "Patient",
                        "PATIENT",
                        "^Patient",
                        "*^patient",
                        "Patient (person)"
                    ],
                    "UMLS:C0029921": [
                        "out-patients",
                        "Out-patients",
                        "Out patients",
                        "outpatient",
                        "Outpatient",
                        "Outpatients",
                        "out-patient",
                        "outpatients",
                        "Out-patient",
                        "Outpatient (person)"
                    ],
                    "UMLS:C0150831": [
                        "patients sex",
                        "patient sex",
                        "Patient sex",
                        "Patient's Sex",
                        "Patient sex (observable entity)"
                    ],
                    "UMLS:C0030690": [
                        "fall patients",
                        "falls patients",
                        "patient fall",
                        "PATIENT FALL",
                        "falls patient"
                    ],
                    "UMLS:C0150904": [
                        "male patients",
                        "male patient",
                        "patient is male",
                        "Patient is male"
                    ]
                }
            },
            {
                "label": "are taking",
                "id": {
                    "UMLS:C3176195": [
                        "Are you now taking insulin"
                    ],
                    "UMLS:C3176194": [
                        "Are you now taking insulin [PhenX]",
                        "Are you now taking insulin:Find:Pt:^Patient:Ord:PhenX",
                        "Are you now taking insulin:Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX",
                        "Taking insulin PhenX"
                    ],
                    "UMLS:C0946223": [
                        "Medications are taking over my life"
                    ],
                    "UMLS:C3176475": [
                        "Are you taking medicine for diabetes"
                    ],
                    "UMLS:C3166617": [
                        "What medication are you taking for diabetes"
                    ]
                }
            },
            {
                "label": "at least 25 mcg per hour of transdermal fentanyl",
                "id": {}
            }
        ],
        [
            {
                "label": "Patients",
                "id": {
                    "UMLS:C0030705": [
                        "Patients",
                        "patients",
                        "PT",
                        "patient",
                        "Patient",
                        "PATIENT",
                        "^Patient",
                        "*^patient",
                        "Patient (person)"
                    ],
                    "UMLS:C0029921": [
                        "out-patients",
                        "Out-patients",
                        "Out patients",
                        "outpatient",
                        "Outpatient",
                        "Outpatients",
                        "out-patient",
                        "outpatients",
                        "Out-patient",
                        "Outpatient (person)"
                    ],
                    "UMLS:C0150831": [
                        "patients sex",
                        "patient sex",
                        "Patient sex",
                        "Patient's Sex",
                        "Patient sex (observable entity)"
                    ],
                    "UMLS:C0030690": [
                        "fall patients",
                        "falls patients",
                        "patient fall",
                        "PATIENT FALL",
                        "falls patient"
                    ],
                    "UMLS:C0150904": [
                        "male patients",
                        "male patient",
                        "patient is male",
                        "Patient is male"
                    ]
                }
            },
            {
                "label": "are taking",
                "id": {
                    "UMLS:C3176195": [
                        "Are you now taking insulin"
                    ],
                    "UMLS:C3176194": [
                        "Are you now taking insulin [PhenX]",
                        "Are you now taking insulin:Find:Pt:^Patient:Ord:PhenX",
                        "Are you now taking insulin:Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX",
                        "Taking insulin PhenX"
                    ],
                    "UMLS:C0946223": [
                        "Medications are taking over my life"
                    ],
                    "UMLS:C3176475": [
                        "Are you taking medicine for diabetes"
                    ],
                    "UMLS:C3166617": [
                        "What medication are you taking for diabetes"
                    ]
                }
            },
            {
                "label": "at least 30 mg of oral oxycodone per day",
                "id": {}
            }
        ],
        [
            {
                "label": "Patients",
                "id": {
                    "UMLS:C0030705": [
                        "Patients",
                        "patients",
                        "PT",
                        "patient",
                        "Patient",
                        "PATIENT",
                        "^Patient",
                        "*^patient",
                        "Patient (person)"
                    ],
                    "UMLS:C0029921": [
                        "out-patients",
                        "Out-patients",
                        "Out patients",
                        "outpatient",
                        "Outpatient",
                        "Outpatients",
                        "out-patient",
                        "outpatients",
                        "Out-patient",
                        "Outpatient (person)"
                    ],
                    "UMLS:C0150831": [
                        "patients sex",
                        "patient sex",
                        "Patient sex",
                        "Patient's Sex",
                        "Patient sex (observable entity)"
                    ],
                    "UMLS:C0030690": [
                        "fall patients",
                        "falls patients",
                        "patient fall",
                        "PATIENT FALL",
                        "falls patient"
                    ],
                    "UMLS:C0150904": [
                        "male patients",
                        "male patient",
                        "patient is male",
                        "Patient is male"
                    ]
                }
            },
            {
                "label": "are taking",
                "id": {
                    "UMLS:C3176195": [
                        "Are you now taking insulin"
                    ],
                    "UMLS:C3176194": [
                        "Are you now taking insulin [PhenX]",
                        "Are you now taking insulin:Find:Pt:^Patient:Ord:PhenX",
                        "Are you now taking insulin:Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX",
                        "Taking insulin PhenX"
                    ],
                    "UMLS:C0946223": [
                        "Medications are taking over my life"
                    ],
                    "UMLS:C3176475": [
                        "Are you taking medicine for diabetes"
                    ],
                    "UMLS:C3166617": [
                        "What medication are you taking for diabetes"
                    ]
                }
            },
            {
                "label": "at least 8 mg of oral hydromorphone per day",
                "id": {}
            }
        ],
        [
            {
                "label": "Patients",
                "id": {
                    "UMLS:C0030705": [
                        "Patients",
                        "patients",
                        "PT",
                        "patient",
                        "Patient",
                        "PATIENT",
                        "^Patient",
                        "*^patient",
                        "Patient (person)"
                    ],
                    "UMLS:C0029921": [
                        "out-patients",
                        "Out-patients",
                        "Out patients",
                        "outpatient",
                        "Outpatient",
                        "Outpatients",
                        "out-patient",
                        "outpatients",
                        "Out-patient",
                        "Outpatient (person)"
                    ],
                    "UMLS:C0150831": [
                        "patients sex",
                        "patient sex",
                        "Patient sex",
                        "Patient's Sex",
                        "Patient sex (observable entity)"
                    ],
                    "UMLS:C0030690": [
                        "fall patients",
                        "falls patients",
                        "patient fall",
                        "PATIENT FALL",
                        "falls patient"
                    ],
                    "UMLS:C0150904": [
                        "male patients",
                        "male patient",
                        "patient is male",
                        "Patient is male"
                    ]
                }
            },
            {
                "label": "are taking",
                "id": {
                    "UMLS:C3176195": [
                        "Are you now taking insulin"
                    ],
                    "UMLS:C3176194": [
                        "Are you now taking insulin [PhenX]",
                        "Are you now taking insulin:Find:Pt:^Patient:Ord:PhenX",
                        "Are you now taking insulin:Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX",
                        "Taking insulin PhenX"
                    ],
                    "UMLS:C0946223": [
                        "Medications are taking over my life"
                    ],
                    "UMLS:C3176475": [
                        "Are you taking medicine for diabetes"
                    ],
                    "UMLS:C3166617": [
                        "What medication are you taking for diabetes"
                    ]
                }
            },
            {
                "label": "at least 25 mg oral oxymorphone per day",
                "id": {}
            }
        ],
        [
            {
                "label": "Patients",
                "id": {
                    "UMLS:C0030705": [
                        "Patients",
                        "patients",
                        "PT",
                        "patient",
                        "Patient",
                        "PATIENT",
                        "^Patient",
                        "*^patient",
                        "Patient (person)"
                    ],
                    "UMLS:C0029921": [
                        "out-patients",
                        "Out-patients",
                        "Out patients",
                        "outpatient",
                        "Outpatient",
                        "Outpatients",
                        "out-patient",
                        "outpatients",
                        "Out-patient",
                        "Outpatient (person)"
                    ],
                    "UMLS:C0150831": [
                        "patients sex",
                        "patient sex",
                        "Patient sex",
                        "Patient's Sex",
                        "Patient sex (observable entity)"
                    ],
                    "UMLS:C0030690": [
                        "fall patients",
                        "falls patients",
                        "patient fall",
                        "PATIENT FALL",
                        "falls patient"
                    ],
                    "UMLS:C0150904": [
                        "male patients",
                        "male patient",
                        "patient is male",
                        "Patient is male"
                    ]
                }
            },
            {
                "label": "are taking",
                "id": {
                    "UMLS:C3176195": [
                        "Are you now taking insulin"
                    ],
                    "UMLS:C3176194": [
                        "Are you now taking insulin [PhenX]",
                        "Are you now taking insulin:Find:Pt:^Patient:Ord:PhenX",
                        "Are you now taking insulin:Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX",
                        "Taking insulin PhenX"
                    ],
                    "UMLS:C0946223": [
                        "Medications are taking over my life"
                    ],
                    "UMLS:C3176475": [
                        "Are you taking medicine for diabetes"
                    ],
                    "UMLS:C3166617": [
                        "What medication are you taking for diabetes"
                    ]
                }
            },
            {
                "label": "at least 60 mg oral hydrocodone per day",
                "id": {}
            }
        ],
        [
            {
                "label": "Patients",
                "id": {
                    "UMLS:C0030705": [
                        "Patients",
                        "patients",
                        "PT",
                        "patient",
                        "Patient",
                        "PATIENT",
                        "^Patient",
                        "*^patient",
                        "Patient (person)"
                    ],
                    "UMLS:C0029921": [
                        "out-patients",
                        "Out-patients",
                        "Out patients",
                        "outpatient",
                        "Outpatient",
                        "Outpatients",
                        "out-patient",
                        "outpatients",
                        "Out-patient",
                        "Outpatient (person)"
                    ],
                    "UMLS:C0150831": [
                        "patients sex",
                        "patient sex",
                        "Patient sex",
                        "Patient's Sex",
                        "Patient sex (observable entity)"
                    ],
                    "UMLS:C0030690": [
                        "fall patients",
                        "falls patients",
                        "patient fall",
                        "PATIENT FALL",
                        "falls patient"
                    ],
                    "UMLS:C0150904": [
                        "male patients",
                        "male patient",
                        "patient is male",
                        "Patient is male"
                    ]
                }
            },
            {
                "label": "are taking",
                "id": {
                    "UMLS:C3176195": [
                        "Are you now taking insulin"
                    ],
                    "UMLS:C3176194": [
                        "Are you now taking insulin [PhenX]",
                        "Are you now taking insulin:Find:Pt:^Patient:Ord:PhenX",
                        "Are you now taking insulin:Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX",
                        "Taking insulin PhenX"
                    ],
                    "UMLS:C0946223": [
                        "Medications are taking over my life"
                    ],
                    "UMLS:C3176475": [
                        "Are you taking medicine for diabetes"
                    ],
                    "UMLS:C3166617": [
                        "What medication are you taking for diabetes"
                    ]
                }
            },
            {
                "label": "an equianalgesic dose of another opioid medication daily for a week or longer",
                "id": {}
            }
        ]
    ],
    "Diazepam is indicated for the management of anxiety disorders for the short-term relief of the symptoms of anxiety.": [
        [
            {
                "label": "Diazepam",
                "id": {
                    "PUBCHEM.COMPOUND:3016": [
                        "Diazepam",
                        "DiazePAM",
                        "diazepam",
                        "DIAZEPAM",
                        "diazePAM",
                        "Diazepam product",
                        "Diazepam (substance)",
                        "diazepam (medication)",
                        "Diazepam-containing product",
                        "Product containing diazepam (medicinal product)",
                        "Valium",
                        "Valium",
                        "Seduxen",
                        "Faustan",
                        "Apaurin",
                        "Diastat",
                        "Sibazon",
                        "Relanium",
                        "Stesolid",
                        "Diazemuls",
                        "Methyldiazepinone",
                        "Methyl diazepinone",
                        "Methyl diazepinone",
                        "methyl diazepinone",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-"
                    ],
                    "PUBCHEM.COMPOUND:129818764": [
                        "Diazepamon"
                    ],
                    "PUBCHEM.COMPOUND:12205124": [
                        "Diazepam-d3"
                    ],
                    "PUBCHEM.COMPOUND:45358967": [
                        "Diazepam-d5"
                    ],
                    "PUBCHEM.COMPOUND:165361942": [
                        "Diazepam-d8"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the management of anxiety disorders for the short-term relief of the symptoms of anxiety",
                "id": {}
            }
        ]
    ],
    "Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic.": [
        [
            {
                "label": "Anxiety or tension",
                "id": {
                    "UMLS:C4712861": [
                        "Watch for signs of anxiety or fear (e.g., irritability, tension, worry, fear of movement)"
                    ],
                    "UMLS:C3175150": [
                        "Do you experience frustration, tension or anxiety over not being able to go to sleep during the night when you cannot fall asleep"
                    ],
                    "UMLS:C3175149": [
                        "Do you experience frustration, tension or anxiety over not being able to go to sleep during the night when you cannot fall asleep [PhenX]",
                        "Do you experience frustration, tension or anxiety over not being able to go to sleep during the night when you cannot fall asleep:Find:Pt:^Patient:Ord:PhenX",
                        "Do you experience frustration, tension or anxiety over not being able to go to sleep during the night when you cannot fall asleep:Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX",
                        "Difficulty anxiety PhenX"
                    ],
                    "UMLS:C4256679": [
                        "CHASTE TREE 6 [hp_X] in 1 mL / AVENA SATIVA FLOWERING TOP 1 [hp_X] in 1 mL / CINCHONA OFFICINALIS BARK 6 [hp_X] in 1 mL / HOPS 2 [hp_X] in 1 mL / HYOSCYAMUS NIGER 200 [hp_C] in 1 mL / STRYCHNOS IGNATII SEED 200 [hp_C] in 1 mL / PASSIFLORA INCARNATA TOP 3 [hp_X] in 1 mL / VALERIAN 3 [hp_X] in 1 mL ORAL SPRAY [Anxiety plus Tension]"
                    ]
                }
            },
            {
                "label": "associated with",
                "id": {
                    "UMLS:C0332281": [
                        "associated with",
                        "ASSOCIATED WITH",
                        "Associated with",
                        "Associated with (attribute)",
                        "AW",
                        "ASSOC",
                        "associated",
                        "Associated",
                        "associating"
                    ],
                    "UMLS:C1608982": [
                        "Associated with (APAH)"
                    ],
                    "UMLS:C2029691": [
                        "headache associated with",
                        "headache associated",
                        "headache associated factor",
                        "headache associated factor (symptom)"
                    ],
                    "HP:0033705": [
                        "Crying associated with mood",
                        "Crying associated with emotion",
                        "Crying associated with mood (finding)",
                        "weep",
                        "Weepy",
                        "Weeps",
                        "weepy",
                        "weeping",
                        "tearful",
                        "WEEPING",
                        "Weeping",
                        "Tearful",
                        "Weepiness",
                        "weepiness",
                        "Tearfulness",
                        "affect tearful",
                        "tearful (physical finding)"
                    ],
                    "NCBIGene:23077": [
                        "PROTEIN ASSOCIATED WITH MYC",
                        "PAM",
                        "PAM",
                        "PHR1",
                        "PHR1",
                        "MYCBP2",
                        "FLJ10106",
                        "KIAA0916",
                        "FLJ10106",
                        "KIAA0916",
                        "MYCBP2 gene",
                        "MYCBP2 Gene",
                        "MYC-BINDING PROTEIN 2",
                        "MYC binding protein 2",
                        "MYC Binding Protein 2 Gene",
                        "PAM/Highwire/RPM-1 protein 1",
                        "PAM/Highwire/RPM-1 protein 1",
                        "MYC binding protein 2, E3 ubiquitin protein ligase"
                    ]
                }
            },
            {
                "label": "the stress of everyday life",
                "id": {}
            }
        ],
        [
            {
                "label": "Anxiety or tension",
                "id": {
                    "UMLS:C4712861": [
                        "Watch for signs of anxiety or fear (e.g., irritability, tension, worry, fear of movement)"
                    ],
                    "UMLS:C3175150": [
                        "Do you experience frustration, tension or anxiety over not being able to go to sleep during the night when you cannot fall asleep"
                    ],
                    "UMLS:C3175149": [
                        "Do you experience frustration, tension or anxiety over not being able to go to sleep during the night when you cannot fall asleep [PhenX]",
                        "Do you experience frustration, tension or anxiety over not being able to go to sleep during the night when you cannot fall asleep:Find:Pt:^Patient:Ord:PhenX",
                        "Do you experience frustration, tension or anxiety over not being able to go to sleep during the night when you cannot fall asleep:Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX",
                        "Difficulty anxiety PhenX"
                    ],
                    "UMLS:C4256679": [
                        "CHASTE TREE 6 [hp_X] in 1 mL / AVENA SATIVA FLOWERING TOP 1 [hp_X] in 1 mL / CINCHONA OFFICINALIS BARK 6 [hp_X] in 1 mL / HOPS 2 [hp_X] in 1 mL / HYOSCYAMUS NIGER 200 [hp_C] in 1 mL / STRYCHNOS IGNATII SEED 200 [hp_C] in 1 mL / PASSIFLORA INCARNATA TOP 3 [hp_X] in 1 mL / VALERIAN 3 [hp_X] in 1 mL ORAL SPRAY [Anxiety plus Tension]"
                    ]
                }
            },
            {
                "label": "does not require",
                "id": {
                    "UMLS:C3845093": [
                        "Patient does not require assistance"
                    ],
                    "UMLS:C5574464": [
                        "Clinician determines patient does not require referral",
                        "Clin pt no ref"
                    ],
                    "UMLS:C2016249": [
                        "post-adjustment summary: pacemaker does not require further adjustment",
                        "pacemaker evaluation settings do not require further adjustment",
                        "pacemaker evaluation settings do not require further adjustment (procedure)"
                    ],
                    "UMLS:C4711517": [
                        "Offer to complete a commemorative birth certificate if state law does not require one at the gestational age of delivery"
                    ],
                    "UMLS:C4712224": [
                        "Assure that laser assistant does not have competing responsibilities that would require leaving the laser unattended during active use"
                    ]
                }
            },
            {
                "label": "treatment with an anxiolytic",
                "id": {}
            }
        ]
    ],
    "Diazepam injection is a useful adjunct in status epilepticus and severe recurrent convulsive seizures.": [
        [
            {
                "label": "Diazepam injection",
                "id": {
                    "UMLS:C0499022": [
                        "Diazepam injection",
                        "Injection, diazepam, up to 5 mg",
                        "INJECTION, DIAZEPAM, UP TO 5 MG ADMINISTERED"
                    ],
                    "UMLS:C4048461": [
                        "diazepam injection",
                        "Diazepam Injection",
                        "diazepam injection (medication)"
                    ],
                    "UMLS:C0699187": [
                        "diazepam (Valium) injection",
                        "valium",
                        "Valium"
                    ],
                    "UMLS:C4281825": [
                        "Diazepam 10mg/2mL injection"
                    ],
                    "UMLS:C4281827": [
                        "Diazepam 20mg/4mL injection"
                    ]
                }
            },
            {
                "label": "is",
                "id": {
                    "UBERON:0002872": [
                        "IS",
                        "inferior salivary nucleus",
                        "Nucleus salivarius inferior",
                        "nucleus salivarius inferior",
                        "Inferior salivatory nucleus",
                        "inferior salivatary nucleus",
                        "inferior salivatory nucleus",
                        "Nucleus salivatorius inferior",
                        "nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior",
                        "Nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior nervi glossopharyngei",
                        "Nucleus salivatorius inferior nervi glossopharyngei"
                    ],
                    "OMIM:146850": [
                        "IS",
                        "ISCW",
                        "ISSCW",
                        "IMMUNE SUPPRESSION",
                        "STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO"
                    ],
                    "FB:FBgn0001274": [
                        "Is"
                    ],
                    "PUBCHEM.COMPOUND:7021816": [
                        "IS",
                        "isoleucylserine",
                        "Isoleucyl-Serine",
                        "L-isoleucyl-L-serine",
                        "Ile-Ser",
                        "L-Ile-L-Ser",
                        "CHEMBL56803"
                    ],
                    "UMLS:C0021632": [
                        "IS",
                        "INSTRUM",
                        "instrumentation",
                        "instrumentation aspects"
                    ]
                }
            },
            {
                "label": "a useful adjunct in status epilepticus and severe recurrent convulsive seizures",
                "id": {}
            }
        ]
    ],
    "Iloperidone tablets are indicated for the treatment of schizophrenia in adults.": [
        [
            {
                "label": "Iloperidone tablets",
                "id": {
                    "UMLS:C2684221": [
                        "Iloperidone Tablets",
                        "iloperidone Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of schizophrenia in adults",
                "id": {}
            }
        ]
    ],
    "Aripiprazole oral solution is indicated for the treatment of: Schizophrenia.": [
        [
            {
                "label": "Aripiprazole oral solution",
                "id": {
                    "UMLS:C1577202": [
                        "aripiprazole Oral Solution",
                        "Aripiprazole Oral Solution",
                        "ARIPiprazole Oral Solution"
                    ],
                    "UMLS:C1576511": [
                        "aripiprazole 1 MG/ML Oral Solution",
                        "ARIPiprazole 1 MG/ML Oral Solution",
                        "ARIPiprazole 1 mg/mL oral solution",
                        "Aripiprazole 1mg/1mL Oral solution",
                        "Aripiprazole 1 mg/mL oral solution",
                        "Aripiprazole, 1 mg/mL oral solution",
                        "Aripiprazole 1 MG/1 ML Oral Solution",
                        "ARIPIPRAZOLE 1 mg in 1 mL ORAL SOLUTION",
                        "ARIPiprazole 1 MG in 1 mL Oral Solution",
                        "aripiprazole 1 mg/mL ORAL SOLUTION, ORAL",
                        "ARIPiprazole 1 MG per 1 ML Oral Solution",
                        "aripiprazole@1 mg/mL@ORAL@SOLUTION, ORAL",
                        "aripiprazole 1 MG per 1 ML Oral Solution",
                        "Product containing precisely aripiprazole 1 milligram/1 milliliter conventional release oral solution (clinical drug)",
                        "ARIPIPRAZOLE 1MG/ML SOLN,ORAL",
                        "ARIPIPRAZOLE 1MG/ML ORAL SOLN"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of: Schizophrenia",
                "id": {}
            }
        ]
    ],
    "Aripiprazole oral solution is indicated for the treatment of: acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder.": [
        [
            {
                "label": "Aripiprazole oral solution",
                "id": {
                    "UMLS:C1577202": [
                        "aripiprazole Oral Solution",
                        "Aripiprazole Oral Solution",
                        "ARIPiprazole Oral Solution"
                    ],
                    "UMLS:C1576511": [
                        "aripiprazole 1 MG/ML Oral Solution",
                        "ARIPiprazole 1 MG/ML Oral Solution",
                        "ARIPiprazole 1 mg/mL oral solution",
                        "Aripiprazole 1mg/1mL Oral solution",
                        "Aripiprazole 1 mg/mL oral solution",
                        "Aripiprazole, 1 mg/mL oral solution",
                        "Aripiprazole 1 MG/1 ML Oral Solution",
                        "ARIPIPRAZOLE 1 mg in 1 mL ORAL SOLUTION",
                        "ARIPiprazole 1 MG in 1 mL Oral Solution",
                        "aripiprazole 1 mg/mL ORAL SOLUTION, ORAL",
                        "ARIPiprazole 1 MG per 1 ML Oral Solution",
                        "aripiprazole@1 mg/mL@ORAL@SOLUTION, ORAL",
                        "aripiprazole 1 MG per 1 ML Oral Solution",
                        "Product containing precisely aripiprazole 1 milligram/1 milliliter conventional release oral solution (clinical drug)",
                        "ARIPIPRAZOLE 1MG/ML SOLN,ORAL",
                        "ARIPIPRAZOLE 1MG/ML ORAL SOLN"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of: acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder",
                "id": {}
            }
        ]
    ],
    "Aripiprazole oral solution is indicated for the treatment of: Adjunctive Treatment of Major Depressive Disorder": [
        [
            {
                "label": "Aripiprazole oral solution",
                "id": {
                    "UMLS:C1577202": [
                        "aripiprazole Oral Solution",
                        "Aripiprazole Oral Solution",
                        "ARIPiprazole Oral Solution"
                    ],
                    "UMLS:C1576511": [
                        "aripiprazole 1 MG/ML Oral Solution",
                        "ARIPiprazole 1 MG/ML Oral Solution",
                        "ARIPiprazole 1 mg/mL oral solution",
                        "Aripiprazole 1mg/1mL Oral solution",
                        "Aripiprazole 1 mg/mL oral solution",
                        "Aripiprazole, 1 mg/mL oral solution",
                        "Aripiprazole 1 MG/1 ML Oral Solution",
                        "ARIPIPRAZOLE 1 mg in 1 mL ORAL SOLUTION",
                        "ARIPiprazole 1 MG in 1 mL Oral Solution",
                        "aripiprazole 1 mg/mL ORAL SOLUTION, ORAL",
                        "ARIPiprazole 1 MG per 1 ML Oral Solution",
                        "aripiprazole@1 mg/mL@ORAL@SOLUTION, ORAL",
                        "aripiprazole 1 MG per 1 ML Oral Solution",
                        "Product containing precisely aripiprazole 1 milligram/1 milliliter conventional release oral solution (clinical drug)",
                        "ARIPIPRAZOLE 1MG/ML SOLN,ORAL",
                        "ARIPIPRAZOLE 1MG/ML ORAL SOLN"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of: Adjunctive Treatment of Major Depressive Disorder",
                "id": {}
            }
        ]
    ],
    "Aripiprazole oral solution is indicated for the treatment of: Irritability Associated with Autistic Disorder.": [
        [
            {
                "label": "Aripiprazole oral solution",
                "id": {
                    "UMLS:C1577202": [
                        "aripiprazole Oral Solution",
                        "Aripiprazole Oral Solution",
                        "ARIPiprazole Oral Solution"
                    ],
                    "UMLS:C1576511": [
                        "aripiprazole 1 MG/ML Oral Solution",
                        "ARIPiprazole 1 MG/ML Oral Solution",
                        "ARIPiprazole 1 mg/mL oral solution",
                        "Aripiprazole 1mg/1mL Oral solution",
                        "Aripiprazole 1 mg/mL oral solution",
                        "Aripiprazole, 1 mg/mL oral solution",
                        "Aripiprazole 1 MG/1 ML Oral Solution",
                        "ARIPIPRAZOLE 1 mg in 1 mL ORAL SOLUTION",
                        "ARIPiprazole 1 MG in 1 mL Oral Solution",
                        "aripiprazole 1 mg/mL ORAL SOLUTION, ORAL",
                        "ARIPiprazole 1 MG per 1 ML Oral Solution",
                        "aripiprazole@1 mg/mL@ORAL@SOLUTION, ORAL",
                        "aripiprazole 1 MG per 1 ML Oral Solution",
                        "Product containing precisely aripiprazole 1 milligram/1 milliliter conventional release oral solution (clinical drug)",
                        "ARIPIPRAZOLE 1MG/ML SOLN,ORAL",
                        "ARIPIPRAZOLE 1MG/ML ORAL SOLN"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of: Irritability Associated with Autistic Disorder",
                "id": {}
            }
        ]
    ],
    "Felbamate oral suspension is recommended for use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use": [
        [
            {
                "label": "Felbamate oral suspension",
                "id": {
                    "UMLS:C1246189": [
                        "felbamate Oral Suspension",
                        "Felbamate Oral Suspension"
                    ],
                    "UMLS:C0976868": [
                        "Felbamate 600mg/5mL Oral suspension",
                        "felbamate 120 MG/ML Oral Suspension",
                        "Felbamate 120 mg/mL oral suspension",
                        "felbamate 600 mg/5 mL oral suspension",
                        "Felbamate 600 MG/5 ML Oral Suspension",
                        "Felbamate, 600 mg/5 mL oral suspension",
                        "FELBAMATE 600 mg in 5 mL ORAL SUSPENSION",
                        "Felbamate 600 mg in 5 mL ORAL SUSPENSION",
                        "felbamate 600 MG in 5 mL Oral Suspension",
                        "felbamate 600 MG per 5 ML Oral Suspension",
                        "FELBAMATE 600 mg in 5 mL ORAL SUSPENSION [Felbamate]",
                        "felbamate 600 mg/5 mL ORAL SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "felbamate@600 mg/5 mL@ORAL@SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "Product containing precisely felbamate 120 milligram/1 milliliter conventional release oral suspension (clinical drug)",
                        "FELBAMATE 600MG/5ML SUSP",
                        "FELBAMATE 600MG/5ML SUSP,ORAL",
                        "FELT 120 MG/ML Oral Suspension"
                    ],
                    "UMLS:C1239843": [
                        "felbamate Oral Suspension [Felbatol]"
                    ],
                    "UMLS:C0710706": [
                        "felbamate 120 MG/ML Oral Suspension [Felbatol]",
                        "Felbamate 600 MG/5 ML Oral Suspension [FELBATOL]",
                        "FELBAMATE 600 mg in 5 mL ORAL SUSPENSION [Felbatol]",
                        "Felbatol 600mg/5ml Suspension",
                        "Felbatol 120 MG/ML Oral Suspension",
                        "Felbatol 600 MG in 5 mL Oral Suspension",
                        "Felbatol 600 MG per 5 ML Oral Suspension",
                        "FELT 120 MG/ML Oral Suspension [Felbatol]"
                    ]
                }
            },
            {
                "label": "is recommended for use only in",
                "id": {}
            },
            {
                "label": "those patients who respond inadequately to alternative treatments",
                "id": {}
            }
        ],
        [
            {
                "label": "those patients",
                "id": {
                    "UMLS:C4713117": [
                        "Use a slide board to assist transfer to a chair or wheel chair for those patients with fair balance"
                    ],
                    "UMLS:C4710824": [
                        "Obtain a fasting blood glucose reading preprocedure and postprocedure for those patients who have insulin-dependent diabetes"
                    ],
                    "UMLS:C0547608": [
                        "Avoid exposing patient to persons with infectious diseases, including upper respiratory infections; or to those recently exposed or vaccinated; or to staff caring for infected patients."
                    ],
                    "UMLS:C4710266": [
                        "Target at risk patients (e.g., diabetics, smokers, elderly, hypertensive patients and those with elevated cholesterols levels) for comprehensive peripheral assessments and modification of risk factors"
                    ],
                    "UMLS:C5574463": [
                        "On date of encounter, patient is not able to participate in assessment or screening, including non-verbal patients, delirious, severely aphasic, severely developmentally delayed, severe visual or hearing impairment and for those patients, no knowledgeable informant available",
                        "Pt not able to participate"
                    ]
                }
            },
            {
                "label": "whose epilepsy",
                "id": {}
            },
            {
                "label": "is so severe",
                "id": {
                    "UMLS:C4036148": [
                        "Severe dysarthria; patient's speech is so slurred as to be unintelligible in the absence of or out of proportion to any dysphasia, or is mute/anarthric"
                    ]
                }
            }
        ],
        [
            {
                "label": "a substantial risk",
                "id": {
                    "UMLS:C2368534": [
                        "Documentation that a patient has a substantial risk of death within 1 year (pall cr)",
                        "Documentation that a patient has a substantial risk of death within 1 year (Pall Cr)",
                        "Doc pt rsk death w/in 1yr",
                        "DOC PT RSK DEATH W/IN 1YR",
                        "DOC PT W/SUBSTANTIAL RISK DEATH WITHIN 1 YEAR"
                    ],
                    "UMLS:C2368535": [
                        "Documentation that a patient does not have a substantial risk of death within one year (pall cr)",
                        "Documentation that a patient does not have a substantial risk of death within one year (Pall Cr)",
                        "DOC NO PT RSK DEATH W/IN 1YR",
                        "Doc no pt rsk death w/in 1yr",
                        "DOC PT W/O SUBSTANTIAL RISK DEATH WITHIN 1 YEAR"
                    ]
                }
            },
            {
                "label": "is deemed",
                "id": {
                    "UMLS:C4532833": [
                        "Is there documentation of reason(s) in the patient's medical record that the patient was deemed medically unready for SBT by day 2 of stay",
                        "Is there documentation of reason(s) in the patient's medical record that the patient was deemed medically unready for SBT by day 2 of stay?"
                    ],
                    "UMLS:C4532832": [
                        "Is there documentation of reason(s) in the patient's medical record that the patient was deemed medically unready for SBT by day 2 of stay? [CMS Assessment]",
                        "Is there documentation of reason(s) in the patient's medical record that the patient was deemed medically unready for SBT by day 2 of stay:Find:Pt:^Patient:Ord:CMS Assessment",
                        "Is there documentation of reason(s) in the patient's medical record that the patient was deemed medically unready for SBT by day 2 of stay:Finding:To identify measures at a point in time:^Patient:Ordinal:CMS Assessment"
                    ],
                    "UMLS:C4709693": [
                        "Establish that the least restrictive measure is being initiated (if a lower level was used, establish that it was deemed ineffective before advancing to the next level of restriction)"
                    ]
                }
            },
            {
                "label": "acceptable in light of the benefits conferred by its use",
                "id": {}
            }
        ]
    ],
    "If these criteria are met and the patient has been fully advised of the risk, and has provided written acknowledgment, felbamate oral suspension can be considered for either monotherapy or adjunctive therapy in the treatment of partial seizures, with and without generalization, in adults with epilepsy and as adjunctive therapy in the treatment of partial and generalized seizures associated with Lennox-Gastaut syndrome in children": [
        [
            {
                "label": "these criteria",
                "id": {}
            },
            {
                "label": "are met",
                "id": {
                    "UMLS:C0801034": [
                        "AV AV area method",
                        "Aortic valve area method",
                        "Aortic valve area method:Prid:Pt:Aortic valve:Nom:*",
                        "Aortic valve area method:Presence or Identity:Point in time:Aortic valve:Nominal:*",
                        "Aortic valve area method:Presence or Identity:To identify measures at a point in time:Aortic valve:Nominal:*"
                    ],
                    "UMLS:C0801833": [
                        "AV AV area method",
                        "Aortic valve area method Narrative",
                        "Aortic valve area method:Prid:Pt:Aortic valve:Nar:*",
                        "Aortic valve area method:Presence or Identity:Point in time:Aortic valve:Narrative:*",
                        "Aortic valve area method:Presence or Identity:To identify measures at a point in time:Aortic valve:Narrative:*"
                    ],
                    "UMLS:C0815251": [
                        "metropolitan area"
                    ],
                    "NCBITaxon:948077": [
                        "Arenimonas metalli",
                        "Arenimonas metalli Chen et al. 2012"
                    ],
                    "PUBCHEM.COMPOUND:135929": [
                        "arecolone methiodide",
                        "Pyridinium, 3-acetyl-1,2,5,6-tetrahydro-1,1-dimethyl-, iodide"
                    ]
                }
            },
            {
                "label": "",
                "id": {}
            }
        ],
        [
            {
                "label": "the patient",
                "id": {
                    "UMLS:C0524319": [
                        "Cooling the patient",
                        "Cooling the patient, NOS",
                        "Cooling the patient (procedure)"
                    ],
                    "UMLS:C0677169": [
                        "Educate the patient",
                        "educate the patient",
                        "educate patients",
                        "educated patients",
                        "educating patients"
                    ],
                    "UMLS:C1611695": [
                        "Patient thermometer",
                        "Patient Thermometers",
                        "Patient thermometer (physical object)"
                    ],
                    "UMLS:C0419179": [
                        "Starving the patient",
                        "NPO",
                        "nil peros",
                        "Nil per os",
                        "nil per os",
                        "Nil by mouth",
                        "nil by mouth",
                        "Fasting patient",
                        "fasting patients",
                        "nothing by mouth",
                        "Nothing by mouth",
                        "Nothing by Mouth",
                        "patients starving",
                        "NBM - Nil by mouth",
                        "doctor's orders: NPO",
                        "NPO - Nothing by mouth",
                        "Give nothing by mouth (NPO).",
                        "Nil by mouth (regime/therapy)",
                        "doctor's orders: NPO (treatment)"
                    ],
                    "UMLS:C1561964": [
                        "Positions the patient",
                        "Pt.psxn'g",
                        "Positioning",
                        "Positions patient",
                        "Patient positioning",
                        "Positioning patient",
                        "Patient Positioning",
                        "patient positioning",
                        "positioning patient",
                        "Patient Positionings",
                        "Positioning, Patient",
                        "Patients--Positioning",
                        "Positionings, Patient",
                        "patient positioning procedure",
                        "Putting patient in a position",
                        "Positioning patient (procedure)",
                        "Patient positioning each 15 minutes"
                    ]
                }
            },
            {
                "label": "has been fully advised of the risk",
                "id": {}
            },
            {
                "label": "",
                "id": {}
            }
        ],
        [
            {
                "label": "felbamate oral suspension",
                "id": {
                    "UMLS:C1246189": [
                        "felbamate Oral Suspension",
                        "Felbamate Oral Suspension"
                    ],
                    "UMLS:C0976868": [
                        "Felbamate 600mg/5mL Oral suspension",
                        "felbamate 120 MG/ML Oral Suspension",
                        "Felbamate 120 mg/mL oral suspension",
                        "felbamate 600 mg/5 mL oral suspension",
                        "Felbamate 600 MG/5 ML Oral Suspension",
                        "Felbamate, 600 mg/5 mL oral suspension",
                        "FELBAMATE 600 mg in 5 mL ORAL SUSPENSION",
                        "Felbamate 600 mg in 5 mL ORAL SUSPENSION",
                        "felbamate 600 MG in 5 mL Oral Suspension",
                        "felbamate 600 MG per 5 ML Oral Suspension",
                        "FELBAMATE 600 mg in 5 mL ORAL SUSPENSION [Felbamate]",
                        "felbamate 600 mg/5 mL ORAL SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "felbamate@600 mg/5 mL@ORAL@SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "Product containing precisely felbamate 120 milligram/1 milliliter conventional release oral suspension (clinical drug)",
                        "FELBAMATE 600MG/5ML SUSP",
                        "FELBAMATE 600MG/5ML SUSP,ORAL",
                        "FELT 120 MG/ML Oral Suspension"
                    ],
                    "UMLS:C1239843": [
                        "felbamate Oral Suspension [Felbatol]"
                    ],
                    "UMLS:C0710706": [
                        "felbamate 120 MG/ML Oral Suspension [Felbatol]",
                        "Felbamate 600 MG/5 ML Oral Suspension [FELBATOL]",
                        "FELBAMATE 600 mg in 5 mL ORAL SUSPENSION [Felbatol]",
                        "Felbatol 600mg/5ml Suspension",
                        "Felbatol 120 MG/ML Oral Suspension",
                        "Felbatol 600 MG in 5 mL Oral Suspension",
                        "Felbatol 600 MG per 5 ML Oral Suspension",
                        "FELT 120 MG/ML Oral Suspension [Felbatol]"
                    ]
                }
            },
            {
                "label": "can be considered for either monotherapy or adjunctive therapy",
                "id": {}
            },
            {
                "label": "in the treatment of partial seizures",
                "id": {}
            }
        ],
        [
            {
                "label": "seizures",
                "id": {
                    "MONDO:0005027": [
                        "seizures",
                        "Seizures",
                        "seizures syndrome",
                        "disorder seizures",
                        "disorders seizures",
                        "epileptic seizures",
                        "Epileptic Seizures",
                        "seizures syndromes",
                        "Seizures, Epileptic",
                        "Epileptic seizures NOS",
                        "Epileptic seizures, NOS",
                        "CLINICAL EPILEPTIC SYNDROMES AND SEIZURES",
                        "A-30-31 CLINICAL EPILEPTIC SYNDROMES AND SEIZURES",
                        "sz",
                        "fit",
                        "Fit",
                        "fits",
                        "fit's",
                        "fitted",
                        "Fit(s)",
                        "SEIZURE",
                        "Seizure",
                        "seizure",
                        "Fitting",
                        "Epilepsy",
                        "Fit, NOS",
                        "epilepsy",
                        "EPILEPSY",
                        "Fits NOS",
                        "Epilepsy",
                        "FITS NOS",
                        "epilepsy",
                        "Epileptic",
                        "seizure d",
                        "epilepsis",
                        "epileptic",
                        "epilepsia",
                        "epileptics",
                        "Convulsion",
                        "convulsion",
                        "epilepsies",
                        "CONVULSION",
                        "Epilepsies",
                        "SEIZURE DIS",
                        "CONVULSIONS",
                        "Seizure NOS",
                        "convulsions",
                        "Convulsions",
                        "Seizure, NOS",
                        "Epilepsy NOS",
                        "epileptic fit",
                        "epilepsy; fit",
                        "Epilepsy, NOS",
                        "Epileptic fit",
                        "EP - Epilepsy",
                        "fit; epileptic",
                        "epilepsy types",
                        "epileptic fits",
                        "Convulsion, NOS",
                        "Convulsions NOS",
                        "morbus; caducus",
                        "caducus; morbus",
                        "convulsions nos",
                        "seizure disorder",
                        "Fit - convulsion",
                        "epileptic attack",
                        "seizure syndrome",
                        "Seizure Disorder",
                        "disorder seizure",
                        "syndrome seizure",
                        "SEIZURE DISORDER",
                        "Seizure syndrome",
                        "CONVULSION (NOS)",
                        "Epileptic attack",
                        "Seizure disorder",
                        "Epileptic Seizure",
                        "Seizure Syndromes",
                        "Types of epilepsy",
                        "seizure epileptic",
                        "seizure disorders",
                        "disorder epilepsy",
                        "attacks epileptic",
                        "epileptic seizure",
                        "Seizure;epileptic",
                        "epilepsy; seizure",
                        "Epileptic seizure",
                        "epilepsy syndrome",
                        "Seizure Disorders",
                        "Seizure (finding)",
                        "disorders seizure",
                        "epileptic syndrome",
                        "Epileptic disorder",
                        "EF - Epileptic fit",
                        "Fits - convulsions",
                        "Epileptic fits NOS",
                        "Epilepsy all types",
                        "epilepsy; cerebral",
                        "Convulsion/Seizure",
                        "seizure; epileptic",
                        "epilepsy; cortical",
                        "Seizure, Epileptic",
                        "epileptic; syndrome",
                        "Epileptic fits, NOS",
                        "cerebral; epileptic",
                        "syndrome; epileptic",
                        "disorders epileptic",
                        "Epilepsy (disorder)",
                        "A70-A72 CONVULSIONS",
                        "epilepsy (diagnosis)",
                        "Seizure disorder NOS",
                        "Epileptic convulsion",
                        "convulsion epileptic",
                        "Epilepsy, unspecified",
                        "Epileptic attack, NOS",
                        "convulsions (symptom)",
                        "epileptic; convulsions",
                        "convulsions; epileptic",
                        "Epileptic disorder, NOS",
                        "Epileptic convulsions NOS",
                        "seizure (physical finding)",
                        "Epileptic convulsions, NOS",
                        "CLINICAL EPILEPSY DIAGNOSES",
                        "Epileptic seizure (finding)",
                        "Seizure disorder (disorder)",
                        "A-30 CLINICAL EPILEPSY DIAGNOSES"
                    ],
                    "MONDO:0001386": [
                        "Seizures",
                        "Visual Seizures",
                        "Seizures, Visual",
                        "seizure visual",
                        "Visual Seizure",
                        "Visual seizure",
                        "visual seizure",
                        "Seizure, Visual",
                        "visual epilepsy",
                        "epilepsy visual",
                        "visual epilepsy",
                        "Visual epilepsy",
                        "Visual Epilepsy",
                        "Epilepsy, visual",
                        "epilepsy; visual",
                        "epilepsy, visual",
                        "epilepsy, visual",
                        "visual; epileptic",
                        "Hallucination seizure",
                        "Seizure, hallucination",
                        "Visual epilepsy (disorder)",
                        "visual partial simple seizure",
                        "visual partial simple seizure (diagnosis)"
                    ],
                    "UMLS:C1856553": [
                        "No seizures"
                    ],
                    "HP:0033053": [
                        "Sham seizures",
                        "Factitious seizures",
                        "hysterical seizures",
                        "Hysterical seizures",
                        "psychogenic seizures",
                        "Psychogenic seizures",
                        "Dissociative seizures",
                        "Dissociative Seizures",
                        "Psychogenic Nonepileptic Seizures",
                        "pseudoseizure",
                        "Pseudoseizure",
                        "pseudoseizures",
                        "Pseudoseizures",
                        "Hysterical fit",
                        "fit; hysterical",
                        "hysterical; fit",
                        "Hysterical fits",
                        "hysterical seizure",
                        "Psychogenic Seizure",
                        "Psychogenic seizure",
                        "psychogenic seizure",
                        "seizure; hysterical",
                        "Dissociative Seizure",
                        "Seizure, Dissociative",
                        "hysteria; convulsions",
                        "convulsions; hysteria",
                        "hysterical; convulsions",
                        "convulsions; hysterical",
                        "Dissociative convulsions",
                        "dissociative; convulsions",
                        "Psychogenic Pseudoseizure",
                        "convulsions; dissociative",
                        "Psychogenic Pseudoseizures",
                        "Psychogenic Nonepileptic Seizure",
                        "Seizure, Psychogenic Nonepileptic",
                        "Nonepileptic Seizure, Psychogenic",
                        "Psychogenic Non-Epileptic Seizure",
                        "Psychogenic non-epileptic seizure",
                        "Dissociative convulsions (disorder)",
                        "Dissociative convulsions (diagnosis)",
                        "factitious disorder dissociative convulsions",
                        "attack; hysterical, convulsive (hysterical seizure)",
                        "seizure; hysterical, convulsive (hysterical seizure)"
                    ],
                    "HP:0010819": [
                        "Drop seizures",
                        "Atonic seizures",
                        "atonic seizures",
                        "Atonic Seizures",
                        "ATONIC SEIZURES",
                        "atonic; seizures",
                        "astatic seizures",
                        "Seizures, atonic",
                        "Astatic seizures",
                        "Hypotonic seizures",
                        "Hypotonic seizures",
                        "Drop attacks",
                        "Atonic seizure",
                        "atonic seizure",
                        "Atonic Seizure",
                        "Seizure;atonic",
                        "seizure; atonic",
                        "Seizure, Atonic",
                        "Astatic seizure",
                        "astatic seizure",
                        "Hypotonic seizure",
                        "Epileptic drop attack",
                        "atonic seizure disorder",
                        "atonic seizure was noted",
                        "Atonic seizure (disorder)",
                        "Sudden loss of muscle tone",
                        "atonic seizure (diagnosis)",
                        "Sudden loss of muscle tone",
                        "Epileptic drop attack (disorder)",
                        "atonic seizure (physical finding)"
                    ]
                }
            },
            {
                "label": "without",
                "id": {
                    "UMLS:C0332288": [
                        "Without",
                        "without",
                        "Without (attribute)",
                        "MI",
                        "nono",
                        "Minus",
                        "minus"
                    ],
                    "UMLS:C3827452": [
                        "Without Help"
                    ],
                    "MONDO:0018849": [
                        "DGI without OI",
                        "Opalescent teeth without OI",
                        "opalescent teeth without OI",
                        "Opalescent teeth without osteogenesis imperfecta",
                        "opalescent teeth without osteogenesis imperfecta",
                        "dentinogenesis imperfecta without osteogenesis imperfecta",
                        "Dentinogenesis imperfecta without osteogenesis imperfecta",
                        "DI",
                        "DGI",
                        "non-syndromic DGI",
                        "Non-syndromic DGI",
                        "dentinogenesis imperfecta",
                        "dentinogenesis imperfecta",
                        "Dentinogenesis Imperfecta",
                        "Dentinogenesis imperfecta",
                        "Hereditary opalescent dentin",
                        "dentinogenesis imperfecta (disease)",
                        "Dentinogenesis imperfecta (disorder)",
                        "dentinogenesis imperfecta (diagnosis)",
                        "Non-syndromic dentinogenesis imperfecta",
                        "non-syndromic dentinogenesis imperfecta"
                    ],
                    "UMLS:C2709100": [
                        "without clothes"
                    ],
                    "UMLS:C0445419": [
                        "Without remount",
                        "Without remount (qualifier value)"
                    ]
                }
            },
            {
                "label": "generalization",
                "id": {
                    "UMLS:C0017324": [
                        "generalization",
                        "Generalization",
                        "generalizations",
                        "GENERALIZATION PSYCHOL",
                        "Psychology Generalization",
                        "Generalization, Psychology",
                        "Psychology Generalizations",
                        "Generalization (Psychology)",
                        "Generalizations, Psychology",
                        "Generalizations (Psychology)",
                        "Psychological Generalization",
                        "Generalization, Psychological",
                        "Psychological Generalizations",
                        "Generalizations, Psychological"
                    ],
                    "UMLS:C1550547": [
                        "has generalization",
                        "has generalization - ActRelationshipType"
                    ],
                    "UMLS:C1550606": [
                        "has generalization",
                        "has generalization - RoleClass"
                    ],
                    "UMLS:C0017325": [
                        "Response Generalization",
                        "response generalization",
                        "Generalization, Response",
                        "Response Generalizations",
                        "Generalizations, Response",
                        "Generalization (Response)"
                    ],
                    "UMLS:C0017326": [
                        "Stimulus generalization",
                        "stimulus generalization",
                        "Stimulus Generalization",
                        "Stimulus Generalizations",
                        "Generalization, Stimulus",
                        "Generalization (Stimulus)",
                        "Generalizations, Stimulus",
                        "Stimulus generalization, function",
                        "Stimulus generalization, function (observable entity)",
                        "Stimulus generalisation"
                    ]
                }
            }
        ],
        [
            {
                "label": "felbamate oral suspension",
                "id": {
                    "UMLS:C1246189": [
                        "felbamate Oral Suspension",
                        "Felbamate Oral Suspension"
                    ],
                    "UMLS:C0976868": [
                        "Felbamate 600mg/5mL Oral suspension",
                        "felbamate 120 MG/ML Oral Suspension",
                        "Felbamate 120 mg/mL oral suspension",
                        "felbamate 600 mg/5 mL oral suspension",
                        "Felbamate 600 MG/5 ML Oral Suspension",
                        "Felbamate, 600 mg/5 mL oral suspension",
                        "FELBAMATE 600 mg in 5 mL ORAL SUSPENSION",
                        "Felbamate 600 mg in 5 mL ORAL SUSPENSION",
                        "felbamate 600 MG in 5 mL Oral Suspension",
                        "felbamate 600 MG per 5 ML Oral Suspension",
                        "FELBAMATE 600 mg in 5 mL ORAL SUSPENSION [Felbamate]",
                        "felbamate 600 mg/5 mL ORAL SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "felbamate@600 mg/5 mL@ORAL@SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "Product containing precisely felbamate 120 milligram/1 milliliter conventional release oral suspension (clinical drug)",
                        "FELBAMATE 600MG/5ML SUSP",
                        "FELBAMATE 600MG/5ML SUSP,ORAL",
                        "FELT 120 MG/ML Oral Suspension"
                    ],
                    "UMLS:C1239843": [
                        "felbamate Oral Suspension [Felbatol]"
                    ],
                    "UMLS:C0710706": [
                        "felbamate 120 MG/ML Oral Suspension [Felbatol]",
                        "Felbamate 600 MG/5 ML Oral Suspension [FELBATOL]",
                        "FELBAMATE 600 mg in 5 mL ORAL SUSPENSION [Felbatol]",
                        "Felbatol 600mg/5ml Suspension",
                        "Felbatol 120 MG/ML Oral Suspension",
                        "Felbatol 600 MG in 5 mL Oral Suspension",
                        "Felbatol 600 MG per 5 ML Oral Suspension",
                        "FELT 120 MG/ML Oral Suspension [Felbatol]"
                    ]
                }
            },
            {
                "label": "can be considered as adjunctive therapy",
                "id": {}
            },
            {
                "label": "in the treatment of partial and generalized seizures associated with Lennox-Gastaut syndrome in children",
                "id": {}
            }
        ]
    ],
    "Vigabatrin for oral solution is indicated as adjunctive therapy for adults and pediatric patients 2 years of age and older with refractory complex partial seizures who have inadequately responded to several alternative treatments and for whom the potential benefits outweigh the risk of vision loss": [
        [
            {
                "label": "Vigabatrin for oral solution",
                "id": {
                    "UMLS:C4529382": [
                        "Vigabatrin for Oral Solution",
                        "vigabatrin Powder for Oral Solution"
                    ],
                    "UMLS:C0792775": [
                        "VIGABATRIN 500 mg ORAL FOR SOLUTION",
                        "vigabatrin 500 MG Powder for Oral Solution",
                        "VIGABATRIN 500 mg ORAL POWDER, FOR SOLUTION",
                        "Vigabatrin 500 mg powder for oral solution sachet",
                        "VIGABATRIN 50 mg in 1 mL ORAL POWDER, FOR SOLUTION",
                        "Vigabatrin 50 mg in 1 mL ORAL POWDER, FOR SOLUTION",
                        "Vigabatrin 500 MG/1 PACKET Oral Powder for Solution",
                        "Vigabatrin 500 mg in 10 mL ORAL POWDER, FOR SOLUTION",
                        "VIGABATRIN 50 mg in 1 mL ORAL FOR SOLUTION [Vigabatrin]",
                        "VIGABATRIN 500 mg ORAL POWDER, FOR SOLUTION [VIGABATRIN]",
                        "VIGABATRIN 50 mg in 1 mL ORAL POWDER, FOR SOLUTION [VIGABATRIN]",
                        "VIGABATRIN 500 mg in 1 mL ORAL POWDER, FOR SOLUTION [VIGABATRIN]",
                        "VIGABATRIN 500 mg ORAL FOR SOLUTION [Vigabatrin for oral solution USP, 500 mg]",
                        "VIGABATRIN 50 mg in 1 mL ORAL FOR SOLUTION [Vigabatrin for oral solution USP, 500 mg]",
                        "Product containing precisely vigabatrin 500 milligram/1 sachet powder for conventional release oral solution (clinical drug)",
                        "VIGABATRIN 500MG/PKT PWDR",
                        "Vigabatrin 500mg Oral powder",
                        "Vigabatrin 500mg/sachet powder",
                        "vigabatrin@500 mg@ORAL@POWDER IN PACKET (EA)",
                        "vigabatrin 500 mg ORAL POWDER IN PACKET (EA)",
                        "vigabatrin 500 mg oral powder for reconstitution",
                        "Vigabatrin, 500 mg oral powder for reconstitution"
                    ],
                    "UMLS:C4529383": [
                        "vigabatrin Powder for Oral Solution [Sabril]"
                    ],
                    "UMLS:C4695085": [
                        "vigabatrin Powder for Oral Solution [Vigadrone]"
                    ],
                    "UMLS:C2719725": [
                        "vigabatrin 500 MG Powder for Oral Solution [Sabril]",
                        "VIGABATRIN 50 mg in 1 mL ORAL POWDER, FOR SOLUTION [SABRIL]",
                        "Vigabatrin 500 MG/1 PACKET Oral Powder for Solution [SABRIL]",
                        "Sabril 500mg Powder for Solution",
                        "Sabril 500 MG Powder for Oral Solution",
                        "Sabril, 500 mg oral powder for reconstitution",
                        "Sabril 50 MG/ML (500 MG packet) Powder for Oral Solution"
                    ]
                }
            },
            {
                "label": "is indicated as",
                "id": {
                    "UMLS:C4710292": [
                        "Assure that someone is oxygenating the patient and assisting with intubation, as indicated"
                    ],
                    "UMLS:C4713987": [
                        "Assure that the surgical site is marked with a permanent marker by the surgeon, as indicated"
                    ],
                    "UMLS:C4714380": [
                        "Perform targeted assessment of the system that is indicated by the history of present illness"
                    ],
                    "UMLS:C4711109": [
                        "Ensure that equipment is operational via trial run (i.e., assemble laryngoscope and check light bulb function), as indicated"
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ]
                }
            },
            {
                "label": "adjunctive therapy for adults and pediatric patients 2 years of age and older with refractory complex partial seizures",
                "id": {}
            }
        ],
        [
            {
                "label": "adults and pediatric patients 2 years of age and older with refractory complex partial seizures",
                "id": {}
            },
            {
                "label": "have inadequately responded to",
                "id": {}
            },
            {
                "label": "several alternative treatments",
                "id": {}
            }
        ],
        [
            {
                "label": "for whom",
                "id": {
                    "UMLS:C4725064": [
                        "Knew Whom to Contact for Questions",
                        "Know Who to Contact for Questions",
                        "I knew who to contact when I had a question"
                    ],
                    "UMLS:C3533328": [
                        "For whom did you work for at your main job or business"
                    ],
                    "UMLS:C3171831": [
                        "For whom did you work for at your main job or business [NHANES]",
                        "For whom did you work for at your main job or business:Find:Pt:^Patient:Nom:NHANES",
                        "For whom did you work for at your main job or business:Finding:To identify measures at a point in time:^Patient:Nominal:NHANES",
                        "Job employer NHANES"
                    ],
                    "UMLS:C0694908": [
                        "Esrd patient for whom less than six dialysis sessions have been provided in a month",
                        "Esrd patient <6 dialysis/mth"
                    ],
                    "UMLS:C0514592": [
                        "Provide a low-stimulation environment for patient in whom disorientation is increased by overstimulation"
                    ]
                }
            },
            {
                "label": "the potential benefits outweigh",
                "id": {}
            },
            {
                "label": "the risk of vision loss",
                "id": {
                    "UMLS:C2012306": [
                        "the goal is to reduce the risk of vision loss",
                        "ophthalmology goal to reduce risk of vision loss",
                        "ophthalmology goal to reduce risk of vision loss (treatment)"
                    ],
                    "UMLS:C2012304": [
                        "the goal is to reduce the risk of central vision loss",
                        "ophthalmology goal to reduce risk of central vision loss",
                        "ophthalmology goal to reduce risk of central vision loss (treatment)"
                    ],
                    "UMLS:C2012305": [
                        "the goal is to reduce the risk of peripheral vision loss",
                        "ophthalmology goal to reduce risk of peripheral vision loss",
                        "ophthalmology goal to reduce risk of peripheral vision loss (treatment)"
                    ]
                }
            }
        ]
    ],
    "Vigabatrin for oral solution is indicated as monotherapy for pediatric patients with infantile spasms 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss": [
        [
            {
                "label": "Vigabatrin for oral solution",
                "id": {
                    "UMLS:C4529382": [
                        "Vigabatrin for Oral Solution",
                        "vigabatrin Powder for Oral Solution"
                    ],
                    "UMLS:C0792775": [
                        "VIGABATRIN 500 mg ORAL FOR SOLUTION",
                        "vigabatrin 500 MG Powder for Oral Solution",
                        "VIGABATRIN 500 mg ORAL POWDER, FOR SOLUTION",
                        "Vigabatrin 500 mg powder for oral solution sachet",
                        "VIGABATRIN 50 mg in 1 mL ORAL POWDER, FOR SOLUTION",
                        "Vigabatrin 50 mg in 1 mL ORAL POWDER, FOR SOLUTION",
                        "Vigabatrin 500 MG/1 PACKET Oral Powder for Solution",
                        "Vigabatrin 500 mg in 10 mL ORAL POWDER, FOR SOLUTION",
                        "VIGABATRIN 50 mg in 1 mL ORAL FOR SOLUTION [Vigabatrin]",
                        "VIGABATRIN 500 mg ORAL POWDER, FOR SOLUTION [VIGABATRIN]",
                        "VIGABATRIN 50 mg in 1 mL ORAL POWDER, FOR SOLUTION [VIGABATRIN]",
                        "VIGABATRIN 500 mg in 1 mL ORAL POWDER, FOR SOLUTION [VIGABATRIN]",
                        "VIGABATRIN 500 mg ORAL FOR SOLUTION [Vigabatrin for oral solution USP, 500 mg]",
                        "VIGABATRIN 50 mg in 1 mL ORAL FOR SOLUTION [Vigabatrin for oral solution USP, 500 mg]",
                        "Product containing precisely vigabatrin 500 milligram/1 sachet powder for conventional release oral solution (clinical drug)",
                        "VIGABATRIN 500MG/PKT PWDR",
                        "Vigabatrin 500mg Oral powder",
                        "Vigabatrin 500mg/sachet powder",
                        "vigabatrin@500 mg@ORAL@POWDER IN PACKET (EA)",
                        "vigabatrin 500 mg ORAL POWDER IN PACKET (EA)",
                        "vigabatrin 500 mg oral powder for reconstitution",
                        "Vigabatrin, 500 mg oral powder for reconstitution"
                    ],
                    "UMLS:C4529383": [
                        "vigabatrin Powder for Oral Solution [Sabril]"
                    ],
                    "UMLS:C4695085": [
                        "vigabatrin Powder for Oral Solution [Vigadrone]"
                    ],
                    "UMLS:C2719725": [
                        "vigabatrin 500 MG Powder for Oral Solution [Sabril]",
                        "VIGABATRIN 50 mg in 1 mL ORAL POWDER, FOR SOLUTION [SABRIL]",
                        "Vigabatrin 500 MG/1 PACKET Oral Powder for Solution [SABRIL]",
                        "Sabril 500mg Powder for Solution",
                        "Sabril 500 MG Powder for Oral Solution",
                        "Sabril, 500 mg oral powder for reconstitution",
                        "Sabril 50 MG/ML (500 MG packet) Powder for Oral Solution"
                    ]
                }
            },
            {
                "label": "is indicated",
                "id": {
                    "UMLS:C1548409": [
                        "The indicated appointment is booked"
                    ],
                    "UMLS:C1548408": [
                        "The indicated time slot(s) is(are) blocked"
                    ],
                    "UMLS:C4489688": [
                        "No, and walking goal is clinically indicated"
                    ],
                    "UMLS:C4489223": [
                        "No, and walking goal is not clinically indicated"
                    ],
                    "UMLS:C1548417": [
                        "The indicated appointment has begun and is currently in progress"
                    ]
                }
            },
            {
                "label": "as monotherapy for pediatric patients with infantile spasms 1 month to 2 years of age",
                "id": {}
            }
        ],
        [
            {
                "label": "the potential benefits",
                "id": {}
            },
            {
                "label": "outweigh",
                "id": {
                    "UMLS:C4331379": [
                        "TSQM Version 1.4 - Certain Good Things Outweigh Bad"
                    ],
                    "UMLS:C3831148": [
                        "Certainty that Good Outweighs the Bad Things About Medication"
                    ],
                    "UMLS:C4714456": [
                        "Determine need for transfer of patient, ensuring that the patient requires treatment at the receiving facility and the benefits of the transfer outweigh the risks"
                    ]
                }
            },
            {
                "label": "the potential risk of vision loss",
                "id": {}
            }
        ]
    ],
    "Extended phenytoin sodium capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery": [
        [
            {
                "label": "Extended phenytoin sodium capsules",
                "id": {
                    "UMLS:C4720033": [
                        "Extended Phenytoin Sodium Capsules"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures",
                "id": {}
            }
        ],
        [
            {
                "label": "Extended phenytoin sodium capsules",
                "id": {
                    "UMLS:C4720033": [
                        "Extended Phenytoin Sodium Capsules"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "prevention and treatment of seizures occurring during or following neurosurgery",
                "id": {}
            }
        ]
    ],
    "Fosphenytoin sodium injection is indicated for the treatment of generalized tonic-clonic status epilepticus and prevention and treatment of seizures occurring during neurosurgery.": [
        [
            {
                "label": "Fosphenytoin sodium injection",
                "id": {
                    "UMLS:C5222441": [
                        "Fosphenytoin Sodium Injection"
                    ],
                    "UMLS:C0812792": [
                        "Injection, fosphenytoin sodium, 750 mg",
                        "Injection, fosphenytoin sodi"
                    ],
                    "UMLS:C4048483": [
                        "fosphenytoin sodium 75 MG/ML Injection",
                        "Fosphenytoin sodium 75 mg/mL solution for injection",
                        "Fosphenytoin Sodium 75mg/1mL Solution for injection",
                        "Fosphenytoin Sodium 50 MG PE/1 ML Injection Solution",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [Fosphenytoin]",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION, SOLUTION [Fosphenytoin]",
                        "Product containing precisely fosphenytoin sodium 75 milligram/1 milliliter conventional release solution for injection (clinical drug)",
                        "FOSPHENYTOIN NA 50MG-PE/ML INJ"
                    ],
                    "UMLS:C0780444": [
                        "2 ML fosphenytoin sodium 75 MG/ML Injection",
                        "fosphenytoin sodium 100 MG PE per 2 ML Injection",
                        "Fosphenytoin Sodium 75mg/1mL Solution for injection_#1",
                        "fosphenytoin sodium 100 mg PE/2 mL INJECTION VIAL (ML)",
                        "fosphenytoin sodium@100 mg PE/2 mL@INJECTION@VIAL (ML)",
                        "Fosphenytoin Sodium 50 MG PE/1 ML Injection Solution_#1",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION",
                        "fosphenytoin sodium 150 MG (as PE 100 MG) per 2 ML Injection",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION, SOLUTION",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION [FOSPHENYTOIN SODIUM]",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION [Fosphenytoin Sodium]",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION [FOSPHENYTOIN SODIUM]",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION [Fosphenytoin Sodium]",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [Fosphenytoin]_#1",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION, SOLUTION [Fosphenytoin]_#1",
                        "fosphenytoin sodium 75 MG/ML (as phenytoin sodium equivalents 100 MG per 2 ML) Injection",
                        "FOSPHENYTOIN NA 50MG-PE/ML INJ_#1",
                        "fosphenytoin 100 mgPE/2 mL injectable solution",
                        "Fosphenytoin, 100 mgPE/2 mL injectable solution"
                    ],
                    "UMLS:C4048484": [
                        "10 ML fosphenytoin sodium 75 MG/ML Injection",
                        "fosphenytoin sodium 500 MG PE per 10 ML Injection",
                        "Fosphenytoin sodium 750mg/10mL injection concentrate",
                        "Fosphenytoin Sodium 75mg/1mL Solution for injection_#2",
                        "Fosphenytoin Sodium 50 MG PE/1 ML Injection Solution_#2",
                        "fosphenytoin sodium@500 mg PE/10 mL@INJECTION@VIAL (ML)",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION",
                        "fosphenytoin sodium 500 mg PE/10 mL INJECTION VIAL (ML)",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION",
                        "fosphenytoin sodium 750 MG (as PE 500 MG) per 10 ML Injection",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION, SOLUTION",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION [FOSPHENYTOIN SODIUM]",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION [Fosphenytoin Sodium]",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION [FOSPHENYTOIN SODIUM]",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION [Fosphenytoin Sodium]",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [Fosphenytoin]_#2",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION, SOLUTION [Fosphenytoin]_#2",
                        "fosphenytoin sodium 75 MG/ML (as phenytoin sodium equivalents 500 MG per 10 ML) Injection",
                        "Fosphenytoin Na 750mg/10mL inj",
                        "FOSPHENYTOIN NA 50MG-PE/ML INJ_#2",
                        "fosphenytoin 500 mgPE/10 mL injectable solution",
                        "Fosphenytoin, 500 mgPE/10 mL injectable solution"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of generalized tonic-clonic status epilepticus",
                "id": {}
            }
        ],
        [
            {
                "label": "Fosphenytoin sodium injection",
                "id": {
                    "UMLS:C5222441": [
                        "Fosphenytoin Sodium Injection"
                    ],
                    "UMLS:C0812792": [
                        "Injection, fosphenytoin sodium, 750 mg",
                        "Injection, fosphenytoin sodi"
                    ],
                    "UMLS:C4048483": [
                        "fosphenytoin sodium 75 MG/ML Injection",
                        "Fosphenytoin sodium 75 mg/mL solution for injection",
                        "Fosphenytoin Sodium 75mg/1mL Solution for injection",
                        "Fosphenytoin Sodium 50 MG PE/1 ML Injection Solution",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [Fosphenytoin]",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION, SOLUTION [Fosphenytoin]",
                        "Product containing precisely fosphenytoin sodium 75 milligram/1 milliliter conventional release solution for injection (clinical drug)",
                        "FOSPHENYTOIN NA 50MG-PE/ML INJ"
                    ],
                    "UMLS:C0780444": [
                        "2 ML fosphenytoin sodium 75 MG/ML Injection",
                        "fosphenytoin sodium 100 MG PE per 2 ML Injection",
                        "Fosphenytoin Sodium 75mg/1mL Solution for injection_#1",
                        "fosphenytoin sodium 100 mg PE/2 mL INJECTION VIAL (ML)",
                        "fosphenytoin sodium@100 mg PE/2 mL@INJECTION@VIAL (ML)",
                        "Fosphenytoin Sodium 50 MG PE/1 ML Injection Solution_#1",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION",
                        "fosphenytoin sodium 150 MG (as PE 100 MG) per 2 ML Injection",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION, SOLUTION",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION [FOSPHENYTOIN SODIUM]",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION [Fosphenytoin Sodium]",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION [FOSPHENYTOIN SODIUM]",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION [Fosphenytoin Sodium]",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [Fosphenytoin]_#1",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION, SOLUTION [Fosphenytoin]_#1",
                        "fosphenytoin sodium 75 MG/ML (as phenytoin sodium equivalents 100 MG per 2 ML) Injection",
                        "FOSPHENYTOIN NA 50MG-PE/ML INJ_#1",
                        "fosphenytoin 100 mgPE/2 mL injectable solution",
                        "Fosphenytoin, 100 mgPE/2 mL injectable solution"
                    ],
                    "UMLS:C4048484": [
                        "10 ML fosphenytoin sodium 75 MG/ML Injection",
                        "fosphenytoin sodium 500 MG PE per 10 ML Injection",
                        "Fosphenytoin sodium 750mg/10mL injection concentrate",
                        "Fosphenytoin Sodium 75mg/1mL Solution for injection_#2",
                        "Fosphenytoin Sodium 50 MG PE/1 ML Injection Solution_#2",
                        "fosphenytoin sodium@500 mg PE/10 mL@INJECTION@VIAL (ML)",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION",
                        "fosphenytoin sodium 500 mg PE/10 mL INJECTION VIAL (ML)",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION",
                        "fosphenytoin sodium 750 MG (as PE 500 MG) per 10 ML Injection",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION, SOLUTION",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION [FOSPHENYTOIN SODIUM]",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION [Fosphenytoin Sodium]",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION [FOSPHENYTOIN SODIUM]",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION [Fosphenytoin Sodium]",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION [Fosphenytoin]_#2",
                        "FOSPHENYTOIN SODIUM 50 mg in 1 mL INTRAMUSCULAR INJECTION, SOLUTION [Fosphenytoin]_#2",
                        "fosphenytoin sodium 75 MG/ML (as phenytoin sodium equivalents 500 MG per 10 ML) Injection",
                        "Fosphenytoin Na 750mg/10mL inj",
                        "FOSPHENYTOIN NA 50MG-PE/ML INJ_#2",
                        "fosphenytoin 500 mgPE/10 mL injectable solution",
                        "Fosphenytoin, 500 mgPE/10 mL injectable solution"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "prevention and treatment of seizures occurring during neurosurgery",
                "id": {}
            }
        ]
    ],
    "NUPLAZID® is indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis": [
        [
            {
                "label": "NUPLAZID®",
                "id": {
                    "UMLS:C4238587": [
                        "Nuplazid"
                    ],
                    "PUBCHEM.COMPOUND:11672491": [
                        "Nuplazid",
                        "ACP-103",
                        "ACP 103",
                        "Pimavanserin tartrate",
                        "pimavanserin tartrate",
                        "PIMAVANSERIN TARTRATE",
                        "pimavanserin hemitartrate",
                        "Bis(1-(4-Fluorobenzyl)-1-(1-methylpiperidin-4-yl)-3-(4-(2-methylpropoxy)benzyl)urea) (2R,3R)-2,3-dihydroxybutanedioate",
                        "bis{N-[(4-fluorophenyl)methyl]-N-(1-methylpiperidin-4-yl)-N'-{[4-(2-methylpropoxy)phenyl]methyl}urea} (2R,3R)-2,3-dihydroxybutanedioate",
                        "bis(4-{[(4-fluorophenyl)methyl]({[4-(2-methylpropoxy)phenyl]methyl}carbamoyl)amino}-1-methylpiperidin-1-ium) (2R,3R)-2,3-dihydroxybutanedioate"
                    ],
                    "HMDB:HMDB0256551": [
                        "Nuplazid",
                        "ACP 103",
                        "ACP-103",
                        "Pimavanserin",
                        "Pimavanserin tartrate",
                        "N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide",
                        "N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl) carbamide",
                        "Bis(1-(4-fluorobenzyl)-1-(1-methylpiperidin-4-yl)-3-(4-(2-methylpropoxy)benzyl)urea) (2R,3R)-2,3-dihydroxybutanedioate",
                        "Urea, N-((4-fluorophenyl)methyl)-N-(1-methyl-4-piperidinyl)-n'-((4-(2-methylpropoxy)phenyl)methyl)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1)"
                    ],
                    "UMLS:C4238591": [
                        "Nuplazid Pill"
                    ],
                    "UMLS:C4704361": [
                        "NUPLAZID 10mg Tablet",
                        "Nuplazid 10 MG Oral Tablet",
                        "NUPLAZID 10 MG Oral Tablet",
                        "Nuplazid, 10 mg oral tablet",
                        "Pimavanserin 10 MG Oral Tablet [NUPLAZID]",
                        "pimavanserin 10 MG Oral Tablet [Nuplazid]",
                        "pimavanserin tartrate 10 mg ORAL TABLET, COATED [NUPLAZID]",
                        "pimavanserin 10 mg (as pimavanserin tartrate 11.8 MG) Oral Tablet [Nuplazid]"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of hallucinations and delusions associated with Parkinson's disease psychosis",
                "id": {}
            }
        ]
    ],
    "Risperidone tablets are indicated for the acute and maintenance treatment of schizophrenia": [
        [
            {
                "label": "Risperidone tablets",
                "id": {
                    "UMLS:C1247861": [
                        "Risperidone Tablets",
                        "risperidone Oral Tablet",
                        "risperiDONE Oral Tablet"
                    ],
                    "UMLS:C1321642": [
                        "Risperidone Orally Disintegrating Tablets",
                        "risperidone Disintegrating Oral Tablet",
                        "risperiDONE Disintegrating Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the acute and maintenance treatment of schizophrenia",
                "id": {}
            }
        ]
    ],
    "Due to Janssen Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled for use in pediatric patients with schizophrenia.": [
        [
            {
                "label": "Janssen Pharmaceuticals Corporation’s marketing exclusivity rights",
                "id": {}
            },
            {
                "label": "Due to",
                "id": {
                    "UMLS:C0678226": [
                        "Due To",
                        "due to",
                        "Due to",
                        "Due to (attribute)",
                        "DT",
                        "due",
                        "resulting",
                        "Resulting from",
                        "resulting from"
                    ],
                    "MONDO:0012994": [
                        "DRD due to SRD",
                        "DRD due to SRD",
                        "dopa-responsive dystonia due to sepiapterin reductase deficiency",
                        "Dopa-Responsive Dystonia Due To Sepiapterin Reductase Deficiency",
                        "dopa-responsive dystonia due to sepiapterin reductase deficiency",
                        "Dopa-responsive dystonia due to sepiapterin reductase deficiency",
                        "Dopa responsive dystonia due to sepiapterin reductase deficiency",
                        "Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency",
                        "DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY",
                        "dystonia, DOPA-responsive, due to sepiapterin reductase deficiency",
                        "Dopa responsive dystonia due to sepiapterin reductase deficiency (disorder)",
                        "SRD",
                        "SRD",
                        "DYT-SPR",
                        "Spr Deficiency",
                        "SPR DEFICIENCY",
                        "SPR deficiency",
                        "SPR deficiency",
                        "Biopterin deficiency",
                        "Sepiapterin reductase defic",
                        "sepiapterin reductase deficiency",
                        "Sepiapterin Reductase Deficiency",
                        "sepiapterin reductase deficiency",
                        "Sepiapterin reductase deficiency",
                        "SEPIAPTERIN REDUCTASE DEFICIENCY",
                        "7,8-Dihydrobiopterin synthetase deficiency",
                        "Sepiapterin reductase deficiency (disorder)",
                        "autosomal recessive sepiapterin reductase-deficient DRD",
                        "Autosomal recessive sepiapterin reductase-deficient DRD"
                    ],
                    "UMLS:C1456116": [
                        "Due to cat hair"
                    ],
                    "UMLS:C1456117": [
                        "Due to dog hair"
                    ],
                    "MONDO:0100097": [
                        "CAD due to TBX4",
                        "congenital alveolar dysplasia due to TBX4"
                    ]
                }
            },
            {
                "label": "this drug product is not labeled for use in pediatric patients with schizophrenia",
                "id": {}
            }
        ]
    ],
    "Pediatric use information for the treatment of pediatric patients with schizophrenia, 13 to 17 years of age, is approved for Janssen Pharmaceuticals Corporation’s risperidone drug products.": [
        [
            {
                "label": "Pediatric use information for the treatment of pediatric patients with schizophrenia, 13 to 17 years of age",
                "id": {}
            },
            {
                "label": "is approved for",
                "id": {
                    "UMLS:C0520208": [
                        "Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram",
                        "Isoetharine non-comp unit",
                        "ISOETHARINE HCL, INHALATION SOLUTION ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER MILLIGRAM"
                    ],
                    "UMLS:C0520210": [
                        "Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram",
                        "Isoproterenol non-comp unit",
                        "ISOPROTERENOL HCL, INHALATION SOLUTION ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER MILLIGRAM"
                    ],
                    "UMLS:C0520207": [
                        "Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram",
                        "Isoetharine non-comp con",
                        "ISOETHARINE HYDROCHLORIDE, INHALATION SOLUTION ADMINISTERED THROUGH DME, CONCENTRATED FORM, PER MILLIGRAM"
                    ],
                    "UMLS:C0498960": [
                        "Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg",
                        "Pentamidine non-comp unit"
                    ],
                    "UMLS:C0520209": [
                        "Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram",
                        "Isoproterenol non-comp con",
                        "ISOPROTERENOL HCL, INHALATION SOLUTION ADMINISTERED THROUGH DME, CONCENTRATED FORM, PER MILLIGRAM"
                    ]
                }
            },
            {
                "label": "Janssen Pharmaceuticals Corporation’s risperidone drug products",
                "id": {}
            }
        ]
    ],
    "Risperidone tablets are indicated for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder in Adults": [
        [
            {
                "label": "Risperidone tablets",
                "id": {
                    "UMLS:C1247861": [
                        "Risperidone Tablets",
                        "risperidone Oral Tablet",
                        "risperiDONE Oral Tablet"
                    ],
                    "UMLS:C1321642": [
                        "Risperidone Orally Disintegrating Tablets",
                        "risperidone Disintegrating Oral Tablet",
                        "risperiDONE Disintegrating Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated",
                "id": {
                    "UMLS:C1548408": [
                        "The indicated time slot(s) is(are) blocked"
                    ],
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C0514907": [
                        "Provide input in areas of strength and development needs, as indicated"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4714006": [
                        "Activate the rapid response team if indicated by presence of trigger areas, per agency protocol"
                    ]
                }
            },
            {
                "label": "for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder in Adults",
                "id": {}
            }
        ]
    ],
    "Due to Janssen Pharmaceuticals Corporation’s marketing exclusivity rights, this drug product is not labeled for use in pediatric patients with bipolar mania.": [
        [
            {
                "label": "Janssen Pharmaceuticals Corporation’s marketing exclusivity rights",
                "id": {}
            },
            {
                "label": "is",
                "id": {
                    "UBERON:0002872": [
                        "IS",
                        "inferior salivary nucleus",
                        "Nucleus salivarius inferior",
                        "nucleus salivarius inferior",
                        "Inferior salivatory nucleus",
                        "inferior salivatary nucleus",
                        "inferior salivatory nucleus",
                        "Nucleus salivatorius inferior",
                        "nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior",
                        "Nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior nervi glossopharyngei",
                        "Nucleus salivatorius inferior nervi glossopharyngei"
                    ],
                    "OMIM:146850": [
                        "IS",
                        "ISCW",
                        "ISSCW",
                        "IMMUNE SUPPRESSION",
                        "STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO"
                    ],
                    "FB:FBgn0001274": [
                        "Is"
                    ],
                    "PUBCHEM.COMPOUND:7021816": [
                        "IS",
                        "isoleucylserine",
                        "Isoleucyl-Serine",
                        "L-isoleucyl-L-serine",
                        "Ile-Ser",
                        "L-Ile-L-Ser",
                        "CHEMBL56803"
                    ],
                    "UMLS:C0021632": [
                        "IS",
                        "INSTRUM",
                        "instrumentation",
                        "instrumentation aspects"
                    ]
                }
            },
            {
                "label": "not labeled for use in pediatric patients with bipolar mania",
                "id": {}
            }
        ],
        [
            {
                "label": "this drug product",
                "id": {}
            },
            {
                "label": "is not labeled for",
                "id": {}
            },
            {
                "label": "use in pediatric patients with bipolar mania",
                "id": {}
            }
        ]
    ],
    "Pediatric use information for the treatment of pediatric patients with bipolar mania, 10 to 17 years of age, is approved for Janssen Pharmaceuticals Corporation’s risperidone drug products.": [
        [
            {
                "label": "Pediatric use information for the treatment of pediatric patients with bipolar mania, 10 to 17 years of age",
                "id": {}
            },
            {
                "label": "is approved for",
                "id": {
                    "UMLS:C0520208": [
                        "Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram",
                        "Isoetharine non-comp unit",
                        "ISOETHARINE HCL, INHALATION SOLUTION ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER MILLIGRAM"
                    ],
                    "UMLS:C0520210": [
                        "Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram",
                        "Isoproterenol non-comp unit",
                        "ISOPROTERENOL HCL, INHALATION SOLUTION ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER MILLIGRAM"
                    ],
                    "UMLS:C0520207": [
                        "Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram",
                        "Isoetharine non-comp con",
                        "ISOETHARINE HYDROCHLORIDE, INHALATION SOLUTION ADMINISTERED THROUGH DME, CONCENTRATED FORM, PER MILLIGRAM"
                    ],
                    "UMLS:C0498960": [
                        "Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg",
                        "Pentamidine non-comp unit"
                    ],
                    "UMLS:C0520209": [
                        "Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram",
                        "Isoproterenol non-comp con",
                        "ISOPROTERENOL HCL, INHALATION SOLUTION ADMINISTERED THROUGH DME, CONCENTRATED FORM, PER MILLIGRAM"
                    ]
                }
            },
            {
                "label": "Janssen Pharmaceuticals Corporation’s risperidone drug products",
                "id": {}
            }
        ],
        [
            {
                "label": "Janssen Pharmaceuticals Corporation’s risperidone drug products",
                "id": {}
            },
            {
                "label": "is",
                "id": {
                    "UBERON:0002872": [
                        "IS",
                        "inferior salivary nucleus",
                        "Nucleus salivarius inferior",
                        "nucleus salivarius inferior",
                        "Inferior salivatory nucleus",
                        "inferior salivatary nucleus",
                        "inferior salivatory nucleus",
                        "Nucleus salivatorius inferior",
                        "nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior",
                        "Nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior nervi glossopharyngei",
                        "Nucleus salivatorius inferior nervi glossopharyngei"
                    ],
                    "OMIM:146850": [
                        "IS",
                        "ISCW",
                        "ISSCW",
                        "IMMUNE SUPPRESSION",
                        "STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO"
                    ],
                    "FB:FBgn0001274": [
                        "Is"
                    ],
                    "PUBCHEM.COMPOUND:7021816": [
                        "IS",
                        "isoleucylserine",
                        "Isoleucyl-Serine",
                        "L-isoleucyl-L-serine",
                        "Ile-Ser",
                        "L-Ile-L-Ser",
                        "CHEMBL56803"
                    ],
                    "UMLS:C0021632": [
                        "IS",
                        "INSTRUM",
                        "instrumentation",
                        "instrumentation aspects"
                    ]
                }
            },
            {
                "label": "approved for the treatment of pediatric patients with bipolar mania, 10 to 17 years of age",
                "id": {}
            }
        ]
    ],
    "Combination Therapy - Adults: The combination of risperidone with lithium or valproate is indicated for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder.": [
        [
            {
                "label": "The combination of risperidone with lithium or valproate",
                "id": {}
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder",
                "id": {}
            }
        ]
    ],
    "Risperidone tablets are indicated for the treatment of irritability associated with autistic disorder in children and adolescents aged 5-16 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods": [
        [
            {
                "label": "Risperidone tablets",
                "id": {
                    "UMLS:C1247861": [
                        "Risperidone Tablets",
                        "risperidone Oral Tablet",
                        "risperiDONE Oral Tablet"
                    ],
                    "UMLS:C1321642": [
                        "Risperidone Orally Disintegrating Tablets",
                        "risperidone Disintegrating Oral Tablet",
                        "risperiDONE Disintegrating Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of irritability associated with autistic disorder in children and adolescents aged 5-16 years",
                "id": {}
            }
        ],
        [
            {
                "label": "treatment",
                "id": {
                    "UMLS:C0039798": [
                        "treatment",
                        "TH",
                        "THER",
                        "therapy",
                        "disease management",
                        "therapeutic aspects"
                    ],
                    "UMLS:C0087111": [
                        "Treatment",
                        "treatment",
                        "treatments",
                        "Treatments",
                        "method treatment",
                        "treatment method",
                        "methods treatment",
                        "therapy (treatment)",
                        "TX",
                        "THER",
                        "therapy",
                        "Therapy",
                        "Therapies",
                        "therapies",
                        "Therapeutic",
                        "therapeutics",
                        "Therapy, NOS",
                        "Therapeutics",
                        "Therapeutic Method",
                        "therapeutic method",
                        "Therapeutic proced",
                        "Therapeutic Procedure",
                        "Therapeutic procedure",
                        "Therapeutic Technique",
                        "therapeutic procedure",
                        "Therapeutic Procedures",
                        "Therapy (regime/therapy)",
                        "Therapeutic procedure NOS",
                        "Therapeutic Interventions",
                        "Therapeutic procedure, NOS",
                        "Therapeutic procedure (procedure)"
                    ],
                    "UMLS:C1522326": [
                        "Treatment",
                        "Treat",
                        "Treated",
                        "treated",
                        "treating",
                        "Treating",
                        "treated with"
                    ],
                    "UMLS:C1533734": [
                        "Treatment",
                        "Administering",
                        "Administration",
                        "Administration procedure",
                        "administration procedures",
                        "Administration (Procedure)"
                    ],
                    "UMLS:C1705169": [
                        "Treatment",
                        "Biomaterial Treatment"
                    ]
                }
            },
            {
                "label": "includes symptoms",
                "id": {
                    "UMLS:C1610664": [
                        "Asthma symptoms evaluated (includes physician documentation of numeric frequency of symptoms or patient completion of an asthma assessment tool/survey/questionnaire) (Asthma)",
                        "Asthma symptoms evaluated (includes documentation of numeric frequency of symptoms or patient completion of an asthma assessment tool/survey/questionnaire) (NMA-No Measure Associated)",
                        "Asthma symptoms evaluated (includes documentation of numeric frequency of symptoms or patient completion of an asthma assessment tool/survey/questionnaire) (nma-no measure associated)",
                        "Asthma symptoms evaluate",
                        "ASTHMA SYMPTOMS EVALUATE",
                        "ASTHMA SYMPTOMS EVALUATED",
                        "asthma symptoms evaluated",
                        "asthma symptoms evaluated (treatment)"
                    ],
                    "UMLS:C1737716": [
                        "Chronic obstructive pulmonary disease (copd) symptoms assessed (includes assessment of at least 1 of the following: dyspnea, cough/sputum, wheezing), or respiratory symptom assessment tool completed (copd)",
                        "Chronic obstructive pulmonary disease (COPD) symptoms assessed (Includes assessment of at least 1 of the following: dyspnea, cough/sputum, wheezing), or respiratory symptom assessment tool completed (COPD)",
                        "COPD SYMPTOMS ASSESS",
                        "Copd symptoms assess",
                        "COPD SYMPTOMS ASSESSED/TOOL COMPLETED"
                    ],
                    "UMLS:C4732702": [
                        "Continuous recording of movement disorder symptoms, including bradykinesia, dyskinesia, and tremor for 6 days up to 10 days; includes set-up, patient training, configuration of monitor, data upload, analysis and initial report configuration, download review, interpretation and report",
                        "CONT REC MVMT DO 6-10 DAYS",
                        "Cont rec mvmt do 6-10 days",
                        "CONTINUOUS REC MVMT DO SX 6 D<10 D"
                    ],
                    "UMLS:C1608455": [
                        "Heart failure assessed (includes assessment of all the following components) (cad): blood pressure measured (2000f) level of activity assessed (1003f) clinical symptoms of volume overload (excess) assessed (1004f) weight, recorded (2001f) clinical signs of volume overload (excess) assessed (2002f)",
                        "Heart failure assessed (includes assessment of all the following components) (CAD): Blood pressure measured (2000F) Level of activity assessed (1003F) Clinical symptoms of volume overload (excess) assessed (1004F) Weight, recorded (2001F) Clinical signs of volume overload (excess) assessed (2002F)",
                        "HRT FAILURE ASSESSED",
                        "Heart failure composite",
                        "HEART FAILURE COMPOSITE"
                    ],
                    "UMLS:C1611769": [
                        "Osteoarthritis assessed (oa) includes assessment of all the following components: osteoarthritis symptoms and functional status assessed (1006f) use of anti-inflammatory or over-the-counter (otc) analgesic medications assessed (1007f) initial examination of the involved joint(s) (includes visual inspection, palpation, range of motion) (2004f)",
                        "Osteoarthritis assessed (OA) Includes assessment of all the following components: Osteoarthritis symptoms and functional status assessed (1006F) Use of anti-inflammatory or over-the-counter (OTC) analgesic medications assessed (1007F) Initial examination of the involved joint(s) (includes visual inspection, palpation, range of motion) (2004F)",
                        "Osteoarthritis composite",
                        "OSTEOARTHRITIS COMPOSITE"
                    ]
                }
            },
            {
                "label": "of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods",
                "id": {}
            }
        ]
    ],
    "ONGENTYS is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes": [
        [
            {
                "label": "ONGENTYS",
                "id": {
                    "PUBCHEM.COMPOUND:135565903": [
                        "ongentys",
                        "opicapone",
                        "OPICAPONE",
                        "Opicapona",
                        "Opicapone",
                        "BIA 9-1067",
                        "Opicapone (substance)",
                        "opicapone (medication)",
                        "Opicapone-containing product",
                        "Product containing opicapone (medicinal product)",
                        "2,5-dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine 1-oxide"
                    ],
                    "UMLS:C5244849": [
                        "Ongentys",
                        "ongentys"
                    ],
                    "UMLS:C5244853": [
                        "Ongentys Pill"
                    ],
                    "UMLS:C5244852": [
                        "Ongentys Oral Product"
                    ],
                    "UMLS:C5244854": [
                        "ONGENTYS 25mg Capsule",
                        "Ongentys 25 MG Oral Capsule",
                        "Ongentys, 25 mg oral capsule",
                        "OPICAPONE 25 mg ORAL CAPSULE [ONGENTYS]",
                        "Opicapone 25 MG Oral Capsule [ONGENTYS]",
                        "opicapone 25 MG Oral Capsule [Ongentys]"
                    ]
                }
            },
            {
                "label": "is indicated as",
                "id": {
                    "UMLS:C4710292": [
                        "Assure that someone is oxygenating the patient and assisting with intubation, as indicated"
                    ],
                    "UMLS:C4713987": [
                        "Assure that the surgical site is marked with a permanent marker by the surgeon, as indicated"
                    ],
                    "UMLS:C4714380": [
                        "Perform targeted assessment of the system that is indicated by the history of present illness"
                    ],
                    "UMLS:C4711109": [
                        "Ensure that equipment is operational via trial run (i.e., assemble laryngoscope and check light bulb function), as indicated"
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ]
                }
            },
            {
                "label": "adjunctive treatment to levodopa/carbidopa",
                "id": {}
            }
        ],
        [
            {
                "label": "adjunctive treatment to levodopa/carbidopa",
                "id": {}
            },
            {
                "label": "is for",
                "id": {
                    "CHEBI:140821": [
                        "iso-Forssman",
                        "i-Forssman",
                        "isogloboside iGb5Cer",
                        "alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer",
                        "N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide"
                    ],
                    "UMLS:C1552560": [
                        "is backup for"
                    ],
                    "PUBCHEM.COMPOUND:8052": [
                        "Isoamyl formate",
                        "Isoamyl formate",
                        "isoamyl formate",
                        "ISOAMYL FORMATE",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formic acid",
                        "Formate, isopentyl ester",
                        "Isopentyl alcohol, formate",
                        "Formic acid, isopentyl ester",
                        "Formic acid, isopentyl ester",
                        "Isoamyl methanoate",
                        "Isoamyl methanoate",
                        "Isopentyl methanoate",
                        "Isopentyl methanoate",
                        "3-methylbutyl formate",
                        "3-Methylbutyl formate",
                        "Isoamyl methanoic acid",
                        "Isopentyl methanoic acid",
                        "3-Methyl-1-butyl formate",
                        "3-Methylbutyl formic acid",
                        "1-Butanol, 3-methyl-, formate",
                        "3-Methyl-2-butenyl formic acid",
                        "1-Butanol, 3-methyl-, 1-formate"
                    ],
                    "UMLS:C2346508": [
                        "ISS for Myeloma",
                        "International Staging System for Myeloma"
                    ],
                    "UMLS:C1562189": [
                        "Is etiology for",
                        "is etiology for",
                        "Is aetiology for",
                        "Is etiology for (link assertion)"
                    ]
                }
            },
            {
                "label": "patients with Parkinson’s disease (PD) experiencing “off” episodes",
                "id": {}
            }
        ]
    ],
    "Entacapone tablets are indicated as an adjunct to levodopa and carbidopa to treat end-of-dose “wearing-off” in patients with Parkinson’s disease": [
        [
            {
                "label": "Entacapone tablets",
                "id": {
                    "UMLS:C1248703": [
                        "Entacapone Tablets",
                        "entacapone Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated as an adjunct to",
                "id": {}
            },
            {
                "label": "levodopa and carbidopa",
                "id": {
                    "PUBCHEM.COMPOUND:104778": [
                        "Carbidopa and levodopa",
                        "carbidopa, levodopa drug combination"
                    ],
                    "UMLS:C1245308": [
                        "Carbidopa and Levodopa Tablets",
                        "carbidopa / levodopa Oral Tablet"
                    ],
                    "UMLS:C5397081": [
                        "Carbidopa and/or levodopa allergy",
                        "Allergy to carbidopa and/or levodopa",
                        "Allergy to carbidopa and/or levodopa (finding)"
                    ],
                    "PUBCHEM.COMPOUND:9831783": [
                        "Carbidopa, levodopa, and entacapone"
                    ],
                    "UMLS:C4752334": [
                        "Carbidopa and levodopa only product",
                        "Product containing only carbidopa and levodopa (medicinal product)"
                    ]
                }
            }
        ],
        [
            {
                "label": "levodopa and carbidopa",
                "id": {
                    "PUBCHEM.COMPOUND:104778": [
                        "Carbidopa and levodopa",
                        "carbidopa, levodopa drug combination"
                    ],
                    "UMLS:C1245308": [
                        "Carbidopa and Levodopa Tablets",
                        "carbidopa / levodopa Oral Tablet"
                    ],
                    "UMLS:C5397081": [
                        "Carbidopa and/or levodopa allergy",
                        "Allergy to carbidopa and/or levodopa",
                        "Allergy to carbidopa and/or levodopa (finding)"
                    ],
                    "PUBCHEM.COMPOUND:9831783": [
                        "Carbidopa, levodopa, and entacapone"
                    ],
                    "UMLS:C4752334": [
                        "Carbidopa and levodopa only product",
                        "Product containing only carbidopa and levodopa (medicinal product)"
                    ]
                }
            },
            {
                "label": "to treat",
                "id": {
                    "UMLS:C1292734": [
                        "Intent To Treat",
                        "treat",
                        "Treats",
                        "treats",
                        "Treatment Intent",
                        "Treatment intent",
                        "Treats (attribute)",
                        "Treatment intent (situation)"
                    ],
                    "UMLS:C0080100": [
                        "Refusal to Treat"
                    ],
                    "UMLS:C1562198": [
                        "Toggle Treatment",
                        "Toggle Method",
                        "Toggle technique",
                        "Toggle Technique",
                        "Toggle technique (procedure)"
                    ],
                    "UMLS:C3494202": [
                        "Time to Treatment",
                        "Time-to-Treatment",
                        "Time-to-Treatments",
                        "Time to Treatments"
                    ],
                    "UMLS:C0035618": [
                        "Right to Treatment",
                        "right to treatment",
                        "Right to Treatments",
                        "Treatment, Right to",
                        "Treatments, Right to",
                        "rights treatment",
                        "right treatments"
                    ]
                }
            },
            {
                "label": "end-of-dose “wearing-off”",
                "id": {}
            }
        ],
        [
            {
                "label": "end-of-dose “wearing-off”",
                "id": {}
            },
            {
                "label": "in",
                "id": {
                    "NCBIGene:960": [
                        "IN",
                        "IN",
                        "In(Lu) related-p80",
                        "INLU-RELATED p80 GLYCOPROTEIN",
                        "CD44 molecule (Indian blood group)",
                        "CD44 Molecule (Indian Blood Group) Gene",
                        "CD44 antigen (homing function and Indian blood group system)",
                        "MC56",
                        "MIC4",
                        "Pgp1",
                        "MDU2",
                        "Pgp1",
                        "CD44",
                        "MC56",
                        "MDU3",
                        "CSPG8",
                        "HCELL",
                        "CD44R",
                        "CDw44",
                        "HCELL",
                        "CD44R",
                        "H-CAM",
                        "CSPG8",
                        "PGP-1",
                        "HUTCH-1",
                        "ECM-III",
                        "HUTCH-I",
                        "Hermes-1",
                        "CD44 gene",
                        "CD44 Gene",
                        "CD44 ANTIGEN",
                        "HERMES ANTIGEN",
                        "phagocyte glycoprotein 1",
                        "homing cell adhesion molecule",
                        "extracellular matrix receptor-III",
                        "chondroitin sulfate proteoglycan 8",
                        "chondroitin sulfate proteoglycan 8",
                        "hematopoietic cell E- and L-selectin ligand",
                        "hematopoietic cell E- and L-selectin ligand"
                    ],
                    "NCBIGene:40246": [
                        "in"
                    ],
                    "PUBCHEM.COMPOUND:24000": [
                        "In",
                        "in",
                        "InH3",
                        "indio",
                        "Indium",
                        "[InH3]",
                        "INDIUM",
                        "indium",
                        "indigane",
                        "Indigane",
                        "In element",
                        "Indium, NOS",
                        "indium trihydride",
                        "Indium (substance)",
                        "Indium-containing product",
                        "Product containing indium (medicinal product)",
                        "trihydridoindium"
                    ],
                    "PUBCHEM.COMPOUND:7016080": [
                        "IN",
                        "Ile-Asn",
                        "CHEMBL55004",
                        "L-Ile-L-Asn",
                        "isoleucylasparagine",
                        "Isoleucyl-Asparagine",
                        "L-isoleucyl-L-asparagine"
                    ],
                    "PUBCHEM.COMPOUND:5359967": [
                        "In",
                        "indio",
                        "Indium",
                        "indium",
                        "INDIUM",
                        "Indium",
                        "indium",
                        "indium atom",
                        "49In"
                    ]
                }
            },
            {
                "label": "patients with Parkinson’s disease",
                "id": {}
            }
        ]
    ],
    "For the relief of symptoms of depression.": [
        [
            {
                "label": "For the relief",
                "id": {
                    "UMLS:C2224814": [
                        "bronchoscopy for relief of stenosis by stent placement in the trachea",
                        "bronchoscopy for relief of stenosis by stent in trachea",
                        "bronchoscopy for relief of stenosis by stent in trachea (treatment)"
                    ],
                    "UMLS:C2224815": [
                        "bronchoscopy for relief of stenosis by stent placement in the bronchus",
                        "bronchoscopy for relief of stenosis by stent in bronchus",
                        "bronchoscopy for relief of stenosis by stent in bronchus (treatment)"
                    ],
                    "UMLS:C1609560": [
                        "Use of anti-inflammatory or analgesic over-the-counter (otc) medications for symptom relief assessed (oa)",
                        "Use of anti-inflammatory or analgesic over-the-counter (OTC) medications for symptom relief assessed (OA)",
                        "ANTI-INFLM/ANLGSC OTC ASSESS",
                        "Anti-inflm/anlgsc otc assess",
                        "ANTI-INFLAMMATORY/ANALGESIC SYMPTOM RELIEF ASSES"
                    ],
                    "UMLS:C5187674": [
                        "DEXTROMETHORPHAN HYDROBROMIDE 20 mg / GUAIFENESIN 400 mg ORAL POWDER, FOR SOLUTION [Theraflu Cough Relief]",
                        "dextromethorphan HBr 20 MG / guaiFENesin 400 MG Powder for Oral Solution",
                        "dextromethorphan HBr 20 MG / guaifenesin 400 MG Powder for Oral Solution",
                        "dextromethorphan hydrobromide 20 MG / guaiFENesin 400 MG Powder for Oral Solution",
                        "dextromethorphan hydrobromide 20 MG / guaifenesin 400 MG Powder for Oral Solution"
                    ],
                    "UMLS:C0978400": [
                        "MENTHOL, UNSPECIFIED FORM 100 mg in 1 g / METHYL SALICYLATE 150 mg in 1 g TOPICAL CREAM [TheraCare Muscle and Join Pain Relief Cream]",
                        "Muscle Rub Topical Cream",
                        "CVS Muscle Rub Topical Cream",
                        "Muscle Rub 10%-15% Topical Cream",
                        "Sunmark Muscle Rub Topical Cream",
                        "Muscle Rub, 10%-15% topical cream",
                        "MENTHOL/M-SALICYLATE 10-15% TOP CREAM",
                        "GNP Greaseless Muscle Rub Topical Cream",
                        "BENGAY Greaseless, 10%-15% topical cream",
                        "Bengay Greaseless Pain Relieving Topical Cream",
                        "menthol 10 % / methyl salicylate 15 % Topical Cream",
                        "MENTHOL/METHYL SALICYLATE (10-15%) LOW CONC. CREAM,TOP",
                        "menthol-methyl salicylate topical 10%-15% topical cream",
                        "methyl salicylate/menthol@15 %-10 %@TOPICAL@CREAM (GRAM)",
                        "methyl salicylate/menthol 15 %-10 % TOPICAL CREAM (GRAM)",
                        "Menthol/Methyl Salicylate 10%-15% Topical application Cream",
                        "menthol 100 MG/ML / methyl salicylate 150 MG/ML Topical Cream",
                        "menthol 10 GM / methyl salicylate 15 GM per 100 GM Topical Cream",
                        "MENTHOL 10 g in 100 g / METHYL SALICYLATE 15 g in 100 g TOPICAL CREAM",
                        "Menthol/Methyl Salicylate 10%-15% Topical application Cream [CALYPXO HP]",
                        "Menthol/Methyl Salicylate 10%-15% Topical application Cream [MUSCLE RUB]",
                        "Menthol/Methyl Salicylate 10%-15% Topical application Cream [ANALGESIC BALM]",
                        "MENTHOL 10 g in 100 g / METHYL SALICYLATE 15 g in 100 g TOPICAL CREAM [DynaRub]",
                        "Menthol/Methyl Salicylate 10%-15% Topical application Cream [CAREALL MUSCLE RUB]",
                        "MENTHOL 10 g in 100 g / METHYL SALICYLATE 15 g in 100 g TOPICAL CREAM [muscle rub]",
                        "MENTHOL 10 g in 100 g / METHYL SALICYLATE 15 g in 100 g TOPICAL CREAM [Muscle Rub]",
                        "MENTHOL 10 g in 100 g / METHYL SALICYLATE 15 g in 100 g TOPICAL CREAM [Analgesic Balm]",
                        "Menthol/Methyl Salicylate 10%-15% Topical application Cream [ARTHRITIS HOT PAIN RELIEF]",
                        "Menthol/Methyl Salicylate 10%-15% Topical application Cream [DR. SHEFFIELD'S MUSCLE RUB]",
                        "MENTHOL 10 g in 100 g / METHYL SALICYLATE 15 g in 100 g TOPICAL CREAM [Muscle Rub Cream]",
                        "MENTHOL 10 g in 100 g / METHYL SALICYLATE 15 g in 100 g TOPICAL CREAM [Sunmark Muscle Rub]",
                        "MENTHOL 0.1 g in 100 g / METHYL SALICYLATE 0.15 g in 100 g TOPICAL CREAM [Muscle Rub Cream]",
                        "METHYL SALICYLATE 15 g in 100 g / MENTHOL 10 g in 100 g TOPICAL CREAM [Calypxo HP Pain Relief]",
                        "MENTHOL 100 mg in 1 g / METHYL SALICYLATE 150 mg in 1 g TOPICAL CREAM [Rugby Muscle Rub Cream]",
                        "Menthol/Methyl Salicylate 10%-15% Topical application Cream [GOOD NEIGHBOR PHARMACY MUSCLE RUB]",
                        "MENTHOL 10 g in 100 g / METHYL SALICYLATE 15 g in 100 g TOPICAL CREAM [Muscle and Joint Pain Relief]",
                        "MENTHOL, UNSPECIFIED FORM 100 mg in 1 g / METHYL SALICYLATE 150 mg in 1 g TOPICAL CREAM [Muscle Rub]",
                        "MENTHOL, UNSPECIFIED FORM 10 g in 100 g / METHYL SALICYLATE 15 g in 100 g TOPICAL CREAM [Muscle Rub]",
                        "MENTHOL 100 mg in 1 g / METHYL SALICYLATE 150 mg in 1 g TOPICAL CREAM [Dr Sheffield Muscle Rub Cream]",
                        "Menthol 100 mg in 1 g / Methyl Salicylate 150 mg in 1 g TOPICAL CREAM [CAREALL Muscle Rub Ultra Strength]",
                        "MENTHOL, UNSPECIFIED FORM 100 mg in 1 g / METHYL SALICYLATE 150 mg in 1 g TOPICAL CREAM [Bengay Greaseless]",
                        "MENTHOL, UNSPECIFIED FORM 10 g in 100 g / METHYL SALICYLATE 15 g in 100 g TOPICAL CREAM [Equaline Muscle Rub]",
                        "MENTHOL, UNSPECIFIED FORM 10 g in 100 g / METHYL SALICYLATE 15 g in 100 g TOPICAL CREAM [Good Neighbor pharmacy muscle rub]"
                    ]
                }
            },
            {
                "label": "of",
                "id": {
                    "PUBCHEM.COMPOUND:6432002": [
                        "OF",
                        "OF(.)",
                        "oxygen fluoride",
                        "fluoridooxygen(.)",
                        "oxygen monofluoride"
                    ],
                    "NCBIGene:6688": [
                        "OF",
                        "OF",
                        "SFFV VIRUS-INDUCED MURINE ERYTHROLEUKEMIA ONCOGENE, MOUSE, HOMOLOG OF",
                        "PU.1",
                        "PU.1",
                        "SPI1",
                        "SPI-A",
                        "SFPI1",
                        "SPI-1",
                        "SPI-A",
                        "SPI-1",
                        "SFPI1",
                        "SPI1 gene",
                        "SPI1 Gene",
                        "Oncogene SPI1",
                        "ONCOGENE SPI1",
                        "SPI1 PROTOONCOGENE",
                        "Spi-1 proto-oncogene",
                        "Spi-1 Proto-Oncogene Gene",
                        "31 kDa transforming protein",
                        "31 kDa transforming protein",
                        "HEMATOPOIETIC TRANSCRIPTION FACTOR PU.1",
                        "hematopoietic transcription factor PU.1",
                        "hematopoietic transcription factor PU.1",
                        "SPLEEN FOCUS FORMING VIRUS PROVIRAL INTEGRATION ONCOGENE SPI1",
                        "Spleen Focus Forming Virus Proviral Integration Oncogene SPI1",
                        "spleen focus forming virus (SFFV) proviral integration oncogene"
                    ],
                    "NCBIGene:83990": [
                        "OF",
                        "OF",
                        "DOG1, HOMOLOG OF",
                        "DELETIONS OF GUANINE-RICH DNA, C. ELEGANS, HOMOLOG OF",
                        "FANCJ",
                        "BACH1",
                        "BRIP1",
                        "BACH1",
                        "FANCJ",
                        "FANCJ GENE",
                        "BRIP1 Gene",
                        "BRIP1 gene",
                        "FANCJ helicase",
                        "FANCJ helicase",
                        "BRCA1 interacting protein 1",
                        "BRCA1-INTERACTING PROTEIN 1",
                        "BRCA1 interacting protein 1",
                        "BRCA1 interacting helicase 1",
                        "BRCA1/BRCA2-associated helicase 1",
                        "BRCA1/BRCA2-associated helicase 1",
                        "BRCA1-associated C-terminal helicase",
                        "BRCA1-associated C-terminal helicase",
                        "BRCA1-ASSOCIATED C-TERMINAL HELICASE 1",
                        "BRCA1 interacting protein C-terminal helicase 1",
                        "BRCA1 Interacting Protein C-Terminal Helicase 1 Gene"
                    ],
                    "UMLS:C0332285": [
                        "Of",
                        "In",
                        "in",
                        "Within",
                        "Inside",
                        "Found in",
                        "Located in",
                        "Has setting",
                        "Has location",
                        "Arising from",
                        "In (attribute)"
                    ],
                    "UMLS:C0456628": [
                        "oF",
                        "F",
                        "degrees F",
                        "fahrenheit",
                        "Degree Fahrenheit",
                        "degree fahrenheit",
                        "degrees fahrenheit",
                        "fahrenheit degrees",
                        "Degrees fahrenheit",
                        "Degrees Fahrenheit",
                        "Degrees Fahrenheit (qualifier value)"
                    ]
                }
            },
            {
                "label": "symptoms of depression",
                "id": {
                    "UMLS:C0086132": [
                        "Symptoms of depression",
                        "symptoms of depression",
                        "Symptoms of depression (finding)",
                        "depression symptom",
                        "Depressive Symptom",
                        "depressive symptom",
                        "Depressive symptom",
                        "depressive symptoms",
                        "Symptom, Depressive",
                        "Depressive symptoms",
                        "Depression symptoms",
                        "depression symptoms",
                        "Depressive Symptoms",
                        "symptoms depression",
                        "depressions symptoms",
                        "Emotional Depression",
                        "emotional depression",
                        "Depression, Emotional"
                    ],
                    "UMLS:C4716638": [
                        "Signs and symptoms of depression"
                    ],
                    "UMLS:C1821816": [
                        "Reports signs and symptoms of depression"
                    ],
                    "UMLS:C4718714": [
                        "Physical signs and symptoms of depression"
                    ],
                    "UMLS:C4716561": [
                        "Emotional signs and symptoms of depression"
                    ]
                }
            }
        ]
    ],
    "Endogenous depression is more likely to be alleviated than other depressive states": [
        [
            {
                "label": "Endogenous depression",
                "id": {
                    "MONDO:0012048": [
                        "DEPRESSION ENDOGENOUS",
                        "depression endogenous",
                        "endogenous depression",
                        "Endogenous depression",
                        "ENDOGENOUS DEPRESSION",
                        "endogenous depression",
                        "Depression endogenous",
                        "Endogenous Depression",
                        "Depression;endogenous",
                        "Endogenous Depressions",
                        "Depression, Endogenous",
                        "endogenous; depression",
                        "depression; endogenous",
                        "Depressions, Endogenous",
                        "Endogenous depression (disorder)",
                        "Endogenous depression (diagnosis)",
                        "MDD",
                        "clinical depression",
                        "unipolar depression",
                        "unipolar depression",
                        "clinical depression",
                        "major depressive disorder"
                    ],
                    "UMLS:C0553816": [
                        "Endogenous depression - recurrent",
                        "depression endogenous - recurrent",
                        "Endogenous depression - recurrent (disorder)",
                        "Endogenous depression - recurrent (diagnosis)"
                    ],
                    "UMLS:C0338895": [
                        "Endogenous depression first episode",
                        "depression endogenous - first episode",
                        "endogenous depression - first episode",
                        "Endogenous depression first episode (disorder)",
                        "endogenous depression - first episode (diagnosis)"
                    ],
                    "UMLS:C4290113": [
                        "recurrent episodes of endogenous depression"
                    ],
                    "UMLS:C1395188": [
                        "Endogenous depression with psychotic symptoms",
                        "depression; endogenous, with psychotic symptoms"
                    ]
                }
            },
            {
                "label": "is",
                "id": {
                    "UBERON:0002872": [
                        "IS",
                        "inferior salivary nucleus",
                        "Nucleus salivarius inferior",
                        "nucleus salivarius inferior",
                        "Inferior salivatory nucleus",
                        "inferior salivatary nucleus",
                        "inferior salivatory nucleus",
                        "Nucleus salivatorius inferior",
                        "nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior",
                        "Nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior nervi glossopharyngei",
                        "Nucleus salivatorius inferior nervi glossopharyngei"
                    ],
                    "OMIM:146850": [
                        "IS",
                        "ISCW",
                        "ISSCW",
                        "IMMUNE SUPPRESSION",
                        "STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO"
                    ],
                    "FB:FBgn0001274": [
                        "Is"
                    ],
                    "PUBCHEM.COMPOUND:7021816": [
                        "IS",
                        "isoleucylserine",
                        "Isoleucyl-Serine",
                        "L-isoleucyl-L-serine",
                        "Ile-Ser",
                        "L-Ile-L-Ser",
                        "CHEMBL56803"
                    ],
                    "UMLS:C0021632": [
                        "IS",
                        "INSTRUM",
                        "instrumentation",
                        "instrumentation aspects"
                    ]
                }
            },
            {
                "label": "more likely to be alleviated than other depressive states",
                "id": {}
            }
        ]
    ],
    "Sertraline Tablets, USP are indicated for the treatment of major depressive disorder in adults.": [
        [
            {
                "label": "Sertraline Tablets, USP",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of major depressive disorder in adults",
                "id": {}
            }
        ]
    ],
    "Sertraline tablets are indicated for the treatment of obsessions and compulsions in patients with obsessive-compulsive disorder (OCD), as defined in the DSM-III-R; i.e., the obsessions or compulsions cause marked distress, are time-consuming, or significantly interfere with social or occupational functioning.": [
        [
            {
                "label": "Sertraline tablets",
                "id": {
                    "UMLS:C4719798": [
                        "Sertraline Hydrochloride Tablets"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of obsessions and compulsions in patients with obsessive-compulsive disorder (OCD)",
                "id": {}
            }
        ],
        [
            {
                "label": "obsessions or compulsions",
                "id": {}
            },
            {
                "label": "cause",
                "id": {
                    "UMLS:C0015127": [
                        "cause",
                        "causes",
                        "caused by",
                        "ET",
                        "ETIOL",
                        "etiology",
                        "aetiology",
                        "causality",
                        "etiologies",
                        "Etiology aspects"
                    ],
                    "UMLS:C1524003": [
                        "Cause",
                        "Etiology",
                        "Causation",
                        "Science of Etiology"
                    ],
                    "UMLS:C1314792": [
                        "Causes",
                        "Caused by",
                        "disease cause",
                        "disorder by cause",
                        "Etiology",
                        "etiology",
                        "Causality",
                        "Aetiology",
                        "Causalities",
                        "disease etiology",
                        "General Etiology",
                        "disorder etiology",
                        "disease causation",
                        "Etiology (attribute)",
                        "disease/disorder etiology"
                    ],
                    "NCIT:C81239": [
                        "death cause",
                        "Death Cause",
                        "death causes",
                        "Death Causes",
                        "Death--Causes",
                        "Cause of death",
                        "CAUSE_OF_DEATH",
                        "Cause of Death",
                        "cause of death",
                        "cause_of_death",
                        "causes of death",
                        "Causes of Death",
                        "Major cause of death",
                        "major cause of death",
                        "Condition fatal-cause of death",
                        "Cause of death (observable entity)",
                        "DD",
                        "COD",
                        "DEATHD",
                        "Death Diagnosis",
                        "Death diagnosis",
                        "death diagnosis",
                        "Death diagnosis (contextual qualifier)",
                        "Death diagnosis (contextual qualifier) (qualifier value)"
                    ],
                    "UMLS:C0551542": [
                        "Injury cause",
                        "Injury cause:Type:Pt:^Patient:Nom",
                        "Injury cause:Type:Point in time:^Patient:Nominal",
                        "Injury cause:Type:To identify measures at a point in time:^Patient:Nominal"
                    ]
                }
            },
            {
                "label": "marked distress",
                "id": {}
            }
        ],
        [
            {
                "label": "obsessions or compulsions",
                "id": {}
            },
            {
                "label": "are",
                "id": {
                    "NCIT:C13662": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1515984": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1551058": [
                        "Are",
                        "are unit of measure"
                    ],
                    "MONDO:0044742": [
                        "AREI",
                        "autosomal recessive epidermolytic ichthyosis"
                    ],
                    "MONDO:0017339": [
                        "AREI",
                        "Ichthyosis exfoliativa",
                        "ICHTHYOSIS EXFOLIATIVA",
                        "ichthyosis exfoliativa",
                        "Exfoliative ichthyosis",
                        "Ichthyosis Exfoliativa",
                        "exfoliative ichthyosis",
                        "ICHTHYOSIS BULLOSA OF SIEMENS-LIKE",
                        "autosomal recessive exfoliative ichthyosis",
                        "Autosomal recessive exfoliative ichthyosis",
                        "ICHTHYOSIS, EXFOLIATIVE, AUTOSOMAL RECESSIVE",
                        "ichthyosis congenital autosomal recessive exfoliative",
                        "Autosomal recessive exfoliative ichthyosis (disorder)",
                        "Autosomal recessive exfoliative ichthyosis (diagnosis)"
                    ]
                }
            },
            {
                "label": "time-consuming",
                "id": {
                    "UMLS:C3827829": [
                        "Time-Consuming"
                    ],
                    "UMLS:C3166435": [
                        "Time between consuming dextrose solution and administering the second blood draw"
                    ],
                    "UMLS:C3176778": [
                        "Time between consuming dextrose solution and administering the second blood draw [PhenX]",
                        "Time between consuming dextrose solution and administering the second blood draw:Time:Pt:^Patient:Qn:PhenX",
                        "Time between consuming dextrose solution and administering the second blood draw:Time:To identify measures at a point in time:^Patient:Quantitative:PhenX",
                        "Ms between dextrose blood draw PhenX"
                    ],
                    "UMLS:C4710705": [
                        "Instruct patient to sip room-temperature liquids (e.g., broth, unsweetened juice, milk) slowly, consuming between two to three ounces at a time"
                    ]
                }
            }
        ],
        [
            {
                "label": "obsessions or compulsions",
                "id": {}
            },
            {
                "label": "interfere with",
                "id": {
                    "UMLS:C0521102": [
                        "interferes with",
                        "Interferes with",
                        "Interfered with",
                        "Interferes with (contextual qualifier)",
                        "Interferes with (contextual qualifier) (qualifier value)",
                        "interfere",
                        "interfered",
                        "interferes",
                        "interfering",
                        "Interference",
                        "interfered by"
                    ],
                    "UMLS:C0521103": [
                        "Did not interfere with",
                        "Does not interfere with",
                        "Does not interfere with (contextual qualifier)",
                        "Does not interfere with (contextual qualifier) (qualifier value)"
                    ],
                    "UMLS:C0422966": [
                        "Interference with vision",
                        "Interference with vision (finding)"
                    ],
                    "UMLS:C3828670": [
                        "Pain Interferes with Mood"
                    ],
                    "UMLS:C3828668": [
                        "Pain Interferes with Sleep"
                    ]
                }
            },
            {
                "label": "social or occupational functioning",
                "id": {}
            }
        ]
    ],
    "Sertraline tablets are indicated for the treatment of panic disorder in adults, with or without agoraphobia, as defined in DSM-IV.": [
        [
            {
                "label": "Sertraline tablets",
                "id": {
                    "UMLS:C4719798": [
                        "Sertraline Hydrochloride Tablets"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of panic disorder in adults",
                "id": {}
            }
        ],
        [
            {
                "label": "Sertraline tablets",
                "id": {
                    "UMLS:C4719798": [
                        "Sertraline Hydrochloride Tablets"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of panic disorder with agoraphobia",
                "id": {}
            }
        ],
        [
            {
                "label": "Sertraline tablets",
                "id": {
                    "UMLS:C4719798": [
                        "Sertraline Hydrochloride Tablets"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of panic disorder without agoraphobia",
                "id": {}
            }
        ]
    ],
    "Sertraline is indicated for the treatment of posttraumatic stress disorder in adults.": [
        [
            {
                "label": "Sertraline",
                "id": {
                    "PUBCHEM.COMPOUND:68617": [
                        "sertraline",
                        "Sertraline",
                        "sertraline",
                        "SERTRALINE",
                        "Gen sertraline",
                        "(+)-sertraline",
                        "Apo-sertraline",
                        "(+)-Sertraline",
                        "(+)-Sertraline",
                        "Gen-sertraline",
                        "Apo sertraline",
                        "Novo sertraline",
                        "Novo-sertraline",
                        "Ratio sertraline",
                        "Ratio-sertraline",
                        "Rhoxal-sertraline",
                        "Rhoxal sertraline",
                        "cis-(+)-sertraline",
                        "cis-(+)-Sertraline",
                        "(1S,4S)-sertraline",
                        "cis-(+)-sertraline",
                        "(1S,4S)-Sertraline",
                        "(1S,4S)-sertraline",
                        "Sertraline (substance)",
                        "Sertraline hydrochloride",
                        "Hydrochloride, sertraline",
                        "Sertraline-containing product",
                        "Lacer brand OF sertraline hydrochloride",
                        "Sertraline hydrochloride (1S-cis)-isomer",
                        "Roerig brand OF sertraline hydrochloride",
                        "Pfizer brand OF sertraline hydrochloride",
                        "Esteve brand OF sertraline hydrochloride",
                        "Apotex brand OF sertraline hydrochloride",
                        "Genpharm brand OF sertraline hydrochloride",
                        "Novopharm brand OF sertraline hydrochloride",
                        "Ratiopharm brand OF sertraline hydrochloride",
                        "Parke davis brand OF sertraline hydrochloride",
                        "Rhoxalpharma brand OF sertraline hydrochloride",
                        "Product containing sertraline (medicinal product)",
                        "Boehringer ingelheim brand OF sertraline hydrochloride",
                        "Aremis",
                        "Zoloft",
                        "Gladem",
                        "Sealdin",
                        "Lustral",
                        "CP 51974",
                        "Besitran",
                        "CP 51974",
                        "Altruline",
                        "sertralina",
                        "Sertralina",
                        "Sertralina",
                        "Sertralinum",
                        "sertralinum",
                        "Sertralinum",
                        "(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine",
                        "(1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine",
                        "(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine",
                        "(1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine",
                        "1-Naphthalenamine,1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-, (1S-cis)-"
                    ],
                    "PUBCHEM.COMPOUND:25216770": [
                        "Sertraline-d1"
                    ],
                    "UMLS:C0796770": [
                        "Sertraline Ql",
                        "Sertraline SerPl Ql",
                        "Sertraline:PrThr:Pt:Ser/Plas:Ord",
                        "Sertraline [Presence] in Serum or Plasma",
                        "Sertraline:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ],
                    "PUBCHEM.COMPOUND:50986904": [
                        "sertraline HCl",
                        "sertraline hydrochloride",
                        "SERTRALINE HYDROCHLORIDE",
                        "(+)-sertraline hydrochloride",
                        "Zoloft",
                        "Lustral",
                        "(+)-cis-(1S,4S)-1-methylamino-4-(3,4-dichlorophenyl)tetralin hydrochloride",
                        "(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-aminium chloride",
                        "(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride",
                        "(1S-cis)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride",
                        "(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine;hydron;chloride"
                    ],
                    "PUBCHEM.COMPOUND:1616961": [
                        "sertraline(1+)",
                        "Sertraline(1+)",
                        "(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-aminium"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of posttraumatic stress disorder in adults",
                "id": {}
            }
        ]
    ],
    "Sertraline tablets are indicated for the treatment of social anxiety disorder, also known as social phobia in adults.": [
        [
            {
                "label": "Sertraline tablets",
                "id": {
                    "UMLS:C4719798": [
                        "Sertraline Hydrochloride Tablets"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of social anxiety disorder",
                "id": {}
            }
        ],
        [
            {
                "label": "social anxiety disorder",
                "id": {
                    "MONDO:0001247": [
                        "Social Anxiety Disorder",
                        "anxiety disorder social",
                        "social anxiety disorder",
                        "Social anxiety disorder",
                        "anxiety disorders social",
                        "Anxiety Disorder, Social",
                        "Social Anxiety Disorders",
                        "Disorder, Social Anxiety",
                        "anxiety disorder; social",
                        "Sociophobia",
                        "Sociophobias",
                        "Social Phobia",
                        "Social phobia",
                        "social phobia",
                        "phobia social",
                        "social phobia",
                        "social; phobia",
                        "Social Phobias",
                        "social phobias",
                        "phobias social",
                        "phobia; social",
                        "Social phobias",
                        "Phobia, Social",
                        "Social neurosis",
                        "neurosis; social",
                        "social; neurosis",
                        "Social phobia, NOS",
                        "Social Evaluation Fear",
                        "disorder social phobia",
                        "social phobia disorder",
                        "Evaluation Fear, Social",
                        "disorders phobia social",
                        "Social Evaluation Phobia",
                        "Social phobia (disorder)",
                        "Fear of Social Evaluation",
                        "social phobia (diagnosis)",
                        "Phobia, Social Evaluation",
                        "Social Evaluation Phobias",
                        "Social phobia, unspecified"
                    ],
                    "UMLS:C0270305": [
                        "Childhood social anxiety disorder",
                        "social; anxiety disorder, childhood",
                        "anxiety disorder; social, childhood",
                        "Social anxiety disorder of childhood",
                        "social anxiety disorder of childhood",
                        "disorder; social, anxiety, childhood",
                        "social anxiety disorder of childhood (diagnosis)",
                        "Childhood social anx disord",
                        "Childhood avoidant disorder",
                        "avoidant disorder; childhood",
                        "Avoidance disorder, childhood",
                        "Avoidant disorder of childhood",
                        "avoidant disorder of childhood",
                        "Withdrawing reaction of childhood",
                        "Avoidant disorder of childhood (disorder)",
                        "avoidant disorder of childhood (diagnosis)"
                    ],
                    "UMLS:C4237417": [
                        "Social anxiety disorder (social phobia)"
                    ],
                    "UMLS:C3835719": [
                        "social anxiety disorder, performance only",
                        "social anxiety disorder, performance only (diagnosis)",
                        "social phobia, performance only"
                    ]
                }
            },
            {
                "label": "also known as",
                "id": {
                    "MONDO:0001586": [
                        "severe MPS I (subtype, also known as Hurler syndrome)",
                        "MPS1",
                        "MPSI",
                        "mps i",
                        "MPS I",
                        "MPS I",
                        "MPS 1",
                        "MPS 1",
                        "Hurler syndrome",
                        "IDUA deficiency",
                        "Hurler syndrome",
                        "lipochondrodystrophy",
                        "Lipochondrodystrophy",
                        "Lipochondrodystrophy",
                        "Lipochondrodystrophies",
                        "Hurler-Scheie syndrome",
                        "mucopolysaccharidosis i",
                        "MPS I - Hurler syndrome",
                        "mucopolysaccharidosis I",
                        "i mucopolysaccharidosis",
                        "Mucopolysaccharidosis I",
                        "mucopolysaccharidosis I",
                        "Mucopolysaccharidosis 1",
                        "MUCOPOLYSACCHARIDOSIS I",
                        "MPS I - Hurler syndrome",
                        "mucopolysaccharidosis I",
                        "Mucopolysaccharidosis Is",
                        "L-iduronidase deficiency",
                        "Hurler syndrome (subtype)",
                        "mucopolysaccharidosis type 1",
                        "Mucopolysaccharidosis Type I",
                        "mucopolysaccharidosis type I",
                        "MPSI-Mucopolysaccharidosis I",
                        "Mucopolysaccharidosis, MPS-I",
                        "mucopolysaccharidosis, MPS-I",
                        "mucopolysaccharidosis type i",
                        "Mucopolysaccharidosis, MPS-I",
                        "Mucopolysaccharidosis type 1",
                        "Mucopolysaccharidosis type I",
                        "type I; mucopolysaccharidosis",
                        "Mucopolysaccharidosis, type 1",
                        "Mucopolysaccharidosis, type I",
                        "mucopolysaccharidosis, type 1",
                        "mucopolysaccharidosis (MPS) I",
                        "mucopolysaccharidosis; type I",
                        "alpha-L-iduronidase deficiency",
                        "iduronidase deficiency disease",
                        "iduronidase deficiency disease",
                        "Alpha-L-iduronidase deficiency",
                        "lipochondrodystrophy (diagnosis)",
                        "Hurler-Scheie syndrome (subtype)",
                        "MPSI - Mucopolysaccharidosis type I",
                        "mucopolysaccharide storage disease I",
                        "Mucopolysaccharidosis, type I (MPS I)",
                        "Mucopolysaccharidosis type I (disorder)",
                        "mucopolysaccharidosis type 1 (diagnosis)",
                        "alpha-L-iduronidase (IDA, IDUA) deficiency",
                        "attenuated MPS I (subtype, includes Hurler-Scheie and Scheie syndrome)",
                        "Scheie syndrome (subtype) formerly known as Mucopoly-saccharidosis type V)"
                    ],
                    "UMLS:C0470939": [
                        "Leo Laboratories Ltd (also known as Leo Pharmaceuticals)",
                        "Leo Laboratories Ltd"
                    ],
                    "UMLS:C0600352": [
                        "Electron beam computed tomography (also known as ultrafast ct, cine ct)",
                        "Electron Beam Tomography",
                        "electron beam tomography",
                        "Beam Tomography, Electron",
                        "Tomography, Electron Beam",
                        "Electron beam computed tomog",
                        "beam computed electron tomography",
                        "Electron Beam Computed Tomography"
                    ],
                    "NCBIGene:3684": [
                        "integrin, alpha M (complement component receptor 3, alpha; also known as CD11b (p170), macrophage antigen alpha polypeptide)",
                        "CR3A",
                        "MO1A",
                        "MAC-1",
                        "ITGAM",
                        "CD11b",
                        "MAC1A",
                        "CD11b",
                        "MAC-1",
                        "CD11B",
                        "ITGAM gene",
                        "ITGAM Gene",
                        "INTEGRIN, ALPHA-M",
                        "Mo1, ALPHA SUBUNIT",
                        "Mac1, ALPHA SUBUNIT",
                        "integrin subunit alpha M",
                        "macrophage-1 antigen alpha subunit",
                        "macrophage-1 antigen alpha subunit",
                        "complement component 3 receptor 3 subunit",
                        "COMPLEMENT RECEPTOR TYPE 3, ALPHA SUBUNIT",
                        "complement component 3 receptor 3 subunit",
                        "integrin, alpha M (complement component 3 receptor 3 subunit)",
                        "Integrin, Alpha M (Complement Component 3 Receptor 3 Subunit) Gene"
                    ],
                    "UMLS:C1706439": [
                        "Integrin, Alpha M (Complement Component Receptor 3, Alpha; Also Known As CD11b (p170), Macrophage Antigen Alpha Polypeptide) Gene",
                        "MO1A",
                        "CR3A",
                        "MAC1A",
                        "CD11B",
                        "MAC-1",
                        "SLEB6",
                        "ITGAM wt Allele",
                        "Integrin, Alpha-M Gene",
                        "Mo1, Alpha Subunit Gene",
                        "Mac1, Alpha Subunit Gene",
                        "Antigen CD11b (P170) Gene",
                        "Integrin, Alpha M (Complement Component 3 Receptor 3 Subunit) wt Allele"
                    ]
                }
            },
            {
                "label": "social phobia in adults",
                "id": {}
            }
        ]
    ],
    "Fluoxetine is indicated for the acute and maintenance treatment of Major Depressive Disorder in adult patients and in pediatric patients aged 8 to18 years": [
        [
            {
                "label": "Fluoxetine",
                "id": {
                    "PUBCHEM.COMPOUND:3386": [
                        "fluoxetine",
                        "Fluoxetine",
                        "FLUoxetine",
                        "fluoxetine",
                        "FLUOXETINE",
                        "Fluoxetine (substance)",
                        "Fluoxetine hydrochloride",
                        "Fluoxetine-containing product",
                        "Product containing fluoxetine (medicinal product)",
                        "FLUOX",
                        "Prozac",
                        "Prozac",
                        "Symbyax",
                        "Sarafem",
                        "fluoxetin",
                        "Fluoxetin",
                        "Fluoxetin",
                        "Fluoxétine",
                        "Fluoxetina",
                        "fluoxetina",
                        "Fluoxetinum",
                        "fluoxetinum",
                        "N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                        "N-methyl-gamma-(4-(trifluoromethyl) -phenoxy)-benzenepropanamine",
                        "(+-)-N-methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "rac-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                        "(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, (+-)-",
                        "(+-)-N-methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine",
                        "(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine"
                    ],
                    "PUBCHEM.COMPOUND:1548970": [
                        "R-FLUOXETINE",
                        "(R)-fluoxetine",
                        "(+)-fluoxetine",
                        "(R)-Fluoxetine",
                        "FLUOXETINE, (R)-",
                        "(R)-(+)-fluoxetine",
                        "(R)-Prozac",
                        "(R)-N-methyl-3-(4-trifluoromethylphenoxy)-3-phenylpropylamine",
                        "(R)-N-methyl-3-(4-trifluoromethylphenyloxy)-3-(phenyl)propylamine",
                        "(R)-N-methyl-gamma-(4-trifluoromethylphenoxy)-3-phenylpropylamine",
                        "(3R)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                        "(R)-N-methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine"
                    ],
                    "PUBCHEM.COMPOUND:138402735": [
                        "Fluoxetine-d1"
                    ],
                    "PUBCHEM.COMPOUND:131801594": [
                        "Fluoxetine-d6"
                    ],
                    "UMLS:C0365872": [
                        "FLUoxetine Ql",
                        "FLUoxetine SerPl Ql",
                        "FLUoxetine:PrThr:Pt:Ser/Plas:Ord",
                        "FLUoxetine [Presence] in Serum or Plasma",
                        "FLUoxetine:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the acute and maintenance treatment of Major Depressive Disorder in adult patients",
                "id": {}
            }
        ],
        [
            {
                "label": "Fluoxetine",
                "id": {
                    "PUBCHEM.COMPOUND:3386": [
                        "fluoxetine",
                        "Fluoxetine",
                        "FLUoxetine",
                        "fluoxetine",
                        "FLUOXETINE",
                        "Fluoxetine (substance)",
                        "Fluoxetine hydrochloride",
                        "Fluoxetine-containing product",
                        "Product containing fluoxetine (medicinal product)",
                        "FLUOX",
                        "Prozac",
                        "Prozac",
                        "Symbyax",
                        "Sarafem",
                        "fluoxetin",
                        "Fluoxetin",
                        "Fluoxetin",
                        "Fluoxétine",
                        "Fluoxetina",
                        "fluoxetina",
                        "Fluoxetinum",
                        "fluoxetinum",
                        "N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                        "N-methyl-gamma-(4-(trifluoromethyl) -phenoxy)-benzenepropanamine",
                        "(+-)-N-methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "rac-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                        "(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, (+-)-",
                        "(+-)-N-methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine",
                        "(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine"
                    ],
                    "PUBCHEM.COMPOUND:1548970": [
                        "R-FLUOXETINE",
                        "(R)-fluoxetine",
                        "(+)-fluoxetine",
                        "(R)-Fluoxetine",
                        "FLUOXETINE, (R)-",
                        "(R)-(+)-fluoxetine",
                        "(R)-Prozac",
                        "(R)-N-methyl-3-(4-trifluoromethylphenoxy)-3-phenylpropylamine",
                        "(R)-N-methyl-3-(4-trifluoromethylphenyloxy)-3-(phenyl)propylamine",
                        "(R)-N-methyl-gamma-(4-trifluoromethylphenoxy)-3-phenylpropylamine",
                        "(3R)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                        "(R)-N-methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine"
                    ],
                    "PUBCHEM.COMPOUND:138402735": [
                        "Fluoxetine-d1"
                    ],
                    "PUBCHEM.COMPOUND:131801594": [
                        "Fluoxetine-d6"
                    ],
                    "UMLS:C0365872": [
                        "FLUoxetine Ql",
                        "FLUoxetine SerPl Ql",
                        "FLUoxetine:PrThr:Pt:Ser/Plas:Ord",
                        "FLUoxetine [Presence] in Serum or Plasma",
                        "FLUoxetine:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the acute and maintenance treatment of Major Depressive Disorder in pediatric patients aged 8 to18 years",
                "id": {}
            }
        ]
    ],
    "Fluoxetine is indicated for the acute and maintenance treatment of obsessions and compulsions in adult patients and in pediatric patients aged 7 to 17 years with Obsessive Compulsive Disorder (OCD)": [
        [
            {
                "label": "Fluoxetine",
                "id": {
                    "PUBCHEM.COMPOUND:3386": [
                        "fluoxetine",
                        "Fluoxetine",
                        "FLUoxetine",
                        "fluoxetine",
                        "FLUOXETINE",
                        "Fluoxetine (substance)",
                        "Fluoxetine hydrochloride",
                        "Fluoxetine-containing product",
                        "Product containing fluoxetine (medicinal product)",
                        "FLUOX",
                        "Prozac",
                        "Prozac",
                        "Symbyax",
                        "Sarafem",
                        "fluoxetin",
                        "Fluoxetin",
                        "Fluoxetin",
                        "Fluoxétine",
                        "Fluoxetina",
                        "fluoxetina",
                        "Fluoxetinum",
                        "fluoxetinum",
                        "N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                        "N-methyl-gamma-(4-(trifluoromethyl) -phenoxy)-benzenepropanamine",
                        "(+-)-N-methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "rac-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                        "(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, (+-)-",
                        "(+-)-N-methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine",
                        "(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine"
                    ],
                    "PUBCHEM.COMPOUND:1548970": [
                        "R-FLUOXETINE",
                        "(R)-fluoxetine",
                        "(+)-fluoxetine",
                        "(R)-Fluoxetine",
                        "FLUOXETINE, (R)-",
                        "(R)-(+)-fluoxetine",
                        "(R)-Prozac",
                        "(R)-N-methyl-3-(4-trifluoromethylphenoxy)-3-phenylpropylamine",
                        "(R)-N-methyl-3-(4-trifluoromethylphenyloxy)-3-(phenyl)propylamine",
                        "(R)-N-methyl-gamma-(4-trifluoromethylphenoxy)-3-phenylpropylamine",
                        "(3R)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                        "(R)-N-methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine"
                    ],
                    "PUBCHEM.COMPOUND:138402735": [
                        "Fluoxetine-d1"
                    ],
                    "PUBCHEM.COMPOUND:131801594": [
                        "Fluoxetine-d6"
                    ],
                    "UMLS:C0365872": [
                        "FLUoxetine Ql",
                        "FLUoxetine SerPl Ql",
                        "FLUoxetine:PrThr:Pt:Ser/Plas:Ord",
                        "FLUoxetine [Presence] in Serum or Plasma",
                        "FLUoxetine:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the acute and maintenance treatment of obsessions and compulsions in adult patients",
                "id": {}
            }
        ],
        [
            {
                "label": "Fluoxetine",
                "id": {
                    "PUBCHEM.COMPOUND:3386": [
                        "fluoxetine",
                        "Fluoxetine",
                        "FLUoxetine",
                        "fluoxetine",
                        "FLUOXETINE",
                        "Fluoxetine (substance)",
                        "Fluoxetine hydrochloride",
                        "Fluoxetine-containing product",
                        "Product containing fluoxetine (medicinal product)",
                        "FLUOX",
                        "Prozac",
                        "Prozac",
                        "Symbyax",
                        "Sarafem",
                        "fluoxetin",
                        "Fluoxetin",
                        "Fluoxetin",
                        "Fluoxétine",
                        "Fluoxetina",
                        "fluoxetina",
                        "Fluoxetinum",
                        "fluoxetinum",
                        "N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                        "N-methyl-gamma-(4-(trifluoromethyl) -phenoxy)-benzenepropanamine",
                        "(+-)-N-methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "rac-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                        "(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, (+-)-",
                        "(+-)-N-methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine",
                        "(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine"
                    ],
                    "PUBCHEM.COMPOUND:1548970": [
                        "R-FLUOXETINE",
                        "(R)-fluoxetine",
                        "(+)-fluoxetine",
                        "(R)-Fluoxetine",
                        "FLUOXETINE, (R)-",
                        "(R)-(+)-fluoxetine",
                        "(R)-Prozac",
                        "(R)-N-methyl-3-(4-trifluoromethylphenoxy)-3-phenylpropylamine",
                        "(R)-N-methyl-3-(4-trifluoromethylphenyloxy)-3-(phenyl)propylamine",
                        "(R)-N-methyl-gamma-(4-trifluoromethylphenoxy)-3-phenylpropylamine",
                        "(3R)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                        "(R)-N-methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine"
                    ],
                    "PUBCHEM.COMPOUND:138402735": [
                        "Fluoxetine-d1"
                    ],
                    "PUBCHEM.COMPOUND:131801594": [
                        "Fluoxetine-d6"
                    ],
                    "UMLS:C0365872": [
                        "FLUoxetine Ql",
                        "FLUoxetine SerPl Ql",
                        "FLUoxetine:PrThr:Pt:Ser/Plas:Ord",
                        "FLUoxetine [Presence] in Serum or Plasma",
                        "FLUoxetine:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the acute and maintenance treatment of obsessions and compulsions in pediatric patients aged 7 to 17 years with Obsessive Compulsive Disorder (OCD)",
                "id": {}
            }
        ]
    ],
    "Fluoxetine is indicated for the acute and maintenance treatment of binge-eating and vomiting behaviors in adult patients with moderate to severe Bulimia Nervosa": [
        [
            {
                "label": "Fluoxetine",
                "id": {
                    "PUBCHEM.COMPOUND:3386": [
                        "fluoxetine",
                        "Fluoxetine",
                        "FLUoxetine",
                        "fluoxetine",
                        "FLUOXETINE",
                        "Fluoxetine (substance)",
                        "Fluoxetine hydrochloride",
                        "Fluoxetine-containing product",
                        "Product containing fluoxetine (medicinal product)",
                        "FLUOX",
                        "Prozac",
                        "Prozac",
                        "Symbyax",
                        "Sarafem",
                        "fluoxetin",
                        "Fluoxetin",
                        "Fluoxetin",
                        "Fluoxétine",
                        "Fluoxetina",
                        "fluoxetina",
                        "Fluoxetinum",
                        "fluoxetinum",
                        "N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                        "N-methyl-gamma-(4-(trifluoromethyl) -phenoxy)-benzenepropanamine",
                        "(+-)-N-methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "rac-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                        "(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, (+-)-",
                        "(+-)-N-methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine",
                        "(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine"
                    ],
                    "PUBCHEM.COMPOUND:1548970": [
                        "R-FLUOXETINE",
                        "(R)-fluoxetine",
                        "(+)-fluoxetine",
                        "(R)-Fluoxetine",
                        "FLUOXETINE, (R)-",
                        "(R)-(+)-fluoxetine",
                        "(R)-Prozac",
                        "(R)-N-methyl-3-(4-trifluoromethylphenoxy)-3-phenylpropylamine",
                        "(R)-N-methyl-3-(4-trifluoromethylphenyloxy)-3-(phenyl)propylamine",
                        "(R)-N-methyl-gamma-(4-trifluoromethylphenoxy)-3-phenylpropylamine",
                        "(3R)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                        "(R)-N-methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine"
                    ],
                    "PUBCHEM.COMPOUND:138402735": [
                        "Fluoxetine-d1"
                    ],
                    "PUBCHEM.COMPOUND:131801594": [
                        "Fluoxetine-d6"
                    ],
                    "UMLS:C0365872": [
                        "FLUoxetine Ql",
                        "FLUoxetine SerPl Ql",
                        "FLUoxetine:PrThr:Pt:Ser/Plas:Ord",
                        "FLUoxetine [Presence] in Serum or Plasma",
                        "FLUoxetine:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the acute and maintenance treatment of binge-eating and vomiting behaviors in adult patients with moderate to severe Bulimia Nervosa",
                "id": {}
            }
        ]
    ],
    "Fluoxetine is indicated for the acute treatment of Panic Disorder, with or without agoraphobia, in adult patients": [
        [
            {
                "label": "Fluoxetine",
                "id": {
                    "PUBCHEM.COMPOUND:3386": [
                        "fluoxetine",
                        "Fluoxetine",
                        "FLUoxetine",
                        "fluoxetine",
                        "FLUOXETINE",
                        "Fluoxetine (substance)",
                        "Fluoxetine hydrochloride",
                        "Fluoxetine-containing product",
                        "Product containing fluoxetine (medicinal product)",
                        "FLUOX",
                        "Prozac",
                        "Prozac",
                        "Symbyax",
                        "Sarafem",
                        "fluoxetin",
                        "Fluoxetin",
                        "Fluoxetin",
                        "Fluoxétine",
                        "Fluoxetina",
                        "fluoxetina",
                        "Fluoxetinum",
                        "fluoxetinum",
                        "N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                        "N-methyl-gamma-(4-(trifluoromethyl) -phenoxy)-benzenepropanamine",
                        "(+-)-N-methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "rac-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                        "(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine",
                        "Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, (+-)-",
                        "(+-)-N-methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine",
                        "(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-P-tolyl)oxy)propylamine"
                    ],
                    "PUBCHEM.COMPOUND:1548970": [
                        "R-FLUOXETINE",
                        "(R)-fluoxetine",
                        "(+)-fluoxetine",
                        "(R)-Fluoxetine",
                        "FLUOXETINE, (R)-",
                        "(R)-(+)-fluoxetine",
                        "(R)-Prozac",
                        "(R)-N-methyl-3-(4-trifluoromethylphenoxy)-3-phenylpropylamine",
                        "(R)-N-methyl-3-(4-trifluoromethylphenyloxy)-3-(phenyl)propylamine",
                        "(R)-N-methyl-gamma-(4-trifluoromethylphenoxy)-3-phenylpropylamine",
                        "(3R)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine",
                        "(R)-N-methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine"
                    ],
                    "PUBCHEM.COMPOUND:138402735": [
                        "Fluoxetine-d1"
                    ],
                    "PUBCHEM.COMPOUND:131801594": [
                        "Fluoxetine-d6"
                    ],
                    "UMLS:C0365872": [
                        "FLUoxetine Ql",
                        "FLUoxetine SerPl Ql",
                        "FLUoxetine:PrThr:Pt:Ser/Plas:Ord",
                        "FLUoxetine [Presence] in Serum or Plasma",
                        "FLUoxetine:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the acute treatment of Panic Disorder, with or without agoraphobia, in adult patients",
                "id": {}
            }
        ]
    ],
    "Fluoxetine and olanzapine in combination is indicated for the acute treatment of depressive episodes associated with Bipolar I Disorder in adult patients.": [
        [
            {
                "label": "Fluoxetine and olanzapine in combination",
                "id": {}
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the acute treatment of depressive episodes associated with Bipolar I Disorder in adult patients",
                "id": {}
            }
        ]
    ],
    "Orphenadrine citrate is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculo-skeletal conditions.": [
        [
            {
                "label": "Orphenadrine citrate",
                "id": {
                    "UMLS:C0029310": [
                        "orphenadrine citrate",
                        "ORPHENADRINE CITRATE",
                        "Orphenadrine citrate",
                        "Orphenadrine Citrate",
                        "Citrate, Orphenadrine",
                        "orphenadrine (citrate)",
                        "Orphenadrine citrate (substance)",
                        "orphenadrine citrate (medication)",
                        "Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-, 2-hydroxy-1,2,3-propanetricarboxylate(1:1)"
                    ],
                    "PUBCHEM.COMPOUND:83823": [
                        "orphenadrine citrate",
                        "ORPHENADRINE CITRATE",
                        "Orphenadrine citrate",
                        "orphenadrine dihydrogen citrate",
                        "Flexon",
                        "X-Otag",
                        "Norflex",
                        "Banflex",
                        "N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate",
                        "(+-)-N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate",
                        "N,N-dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethanamine 2-hydroxypropane-1,2,3-tricarboxylate"
                    ],
                    "PUBCHEM.COMPOUND:4601": [
                        "Orphenadrine citrate",
                        "Citrate, orphenadrine",
                        "Norflex orphenadrine citrate",
                        "Citrate, norflex orphenadrine",
                        "Orphenadrine citrate, norflex",
                        "Norflex",
                        "Mialgin",
                        "Disipal",
                        "Lysantin",
                        "Orphenate",
                        "Mefenamine",
                        "Mephenamine",
                        "orfenadrina",
                        "Orfenadrina",
                        "Orfenadrina",
                        "Orphenadrin",
                        "Orphenadine",
                        "orphenadrine",
                        "Orphenedrine",
                        "Orphenadrine",
                        "ORPHENADRINE",
                        "orphenadrine",
                        "Orphenadrinum",
                        "orphenadrinum",
                        "Orphenadrinum",
                        "Sodium mefenamine",
                        "Mefenamine, sodium",
                        "O-Methyldiphenhydramine",
                        "2-Methyldiphenhydramine",
                        "o-methyldiphenhydramine",
                        "2-methyldiphenhydramine",
                        "Methyldiphenylhydramine",
                        "o-methyldiphenhydramine",
                        "Methyldiphenylhydramine",
                        "2-methyldiphenhydramine",
                        "Orphenadrine (substance)",
                        "orphenadrine (medication)",
                        "Orphenadrine hydrochloride",
                        "o-monomethyldiphenhydramine",
                        "Hydrochloride, orphenadrine",
                        "o-monomethyldiphenhydramine",
                        "O-Monomethyldiphenhydramine",
                        "Orphenadrine-containing product",
                        "2-(phenyl-o-tolylmethoxy)ethyldimethylamine",
                        "2-(Phenyl-O-tolylmethoxy)ethyldimethylamine",
                        "2-(phenyl-o-tolylmethoxy)ethyldimethylamine",
                        "Phenyl-O-tolylmethyl dimethyaminoethyl ether",
                        "phenyl-o-tolylmethyl dimethyaminoethyl ether",
                        "phenyl-o-tolylmethyl dimethyaminoethyl ether",
                        "b-Dimethylaminoethyl 2-methylbenzhydryl ether",
                        "Β-dimethylaminoethyl 2-methylbenzhydryl ether",
                        "β-dimethylaminoethyl 2-methylbenzhydryl ether",
                        "N,N-Dimethyl-2-(a-2-tolylbenzoyloxy)ethylamine",
                        "N,N-Dimethyl-2-(α-2-tolylbenzoyloxy)ethylamine",
                        "beta-dimethylaminoethyl 2-methylbenzhydryl ether",
                        "beta-Dimethylaminoethyl 2-methylbenzhydryl ether",
                        "beta-Dimethylaminoethyl 2-methylbenzhydryl ether",
                        "Dimethyl-[2-(phenyl-o-tolyl-methoxy)-ethyl]-amine",
                        "N,N-Dimethyl-2-(phenyl(O-tolyl)methoxy)ethanamine",
                        "Dimethyl-[2-(phenyl-O-tolyl-methoxy)-ethyl]-amine",
                        "N,N-dimethyl-2-(phenyl(o-tolyl)methoxy)ethanamine",
                        "Dimethyl-[2-(phenyl-o-tolyl-methoxy)-ethyl]-amine",
                        "N,N-dimethyl-2-(phenyl(o-tolyl)methoxy)ethanamine",
                        "N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine",
                        "N,N-Dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine",
                        "N,N-dimethyl-2-(alpha-2-tolylbenzoyloxy)ethylamine",
                        "Product containing orphenadrine (medicinal product)",
                        "N,N-Dimethyl-2-[(O-methyl-α-phenylbenzyl)oxy]ethylamine",
                        "N,N-dimethyl-2-[(o-methyl-α-phenylbenzyl)oxy]ethylamine",
                        "N,N-Dimethyl-2-[(O-methyl-a-phenylbenzyl)oxy]ethylamine",
                        "N,N-dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethanamine",
                        "N,N-dimethyl-2-[(o-methyl-alpha-phenylbenzyl)oxy]ethylamine",
                        "N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine",
                        "Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-"
                    ],
                    "PUBCHEM.COMPOUND:162641928": [
                        "Orphenadrine-d3 (citrate)"
                    ],
                    "UMLS:C2918136": [
                        "orphenadrine citrate 25 MG"
                    ]
                }
            },
            {
                "label": "is indicated as",
                "id": {
                    "UMLS:C4710292": [
                        "Assure that someone is oxygenating the patient and assisting with intubation, as indicated"
                    ],
                    "UMLS:C4713987": [
                        "Assure that the surgical site is marked with a permanent marker by the surgeon, as indicated"
                    ],
                    "UMLS:C4714380": [
                        "Perform targeted assessment of the system that is indicated by the history of present illness"
                    ],
                    "UMLS:C4711109": [
                        "Ensure that equipment is operational via trial run (i.e., assemble laryngoscope and check light bulb function), as indicated"
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ]
                }
            },
            {
                "label": "an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculo-skeletal conditions",
                "id": {}
            }
        ]
    ],
    "Ramelteon tablets are indicated for the treatment of insomnia characterized by difficulty with sleep onset.": [
        [
            {
                "label": "Ramelteon tablets",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of insomnia characterized by difficulty with sleep onset",
                "id": {}
            }
        ]
    ],
    "Frovatriptan succinate tablets are indicated for the acute treatment of migraine with or without aura in adults.": [
        [
            {
                "label": "Frovatriptan succinate tablets",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the acute treatment of migraine with or without aura in adults",
                "id": {}
            }
        ]
    ],
    "Sumatriptan tablets are indicated for the acute treatment of migraine with or without aura in adults.": [
        [
            {
                "label": "Sumatriptan tablets",
                "id": {
                    "UMLS:C1248084": [
                        "Sumatriptan Tablets",
                        "sumatriptan Oral Tablet",
                        "SUMAtriptan Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the acute treatment of migraine with or without aura in adults",
                "id": {}
            }
        ]
    ],
    "Marplan is indicated for the treatment of depression.": [
        [
            {
                "label": "Marplan",
                "id": {
                    "UMLS:C0591755": [
                        "Marplan"
                    ],
                    "PUBCHEM.COMPOUND:3759": [
                        "Marplan",
                        "marplan",
                        "benazide",
                        "Ro 5-0831",
                        "Ro 5-0831/1",
                        "isocarboxazid",
                        "Isocarbonazid",
                        "Isocarboxyzid",
                        "ISOCARBOXAZID",
                        "Isocarboxazid",
                        "isocarboxyzid",
                        "isocarboxazide",
                        "Isocarboxazide",
                        "Isocarboxazide",
                        "Isocarboxazida",
                        "Isocarboxazidum",
                        "Isocarbossazide",
                        "MAOI - Isocarboxazid",
                        "Isocarboxazid (substance)",
                        "isocarboxazid (medication)",
                        "Isocarboxazid-containing product",
                        "Product containing isocarboxazid (medicinal product)",
                        "5-methyl-N'-(phenylmethyl)-3-isoxazolecarbohydrazide",
                        "3-Isoxazolecarboxylic Acid, 5-methyl-, 2-(phenylmethyl)hydrazide",
                        "3-Isoxazolecarboxylic acid, 5-methyl-, 2-(phenylmethyl)hydrazide"
                    ],
                    "UMLS:C3234871": [
                        "Marplan Pill"
                    ],
                    "UMLS:C1241695": [
                        "Marplan Tablets",
                        "isocarboxazid Oral Tablet [Marplan]"
                    ],
                    "UMLS:C0698295": [
                        "Marplan 10mg tablet",
                        "Marplan 10mg Tablet",
                        "Marplan 10 MG Oral Tablet",
                        "Marplan, 10 mg oral tablet",
                        "Isocarboxazid 10 MG Oral Tablet [MARPLAN]",
                        "ISOCARBOXAZID 10 mg ORAL TABLET [Marplan]",
                        "isocarboxazid 10 MG Oral Tablet [Marplan]"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of depression",
                "id": {}
            }
        ]
    ],
    "Because of its potentially serious side effects, Marplan is not an antidepressant of first choice in the treatment of newly diagnosed depressed patient": [
        [
            {
                "label": "Marplan",
                "id": {
                    "UMLS:C0591755": [
                        "Marplan"
                    ],
                    "PUBCHEM.COMPOUND:3759": [
                        "Marplan",
                        "marplan",
                        "benazide",
                        "Ro 5-0831",
                        "Ro 5-0831/1",
                        "isocarboxazid",
                        "Isocarbonazid",
                        "Isocarboxyzid",
                        "ISOCARBOXAZID",
                        "Isocarboxazid",
                        "isocarboxyzid",
                        "isocarboxazide",
                        "Isocarboxazide",
                        "Isocarboxazide",
                        "Isocarboxazida",
                        "Isocarboxazidum",
                        "Isocarbossazide",
                        "MAOI - Isocarboxazid",
                        "Isocarboxazid (substance)",
                        "isocarboxazid (medication)",
                        "Isocarboxazid-containing product",
                        "Product containing isocarboxazid (medicinal product)",
                        "5-methyl-N'-(phenylmethyl)-3-isoxazolecarbohydrazide",
                        "3-Isoxazolecarboxylic Acid, 5-methyl-, 2-(phenylmethyl)hydrazide",
                        "3-Isoxazolecarboxylic acid, 5-methyl-, 2-(phenylmethyl)hydrazide"
                    ],
                    "UMLS:C3234871": [
                        "Marplan Pill"
                    ],
                    "UMLS:C1241695": [
                        "Marplan Tablets",
                        "isocarboxazid Oral Tablet [Marplan]"
                    ],
                    "UMLS:C0698295": [
                        "Marplan 10mg tablet",
                        "Marplan 10mg Tablet",
                        "Marplan 10 MG Oral Tablet",
                        "Marplan, 10 mg oral tablet",
                        "Isocarboxazid 10 MG Oral Tablet [MARPLAN]",
                        "ISOCARBOXAZID 10 mg ORAL TABLET [Marplan]",
                        "isocarboxazid 10 MG Oral Tablet [Marplan]"
                    ]
                }
            },
            {
                "label": "is",
                "id": {
                    "UBERON:0002872": [
                        "IS",
                        "inferior salivary nucleus",
                        "Nucleus salivarius inferior",
                        "nucleus salivarius inferior",
                        "Inferior salivatory nucleus",
                        "inferior salivatary nucleus",
                        "inferior salivatory nucleus",
                        "Nucleus salivatorius inferior",
                        "nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior",
                        "Nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior nervi glossopharyngei",
                        "Nucleus salivatorius inferior nervi glossopharyngei"
                    ],
                    "OMIM:146850": [
                        "IS",
                        "ISCW",
                        "ISSCW",
                        "IMMUNE SUPPRESSION",
                        "STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO"
                    ],
                    "FB:FBgn0001274": [
                        "Is"
                    ],
                    "PUBCHEM.COMPOUND:7021816": [
                        "IS",
                        "isoleucylserine",
                        "Isoleucyl-Serine",
                        "L-isoleucyl-L-serine",
                        "Ile-Ser",
                        "L-Ile-L-Ser",
                        "CHEMBL56803"
                    ],
                    "UMLS:C0021632": [
                        "IS",
                        "INSTRUM",
                        "instrumentation",
                        "instrumentation aspects"
                    ]
                }
            },
            {
                "label": "not an antidepressant of first choice in the treatment of newly diagnosed depressed patient",
                "id": {}
            }
        ],
        [
            {
                "label": "its potentially serious side effects",
                "id": {}
            },
            {
                "label": "are",
                "id": {
                    "NCIT:C13662": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1515984": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1551058": [
                        "Are",
                        "are unit of measure"
                    ],
                    "MONDO:0044742": [
                        "AREI",
                        "autosomal recessive epidermolytic ichthyosis"
                    ],
                    "MONDO:0017339": [
                        "AREI",
                        "Ichthyosis exfoliativa",
                        "ICHTHYOSIS EXFOLIATIVA",
                        "ichthyosis exfoliativa",
                        "Exfoliative ichthyosis",
                        "Ichthyosis Exfoliativa",
                        "exfoliative ichthyosis",
                        "ICHTHYOSIS BULLOSA OF SIEMENS-LIKE",
                        "autosomal recessive exfoliative ichthyosis",
                        "Autosomal recessive exfoliative ichthyosis",
                        "ICHTHYOSIS, EXFOLIATIVE, AUTOSOMAL RECESSIVE",
                        "ichthyosis congenital autosomal recessive exfoliative",
                        "Autosomal recessive exfoliative ichthyosis (disorder)",
                        "Autosomal recessive exfoliative ichthyosis (diagnosis)"
                    ]
                }
            },
            {
                "label": "a reason why Marplan is not an antidepressant of first choice",
                "id": {}
            }
        ]
    ],
    "Pimozide Tablets, USP is indicated for the suppression of motor and phonic tics in patients with Tourette’s Disorder who have failed to respond satisfactorily to standard treatment.": [
        [
            {
                "label": "Pimozide Tablets, USP",
                "id": {}
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the suppression of motor and phonic tics in patients with Tourette’s Disorder who have failed to respond satisfactorily to standard treatment",
                "id": {}
            }
        ]
    ],
    "Thiothixene capsules are effective in the management of schizophrenia.": [
        [
            {
                "label": "Thiothixene capsules",
                "id": {
                    "UMLS:C1248183": [
                        "Thiothixene Capsules",
                        "thiothixene Oral Capsule"
                    ]
                }
            },
            {
                "label": "are effective in",
                "id": {
                    "NCIT:C147150": [
                        "Effective Orifice Area Index",
                        "EOAINDEX"
                    ],
                    "UMLS:C2609085": [
                        "Effective peritoneal surface area increased"
                    ],
                    "UMLS:C2963670": [
                        "How often are you less effective at work due to your fatigue (include work at home) in past 7D",
                        "How often are you less effective at work due to your fatigue (include work at home) in past 7 days"
                    ],
                    "UMLS:C3698914": [
                        "How often are you less effective at work due to your fatigue (include work at home) in past 7 days [PROMIS]",
                        "How often are you less effective at work due to your fatigue (include work at home) in past 7D:Find:7D:^Patient:Ord:PROMIS",
                        "How often are you less effective at work due to your fatigue (include work at home) in past 7D:Finding:7 days:^Patient:Ordinal:PROMIS"
                    ],
                    "UMLS:C5551722": [
                        "Agreement with statement: childhood vaccines are useful and effective:Finding:To identify measures at a point in time:^Patient:Ordinal",
                        "Agreement with statement: childhood vaccines are useful and effective",
                        "Agreement with statement: childhood vaccines are useful and effective:Find:Pt:^Patient:Ord"
                    ]
                }
            },
            {
                "label": "the management of schizophrenia",
                "id": {}
            }
        ]
    ],
    "Treatment of adult and adolescent patients (13 to 17 years) with schizophrenia": [
        [
            {
                "label": "Treatment",
                "id": {
                    "UMLS:C0039798": [
                        "treatment",
                        "TH",
                        "THER",
                        "therapy",
                        "disease management",
                        "therapeutic aspects"
                    ],
                    "UMLS:C0087111": [
                        "Treatment",
                        "treatment",
                        "treatments",
                        "Treatments",
                        "method treatment",
                        "treatment method",
                        "methods treatment",
                        "therapy (treatment)",
                        "TX",
                        "THER",
                        "therapy",
                        "Therapy",
                        "Therapies",
                        "therapies",
                        "Therapeutic",
                        "therapeutics",
                        "Therapy, NOS",
                        "Therapeutics",
                        "Therapeutic Method",
                        "therapeutic method",
                        "Therapeutic proced",
                        "Therapeutic Procedure",
                        "Therapeutic procedure",
                        "Therapeutic Technique",
                        "therapeutic procedure",
                        "Therapeutic Procedures",
                        "Therapy (regime/therapy)",
                        "Therapeutic procedure NOS",
                        "Therapeutic Interventions",
                        "Therapeutic procedure, NOS",
                        "Therapeutic procedure (procedure)"
                    ],
                    "UMLS:C1522326": [
                        "Treatment",
                        "Treat",
                        "Treated",
                        "treated",
                        "treating",
                        "Treating",
                        "treated with"
                    ],
                    "UMLS:C1533734": [
                        "Treatment",
                        "Administering",
                        "Administration",
                        "Administration procedure",
                        "administration procedures",
                        "Administration (Procedure)"
                    ],
                    "UMLS:C1705169": [
                        "Treatment",
                        "Biomaterial Treatment"
                    ]
                }
            },
            {
                "label": "of",
                "id": {
                    "PUBCHEM.COMPOUND:6432002": [
                        "OF",
                        "OF(.)",
                        "oxygen fluoride",
                        "fluoridooxygen(.)",
                        "oxygen monofluoride"
                    ],
                    "NCBIGene:6688": [
                        "OF",
                        "OF",
                        "SFFV VIRUS-INDUCED MURINE ERYTHROLEUKEMIA ONCOGENE, MOUSE, HOMOLOG OF",
                        "PU.1",
                        "PU.1",
                        "SPI1",
                        "SPI-A",
                        "SFPI1",
                        "SPI-1",
                        "SPI-A",
                        "SPI-1",
                        "SFPI1",
                        "SPI1 gene",
                        "SPI1 Gene",
                        "Oncogene SPI1",
                        "ONCOGENE SPI1",
                        "SPI1 PROTOONCOGENE",
                        "Spi-1 proto-oncogene",
                        "Spi-1 Proto-Oncogene Gene",
                        "31 kDa transforming protein",
                        "31 kDa transforming protein",
                        "HEMATOPOIETIC TRANSCRIPTION FACTOR PU.1",
                        "hematopoietic transcription factor PU.1",
                        "hematopoietic transcription factor PU.1",
                        "SPLEEN FOCUS FORMING VIRUS PROVIRAL INTEGRATION ONCOGENE SPI1",
                        "Spleen Focus Forming Virus Proviral Integration Oncogene SPI1",
                        "spleen focus forming virus (SFFV) proviral integration oncogene"
                    ],
                    "NCBIGene:83990": [
                        "OF",
                        "OF",
                        "DOG1, HOMOLOG OF",
                        "DELETIONS OF GUANINE-RICH DNA, C. ELEGANS, HOMOLOG OF",
                        "FANCJ",
                        "BACH1",
                        "BRIP1",
                        "BACH1",
                        "FANCJ",
                        "FANCJ GENE",
                        "BRIP1 Gene",
                        "BRIP1 gene",
                        "FANCJ helicase",
                        "FANCJ helicase",
                        "BRCA1 interacting protein 1",
                        "BRCA1-INTERACTING PROTEIN 1",
                        "BRCA1 interacting protein 1",
                        "BRCA1 interacting helicase 1",
                        "BRCA1/BRCA2-associated helicase 1",
                        "BRCA1/BRCA2-associated helicase 1",
                        "BRCA1-associated C-terminal helicase",
                        "BRCA1-associated C-terminal helicase",
                        "BRCA1-ASSOCIATED C-TERMINAL HELICASE 1",
                        "BRCA1 interacting protein C-terminal helicase 1",
                        "BRCA1 Interacting Protein C-Terminal Helicase 1 Gene"
                    ],
                    "UMLS:C0332285": [
                        "Of",
                        "In",
                        "in",
                        "Within",
                        "Inside",
                        "Found in",
                        "Located in",
                        "Has setting",
                        "Has location",
                        "Arising from",
                        "In (attribute)"
                    ],
                    "UMLS:C0456628": [
                        "oF",
                        "F",
                        "degrees F",
                        "fahrenheit",
                        "Degree Fahrenheit",
                        "degree fahrenheit",
                        "degrees fahrenheit",
                        "fahrenheit degrees",
                        "Degrees fahrenheit",
                        "Degrees Fahrenheit",
                        "Degrees Fahrenheit (qualifier value)"
                    ]
                }
            },
            {
                "label": "adult and adolescent patients",
                "id": {}
            }
        ],
        [
            {
                "label": "adult and adolescent patients",
                "id": {}
            },
            {
                "label": "with",
                "id": {
                    "FB:FBgn0004015": [
                        "with"
                    ],
                    "UMLS:C0332287": [
                        "With",
                        "With (attribute)",
                        "c",
                        "W",
                        "PL",
                        "Cum",
                        "Plus",
                        "Addition",
                        "In addition to"
                    ],
                    "UMLS:C1705690": [
                        "With",
                        "With - dosing instruction fragment",
                        "With - dosing instruction fragment (qualifier value)"
                    ],
                    "UMLS:C0332285": [
                        "Within",
                        "Of",
                        "In",
                        "in",
                        "Inside",
                        "Found in",
                        "Located in",
                        "Has setting",
                        "Has location",
                        "Arising from",
                        "In (attribute)"
                    ],
                    "UBERON:0017749": [
                        "withers"
                    ]
                }
            },
            {
                "label": "schizophrenia",
                "id": {
                    "MONDO:0005090": [
                        "schizophrenia",
                        "Schizophrenia",
                        "SCHIZOPHRENIA",
                        "schizophrenia",
                        "SCHIZOPHRENIAS",
                        "schizophrenias",
                        "Schizophrenias",
                        "schizophrenia-1",
                        "schizophrenia-1",
                        "schizophrenia 12",
                        "Schizophrenia NOS",
                        "schizophrenia type",
                        "Schizophrenia, NOS",
                        "type schizophrenia",
                        "schizophrenia types",
                        "schizophrenia disorder",
                        "disorder schizophrenia",
                        "schizophrenia (disease)",
                        "disorders schizophrenia",
                        "Schizophrenia all types",
                        "schizophrenia disorders",
                        "Schizophrenia (disorder)",
                        "Schizophrenia NOS-unspec",
                        "schizophrenia (diagnosis)",
                        "unspecified schizophrenia",
                        "Unspecified schizophrenia",
                        "SECTION 9-4 SCHIZOPHRENIAS",
                        "Schizophrenia, unspecified",
                        "schizophrenia, susceptibility to",
                        "schizophrenia disorders (diagnosis)",
                        "Unspecified schizophrenia, unspecified",
                        "Unspecified schizophrenia, unspecified state",
                        "schizophrenia with or without an affective disorder",
                        "SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER",
                        "SCZD",
                        "SCZD",
                        "dementia praecox",
                        "Dementia Praecox",
                        "Dementia praecox",
                        "praecox; dementia",
                        "SCHIZOPHRENIC DIS",
                        "disorder schizophrenic",
                        "schizophrenic disorder",
                        "Schizophrenic Disorder",
                        "Schizophrenic disorders",
                        "Disorder, Schizophrenic",
                        "Schizophrenic Disorders",
                        "schizophrenic disorders",
                        "disorders schizophrenic",
                        "schizoaffective disorder",
                        "disorders schizophrenics",
                        "Disorders, Schizophrenic",
                        "Schizophrenic disorders (disorder)"
                    ],
                    "MONDO:0010943": [
                        "schizophrenia 4",
                        "schizophrenia 4",
                        "SCHIZOPHRENIA 4",
                        "schizophrenia type 4",
                        "SCHIZOPHRENIA 4 (disorder)",
                        "schizophrenia, susceptibility to, 4",
                        "SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 22q11-RELATED",
                        "schizophrenia susceptibility locus, chromosome 22Q11-related",
                        "SCZD4",
                        "SCZD4"
                    ],
                    "MONDO:0010897": [
                        "schizophrenia 3",
                        "schizophrenia 3",
                        "SCHIZOPHRENIA 3",
                        "SCHIZOPHRENIA 3 (disorder)",
                        "SCHIZOPHRENIA 3 WITH OR WITHOUT AN AFFECTIVE DISORDER",
                        "schizophrenia 3 with or without an affective disorder",
                        "SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED",
                        "schizophrenia susceptibility locus, chromosome 6-related",
                        "SCZD3",
                        "SCZD3"
                    ],
                    "MONDO:0011280": [
                        "schizophrenia 6",
                        "SCHIZOPHRENIA 6",
                        "schizophrenia 6",
                        "SCHIZOPHRENIA 6 (disorder)",
                        "schizophrenia, susceptibility to",
                        "SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 8p-RELATED",
                        "schizophrenia susceptibility locus, chromosome 8P-related",
                        "SCZD6",
                        "SCZD6"
                    ],
                    "MONDO:0008414": [
                        "SCHIZOPHRENIA 1",
                        "schizophrenia 1",
                        "schizophrenia 1",
                        "SCHIZOPHRENIA 1 (disorder)",
                        "schizophrenia 1 with or without an affective disorder",
                        "SCHIZOPHRENIA 1 WITH OR WITHOUT AN AFFECTIVE DISORDER",
                        "SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 5-RELATED",
                        "schizophrenia susceptibility locus, chromosome 5-related",
                        "SCZD1",
                        "SCZD1"
                    ]
                }
            }
        ]
    ],
    "Monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode associated with bipolar I disorder (bipolar depression)": [
        [
            {
                "label": "Monotherapy treatment",
                "id": {}
            },
            {
                "label": "is for",
                "id": {
                    "CHEBI:140821": [
                        "iso-Forssman",
                        "i-Forssman",
                        "isogloboside iGb5Cer",
                        "alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer",
                        "N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide"
                    ],
                    "UMLS:C1552560": [
                        "is backup for"
                    ],
                    "PUBCHEM.COMPOUND:8052": [
                        "Isoamyl formate",
                        "Isoamyl formate",
                        "isoamyl formate",
                        "ISOAMYL FORMATE",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formic acid",
                        "Formate, isopentyl ester",
                        "Isopentyl alcohol, formate",
                        "Formic acid, isopentyl ester",
                        "Formic acid, isopentyl ester",
                        "Isoamyl methanoate",
                        "Isoamyl methanoate",
                        "Isopentyl methanoate",
                        "Isopentyl methanoate",
                        "3-methylbutyl formate",
                        "3-Methylbutyl formate",
                        "Isoamyl methanoic acid",
                        "Isopentyl methanoic acid",
                        "3-Methyl-1-butyl formate",
                        "3-Methylbutyl formic acid",
                        "1-Butanol, 3-methyl-, formate",
                        "3-Methyl-2-butenyl formic acid",
                        "1-Butanol, 3-methyl-, 1-formate"
                    ],
                    "UMLS:C2346508": [
                        "ISS for Myeloma",
                        "International Staging System for Myeloma"
                    ],
                    "UMLS:C1562189": [
                        "Is etiology for",
                        "is etiology for",
                        "Is aetiology for",
                        "Is etiology for (link assertion)"
                    ]
                }
            },
            {
                "label": "adult and pediatric patients",
                "id": {
                    "UMLS:C5574633": [
                        "Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg",
                        "Tocilizumab for covid-19"
                    ],
                    "UMLS:C5574598": [
                        "Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose",
                        "Adm tocilizu covid-19 1st"
                    ],
                    "UMLS:C5574599": [
                        "Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose",
                        "Adm tocilizu covid-19 2nd"
                    ]
                }
            }
        ],
        [
            {
                "label": "adult and pediatric patients",
                "id": {
                    "UMLS:C5574633": [
                        "Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg",
                        "Tocilizumab for covid-19"
                    ],
                    "UMLS:C5574598": [
                        "Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose",
                        "Adm tocilizu covid-19 1st"
                    ],
                    "UMLS:C5574599": [
                        "Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose",
                        "Adm tocilizu covid-19 2nd"
                    ]
                }
            },
            {
                "label": "are with",
                "id": {
                    "UMLS:C2039216": [
                        "rash in diaper area with scabs",
                        "skin lesion of diaper area with scabs",
                        "skin lesion of diaper area with scabs (symptom)"
                    ],
                    "UMLS:C2158598": [
                        "cyst of diaper area with scabs",
                        "cyst of diaper area with scabs (physical finding)"
                    ],
                    "UMLS:C2171468": [
                        "ulcer of areola with skin loss",
                        "ulcer of areola with skin loss (physical finding)"
                    ],
                    "UMLS:C4035928": [
                        "Other area within the facility"
                    ],
                    "UMLS:C2050677": [
                        "patch of diaper area with scabs",
                        "patch of diaper area with scabs (physical finding)"
                    ]
                }
            },
            {
                "label": "major depressive episode",
                "id": {
                    "MONDO:0002009": [
                        "major depressive episode",
                        "depressive; episode, major",
                        "single major depressive episode",
                        "single major depressive episode",
                        "Recurrent major depressive episodes",
                        "DEPRESSIVE DISORDER MAJOR SINGLE EPISODE",
                        "Major depressive disorder; single episode",
                        "Major depressive disorder, single episode",
                        "Single Episode of Major Depressive Disorder",
                        "Major depressive disorder; recurrent episode",
                        "major depressive disorder, recurrent episode",
                        "Major depressive disorder, recurrent episode",
                        "Recurrent major depressive episodes (disorder)",
                        "Recurrent major depressive episodes (diagnosis)",
                        "Major depressive disorder, single episode, unspecified",
                        "Major depressive disorder, Recurrent episode, Unspecified",
                        "Major depressive disorder, single episode, unspecified degree",
                        "Major depressive disorder, recurrent episode, unspecified degree",
                        "Major depressive affective disorder, single episode, unspecified",
                        "Major depressive affective disorder, recurrent episode, unspecified",
                        "MDD",
                        "major depression",
                        "Major depression",
                        "Major Depression",
                        "MAJOR DEPRESSION",
                        "Unipolar Depression",
                        "UNIPOLAR DEPRESSION",
                        "depression unipolar",
                        "Unipolar depression",
                        "unipolar depression",
                        "Unipolar Depressions",
                        "Major depression NOS",
                        "MAJOR DEPRESSIVE DIS",
                        "Depression, Unipolar",
                        "DEPRESSIVE DIS MAJOR",
                        "Depressions, Unipolar",
                        "Major depression, NOS",
                        "Depress psychosis-unspec",
                        "Recurr depr psychos-unsp",
                        "Major depressive illness",
                        "major depressive illness",
                        "DEPRESSIVE DISORDER MAJOR",
                        "Major Depressive Disorder",
                        "Major depressive disorder",
                        "major depressive disorder",
                        "MAJOR DEPRESSIVE DISORDER",
                        "major depressive disorder",
                        "Recurrent major depression",
                        "recurrent major depression",
                        "Major Depressive Disorders",
                        "recurrent major depression",
                        "Depressive Disorder, Major",
                        "major depressive disorder 2",
                        "major depressive disorder 1",
                        "Depressive Disorders, Major",
                        "Unipolar depressive illness",
                        "Major depressive disorder NOS",
                        "Major depressive disorder, NOS",
                        "Recurrent major depression, NOS",
                        "major depression, single episode",
                        "Major depression, single episode",
                        "single episode of major depression",
                        "DEPRESSIVE DISORDER MAJOR RECURRENT",
                        "Recurrent major depressive disorder",
                        "major depression recurrent episodes",
                        "Major depressive disorder, recurrent",
                        "Major depressive disorder (disorder)",
                        "Recurrent major depression (disorder)",
                        "Major depressive disorder (diagnosis)",
                        "Major depression, single episode, NOS",
                        "recurrent episodes of major depression",
                        "recurrent major depression (diagnosis)",
                        "unipolar depression, susceptibility to",
                        "Recurrent major depressive disorder, NOS",
                        "Major depression, single episode (disorder)",
                        "major depression, single episode (diagnosis)",
                        "seasonal affective disorder, susceptibility to",
                        "Major depressive disorder, recurrent, unspecified",
                        "major depressive disorder, response to citalopram therapy in",
                        "major depressive disorder and accelerated response to antidepressant drug treatment"
                    ],
                    "UMLS:C3665435": [
                        "recurrent major depressive episode, mild",
                        "Recurrent major depressive episodes, mild",
                        "Major depressive disorder, Recurrent episode, Mild",
                        "recurrent major depressive episode, mild (diagnosis)",
                        "Recurrent major depressive episodes, mild (disorder)",
                        "Major depressive disorder, recurrent episode, mild degree",
                        "Major depressive affective disorder, recurrent episode, mild",
                        "Recurr depr psychos-mild",
                        "major depression, recurrent, mild episode"
                    ],
                    "UMLS:C0338890": [
                        "Recurrent major depressive episodes, moderate",
                        "Major depressive disorder, Recurrent episode, Moderate",
                        "Recurrent major depressive episodes, moderate (disorder)",
                        "major depression, recurrent, moderate episode",
                        "major depression, recurrent, moderate episode (diagnosis)"
                    ],
                    "MONDO:0005929": [
                        "Major Depressive Episode with Peripartum Onset",
                        "major depressive episode with peripartum onset",
                        "Baby blues",
                        "Baby Blues",
                        "baby blues",
                        "blue maternity",
                        "Maternity blues",
                        "maternity blues",
                        "Maternity blues",
                        "Third day blues",
                        "Postnatal blues",
                        "postnatal blues",
                        "puerperal depression",
                        "Postnatal Depression",
                        "postnatal depression",
                        "Depression puerperal",
                        "depression postnatal",
                        "DEPRESSION PUERPERAL",
                        "Puerperal Depression",
                        "postnatal depression",
                        "Postnatal depression",
                        "Puerperal depression",
                        "Depression;postnatal",
                        "Depression;puerperal",
                        "Postpartum depression",
                        "postnatal; depression",
                        "depression; postnatal",
                        "Postpartum Depression",
                        "DEPRESSION POSTPARTUM",
                        "post-Natal depression",
                        "Post Natal Depression",
                        "Post-Natal Depression",
                        "postpartum depression",
                        "post Natal depression",
                        "post-natal depression",
                        "depression, postnatal",
                        "post natal depression",
                        "depression postpartum",
                        "postpartum depression",
                        "Depression, Postnatal",
                        "Post-Partum Depression",
                        "postpartum; depression",
                        "Depression, Postpartum",
                        "depression; postpartum",
                        "Post Partum Depression",
                        "post partum depression",
                        "Depression, Post-Natal",
                        "post partum depression",
                        "depression, post-Natal",
                        "post-partum depression",
                        "post-partum depression",
                        "depression, post-partum",
                        "Depression, Post-Partum",
                        "Postnatal depression, NOS",
                        "Post-pregnancy depression",
                        "Maternity blues (disorder)",
                        "Postpartum depression, NOS",
                        "Maternity blues (diagnosis)",
                        "Postnatal depressive disorder",
                        "Postpartum depression (disorder)",
                        "postpartum depression (diagnosis)",
                        "Postnatal depression (excl psychosis)",
                        "postpartum depression maternity blues",
                        "depressive episode with postpartum onset",
                        "Depressive Episode with Postpartum Onset",
                        "Postnatal depression (excluding psychosis)"
                    ],
                    "UMLS:C0154403": [
                        "Major depressive disorder, Single episode, Mild",
                        "Major depressive disorder, single episode, mild",
                        "disorder; depressive, major, single episode, mild",
                        "Major depressive disorder, single episode, mild degree",
                        "Major depressive affective disorder, single episode, mild",
                        "Depress psychosis-mild",
                        "Mild major depression, single episode",
                        "Mild major depression, single episode (disorder)",
                        "Mild major depression, single episode (diagnosis)"
                    ]
                }
            }
        ],
        [
            {
                "label": "major depressive episode",
                "id": {
                    "MONDO:0002009": [
                        "major depressive episode",
                        "depressive; episode, major",
                        "single major depressive episode",
                        "single major depressive episode",
                        "Recurrent major depressive episodes",
                        "DEPRESSIVE DISORDER MAJOR SINGLE EPISODE",
                        "Major depressive disorder; single episode",
                        "Major depressive disorder, single episode",
                        "Single Episode of Major Depressive Disorder",
                        "Major depressive disorder; recurrent episode",
                        "major depressive disorder, recurrent episode",
                        "Major depressive disorder, recurrent episode",
                        "Recurrent major depressive episodes (disorder)",
                        "Recurrent major depressive episodes (diagnosis)",
                        "Major depressive disorder, single episode, unspecified",
                        "Major depressive disorder, Recurrent episode, Unspecified",
                        "Major depressive disorder, single episode, unspecified degree",
                        "Major depressive disorder, recurrent episode, unspecified degree",
                        "Major depressive affective disorder, single episode, unspecified",
                        "Major depressive affective disorder, recurrent episode, unspecified",
                        "MDD",
                        "major depression",
                        "Major depression",
                        "Major Depression",
                        "MAJOR DEPRESSION",
                        "Unipolar Depression",
                        "UNIPOLAR DEPRESSION",
                        "depression unipolar",
                        "Unipolar depression",
                        "unipolar depression",
                        "Unipolar Depressions",
                        "Major depression NOS",
                        "MAJOR DEPRESSIVE DIS",
                        "Depression, Unipolar",
                        "DEPRESSIVE DIS MAJOR",
                        "Depressions, Unipolar",
                        "Major depression, NOS",
                        "Depress psychosis-unspec",
                        "Recurr depr psychos-unsp",
                        "Major depressive illness",
                        "major depressive illness",
                        "DEPRESSIVE DISORDER MAJOR",
                        "Major Depressive Disorder",
                        "Major depressive disorder",
                        "major depressive disorder",
                        "MAJOR DEPRESSIVE DISORDER",
                        "major depressive disorder",
                        "Recurrent major depression",
                        "recurrent major depression",
                        "Major Depressive Disorders",
                        "recurrent major depression",
                        "Depressive Disorder, Major",
                        "major depressive disorder 2",
                        "major depressive disorder 1",
                        "Depressive Disorders, Major",
                        "Unipolar depressive illness",
                        "Major depressive disorder NOS",
                        "Major depressive disorder, NOS",
                        "Recurrent major depression, NOS",
                        "major depression, single episode",
                        "Major depression, single episode",
                        "single episode of major depression",
                        "DEPRESSIVE DISORDER MAJOR RECURRENT",
                        "Recurrent major depressive disorder",
                        "major depression recurrent episodes",
                        "Major depressive disorder, recurrent",
                        "Major depressive disorder (disorder)",
                        "Recurrent major depression (disorder)",
                        "Major depressive disorder (diagnosis)",
                        "Major depression, single episode, NOS",
                        "recurrent episodes of major depression",
                        "recurrent major depression (diagnosis)",
                        "unipolar depression, susceptibility to",
                        "Recurrent major depressive disorder, NOS",
                        "Major depression, single episode (disorder)",
                        "major depression, single episode (diagnosis)",
                        "seasonal affective disorder, susceptibility to",
                        "Major depressive disorder, recurrent, unspecified",
                        "major depressive disorder, response to citalopram therapy in",
                        "major depressive disorder and accelerated response to antidepressant drug treatment"
                    ],
                    "UMLS:C3665435": [
                        "recurrent major depressive episode, mild",
                        "Recurrent major depressive episodes, mild",
                        "Major depressive disorder, Recurrent episode, Mild",
                        "recurrent major depressive episode, mild (diagnosis)",
                        "Recurrent major depressive episodes, mild (disorder)",
                        "Major depressive disorder, recurrent episode, mild degree",
                        "Major depressive affective disorder, recurrent episode, mild",
                        "Recurr depr psychos-mild",
                        "major depression, recurrent, mild episode"
                    ],
                    "UMLS:C0338890": [
                        "Recurrent major depressive episodes, moderate",
                        "Major depressive disorder, Recurrent episode, Moderate",
                        "Recurrent major depressive episodes, moderate (disorder)",
                        "major depression, recurrent, moderate episode",
                        "major depression, recurrent, moderate episode (diagnosis)"
                    ],
                    "MONDO:0005929": [
                        "Major Depressive Episode with Peripartum Onset",
                        "major depressive episode with peripartum onset",
                        "Baby blues",
                        "Baby Blues",
                        "baby blues",
                        "blue maternity",
                        "Maternity blues",
                        "maternity blues",
                        "Maternity blues",
                        "Third day blues",
                        "Postnatal blues",
                        "postnatal blues",
                        "puerperal depression",
                        "Postnatal Depression",
                        "postnatal depression",
                        "Depression puerperal",
                        "depression postnatal",
                        "DEPRESSION PUERPERAL",
                        "Puerperal Depression",
                        "postnatal depression",
                        "Postnatal depression",
                        "Puerperal depression",
                        "Depression;postnatal",
                        "Depression;puerperal",
                        "Postpartum depression",
                        "postnatal; depression",
                        "depression; postnatal",
                        "Postpartum Depression",
                        "DEPRESSION POSTPARTUM",
                        "post-Natal depression",
                        "Post Natal Depression",
                        "Post-Natal Depression",
                        "postpartum depression",
                        "post Natal depression",
                        "post-natal depression",
                        "depression, postnatal",
                        "post natal depression",
                        "depression postpartum",
                        "postpartum depression",
                        "Depression, Postnatal",
                        "Post-Partum Depression",
                        "postpartum; depression",
                        "Depression, Postpartum",
                        "depression; postpartum",
                        "Post Partum Depression",
                        "post partum depression",
                        "Depression, Post-Natal",
                        "post partum depression",
                        "depression, post-Natal",
                        "post-partum depression",
                        "post-partum depression",
                        "depression, post-partum",
                        "Depression, Post-Partum",
                        "Postnatal depression, NOS",
                        "Post-pregnancy depression",
                        "Maternity blues (disorder)",
                        "Postpartum depression, NOS",
                        "Maternity blues (diagnosis)",
                        "Postnatal depressive disorder",
                        "Postpartum depression (disorder)",
                        "postpartum depression (diagnosis)",
                        "Postnatal depression (excl psychosis)",
                        "postpartum depression maternity blues",
                        "depressive episode with postpartum onset",
                        "Depressive Episode with Postpartum Onset",
                        "Postnatal depression (excluding psychosis)"
                    ],
                    "UMLS:C0154403": [
                        "Major depressive disorder, Single episode, Mild",
                        "Major depressive disorder, single episode, mild",
                        "disorder; depressive, major, single episode, mild",
                        "Major depressive disorder, single episode, mild degree",
                        "Major depressive affective disorder, single episode, mild",
                        "Depress psychosis-mild",
                        "Mild major depression, single episode",
                        "Mild major depression, single episode (disorder)",
                        "Mild major depression, single episode (diagnosis)"
                    ]
                }
            },
            {
                "label": "is associated with",
                "id": {
                    "UMLS:C0544684": [
                        "Deafness associated with ischemia"
                    ],
                    "NCBIGene:9798": [
                        "IST1 FACTOR ASSOCIATED WITH ESCRT-III",
                        "IST1 factor associated with ESCRT-III",
                        "IST1",
                        "CHMP8",
                        "CHMP8",
                        "KIAA0174",
                        "IST1 gene",
                        "IST1, ESCRT-III associated factor",
                        "increased sodium tolerance 1 homolog (yeast)",
                        "INCREASED SODIUM TOLERANCE 1, YEAST, HOMOLOG OF",
                        "IST1, endosomal sorting complex required for transport-III component",
                        "IST1, endosomal sorting complex required for transport-III component"
                    ],
                    "UMLS:C4019004": [
                        "Case is associated with a known outbreak"
                    ],
                    "UMLS:C4019185": [
                        "Case is associated with a known outbreak",
                        "Case is associated with a known outbreak:Find:Pt:^Event:Ord",
                        "Case is associated with a known outbreak:Finding:To identify measures at a point in time:^Event:Ordinal"
                    ],
                    "UMLS:C1883213": [
                        "Suction Issue Associated with Medical Device",
                        "Suction Problem"
                    ]
                }
            },
            {
                "label": "bipolar I disorder",
                "id": {
                    "MONDO:0001866": [
                        "bipolar I disorder",
                        "Bipolar I disorder",
                        "bipolar I disorder",
                        "bipolar i disorder",
                        "bipolar; disorder, I",
                        "disorder; bipolar, I",
                        "bipolar type I disorder",
                        "Depressed bipolar I disorder",
                        "Bipolar I disorder (disorder)",
                        "Bipolar I disorder (diagnosis)",
                        "Depressed bipolar I disorder, NOS",
                        "Depressed bipolar I disorder (disorder)",
                        "Bipolar I disorder, most recent episode depressed",
                        "bipolar I disorder, most recent episode, depressed",
                        "bipolar I disorder, most recent episode, depressed (diagnosis)",
                        "Bipolar I disorder, Current or most recent episode depressed, Unspecified",
                        "Bipolar I disorder, most recent episode (or current) depressed, unspecified",
                        "Bipolar 1 disorder",
                        "bipolar 1 disorder",
                        "Bipol I cur depres NOS",
                        "Manic-depressive illness, depressive type",
                        "Manic-depressive psychosis, depressed type",
                        "Bipolar affective disorder, depressed, unspecified degree"
                    ],
                    "MONDO:0000693": [
                        "Bipolar II disorder",
                        "bipolar ii disorder",
                        "bipolar disorder ii",
                        "bipolar II disorder",
                        "disorder; bipolar, II",
                        "bipolar; disorder, II",
                        "Bipolar II disorder, NOS",
                        "Bipolar II disorder (disorder)",
                        "bipolar II disorder (diagnosis)",
                        "bipolar 2 disorder",
                        "Bipolar 2 disorder",
                        "bipolar ll disorder",
                        "bipolar ll disorder",
                        "bipolar ll disorder",
                        "Bipolar Disorder Type 2",
                        "Type 2 Bipolar Disorder",
                        "Bipolar disorder, type 2",
                        "Bipolar disorder, Type 2"
                    ],
                    "MONDO:0024612": [
                        "Manic bipolar I disorder",
                        "Manic bipolar I disorder, NOS",
                        "Manic bipolar I disorder (disorder)",
                        "Bipolar I disorder, most recent episode manic",
                        "bipolar I disorder, most recent episode, manic",
                        "disorder; bipolar, I, most recent episode, manic",
                        "Bipolar I disorder, most recent episode manic (disorder)",
                        "bipolar I disorder, most recent episode, manic (diagnosis)",
                        "Bipolar I disorder, Current or most recent episode manic, Unspecified",
                        "Bipolar I disorder, most recent episode (or current) manic, unspecified",
                        "MANIC DIS",
                        "Manic Disorder",
                        "manic disorder",
                        "MANIC DISORDER",
                        "disorder; manic",
                        "manic disorders",
                        "Manic Disorders",
                        "manic; disorder",
                        "monopolar mania",
                        "Disorder, Manic",
                        "BIPOLAR DISEASE, MANIC",
                        "bipolar disorder manic",
                        "BIPOLAR DISORDER, MANIC",
                        "Bipol I currnt manic NOS",
                        "CYCLOTHYMIC DISORDER, MANIC",
                        "bipolar disorder manic phase",
                        "Manic-depressive - now manic",
                        "manic-depressive - now manic",
                        "Bipolar affective - now manic",
                        "bipolar depression manic phase",
                        "manic bipolar affective disorder",
                        "Manic Bipolar Affective Disorder",
                        "Bipolar affective disorder, manic",
                        "BIPOLAR DISORDER MANIC UNSPECIFIED",
                        "MANIC DEPRESSIVE DISEASE MANIC PHASE",
                        "MANIC DEPRESSIVE DISEASE, MANIC PHASE",
                        "bipolar disorder affective, current episode manic",
                        "bipolar affective disorder, current episode manic",
                        "Bipolar affective disorder, current episode manic",
                        "disorder; bipolar, affective, current episode, manic",
                        "Bipolar affective disorder, manic, unspecified degree",
                        "Bipolar affective disorder, current episode manic (disorder)",
                        "Bipolar affective disorder, current episode manic (diagnosis)"
                    ],
                    "MONDO:0004985": [
                        "Manic bipolar I disorder",
                        "Mixed bipolar I disorder",
                        "manic bipolar I disorder",
                        "Mixed bipolar I disorder, NOS",
                        "Mixed bipolar I disorder (disorder)",
                        "Bipolar I disorder, most recent episode mixed",
                        "bipolar I disorder, most recent episode, mixed",
                        "disorder; bipolar, I, most recent episode, mixed",
                        "bipolar I disorder, most recent episode, mixed (diagnosis)",
                        "Bipolar I disorder, most recent episode (or current) mixed, unspecified",
                        "MAFD",
                        "BPAD",
                        "BIPOLAR DIS",
                        "manic disorder",
                        "manic disorder",
                        "bipolar illness",
                        "Bipolar disorder",
                        "Manic Depression",
                        "manic depressive",
                        "BIPOLAR DISORDER",
                        "Bipolar Disorder",
                        "Manic depressive",
                        "manic depression",
                        "Manic depression",
                        "bipolar disorder",
                        "manic-depression",
                        "manic depression",
                        "Manic-Depression",
                        "Disorder;bipolar",
                        "bipolar disorder",
                        "Depression;manic",
                        "manic depression",
                        "Bipolar Disorders",
                        "bipolar; disorder",
                        "Disorder, Bipolar",
                        "Bi-polar Disorder",
                        "Bipolar disorders",
                        "bipolar disorders",
                        "BIPOLAR DISORDERS",
                        "manic depressions",
                        "disorder; bipolar",
                        "bipolar depression",
                        "bipolar depression",
                        "bipolar disorder NOS",
                        "bipolar disorder nos",
                        "Bipolar disorder NOS",
                        "Bipolar Mood Disorder",
                        "Bipolar disorder, NOS",
                        "bipolar mood disorder",
                        "Disorder, Bipolar Mood",
                        "Mood Disorder, Bipolar",
                        "Bipolar Mood Disorders",
                        "mixed bipolar disorder",
                        "mixed bipolar disorder",
                        "9-51 BIPOLAR DISORDERS",
                        "depressive-manic psych.",
                        "Depressive-manic psych.",
                        "manic-depressive illness",
                        "Manic depressive illness",
                        "major affective disorder",
                        "Manic-depressive illness",
                        "Bipol I currnt mixed NOS",
                        "Manic-Depressive Illness",
                        "manic depressive illness",
                        "MANIC DEPRESSIVE ILLNESS",
                        "manic-depressive illness",
                        "Reaction manic-depressive",
                        "manic depressive disorder",
                        "Manic depressive reaction",
                        "REACTION MANIC-DEPRESSIVE",
                        "MANIC DEPRESSIVE REACTION",
                        "manic-depressive reaction",
                        "Manic Depressive disorder",
                        "manic depressive disorder",
                        "Manic Depressive Disorder",
                        "affective bipolar disorder",
                        "Manic-depressive psychosis",
                        "manic-depressive; syndrome",
                        "bipolar affective disorder",
                        "BIPOLAR AFFECTIVE DISORDER",
                        "bipolar affective disorder",
                        "Manic-Depressive Psychosis",
                        "PSYCHOSIS MANIC-DEPRESSIVE",
                        "manic depressive psychosis",
                        "Psychosis manic-depressive",
                        "Bipolar affective disorder",
                        "manic-depressive; disorder",
                        "manic-depressive disorders",
                        "Manic depressive psychosis",
                        "manic-depressive psychosis",
                        "Psychosis;manic depressive",
                        "Manic Depressive Psychosis",
                        "manic-depressive psychosis",
                        "Bipolar Affective Disorder",
                        "syndrome; manic-depressive",
                        "Psychosis, Manic-Depressive",
                        "Psychoses, Manic-Depressive",
                        "Psychosis, Manic Depressive",
                        "manic-depressive; psychosis",
                        "psychosis; manic-depressive",
                        "bipolar affective psychosis",
                        "Psychoses, Manic Depressive",
                        "Bipolar Affective Psychosis",
                        "Bipolar disorder (disorder)",
                        "affective bipolar disorders",
                        "disorder; bipolar, affective",
                        "bipolar disorder manic phase",
                        "Psychoses, Bipolar Affective",
                        "bipolar; disorder, affective",
                        "Psychosis, Bipolar Affective",
                        "Affective Psychosis, Bipolar",
                        "bipolar disorder manic phase",
                        "Bipolar disorder, unspecified",
                        "Manic-depressive reaction NOS",
                        "Manic-depressive syndrome NOS",
                        "MDI - Manic-depressive illness",
                        "Manic Bipolar Affective disorder",
                        "bipolar disorder NOS (diagnosis)",
                        "major bipolar affective disorder",
                        "manic bipolar affective disorder",
                        "Bipolar affective disorder, unspecified",
                        "Bipolar affective disorder, mixed, unspecified degree"
                    ],
                    "UMLS:C1276786": [
                        "Severe bipolar I disorder",
                        "Severe bipolar I disorder (disorder)",
                        "Severe bipolar I disorder (diagnosis)"
                    ]
                }
            }
        ]
    ],
    "Adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar I disorder (bipolar depression).": [
        [
            {
                "label": "Adjunctive treatment",
                "id": {
                    "UMLS:C3858690": [
                        "adjunctive treatment"
                    ],
                    "UMLS:C0498348": [
                        "adjunctive procedure (treatment)",
                        "adjunctive procedure",
                        "Adjunctive procedure",
                        "Adjunctive procedure (dental procedure)",
                        "Unspecified adjunctive procedure, by report",
                        "unspecified adjunctive procedure, by report"
                    ]
                }
            },
            {
                "label": "with",
                "id": {
                    "FB:FBgn0004015": [
                        "with"
                    ],
                    "UMLS:C0332287": [
                        "With",
                        "With (attribute)",
                        "c",
                        "W",
                        "PL",
                        "Cum",
                        "Plus",
                        "Addition",
                        "In addition to"
                    ],
                    "UMLS:C1705690": [
                        "With",
                        "With - dosing instruction fragment",
                        "With - dosing instruction fragment (qualifier value)"
                    ],
                    "UMLS:C0332285": [
                        "Within",
                        "Of",
                        "In",
                        "in",
                        "Inside",
                        "Found in",
                        "Located in",
                        "Has setting",
                        "Has location",
                        "Arising from",
                        "In (attribute)"
                    ],
                    "UBERON:0017749": [
                        "withers"
                    ]
                }
            },
            {
                "label": "lithium",
                "id": {
                    "MESH:D008094": [
                        "Lithium",
                        "LITHIUM",
                        "lithium",
                        "Lithium 7",
                        "Lithium-7",
                        "Lithium, NOS",
                        "Li - Lithium",
                        "Lithium product",
                        "lithium hydride",
                        "hydrure de lithium",
                        "Lithium Metallicum",
                        "Lithium (substance)",
                        "Lithium monohydride",
                        "lithium (medication)",
                        "Lithium-containing product",
                        "Product containing lithium (medicinal product)",
                        "Li",
                        "LiH",
                        "[LiH]",
                        "Li element",
                        "Li+ element",
                        "hydridolithium"
                    ],
                    "PUBCHEM.COMPOUND:28486": [
                        "Lithium",
                        "LITHIUM ION",
                        "Lithium ion",
                        "LITHIUM ion",
                        "LITHIUM ION",
                        "lithium(1+)",
                        "Lithium, ion",
                        "Lithium atom",
                        "lithium, ion",
                        "LITHIUM CATION",
                        "Lithium cation",
                        "lithium cation",
                        "Lithium element",
                        "lithium(1+) ion",
                        "lithium(I) cation",
                        "Lithium, ion (Li1+)",
                        "Lithium, ion (li1+)",
                        "Li",
                        "Li(+)",
                        "Li(+)",
                        "Li(+) ion",
                        "Li(+) cation"
                    ],
                    "PUBCHEM.COMPOUND:3028194": [
                        "Lithium",
                        "lithium",
                        "LITHIUM",
                        "Lithium",
                        "lithium",
                        "lithium atom",
                        "Li",
                        "3Li",
                        "litio"
                    ],
                    "UMLS:C0337452": [
                        "LITHIUM",
                        "Lithium",
                        "Lithium level",
                        "Assay of lithium",
                        "ASSAY OF LITHIUM",
                        "lithium level test",
                        "Lithium measurement",
                        "Measurement of lithium",
                        "Lithium measurement (procedure)",
                        "DRUG SCREEN QUANTITATIVE LITHIUM"
                    ],
                    "UMLS:C3540800": [
                        "Lithium",
                        "Lithium antipsychotics"
                    ]
                }
            }
        ],
        [
            {
                "label": "Adjunctive treatment",
                "id": {
                    "UMLS:C3858690": [
                        "adjunctive treatment"
                    ],
                    "UMLS:C0498348": [
                        "adjunctive procedure (treatment)",
                        "adjunctive procedure",
                        "Adjunctive procedure",
                        "Adjunctive procedure (dental procedure)",
                        "Unspecified adjunctive procedure, by report",
                        "unspecified adjunctive procedure, by report"
                    ]
                }
            },
            {
                "label": "with",
                "id": {
                    "FB:FBgn0004015": [
                        "with"
                    ],
                    "UMLS:C0332287": [
                        "With",
                        "With (attribute)",
                        "c",
                        "W",
                        "PL",
                        "Cum",
                        "Plus",
                        "Addition",
                        "In addition to"
                    ],
                    "UMLS:C1705690": [
                        "With",
                        "With - dosing instruction fragment",
                        "With - dosing instruction fragment (qualifier value)"
                    ],
                    "UMLS:C0332285": [
                        "Within",
                        "Of",
                        "In",
                        "in",
                        "Inside",
                        "Found in",
                        "Located in",
                        "Has setting",
                        "Has location",
                        "Arising from",
                        "In (attribute)"
                    ],
                    "UBERON:0017749": [
                        "withers"
                    ]
                }
            },
            {
                "label": "valproate",
                "id": {
                    "PUBCHEM.COMPOUND:3549980": [
                        "valproate",
                        "Valproate",
                        "dipropylacetate",
                        "2-propylvalerate",
                        "2-propylpentanoate"
                    ],
                    "PUBCHEM.COMPOUND:3121": [
                        "Valproate",
                        "Valproate",
                        "valproate",
                        "PHL-Valproate",
                        "PMS-Valproate",
                        "Dom-valproate",
                        "Sodium valproate",
                        "Valproate sodium",
                        "Valproate calcium",
                        "Sodium, valproate",
                        "Valproate product",
                        "Calcium valproate",
                        "Valproate, sodium",
                        "Valproate, calcium",
                        "Calcium, valproate",
                        "Magnesium valproate",
                        "S(-)-4-En-valproate",
                        "Valproate, magnesium",
                        "Semisodium valproate",
                        "Valproate, semisodium",
                        "Valproate (substance)",
                        "VA",
                        "DPA",
                        "VPA",
                        "DPA",
                        "VPA",
                        "VPA",
                        "dpa",
                        "DPA",
                        "PEAC",
                        "n-DPA",
                        "n-DPA",
                        "N-DPA",
                        "Epilex",
                        "Epilim",
                        "Vupral",
                        "Epival",
                        "Baceca",
                        "Savicol",
                        "Valcote",
                        "Deproic",
                        "Depakin",
                        "Ergenyl",
                        "Avugane",
                        "Depakene",
                        "Myproate",
                        "Convulex",
                        "Valparin",
                        "Sprinkle",
                        "Depakene",
                        "Depakine",
                        "Mylproin",
                        "Depakote",
                        "Delepsine",
                        "Epival er",
                        "divalproex",
                        "DIVALPROEX",
                        "Divalproex",
                        "Divalproex",
                        "Nu-valproic",
                        "Convulsofin",
                        "Med valproic",
                        "DOM-valproic",
                        "Apo-valproic",
                        "Myproic acid",
                        "Epiject i.v.",
                        "Valproic acid",
                        "Valproinsäure",
                        "Novo-valproic",
                        "VALPROIC ACID",
                        "Alti-valproic",
                        "Valproic Acid",
                        "valproic acid",
                        "valproic acid",
                        "Acid, valproic",
                        "DOM-divalproex",
                        "PMS-Divalproex",
                        "Penta-valproic",
                        "Valproinsaeure",
                        "Apo-divalproex",
                        "Gen-divalproex",
                        "Valproinsaeure",
                        "Depakin chrono",
                        "(N-C3H7)2chcooh",
                        "Novo-divalproex",
                        "Acido valproico",
                        "Depakine chrono",
                        "Sandoz valproic",
                        "Dipropylacetate",
                        "ácido valproico",
                        "acido valproico",
                        "2 propylvalerate",
                        "acide valproïque",
                        "Dipropyl acetate",
                        "2-Propylvalerate",
                        "acide valproique",
                        "Acide valproique",
                        "Dom-valproic acid",
                        "Acidum valproicum",
                        "PMS-Valproic acid",
                        "PHL-Valproic acid",
                        "Valproic acid usp",
                        "Acetate, dipropyl",
                        "acidum valproicum",
                        "Divalproex sodium",
                        "acidum valproicum",
                        "Apo-valproic syrup",
                        "Propylvaleric acid",
                        "Di-N-propylacetate",
                        "2-Propylpentanoate",
                        "Sodium, divalproex",
                        "Dipropylacetic acid",
                        "Dipropylacetic acid",
                        "2-PROPYL-pentanoate",
                        "Novo-valproic - ecc",
                        "dipropylacetic acid",
                        "dipropylacetic acid",
                        "2-Propylvaleric acid",
                        "Ratio-valproic - ecc",
                        "4-Heptanecarboxylate",
                        "2-propylvaleric acid",
                        "2-propylvaleric acid",
                        "2-Propylvaleric acid",
                        "2-Propylvaleric Acid",
                        "Di-N-propylessigsaure",
                        "2-N-Propyl-N-valerate",
                        "Di-n-propylessigsäure",
                        "N-Dipropylacetic acid",
                        "di-n-propylacetic acid",
                        "2-Propylpentanoic Acid",
                        "2-propylpentanoic acid",
                        "Di-N-propylacetic acid",
                        "2-Propylpentanoic acid",
                        "Di-n-propylacetic Acid",
                        "di-n-propylacetic acid",
                        "2 Propylpentanoic Acid",
                        "2-propylpentanoic acid",
                        "Di-n-propylessigsaeure",
                        "2 Propylpentanoic acid",
                        "2-Propylpentanoic acid",
                        "PMS-Valproic acid e.c.",
                        "PHL-Valproic acid e.c.",
                        "DOM-valproic acid e.c.",
                        "Di-N-propylessigsaeure",
                        "2-PROPYL-PENTANOIC ACID",
                        "2-propyl-pentanoic acid",
                        "Dom-valproic acid syrup",
                        "S(-)-4-En-valproic acid",
                        "2-PROPYL-pentanoIC ACID",
                        "4-heptanecarboxylic acid",
                        "4-heptanecarboxylic acid",
                        "4-Heptanecarboxylic acid",
                        "dipropylacetic acid (DPA)",
                        "Pentanoic acid, 2-propyl-",
                        "Kyselina 2-propylvalerova",
                        "(S)-2-Propyl-4-pentanoate",
                        "2-n-propyl-n-valeric acid",
                        "2-n-propyl-n-valeric acid",
                        "S-2-N-Propyl-4-pentenoate",
                        "DPA - dipropylacetic acid",
                        "2-N-Propyl-N-valeric acid",
                        "Valproic acid (substance)",
                        "Novo-valproic soft gel cap",
                        "valproic acid (medication)",
                        "Propylisopropylacetic Acid",
                        "Propylisopropylacetic acid",
                        "Acid, propylisopropylacetic",
                        "S-2-N-Propyl-4-pentenoic acid",
                        "(S)-2-Propyl-4-pentanoic acid",
                        "Valproic acid-containing product",
                        "Valproic acid, sodium salt (2:1)",
                        "divalproex sodium (as valproic acid)",
                        "Product containing valproic acid (medicinal product)"
                    ],
                    "PUBCHEM.COMPOUND:88111": [
                        "Valproate",
                        "VALPROATE GLUCURONIDE",
                        "Valproate glucuronide",
                        "VPAG",
                        "VPAG",
                        "VPA-g",
                        "Myproate",
                        "Myproic acid",
                        "Valproic acid",
                        "CHEMBL3526941",
                        "1-(2-Propylpentanoate",
                        "valproic acid glucuronide",
                        "1-(2-Propylpentanoic acid",
                        "Valproic acid glucuronide",
                        "Dipropylacetate glucuronide",
                        "1-O-Valproyl-b-D-glucopyranuronic acid",
                        "1-O-Valproyl-beta-delta-glucopyranuronic acid",
                        "1-(2-Propylpentanoate) beta-D-glucopyranuronate",
                        "1-(2-Propylpentanoate) beta-delta-glucopyranuronate",
                        "1-(2-Propylpentanoate) beta-D-glucopyranuronic acid",
                        "1-(2-Propylpentanoate) beta-delta-glucopyranuronic acid",
                        "3,4,5-Trihydroxy-6-(2-propyl-pentanoyloxy)-tetrahydro-pyran-2-carboxylate",
                        "3,4,5-Trihydroxy-6-(2-propyl-pentanoyloxy)-tetrahydro-pyran-2-carboxylic acid",
                        "(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(2-propylpentanoyloxy)oxane-2-carboxylic acid"
                    ],
                    "PUBCHEM.COMPOUND:379073": [
                        "Cu Valproate",
                        "Dicopper 2-propylpentanoic acid"
                    ],
                    "PUBCHEM.COMPOUND:131769983": [
                        "Valproate CoA",
                        "Valproic acid CoA"
                    ]
                }
            }
        ],
        [
            {
                "label": "adult patients",
                "id": {
                    "UMLS:C1855413": [
                        "Nystagmus in adult patients"
                    ],
                    "UMLS:C1855412": [
                        "Impaired smooth pursuit in adult patients"
                    ],
                    "UMLS:C1855411": [
                        "Retinal degeneration in adult patients, progressive"
                    ],
                    "UMLS:C4746352": [
                        "Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5",
                        "Adit mdd dys rem 12 mnths"
                    ],
                    "UMLS:C5229138": [
                        "Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq- 9 or phq-9m score was not assessed or is greater than or equal to 5",
                        "Remis12m not phq-9 score <5"
                    ]
                }
            },
            {
                "label": "with",
                "id": {
                    "FB:FBgn0004015": [
                        "with"
                    ],
                    "UMLS:C0332287": [
                        "With",
                        "With (attribute)",
                        "c",
                        "W",
                        "PL",
                        "Cum",
                        "Plus",
                        "Addition",
                        "In addition to"
                    ],
                    "UMLS:C1705690": [
                        "With",
                        "With - dosing instruction fragment",
                        "With - dosing instruction fragment (qualifier value)"
                    ],
                    "UMLS:C0332285": [
                        "Within",
                        "Of",
                        "In",
                        "in",
                        "Inside",
                        "Found in",
                        "Located in",
                        "Has setting",
                        "Has location",
                        "Arising from",
                        "In (attribute)"
                    ],
                    "UBERON:0017749": [
                        "withers"
                    ]
                }
            },
            {
                "label": "major depressive episode",
                "id": {
                    "MONDO:0002009": [
                        "major depressive episode",
                        "depressive; episode, major",
                        "single major depressive episode",
                        "single major depressive episode",
                        "Recurrent major depressive episodes",
                        "DEPRESSIVE DISORDER MAJOR SINGLE EPISODE",
                        "Major depressive disorder; single episode",
                        "Major depressive disorder, single episode",
                        "Single Episode of Major Depressive Disorder",
                        "Major depressive disorder; recurrent episode",
                        "major depressive disorder, recurrent episode",
                        "Major depressive disorder, recurrent episode",
                        "Recurrent major depressive episodes (disorder)",
                        "Recurrent major depressive episodes (diagnosis)",
                        "Major depressive disorder, single episode, unspecified",
                        "Major depressive disorder, Recurrent episode, Unspecified",
                        "Major depressive disorder, single episode, unspecified degree",
                        "Major depressive disorder, recurrent episode, unspecified degree",
                        "Major depressive affective disorder, single episode, unspecified",
                        "Major depressive affective disorder, recurrent episode, unspecified",
                        "MDD",
                        "major depression",
                        "Major depression",
                        "Major Depression",
                        "MAJOR DEPRESSION",
                        "Unipolar Depression",
                        "UNIPOLAR DEPRESSION",
                        "depression unipolar",
                        "Unipolar depression",
                        "unipolar depression",
                        "Unipolar Depressions",
                        "Major depression NOS",
                        "MAJOR DEPRESSIVE DIS",
                        "Depression, Unipolar",
                        "DEPRESSIVE DIS MAJOR",
                        "Depressions, Unipolar",
                        "Major depression, NOS",
                        "Depress psychosis-unspec",
                        "Recurr depr psychos-unsp",
                        "Major depressive illness",
                        "major depressive illness",
                        "DEPRESSIVE DISORDER MAJOR",
                        "Major Depressive Disorder",
                        "Major depressive disorder",
                        "major depressive disorder",
                        "MAJOR DEPRESSIVE DISORDER",
                        "major depressive disorder",
                        "Recurrent major depression",
                        "recurrent major depression",
                        "Major Depressive Disorders",
                        "recurrent major depression",
                        "Depressive Disorder, Major",
                        "major depressive disorder 2",
                        "major depressive disorder 1",
                        "Depressive Disorders, Major",
                        "Unipolar depressive illness",
                        "Major depressive disorder NOS",
                        "Major depressive disorder, NOS",
                        "Recurrent major depression, NOS",
                        "major depression, single episode",
                        "Major depression, single episode",
                        "single episode of major depression",
                        "DEPRESSIVE DISORDER MAJOR RECURRENT",
                        "Recurrent major depressive disorder",
                        "major depression recurrent episodes",
                        "Major depressive disorder, recurrent",
                        "Major depressive disorder (disorder)",
                        "Recurrent major depression (disorder)",
                        "Major depressive disorder (diagnosis)",
                        "Major depression, single episode, NOS",
                        "recurrent episodes of major depression",
                        "recurrent major depression (diagnosis)",
                        "unipolar depression, susceptibility to",
                        "Recurrent major depressive disorder, NOS",
                        "Major depression, single episode (disorder)",
                        "major depression, single episode (diagnosis)",
                        "seasonal affective disorder, susceptibility to",
                        "Major depressive disorder, recurrent, unspecified",
                        "major depressive disorder, response to citalopram therapy in",
                        "major depressive disorder and accelerated response to antidepressant drug treatment"
                    ],
                    "UMLS:C3665435": [
                        "recurrent major depressive episode, mild",
                        "Recurrent major depressive episodes, mild",
                        "Major depressive disorder, Recurrent episode, Mild",
                        "recurrent major depressive episode, mild (diagnosis)",
                        "Recurrent major depressive episodes, mild (disorder)",
                        "Major depressive disorder, recurrent episode, mild degree",
                        "Major depressive affective disorder, recurrent episode, mild",
                        "Recurr depr psychos-mild",
                        "major depression, recurrent, mild episode"
                    ],
                    "UMLS:C0338890": [
                        "Recurrent major depressive episodes, moderate",
                        "Major depressive disorder, Recurrent episode, Moderate",
                        "Recurrent major depressive episodes, moderate (disorder)",
                        "major depression, recurrent, moderate episode",
                        "major depression, recurrent, moderate episode (diagnosis)"
                    ],
                    "MONDO:0005929": [
                        "Major Depressive Episode with Peripartum Onset",
                        "major depressive episode with peripartum onset",
                        "Baby blues",
                        "Baby Blues",
                        "baby blues",
                        "blue maternity",
                        "Maternity blues",
                        "maternity blues",
                        "Maternity blues",
                        "Third day blues",
                        "Postnatal blues",
                        "postnatal blues",
                        "puerperal depression",
                        "Postnatal Depression",
                        "postnatal depression",
                        "Depression puerperal",
                        "depression postnatal",
                        "DEPRESSION PUERPERAL",
                        "Puerperal Depression",
                        "postnatal depression",
                        "Postnatal depression",
                        "Puerperal depression",
                        "Depression;postnatal",
                        "Depression;puerperal",
                        "Postpartum depression",
                        "postnatal; depression",
                        "depression; postnatal",
                        "Postpartum Depression",
                        "DEPRESSION POSTPARTUM",
                        "post-Natal depression",
                        "Post Natal Depression",
                        "Post-Natal Depression",
                        "postpartum depression",
                        "post Natal depression",
                        "post-natal depression",
                        "depression, postnatal",
                        "post natal depression",
                        "depression postpartum",
                        "postpartum depression",
                        "Depression, Postnatal",
                        "Post-Partum Depression",
                        "postpartum; depression",
                        "Depression, Postpartum",
                        "depression; postpartum",
                        "Post Partum Depression",
                        "post partum depression",
                        "Depression, Post-Natal",
                        "post partum depression",
                        "depression, post-Natal",
                        "post-partum depression",
                        "post-partum depression",
                        "depression, post-partum",
                        "Depression, Post-Partum",
                        "Postnatal depression, NOS",
                        "Post-pregnancy depression",
                        "Maternity blues (disorder)",
                        "Postpartum depression, NOS",
                        "Maternity blues (diagnosis)",
                        "Postnatal depressive disorder",
                        "Postpartum depression (disorder)",
                        "postpartum depression (diagnosis)",
                        "Postnatal depression (excl psychosis)",
                        "postpartum depression maternity blues",
                        "depressive episode with postpartum onset",
                        "Depressive Episode with Postpartum Onset",
                        "Postnatal depression (excluding psychosis)"
                    ],
                    "UMLS:C0154403": [
                        "Major depressive disorder, Single episode, Mild",
                        "Major depressive disorder, single episode, mild",
                        "disorder; depressive, major, single episode, mild",
                        "Major depressive disorder, single episode, mild degree",
                        "Major depressive affective disorder, single episode, mild",
                        "Depress psychosis-mild",
                        "Mild major depression, single episode",
                        "Mild major depression, single episode (disorder)",
                        "Mild major depression, single episode (diagnosis)"
                    ]
                }
            }
        ],
        [
            {
                "label": "major depressive episode",
                "id": {
                    "MONDO:0002009": [
                        "major depressive episode",
                        "depressive; episode, major",
                        "single major depressive episode",
                        "single major depressive episode",
                        "Recurrent major depressive episodes",
                        "DEPRESSIVE DISORDER MAJOR SINGLE EPISODE",
                        "Major depressive disorder; single episode",
                        "Major depressive disorder, single episode",
                        "Single Episode of Major Depressive Disorder",
                        "Major depressive disorder; recurrent episode",
                        "major depressive disorder, recurrent episode",
                        "Major depressive disorder, recurrent episode",
                        "Recurrent major depressive episodes (disorder)",
                        "Recurrent major depressive episodes (diagnosis)",
                        "Major depressive disorder, single episode, unspecified",
                        "Major depressive disorder, Recurrent episode, Unspecified",
                        "Major depressive disorder, single episode, unspecified degree",
                        "Major depressive disorder, recurrent episode, unspecified degree",
                        "Major depressive affective disorder, single episode, unspecified",
                        "Major depressive affective disorder, recurrent episode, unspecified",
                        "MDD",
                        "major depression",
                        "Major depression",
                        "Major Depression",
                        "MAJOR DEPRESSION",
                        "Unipolar Depression",
                        "UNIPOLAR DEPRESSION",
                        "depression unipolar",
                        "Unipolar depression",
                        "unipolar depression",
                        "Unipolar Depressions",
                        "Major depression NOS",
                        "MAJOR DEPRESSIVE DIS",
                        "Depression, Unipolar",
                        "DEPRESSIVE DIS MAJOR",
                        "Depressions, Unipolar",
                        "Major depression, NOS",
                        "Depress psychosis-unspec",
                        "Recurr depr psychos-unsp",
                        "Major depressive illness",
                        "major depressive illness",
                        "DEPRESSIVE DISORDER MAJOR",
                        "Major Depressive Disorder",
                        "Major depressive disorder",
                        "major depressive disorder",
                        "MAJOR DEPRESSIVE DISORDER",
                        "major depressive disorder",
                        "Recurrent major depression",
                        "recurrent major depression",
                        "Major Depressive Disorders",
                        "recurrent major depression",
                        "Depressive Disorder, Major",
                        "major depressive disorder 2",
                        "major depressive disorder 1",
                        "Depressive Disorders, Major",
                        "Unipolar depressive illness",
                        "Major depressive disorder NOS",
                        "Major depressive disorder, NOS",
                        "Recurrent major depression, NOS",
                        "major depression, single episode",
                        "Major depression, single episode",
                        "single episode of major depression",
                        "DEPRESSIVE DISORDER MAJOR RECURRENT",
                        "Recurrent major depressive disorder",
                        "major depression recurrent episodes",
                        "Major depressive disorder, recurrent",
                        "Major depressive disorder (disorder)",
                        "Recurrent major depression (disorder)",
                        "Major depressive disorder (diagnosis)",
                        "Major depression, single episode, NOS",
                        "recurrent episodes of major depression",
                        "recurrent major depression (diagnosis)",
                        "unipolar depression, susceptibility to",
                        "Recurrent major depressive disorder, NOS",
                        "Major depression, single episode (disorder)",
                        "major depression, single episode (diagnosis)",
                        "seasonal affective disorder, susceptibility to",
                        "Major depressive disorder, recurrent, unspecified",
                        "major depressive disorder, response to citalopram therapy in",
                        "major depressive disorder and accelerated response to antidepressant drug treatment"
                    ],
                    "UMLS:C3665435": [
                        "recurrent major depressive episode, mild",
                        "Recurrent major depressive episodes, mild",
                        "Major depressive disorder, Recurrent episode, Mild",
                        "recurrent major depressive episode, mild (diagnosis)",
                        "Recurrent major depressive episodes, mild (disorder)",
                        "Major depressive disorder, recurrent episode, mild degree",
                        "Major depressive affective disorder, recurrent episode, mild",
                        "Recurr depr psychos-mild",
                        "major depression, recurrent, mild episode"
                    ],
                    "UMLS:C0338890": [
                        "Recurrent major depressive episodes, moderate",
                        "Major depressive disorder, Recurrent episode, Moderate",
                        "Recurrent major depressive episodes, moderate (disorder)",
                        "major depression, recurrent, moderate episode",
                        "major depression, recurrent, moderate episode (diagnosis)"
                    ],
                    "MONDO:0005929": [
                        "Major Depressive Episode with Peripartum Onset",
                        "major depressive episode with peripartum onset",
                        "Baby blues",
                        "Baby Blues",
                        "baby blues",
                        "blue maternity",
                        "Maternity blues",
                        "maternity blues",
                        "Maternity blues",
                        "Third day blues",
                        "Postnatal blues",
                        "postnatal blues",
                        "puerperal depression",
                        "Postnatal Depression",
                        "postnatal depression",
                        "Depression puerperal",
                        "depression postnatal",
                        "DEPRESSION PUERPERAL",
                        "Puerperal Depression",
                        "postnatal depression",
                        "Postnatal depression",
                        "Puerperal depression",
                        "Depression;postnatal",
                        "Depression;puerperal",
                        "Postpartum depression",
                        "postnatal; depression",
                        "depression; postnatal",
                        "Postpartum Depression",
                        "DEPRESSION POSTPARTUM",
                        "post-Natal depression",
                        "Post Natal Depression",
                        "Post-Natal Depression",
                        "postpartum depression",
                        "post Natal depression",
                        "post-natal depression",
                        "depression, postnatal",
                        "post natal depression",
                        "depression postpartum",
                        "postpartum depression",
                        "Depression, Postnatal",
                        "Post-Partum Depression",
                        "postpartum; depression",
                        "Depression, Postpartum",
                        "depression; postpartum",
                        "Post Partum Depression",
                        "post partum depression",
                        "Depression, Post-Natal",
                        "post partum depression",
                        "depression, post-Natal",
                        "post-partum depression",
                        "post-partum depression",
                        "depression, post-partum",
                        "Depression, Post-Partum",
                        "Postnatal depression, NOS",
                        "Post-pregnancy depression",
                        "Maternity blues (disorder)",
                        "Postpartum depression, NOS",
                        "Maternity blues (diagnosis)",
                        "Postnatal depressive disorder",
                        "Postpartum depression (disorder)",
                        "postpartum depression (diagnosis)",
                        "Postnatal depression (excl psychosis)",
                        "postpartum depression maternity blues",
                        "depressive episode with postpartum onset",
                        "Depressive Episode with Postpartum Onset",
                        "Postnatal depression (excluding psychosis)"
                    ],
                    "UMLS:C0154403": [
                        "Major depressive disorder, Single episode, Mild",
                        "Major depressive disorder, single episode, mild",
                        "disorder; depressive, major, single episode, mild",
                        "Major depressive disorder, single episode, mild degree",
                        "Major depressive affective disorder, single episode, mild",
                        "Depress psychosis-mild",
                        "Mild major depression, single episode",
                        "Mild major depression, single episode (disorder)",
                        "Mild major depression, single episode (diagnosis)"
                    ]
                }
            },
            {
                "label": "associated with",
                "id": {
                    "UMLS:C0332281": [
                        "associated with",
                        "ASSOCIATED WITH",
                        "Associated with",
                        "Associated with (attribute)",
                        "AW",
                        "ASSOC",
                        "associated",
                        "Associated",
                        "associating"
                    ],
                    "UMLS:C1608982": [
                        "Associated with (APAH)"
                    ],
                    "UMLS:C2029691": [
                        "headache associated with",
                        "headache associated",
                        "headache associated factor",
                        "headache associated factor (symptom)"
                    ],
                    "HP:0033705": [
                        "Crying associated with mood",
                        "Crying associated with emotion",
                        "Crying associated with mood (finding)",
                        "weep",
                        "Weepy",
                        "Weeps",
                        "weepy",
                        "weeping",
                        "tearful",
                        "WEEPING",
                        "Weeping",
                        "Tearful",
                        "Weepiness",
                        "weepiness",
                        "Tearfulness",
                        "affect tearful",
                        "tearful (physical finding)"
                    ],
                    "NCBIGene:23077": [
                        "PROTEIN ASSOCIATED WITH MYC",
                        "PAM",
                        "PAM",
                        "PHR1",
                        "PHR1",
                        "MYCBP2",
                        "FLJ10106",
                        "KIAA0916",
                        "FLJ10106",
                        "KIAA0916",
                        "MYCBP2 gene",
                        "MYCBP2 Gene",
                        "MYC-BINDING PROTEIN 2",
                        "MYC binding protein 2",
                        "MYC Binding Protein 2 Gene",
                        "PAM/Highwire/RPM-1 protein 1",
                        "PAM/Highwire/RPM-1 protein 1",
                        "MYC binding protein 2, E3 ubiquitin protein ligase"
                    ]
                }
            },
            {
                "label": "bipolar I disorder",
                "id": {
                    "MONDO:0001866": [
                        "bipolar I disorder",
                        "Bipolar I disorder",
                        "bipolar I disorder",
                        "bipolar i disorder",
                        "bipolar; disorder, I",
                        "disorder; bipolar, I",
                        "bipolar type I disorder",
                        "Depressed bipolar I disorder",
                        "Bipolar I disorder (disorder)",
                        "Bipolar I disorder (diagnosis)",
                        "Depressed bipolar I disorder, NOS",
                        "Depressed bipolar I disorder (disorder)",
                        "Bipolar I disorder, most recent episode depressed",
                        "bipolar I disorder, most recent episode, depressed",
                        "bipolar I disorder, most recent episode, depressed (diagnosis)",
                        "Bipolar I disorder, Current or most recent episode depressed, Unspecified",
                        "Bipolar I disorder, most recent episode (or current) depressed, unspecified",
                        "Bipolar 1 disorder",
                        "bipolar 1 disorder",
                        "Bipol I cur depres NOS",
                        "Manic-depressive illness, depressive type",
                        "Manic-depressive psychosis, depressed type",
                        "Bipolar affective disorder, depressed, unspecified degree"
                    ],
                    "MONDO:0000693": [
                        "Bipolar II disorder",
                        "bipolar ii disorder",
                        "bipolar disorder ii",
                        "bipolar II disorder",
                        "disorder; bipolar, II",
                        "bipolar; disorder, II",
                        "Bipolar II disorder, NOS",
                        "Bipolar II disorder (disorder)",
                        "bipolar II disorder (diagnosis)",
                        "bipolar 2 disorder",
                        "Bipolar 2 disorder",
                        "bipolar ll disorder",
                        "bipolar ll disorder",
                        "bipolar ll disorder",
                        "Bipolar Disorder Type 2",
                        "Type 2 Bipolar Disorder",
                        "Bipolar disorder, type 2",
                        "Bipolar disorder, Type 2"
                    ],
                    "MONDO:0024612": [
                        "Manic bipolar I disorder",
                        "Manic bipolar I disorder, NOS",
                        "Manic bipolar I disorder (disorder)",
                        "Bipolar I disorder, most recent episode manic",
                        "bipolar I disorder, most recent episode, manic",
                        "disorder; bipolar, I, most recent episode, manic",
                        "Bipolar I disorder, most recent episode manic (disorder)",
                        "bipolar I disorder, most recent episode, manic (diagnosis)",
                        "Bipolar I disorder, Current or most recent episode manic, Unspecified",
                        "Bipolar I disorder, most recent episode (or current) manic, unspecified",
                        "MANIC DIS",
                        "Manic Disorder",
                        "manic disorder",
                        "MANIC DISORDER",
                        "disorder; manic",
                        "manic disorders",
                        "Manic Disorders",
                        "manic; disorder",
                        "monopolar mania",
                        "Disorder, Manic",
                        "BIPOLAR DISEASE, MANIC",
                        "bipolar disorder manic",
                        "BIPOLAR DISORDER, MANIC",
                        "Bipol I currnt manic NOS",
                        "CYCLOTHYMIC DISORDER, MANIC",
                        "bipolar disorder manic phase",
                        "Manic-depressive - now manic",
                        "manic-depressive - now manic",
                        "Bipolar affective - now manic",
                        "bipolar depression manic phase",
                        "manic bipolar affective disorder",
                        "Manic Bipolar Affective Disorder",
                        "Bipolar affective disorder, manic",
                        "BIPOLAR DISORDER MANIC UNSPECIFIED",
                        "MANIC DEPRESSIVE DISEASE MANIC PHASE",
                        "MANIC DEPRESSIVE DISEASE, MANIC PHASE",
                        "bipolar disorder affective, current episode manic",
                        "bipolar affective disorder, current episode manic",
                        "Bipolar affective disorder, current episode manic",
                        "disorder; bipolar, affective, current episode, manic",
                        "Bipolar affective disorder, manic, unspecified degree",
                        "Bipolar affective disorder, current episode manic (disorder)",
                        "Bipolar affective disorder, current episode manic (diagnosis)"
                    ],
                    "MONDO:0004985": [
                        "Manic bipolar I disorder",
                        "Mixed bipolar I disorder",
                        "manic bipolar I disorder",
                        "Mixed bipolar I disorder, NOS",
                        "Mixed bipolar I disorder (disorder)",
                        "Bipolar I disorder, most recent episode mixed",
                        "bipolar I disorder, most recent episode, mixed",
                        "disorder; bipolar, I, most recent episode, mixed",
                        "bipolar I disorder, most recent episode, mixed (diagnosis)",
                        "Bipolar I disorder, most recent episode (or current) mixed, unspecified",
                        "MAFD",
                        "BPAD",
                        "BIPOLAR DIS",
                        "manic disorder",
                        "manic disorder",
                        "bipolar illness",
                        "Bipolar disorder",
                        "Manic Depression",
                        "manic depressive",
                        "BIPOLAR DISORDER",
                        "Bipolar Disorder",
                        "Manic depressive",
                        "manic depression",
                        "Manic depression",
                        "bipolar disorder",
                        "manic-depression",
                        "manic depression",
                        "Manic-Depression",
                        "Disorder;bipolar",
                        "bipolar disorder",
                        "Depression;manic",
                        "manic depression",
                        "Bipolar Disorders",
                        "bipolar; disorder",
                        "Disorder, Bipolar",
                        "Bi-polar Disorder",
                        "Bipolar disorders",
                        "bipolar disorders",
                        "BIPOLAR DISORDERS",
                        "manic depressions",
                        "disorder; bipolar",
                        "bipolar depression",
                        "bipolar depression",
                        "bipolar disorder NOS",
                        "bipolar disorder nos",
                        "Bipolar disorder NOS",
                        "Bipolar Mood Disorder",
                        "Bipolar disorder, NOS",
                        "bipolar mood disorder",
                        "Disorder, Bipolar Mood",
                        "Mood Disorder, Bipolar",
                        "Bipolar Mood Disorders",
                        "mixed bipolar disorder",
                        "mixed bipolar disorder",
                        "9-51 BIPOLAR DISORDERS",
                        "depressive-manic psych.",
                        "Depressive-manic psych.",
                        "manic-depressive illness",
                        "Manic depressive illness",
                        "major affective disorder",
                        "Manic-depressive illness",
                        "Bipol I currnt mixed NOS",
                        "Manic-Depressive Illness",
                        "manic depressive illness",
                        "MANIC DEPRESSIVE ILLNESS",
                        "manic-depressive illness",
                        "Reaction manic-depressive",
                        "manic depressive disorder",
                        "Manic depressive reaction",
                        "REACTION MANIC-DEPRESSIVE",
                        "MANIC DEPRESSIVE REACTION",
                        "manic-depressive reaction",
                        "Manic Depressive disorder",
                        "manic depressive disorder",
                        "Manic Depressive Disorder",
                        "affective bipolar disorder",
                        "Manic-depressive psychosis",
                        "manic-depressive; syndrome",
                        "bipolar affective disorder",
                        "BIPOLAR AFFECTIVE DISORDER",
                        "bipolar affective disorder",
                        "Manic-Depressive Psychosis",
                        "PSYCHOSIS MANIC-DEPRESSIVE",
                        "manic depressive psychosis",
                        "Psychosis manic-depressive",
                        "Bipolar affective disorder",
                        "manic-depressive; disorder",
                        "manic-depressive disorders",
                        "Manic depressive psychosis",
                        "manic-depressive psychosis",
                        "Psychosis;manic depressive",
                        "Manic Depressive Psychosis",
                        "manic-depressive psychosis",
                        "Bipolar Affective Disorder",
                        "syndrome; manic-depressive",
                        "Psychosis, Manic-Depressive",
                        "Psychoses, Manic-Depressive",
                        "Psychosis, Manic Depressive",
                        "manic-depressive; psychosis",
                        "psychosis; manic-depressive",
                        "bipolar affective psychosis",
                        "Psychoses, Manic Depressive",
                        "Bipolar Affective Psychosis",
                        "Bipolar disorder (disorder)",
                        "affective bipolar disorders",
                        "disorder; bipolar, affective",
                        "bipolar disorder manic phase",
                        "Psychoses, Bipolar Affective",
                        "bipolar; disorder, affective",
                        "Psychosis, Bipolar Affective",
                        "Affective Psychosis, Bipolar",
                        "bipolar disorder manic phase",
                        "Bipolar disorder, unspecified",
                        "Manic-depressive reaction NOS",
                        "Manic-depressive syndrome NOS",
                        "MDI - Manic-depressive illness",
                        "Manic Bipolar Affective disorder",
                        "bipolar disorder NOS (diagnosis)",
                        "major bipolar affective disorder",
                        "manic bipolar affective disorder",
                        "Bipolar affective disorder, unspecified",
                        "Bipolar affective disorder, mixed, unspecified degree"
                    ],
                    "UMLS:C1276786": [
                        "Severe bipolar I disorder",
                        "Severe bipolar I disorder (disorder)",
                        "Severe bipolar I disorder (diagnosis)"
                    ]
                }
            }
        ]
    ],
    "Duloxetine delayed-release capsules are indicated for the treatment of: Major Depressive Disorder, Generalized Anxiety Disorder, Diabetic Peripheral Neuropathy, Fibromyalgia, Chronic Muscoskeletal Pain": [
        [
            {
                "label": "Duloxetine delayed-release capsules",
                "id": {
                    "UMLS:C1601865": [
                        "Duloxetine Delayed-Release Capsules",
                        "DULoxetine Delayed Release Oral Capsule",
                        "duloxetine Delayed Release Oral Capsule"
                    ]
                }
            },
            {
                "label": "are indicated for the treatment of",
                "id": {
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "Major Depressive Disorder",
                "id": {
                    "MONDO:0012048": [
                        "major depressive disorder",
                        "MDD",
                        "clinical depression",
                        "unipolar depression",
                        "unipolar depression",
                        "clinical depression",
                        "DEPRESSION ENDOGENOUS",
                        "depression endogenous",
                        "endogenous depression",
                        "Endogenous depression",
                        "ENDOGENOUS DEPRESSION",
                        "endogenous depression",
                        "Depression endogenous",
                        "Endogenous Depression",
                        "Depression;endogenous",
                        "Endogenous Depressions",
                        "Depression, Endogenous",
                        "endogenous; depression",
                        "depression; endogenous",
                        "Depressions, Endogenous",
                        "Endogenous depression (disorder)",
                        "Endogenous depression (diagnosis)"
                    ],
                    "MONDO:0002009": [
                        "DEPRESSIVE DISORDER MAJOR",
                        "Major Depressive Disorder",
                        "Major depressive disorder",
                        "major depressive disorder",
                        "MAJOR DEPRESSIVE DISORDER",
                        "major depressive disorder",
                        "Major Depressive Disorders",
                        "Depressive Disorder, Major",
                        "major depressive disorder 2",
                        "major depressive disorder 1",
                        "Depressive Disorders, Major",
                        "Major depressive disorder NOS",
                        "Major depressive disorder, NOS",
                        "DEPRESSIVE DISORDER MAJOR RECURRENT",
                        "Recurrent major depressive disorder",
                        "Major depressive disorder, recurrent",
                        "Major depressive disorder (disorder)",
                        "Major depressive disorder (diagnosis)",
                        "DEPRESSIVE DISORDER MAJOR SINGLE EPISODE",
                        "Recurrent major depressive disorder, NOS",
                        "Major depressive disorder; single episode",
                        "Major depressive disorder, single episode",
                        "Single Episode of Major Depressive Disorder",
                        "Major depressive disorder; recurrent episode",
                        "major depressive disorder, recurrent episode",
                        "Major depressive disorder, recurrent episode",
                        "Recurrent major depressive episodes (disorder)",
                        "Major depressive disorder, recurrent, unspecified",
                        "Major depressive disorder, single episode, unspecified",
                        "Major depressive disorder, Recurrent episode, Unspecified",
                        "major depressive disorder, response to citalopram therapy in",
                        "Major depressive disorder, single episode, unspecified degree",
                        "Major depressive disorder, recurrent episode, unspecified degree",
                        "Major depressive affective disorder, single episode, unspecified",
                        "Major depressive affective disorder, recurrent episode, unspecified",
                        "major depressive disorder and accelerated response to antidepressant drug treatment",
                        "MDD",
                        "major depression",
                        "Major depression",
                        "Major Depression",
                        "MAJOR DEPRESSION",
                        "Unipolar Depression",
                        "UNIPOLAR DEPRESSION",
                        "depression unipolar",
                        "Unipolar depression",
                        "unipolar depression",
                        "Unipolar Depressions",
                        "Major depression NOS",
                        "MAJOR DEPRESSIVE DIS",
                        "Depression, Unipolar",
                        "DEPRESSIVE DIS MAJOR",
                        "Depressions, Unipolar",
                        "Major depression, NOS",
                        "Depress psychosis-unspec",
                        "Recurr depr psychos-unsp",
                        "Major depressive illness",
                        "major depressive episode",
                        "major depressive illness",
                        "depressive; episode, major",
                        "Recurrent major depression",
                        "recurrent major depression",
                        "recurrent major depression",
                        "Unipolar depressive illness",
                        "single major depressive episode",
                        "Recurrent major depression, NOS",
                        "single major depressive episode",
                        "major depression, single episode",
                        "Major depression, single episode",
                        "single episode of major depression",
                        "Recurrent major depressive episodes",
                        "major depression recurrent episodes",
                        "Recurrent major depression (disorder)",
                        "Major depression, single episode, NOS",
                        "recurrent episodes of major depression",
                        "recurrent major depression (diagnosis)",
                        "unipolar depression, susceptibility to",
                        "Major depression, single episode (disorder)",
                        "major depression, single episode (diagnosis)",
                        "seasonal affective disorder, susceptibility to",
                        "Recurrent major depressive episodes (diagnosis)"
                    ],
                    "MONDO:0012100": [
                        "major depressive disorder 2",
                        "MAJOR DEPRESSIVE DISORDER 2",
                        "Major Depressive Disorder 2",
                        "major depressive disorder type 2",
                        "MDD2",
                        "MDD2",
                        "unipolar depression 2",
                        "UNIPOLAR DEPRESSION 2",
                        "Unipolar Depression 2"
                    ],
                    "MONDO:0012050": [
                        "major depressive disorder 1",
                        "Major Depressive Disorder 1",
                        "MAJOR DEPRESSIVE DISORDER 1",
                        "major depressive disorder type 1",
                        "MDD1",
                        "MDD1",
                        "Unipolar Depression 1",
                        "unipolar depression 1",
                        "UNIPOLAR DEPRESSION 1"
                    ],
                    "UMLS:C1740001": [
                        "MAJOR DEPRESSIVE DISORDER MILD",
                        "Major depressive disorder, mild (mdd)",
                        "Major depressive disorder, mild (MDD)",
                        "MDD MILD",
                        "Mdd mild"
                    ]
                }
            }
        ],
        [
            {
                "label": "Duloxetine delayed-release capsules",
                "id": {
                    "UMLS:C1601865": [
                        "Duloxetine Delayed-Release Capsules",
                        "DULoxetine Delayed Release Oral Capsule",
                        "duloxetine Delayed Release Oral Capsule"
                    ]
                }
            },
            {
                "label": "are indicated for the treatment of",
                "id": {
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "Generalized Anxiety Disorder",
                "id": {
                    "MONDO:0001942": [
                        "generalized anxiety disorder",
                        "anxiety disorder generalized",
                        "generalized anxiety disorder",
                        "GENERALIZED ANXIETY DISORDER",
                        "Generalized Anxiety Disorder",
                        "Generalized anxiety disorder",
                        "ANXIETY DISORDER GENERALIZED",
                        "anxiety disorder; generalized",
                        "generalized anxiety disorders",
                        "anxiety disorders generalized",
                        "generalized; anxiety disorder",
                        "GAD - Generalized anxiety disorder",
                        "Generalized anxiety disorder (disorder)",
                        "generalized anxiety disorder (diagnosis)",
                        "gad",
                        "GAD",
                        "gads",
                        "Generalized anxiety dis",
                        "anxiety disorder generalize",
                        "generalised anxiety disorder",
                        "Generalised anxiety disorder",
                        "GAD - General anxiety disorder",
                        "GAD - Generalised anxiety disorder"
                    ],
                    "UMLS:C3641330": [
                        "Generalized Anxiety Disorder Scale",
                        "Generalized Anxiety Disorder 7 item scale",
                        "Generalized Anxiety Disorder - 7 Questionnaire",
                        "GAD-7 (Generalized Anxiety Disorder 7 item) scale",
                        "Generalized Anxiety Disorder 7 item scale (assessment scale)",
                        "GAD-7",
                        "General Anxiety Disorder-7",
                        "General Anxiety Disorder-7 Questionnaire"
                    ],
                    "UMLS:C3263525": [
                        "Generalized anxiety disorder 7 item"
                    ],
                    "UMLS:C2919162": [
                        "Generalized Anxiety Disorder 7 item score",
                        "GAD-7 (Generalized Anxiety Disorder 7 item) score",
                        "Generalized Anxiety Disorder 7 item score (observable entity)"
                    ],
                    "UMLS:C2982365": [
                        "Generalized Anxiety Disorder Questionnaire"
                    ]
                }
            }
        ],
        [
            {
                "label": "Duloxetine delayed-release capsules",
                "id": {
                    "UMLS:C1601865": [
                        "Duloxetine Delayed-Release Capsules",
                        "DULoxetine Delayed Release Oral Capsule",
                        "duloxetine Delayed Release Oral Capsule"
                    ]
                }
            },
            {
                "label": "are indicated for the treatment of",
                "id": {
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "Diabetic Peripheral Neuropathy",
                "id": {
                    "UMLS:C0740447": [
                        "NEUROPATHY DIABETIC PERIPHERAL",
                        "diabetic neuropathy peripheral",
                        "diabetic peripheral neuropathy",
                        "peripheral diabetic neuropathy",
                        "Diabetic peripheral neuropathy",
                        "diabetic peripheral neuropathy (diagnosis)",
                        "Peripheral neuropathy due to diabetes mellitus",
                        "Peripheral neuropathy due to diabetes mellitus (disorder)"
                    ],
                    "UMLS:C3171763": [
                        "Diabetic peripheral neuropathy proto",
                        "PhenX - diabetic peripheral neuropathy protocol 140401",
                        "PhenX - diabetic peripheral neuropathy protocol 140401:-:Pt:^Patient:-:PhenX",
                        "PhenX - diabetic peripheral neuropathy protocol:-:Point in time:^Patient:-:PhenX",
                        "PhenX - diabetic peripheral neuropathy protocol 140401:-:To identify measures at a point in time:^Patient:-:PhenX"
                    ],
                    "UMLS:C2119281": [
                        "diabetic peripheral neuropathy type 2",
                        "type 2 diabetes mellitus with peripheral neuropathy",
                        "type 2 diabetes mellitus with peripheral neuropathy (diagnosis)"
                    ],
                    "UMLS:C0860164": [
                        "Diabetic peripheral autonomic neuropathy"
                    ],
                    "UMLS:C1303091": [
                        "Diabetic peripheral neuropathy screening",
                        "Diabetic peripheral neuropathy screening (regime/therapy)"
                    ]
                }
            }
        ],
        [
            {
                "label": "Duloxetine delayed-release capsules",
                "id": {
                    "UMLS:C1601865": [
                        "Duloxetine Delayed-Release Capsules",
                        "DULoxetine Delayed Release Oral Capsule",
                        "duloxetine Delayed Release Oral Capsule"
                    ]
                }
            },
            {
                "label": "are indicated for the treatment of",
                "id": {
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "Fibromyalgia",
                "id": {
                    "MONDO:0005546": [
                        "fibromyalgia",
                        "FIBROMYALGIA",
                        "fibromyalgia",
                        "Fibromyalgia",
                        "fibromyalgias",
                        "Fibromyalgias",
                        "fibromyalgia (FM)",
                        "Fibromyalgia, NOS",
                        "fibromyalgia (FMS)",
                        "Fibromyalgia syndrome",
                        "Fibromyalgia Syndrome",
                        "fibromyalgia syndrome",
                        "syndrome fibromyalgia",
                        "Fibromyalgia (disorder)",
                        "fibromyalgia (diagnosis)",
                        "fibromyositis fibromyalgia syndrome",
                        "Fibromyalgia-Fibromyositis Syndrome",
                        "Fibromyositis Fibromyalgia Syndrome",
                        "Fibromyositis-Fibromyalgia Syndrome",
                        "Fibromyalgia Fibromyositis Syndrome",
                        "Syndrome, Fibromyositis-Fibromyalgia",
                        "Fibromyalgia-Fibromyositis Syndromes",
                        "Fibromyositis-Fibromyalgia Syndromes",
                        "Syndrome, Fibromyalgia-Fibromyositis",
                        "Syndromes, Fibromyalgia-Fibromyositis",
                        "Syndromes, Fibromyositis-Fibromyalgia",
                        "fms",
                        "FMS",
                        "Fibro",
                        "fibrositis",
                        "Fibrositis",
                        "FIBROSITIS",
                        "mpd syndrome",
                        "Fibrositides",
                        "MPD syndrome",
                        "FIBROMYOSITIS",
                        "Fibromyositis",
                        "fibromyositis",
                        "Fibrositis, NOS",
                        "Fibromyositis NOS",
                        "Fibromyositis, NOS",
                        "Muscular Rheumatism",
                        "RHEUMATISM, TENSION",
                        "Muscular rheumatism",
                        "muscular rheumatism",
                        "Rheumatism, Muscular",
                        "Fibrositis (disorder)",
                        "fibrositis (diagnosis)",
                        "pain syndrome myofascial",
                        "Myofascial pain syndrome",
                        "Fibromyositis (disorder)",
                        "Fibromyositis (diagnosis)",
                        "Myofascial pain dysfunct syn",
                        "Diffuse myofascial pain synd",
                        "MPDS-Myofac pain dysfunct syn",
                        "Myofac pain dysfunct syndrome",
                        "MPS - myofascial pain syndrome",
                        "Muscular rheumatism (disorder)",
                        "Diffuse myofascial pain syndrome",
                        "Diffuse Myofascial Pain Syndrome",
                        "Myofascial Pain Syndrome, Diffuse",
                        "Myofascial trigger point syndrome",
                        "Myofascial pain syndrome (disorder)",
                        "inflammatory myopathy fibromyositis",
                        "Myofacial pain dysfunction syndrome",
                        "myofascial pain dysfunction syndrome",
                        "Myofascial pain dysfunction syndrome",
                        "MPDS - Myofacial pain dysfunction syndrome"
                    ],
                    "UMLS:C4020595": [
                        "Fibromyalgia Agents"
                    ],
                    "UMLS:C0751152": [
                        "fibromyalgia primary",
                        "Primary Fibromyalgia",
                        "Fibromyalgia, Primary",
                        "Primary Fibromyalgias",
                        "Fibromyalgias, Primary",
                        "Primary fibromyalgia syndrome",
                        "Primary fibromyalgia syndrome (disorder)",
                        "Primary fibromyalgia syndrome (diagnosis)"
                    ],
                    "UMLS:C1739144": [
                        "Fibromyalgia worsened"
                    ],
                    "UMLS:C0751153": [
                        "Secondary Fibromyalgia",
                        "Fibromyalgia, Secondary",
                        "Secondary Fibromyalgias",
                        "Fibromyalgias, Secondary"
                    ]
                }
            }
        ],
        [
            {
                "label": "Duloxetine delayed-release capsules",
                "id": {
                    "UMLS:C1601865": [
                        "Duloxetine Delayed-Release Capsules",
                        "DULoxetine Delayed Release Oral Capsule",
                        "duloxetine Delayed Release Oral Capsule"
                    ]
                }
            },
            {
                "label": "are indicated for the treatment of",
                "id": {
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "Chronic Muscoskeletal Pain",
                "id": {}
            }
        ]
    ],
    "Protriptyline hydrochloride is indicated for the treatment of symptoms of mental depression in patients who are under close medical supervision.": [
        [
            {
                "label": "Protriptyline hydrochloride",
                "id": {
                    "UMLS:C0700557": [
                        "Protriptyline hydrochloride",
                        "protriptyline hydrochloride",
                        "PROTRIPTYLINE HYDROCHLORIDE",
                        "Protriptyline Hydrochloride",
                        "Hydrochloride, Protriptyline",
                        "Protriptyline hydrochloride (substance)",
                        "protriptyline hydrochloride (medication)",
                        "protriptyline HCl",
                        "protriptyline hcl",
                        "Triptil Hydrochloride",
                        "5H-Dibenzo(a,d)cycloheptene-5-propanamine, N-methyl-, Hydrochloride"
                    ],
                    "PUBCHEM.COMPOUND:6603149": [
                        "Protriptyline hydrochloride",
                        "protriptyline hydrochloride",
                        "PROTRIPTYLINE HYDROCHLORIDE",
                        "MK-240",
                        "Triptil",
                        "Concordin",
                        "Concordin",
                        "3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-aminium chloride",
                        "hydron;N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)propan-1-amine;chloride"
                    ],
                    "PUBCHEM.COMPOUND:4976": [
                        "Protriptyline hydrochloride",
                        "Hydrochloride, protriptyline",
                        "Odyssey brand OF protriptyline hydrochloride",
                        "Vivactil",
                        "amimetilina",
                        "Amimetilina",
                        "Amimetilina",
                        "Protriptylin",
                        "protryptyline",
                        "PROTRIPTYLINE",
                        "protriptyline",
                        "Protriptyline",
                        "Protryptyline",
                        "Protryptyline",
                        "Protriptilina",
                        "Protriptylinum",
                        "Protriptyline (substance)",
                        "protriptyline (medication)",
                        "antidepressants protriptyline",
                        "Protriptyline-containing product",
                        "N-methyl-5H-dibenzo[a,d]cycloheptene-5-propanamine",
                        "N-methyl-5H-dibenzo[a,d]cycloheptene-5-propylamine",
                        "N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine",
                        "N-methyl-5H-dibenzo[a,d]cycloheptene-5-propanamine",
                        "N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine",
                        "N-methyl-5H-dibenzo[a,d]cycloheptene-5-propylamine",
                        "5-(3-methylaminopropyl)-5H-dibenzo[a,d]cycloheptene",
                        "5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene",
                        "5-(3-methylaminopropyl)-5H-dibenzo[a,d]cycloheptene",
                        "Product containing protriptyline (medicinal product)",
                        "5H-Dibenzo(a,d)cycloheptene-5-propanamine, N-methyl-",
                        "7-(3-methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene",
                        "7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene",
                        "7-(3-methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene",
                        "3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine",
                        "3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine",
                        "3-(5H-dibenzo[a,d]cyclohepten-5-yl)-N-methyl-1-propanamine",
                        "3-(5H-dibenzo[a,d]cyclohepten-5-yl)-N-methyl-1-propanamine"
                    ],
                    "PUBCHEM.COMPOUND:117065181": [
                        "Protriptyline-d3 Hydrochloride"
                    ],
                    "UMLS:C2747212": [
                        "protriptyline hydrochloride 5 MG"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of symptoms of mental depression",
                "id": {}
            }
        ],
        [
            {
                "label": "Protriptyline hydrochloride",
                "id": {
                    "UMLS:C0700557": [
                        "Protriptyline hydrochloride",
                        "protriptyline hydrochloride",
                        "PROTRIPTYLINE HYDROCHLORIDE",
                        "Protriptyline Hydrochloride",
                        "Hydrochloride, Protriptyline",
                        "Protriptyline hydrochloride (substance)",
                        "protriptyline hydrochloride (medication)",
                        "protriptyline HCl",
                        "protriptyline hcl",
                        "Triptil Hydrochloride",
                        "5H-Dibenzo(a,d)cycloheptene-5-propanamine, N-methyl-, Hydrochloride"
                    ],
                    "PUBCHEM.COMPOUND:6603149": [
                        "Protriptyline hydrochloride",
                        "protriptyline hydrochloride",
                        "PROTRIPTYLINE HYDROCHLORIDE",
                        "MK-240",
                        "Triptil",
                        "Concordin",
                        "Concordin",
                        "3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-aminium chloride",
                        "hydron;N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)propan-1-amine;chloride"
                    ],
                    "PUBCHEM.COMPOUND:4976": [
                        "Protriptyline hydrochloride",
                        "Hydrochloride, protriptyline",
                        "Odyssey brand OF protriptyline hydrochloride",
                        "Vivactil",
                        "amimetilina",
                        "Amimetilina",
                        "Amimetilina",
                        "Protriptylin",
                        "protryptyline",
                        "PROTRIPTYLINE",
                        "protriptyline",
                        "Protriptyline",
                        "Protryptyline",
                        "Protryptyline",
                        "Protriptilina",
                        "Protriptylinum",
                        "Protriptyline (substance)",
                        "protriptyline (medication)",
                        "antidepressants protriptyline",
                        "Protriptyline-containing product",
                        "N-methyl-5H-dibenzo[a,d]cycloheptene-5-propanamine",
                        "N-methyl-5H-dibenzo[a,d]cycloheptene-5-propylamine",
                        "N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propylamine",
                        "N-methyl-5H-dibenzo[a,d]cycloheptene-5-propanamine",
                        "N-Methyl-5H-dibenzo[a,D]cycloheptene-5-propanamine",
                        "N-methyl-5H-dibenzo[a,d]cycloheptene-5-propylamine",
                        "5-(3-methylaminopropyl)-5H-dibenzo[a,d]cycloheptene",
                        "5-(3-Methylaminopropyl)-5H-dibenzo[a,D]cycloheptene",
                        "5-(3-methylaminopropyl)-5H-dibenzo[a,d]cycloheptene",
                        "Product containing protriptyline (medicinal product)",
                        "5H-Dibenzo(a,d)cycloheptene-5-propanamine, N-methyl-",
                        "7-(3-methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene",
                        "7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene",
                        "7-(3-methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene",
                        "3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine",
                        "3-(5H-Dibenzo[a,D]cyclohepten-5-yl)-N-methyl-1-propanamine",
                        "3-(5H-dibenzo[a,d]cyclohepten-5-yl)-N-methyl-1-propanamine",
                        "3-(5H-dibenzo[a,d]cyclohepten-5-yl)-N-methyl-1-propanamine"
                    ],
                    "PUBCHEM.COMPOUND:117065181": [
                        "Protriptyline-d3 Hydrochloride"
                    ],
                    "UMLS:C2747212": [
                        "protriptyline hydrochloride 5 MG"
                    ]
                }
            },
            {
                "label": "is indicated for the treatment of symptoms of mental depression in",
                "id": {}
            },
            {
                "label": "patients",
                "id": {
                    "UMLS:C0030705": [
                        "Patients",
                        "patients",
                        "PT",
                        "patient",
                        "Patient",
                        "PATIENT",
                        "^Patient",
                        "*^patient",
                        "Patient (person)"
                    ],
                    "UMLS:C0029921": [
                        "out-patients",
                        "Out-patients",
                        "Out patients",
                        "outpatient",
                        "Outpatient",
                        "Outpatients",
                        "out-patient",
                        "outpatients",
                        "Out-patient",
                        "Outpatient (person)"
                    ],
                    "UMLS:C0150831": [
                        "patients sex",
                        "patient sex",
                        "Patient sex",
                        "Patient's Sex",
                        "Patient sex (observable entity)"
                    ],
                    "UMLS:C0030690": [
                        "fall patients",
                        "falls patients",
                        "patient fall",
                        "PATIENT FALL",
                        "falls patient"
                    ],
                    "UMLS:C0150904": [
                        "male patients",
                        "male patient",
                        "patient is male",
                        "Patient is male"
                    ]
                }
            }
        ],
        [
            {
                "label": "patients",
                "id": {
                    "UMLS:C0030705": [
                        "Patients",
                        "patients",
                        "PT",
                        "patient",
                        "Patient",
                        "PATIENT",
                        "^Patient",
                        "*^patient",
                        "Patient (person)"
                    ],
                    "UMLS:C0029921": [
                        "out-patients",
                        "Out-patients",
                        "Out patients",
                        "outpatient",
                        "Outpatient",
                        "Outpatients",
                        "out-patient",
                        "outpatients",
                        "Out-patient",
                        "Outpatient (person)"
                    ],
                    "UMLS:C0150831": [
                        "patients sex",
                        "patient sex",
                        "Patient sex",
                        "Patient's Sex",
                        "Patient sex (observable entity)"
                    ],
                    "UMLS:C0030690": [
                        "fall patients",
                        "falls patients",
                        "patient fall",
                        "PATIENT FALL",
                        "falls patient"
                    ],
                    "UMLS:C0150904": [
                        "male patients",
                        "male patient",
                        "patient is male",
                        "Patient is male"
                    ]
                }
            },
            {
                "label": "are under",
                "id": {
                    "UMLS:C0376690": [
                        "area under curve",
                        "Area Under Curve",
                        "Curve, Area Under",
                        "Area Under Curves",
                        "Under Curve, Area",
                        "Curves, Area Under",
                        "Under Curves, Area",
                        "Area under the curve",
                        "area under the curve (AUC)",
                        "Area under the curve (qualifier value)",
                        "auc",
                        "AUC"
                    ],
                    "UMLS:C0025112": [
                        "MED UNDERSERV AREA",
                        "AREA MED UNDERSERV",
                        "Medically Underserved Area",
                        "Medically Underserved Areas",
                        "Medically underserved areas",
                        "Underserved Area, Medically",
                        "Area, Medically Underserved",
                        "Areas, Medically Underserved",
                        "Underserved Areas, Medically"
                    ],
                    "UMLS:C5187375": [
                        "Area under the curve",
                        "TmMCnc",
                        "Time mass concentration"
                    ],
                    "UMLS:C5221096": [
                        "Area under the curve",
                        "TmSCnc",
                        "Time substance concentration"
                    ],
                    "UMLS:C5551514": [
                        "Area under the curve",
                        "TmElpot"
                    ]
                }
            },
            {
                "label": "close medical supervision",
                "id": {}
            }
        ]
    ],
    "Its activating properties make it particularly suitable for withdrawn and anergic patients.": [
        [
            {
                "label": "Its activating properties",
                "id": {}
            },
            {
                "label": "make",
                "id": {
                    "UMLS:C0947322": [
                        "Make",
                        "Maker",
                        "Manufacturer",
                        "Manufacturing",
                        "Manufacturer Name",
                        "Manufacturer name",
                        "manufacturer name",
                        "name manufacturer",
                        "manufacturers name"
                    ],
                    "UMLS:C1881534": [
                        "Make",
                        "Make - Instruction Imperative",
                        "ft.",
                        "fiat",
                        "let it be made"
                    ],
                    "UMLS:C0554244": [
                        "Maker",
                        "maker",
                        "makers",
                        "maker [occupation]",
                        "Maker (occupation)"
                    ],
                    "PUBCHEM.COMPOUND:169870": [
                        "makena",
                        "delalutin",
                        "gestageno",
                        "Primolut depot",
                        "progesterone caproate",
                        "Oxyprogesterone Caproate",
                        "oxyprogesterone caproate",
                        "17alpha-hydroxyprogesterone",
                        "Hydroxyprogesterone Caproate",
                        "HYDROXYPROGESTERONE CAPROATE",
                        "hydroxyprogesterone caproate",
                        "Hydroxyprogesterone caproate",
                        "caproate hydroxyprogesterone",
                        "Hydroxyprogesterone hexanoate",
                        "hydroxyprogesterone hexanoate",
                        "Hydroxyprogesterone Hexanoate",
                        "Caproate d'hydroxyprogesterone",
                        "Caproato de hidroxiprogesterona",
                        "17 Hydroxyprogesterone Capronate",
                        "17-Hydroxyprogesterone Capronate",
                        "HYDROXYprogesterone caproate (USP)",
                        "hydroxyprogesterone caproate (USP)",
                        "17 alpha Oxyprogesterone Capronate",
                        "17 alpha-Oxyprogesterone Capronate",
                        "17alpha-Hydroxyprogesterone Caproate",
                        "17alpha-Hydroxyprogesterone hexanoate",
                        "17 alpha Hydroxyprogesterone Caproate",
                        "17 alpha-Hydroxyprogesterone Caproate",
                        "17alpha-Hydroxyprogesterone hexanoate",
                        "17-alpha-Hydroxy-Progesterone Caproate",
                        "17-alpha-hydroxy-progesterone caproate",
                        "17 alpha Hydroxy Progesterone Caproate",
                        "17-alpha-hydroxy-progesterone caproate",
                        "Caproate, 17-alpha-Hydroxy-Progesterone",
                        "Hydroxyprogesterone caproate (substance)",
                        "17alpha-Caproyloxypregn-4-ene-3,20-dione",
                        "17alpha-Caproyloxypregn-4-ene-3,20-dione",
                        "Hydroxyprogesterone caproate preparation",
                        "hydroxyprogesterone caproate (medication)",
                        "Hydroxyprogesterone hexanoate preparation",
                        "17-[(1-Oxohexyl)oxy]pregn-4-ene-3,20-dione",
                        "Hexanoic acid, 3,20-dioxopregn-4-en-17-yl ester",
                        "[OBSOLETE] 17-alpha-hydroxy-progesterone caproate"
                    ],
                    "UMLS:C1998591": [
                        "Makeup"
                    ]
                }
            },
            {
                "label": "it particularly suitable for withdrawn and anergic patients",
                "id": {}
            }
        ]
    ],
    "Bupropion hydrochloride extended-release tablets (XL) are indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM).": [
        [
            {
                "label": "Bupropion hydrochloride extended-release tablets (XL)",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of major depressive disorder (MDD)",
                "id": {}
            }
        ],
        [
            {
                "label": "major depressive disorder (MDD)",
                "id": {
                    "UMLS:C1740001": [
                        "Major depressive disorder, mild (mdd)",
                        "Major depressive disorder, mild (MDD)",
                        "MDD MILD",
                        "Mdd mild",
                        "MAJOR DEPRESSIVE DISORDER MILD"
                    ],
                    "UMLS:C1741422": [
                        "Major depressive disorder, moderate (MDD)",
                        "Major depressive disorder, moderate (mdd)",
                        "MDD MODERATE",
                        "Mdd moderate",
                        "MAJOR DEPRESSIVE DISORDER MODERATE"
                    ],
                    "UMLS:C0270461": [
                        "Major depressive disorder, in remission (MDD)",
                        "Major depressive disorder, in remission (mdd)",
                        "MDD IN REMISSION",
                        "Mdd in remission",
                        "Major depression in remission",
                        "Major depression, in remission",
                        "major depression - in remission",
                        "Major depression in remission, NOS",
                        "MAJOR DEPRESSIVE DISORDER REMISSION",
                        "major depressive disorder, in remission",
                        "major depressive disorder - in remission",
                        "Major depression in remission (disorder)",
                        "major depressive disorder, in remission (diagnosis)"
                    ],
                    "UMLS:C1737769": [
                        "Major depressive disorder, severe with psychotic features (MDD)",
                        "Major depressive disorder, severe with psychotic features (mdd)",
                        "Mdd severe w/psych",
                        "MDD SEVERE W/PSYCH",
                        "MAJOR DESPRESV DISORDER SEVERE W/PSYCHOT FEATURE"
                    ],
                    "UMLS:C1738037": [
                        "Major depressive disorder, severe without psychotic features (mdd)",
                        "Major depressive disorder, severe without psychotic features (MDD)",
                        "Mdd severe w/o psych",
                        "MDD SEVERE W/O PSYCH",
                        "MDD SEVERE WITHOUT PSYCHOTIC FEATURES"
                    ]
                }
            },
            {
                "label": "defined by",
                "id": {
                    "UMLS:C0683592": [
                        "context defined by time",
                        "temporal context",
                        "Temporal context",
                        "Temporal context (attribute)"
                    ],
                    "UMLS:C0442504": [
                        "context defined by space or location",
                        "place",
                        "Place",
                        "places",
                        "Places",
                        "placing",
                        "physical context",
                        "Place (attribute)",
                        "Place (environment)",
                        "physical context or place"
                    ],
                    "UMLS:C5420474": [
                        "Eligibility Defined by Disease Diagnosis",
                        "Disease Diagnosis Defined Eligibility Criterion"
                    ],
                    "UMLS:C0813940": [
                        "overall AOD use pattern defined by amount",
                        "overall Alcohol or Other Drugs use pattern defined by amount"
                    ],
                    "MESH:C545989": [
                        "Antigen Defined By Monoclonal Antibody 4F2",
                        "4F2hc",
                        "CD98 Antigen",
                        "4F2 Heavy Chain",
                        "CD98 Heavy Chain",
                        "4F2hc protein, human",
                        "SLC3A2 protein, human",
                        "CD98HC protein, human",
                        "4F2 Heavy Chain Antigen",
                        "Monoclonal Antibody 44D7 Antigen",
                        "Solute Carrier Family 3 Member 2",
                        "4F2 Cell-Surface Antigen Heavy Chain",
                        "solute carrier family 3 member 2 protein, human",
                        "Lymphocyte Activation Antigen 4F2 Large Subunit"
                    ]
                }
            },
            {
                "label": "the Diagnostic and Statistical Manual (DSM)",
                "id": {}
            }
        ]
    ],
    "Bupropion hydrochloride extended-release tablets (XL) are indicated for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (SAD).": [
        [
            {
                "label": "Bupropion hydrochloride extended-release tablets (XL)",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the prevention of seasonal major depressive episodes",
                "id": {}
            }
        ],
        [
            {
                "label": "Bupropion hydrochloride extended-release tablets (XL)",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "patients with a diagnosis of seasonal affective disorder (SAD)",
                "id": {}
            }
        ]
    ],
    "Endogenous depression is more likely to be alleviated than are other depressive states.": [
        [
            {
                "label": "Endogenous depression",
                "id": {
                    "MONDO:0012048": [
                        "DEPRESSION ENDOGENOUS",
                        "depression endogenous",
                        "endogenous depression",
                        "Endogenous depression",
                        "ENDOGENOUS DEPRESSION",
                        "endogenous depression",
                        "Depression endogenous",
                        "Endogenous Depression",
                        "Depression;endogenous",
                        "Endogenous Depressions",
                        "Depression, Endogenous",
                        "endogenous; depression",
                        "depression; endogenous",
                        "Depressions, Endogenous",
                        "Endogenous depression (disorder)",
                        "Endogenous depression (diagnosis)",
                        "MDD",
                        "clinical depression",
                        "unipolar depression",
                        "unipolar depression",
                        "clinical depression",
                        "major depressive disorder"
                    ],
                    "UMLS:C0553816": [
                        "Endogenous depression - recurrent",
                        "depression endogenous - recurrent",
                        "Endogenous depression - recurrent (disorder)",
                        "Endogenous depression - recurrent (diagnosis)"
                    ],
                    "UMLS:C0338895": [
                        "Endogenous depression first episode",
                        "depression endogenous - first episode",
                        "endogenous depression - first episode",
                        "Endogenous depression first episode (disorder)",
                        "endogenous depression - first episode (diagnosis)"
                    ],
                    "UMLS:C4290113": [
                        "recurrent episodes of endogenous depression"
                    ],
                    "UMLS:C1395188": [
                        "Endogenous depression with psychotic symptoms",
                        "depression; endogenous, with psychotic symptoms"
                    ]
                }
            },
            {
                "label": "is",
                "id": {
                    "UBERON:0002872": [
                        "IS",
                        "inferior salivary nucleus",
                        "Nucleus salivarius inferior",
                        "nucleus salivarius inferior",
                        "Inferior salivatory nucleus",
                        "inferior salivatary nucleus",
                        "inferior salivatory nucleus",
                        "Nucleus salivatorius inferior",
                        "nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior",
                        "Nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior nervi glossopharyngei",
                        "Nucleus salivatorius inferior nervi glossopharyngei"
                    ],
                    "OMIM:146850": [
                        "IS",
                        "ISCW",
                        "ISSCW",
                        "IMMUNE SUPPRESSION",
                        "STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO"
                    ],
                    "FB:FBgn0001274": [
                        "Is"
                    ],
                    "PUBCHEM.COMPOUND:7021816": [
                        "IS",
                        "isoleucylserine",
                        "Isoleucyl-Serine",
                        "L-isoleucyl-L-serine",
                        "Ile-Ser",
                        "L-Ile-L-Ser",
                        "CHEMBL56803"
                    ],
                    "UMLS:C0021632": [
                        "IS",
                        "INSTRUM",
                        "instrumentation",
                        "instrumentation aspects"
                    ]
                }
            },
            {
                "label": "more likely to be alleviated",
                "id": {}
            }
        ],
        [
            {
                "label": "Endogenous depression",
                "id": {
                    "MONDO:0012048": [
                        "DEPRESSION ENDOGENOUS",
                        "depression endogenous",
                        "endogenous depression",
                        "Endogenous depression",
                        "ENDOGENOUS DEPRESSION",
                        "endogenous depression",
                        "Depression endogenous",
                        "Endogenous Depression",
                        "Depression;endogenous",
                        "Endogenous Depressions",
                        "Depression, Endogenous",
                        "endogenous; depression",
                        "depression; endogenous",
                        "Depressions, Endogenous",
                        "Endogenous depression (disorder)",
                        "Endogenous depression (diagnosis)",
                        "MDD",
                        "clinical depression",
                        "unipolar depression",
                        "unipolar depression",
                        "clinical depression",
                        "major depressive disorder"
                    ],
                    "UMLS:C0553816": [
                        "Endogenous depression - recurrent",
                        "depression endogenous - recurrent",
                        "Endogenous depression - recurrent (disorder)",
                        "Endogenous depression - recurrent (diagnosis)"
                    ],
                    "UMLS:C0338895": [
                        "Endogenous depression first episode",
                        "depression endogenous - first episode",
                        "endogenous depression - first episode",
                        "Endogenous depression first episode (disorder)",
                        "endogenous depression - first episode (diagnosis)"
                    ],
                    "UMLS:C4290113": [
                        "recurrent episodes of endogenous depression"
                    ],
                    "UMLS:C1395188": [
                        "Endogenous depression with psychotic symptoms",
                        "depression; endogenous, with psychotic symptoms"
                    ]
                }
            },
            {
                "label": "is",
                "id": {
                    "UBERON:0002872": [
                        "IS",
                        "inferior salivary nucleus",
                        "Nucleus salivarius inferior",
                        "nucleus salivarius inferior",
                        "Inferior salivatory nucleus",
                        "inferior salivatary nucleus",
                        "inferior salivatory nucleus",
                        "Nucleus salivatorius inferior",
                        "nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior",
                        "Nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior nervi glossopharyngei",
                        "Nucleus salivatorius inferior nervi glossopharyngei"
                    ],
                    "OMIM:146850": [
                        "IS",
                        "ISCW",
                        "ISSCW",
                        "IMMUNE SUPPRESSION",
                        "STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO"
                    ],
                    "FB:FBgn0001274": [
                        "Is"
                    ],
                    "PUBCHEM.COMPOUND:7021816": [
                        "IS",
                        "isoleucylserine",
                        "Isoleucyl-Serine",
                        "L-isoleucyl-L-serine",
                        "Ile-Ser",
                        "L-Ile-L-Ser",
                        "CHEMBL56803"
                    ],
                    "UMLS:C0021632": [
                        "IS",
                        "INSTRUM",
                        "instrumentation",
                        "instrumentation aspects"
                    ]
                }
            },
            {
                "label": "other depressive states",
                "id": {}
            }
        ]
    ],
    "Trimipramine maleate capsules are indicated for the relief of symptoms of depression.": [
        [
            {
                "label": "Trimipramine maleate capsules",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the relief of symptoms of depression",
                "id": {}
            }
        ]
    ],
    "Endogenous depression is more likely to be alleviated than other depressive states.": [
        [
            {
                "label": "Endogenous depression",
                "id": {
                    "MONDO:0012048": [
                        "DEPRESSION ENDOGENOUS",
                        "depression endogenous",
                        "endogenous depression",
                        "Endogenous depression",
                        "ENDOGENOUS DEPRESSION",
                        "endogenous depression",
                        "Depression endogenous",
                        "Endogenous Depression",
                        "Depression;endogenous",
                        "Endogenous Depressions",
                        "Depression, Endogenous",
                        "endogenous; depression",
                        "depression; endogenous",
                        "Depressions, Endogenous",
                        "Endogenous depression (disorder)",
                        "Endogenous depression (diagnosis)",
                        "MDD",
                        "clinical depression",
                        "unipolar depression",
                        "unipolar depression",
                        "clinical depression",
                        "major depressive disorder"
                    ],
                    "UMLS:C0553816": [
                        "Endogenous depression - recurrent",
                        "depression endogenous - recurrent",
                        "Endogenous depression - recurrent (disorder)",
                        "Endogenous depression - recurrent (diagnosis)"
                    ],
                    "UMLS:C0338895": [
                        "Endogenous depression first episode",
                        "depression endogenous - first episode",
                        "endogenous depression - first episode",
                        "Endogenous depression first episode (disorder)",
                        "endogenous depression - first episode (diagnosis)"
                    ],
                    "UMLS:C4290113": [
                        "recurrent episodes of endogenous depression"
                    ],
                    "UMLS:C1395188": [
                        "Endogenous depression with psychotic symptoms",
                        "depression; endogenous, with psychotic symptoms"
                    ]
                }
            },
            {
                "label": "is",
                "id": {
                    "UBERON:0002872": [
                        "IS",
                        "inferior salivary nucleus",
                        "Nucleus salivarius inferior",
                        "nucleus salivarius inferior",
                        "Inferior salivatory nucleus",
                        "inferior salivatary nucleus",
                        "inferior salivatory nucleus",
                        "Nucleus salivatorius inferior",
                        "nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior",
                        "Nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior nervi glossopharyngei",
                        "Nucleus salivatorius inferior nervi glossopharyngei"
                    ],
                    "OMIM:146850": [
                        "IS",
                        "ISCW",
                        "ISSCW",
                        "IMMUNE SUPPRESSION",
                        "STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO"
                    ],
                    "FB:FBgn0001274": [
                        "Is"
                    ],
                    "PUBCHEM.COMPOUND:7021816": [
                        "IS",
                        "isoleucylserine",
                        "Isoleucyl-Serine",
                        "L-isoleucyl-L-serine",
                        "Ile-Ser",
                        "L-Ile-L-Ser",
                        "CHEMBL56803"
                    ],
                    "UMLS:C0021632": [
                        "IS",
                        "INSTRUM",
                        "instrumentation",
                        "instrumentation aspects"
                    ]
                }
            },
            {
                "label": "more likely to be alleviated than other depressive states",
                "id": {}
            }
        ]
    ],
    "Clobazam tablet is indicated for the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.": [
        [
            {
                "label": "Clobazam tablet",
                "id": {
                    "UMLS:C1245601": [
                        "Clobazam Tablets",
                        "cloBAZam Oral Tablet",
                        "clobazam Oral Tablet"
                    ],
                    "UMLS:C0692946": [
                        "Clobazam 10mg tablet",
                        "Clobazam 10mg Oral tablet",
                        "Clobazam 10 MG Oral Tablet",
                        "cloBAZam 10 MG Oral Tablet",
                        "cloBAZam 10 mg oral tablet",
                        "clobazam 10 MG Oral Tablet",
                        "Clobazam 10 mg ORAL TABLET",
                        "clobazam@10 mg@ORAL@TABLET",
                        "Clobazam 10 mg oral tablet",
                        "clobazam 10 mg ORAL TABLET",
                        "CLOBAZAM 10 mg ORAL TABLET",
                        "CloBAZam, 10 mg oral tablet",
                        "CLOBAZAM 10 mg ORAL TABLET [Clobazam]",
                        "CLOBAZAM 10 mg ORAL TABLET [clobazam]",
                        "clobazam 10 mg ORAL TABLET [Clobazam]",
                        "CLOBAZAM 10 mg ORAL TABLET [CLOBAZAM]",
                        "Product containing precisely clobazam 10 milligram/1 each conventional release oral tablet (clinical drug)",
                        "CLOBAZAM 10MG TAB,ORAL",
                        "CLOBAZAM 10MG ORAL TAB"
                    ],
                    "UMLS:C0786984": [
                        "Clobazam 20mg Oral tablet",
                        "clobazam@20 mg@ORAL@TABLET",
                        "CLOBAZAM 20 mg ORAL TABLET",
                        "Clobazam 20 MG Oral Tablet",
                        "clobazam 20 MG Oral Tablet",
                        "cloBAZam 20 MG Oral Tablet",
                        "clobazam 20 mg ORAL TABLET",
                        "cloBAZam 20 mg oral tablet",
                        "Clobazam 20 mg ORAL TABLET",
                        "CloBAZam, 20 mg oral tablet",
                        "CLOBAZAM 20 mg ORAL TABLET [clobazam]",
                        "CLOBAZAM 20 mg ORAL TABLET [Clobazam]",
                        "clobazam 20 mg ORAL TABLET [Clobazam]",
                        "CLOBAZAM 20 mg ORAL TABLET [CLOBAZAM]",
                        "CLOBAZAM 20MG TAB,ORAL",
                        "CLOBAZAM 20MG ORAL TAB"
                    ],
                    "UMLS:C1356806": [
                        "clobazam 5 MG Oral Tablet",
                        "cloBAZam 5 MG Oral Tablet",
                        "CLOBAZAM 5 mg ORAL TABLET [clobazam]"
                    ],
                    "UMLS:C3245344": [
                        "clobazam Oral Tablet [Onfi]",
                        "cloBAZam Oral Tablet [Onfi]"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS)",
                "id": {}
            }
        ],
        [
            {
                "label": "Clobazam tablet",
                "id": {
                    "UMLS:C1245601": [
                        "Clobazam Tablets",
                        "cloBAZam Oral Tablet",
                        "clobazam Oral Tablet"
                    ],
                    "UMLS:C0692946": [
                        "Clobazam 10mg tablet",
                        "Clobazam 10mg Oral tablet",
                        "Clobazam 10 MG Oral Tablet",
                        "cloBAZam 10 MG Oral Tablet",
                        "cloBAZam 10 mg oral tablet",
                        "clobazam 10 MG Oral Tablet",
                        "Clobazam 10 mg ORAL TABLET",
                        "clobazam@10 mg@ORAL@TABLET",
                        "Clobazam 10 mg oral tablet",
                        "clobazam 10 mg ORAL TABLET",
                        "CLOBAZAM 10 mg ORAL TABLET",
                        "CloBAZam, 10 mg oral tablet",
                        "CLOBAZAM 10 mg ORAL TABLET [Clobazam]",
                        "CLOBAZAM 10 mg ORAL TABLET [clobazam]",
                        "clobazam 10 mg ORAL TABLET [Clobazam]",
                        "CLOBAZAM 10 mg ORAL TABLET [CLOBAZAM]",
                        "Product containing precisely clobazam 10 milligram/1 each conventional release oral tablet (clinical drug)",
                        "CLOBAZAM 10MG TAB,ORAL",
                        "CLOBAZAM 10MG ORAL TAB"
                    ],
                    "UMLS:C0786984": [
                        "Clobazam 20mg Oral tablet",
                        "clobazam@20 mg@ORAL@TABLET",
                        "CLOBAZAM 20 mg ORAL TABLET",
                        "Clobazam 20 MG Oral Tablet",
                        "clobazam 20 MG Oral Tablet",
                        "cloBAZam 20 MG Oral Tablet",
                        "clobazam 20 mg ORAL TABLET",
                        "cloBAZam 20 mg oral tablet",
                        "Clobazam 20 mg ORAL TABLET",
                        "CloBAZam, 20 mg oral tablet",
                        "CLOBAZAM 20 mg ORAL TABLET [clobazam]",
                        "CLOBAZAM 20 mg ORAL TABLET [Clobazam]",
                        "clobazam 20 mg ORAL TABLET [Clobazam]",
                        "CLOBAZAM 20 mg ORAL TABLET [CLOBAZAM]",
                        "CLOBAZAM 20MG TAB,ORAL",
                        "CLOBAZAM 20MG ORAL TAB"
                    ],
                    "UMLS:C1356806": [
                        "clobazam 5 MG Oral Tablet",
                        "cloBAZam 5 MG Oral Tablet",
                        "CLOBAZAM 5 mg ORAL TABLET [clobazam]"
                    ],
                    "UMLS:C3245344": [
                        "clobazam Oral Tablet [Onfi]",
                        "cloBAZam Oral Tablet [Onfi]"
                    ]
                }
            },
            {
                "label": "is indicated for patients",
                "id": {}
            },
            {
                "label": "2 years of age or older",
                "id": {
                    "UMLS:C3704001": [
                        "Home dialysis services per month, patient 20 years of age or older"
                    ],
                    "UMLS:C5414936": [
                        "End-stage renal disease (ESRD) related monthly services, patient 20 years of age or older"
                    ],
                    "UMLS:C3516811": [
                        "Dialysis services (4 or more physician visits per month), patient 20 years of age and older"
                    ],
                    "UMLS:C3516821": [
                        "Dialysis services, per day (less than full month service), patient 20 years of age or older"
                    ],
                    "UMLS:C5414940": [
                        "End-stage renal disease (ESRD) related services less than a full month of service, per day, patient 20 years of age or older"
                    ]
                }
            }
        ]
    ],
    "Perphenazine is indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults.": [
        [
            {
                "label": "Perphenazine",
                "id": {
                    "PUBCHEM.COMPOUND:4748": [
                        "perphenazine",
                        "Perphenazine",
                        "PERPHENAZINE",
                        "perphenazine",
                        "Perphenazine (substance)",
                        "perphenazine (medication)",
                        "Perphenazine-containing product",
                        "Product containing perphenazine (medicinal product)",
                        "PZC",
                        "Trilafon",
                        "Trilafon",
                        "Etaperazin",
                        "Etaperazin",
                        "Perphenazin",
                        "Etaperazine",
                        "Etaperazine",
                        "Perphenazin",
                        "Perphenazin",
                        "perfenazina",
                        "Perfenazina",
                        "Perfenazine",
                        "Perfenazina",
                        "perfenazine",
                        "Perfenazine",
                        "Perfenazine",
                        "Ethaperazine",
                        "Ethaperazine",
                        "Perphénazine",
                        "perphenazinum",
                        "Perphenazinum",
                        "Perphenazinum",
                        "Chlorpiprazine",
                        "Chlorpiprazine",
                        "Chlorpiprazine",
                        "Chlorperphenazine",
                        "4-[3-(2-chlorophenothiazin-10-yl)propyl]-1-piperazineethanol",
                        "4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol",
                        "4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol",
                        "4-[3-(2-chlorophenothiazin-10-yl)propyl]-1-piperazineethanol",
                        "Γ-(4-(β-hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine",
                        "g-(4-(b-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine",
                        "γ-(4-(β-hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine",
                        "4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol",
                        "4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol",
                        "4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol",
                        "4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol",
                        "1-Piperazineethanol, 4-(3-(2-chloro-10H-phenothiazin-10-yl)propyl)-",
                        "2-chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine",
                        "2-chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine",
                        "2-Chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine",
                        "2-(4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol",
                        "2-(4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol",
                        "2-(4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol",
                        "2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol",
                        "gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine",
                        "gamma-(4-(beta-hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine"
                    ],
                    "PUBCHEM.COMPOUND:10319251": [
                        "Perphenazine-d4"
                    ],
                    "UMLS:C0945415": [
                        "Perphenazine Ql",
                        "Perphenazine SerPl Ql",
                        "Perphenazine:PrThr:Pt:Ser/Plas:Ord",
                        "Perphenazine [Presence] in Serum or Plasma",
                        "Perphenazine:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ],
                    "UMLS:C0366612": [
                        "Perphenazine Dose",
                        "Perphenazine (Dose) [Mass]",
                        "Perphenazine [Mass] of Dose",
                        "Perphenazine:Mass:Pt:Dose:Qn",
                        "Perphenazine:Mass:To identify measures at a point in time:Dose:Quantitative"
                    ],
                    "UMLS:C0988550": [
                        "perphenazine 2 MG"
                    ]
                }
            },
            {
                "label": "is indicated for use in the treatment of",
                "id": {}
            },
            {
                "label": "schizophrenia",
                "id": {
                    "MONDO:0005090": [
                        "schizophrenia",
                        "Schizophrenia",
                        "SCHIZOPHRENIA",
                        "schizophrenia",
                        "SCHIZOPHRENIAS",
                        "schizophrenias",
                        "Schizophrenias",
                        "schizophrenia-1",
                        "schizophrenia-1",
                        "schizophrenia 12",
                        "Schizophrenia NOS",
                        "schizophrenia type",
                        "Schizophrenia, NOS",
                        "type schizophrenia",
                        "schizophrenia types",
                        "schizophrenia disorder",
                        "disorder schizophrenia",
                        "schizophrenia (disease)",
                        "disorders schizophrenia",
                        "Schizophrenia all types",
                        "schizophrenia disorders",
                        "Schizophrenia (disorder)",
                        "Schizophrenia NOS-unspec",
                        "schizophrenia (diagnosis)",
                        "unspecified schizophrenia",
                        "Unspecified schizophrenia",
                        "SECTION 9-4 SCHIZOPHRENIAS",
                        "Schizophrenia, unspecified",
                        "schizophrenia, susceptibility to",
                        "schizophrenia disorders (diagnosis)",
                        "Unspecified schizophrenia, unspecified",
                        "Unspecified schizophrenia, unspecified state",
                        "schizophrenia with or without an affective disorder",
                        "SCHIZOPHRENIA WITH OR WITHOUT AN AFFECTIVE DISORDER",
                        "SCZD",
                        "SCZD",
                        "dementia praecox",
                        "Dementia Praecox",
                        "Dementia praecox",
                        "praecox; dementia",
                        "SCHIZOPHRENIC DIS",
                        "disorder schizophrenic",
                        "schizophrenic disorder",
                        "Schizophrenic Disorder",
                        "Schizophrenic disorders",
                        "Disorder, Schizophrenic",
                        "Schizophrenic Disorders",
                        "schizophrenic disorders",
                        "disorders schizophrenic",
                        "schizoaffective disorder",
                        "disorders schizophrenics",
                        "Disorders, Schizophrenic",
                        "Schizophrenic disorders (disorder)"
                    ],
                    "MONDO:0010943": [
                        "schizophrenia 4",
                        "schizophrenia 4",
                        "SCHIZOPHRENIA 4",
                        "schizophrenia type 4",
                        "SCHIZOPHRENIA 4 (disorder)",
                        "schizophrenia, susceptibility to, 4",
                        "SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 22q11-RELATED",
                        "schizophrenia susceptibility locus, chromosome 22Q11-related",
                        "SCZD4",
                        "SCZD4"
                    ],
                    "MONDO:0010897": [
                        "schizophrenia 3",
                        "schizophrenia 3",
                        "SCHIZOPHRENIA 3",
                        "SCHIZOPHRENIA 3 (disorder)",
                        "SCHIZOPHRENIA 3 WITH OR WITHOUT AN AFFECTIVE DISORDER",
                        "schizophrenia 3 with or without an affective disorder",
                        "SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED",
                        "schizophrenia susceptibility locus, chromosome 6-related",
                        "SCZD3",
                        "SCZD3"
                    ],
                    "MONDO:0011280": [
                        "schizophrenia 6",
                        "SCHIZOPHRENIA 6",
                        "schizophrenia 6",
                        "SCHIZOPHRENIA 6 (disorder)",
                        "schizophrenia, susceptibility to",
                        "SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 8p-RELATED",
                        "schizophrenia susceptibility locus, chromosome 8P-related",
                        "SCZD6",
                        "SCZD6"
                    ],
                    "MONDO:0008414": [
                        "SCHIZOPHRENIA 1",
                        "schizophrenia 1",
                        "schizophrenia 1",
                        "SCHIZOPHRENIA 1 (disorder)",
                        "schizophrenia 1 with or without an affective disorder",
                        "SCHIZOPHRENIA 1 WITH OR WITHOUT AN AFFECTIVE DISORDER",
                        "SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 5-RELATED",
                        "schizophrenia susceptibility locus, chromosome 5-related",
                        "SCZD1",
                        "SCZD1"
                    ]
                }
            }
        ],
        [
            {
                "label": "Perphenazine",
                "id": {
                    "PUBCHEM.COMPOUND:4748": [
                        "perphenazine",
                        "Perphenazine",
                        "PERPHENAZINE",
                        "perphenazine",
                        "Perphenazine (substance)",
                        "perphenazine (medication)",
                        "Perphenazine-containing product",
                        "Product containing perphenazine (medicinal product)",
                        "PZC",
                        "Trilafon",
                        "Trilafon",
                        "Etaperazin",
                        "Etaperazin",
                        "Perphenazin",
                        "Etaperazine",
                        "Etaperazine",
                        "Perphenazin",
                        "Perphenazin",
                        "perfenazina",
                        "Perfenazina",
                        "Perfenazine",
                        "Perfenazina",
                        "perfenazine",
                        "Perfenazine",
                        "Perfenazine",
                        "Ethaperazine",
                        "Ethaperazine",
                        "Perphénazine",
                        "perphenazinum",
                        "Perphenazinum",
                        "Perphenazinum",
                        "Chlorpiprazine",
                        "Chlorpiprazine",
                        "Chlorpiprazine",
                        "Chlorperphenazine",
                        "4-[3-(2-chlorophenothiazin-10-yl)propyl]-1-piperazineethanol",
                        "4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol",
                        "4-(3-(2-Chlorophenothiazin-10-yl)propyl)-1-piperazineethanol",
                        "4-[3-(2-chlorophenothiazin-10-yl)propyl]-1-piperazineethanol",
                        "Γ-(4-(β-hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine",
                        "g-(4-(b-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine",
                        "γ-(4-(β-hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine",
                        "4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol",
                        "4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol",
                        "4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol",
                        "4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol",
                        "1-Piperazineethanol, 4-(3-(2-chloro-10H-phenothiazin-10-yl)propyl)-",
                        "2-chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine",
                        "2-chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine",
                        "2-Chloro-10-(3-(4-(2-hydroxyethyl)piperazin-1-yl)propyl)phenothiazine",
                        "2-(4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol",
                        "2-(4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol",
                        "2-(4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol",
                        "2-{4-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]piperazin-1-yl}ethanol",
                        "gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine",
                        "gamma-(4-(beta-hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine"
                    ],
                    "PUBCHEM.COMPOUND:10319251": [
                        "Perphenazine-d4"
                    ],
                    "UMLS:C0945415": [
                        "Perphenazine Ql",
                        "Perphenazine SerPl Ql",
                        "Perphenazine:PrThr:Pt:Ser/Plas:Ord",
                        "Perphenazine [Presence] in Serum or Plasma",
                        "Perphenazine:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ],
                    "UMLS:C0366612": [
                        "Perphenazine Dose",
                        "Perphenazine (Dose) [Mass]",
                        "Perphenazine [Mass] of Dose",
                        "Perphenazine:Mass:Pt:Dose:Qn",
                        "Perphenazine:Mass:To identify measures at a point in time:Dose:Quantitative"
                    ],
                    "UMLS:C0988550": [
                        "perphenazine 2 MG"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the control of severe nausea and vomiting in adults",
                "id": {}
            }
        ]
    ],
    "In acute alcohol withdrawal, diazepam may be useful in the symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis.": [
        [
            {
                "label": "diazepam",
                "id": {
                    "PUBCHEM.COMPOUND:3016": [
                        "Diazepam",
                        "DiazePAM",
                        "diazepam",
                        "DIAZEPAM",
                        "diazePAM",
                        "Diazepam product",
                        "Diazepam (substance)",
                        "diazepam (medication)",
                        "Diazepam-containing product",
                        "Product containing diazepam (medicinal product)",
                        "Valium",
                        "Valium",
                        "Seduxen",
                        "Faustan",
                        "Apaurin",
                        "Diastat",
                        "Sibazon",
                        "Relanium",
                        "Stesolid",
                        "Diazemuls",
                        "Methyldiazepinone",
                        "Methyl diazepinone",
                        "Methyl diazepinone",
                        "methyl diazepinone",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-"
                    ],
                    "PUBCHEM.COMPOUND:129818764": [
                        "Diazepamon"
                    ],
                    "PUBCHEM.COMPOUND:12205124": [
                        "Diazepam-d3"
                    ],
                    "PUBCHEM.COMPOUND:45358967": [
                        "Diazepam-d5"
                    ],
                    "PUBCHEM.COMPOUND:165361942": [
                        "Diazepam-d8"
                    ]
                }
            },
            {
                "label": "may be useful in",
                "id": {}
            },
            {
                "label": "symptomatic relief",
                "id": {
                    "UMLS:C3242309": [
                        "symptomatic relief"
                    ],
                    "UMLS:C4543682": [
                        "Symptomatic relief on limb elevation",
                        "Relief of symptom on limb elevation",
                        "Relief of symptom on limb elevation (finding)"
                    ]
                }
            }
        ],
        [
            {
                "label": "diazepam",
                "id": {
                    "PUBCHEM.COMPOUND:3016": [
                        "Diazepam",
                        "DiazePAM",
                        "diazepam",
                        "DIAZEPAM",
                        "diazePAM",
                        "Diazepam product",
                        "Diazepam (substance)",
                        "diazepam (medication)",
                        "Diazepam-containing product",
                        "Product containing diazepam (medicinal product)",
                        "Valium",
                        "Valium",
                        "Seduxen",
                        "Faustan",
                        "Apaurin",
                        "Diastat",
                        "Sibazon",
                        "Relanium",
                        "Stesolid",
                        "Diazemuls",
                        "Methyldiazepinone",
                        "Methyl diazepinone",
                        "Methyl diazepinone",
                        "methyl diazepinone",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-"
                    ],
                    "PUBCHEM.COMPOUND:129818764": [
                        "Diazepamon"
                    ],
                    "PUBCHEM.COMPOUND:12205124": [
                        "Diazepam-d3"
                    ],
                    "PUBCHEM.COMPOUND:45358967": [
                        "Diazepam-d5"
                    ],
                    "PUBCHEM.COMPOUND:165361942": [
                        "Diazepam-d8"
                    ]
                }
            },
            {
                "label": "may be useful in",
                "id": {}
            },
            {
                "label": "acute agitation",
                "id": {
                    "UMLS:C0865397": [
                        "Agitation states as acute reaction to gross stress"
                    ],
                    "UMLS:C0865396": [
                        "Agitation states as acute reaction to exceptional stress"
                    ]
                }
            }
        ],
        [
            {
                "label": "diazepam",
                "id": {
                    "PUBCHEM.COMPOUND:3016": [
                        "Diazepam",
                        "DiazePAM",
                        "diazepam",
                        "DIAZEPAM",
                        "diazePAM",
                        "Diazepam product",
                        "Diazepam (substance)",
                        "diazepam (medication)",
                        "Diazepam-containing product",
                        "Product containing diazepam (medicinal product)",
                        "Valium",
                        "Valium",
                        "Seduxen",
                        "Faustan",
                        "Apaurin",
                        "Diastat",
                        "Sibazon",
                        "Relanium",
                        "Stesolid",
                        "Diazemuls",
                        "Methyldiazepinone",
                        "Methyl diazepinone",
                        "Methyl diazepinone",
                        "methyl diazepinone",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-"
                    ],
                    "PUBCHEM.COMPOUND:129818764": [
                        "Diazepamon"
                    ],
                    "PUBCHEM.COMPOUND:12205124": [
                        "Diazepam-d3"
                    ],
                    "PUBCHEM.COMPOUND:45358967": [
                        "Diazepam-d5"
                    ],
                    "PUBCHEM.COMPOUND:165361942": [
                        "Diazepam-d8"
                    ]
                }
            },
            {
                "label": "may be useful in",
                "id": {}
            },
            {
                "label": "tremor",
                "id": {
                    "NCIT:C146780": [
                        "Tremor",
                        "Tremor, CTCAE_5",
                        "Tremor, CTCAE 5.0"
                    ],
                    "HP:0001337": [
                        "tremor",
                        "Tremor",
                        "TREMOR",
                        "tremors",
                        "TREMORS",
                        "Tremors",
                        "d tremors",
                        "Tremor NOS",
                        "Tremor, NOS",
                        "Has a tremor",
                        "A46-A47 TREMORS",
                        "Shaking/Tremors",
                        "Tremor (finding)",
                        "tremor (diagnosis)",
                        "tremors as symptom",
                        "Tremor, unspecified",
                        "tremor (physical finding)",
                        "motor exam involuntary movements tremor trembles",
                        "involuntary shaking or trembling movements (tremor)",
                        "shake",
                        "quiver",
                        "Shakes",
                        "shakes",
                        "quivers",
                        "Shaking",
                        "SHAKING",
                        "tremble",
                        "Tremble",
                        "shaking",
                        "Trembled",
                        "Trembles",
                        "trembles",
                        "Quivered",
                        "quivering",
                        "trembling",
                        "Quivering",
                        "TREMULOUS",
                        "tremulous",
                        "TREMBLING",
                        "Trembling",
                        "the shakes",
                        "The shakes",
                        "Shaking all over",
                        "Involuntary quiver",
                        "Trembles (finding)",
                        "Involuntary Quiver",
                        "Involuntary shaking",
                        "Involuntary Quivers",
                        "Quiver, Involuntary",
                        "Involuntary trembling",
                        "trembles (physical finding)",
                        "involuntary shaking or trembling movements",
                        "involuntary shaking or trembling movements (symptom)"
                    ],
                    "NCIT:C55596": [
                        "Tremor",
                        "Tremor, CTCAE_3",
                        "Tremor, CTCAE 3.0"
                    ],
                    "HMDB:HMDB0242736": [
                        "Tremortin",
                        "Tremortin b",
                        "Tremortin a",
                        "Penitrems",
                        "Penitrem e",
                        "penitrem A",
                        "Penitrem D",
                        "Penitrem b"
                    ],
                    "PUBCHEM.COMPOUND:337313": [
                        "tremortin",
                        "Tremortin A",
                        "penitrem"
                    ]
                }
            }
        ],
        [
            {
                "label": "diazepam",
                "id": {
                    "PUBCHEM.COMPOUND:3016": [
                        "Diazepam",
                        "DiazePAM",
                        "diazepam",
                        "DIAZEPAM",
                        "diazePAM",
                        "Diazepam product",
                        "Diazepam (substance)",
                        "diazepam (medication)",
                        "Diazepam-containing product",
                        "Product containing diazepam (medicinal product)",
                        "Valium",
                        "Valium",
                        "Seduxen",
                        "Faustan",
                        "Apaurin",
                        "Diastat",
                        "Sibazon",
                        "Relanium",
                        "Stesolid",
                        "Diazemuls",
                        "Methyldiazepinone",
                        "Methyl diazepinone",
                        "Methyl diazepinone",
                        "methyl diazepinone",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-"
                    ],
                    "PUBCHEM.COMPOUND:129818764": [
                        "Diazepamon"
                    ],
                    "PUBCHEM.COMPOUND:12205124": [
                        "Diazepam-d3"
                    ],
                    "PUBCHEM.COMPOUND:45358967": [
                        "Diazepam-d5"
                    ],
                    "PUBCHEM.COMPOUND:165361942": [
                        "Diazepam-d8"
                    ]
                }
            },
            {
                "label": "may be useful in",
                "id": {}
            },
            {
                "label": "impending or acute delirium tremens",
                "id": {}
            }
        ],
        [
            {
                "label": "diazepam",
                "id": {
                    "PUBCHEM.COMPOUND:3016": [
                        "Diazepam",
                        "DiazePAM",
                        "diazepam",
                        "DIAZEPAM",
                        "diazePAM",
                        "Diazepam product",
                        "Diazepam (substance)",
                        "diazepam (medication)",
                        "Diazepam-containing product",
                        "Product containing diazepam (medicinal product)",
                        "Valium",
                        "Valium",
                        "Seduxen",
                        "Faustan",
                        "Apaurin",
                        "Diastat",
                        "Sibazon",
                        "Relanium",
                        "Stesolid",
                        "Diazemuls",
                        "Methyldiazepinone",
                        "Methyl diazepinone",
                        "Methyl diazepinone",
                        "methyl diazepinone",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-"
                    ],
                    "PUBCHEM.COMPOUND:129818764": [
                        "Diazepamon"
                    ],
                    "PUBCHEM.COMPOUND:12205124": [
                        "Diazepam-d3"
                    ],
                    "PUBCHEM.COMPOUND:45358967": [
                        "Diazepam-d5"
                    ],
                    "PUBCHEM.COMPOUND:165361942": [
                        "Diazepam-d8"
                    ]
                }
            },
            {
                "label": "may be useful in",
                "id": {}
            },
            {
                "label": "hallucinosis",
                "id": {
                    "UMLS:C0233777": [
                        "HALLUCINOSIS",
                        "Hallucinosis",
                        "hallucinosis",
                        "Hallucinosis (finding)"
                    ],
                    "UMLS:C0679301": [
                        "AODR hallucinosis",
                        "Alcohol or Other Drug Related hallucinosis"
                    ],
                    "UMLS:C0302369": [
                        "ALCOHOL HALLUCINOSIS",
                        "Alcohol hallucinosis",
                        "alcohol hallucinosis",
                        "hallucinosis; alcohol",
                        "alcohol; hallucinosis",
                        "alcoholic hallucinosis",
                        "Alcoholic hallucinosis",
                        "Alcoholic Hallucinosis",
                        "Alcohol induced hallucinosis",
                        "Acute alcoholic hallucinosis",
                        "alcohol withdrawal hallucinosis",
                        "Alcohol Withdrawal Hallucinosis",
                        "Alcohol hallucinosis (disorder)",
                        "ALCOHOL WITHDRAWAL HALLUCINOSIS",
                        "Alcohol withdrawal hallucinosis",
                        "Hallucinosis, Alcohol Withdrawal",
                        "psychosis; alcoholic, hallucinosis",
                        "Alcoholic psychosis with hallucinosis",
                        "Alcohol withdrawal hallucinosis (disorder)",
                        "Alcohol withdrawal hallucinosis (diagnosis)",
                        "alcohol-induced psychotic disorder during withdrawal hallucinosis",
                        "Alcoh psy dis w hallucin",
                        "Alcohol withdrawal hallucinos.",
                        "Alcohol-induced psychotic disorder with hallucinations",
                        "alcohol-induced psychotic disorder with hallucinations",
                        "alcohol-induced psychotic disorder with hallucinations (diagnosis)"
                    ],
                    "UMLS:C0029226": [
                        "Organic hallucinosis",
                        "organic hallucinosis",
                        "HALLUCINOSIS ORGANIC",
                        "hallucinosis; organic",
                        "Organic hallucinosis, NOS",
                        "Organic hallucinosis syndrome",
                        "organic hallucinosis syndrome",
                        "Organic hallucinosis (disorder)",
                        "Organic hallucinosis (diagnosis)",
                        "organic; hallucinosis (nonalcoholic)",
                        "organic mental disorder of unknown etiology hallucinosis",
                        "Organic Hallucination",
                        "organic hallucinations",
                        "Hallucination, Organic",
                        "Organic Hallucinations",
                        "ORGANIC HALLUCINATIONS",
                        "hallucination; organic",
                        "Hallucinations, Organic",
                        "Psy dis w halluc oth dis",
                        "Organic hallucinatory state (nonalcoholic)",
                        "organic; hallucinatory state (nonalcoholic)",
                        "state; organic, hallucinatory (nonalcoholic)",
                        "Transient organic psychotic condition, hallucinatory type",
                        "Psychotic disorder with hallucinations in conditions classified elsewhere"
                    ],
                    "UMLS:C0242004": [
                        "MUSHROOM HALLUCINOSIS",
                        "MUSHROOM HALLUCINATIONS"
                    ]
                }
            }
        ]
    ],
    "Fluphenazine Decanoate Injection, USP is a long-acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g., chronic schizophrenics).": [
        [
            {
                "label": "Fluphenazine Decanoate Injection, USP",
                "id": {}
            },
            {
                "label": "is",
                "id": {
                    "UBERON:0002872": [
                        "IS",
                        "inferior salivary nucleus",
                        "Nucleus salivarius inferior",
                        "nucleus salivarius inferior",
                        "Inferior salivatory nucleus",
                        "inferior salivatary nucleus",
                        "inferior salivatory nucleus",
                        "Nucleus salivatorius inferior",
                        "nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior",
                        "Nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior nervi glossopharyngei",
                        "Nucleus salivatorius inferior nervi glossopharyngei"
                    ],
                    "OMIM:146850": [
                        "IS",
                        "ISCW",
                        "ISSCW",
                        "IMMUNE SUPPRESSION",
                        "STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO"
                    ],
                    "FB:FBgn0001274": [
                        "Is"
                    ],
                    "PUBCHEM.COMPOUND:7021816": [
                        "IS",
                        "isoleucylserine",
                        "Isoleucyl-Serine",
                        "L-isoleucyl-L-serine",
                        "Ile-Ser",
                        "L-Ile-L-Ser",
                        "CHEMBL56803"
                    ],
                    "UMLS:C0021632": [
                        "IS",
                        "INSTRUM",
                        "instrumentation",
                        "instrumentation aspects"
                    ]
                }
            },
            {
                "label": "a long-acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy",
                "id": {}
            }
        ]
    ],
    "Phenelzine Sulfate Tablets, USP has been found to be effective in depressed patients clinically characterized as \"atypical,\" \"nonendogenous,\" or \"neurotic.\"": [
        [
            {
                "label": "Phenelzine Sulfate Tablets, USP",
                "id": {}
            },
            {
                "label": "has been found to be effective in",
                "id": {}
            },
            {
                "label": "depressed patients clinically characterized as \"atypical,\" \"nonendogenous,\" or \"neurotic.\"",
                "id": {}
            }
        ]
    ],
    "These patients often have mixed anxiety and depression and phobic or hypochondriacal features.": [
        [
            {
                "label": "These patients",
                "id": {
                    "UMLS:C0508953": [
                        "Assist patients in identifying inadequate and harmful care arrangements, and help them and their family members identify mechanisms for addressing these problems"
                    ]
                }
            },
            {
                "label": "have",
                "id": {
                    "UMLS:C3154893": [
                        "Have",
                        "Possess"
                    ],
                    "UMLS:C3539897": [
                        "Have",
                        "Had",
                        "Has"
                    ],
                    "UniProtKB:Q9NQS1": [
                        "hAVEN",
                        "AVEN",
                        "cell death regulator Aven (human)"
                    ],
                    "UMLS:C1226488": [
                        "Havetia"
                    ],
                    "UMLS:C2984058": [
                        "Have Pain",
                        "Have Any Pain",
                        "Had Pain"
                    ]
                }
            },
            {
                "label": "mixed anxiety and depression",
                "id": {}
            }
        ],
        [
            {
                "label": "These patients",
                "id": {
                    "UMLS:C0508953": [
                        "Assist patients in identifying inadequate and harmful care arrangements, and help them and their family members identify mechanisms for addressing these problems"
                    ]
                }
            },
            {
                "label": "have",
                "id": {
                    "UMLS:C3154893": [
                        "Have",
                        "Possess"
                    ],
                    "UMLS:C3539897": [
                        "Have",
                        "Had",
                        "Has"
                    ],
                    "UniProtKB:Q9NQS1": [
                        "hAVEN",
                        "AVEN",
                        "cell death regulator Aven (human)"
                    ],
                    "UMLS:C1226488": [
                        "Havetia"
                    ],
                    "UMLS:C2984058": [
                        "Have Pain",
                        "Have Any Pain",
                        "Had Pain"
                    ]
                }
            },
            {
                "label": "phobic or hypochondriacal features",
                "id": {}
            }
        ]
    ],
    "Rather, it is more suitable for use with patients who have failed to respond to the drugs more commonly used for these conditions.": [
        [
            {
                "label": "it",
                "id": {
                    "MGI:96598": [
                        "It"
                    ],
                    "PUBCHEM.COMPOUND:44298493": [
                        "IT",
                        "IT dipeptide",
                        "I-T",
                        "Ile-Thr",
                        "CHEMBL54609",
                        "I-T dipeptide",
                        "isoleucylthreonine",
                        "L-Isoleucyl-L-threonine",
                        "L-isoleucyl-L-threonine",
                        "isoleucine threonine dipeptide",
                        "(2S,3R)-2-{[(2S,3S)-2-amino-3-methylpentanoyl]amino}-3-hydroxybutanoic acid"
                    ],
                    "UMLS:C0677897": [
                        "IT",
                        "IT - Intrathecal route",
                        "intrathecal",
                        "Intrathecal",
                        "Intrathecal use",
                        "IntrathecalRoute",
                        "Intrathecal route",
                        "into the spinal space",
                        "Intrathecal route (qualifier value)",
                        "Intrathecal Route of Administration",
                        "Intrathecal Route of Drug Administration"
                    ],
                    "MONDO:0008558": [
                        "itp",
                        "ITP",
                        "ITP, NOS",
                        "ITP - Idiopat thrombocytop pur",
                        "ITP (immune thrombocytopenic purpura)",
                        "Idiopathic thrombocytopenic purpura (ITP)",
                        "ITP (idiopathic thrombocytopenic purpura)",
                        "idiopathic thrombocytopenic purpura (ITP)",
                        "ITP - Idiopathic thrombocytopenic purpura",
                        "AITP",
                        "AITP",
                        "Frank",
                        "Werlhof",
                        "WERLHOF DIS",
                        "WERLHOFS DIS",
                        "Werlhof Disease",
                        "WERLHOF DISEASE",
                        "Werlhofs Disease",
                        "Disease, Werlhof",
                        "werlhof's disease",
                        "Werlhof's Disease",
                        "Werlhof's disease",
                        "Werlhof's disease",
                        "werlhof's disease",
                        "Idiopathic purpura",
                        "Idiopathic purpura",
                        "Werlhof's syndrome",
                        "idiopathic purpura",
                        "idiopathic purpura",
                        "Disease, Werlhof's",
                        "purpura; idiopathic",
                        "idiopathic; purpura",
                        "Immune thrombocytopenia",
                        "Immune Thrombocytopenia",
                        "immune thrombocytopenia",
                        "Idiopathic purpura, NOS",
                        "Thrombocytopenia, Immune",
                        "Immune Thrombocytopenias",
                        "Immune thrombocyt purpra",
                        "Thrombocytopenias, Immune",
                        "Idiopathic Thrombocytopenia",
                        "Autoimmune Thrombocytopenia",
                        "idiopathic thrombocytopenia",
                        "Autoimmune Thrombocytopenias",
                        "Thrombocytopenia, Autoimmune",
                        "Thrombocytopenias, Autoimmune",
                        "Ideopath thrombocytopenic pur",
                        "ideopath thrombocytopenic pur",
                        "Idiopath thrombocytopen purpur",
                        "Autoimmune thrombocytopen purp",
                        "Immune thrombocytopenic purpur",
                        "Idiopath Thrombocytopenic Purp",
                        "immune purpura thrombocytopenic",
                        "thrombocytopenic purpura immune",
                        "Primary immune thrombocytopenia",
                        "Immune thrombocytopenic purpura",
                        "IMMUNE THROMBOCYTOPENIC PURPURA",
                        "immune thrombocytopenic purpura",
                        "Immune thrombocytopenic purpura",
                        "Primary Immune Thrombocytopenia",
                        "Immune Thrombocytopenic Purpura",
                        "immune thrombocytopenic purpura",
                        "primary thrombocytopenic purpura",
                        "primary thrombocytopenic purpura",
                        "Immune Thrombocytopenic Purpuras",
                        "Thrombocytopenic Purpura, Immune",
                        "Purpura, Immune Thrombocytopenic",
                        "Thrombocytopenic Purpuras, Immune",
                        "Purpuras, Immune Thrombocytopenic",
                        "IDIOPATHIC THROMBOCYTOPENIC PURPURA",
                        "idiopathic thrombocytopenic purpura",
                        "Idiopathic thrombocytopenia purpura",
                        "idiopathic thrombocytopenia purpura",
                        "Idiopathic Thrombocytopenic Purpura",
                        "autoimmune thrombocytopenic purpura",
                        "idiopathic thrombocytopenic purpura",
                        "thrombocytopenic purpura autoimmune",
                        "autoimmune thrombocytopenic purpura",
                        "Autoimmune thrombocytopenic purpura",
                        "Idiopathic Thrombocytopenia Purpura",
                        "Idiopathic thrombocytopenic purpura",
                        "Autoimmune Thrombocytopenic Purpura",
                        "THROMBOCYTOPENIC PURPURA, AUTOIMMUNE",
                        "Idiopathic Thrombocytopenic Purpuras",
                        "Autoimmune Thrombocytopenic Purpuras",
                        "Thrombocytopenic Purpura, Idiopathic",
                        "Purpura, Autoimmune Thrombocytopenic",
                        "thrombocytopenic purpura, autoimmune",
                        "Thrombocytopenic Purpura, Autoimmune",
                        "Purpura, Idiopathic Thrombocytopenic",
                        "thrombocytopenic; purpura, idiopathic",
                        "Purpuras, Autoimmune Thrombocytopenic",
                        "PURPURA, THROMBOCYTOPENIC, IDIOPATHIC",
                        "purpura; thrombocytopenic, idiopathic",
                        "Thrombocytopenic Purpuras, Idiopathic",
                        "Purpura, Thrombocytopenic, Idiopathic",
                        "Purpuras, Idiopathic Thrombocytopenic",
                        "Purpura, Thrombocytopenic, Autoimmune",
                        "Idiopathic thrombocytopenic purpura, NOS",
                        "immune thrombocytopenic purpura (diagnosis)",
                        "idiopathic thrombocytopenic purpura (diagnosis)"
                    ],
                    "MGI:3716200": [
                        "ita"
                    ]
                }
            },
            {
                "label": "is more suitable for use with",
                "id": {}
            },
            {
                "label": "patients who have failed to respond to the drugs more commonly used for these conditions",
                "id": {}
            }
        ]
    ],
    "Milnacipran HCl tablets are indicated for the management of fibromyalgia.": [
        [
            {
                "label": "Milnacipran HCl tablets",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the management of fibromyalgia",
                "id": {}
            }
        ]
    ],
    "Milnacipran HCl tablets are not approved for use in pediatric patients": [
        [
            {
                "label": "Milnacipran HCl tablets",
                "id": {}
            },
            {
                "label": "are not approved for use in",
                "id": {}
            },
            {
                "label": "pediatric patients",
                "id": {
                    "UMLS:C3533257": [
                        "Pediatric - patients with brain cancer - child questionnaire - version 2"
                    ],
                    "UMLS:C3533258": [
                        "Pediatric - patients with brain cancer - adolescent questionnaire - version 2"
                    ],
                    "UMLS:C3533255": [
                        "Pediatric - patients with brain cancer - parent_child questionnaire - version 1"
                    ],
                    "UMLS:C3533256": [
                        "Pediatric - patients with brain cancer - parent_adolescent questionnaire - version 1"
                    ],
                    "UMLS:C3483399": [
                        "Pediatric - patients with brain cancer - child questionnaire - version 2:-:Pt:^Patient:-:FACIT",
                        "Pediatric - patients with brain cancer - Child Questionnaire - version 2 (Peds-FACT-Br - child) [FACIT]",
                        "Pediatric - patients with brain cancer - child questionnaire - version 2:-:To identify measures at a point in time:^Patient:-:FACIT"
                    ]
                }
            }
        ]
    ],
    "Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety.": [
        [
            {
                "label": "Meprobamate tablets",
                "id": {
                    "UMLS:C1246835": [
                        "Meprobamate Tablets",
                        "meprobamate Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the management of anxiety disorders",
                "id": {}
            }
        ],
        [
            {
                "label": "Meprobamate tablets",
                "id": {
                    "UMLS:C1246835": [
                        "Meprobamate Tablets",
                        "meprobamate Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the short-term relief of the symptoms of anxiety",
                "id": {}
            }
        ]
    ],
    "Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic.": [
        [
            {
                "label": "Anxiety or tension",
                "id": {
                    "UMLS:C4712861": [
                        "Watch for signs of anxiety or fear (e.g., irritability, tension, worry, fear of movement)"
                    ],
                    "UMLS:C3175150": [
                        "Do you experience frustration, tension or anxiety over not being able to go to sleep during the night when you cannot fall asleep"
                    ],
                    "UMLS:C3175149": [
                        "Do you experience frustration, tension or anxiety over not being able to go to sleep during the night when you cannot fall asleep [PhenX]",
                        "Do you experience frustration, tension or anxiety over not being able to go to sleep during the night when you cannot fall asleep:Find:Pt:^Patient:Ord:PhenX",
                        "Do you experience frustration, tension or anxiety over not being able to go to sleep during the night when you cannot fall asleep:Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX",
                        "Difficulty anxiety PhenX"
                    ],
                    "UMLS:C4256679": [
                        "CHASTE TREE 6 [hp_X] in 1 mL / AVENA SATIVA FLOWERING TOP 1 [hp_X] in 1 mL / CINCHONA OFFICINALIS BARK 6 [hp_X] in 1 mL / HOPS 2 [hp_X] in 1 mL / HYOSCYAMUS NIGER 200 [hp_C] in 1 mL / STRYCHNOS IGNATII SEED 200 [hp_C] in 1 mL / PASSIFLORA INCARNATA TOP 3 [hp_X] in 1 mL / VALERIAN 3 [hp_X] in 1 mL ORAL SPRAY [Anxiety plus Tension]"
                    ]
                }
            },
            {
                "label": "associated with",
                "id": {
                    "UMLS:C0332281": [
                        "associated with",
                        "ASSOCIATED WITH",
                        "Associated with",
                        "Associated with (attribute)",
                        "AW",
                        "ASSOC",
                        "associated",
                        "Associated",
                        "associating"
                    ],
                    "UMLS:C1608982": [
                        "Associated with (APAH)"
                    ],
                    "UMLS:C2029691": [
                        "headache associated with",
                        "headache associated",
                        "headache associated factor",
                        "headache associated factor (symptom)"
                    ],
                    "HP:0033705": [
                        "Crying associated with mood",
                        "Crying associated with emotion",
                        "Crying associated with mood (finding)",
                        "weep",
                        "Weepy",
                        "Weeps",
                        "weepy",
                        "weeping",
                        "tearful",
                        "WEEPING",
                        "Weeping",
                        "Tearful",
                        "Weepiness",
                        "weepiness",
                        "Tearfulness",
                        "affect tearful",
                        "tearful (physical finding)"
                    ],
                    "NCBIGene:23077": [
                        "PROTEIN ASSOCIATED WITH MYC",
                        "PAM",
                        "PAM",
                        "PHR1",
                        "PHR1",
                        "MYCBP2",
                        "FLJ10106",
                        "KIAA0916",
                        "FLJ10106",
                        "KIAA0916",
                        "MYCBP2 gene",
                        "MYCBP2 Gene",
                        "MYC-BINDING PROTEIN 2",
                        "MYC binding protein 2",
                        "MYC Binding Protein 2 Gene",
                        "PAM/Highwire/RPM-1 protein 1",
                        "PAM/Highwire/RPM-1 protein 1",
                        "MYC binding protein 2, E3 ubiquitin protein ligase"
                    ]
                }
            },
            {
                "label": "the stress of everyday life",
                "id": {}
            }
        ],
        [
            {
                "label": "Anxiety or tension",
                "id": {
                    "UMLS:C4712861": [
                        "Watch for signs of anxiety or fear (e.g., irritability, tension, worry, fear of movement)"
                    ],
                    "UMLS:C3175150": [
                        "Do you experience frustration, tension or anxiety over not being able to go to sleep during the night when you cannot fall asleep"
                    ],
                    "UMLS:C3175149": [
                        "Do you experience frustration, tension or anxiety over not being able to go to sleep during the night when you cannot fall asleep [PhenX]",
                        "Do you experience frustration, tension or anxiety over not being able to go to sleep during the night when you cannot fall asleep:Find:Pt:^Patient:Ord:PhenX",
                        "Do you experience frustration, tension or anxiety over not being able to go to sleep during the night when you cannot fall asleep:Finding:To identify measures at a point in time:^Patient:Ordinal:PhenX",
                        "Difficulty anxiety PhenX"
                    ],
                    "UMLS:C4256679": [
                        "CHASTE TREE 6 [hp_X] in 1 mL / AVENA SATIVA FLOWERING TOP 1 [hp_X] in 1 mL / CINCHONA OFFICINALIS BARK 6 [hp_X] in 1 mL / HOPS 2 [hp_X] in 1 mL / HYOSCYAMUS NIGER 200 [hp_C] in 1 mL / STRYCHNOS IGNATII SEED 200 [hp_C] in 1 mL / PASSIFLORA INCARNATA TOP 3 [hp_X] in 1 mL / VALERIAN 3 [hp_X] in 1 mL ORAL SPRAY [Anxiety plus Tension]"
                    ]
                }
            },
            {
                "label": "do not require",
                "id": {
                    "UMLS:C3845093": [
                        "Patient does not require assistance"
                    ],
                    "UMLS:C2016252": [
                        "pacemaker summary: settings do not require adjustment",
                        "pacemaker evaluation summary settings do not require adjustment",
                        "pacemaker evaluation summary settings do not require adjustment (procedure)"
                    ],
                    "UMLS:C5574464": [
                        "Clinician determines patient does not require referral",
                        "Clin pt no ref"
                    ],
                    "UMLS:C2016249": [
                        "pacemaker evaluation settings do not require further adjustment",
                        "post-adjustment summary: pacemaker does not require further adjustment",
                        "pacemaker evaluation settings do not require further adjustment (procedure)"
                    ],
                    "UMLS:C5420510": [
                        "Missed Medicine Dose Because Food Requirements Could Not be Met",
                        "Food Requirements Could Not be Met"
                    ]
                }
            },
            {
                "label": "treatment with an anxiolytic",
                "id": {}
            }
        ]
    ],
    "For temporary relief of symptoms related to sleep disorders, Seasonal Affective Disorder, jet lag, and depression.": [
        [
            {
                "label": "temporary relief",
                "id": {
                    "UMLS:C3186998": [
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Care One arthritis pain relief temporary minor]",
                        "ACETAMINOPHEN 650MG TAB,SA",
                        "ACETAMINOPHEN 650MG SA TAB",
                        "ACETAMINOPHEN 650 mg ORAL TABLET",
                        "8 HR APAP 650 MG Extended Release Oral Tablet",
                        "Acetaminophen 650mg Oral tablet, extended release",
                        "Pain Relief, 650 mg oral tablet, extended release",
                        "GNP Arthritis Pain Relief Extended-Release Caplet",
                        "Acetaminophen 650mg Oral tablet, biphasic release",
                        "Leader 8HR Arthritis Pain Extended-Release Caplet",
                        "acetaminophen 650 mg ORAL TABLET, EXTENDED RELEASE",
                        "acetaminophen 650 mg oral tablet, extended release",
                        "acetaminophen@650 mg@ORAL@TABLET, EXTENDED RELEASE",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE",
                        "Pain Reliever, 650 mg oral tablet, extended release",
                        "Sunmark Pain Reliever 650mg Extended-Release Caplet",
                        "Acetaminophen, 650 mg oral tablet, extended release",
                        "CVS 8 Hour Pain Relief 650mg Extended-Release Caplet",
                        "acetaminophen 650 MG 8HR Extended Release Oral Tablet",
                        "Health Mart Pain Relief 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Muscle Pain Relief]",
                        "Leader Arthritis Pain Reliever Extended-Release Caplet",
                        "GNP Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "acetaminophen 650 MG 8 HR Extended Release Oral Tablet",
                        "8 HR acetaminophen 650 MG Extended Release Oral Tablet",
                        "CVS Arthritis Pain Relief 650mg Extended-Release Geltab",
                        "CVS Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [ArthritisPain Relief]",
                        "Walgreens Arthritis Pain Relief Extended-Release Caplet",
                        "Midol Long Lasting Relief 650mg Extended-Release Caplet",
                        "GNP Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Sunmark 8 Hour Pain Relief 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [HEB]",
                        "GNP 8HR Muscle Aches & Pain 650mg Extended-Release Caplet",
                        "Leader 8 Hour Pain Reliever 650mg Extended-Release Caplet",
                        "Top Care 8 Hour Pain Relief 650mg Extended-Release Caplet",
                        "CVS 8HR Muscle Aches & Pain 650mg Extended-Release Caplet",
                        "Publix Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Select Brand Arthritis Pain Relief Extended-Release Caplet",
                        "GoodSense 8 Hour Pain Relief 650mg Extended-Release Caplet",
                        "CVS 8HR Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "RITE AID Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "Sunmark Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Arthritis Pain Relief, 650 mg oral tablet, extended release",
                        "Leader Arthritis Pain Reliever 650mg Extended-Release Geltab",
                        "Walgreens Acetaminophen 8-Hour 650mg Extended-Release Caplet",
                        "RITE AID Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Top Care Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Walgreens 8-Hour Pain Reliever 650mg Extended-Release Caplet",
                        "Walgreens Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "GoodSense Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Walgreens Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Premier Value Non-Aspirin 8 Hour 650mg Extended-Release Caplet",
                        "Acetaminophen 8-hr Relief, 650 mg oral tablet, extended release",
                        "8-Hour Acetaminophen E.R., 650 mg oral tablet, extended release",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Arthritis Pain Acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE",
                        "Health Mart Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Walgreens Arthritis Pain Reliever 650mg Extended-Release Caplet",
                        "Walgreens Arthritis Pain Reliever 650mg Extended-Release Geltab",
                        "Premier Value Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Acetaminophen Extended Release]",
                        "Quality Choice Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Acetaminophen Extended-Release]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Acetamiophen]",
                        "Leader 8 Hour Pain Reliever, 650 mg oral tablet, extended release",
                        "Premier Value Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Premier Value Arthritis Pain Relief 650mg Extended-Release Geltab",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Acetaminophen]",
                        "Today's Health Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Arthritis Pain]",
                        "Acetaminophen Extended-Release, 650 mg oral tablet, extended release",
                        "Arthritis Pain Extended Release, 650 mg oral tablet, extended release",
                        "GNP Acetaminophen 8 Hour Arthritis Pain 650mg Extended-Release Tablet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [8HR Arthritis Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [8 Hour Pain Relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [8 HOUR PAIN RELIEF]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [ACETAMINOPHEN AVPAK]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [arthritis pain relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [ARTHRITIS PAIN RELIEF]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [SUNMARK PAIN RELIEVER]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [8 Hour Arthritis Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Arthritis Pain Relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD SENSE PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Arthritis Pain Reliever Extended Release]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [eight hour pain relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [8HR MUSCLE ACHES & PAIN]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Pain Relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD SENSE ARTHRITIS PAIN]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Midol Long Lasting Relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [OHM ARTHRITIS PAIN RELIEF]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [LEADER 8HR ARTHRITIS PAIN]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [8HR ARTHRITIS PAIN RELIEF]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [TOPCARE 8 HOUR PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Arthritis Pain]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [LEADER 8 HOUR PAIN RELIEVER]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [arthritis pain]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [TOPCARE ARTHRITIS PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Pain Relief 8 HR]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [ACETAMINOPHEN ER]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [LEADER ARTHRITIS PAIN RELIEVER]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [LEADER 8HR MUSCLE ACHES & PAIN]",
                        "Quality Choice Arthritis Pain Relief Acetaminophen 8HR 650mg Extended-Release Tablet",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [SUNMARK ARTHRITIS PAIN RELIEVER]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [major acetaminophen]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [HEALTH MART ARTHRITIS PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Sunmark pain reliever]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD NEIGHBOR PHARMACY PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Good Sense Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [up and up acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [health mart pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [arthritis pain reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Up and Up acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [basic care acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Premier Value Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Basic Care Acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Sunmark Arthritis 8 Hour]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Leader 8HR Arthritis Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [8HR muscle aches and pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [8HR Arthritis Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [CareOne 8 Hour Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Topcare 8 Hour Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [care one pain relief 8 hour]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Acetaminophen - APAP 8 Hour]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [members mark arthritis pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Leader 8 Hour Pain Reliever]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD NEIGHBOR PHARMACY 8 HOUR PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Harris Teeter Arthritis Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [DG Health 8 Hour Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Acetaminophen Extended Release]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Leader Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Premier Value Arthritis 8 Hour]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Acetaminophen - APAP Arthritis]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD NEIGHBOR PHARMACY ARTHRITIS PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [dg health arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Sunmark Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Equate 8HR Arthritis Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Acetaminophen Extended-Release Tablets, 650 mg]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Leader 8 HR Muscle Aches and Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Health Mart arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [good neighbor pharmacy pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [topcare 8 hr arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [dg health 8 hr arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [good sense pain relief arthritis pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Premier Value Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Berkley and Jensen Arthritis Pain Relief]"
                    ],
                    "UMLS:C0937220": [
                        "CAPSAICIN 0.25 mg in 1 mL / MENTHOL 100 mg in 1 mL / METHYL SALICYLATE 150 mg in 1 mL TOPICAL CREAM [ZENSEZONE Arthmed Temporary Pain Relief Cream]",
                        "capsaicin 0.025 % / menthol 10 % / methyl salicylate 15 % Topical Cream",
                        "capsaicin 0.25 MG/ML / menthol 100 MG/ML / methyl salicylate 150 MG/ML Topical Cream",
                        "METHYL SALICYLATE 150 mg in 1 mL / MENTHOL 100 mg in 1 mL / CAPSAICIN 0.25 mg in 1 mL TOPICAL CREAM [Arthmed Topical Analgesic]"
                    ],
                    "UMLS:C3504593": [
                        "ATROPA BELLADONNA 6 [hp_C] / BRYONIA ALBA ROOT 6 [hp_C] / CAUSTICUM 6 [hp_C] / PHOSPHORUS 6 [hp_C] / STRYCHNOS NUX-VOMICA SEED 6 [hp_C] / PULSATILLA VULGARIS 6 [hp_C] / TOXICODENDRON PUBESCENS LEAF 6 [hp_C] ORAL TABLET, ORALLY DISINTEGRATING [Temporary Fibromyalgia Pain and Discomfort Relief]"
                    ]
                }
            },
            {
                "label": "is for",
                "id": {
                    "CHEBI:140821": [
                        "iso-Forssman",
                        "i-Forssman",
                        "isogloboside iGb5Cer",
                        "alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer",
                        "N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide"
                    ],
                    "UMLS:C1552560": [
                        "is backup for"
                    ],
                    "PUBCHEM.COMPOUND:8052": [
                        "Isoamyl formate",
                        "Isoamyl formate",
                        "isoamyl formate",
                        "ISOAMYL FORMATE",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formic acid",
                        "Formate, isopentyl ester",
                        "Isopentyl alcohol, formate",
                        "Formic acid, isopentyl ester",
                        "Formic acid, isopentyl ester",
                        "Isoamyl methanoate",
                        "Isoamyl methanoate",
                        "Isopentyl methanoate",
                        "Isopentyl methanoate",
                        "3-methylbutyl formate",
                        "3-Methylbutyl formate",
                        "Isoamyl methanoic acid",
                        "Isopentyl methanoic acid",
                        "3-Methyl-1-butyl formate",
                        "3-Methylbutyl formic acid",
                        "1-Butanol, 3-methyl-, formate",
                        "3-Methyl-2-butenyl formic acid",
                        "1-Butanol, 3-methyl-, 1-formate"
                    ],
                    "UMLS:C2346508": [
                        "ISS for Myeloma",
                        "International Staging System for Myeloma"
                    ],
                    "UMLS:C1562189": [
                        "Is etiology for",
                        "is etiology for",
                        "Is aetiology for",
                        "Is etiology for (link assertion)"
                    ]
                }
            },
            {
                "label": "symptoms related to sleep disorders",
                "id": {}
            }
        ],
        [
            {
                "label": "temporary relief",
                "id": {
                    "UMLS:C3186998": [
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Care One arthritis pain relief temporary minor]",
                        "ACETAMINOPHEN 650MG TAB,SA",
                        "ACETAMINOPHEN 650MG SA TAB",
                        "ACETAMINOPHEN 650 mg ORAL TABLET",
                        "8 HR APAP 650 MG Extended Release Oral Tablet",
                        "Acetaminophen 650mg Oral tablet, extended release",
                        "Pain Relief, 650 mg oral tablet, extended release",
                        "GNP Arthritis Pain Relief Extended-Release Caplet",
                        "Acetaminophen 650mg Oral tablet, biphasic release",
                        "Leader 8HR Arthritis Pain Extended-Release Caplet",
                        "acetaminophen 650 mg ORAL TABLET, EXTENDED RELEASE",
                        "acetaminophen 650 mg oral tablet, extended release",
                        "acetaminophen@650 mg@ORAL@TABLET, EXTENDED RELEASE",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE",
                        "Pain Reliever, 650 mg oral tablet, extended release",
                        "Sunmark Pain Reliever 650mg Extended-Release Caplet",
                        "Acetaminophen, 650 mg oral tablet, extended release",
                        "CVS 8 Hour Pain Relief 650mg Extended-Release Caplet",
                        "acetaminophen 650 MG 8HR Extended Release Oral Tablet",
                        "Health Mart Pain Relief 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Muscle Pain Relief]",
                        "Leader Arthritis Pain Reliever Extended-Release Caplet",
                        "GNP Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "acetaminophen 650 MG 8 HR Extended Release Oral Tablet",
                        "8 HR acetaminophen 650 MG Extended Release Oral Tablet",
                        "CVS Arthritis Pain Relief 650mg Extended-Release Geltab",
                        "CVS Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [ArthritisPain Relief]",
                        "Walgreens Arthritis Pain Relief Extended-Release Caplet",
                        "Midol Long Lasting Relief 650mg Extended-Release Caplet",
                        "GNP Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Sunmark 8 Hour Pain Relief 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [HEB]",
                        "GNP 8HR Muscle Aches & Pain 650mg Extended-Release Caplet",
                        "Leader 8 Hour Pain Reliever 650mg Extended-Release Caplet",
                        "Top Care 8 Hour Pain Relief 650mg Extended-Release Caplet",
                        "CVS 8HR Muscle Aches & Pain 650mg Extended-Release Caplet",
                        "Publix Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Select Brand Arthritis Pain Relief Extended-Release Caplet",
                        "GoodSense 8 Hour Pain Relief 650mg Extended-Release Caplet",
                        "CVS 8HR Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "RITE AID Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "Sunmark Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Arthritis Pain Relief, 650 mg oral tablet, extended release",
                        "Leader Arthritis Pain Reliever 650mg Extended-Release Geltab",
                        "Walgreens Acetaminophen 8-Hour 650mg Extended-Release Caplet",
                        "RITE AID Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Top Care Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Walgreens 8-Hour Pain Reliever 650mg Extended-Release Caplet",
                        "Walgreens Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "GoodSense Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Walgreens Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Premier Value Non-Aspirin 8 Hour 650mg Extended-Release Caplet",
                        "Acetaminophen 8-hr Relief, 650 mg oral tablet, extended release",
                        "8-Hour Acetaminophen E.R., 650 mg oral tablet, extended release",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Arthritis Pain Acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE",
                        "Health Mart Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Walgreens Arthritis Pain Reliever 650mg Extended-Release Caplet",
                        "Walgreens Arthritis Pain Reliever 650mg Extended-Release Geltab",
                        "Premier Value Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Acetaminophen Extended Release]",
                        "Quality Choice Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Acetaminophen Extended-Release]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Acetamiophen]",
                        "Leader 8 Hour Pain Reliever, 650 mg oral tablet, extended release",
                        "Premier Value Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Premier Value Arthritis Pain Relief 650mg Extended-Release Geltab",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Acetaminophen]",
                        "Today's Health Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Arthritis Pain]",
                        "Acetaminophen Extended-Release, 650 mg oral tablet, extended release",
                        "Arthritis Pain Extended Release, 650 mg oral tablet, extended release",
                        "GNP Acetaminophen 8 Hour Arthritis Pain 650mg Extended-Release Tablet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [8HR Arthritis Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [8 Hour Pain Relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [8 HOUR PAIN RELIEF]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [ACETAMINOPHEN AVPAK]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [arthritis pain relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [ARTHRITIS PAIN RELIEF]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [SUNMARK PAIN RELIEVER]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [8 Hour Arthritis Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Arthritis Pain Relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD SENSE PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Arthritis Pain Reliever Extended Release]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [eight hour pain relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [8HR MUSCLE ACHES & PAIN]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Pain Relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD SENSE ARTHRITIS PAIN]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Midol Long Lasting Relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [OHM ARTHRITIS PAIN RELIEF]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [LEADER 8HR ARTHRITIS PAIN]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [8HR ARTHRITIS PAIN RELIEF]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [TOPCARE 8 HOUR PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Arthritis Pain]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [LEADER 8 HOUR PAIN RELIEVER]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [arthritis pain]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [TOPCARE ARTHRITIS PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Pain Relief 8 HR]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [ACETAMINOPHEN ER]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [LEADER ARTHRITIS PAIN RELIEVER]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [LEADER 8HR MUSCLE ACHES & PAIN]",
                        "Quality Choice Arthritis Pain Relief Acetaminophen 8HR 650mg Extended-Release Tablet",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [SUNMARK ARTHRITIS PAIN RELIEVER]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [major acetaminophen]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [HEALTH MART ARTHRITIS PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Sunmark pain reliever]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD NEIGHBOR PHARMACY PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Good Sense Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [up and up acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [health mart pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [arthritis pain reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Up and Up acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [basic care acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Premier Value Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Basic Care Acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Sunmark Arthritis 8 Hour]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Leader 8HR Arthritis Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [8HR muscle aches and pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [8HR Arthritis Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [CareOne 8 Hour Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Topcare 8 Hour Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [care one pain relief 8 hour]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Acetaminophen - APAP 8 Hour]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [members mark arthritis pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Leader 8 Hour Pain Reliever]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD NEIGHBOR PHARMACY 8 HOUR PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Harris Teeter Arthritis Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [DG Health 8 Hour Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Acetaminophen Extended Release]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Leader Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Premier Value Arthritis 8 Hour]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Acetaminophen - APAP Arthritis]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD NEIGHBOR PHARMACY ARTHRITIS PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [dg health arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Sunmark Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Equate 8HR Arthritis Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Acetaminophen Extended-Release Tablets, 650 mg]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Leader 8 HR Muscle Aches and Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Health Mart arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [good neighbor pharmacy pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [topcare 8 hr arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [dg health 8 hr arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [good sense pain relief arthritis pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Premier Value Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Berkley and Jensen Arthritis Pain Relief]"
                    ],
                    "UMLS:C0937220": [
                        "CAPSAICIN 0.25 mg in 1 mL / MENTHOL 100 mg in 1 mL / METHYL SALICYLATE 150 mg in 1 mL TOPICAL CREAM [ZENSEZONE Arthmed Temporary Pain Relief Cream]",
                        "capsaicin 0.025 % / menthol 10 % / methyl salicylate 15 % Topical Cream",
                        "capsaicin 0.25 MG/ML / menthol 100 MG/ML / methyl salicylate 150 MG/ML Topical Cream",
                        "METHYL SALICYLATE 150 mg in 1 mL / MENTHOL 100 mg in 1 mL / CAPSAICIN 0.25 mg in 1 mL TOPICAL CREAM [Arthmed Topical Analgesic]"
                    ],
                    "UMLS:C3504593": [
                        "ATROPA BELLADONNA 6 [hp_C] / BRYONIA ALBA ROOT 6 [hp_C] / CAUSTICUM 6 [hp_C] / PHOSPHORUS 6 [hp_C] / STRYCHNOS NUX-VOMICA SEED 6 [hp_C] / PULSATILLA VULGARIS 6 [hp_C] / TOXICODENDRON PUBESCENS LEAF 6 [hp_C] ORAL TABLET, ORALLY DISINTEGRATING [Temporary Fibromyalgia Pain and Discomfort Relief]"
                    ]
                }
            },
            {
                "label": "is for",
                "id": {
                    "CHEBI:140821": [
                        "iso-Forssman",
                        "i-Forssman",
                        "isogloboside iGb5Cer",
                        "alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer",
                        "N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide"
                    ],
                    "UMLS:C1552560": [
                        "is backup for"
                    ],
                    "PUBCHEM.COMPOUND:8052": [
                        "Isoamyl formate",
                        "Isoamyl formate",
                        "isoamyl formate",
                        "ISOAMYL FORMATE",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formic acid",
                        "Formate, isopentyl ester",
                        "Isopentyl alcohol, formate",
                        "Formic acid, isopentyl ester",
                        "Formic acid, isopentyl ester",
                        "Isoamyl methanoate",
                        "Isoamyl methanoate",
                        "Isopentyl methanoate",
                        "Isopentyl methanoate",
                        "3-methylbutyl formate",
                        "3-Methylbutyl formate",
                        "Isoamyl methanoic acid",
                        "Isopentyl methanoic acid",
                        "3-Methyl-1-butyl formate",
                        "3-Methylbutyl formic acid",
                        "1-Butanol, 3-methyl-, formate",
                        "3-Methyl-2-butenyl formic acid",
                        "1-Butanol, 3-methyl-, 1-formate"
                    ],
                    "UMLS:C2346508": [
                        "ISS for Myeloma",
                        "International Staging System for Myeloma"
                    ],
                    "UMLS:C1562189": [
                        "Is etiology for",
                        "is etiology for",
                        "Is aetiology for",
                        "Is etiology for (link assertion)"
                    ]
                }
            },
            {
                "label": "Seasonal Affective Disorder",
                "id": {
                    "MONDO:0000694": [
                        "Seasonal Affective Disorder",
                        "seasonal affective disorder",
                        "Seasonal affective disorder",
                        "SEASONAL AFFECTIVE DISORDER",
                        "seasonal affective disorder",
                        "Affective Disorder, Seasonal",
                        "Disorder, Seasonal Affective",
                        "Seasonal Affective Disorders",
                        "seasonal affective disorders",
                        "SAD - Seasonal affective disorder",
                        "seasonal affective disorder (SAD)",
                        "Seasonal affective disorder (disorder)",
                        "seasonal affective disorder (diagnosis)",
                        "SAD",
                        "sad",
                        "SADS",
                        "winter depression",
                        "winter depression",
                        "Seasonal depression",
                        "seasonal depression",
                        "seasonal; depression",
                        "depression; seasonal",
                        "Seasonal mood disorder",
                        "Seasonal Mood Disorder",
                        "SEASONAL AFFECTIVE DIS",
                        "Mood Disorder, Seasonal",
                        "Disorder, Seasonal Mood",
                        "Seasonal Mood Disorders",
                        "depression seasonal pattern",
                        "seasonal pattern depression",
                        "seasonal depression (symptom)",
                        "SAD - Seasonal affect disorder",
                        "depression in a seasonal pattern",
                        "depression seasonal pattern (diagnosis)"
                    ],
                    "UMLS:C3266785": [
                        "seasonal affective disorder severe",
                        "Severe seasonal affective disorder",
                        "Severe seasonal affective disorder (disorder)",
                        "Severe seasonal affective disorder (diagnosis)"
                    ],
                    "UMLS:C3880029": [
                        "Seasonal affective disorder phototherapy unit",
                        "Seasonal affective disorder phototherapy unit (physical object)"
                    ],
                    "MONDO:0002009": [
                        "seasonal affective disorder, susceptibility to",
                        "MDD",
                        "major depression",
                        "Major depression",
                        "Major Depression",
                        "MAJOR DEPRESSION",
                        "Unipolar Depression",
                        "UNIPOLAR DEPRESSION",
                        "depression unipolar",
                        "Unipolar depression",
                        "unipolar depression",
                        "Unipolar Depressions",
                        "Major depression NOS",
                        "MAJOR DEPRESSIVE DIS",
                        "Depression, Unipolar",
                        "DEPRESSIVE DIS MAJOR",
                        "Depressions, Unipolar",
                        "Major depression, NOS",
                        "Depress psychosis-unspec",
                        "Recurr depr psychos-unsp",
                        "Major depressive illness",
                        "major depressive episode",
                        "major depressive illness",
                        "DEPRESSIVE DISORDER MAJOR",
                        "Major Depressive Disorder",
                        "Major depressive disorder",
                        "major depressive disorder",
                        "MAJOR DEPRESSIVE DISORDER",
                        "major depressive disorder",
                        "depressive; episode, major",
                        "Recurrent major depression",
                        "recurrent major depression",
                        "Major Depressive Disorders",
                        "recurrent major depression",
                        "Depressive Disorder, Major",
                        "major depressive disorder 2",
                        "major depressive disorder 1",
                        "Depressive Disorders, Major",
                        "Unipolar depressive illness",
                        "Major depressive disorder NOS",
                        "Major depressive disorder, NOS",
                        "single major depressive episode",
                        "Recurrent major depression, NOS",
                        "single major depressive episode",
                        "major depression, single episode",
                        "Major depression, single episode",
                        "single episode of major depression",
                        "DEPRESSIVE DISORDER MAJOR RECURRENT",
                        "Recurrent major depressive episodes",
                        "Recurrent major depressive disorder",
                        "major depression recurrent episodes",
                        "Major depressive disorder, recurrent",
                        "Major depressive disorder (disorder)",
                        "Recurrent major depression (disorder)",
                        "Major depressive disorder (diagnosis)",
                        "Major depression, single episode, NOS",
                        "recurrent episodes of major depression",
                        "recurrent major depression (diagnosis)",
                        "unipolar depression, susceptibility to",
                        "DEPRESSIVE DISORDER MAJOR SINGLE EPISODE",
                        "Recurrent major depressive disorder, NOS",
                        "Major depressive disorder; single episode",
                        "Major depressive disorder, single episode",
                        "Major depression, single episode (disorder)",
                        "Single Episode of Major Depressive Disorder",
                        "Major depressive disorder; recurrent episode",
                        "major depressive disorder, recurrent episode",
                        "Major depressive disorder, recurrent episode",
                        "major depression, single episode (diagnosis)",
                        "Recurrent major depressive episodes (disorder)",
                        "Recurrent major depressive episodes (diagnosis)",
                        "Major depressive disorder, recurrent, unspecified",
                        "Major depressive disorder, single episode, unspecified",
                        "Major depressive disorder, Recurrent episode, Unspecified",
                        "major depressive disorder, response to citalopram therapy in",
                        "Major depressive disorder, single episode, unspecified degree",
                        "Major depressive disorder, recurrent episode, unspecified degree",
                        "Major depressive affective disorder, single episode, unspecified",
                        "Major depressive affective disorder, recurrent episode, unspecified",
                        "major depressive disorder and accelerated response to antidepressant drug treatment"
                    ],
                    "UMLS:C5676455": [
                        "recurrent episodes of seasonal affective disorder"
                    ]
                }
            }
        ],
        [
            {
                "label": "temporary relief",
                "id": {
                    "UMLS:C3186998": [
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Care One arthritis pain relief temporary minor]",
                        "ACETAMINOPHEN 650MG TAB,SA",
                        "ACETAMINOPHEN 650MG SA TAB",
                        "ACETAMINOPHEN 650 mg ORAL TABLET",
                        "8 HR APAP 650 MG Extended Release Oral Tablet",
                        "Acetaminophen 650mg Oral tablet, extended release",
                        "Pain Relief, 650 mg oral tablet, extended release",
                        "GNP Arthritis Pain Relief Extended-Release Caplet",
                        "Acetaminophen 650mg Oral tablet, biphasic release",
                        "Leader 8HR Arthritis Pain Extended-Release Caplet",
                        "acetaminophen 650 mg ORAL TABLET, EXTENDED RELEASE",
                        "acetaminophen 650 mg oral tablet, extended release",
                        "acetaminophen@650 mg@ORAL@TABLET, EXTENDED RELEASE",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE",
                        "Pain Reliever, 650 mg oral tablet, extended release",
                        "Sunmark Pain Reliever 650mg Extended-Release Caplet",
                        "Acetaminophen, 650 mg oral tablet, extended release",
                        "CVS 8 Hour Pain Relief 650mg Extended-Release Caplet",
                        "acetaminophen 650 MG 8HR Extended Release Oral Tablet",
                        "Health Mart Pain Relief 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Muscle Pain Relief]",
                        "Leader Arthritis Pain Reliever Extended-Release Caplet",
                        "GNP Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "acetaminophen 650 MG 8 HR Extended Release Oral Tablet",
                        "8 HR acetaminophen 650 MG Extended Release Oral Tablet",
                        "CVS Arthritis Pain Relief 650mg Extended-Release Geltab",
                        "CVS Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [ArthritisPain Relief]",
                        "Walgreens Arthritis Pain Relief Extended-Release Caplet",
                        "Midol Long Lasting Relief 650mg Extended-Release Caplet",
                        "GNP Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Sunmark 8 Hour Pain Relief 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [HEB]",
                        "GNP 8HR Muscle Aches & Pain 650mg Extended-Release Caplet",
                        "Leader 8 Hour Pain Reliever 650mg Extended-Release Caplet",
                        "Top Care 8 Hour Pain Relief 650mg Extended-Release Caplet",
                        "CVS 8HR Muscle Aches & Pain 650mg Extended-Release Caplet",
                        "Publix Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Select Brand Arthritis Pain Relief Extended-Release Caplet",
                        "GoodSense 8 Hour Pain Relief 650mg Extended-Release Caplet",
                        "CVS 8HR Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "RITE AID Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "Sunmark Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Arthritis Pain Relief, 650 mg oral tablet, extended release",
                        "Leader Arthritis Pain Reliever 650mg Extended-Release Geltab",
                        "Walgreens Acetaminophen 8-Hour 650mg Extended-Release Caplet",
                        "RITE AID Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Top Care Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Walgreens 8-Hour Pain Reliever 650mg Extended-Release Caplet",
                        "Walgreens Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "GoodSense Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Walgreens Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Premier Value Non-Aspirin 8 Hour 650mg Extended-Release Caplet",
                        "Acetaminophen 8-hr Relief, 650 mg oral tablet, extended release",
                        "8-Hour Acetaminophen E.R., 650 mg oral tablet, extended release",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Arthritis Pain Acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE",
                        "Health Mart Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Walgreens Arthritis Pain Reliever 650mg Extended-Release Caplet",
                        "Walgreens Arthritis Pain Reliever 650mg Extended-Release Geltab",
                        "Premier Value Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Acetaminophen Extended Release]",
                        "Quality Choice Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Acetaminophen Extended-Release]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Acetamiophen]",
                        "Leader 8 Hour Pain Reliever, 650 mg oral tablet, extended release",
                        "Premier Value Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Premier Value Arthritis Pain Relief 650mg Extended-Release Geltab",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Acetaminophen]",
                        "Today's Health Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Arthritis Pain]",
                        "Acetaminophen Extended-Release, 650 mg oral tablet, extended release",
                        "Arthritis Pain Extended Release, 650 mg oral tablet, extended release",
                        "GNP Acetaminophen 8 Hour Arthritis Pain 650mg Extended-Release Tablet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [8HR Arthritis Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [8 Hour Pain Relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [8 HOUR PAIN RELIEF]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [ACETAMINOPHEN AVPAK]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [arthritis pain relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [ARTHRITIS PAIN RELIEF]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [SUNMARK PAIN RELIEVER]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [8 Hour Arthritis Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Arthritis Pain Relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD SENSE PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Arthritis Pain Reliever Extended Release]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [eight hour pain relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [8HR MUSCLE ACHES & PAIN]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Pain Relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD SENSE ARTHRITIS PAIN]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Midol Long Lasting Relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [OHM ARTHRITIS PAIN RELIEF]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [LEADER 8HR ARTHRITIS PAIN]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [8HR ARTHRITIS PAIN RELIEF]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [TOPCARE 8 HOUR PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Arthritis Pain]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [LEADER 8 HOUR PAIN RELIEVER]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [arthritis pain]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [TOPCARE ARTHRITIS PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Pain Relief 8 HR]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [ACETAMINOPHEN ER]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [LEADER ARTHRITIS PAIN RELIEVER]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [LEADER 8HR MUSCLE ACHES & PAIN]",
                        "Quality Choice Arthritis Pain Relief Acetaminophen 8HR 650mg Extended-Release Tablet",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [SUNMARK ARTHRITIS PAIN RELIEVER]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [major acetaminophen]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [HEALTH MART ARTHRITIS PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Sunmark pain reliever]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD NEIGHBOR PHARMACY PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Good Sense Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [up and up acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [health mart pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [arthritis pain reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Up and Up acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [basic care acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Premier Value Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Basic Care Acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Sunmark Arthritis 8 Hour]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Leader 8HR Arthritis Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [8HR muscle aches and pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [8HR Arthritis Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [CareOne 8 Hour Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Topcare 8 Hour Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [care one pain relief 8 hour]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Acetaminophen - APAP 8 Hour]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [members mark arthritis pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Leader 8 Hour Pain Reliever]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD NEIGHBOR PHARMACY 8 HOUR PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Harris Teeter Arthritis Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [DG Health 8 Hour Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Acetaminophen Extended Release]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Leader Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Premier Value Arthritis 8 Hour]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Acetaminophen - APAP Arthritis]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD NEIGHBOR PHARMACY ARTHRITIS PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [dg health arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Sunmark Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Equate 8HR Arthritis Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Acetaminophen Extended-Release Tablets, 650 mg]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Leader 8 HR Muscle Aches and Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Health Mart arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [good neighbor pharmacy pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [topcare 8 hr arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [dg health 8 hr arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [good sense pain relief arthritis pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Premier Value Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Berkley and Jensen Arthritis Pain Relief]"
                    ],
                    "UMLS:C0937220": [
                        "CAPSAICIN 0.25 mg in 1 mL / MENTHOL 100 mg in 1 mL / METHYL SALICYLATE 150 mg in 1 mL TOPICAL CREAM [ZENSEZONE Arthmed Temporary Pain Relief Cream]",
                        "capsaicin 0.025 % / menthol 10 % / methyl salicylate 15 % Topical Cream",
                        "capsaicin 0.25 MG/ML / menthol 100 MG/ML / methyl salicylate 150 MG/ML Topical Cream",
                        "METHYL SALICYLATE 150 mg in 1 mL / MENTHOL 100 mg in 1 mL / CAPSAICIN 0.25 mg in 1 mL TOPICAL CREAM [Arthmed Topical Analgesic]"
                    ],
                    "UMLS:C3504593": [
                        "ATROPA BELLADONNA 6 [hp_C] / BRYONIA ALBA ROOT 6 [hp_C] / CAUSTICUM 6 [hp_C] / PHOSPHORUS 6 [hp_C] / STRYCHNOS NUX-VOMICA SEED 6 [hp_C] / PULSATILLA VULGARIS 6 [hp_C] / TOXICODENDRON PUBESCENS LEAF 6 [hp_C] ORAL TABLET, ORALLY DISINTEGRATING [Temporary Fibromyalgia Pain and Discomfort Relief]"
                    ]
                }
            },
            {
                "label": "is for",
                "id": {
                    "CHEBI:140821": [
                        "iso-Forssman",
                        "i-Forssman",
                        "isogloboside iGb5Cer",
                        "alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer",
                        "N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide"
                    ],
                    "UMLS:C1552560": [
                        "is backup for"
                    ],
                    "PUBCHEM.COMPOUND:8052": [
                        "Isoamyl formate",
                        "Isoamyl formate",
                        "isoamyl formate",
                        "ISOAMYL FORMATE",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formic acid",
                        "Formate, isopentyl ester",
                        "Isopentyl alcohol, formate",
                        "Formic acid, isopentyl ester",
                        "Formic acid, isopentyl ester",
                        "Isoamyl methanoate",
                        "Isoamyl methanoate",
                        "Isopentyl methanoate",
                        "Isopentyl methanoate",
                        "3-methylbutyl formate",
                        "3-Methylbutyl formate",
                        "Isoamyl methanoic acid",
                        "Isopentyl methanoic acid",
                        "3-Methyl-1-butyl formate",
                        "3-Methylbutyl formic acid",
                        "1-Butanol, 3-methyl-, formate",
                        "3-Methyl-2-butenyl formic acid",
                        "1-Butanol, 3-methyl-, 1-formate"
                    ],
                    "UMLS:C2346508": [
                        "ISS for Myeloma",
                        "International Staging System for Myeloma"
                    ],
                    "UMLS:C1562189": [
                        "Is etiology for",
                        "is etiology for",
                        "Is aetiology for",
                        "Is etiology for (link assertion)"
                    ]
                }
            },
            {
                "label": "jet lag",
                "id": {
                    "MONDO:0024381": [
                        "Jet Lag",
                        "Jet lag",
                        "jet lag",
                        "Lag, Jet",
                        "Jet Lags",
                        "Lags, Jet",
                        "jet lag syndrome",
                        "Jet Lag Syndrome",
                        "Jet lag syndrome",
                        "Jet Lag Syndromes",
                        "Jet lag (finding)",
                        "Jet Lag Type Circadian Rhythm Sleep Disorder",
                        "sleep disorder circadian rhythm, jet lag type",
                        "circadian rhythm sleep disorder, jet lag type",
                        "Circadian rhythm sleep disorder, jet lag type",
                        "organic circadian rhythm sleep disorder jet lag type",
                        "organic circadian rhythm sleep disorder, jet lag type",
                        "nonorganic circadian rhythm sleep disorder, jet lag type",
                        "Circadian rhythm sleep disorder, jet lag type (diagnosis)",
                        "organic circadian rhythm sleep disorder, jet lag type (diagnosis)",
                        "nonorganic circadian rhythm sleep disorder, jet lag type (diagnosis)",
                        "jetlag",
                        "Jetlag",
                        "Time zone syndrome",
                        "Time Zone Syndrome",
                        "Time Zone Syndromes",
                        "Circadian rhythm-jetlag",
                        "Time Zone Change Syndrome",
                        "time zone change syndrome"
                    ],
                    "UMLS:C3175972": [
                        "Jet lag west PhenX",
                        "When you are traveling east by air and you cross over several time zones, how quickly do you return to your usual sleeping pattern [PhenX]",
                        "When you are traveling east by air and you cross over several time zones, how quickly do you return to your usual sleeping pattern:Time:Pt:^Patient:Qn:PhenX",
                        "When you are traveling east by air and you cross over several time zones, how quickly do you return to your usual sleeping pattern:Time:To identify measures at a point in time:^Patient:Quantitative:PhenX"
                    ],
                    "UMLS:C3175975": [
                        "Jet lag east PhenX",
                        "What about when you are traveling west by air over several time zones [PhenX]",
                        "What about when you are traveling west by air over several time zones:Time:Pt:^Patient:Qn:PhenX",
                        "What about when you are traveling west by air over several time zones:Time:To identify measures at a point in time:^Patient:Quantitative:PhenX"
                    ],
                    "UMLS:C4511502": [
                        "Jet lag type sleep-wake schedule disorder",
                        "Sleep-wake schedule disorder due to jet lag",
                        "Sleep-wake schedule disorder due to jet lag (disorder)"
                    ],
                    "UMLS:C4530122": [
                        "ANAMIRTA COCCULUS SEED 6 [hp_C] / ARNICA MONTANA 6 [hp_C] / STRYCHNOS NUX-VOMICA WHOLE 30 [hp_C] ORAL PELLET [Jet Lag Relief]"
                    ]
                }
            }
        ],
        [
            {
                "label": "temporary relief",
                "id": {
                    "UMLS:C3186998": [
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Care One arthritis pain relief temporary minor]",
                        "ACETAMINOPHEN 650MG TAB,SA",
                        "ACETAMINOPHEN 650MG SA TAB",
                        "ACETAMINOPHEN 650 mg ORAL TABLET",
                        "8 HR APAP 650 MG Extended Release Oral Tablet",
                        "Acetaminophen 650mg Oral tablet, extended release",
                        "Pain Relief, 650 mg oral tablet, extended release",
                        "GNP Arthritis Pain Relief Extended-Release Caplet",
                        "Acetaminophen 650mg Oral tablet, biphasic release",
                        "Leader 8HR Arthritis Pain Extended-Release Caplet",
                        "acetaminophen 650 mg ORAL TABLET, EXTENDED RELEASE",
                        "acetaminophen 650 mg oral tablet, extended release",
                        "acetaminophen@650 mg@ORAL@TABLET, EXTENDED RELEASE",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE",
                        "Pain Reliever, 650 mg oral tablet, extended release",
                        "Sunmark Pain Reliever 650mg Extended-Release Caplet",
                        "Acetaminophen, 650 mg oral tablet, extended release",
                        "CVS 8 Hour Pain Relief 650mg Extended-Release Caplet",
                        "acetaminophen 650 MG 8HR Extended Release Oral Tablet",
                        "Health Mart Pain Relief 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Muscle Pain Relief]",
                        "Leader Arthritis Pain Reliever Extended-Release Caplet",
                        "GNP Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "acetaminophen 650 MG 8 HR Extended Release Oral Tablet",
                        "8 HR acetaminophen 650 MG Extended Release Oral Tablet",
                        "CVS Arthritis Pain Relief 650mg Extended-Release Geltab",
                        "CVS Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [ArthritisPain Relief]",
                        "Walgreens Arthritis Pain Relief Extended-Release Caplet",
                        "Midol Long Lasting Relief 650mg Extended-Release Caplet",
                        "GNP Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Sunmark 8 Hour Pain Relief 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [HEB]",
                        "GNP 8HR Muscle Aches & Pain 650mg Extended-Release Caplet",
                        "Leader 8 Hour Pain Reliever 650mg Extended-Release Caplet",
                        "Top Care 8 Hour Pain Relief 650mg Extended-Release Caplet",
                        "CVS 8HR Muscle Aches & Pain 650mg Extended-Release Caplet",
                        "Publix Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Select Brand Arthritis Pain Relief Extended-Release Caplet",
                        "GoodSense 8 Hour Pain Relief 650mg Extended-Release Caplet",
                        "CVS 8HR Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "RITE AID Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "Sunmark Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Arthritis Pain Relief, 650 mg oral tablet, extended release",
                        "Leader Arthritis Pain Reliever 650mg Extended-Release Geltab",
                        "Walgreens Acetaminophen 8-Hour 650mg Extended-Release Caplet",
                        "RITE AID Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Top Care Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Walgreens 8-Hour Pain Reliever 650mg Extended-Release Caplet",
                        "Walgreens Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "GoodSense Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Walgreens Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Premier Value Non-Aspirin 8 Hour 650mg Extended-Release Caplet",
                        "Acetaminophen 8-hr Relief, 650 mg oral tablet, extended release",
                        "8-Hour Acetaminophen E.R., 650 mg oral tablet, extended release",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Arthritis Pain Acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE",
                        "Health Mart Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Walgreens Arthritis Pain Reliever 650mg Extended-Release Caplet",
                        "Walgreens Arthritis Pain Reliever 650mg Extended-Release Geltab",
                        "Premier Value Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Acetaminophen Extended Release]",
                        "Quality Choice Acetaminophen 8 Hour 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Acetaminophen Extended-Release]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Acetamiophen]",
                        "Leader 8 Hour Pain Reliever, 650 mg oral tablet, extended release",
                        "Premier Value Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "Premier Value Arthritis Pain Relief 650mg Extended-Release Geltab",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Acetaminophen]",
                        "Today's Health Arthritis Pain Relief 650mg Extended-Release Caplet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Arthritis Pain]",
                        "Acetaminophen Extended-Release, 650 mg oral tablet, extended release",
                        "Arthritis Pain Extended Release, 650 mg oral tablet, extended release",
                        "GNP Acetaminophen 8 Hour Arthritis Pain 650mg Extended-Release Tablet",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [8HR Arthritis Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [8 Hour Pain Relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [8 HOUR PAIN RELIEF]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [ACETAMINOPHEN AVPAK]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [arthritis pain relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [ARTHRITIS PAIN RELIEF]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [SUNMARK PAIN RELIEVER]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [8 Hour Arthritis Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Arthritis Pain Relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD SENSE PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET [Arthritis Pain Reliever Extended Release]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [eight hour pain relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [8HR MUSCLE ACHES & PAIN]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Pain Relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD SENSE ARTHRITIS PAIN]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Midol Long Lasting Relief]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [OHM ARTHRITIS PAIN RELIEF]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [LEADER 8HR ARTHRITIS PAIN]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [8HR ARTHRITIS PAIN RELIEF]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [TOPCARE 8 HOUR PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Arthritis Pain]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [LEADER 8 HOUR PAIN RELIEVER]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [arthritis pain]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [TOPCARE ARTHRITIS PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Pain Relief 8 HR]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [ACETAMINOPHEN ER]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [LEADER ARTHRITIS PAIN RELIEVER]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [LEADER 8HR MUSCLE ACHES & PAIN]",
                        "Quality Choice Arthritis Pain Relief Acetaminophen 8HR 650mg Extended-Release Tablet",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [SUNMARK ARTHRITIS PAIN RELIEVER]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [major acetaminophen]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [HEALTH MART ARTHRITIS PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Sunmark pain reliever]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD NEIGHBOR PHARMACY PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Good Sense Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [up and up acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [health mart pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [arthritis pain reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Up and Up acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [basic care acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Premier Value Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Basic Care Acetaminophen]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Sunmark Arthritis 8 Hour]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Leader 8HR Arthritis Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [8HR muscle aches and pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [8HR Arthritis Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [CareOne 8 Hour Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Topcare 8 Hour Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [care one pain relief 8 hour]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Acetaminophen - APAP 8 Hour]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [members mark arthritis pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Leader 8 Hour Pain Reliever]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD NEIGHBOR PHARMACY 8 HOUR PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Harris Teeter Arthritis Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [DG Health 8 Hour Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Acetaminophen Extended Release]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Leader Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Premier Value Arthritis 8 Hour]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Acetaminophen - APAP Arthritis]",
                        "Acetaminophen 650 MG Oral Tablet, Extended Release [GOOD NEIGHBOR PHARMACY ARTHRITIS PAIN RELIEF]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [dg health arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Sunmark Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Equate 8HR Arthritis Pain Relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, EXTENDED RELEASE [Acetaminophen Extended-Release Tablets, 650 mg]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Leader 8 HR Muscle Aches and Pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Health Mart arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [good neighbor pharmacy pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [topcare 8 hr arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [dg health 8 hr arthritis pain relief]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [good sense pain relief arthritis pain]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Premier Value Arthritis Pain Reliever]",
                        "ACETAMINOPHEN 650 mg ORAL TABLET, FILM COATED, EXTENDED RELEASE [Berkley and Jensen Arthritis Pain Relief]"
                    ],
                    "UMLS:C0937220": [
                        "CAPSAICIN 0.25 mg in 1 mL / MENTHOL 100 mg in 1 mL / METHYL SALICYLATE 150 mg in 1 mL TOPICAL CREAM [ZENSEZONE Arthmed Temporary Pain Relief Cream]",
                        "capsaicin 0.025 % / menthol 10 % / methyl salicylate 15 % Topical Cream",
                        "capsaicin 0.25 MG/ML / menthol 100 MG/ML / methyl salicylate 150 MG/ML Topical Cream",
                        "METHYL SALICYLATE 150 mg in 1 mL / MENTHOL 100 mg in 1 mL / CAPSAICIN 0.25 mg in 1 mL TOPICAL CREAM [Arthmed Topical Analgesic]"
                    ],
                    "UMLS:C3504593": [
                        "ATROPA BELLADONNA 6 [hp_C] / BRYONIA ALBA ROOT 6 [hp_C] / CAUSTICUM 6 [hp_C] / PHOSPHORUS 6 [hp_C] / STRYCHNOS NUX-VOMICA SEED 6 [hp_C] / PULSATILLA VULGARIS 6 [hp_C] / TOXICODENDRON PUBESCENS LEAF 6 [hp_C] ORAL TABLET, ORALLY DISINTEGRATING [Temporary Fibromyalgia Pain and Discomfort Relief]"
                    ]
                }
            },
            {
                "label": "is for",
                "id": {
                    "CHEBI:140821": [
                        "iso-Forssman",
                        "i-Forssman",
                        "isogloboside iGb5Cer",
                        "alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer",
                        "N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide"
                    ],
                    "UMLS:C1552560": [
                        "is backup for"
                    ],
                    "PUBCHEM.COMPOUND:8052": [
                        "Isoamyl formate",
                        "Isoamyl formate",
                        "isoamyl formate",
                        "ISOAMYL FORMATE",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formic acid",
                        "Formate, isopentyl ester",
                        "Isopentyl alcohol, formate",
                        "Formic acid, isopentyl ester",
                        "Formic acid, isopentyl ester",
                        "Isoamyl methanoate",
                        "Isoamyl methanoate",
                        "Isopentyl methanoate",
                        "Isopentyl methanoate",
                        "3-methylbutyl formate",
                        "3-Methylbutyl formate",
                        "Isoamyl methanoic acid",
                        "Isopentyl methanoic acid",
                        "3-Methyl-1-butyl formate",
                        "3-Methylbutyl formic acid",
                        "1-Butanol, 3-methyl-, formate",
                        "3-Methyl-2-butenyl formic acid",
                        "1-Butanol, 3-methyl-, 1-formate"
                    ],
                    "UMLS:C2346508": [
                        "ISS for Myeloma",
                        "International Staging System for Myeloma"
                    ],
                    "UMLS:C1562189": [
                        "Is etiology for",
                        "is etiology for",
                        "Is aetiology for",
                        "Is etiology for (link assertion)"
                    ]
                }
            },
            {
                "label": "depression",
                "id": {
                    "NCIT:C55447": [
                        "Depression",
                        "Depression, CTCAE"
                    ],
                    "UBERON:0004704": [
                        "depression",
                        "depressions",
                        "fossa",
                        "fossa",
                        "Fossa",
                        "groove",
                        "fossae",
                        "concavity",
                        "bone fossa",
                        "concavities"
                    ],
                    "UMLS:C0812393": [
                        "depression",
                        "depression and suicide",
                        "suicide and depression",
                        "cancer patients and depression and suicide",
                        "cancer patients and suicide and depression",
                        "Cancer patients and suicide and depression",
                        "suicide"
                    ],
                    "MONDO:0002050": [
                        "DEPRESSION",
                        "depression",
                        "Depression",
                        "Depressions",
                        "Depression NOS",
                        "depression nos",
                        "Depression, NOS",
                        "Mood depression",
                        "Mood depressions",
                        "depression moods",
                        "DEPRESSION MENTAL",
                        "Mental depression",
                        "Depression mental",
                        "mental depression",
                        "Mental Depression",
                        "mental depression",
                        "depression; mental",
                        "Depression, Mental",
                        "mental; depression",
                        "Depression, mental",
                        "DEPRESSION PSYCHIC",
                        "depression (disease)",
                        "Depression (Emotion)",
                        "depression (emotion)",
                        "monopolar depression",
                        "depression; monopolar",
                        "monopolar; depression",
                        "depression (diagnosis)",
                        "Monopolar depression NOS",
                        "Depression, mental function",
                        "depression; behavioral disorder",
                        "Sad",
                        "Low mood",
                        "Low Mood",
                        "Morosity",
                        "miserable",
                        "Depressed",
                        "Miserable",
                        "depressed",
                        "depressing",
                        "melancholy",
                        "Melancholy",
                        "Feeling low",
                        "Morose mood",
                        "Melancholic",
                        "melancholia",
                        "melancholic",
                        "Feeling blue",
                        "Feeling;down",
                        "Feeling down",
                        "Depressivity",
                        "melancholias",
                        "feeling down",
                        "Depressed mood",
                        "Depressed Mood",
                        "DEPRESSIVE DIS",
                        "depressed mood",
                        "MOOD DEPRESSED",
                        "Decreased Mood",
                        "mood depressed",
                        "DEPRESSED STATE",
                        "Depressed state",
                        "Depressive state",
                        "depressive; state",
                        "state; depressive",
                        "depressive illness",
                        "Depressive illness",
                        "DEPRESSIVE NEUROSIS",
                        "Depressive Disorder",
                        "Depressive Neuroses",
                        "depressive disorder",
                        "depressive neurosis",
                        "Depressive Neurosis",
                        "Depressive disorder",
                        "Depressive disorder",
                        "Depressive neurosis",
                        "Neuroses, Depressive",
                        "Neurosis, Depressive",
                        "Disorder, Depressive",
                        "neurosis; depressive",
                        "Neurosis, depressive",
                        "depressive; disorder",
                        "Depressive Disorders",
                        "disorder; depressive",
                        "depressive; neurosis",
                        "Depressive state NOS",
                        "DEPRESSIVE DISORDERS",
                        "syndrome, depressive",
                        "Depressive disorders",
                        "Disorders, Depressive",
                        "syndromes, depressive",
                        "Depressive disorder NOS",
                        "DEPRESSIVE DISORDER NOS",
                        "Depressive disorder, NOS",
                        "Depressed mood (finding)",
                        "9-52 DEPRESSIVE DISORDERS",
                        "Depressive disorder (disorder)",
                        "Mood disorder of depressed type",
                        "depressed mood (physical finding)"
                    ],
                    "UMLS:C0460137": [
                        "Depression",
                        "Depression motion",
                        "Depression - motion",
                        "Depression - motion (qualifier value)",
                        "push down or depress"
                    ]
                }
            }
        ]
    ],
    "Eszopiclone Tablets are indicated for the treatment of insomnia.": [
        [
            {
                "label": "Eszopiclone Tablets",
                "id": {
                    "UMLS:C1577188": [
                        "Eszopiclone Tablets",
                        "eszopiclone Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of insomnia",
                "id": {
                    "UMLS:C1735512": [
                        "Monitor for side effects of the treatment (e.g., headache, eyestrain, nausea, insomnia, hyperactivity)"
                    ]
                }
            }
        ]
    ],
    "Zolpidem Tartrate Tablets is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation": [
        [
            {
                "label": "Zolpidem Tartrate Tablets",
                "id": {
                    "UMLS:C4720064": [
                        "Zolpidem Tartrate Tablets"
                    ],
                    "UMLS:C4720218": [
                        "Zolpidem Tartrate Sublingual Tablets"
                    ],
                    "UMLS:C4720130": [
                        "Zolpidem Tartrate Extended-Release Tablets"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the short-term treatment of insomnia characterized by difficulties with sleep initiation",
                "id": {}
            }
        ]
    ],
    "Quazepam is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings.": [
        [
            {
                "label": "Quazepam",
                "id": {
                    "PUBCHEM.COMPOUND:4999": [
                        "QUAZEPAM",
                        "Quazepam",
                        "quazepam",
                        "Quazepamum",
                        "Quazepam (substance)",
                        "quazepam (medication)",
                        "Quazepam-containing product",
                        "Product containing quazepam (medicinal product)",
                        "Doral",
                        "quazium",
                        "Quiedorm",
                        "prosedar",
                        "Sch-16134",
                        "Sch 16134",
                        "7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-thione",
                        "2H-1,4-Benzodiazepine-2-thione, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-"
                    ],
                    "UMLS:C3211764": [
                        "quazepam Pill"
                    ],
                    "UMLS:C0989572": [
                        "quazepam 15 MG"
                    ],
                    "UMLS:C0989573": [
                        "quazepam 7.5 MG"
                    ],
                    "UMLS:C1247798": [
                        "Quazepam Tablets",
                        "quazepam Oral Tablet"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings",
                "id": {}
            }
        ]
    ],
    "Hydrocodone bitartrate and acetaminophen tablets are indicated for the management of moderate to moderately severe pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.": [
        [
            {
                "label": "Hydrocodone bitartrate and acetaminophen tablets",
                "id": {
                    "UMLS:C4720132": [
                        "Hydrocodone Bitartrate and Acetaminophen Tablets"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the management of moderate to moderately severe pain",
                "id": {}
            }
        ],
        [
            {
                "label": "moderate to moderately severe pain",
                "id": {}
            },
            {
                "label": "is severe enough to require",
                "id": {}
            },
            {
                "label": "an opioid analgesic",
                "id": {
                    "MESH:D000701": [
                        "opioid analgesic",
                        "Opioid Analgesic",
                        "opioid analgesics",
                        "Opioid analgesics",
                        "analgesics opioid",
                        "Analgesic, Opioid",
                        "opioid analgesics",
                        "Opioid Analgesics",
                        "OPIOID ANALGESICS",
                        "Analgesics, Opioid",
                        "OPIOIDS",
                        "narcotic",
                        "narcotics",
                        "narcotic analgesic",
                        "narcotic analgesics"
                    ],
                    "UMLS:C3537237": [
                        "Opioid Analgesic",
                        "Opioid Analgesic [EPC]"
                    ],
                    "UMLS:C4724129": [
                        "Non-Opioid Analgesic",
                        "Non-Opioid Analgesic (answer)"
                    ],
                    "UMLS:C0242937": [
                        "Non-opioid analgesic",
                        "Non-Opioid Analgesic",
                        "Non Opioid Analgesic",
                        "Opioid Analgesic, Non",
                        "Analgesic, Non Opioid",
                        "Non-Opioid Analgesics",
                        "non-opioid analgesics",
                        "Non Opioid Analgesics",
                        "NON-OPIOID ANALGESICS",
                        "Non-opioid analgesics",
                        "Analgesic, Non-Opioid",
                        "analgesics non opioid",
                        "Analgesics, Non-Opioid",
                        "Non-opioid analgesic (substance)",
                        "Nonopioid Analgesic",
                        "Nonopioid Analgesics",
                        "Analgesic, Nonopioid",
                        "Nonnarcotic Analgesic",
                        "nonnarcotic analgesic",
                        "Analgesics, Nonopioid",
                        "analgesic non narcotic",
                        "Nonnarcotic Analgesics",
                        "nonnarcotic analgesics",
                        "non narcotic analgesic",
                        "analgesics non-narcotic",
                        "Analgesics, Nonnarcotic",
                        "Analgesics.non-narcotic",
                        "Non-Narcotic Analgesics",
                        "non narcotic analgesics",
                        "non-narcotic analgesics",
                        "Analgesics Non-narcotic",
                        "Analgesics, Non Narcotic",
                        "Analgesics, Non-Narcotic"
                    ],
                    "UMLS:C3865746": [
                        "Analgesics, non-opioid",
                        "Measurement of non-opioid analgesics"
                    ]
                }
            }
        ],
        [
            {
                "label": "moderate to moderately severe pain",
                "id": {}
            },
            {
                "label": "for which",
                "id": {
                    "UMLS:C0332292": [
                        "For which was done",
                        "For which was done (attribute)",
                        "FW"
                    ],
                    "UMLS:C2585766": [
                        "Language for which interpreter is needed",
                        "Language for which interpreter is needed (observable entity)"
                    ],
                    "UMLS:C2146029": [
                        "travel or foreign residence in a climate which is:",
                        "traveled to or resided in climate which is:",
                        "traveled to or resided in climate which is: (history)"
                    ],
                    "UMLS:C0548134": [
                        "Assess for conditions which pose a risk to safety."
                    ],
                    "UMLS:C3260835": [
                        "Infections for which you received these antibiotics"
                    ]
                }
            },
            {
                "label": "alternative treatments are inadequate",
                "id": {}
            }
        ]
    ],
    "Tramadol hydrochloride tablets are indicated for the management of moderate to moderately severe pain in adults": [
        [
            {
                "label": "Tramadol hydrochloride tablets",
                "id": {
                    "UMLS:C4719950": [
                        "Tramadol Hydrochloride Tablets"
                    ],
                    "UMLS:C4720131": [
                        "Tramadol Hydrochloride Extended-Release Tablets"
                    ],
                    "UMLS:C4720143": [
                        "Tramadol Hydrochloride and Acetaminophen Tablets"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the management of moderate to moderately severe pain in adults",
                "id": {}
            }
        ]
    ],
    "Trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults": [
        [
            {
                "label": "Trazodone hydrochloride tablets",
                "id": {
                    "UMLS:C4719951": [
                        "Trazodone Hydrochloride Tablets"
                    ],
                    "UMLS:C4720055": [
                        "Trazodone Hydrochloride Extended-Release Tablets"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of major depressive disorder (MDD) in adults",
                "id": {}
            }
        ]
    ],
    "Citalopram tablets are indicated for the treatment of depression": [
        [
            {
                "label": "Citalopram tablets",
                "id": {
                    "UMLS:C1245573": [
                        "Citalopram Tablets",
                        "citalopram Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of depression",
                "id": {}
            }
        ]
    ],
    "Paroxetine tablets are indicated for the treatment of major depressive disorder.": [
        [
            {
                "label": "Paroxetine tablets",
                "id": {
                    "UMLS:C1253294": [
                        "Paroxetine Tablets",
                        "PARoxetine Oral Tablet",
                        "paroxetine Oral Tablet"
                    ],
                    "UMLS:C4720193": [
                        "Paroxetine Mesylate Tablets"
                    ],
                    "UMLS:C1591733": [
                        "Paroxetine Extended-Release Tablets",
                        "paroxetine Extended Release Oral Tablet",
                        "PARoxetine Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of major depressive disorder",
                "id": {}
            }
        ]
    ],
    "Paroxetine tablets are indicated for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder (OCD) as defined in the DSM-IV.": [
        [
            {
                "label": "Paroxetine tablets",
                "id": {
                    "UMLS:C1253294": [
                        "Paroxetine Tablets",
                        "PARoxetine Oral Tablet",
                        "paroxetine Oral Tablet"
                    ],
                    "UMLS:C4720193": [
                        "Paroxetine Mesylate Tablets"
                    ],
                    "UMLS:C1591733": [
                        "Paroxetine Extended-Release Tablets",
                        "paroxetine Extended Release Oral Tablet",
                        "PARoxetine Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of obsessions and compulsions",
                "id": {}
            }
        ],
        [
            {
                "label": "Paroxetine tablets",
                "id": {
                    "UMLS:C1253294": [
                        "Paroxetine Tablets",
                        "PARoxetine Oral Tablet",
                        "paroxetine Oral Tablet"
                    ],
                    "UMLS:C4720193": [
                        "Paroxetine Mesylate Tablets"
                    ],
                    "UMLS:C1591733": [
                        "Paroxetine Extended-Release Tablets",
                        "paroxetine Extended Release Oral Tablet",
                        "PARoxetine Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "are for",
                "id": {
                    "UMLS:C0086312": [
                        "Forested Area",
                        "Forested Areas",
                        "Area, Forested",
                        "Areas, Forested",
                        "forest",
                        "Forest",
                        "Forests",
                        "forests",
                        "Woodland",
                        "Woodlands",
                        "Forestland",
                        "Forestlands",
                        "Forest (environment)"
                    ],
                    "UMLS:C5268462": [
                        "Arenaria forrestii",
                        "Arenaria forrestii Diels"
                    ],
                    "UMLS:C2331620": [
                        "basal forebrain area",
                        "Basal Forebrain Area",
                        "Area, Basal Forebrain",
                        "Forebrain Area, Basal",
                        "Basal Forebrain Areas",
                        "Areas, Basal Forebrain",
                        "Forebrain Areas, Basal",
                        "basal forebrain",
                        "Basal Forebrain",
                        "Basal forebrain",
                        "Basal Forebrains",
                        "Forebrain, Basal",
                        "Forebrains, Basal",
                        "Pars Basalis Telencephali",
                        "Pars basalis telencephali",
                        "Telencephali, Pars Basalis",
                        "Basalis Telencephali, Pars",
                        "Pars Basalis Telencephalus",
                        "Telencephalus, Pars Basalis",
                        "Basalis Telencephalus, Pars"
                    ],
                    "UBERON:0002743": [
                        "basal forebrain area",
                        "basal forebrain",
                        "pars basalis telencephali"
                    ],
                    "PUBCHEM.COMPOUND:2230": [
                        "arecoline in any form",
                        "Arekolin",
                        "arecolin",
                        "Arecolin",
                        "Arecolin",
                        "arekolin",
                        "Arecaline",
                        "arecoline",
                        "ARECOLINE",
                        "Arecaline",
                        "arecaline",
                        "Arecholin",
                        "Arecholin",
                        "arecholin",
                        "arecaline",
                        "Arecoline",
                        "Arecholine",
                        "Arecholine",
                        "arecholine",
                        "arecholine",
                        "Arecoline base",
                        "Methylarecaiden",
                        "methylarecaidin",
                        "methylarecaidin",
                        "methylarecaiden",
                        "Methylarecaidin",
                        "Methylarecaidin",
                        "Arecoline (substance)",
                        "Arecoline hydrobromide",
                        "arecaidine methyl ester",
                        "Arecaidine methyl ester",
                        "Methyl N-methyltetrahydronicotinate",
                        "N-Methyl-beta -carboxylic acid methyl ester",
                        "Methyl 1,2,5,6-tetrahydro-1-methylnicotinate",
                        "Methyl N-methyl-1,2,5,6-tetrahydronicotinate",
                        "Methyl N-methyl-1,2,5, 6-tetrahydronicotinate",
                        "Methyl 1,2,5, 6-tetrahydro-1-methylnicotinate",
                        "N-Methyltetrahydronicotinic acid, methyl ester",
                        "Methyl 1-methyl-5,6-dihydro-2H-pyridine-3-carboxylate",
                        "1,2,5,6-Tetrahydro-1-methylnicotinic acid, methyl ester",
                        "methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate",
                        "Methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate",
                        "Methyl 1-methyl-1,2,5,6-tetrahydro-3-pyridinecarboxylate",
                        "Nicotinic acid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester",
                        "3-Pyridinecarboxylic acid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester"
                    ]
                }
            },
            {
                "label": "patients with obsessive compulsive disorder (OCD)",
                "id": {}
            }
        ],
        [
            {
                "label": "obsessive compulsive disorder (OCD)",
                "id": {
                    "MONDO:0008114": [
                        "OCD (obsessive compulsive disorder)",
                        "OCD - Obsessive-compulsive disorder",
                        "obsessive compulsive disorder (OCD)",
                        "OCD",
                        "OCD",
                        "compulsion",
                        "Compulsion",
                        "Compulsions",
                        "compulsions",
                        "compulsiveness",
                        "COMPULSIVENESS",
                        "Compulsion, NOS",
                        "Anancastic neurosis",
                        "Anankastic neurosis",
                        "Compulsive Behavior",
                        "Anancastic neurosis",
                        "anancastic neurosis",
                        "compulsive behavior",
                        "Compulsive behavior",
                        "compulsive behaviour",
                        "anankastic; neurosis",
                        "Compulsive behaviour",
                        "Behavior, Compulsive",
                        "Compulsive Behaviors",
                        "compulsive behaviors",
                        "neurosis; anankastic",
                        "Behaviors, Compulsive",
                        "Anankastic Personality",
                        "Personality, Anankastic",
                        "Obsessive-compulsive dis",
                        "Compulsive behavior, NOS",
                        "Anankastic Personalities",
                        "OBSESSIVE COMPULSIVE DIS",
                        "Personalities, Anankastic",
                        "Compulsive behaviour, NOS",
                        "Obsessive-Compulsive Neuroses",
                        "OBSESSIVE COMPULSIVE DISORDER",
                        "Obsessive-Compulsive Disorder",
                        "Obsessive compulsive neurosis",
                        "compulsive obsessive behavior",
                        "OBSESSIVE-COMPULSIVE NEUROSIS",
                        "obsessive-compulsive behavior",
                        "obsessive-compulsive neurosis",
                        "Compulsive behavior (finding)",
                        "obsessive compulsive neurosis",
                        "Obsessive Compulsive Neurosis",
                        "obsessive-compulsive disorder",
                        "Obsessive-Compulsive Neurosis",
                        "REACTION OBSESSIVE-COMPULSIVE",
                        "Obsessive-compulsive reaction",
                        "Obsessive compulsive behavior",
                        "obsessive-compulsive disorder",
                        "Obsessive Compulsive Disorder",
                        "Obsessive-compulsive disorder",
                        "Reaction obsessive-compulsive",
                        "Obsessive-compulsive disorder",
                        "Obsessive compulsive disorder",
                        "obsessive compulsive behavior",
                        "Obsessive compulsive disorder",
                        "compulsive behavior (symptom)",
                        "OBSESSIVE-COMPULSIVE REACTION",
                        "obsessive compulsive disorder",
                        "OBSESSIVE-COMPULSIVE DISORDER",
                        "behavior obsessive compulsive",
                        "Disorder;obsessive-compulsive",
                        "OBSESSIVE COMPULSIVE NEUROSIS",
                        "Obsessive-compulsive behavior",
                        "obsessive compulsive disorder",
                        "BEHAVIOR OBSESSIVE COMPULSIVE",
                        "Obsessive-compulsive neurosis",
                        "Obsessive-compulsive behaviour",
                        "Neurosis, Obsessive-Compulsive",
                        "Obsessive-Compulsive Disorders",
                        "NEUROSIS, OBSESSIVE COMPULSIVE",
                        "OCD - Obsessive-compuls disord",
                        "Disorder, Obsessive-Compulsive",
                        "Neurosis, obsessive compulsive",
                        "obsessive-compulsive disorders",
                        "obsessive-compulsive; neurosis",
                        "Obsessive compulsive behaviors",
                        "obsessive compulsive behaviour",
                        "Neuroses, Obsessive-Compulsive",
                        "Obsessive compulsive behaviour",
                        "obsessive-compulsive; reaction",
                        "obsessive-compulsive; disorder",
                        "disorder; obsessive-compulsive",
                        "neurosis; obsessive-compulsive",
                        "behaviour obsessive compulsive",
                        "Neurosis, Obsessive Compulsive",
                        "Obsessive-compulsive disorders",
                        "reaction; obsessive-compulsive",
                        "compulsions compulsive disorder",
                        "Disorders, Obsessive-Compulsive",
                        "Obsessive compulsive disorder, NOS",
                        "COMPULSIONS AND COMPULSIVE DISORDERS",
                        "obsessive-compulsive behavior (symptom)",
                        "Obsessive-compulsive disorder (disorder)",
                        "obsessive compulsive disorder (diagnosis)",
                        "obsessive-compulsive neurosis or reaction",
                        "Obsessive-compulsive disorder, unspecified",
                        "936-938 COMPULSIONS AND COMPULSIVE DISORDERS",
                        "obsessive-compulsive psychoneurosis or reaction",
                        "obsessive-compulsive disorder, susceptibility to"
                    ]
                }
            },
            {
                "label": "is defined in",
                "id": {
                    "NCIT:C55331": [
                        "Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L)",
                        "Fever without Neutropenia, CTCAE",
                        "Fever Without Neutropenia Adverse Event"
                    ],
                    "UMLS:C4698817": [
                        "The pump is programmed in an operational mode that does not match one of the defined modes."
                    ],
                    "NCIT:C55293": [
                        "Grade 1 Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L)",
                        "CTCAE Grade 1 Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L)",
                        "Grade 1 Fever Without Neutropenia, CTCAE"
                    ],
                    "NCIT:C55312": [
                        "Grade 3 Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L)",
                        "CTCAE Grade 3 Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L)",
                        "Grade 3 Fever Without Neutropenia, CTCAE"
                    ],
                    "NCIT:C55302": [
                        "Grade 2 Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L)",
                        "CTCAE Grade 2 Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L)",
                        "Grade 2 Fever Without Neutropenia, CTCAE"
                    ]
                }
            },
            {
                "label": "the DSM-IV",
                "id": {
                    "UMLS:C3710316": [
                        "Dsm-ivtm criteria for major depressive disorder documented at the initial evaluation",
                        "Doc of dsm-iv init eval"
                    ],
                    "UMLS:C3710317": [
                        "Dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified",
                        "No doc of dsm-iv"
                    ]
                }
            }
        ]
    ],
    "Paroxetine tablets are indicated for the treatment of panic disorder, with or without agoraphobia, as defined in DSM-IV": [
        [
            {
                "label": "Paroxetine tablets",
                "id": {
                    "UMLS:C1253294": [
                        "Paroxetine Tablets",
                        "PARoxetine Oral Tablet",
                        "paroxetine Oral Tablet"
                    ],
                    "UMLS:C4720193": [
                        "Paroxetine Mesylate Tablets"
                    ],
                    "UMLS:C1591733": [
                        "Paroxetine Extended-Release Tablets",
                        "paroxetine Extended Release Oral Tablet",
                        "PARoxetine Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of panic disorder, with or without agoraphobia, as defined in DSM-IV",
                "id": {}
            }
        ]
    ],
    "Paroxetine tablets are indicated for the treatment of social anxiety disorder, also known as social phobia, as defined in DSM-IV (300.23).": [
        [
            {
                "label": "Paroxetine tablets",
                "id": {
                    "UMLS:C1253294": [
                        "Paroxetine Tablets",
                        "PARoxetine Oral Tablet",
                        "paroxetine Oral Tablet"
                    ],
                    "UMLS:C4720193": [
                        "Paroxetine Mesylate Tablets"
                    ],
                    "UMLS:C1591733": [
                        "Paroxetine Extended-Release Tablets",
                        "paroxetine Extended Release Oral Tablet",
                        "PARoxetine Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of social anxiety disorder",
                "id": {}
            }
        ],
        [
            {
                "label": "social anxiety disorder",
                "id": {
                    "MONDO:0001247": [
                        "Social Anxiety Disorder",
                        "anxiety disorder social",
                        "social anxiety disorder",
                        "Social anxiety disorder",
                        "anxiety disorders social",
                        "Anxiety Disorder, Social",
                        "Social Anxiety Disorders",
                        "Disorder, Social Anxiety",
                        "anxiety disorder; social",
                        "Sociophobia",
                        "Sociophobias",
                        "Social Phobia",
                        "Social phobia",
                        "social phobia",
                        "phobia social",
                        "social phobia",
                        "social; phobia",
                        "Social Phobias",
                        "social phobias",
                        "phobias social",
                        "phobia; social",
                        "Social phobias",
                        "Phobia, Social",
                        "Social neurosis",
                        "neurosis; social",
                        "social; neurosis",
                        "Social phobia, NOS",
                        "Social Evaluation Fear",
                        "disorder social phobia",
                        "social phobia disorder",
                        "Evaluation Fear, Social",
                        "disorders phobia social",
                        "Social Evaluation Phobia",
                        "Social phobia (disorder)",
                        "Fear of Social Evaluation",
                        "social phobia (diagnosis)",
                        "Phobia, Social Evaluation",
                        "Social Evaluation Phobias",
                        "Social phobia, unspecified"
                    ],
                    "UMLS:C0270305": [
                        "Childhood social anxiety disorder",
                        "social; anxiety disorder, childhood",
                        "anxiety disorder; social, childhood",
                        "Social anxiety disorder of childhood",
                        "social anxiety disorder of childhood",
                        "disorder; social, anxiety, childhood",
                        "social anxiety disorder of childhood (diagnosis)",
                        "Childhood social anx disord",
                        "Childhood avoidant disorder",
                        "avoidant disorder; childhood",
                        "Avoidance disorder, childhood",
                        "Avoidant disorder of childhood",
                        "avoidant disorder of childhood",
                        "Withdrawing reaction of childhood",
                        "Avoidant disorder of childhood (disorder)",
                        "avoidant disorder of childhood (diagnosis)"
                    ],
                    "UMLS:C4237417": [
                        "Social anxiety disorder (social phobia)"
                    ],
                    "UMLS:C3835719": [
                        "social anxiety disorder, performance only",
                        "social anxiety disorder, performance only (diagnosis)",
                        "social phobia, performance only"
                    ]
                }
            },
            {
                "label": "also known as",
                "id": {
                    "MONDO:0001586": [
                        "severe MPS I (subtype, also known as Hurler syndrome)",
                        "MPS1",
                        "MPSI",
                        "mps i",
                        "MPS I",
                        "MPS I",
                        "MPS 1",
                        "MPS 1",
                        "Hurler syndrome",
                        "IDUA deficiency",
                        "Hurler syndrome",
                        "lipochondrodystrophy",
                        "Lipochondrodystrophy",
                        "Lipochondrodystrophy",
                        "Lipochondrodystrophies",
                        "Hurler-Scheie syndrome",
                        "mucopolysaccharidosis i",
                        "MPS I - Hurler syndrome",
                        "mucopolysaccharidosis I",
                        "i mucopolysaccharidosis",
                        "Mucopolysaccharidosis I",
                        "mucopolysaccharidosis I",
                        "Mucopolysaccharidosis 1",
                        "MUCOPOLYSACCHARIDOSIS I",
                        "MPS I - Hurler syndrome",
                        "mucopolysaccharidosis I",
                        "Mucopolysaccharidosis Is",
                        "L-iduronidase deficiency",
                        "Hurler syndrome (subtype)",
                        "mucopolysaccharidosis type 1",
                        "Mucopolysaccharidosis Type I",
                        "mucopolysaccharidosis type I",
                        "MPSI-Mucopolysaccharidosis I",
                        "Mucopolysaccharidosis, MPS-I",
                        "mucopolysaccharidosis, MPS-I",
                        "mucopolysaccharidosis type i",
                        "Mucopolysaccharidosis, MPS-I",
                        "Mucopolysaccharidosis type 1",
                        "Mucopolysaccharidosis type I",
                        "type I; mucopolysaccharidosis",
                        "Mucopolysaccharidosis, type 1",
                        "Mucopolysaccharidosis, type I",
                        "mucopolysaccharidosis, type 1",
                        "mucopolysaccharidosis (MPS) I",
                        "mucopolysaccharidosis; type I",
                        "alpha-L-iduronidase deficiency",
                        "iduronidase deficiency disease",
                        "iduronidase deficiency disease",
                        "Alpha-L-iduronidase deficiency",
                        "lipochondrodystrophy (diagnosis)",
                        "Hurler-Scheie syndrome (subtype)",
                        "MPSI - Mucopolysaccharidosis type I",
                        "mucopolysaccharide storage disease I",
                        "Mucopolysaccharidosis, type I (MPS I)",
                        "Mucopolysaccharidosis type I (disorder)",
                        "mucopolysaccharidosis type 1 (diagnosis)",
                        "alpha-L-iduronidase (IDA, IDUA) deficiency",
                        "attenuated MPS I (subtype, includes Hurler-Scheie and Scheie syndrome)",
                        "Scheie syndrome (subtype) formerly known as Mucopoly-saccharidosis type V)"
                    ],
                    "UMLS:C0470939": [
                        "Leo Laboratories Ltd (also known as Leo Pharmaceuticals)",
                        "Leo Laboratories Ltd"
                    ],
                    "UMLS:C0600352": [
                        "Electron beam computed tomography (also known as ultrafast ct, cine ct)",
                        "Electron Beam Tomography",
                        "electron beam tomography",
                        "Beam Tomography, Electron",
                        "Tomography, Electron Beam",
                        "Electron beam computed tomog",
                        "beam computed electron tomography",
                        "Electron Beam Computed Tomography"
                    ],
                    "NCBIGene:3684": [
                        "integrin, alpha M (complement component receptor 3, alpha; also known as CD11b (p170), macrophage antigen alpha polypeptide)",
                        "CR3A",
                        "MO1A",
                        "MAC-1",
                        "ITGAM",
                        "CD11b",
                        "MAC1A",
                        "CD11b",
                        "MAC-1",
                        "CD11B",
                        "ITGAM gene",
                        "ITGAM Gene",
                        "INTEGRIN, ALPHA-M",
                        "Mo1, ALPHA SUBUNIT",
                        "Mac1, ALPHA SUBUNIT",
                        "integrin subunit alpha M",
                        "macrophage-1 antigen alpha subunit",
                        "macrophage-1 antigen alpha subunit",
                        "complement component 3 receptor 3 subunit",
                        "COMPLEMENT RECEPTOR TYPE 3, ALPHA SUBUNIT",
                        "complement component 3 receptor 3 subunit",
                        "integrin, alpha M (complement component 3 receptor 3 subunit)",
                        "Integrin, Alpha M (Complement Component 3 Receptor 3 Subunit) Gene"
                    ],
                    "UMLS:C1706439": [
                        "Integrin, Alpha M (Complement Component Receptor 3, Alpha; Also Known As CD11b (p170), Macrophage Antigen Alpha Polypeptide) Gene",
                        "MO1A",
                        "CR3A",
                        "MAC1A",
                        "CD11B",
                        "MAC-1",
                        "SLEB6",
                        "ITGAM wt Allele",
                        "Integrin, Alpha-M Gene",
                        "Mo1, Alpha Subunit Gene",
                        "Mac1, Alpha Subunit Gene",
                        "Antigen CD11b (P170) Gene",
                        "Integrin, Alpha M (Complement Component 3 Receptor 3 Subunit) wt Allele"
                    ]
                }
            },
            {
                "label": "social phobia",
                "id": {
                    "MONDO:0001247": [
                        "Social Phobia",
                        "Social phobia",
                        "social phobia",
                        "phobia social",
                        "social phobia",
                        "social; phobia",
                        "Social Phobias",
                        "social phobias",
                        "phobias social",
                        "phobia; social",
                        "Social phobias",
                        "Phobia, Social",
                        "Social phobia, NOS",
                        "disorder social phobia",
                        "social phobia disorder",
                        "disorders phobia social",
                        "Social Evaluation Phobia",
                        "Social phobia (disorder)",
                        "social phobia (diagnosis)",
                        "Phobia, Social Evaluation",
                        "Social Evaluation Phobias",
                        "Social phobia, unspecified",
                        "Sociophobia",
                        "Sociophobias",
                        "Social neurosis",
                        "neurosis; social",
                        "social; neurosis",
                        "Social Evaluation Fear",
                        "Evaluation Fear, Social",
                        "Social Anxiety Disorder",
                        "anxiety disorder social",
                        "social anxiety disorder",
                        "Social anxiety disorder",
                        "anxiety disorders social",
                        "Anxiety Disorder, Social",
                        "Social Anxiety Disorders",
                        "Disorder, Social Anxiety",
                        "anxiety disorder; social",
                        "Fear of Social Evaluation"
                    ],
                    "UMLS:C3176419": [
                        "Social phobias CIDI-SF",
                        "Social phobias [CIDI-SF]",
                        "Social phobias:Find:Pt:^Patient:Nom:CIDI-SF",
                        "Social phobias:Finding:To identify measures at a point in time:^Patient:Nominal:CIDI-SF"
                    ],
                    "UMLS:C2919658": [
                        "Social phobia inventory",
                        "Social phobia inventory (assessment scale)"
                    ],
                    "UMLS:C0270587": [
                        "Generalised social phobia",
                        "generalized social phobia",
                        "Generalized social phobia",
                        "social phobia generalized",
                        "Social phobia, generalized",
                        "Generalized social phobia (disorder)",
                        "generalized social phobia (diagnosis)"
                    ],
                    "UMLS:C0338904": [
                        "Social phobia-public speaking",
                        "Social phobia, fear of public speaking",
                        "social phobia - fear of public speaking",
                        "Social phobia, fear of public speaking (disorder)",
                        "social phobia - fear of public speaking (diagnosis)"
                    ]
                }
            }
        ],
        [
            {
                "label": "social anxiety disorder",
                "id": {
                    "MONDO:0001247": [
                        "Social Anxiety Disorder",
                        "anxiety disorder social",
                        "social anxiety disorder",
                        "Social anxiety disorder",
                        "anxiety disorders social",
                        "Anxiety Disorder, Social",
                        "Social Anxiety Disorders",
                        "Disorder, Social Anxiety",
                        "anxiety disorder; social",
                        "Sociophobia",
                        "Sociophobias",
                        "Social Phobia",
                        "Social phobia",
                        "social phobia",
                        "phobia social",
                        "social phobia",
                        "social; phobia",
                        "Social Phobias",
                        "social phobias",
                        "phobias social",
                        "phobia; social",
                        "Social phobias",
                        "Phobia, Social",
                        "Social neurosis",
                        "neurosis; social",
                        "social; neurosis",
                        "Social phobia, NOS",
                        "Social Evaluation Fear",
                        "disorder social phobia",
                        "social phobia disorder",
                        "Evaluation Fear, Social",
                        "disorders phobia social",
                        "Social Evaluation Phobia",
                        "Social phobia (disorder)",
                        "Fear of Social Evaluation",
                        "social phobia (diagnosis)",
                        "Phobia, Social Evaluation",
                        "Social Evaluation Phobias",
                        "Social phobia, unspecified"
                    ],
                    "UMLS:C0270305": [
                        "Childhood social anxiety disorder",
                        "social; anxiety disorder, childhood",
                        "anxiety disorder; social, childhood",
                        "Social anxiety disorder of childhood",
                        "social anxiety disorder of childhood",
                        "disorder; social, anxiety, childhood",
                        "social anxiety disorder of childhood (diagnosis)",
                        "Childhood social anx disord",
                        "Childhood avoidant disorder",
                        "avoidant disorder; childhood",
                        "Avoidance disorder, childhood",
                        "Avoidant disorder of childhood",
                        "avoidant disorder of childhood",
                        "Withdrawing reaction of childhood",
                        "Avoidant disorder of childhood (disorder)",
                        "avoidant disorder of childhood (diagnosis)"
                    ],
                    "UMLS:C4237417": [
                        "Social anxiety disorder (social phobia)"
                    ],
                    "UMLS:C3835719": [
                        "social anxiety disorder, performance only",
                        "social anxiety disorder, performance only (diagnosis)",
                        "social phobia, performance only"
                    ]
                }
            },
            {
                "label": "defined in",
                "id": {
                    "UMLS:C3640643": [
                        "Institution Not Defined"
                    ],
                    "MONDO:0005426": [
                        "MRI defined brain infarct"
                    ],
                    "UMLS:C2985577": [
                        "Defined Inclusion Criterion"
                    ],
                    "UMLS:C0152519": [
                        "Ill-defined intestinal infections",
                        "ill-defined intestinal infections",
                        "Ill-defined intestinal infection, NOS",
                        "ill-defined intestinal infections (diagnosis)"
                    ],
                    "UMLS:C3846523": [
                        "Code - not defined in code system"
                    ]
                }
            },
            {
                "label": "DSM-IV (300.23)",
                "id": {}
            }
        ]
    ],
    "The efficacy of paroxetine tablets was established in three 12-week trials in adult patients with social anxiety disorder (DSM-IV).": [
        [
            {
                "label": "The efficacy of paroxetine tablets",
                "id": {}
            },
            {
                "label": "was established in",
                "id": {}
            },
            {
                "label": "three 12-week trials in adult patients with social anxiety disorder (DSM-IV)",
                "id": {}
            }
        ]
    ],
    "Paroxetine tablets have not been studied in children or adolescents with social phobia": [
        [
            {
                "label": "Paroxetine tablets",
                "id": {
                    "UMLS:C1253294": [
                        "Paroxetine Tablets",
                        "PARoxetine Oral Tablet",
                        "paroxetine Oral Tablet"
                    ],
                    "UMLS:C4720193": [
                        "Paroxetine Mesylate Tablets"
                    ],
                    "UMLS:C1591733": [
                        "Paroxetine Extended-Release Tablets",
                        "paroxetine Extended Release Oral Tablet",
                        "PARoxetine Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "have not been studied in",
                "id": {}
            },
            {
                "label": "children or adolescents with social phobia",
                "id": {}
            }
        ]
    ],
    "Paroxetine tablets are indicated for the treatment of Generalized Anxiety Disorder (GAD), as defined in DSM-IV.": [
        [
            {
                "label": "Paroxetine tablets",
                "id": {
                    "UMLS:C1253294": [
                        "Paroxetine Tablets",
                        "PARoxetine Oral Tablet",
                        "paroxetine Oral Tablet"
                    ],
                    "UMLS:C4720193": [
                        "Paroxetine Mesylate Tablets"
                    ],
                    "UMLS:C1591733": [
                        "Paroxetine Extended-Release Tablets",
                        "paroxetine Extended Release Oral Tablet",
                        "PARoxetine Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of Generalized Anxiety Disorder (GAD)",
                "id": {}
            }
        ],
        [
            {
                "label": "Generalized Anxiety Disorder (GAD)",
                "id": {
                    "MONDO:0001942": [
                        "GAD - Generalized anxiety disorder",
                        "gad",
                        "GAD",
                        "gads",
                        "Generalized anxiety dis",
                        "anxiety disorder generalize",
                        "generalized anxiety disorder",
                        "generalised anxiety disorder",
                        "anxiety disorder generalized",
                        "generalized anxiety disorder",
                        "GENERALIZED ANXIETY DISORDER",
                        "Generalized Anxiety Disorder",
                        "Generalised anxiety disorder",
                        "Generalized anxiety disorder",
                        "ANXIETY DISORDER GENERALIZED",
                        "anxiety disorder; generalized",
                        "generalized anxiety disorders",
                        "anxiety disorders generalized",
                        "generalized; anxiety disorder",
                        "GAD - General anxiety disorder",
                        "GAD - Generalised anxiety disorder",
                        "Generalized anxiety disorder (disorder)",
                        "generalized anxiety disorder (diagnosis)"
                    ],
                    "UMLS:C3263524": [
                        "Generalized anxiety disorder 7 item (GAD-7)",
                        "Generalized anxiety disorder (GAD 7):-:Point in time:^Patient:-",
                        "Generalized anxiety disorder 7 item:-:Pt:^Patient:-",
                        "Generalized anxiety disorder 7 item:-:To identify measures at a point in time:^Patient:-"
                    ],
                    "UMLS:C2919162": [
                        "GAD-7 (Generalized Anxiety Disorder 7 item) score",
                        "Generalized Anxiety Disorder 7 item score",
                        "Generalized Anxiety Disorder 7 item score (observable entity)"
                    ],
                    "UMLS:C3641330": [
                        "GAD-7 (Generalized Anxiety Disorder 7 item) scale",
                        "GAD-7",
                        "General Anxiety Disorder-7",
                        "Generalized Anxiety Disorder Scale",
                        "General Anxiety Disorder-7 Questionnaire",
                        "Generalized Anxiety Disorder 7 item scale",
                        "Generalized Anxiety Disorder - 7 Questionnaire",
                        "Generalized Anxiety Disorder 7 item scale (assessment scale)"
                    ],
                    "UMLS:C4275106": [
                        "GAD-7 (Generalized Anxiety Disorder 7) scale declined",
                        "Assessment using Generalized Anxiety Disorder 7 item scale declined",
                        "Assessment using Generalized Anxiety Disorder 7 item scale declined (situation)"
                    ]
                }
            },
            {
                "label": "is defined in",
                "id": {
                    "NCIT:C55331": [
                        "Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L)",
                        "Fever without Neutropenia, CTCAE",
                        "Fever Without Neutropenia Adverse Event"
                    ],
                    "UMLS:C4698817": [
                        "The pump is programmed in an operational mode that does not match one of the defined modes."
                    ],
                    "NCIT:C55293": [
                        "Grade 1 Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L)",
                        "CTCAE Grade 1 Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L)",
                        "Grade 1 Fever Without Neutropenia, CTCAE"
                    ],
                    "NCIT:C55312": [
                        "Grade 3 Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L)",
                        "CTCAE Grade 3 Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L)",
                        "Grade 3 Fever Without Neutropenia, CTCAE"
                    ],
                    "NCIT:C55302": [
                        "Grade 2 Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L)",
                        "CTCAE Grade 2 Fever (in the absence of neutropenia, where neutropenia is defined as ANC <1.0 x 10e9/L)",
                        "Grade 2 Fever Without Neutropenia, CTCAE"
                    ]
                }
            },
            {
                "label": "DSM-IV",
                "id": {
                    "UMLS:C0220952": [
                        "DSM-IV",
                        "dsm iv",
                        "DSM IV",
                        "dsm-iv",
                        "dsm4",
                        "DSM-4",
                        "Diagnostic and Statistical Manual of Mental Disorders, 4th Edition"
                    ],
                    "UMLS:C3710317": [
                        "No doc of dsm-iv",
                        "Dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified"
                    ],
                    "UMLS:C0236962": [
                        "dsm-iv classification",
                        "classifications dsm iv"
                    ],
                    "UMLS:C3710316": [
                        "Doc of dsm-iv init eval",
                        "Dsm-ivtm criteria for major depressive disorder documented at the initial evaluation"
                    ],
                    "UMLS:C2199206": [
                        "DSM-IV criteria for major depressive disorder documented",
                        "DSM-IV criteria for major depressive disorder documented (treatment)"
                    ]
                }
            }
        ]
    ],
    "The efficacy of paroxetine tablets in the treatment of GAD was established in two 8-week placebo-controlled trials in adults with GAD.": [
        [
            {
                "label": "The efficacy of paroxetine tablets in the treatment of GAD",
                "id": {}
            },
            {
                "label": "was established in",
                "id": {}
            },
            {
                "label": "two 8-week placebo-controlled trials in adults with GAD",
                "id": {}
            }
        ]
    ],
    "Paroxetine tablets have not been studied in children or adolescents with Generalized Anxiety Disorder": [
        [
            {
                "label": "Paroxetine tablets",
                "id": {
                    "UMLS:C1253294": [
                        "Paroxetine Tablets",
                        "PARoxetine Oral Tablet",
                        "paroxetine Oral Tablet"
                    ],
                    "UMLS:C4720193": [
                        "Paroxetine Mesylate Tablets"
                    ],
                    "UMLS:C1591733": [
                        "Paroxetine Extended-Release Tablets",
                        "paroxetine Extended Release Oral Tablet",
                        "PARoxetine Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "have not been studied in",
                "id": {}
            },
            {
                "label": "children or adolescents with Generalized Anxiety Disorder",
                "id": {}
            }
        ]
    ],
    "Paroxetine tablets are indicated for the treatment of Posttraumatic Stress Disorder (PTSD).": [
        [
            {
                "label": "Paroxetine tablets",
                "id": {
                    "UMLS:C1253294": [
                        "Paroxetine Tablets",
                        "PARoxetine Oral Tablet",
                        "paroxetine Oral Tablet"
                    ],
                    "UMLS:C4720193": [
                        "Paroxetine Mesylate Tablets"
                    ],
                    "UMLS:C1591733": [
                        "Paroxetine Extended-Release Tablets",
                        "paroxetine Extended Release Oral Tablet",
                        "PARoxetine Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of Posttraumatic Stress Disorder (PTSD)",
                "id": {}
            }
        ]
    ],
    "The efficacy of paroxetine tablets in the treatment of PTSD was established in two 12-week placebo-controlled trials in adults with PTSD": [
        [
            {
                "label": "The efficacy of paroxetine tablets in the treatment of PTSD",
                "id": {}
            },
            {
                "label": "was established in",
                "id": {}
            },
            {
                "label": "two 12-week placebo-controlled trials in adults with PTSD",
                "id": {}
            }
        ]
    ],
    "Escitalopram oral solution, USP is indicated for the acute and maintenance treatment of major depressive disorder in adults and in adolescents 12 to 17 years of age": [
        [
            {
                "label": "Escitalopram oral solution, USP",
                "id": {}
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the acute and maintenance treatment of major depressive disorder in adults",
                "id": {}
            }
        ],
        [
            {
                "label": "Escitalopram oral solution, USP",
                "id": {}
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the acute and maintenance treatment of major depressive disorder in adolescents 12 to 17 years of age",
                "id": {}
            }
        ]
    ],
    "Escitalopram oral solution, USP is indicated for the acute treatment of Generalized Anxiety Disorder (GAD) in adults.": [
        [
            {
                "label": "Escitalopram oral solution, USP",
                "id": {}
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the acute treatment of Generalized Anxiety Disorder (GAD) in adults",
                "id": {}
            }
        ]
    ],
    "Pregbalin is indicated for:Management of neuropathic pain associated with diabetic peripheral neuropathy": [
        [
            {
                "label": "Pregbalin",
                "id": {}
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "Management of neuropathic pain associated with diabetic peripheral neuropathy",
                "id": {}
            }
        ]
    ],
    "Management of postherpetic neuralgia": [
        [
            {
                "label": "Pregbalin",
                "id": {}
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "Management of postherpetic neuralgia",
                "id": {}
            }
        ]
    ],
    "Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older": [
        [
            {
                "label": "Pregbalin",
                "id": {}
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older",
                "id": {}
            }
        ]
    ],
    "Management of fibromyalgia": [
        [
            {
                "label": "Pregbalin",
                "id": {}
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "Management of fibromyalgia",
                "id": {}
            }
        ]
    ],
    "Management of neuropathic pain associated with spinal cord injury": [
        [
            {
                "label": "Pregbalin",
                "id": {}
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "Management of neuropathic pain associated with spinal cord injury",
                "id": {}
            }
        ]
    ],
    "For the management of acute pain in adults": [],
    "ARICEPT® is indicated for the treatment of dementia of the Alzheimer's type.": [
        [
            {
                "label": "ARICEPT®",
                "id": {
                    "UMLS:C0527315": [
                        "Aricept",
                        "aricept"
                    ],
                    "PUBCHEM.COMPOUND:3152": [
                        "Aricept",
                        "Aricept odt",
                        "Eranz",
                        "Donaz",
                        "donepezil",
                        "DONEPEZIL",
                        "Donepezil",
                        "Domepezil",
                        "Donepezilo",
                        "Donepezilo",
                        "Donepezilum",
                        "Donepezilum",
                        "[OBSOLETE] donepezil",
                        "Donepezil (substance)",
                        "Donepezil hydrochloride",
                        "Donepezil-containing product",
                        "Donepezilium oxalate trihydrate",
                        "Product containing donepezil (medicinal product)",
                        "2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one",
                        "1-Benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine hydrochloride",
                        "1H-Inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-((1-(phenylmethyl)-4-piperidinyl)methyl)-"
                    ],
                    "UMLS:C1650432": [
                        "Aricept ODT"
                    ],
                    "UMLS:C3224860": [
                        "Aricept Pill"
                    ],
                    "PUBCHEM.COMPOUND:122360849": [
                        "Aricept(Donepezil)"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of dementia of the Alzheimer's type",
                "id": {}
            }
        ]
    ],
    "Buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety.": [
        [
            {
                "label": "Buspirone hydrochloride tablets",
                "id": {
                    "UMLS:C4720084": [
                        "Buspirone Hydrochloride Tablets"
                    ]
                }
            },
            {
                "label": "are",
                "id": {
                    "NCIT:C13662": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1515984": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1551058": [
                        "Are",
                        "are unit of measure"
                    ],
                    "MONDO:0044742": [
                        "AREI",
                        "autosomal recessive epidermolytic ichthyosis"
                    ],
                    "MONDO:0017339": [
                        "AREI",
                        "Ichthyosis exfoliativa",
                        "ICHTHYOSIS EXFOLIATIVA",
                        "ichthyosis exfoliativa",
                        "Exfoliative ichthyosis",
                        "Ichthyosis Exfoliativa",
                        "exfoliative ichthyosis",
                        "ICHTHYOSIS BULLOSA OF SIEMENS-LIKE",
                        "autosomal recessive exfoliative ichthyosis",
                        "Autosomal recessive exfoliative ichthyosis",
                        "ICHTHYOSIS, EXFOLIATIVE, AUTOSOMAL RECESSIVE",
                        "ichthyosis congenital autosomal recessive exfoliative",
                        "Autosomal recessive exfoliative ichthyosis (disorder)",
                        "Autosomal recessive exfoliative ichthyosis (diagnosis)"
                    ]
                }
            },
            {
                "label": "indicated for the management of anxiety disorders",
                "id": {}
            }
        ],
        [
            {
                "label": "Buspirone hydrochloride tablets",
                "id": {
                    "UMLS:C4720084": [
                        "Buspirone Hydrochloride Tablets"
                    ]
                }
            },
            {
                "label": "are",
                "id": {
                    "NCIT:C13662": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1515984": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1551058": [
                        "Are",
                        "are unit of measure"
                    ],
                    "MONDO:0044742": [
                        "AREI",
                        "autosomal recessive epidermolytic ichthyosis"
                    ],
                    "MONDO:0017339": [
                        "AREI",
                        "Ichthyosis exfoliativa",
                        "ICHTHYOSIS EXFOLIATIVA",
                        "ichthyosis exfoliativa",
                        "Exfoliative ichthyosis",
                        "Ichthyosis Exfoliativa",
                        "exfoliative ichthyosis",
                        "ICHTHYOSIS BULLOSA OF SIEMENS-LIKE",
                        "autosomal recessive exfoliative ichthyosis",
                        "Autosomal recessive exfoliative ichthyosis",
                        "ICHTHYOSIS, EXFOLIATIVE, AUTOSOMAL RECESSIVE",
                        "ichthyosis congenital autosomal recessive exfoliative",
                        "Autosomal recessive exfoliative ichthyosis (disorder)",
                        "Autosomal recessive exfoliative ichthyosis (diagnosis)"
                    ]
                }
            },
            {
                "label": "indicated for the short-term relief of the symptoms of anxiety",
                "id": {}
            }
        ]
    ],
    "Lithium Carbonate Extended-Release Tablets USP are indicated in the treatment of manic episodes of Bipolar Disorder.": [
        [
            {
                "label": "Lithium Carbonate Extended-Release Tablets USP",
                "id": {}
            },
            {
                "label": "are indicated",
                "id": {
                    "UMLS:C1548408": [
                        "The indicated time slot(s) is(are) blocked"
                    ],
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C0514907": [
                        "Provide input in areas of strength and development needs, as indicated"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4714006": [
                        "Activate the rapid response team if indicated by presence of trigger areas, per agency protocol"
                    ]
                }
            },
            {
                "label": "in the treatment of manic episodes of Bipolar Disorder",
                "id": {}
            }
        ]
    ],
    "Memantine hydrochloride oral solution is indicated for the treatment of moderate to severe dementia of the Alzheimer's type.": [
        [
            {
                "label": "Memantine hydrochloride oral solution",
                "id": {
                    "UMLS:C4730890": [
                        "Memantine Hydrochloride Oral Solution"
                    ],
                    "UMLS:C1614531": [
                        "memantine hydrochloride 2 MG/ML Oral Solution",
                        "Memantine hydrochloride 2 mg/mL oral solution",
                        "Memantine Hydrochloride, 2 mg/mL oral solution",
                        "Memantine Hydrochloride 2 MG/1 ML Oral Solution",
                        "MEMANTINE HYDROCHLORIDE 2 mg in 1 mL ORAL SOLUTION",
                        "MEMANTINE HYDROCHLORIDE 10 mg in 5 mL ORAL SOLUTION",
                        "MEMANTINE HYDROCHLORIDE 2 mg in 1 mL ORAL SOLUTION [MEMANTINE]",
                        "MEMANTINE HYDROCHLORIDE 2 mg in 1 mL ORAL SOLUTION [Memantine Hydrochloride]",
                        "Product containing precisely memantine hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug)",
                        "memantine 2 mg/mL oral solution",
                        "MEMANTINE HCL 10MG/5ML ORAL,SOLN",
                        "Memantine 10mg/5mL Oral solution",
                        "MEMANTINE HCL 10MG/5ML SOLN ORAL",
                        "memantine HCl 2 MG in 1 mL Oral Solution",
                        "memantine HCl@2 mg/mL@ORAL@SOLUTION, ORAL",
                        "memantine HCl 2 MG per 1 ML Oral Solution",
                        "memantine HCl 2 mg/mL ORAL SOLUTION, ORAL",
                        "memantine HCl 10 MG per 5 ML Oral Solution"
                    ],
                    "UMLS:C5568223": [
                        "Memantine hydrochloride 10 mg/mL oral solution",
                        "Product containing precisely memantine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug)"
                    ],
                    "UMLS:C1639496": [
                        "memantine hydrochloride 2 MG/ML Oral Solution [Namenda]",
                        "Memantine Hydrochloride 2 MG/1 ML Oral Solution [NAMENDA]",
                        "Namenda 10mg/5ml Solution",
                        "Namenda 2 MG/ML Oral Solution",
                        "Namenda 2 MG in 1 mL Oral Solution",
                        "Namenda 10 MG per 5 ML Oral Solution"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of moderate to severe dementia of the Alzheimer's type",
                "id": {}
            }
        ]
    ],
    "Clonazepam is useful alone or as an adjunct in the treatment of the Lennox-Gastaut syndrome (petit mal variant), akinetic and myoclonic seizures.": [
        [
            {
                "label": "Clonazepam",
                "id": {
                    "PUBCHEM.COMPOUND:2802": [
                        "CLONAZEPAM",
                        "clonazepam",
                        "clonazepam",
                        "Clonazepam",
                        "ClonazePAM",
                        "clonazePAM",
                        "Clonazepamum",
                        "Clonazepamum",
                        "clonazepamum",
                        "Clonazepam tablets",
                        "Clonazepam (substance)",
                        "clonazepam (medication)",
                        "Clonazepam fine granules",
                        "Clonazepam-containing product",
                        "Product containing clonazepam (medicinal product)",
                        "Rivotril",
                        "Klonopin",
                        "Antelepsin",
                        "Chlonazepam",
                        "5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one",
                        "5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one",
                        "5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one",
                        "1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one",
                        "5-(2-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "1,3-dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one",
                        "5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "1,3-dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one",
                        "2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-",
                        "5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one",
                        "5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one",
                        "5-(2-chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one"
                    ],
                    "PUBCHEM.COMPOUND:45358948": [
                        "Clonazepam-d4"
                    ],
                    "UMLS:C0796741": [
                        "clonazePAM Ql",
                        "clonazePAM SerPl Ql",
                        "clonazePAM:PrThr:Pt:Ser/Plas:Ord",
                        "clonazePAM [Presence] in Serum or Plasma",
                        "clonazePAM:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ],
                    "UMLS:C0366420": [
                        "clonazePAM Dose",
                        "clonazePAM (Dose) [Mass]",
                        "clonazePAM [Mass] of Dose",
                        "clonazePAM:Mass:Pt:Dose:Qn",
                        "clonazePAM:Mass:To identify measures at a point in time:Dose:Quantitative"
                    ],
                    "UMLS:C0985017": [
                        "clonazepam 1 MG",
                        "clonazePAM 1 MG"
                    ]
                }
            },
            {
                "label": "is",
                "id": {
                    "UBERON:0002872": [
                        "IS",
                        "inferior salivary nucleus",
                        "Nucleus salivarius inferior",
                        "nucleus salivarius inferior",
                        "Inferior salivatory nucleus",
                        "inferior salivatary nucleus",
                        "inferior salivatory nucleus",
                        "Nucleus salivatorius inferior",
                        "nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior",
                        "Nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior nervi glossopharyngei",
                        "Nucleus salivatorius inferior nervi glossopharyngei"
                    ],
                    "OMIM:146850": [
                        "IS",
                        "ISCW",
                        "ISSCW",
                        "IMMUNE SUPPRESSION",
                        "STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO"
                    ],
                    "FB:FBgn0001274": [
                        "Is"
                    ],
                    "PUBCHEM.COMPOUND:7021816": [
                        "IS",
                        "isoleucylserine",
                        "Isoleucyl-Serine",
                        "L-isoleucyl-L-serine",
                        "Ile-Ser",
                        "L-Ile-L-Ser",
                        "CHEMBL56803"
                    ],
                    "UMLS:C0021632": [
                        "IS",
                        "INSTRUM",
                        "instrumentation",
                        "instrumentation aspects"
                    ]
                }
            },
            {
                "label": "useful alone",
                "id": {}
            }
        ],
        [
            {
                "label": "Clonazepam",
                "id": {
                    "PUBCHEM.COMPOUND:2802": [
                        "CLONAZEPAM",
                        "clonazepam",
                        "clonazepam",
                        "Clonazepam",
                        "ClonazePAM",
                        "clonazePAM",
                        "Clonazepamum",
                        "Clonazepamum",
                        "clonazepamum",
                        "Clonazepam tablets",
                        "Clonazepam (substance)",
                        "clonazepam (medication)",
                        "Clonazepam fine granules",
                        "Clonazepam-containing product",
                        "Product containing clonazepam (medicinal product)",
                        "Rivotril",
                        "Klonopin",
                        "Antelepsin",
                        "Chlonazepam",
                        "5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one",
                        "5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one",
                        "5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one",
                        "1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one",
                        "5-(2-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "1,3-dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one",
                        "5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "1,3-dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one",
                        "2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-",
                        "5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one",
                        "5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one",
                        "5-(2-chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one"
                    ],
                    "PUBCHEM.COMPOUND:45358948": [
                        "Clonazepam-d4"
                    ],
                    "UMLS:C0796741": [
                        "clonazePAM Ql",
                        "clonazePAM SerPl Ql",
                        "clonazePAM:PrThr:Pt:Ser/Plas:Ord",
                        "clonazePAM [Presence] in Serum or Plasma",
                        "clonazePAM:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ],
                    "UMLS:C0366420": [
                        "clonazePAM Dose",
                        "clonazePAM (Dose) [Mass]",
                        "clonazePAM [Mass] of Dose",
                        "clonazePAM:Mass:Pt:Dose:Qn",
                        "clonazePAM:Mass:To identify measures at a point in time:Dose:Quantitative"
                    ],
                    "UMLS:C0985017": [
                        "clonazepam 1 MG",
                        "clonazePAM 1 MG"
                    ]
                }
            },
            {
                "label": "is",
                "id": {
                    "UBERON:0002872": [
                        "IS",
                        "inferior salivary nucleus",
                        "Nucleus salivarius inferior",
                        "nucleus salivarius inferior",
                        "Inferior salivatory nucleus",
                        "inferior salivatary nucleus",
                        "inferior salivatory nucleus",
                        "Nucleus salivatorius inferior",
                        "nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior",
                        "Nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior nervi glossopharyngei",
                        "Nucleus salivatorius inferior nervi glossopharyngei"
                    ],
                    "OMIM:146850": [
                        "IS",
                        "ISCW",
                        "ISSCW",
                        "IMMUNE SUPPRESSION",
                        "STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO"
                    ],
                    "FB:FBgn0001274": [
                        "Is"
                    ],
                    "PUBCHEM.COMPOUND:7021816": [
                        "IS",
                        "isoleucylserine",
                        "Isoleucyl-Serine",
                        "L-isoleucyl-L-serine",
                        "Ile-Ser",
                        "L-Ile-L-Ser",
                        "CHEMBL56803"
                    ],
                    "UMLS:C0021632": [
                        "IS",
                        "INSTRUM",
                        "instrumentation",
                        "instrumentation aspects"
                    ]
                }
            },
            {
                "label": "as an adjunct in the treatment of the Lennox-Gastaut syndrome",
                "id": {}
            }
        ],
        [
            {
                "label": "Clonazepam",
                "id": {
                    "PUBCHEM.COMPOUND:2802": [
                        "CLONAZEPAM",
                        "clonazepam",
                        "clonazepam",
                        "Clonazepam",
                        "ClonazePAM",
                        "clonazePAM",
                        "Clonazepamum",
                        "Clonazepamum",
                        "clonazepamum",
                        "Clonazepam tablets",
                        "Clonazepam (substance)",
                        "clonazepam (medication)",
                        "Clonazepam fine granules",
                        "Clonazepam-containing product",
                        "Product containing clonazepam (medicinal product)",
                        "Rivotril",
                        "Klonopin",
                        "Antelepsin",
                        "Chlonazepam",
                        "5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one",
                        "5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one",
                        "5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one",
                        "1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one",
                        "5-(2-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "1,3-dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one",
                        "5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "1,3-dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one",
                        "2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-",
                        "5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one",
                        "5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one",
                        "5-(2-chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one"
                    ],
                    "PUBCHEM.COMPOUND:45358948": [
                        "Clonazepam-d4"
                    ],
                    "UMLS:C0796741": [
                        "clonazePAM Ql",
                        "clonazePAM SerPl Ql",
                        "clonazePAM:PrThr:Pt:Ser/Plas:Ord",
                        "clonazePAM [Presence] in Serum or Plasma",
                        "clonazePAM:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ],
                    "UMLS:C0366420": [
                        "clonazePAM Dose",
                        "clonazePAM (Dose) [Mass]",
                        "clonazePAM [Mass] of Dose",
                        "clonazePAM:Mass:Pt:Dose:Qn",
                        "clonazePAM:Mass:To identify measures at a point in time:Dose:Quantitative"
                    ],
                    "UMLS:C0985017": [
                        "clonazepam 1 MG",
                        "clonazePAM 1 MG"
                    ]
                }
            },
            {
                "label": "is",
                "id": {
                    "UBERON:0002872": [
                        "IS",
                        "inferior salivary nucleus",
                        "Nucleus salivarius inferior",
                        "nucleus salivarius inferior",
                        "Inferior salivatory nucleus",
                        "inferior salivatary nucleus",
                        "inferior salivatory nucleus",
                        "Nucleus salivatorius inferior",
                        "nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior",
                        "Nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior nervi glossopharyngei",
                        "Nucleus salivatorius inferior nervi glossopharyngei"
                    ],
                    "OMIM:146850": [
                        "IS",
                        "ISCW",
                        "ISSCW",
                        "IMMUNE SUPPRESSION",
                        "STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO"
                    ],
                    "FB:FBgn0001274": [
                        "Is"
                    ],
                    "PUBCHEM.COMPOUND:7021816": [
                        "IS",
                        "isoleucylserine",
                        "Isoleucyl-Serine",
                        "L-isoleucyl-L-serine",
                        "Ile-Ser",
                        "L-Ile-L-Ser",
                        "CHEMBL56803"
                    ],
                    "UMLS:C0021632": [
                        "IS",
                        "INSTRUM",
                        "instrumentation",
                        "instrumentation aspects"
                    ]
                }
            },
            {
                "label": "useful in the treatment of akinetic seizures",
                "id": {}
            }
        ],
        [
            {
                "label": "Clonazepam",
                "id": {
                    "PUBCHEM.COMPOUND:2802": [
                        "CLONAZEPAM",
                        "clonazepam",
                        "clonazepam",
                        "Clonazepam",
                        "ClonazePAM",
                        "clonazePAM",
                        "Clonazepamum",
                        "Clonazepamum",
                        "clonazepamum",
                        "Clonazepam tablets",
                        "Clonazepam (substance)",
                        "clonazepam (medication)",
                        "Clonazepam fine granules",
                        "Clonazepam-containing product",
                        "Product containing clonazepam (medicinal product)",
                        "Rivotril",
                        "Klonopin",
                        "Antelepsin",
                        "Chlonazepam",
                        "5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one",
                        "5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one",
                        "5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one",
                        "1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one",
                        "5-(2-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "1,3-dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one",
                        "5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "1,3-dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one",
                        "2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-",
                        "5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one",
                        "5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one",
                        "5-(2-chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one"
                    ],
                    "PUBCHEM.COMPOUND:45358948": [
                        "Clonazepam-d4"
                    ],
                    "UMLS:C0796741": [
                        "clonazePAM Ql",
                        "clonazePAM SerPl Ql",
                        "clonazePAM:PrThr:Pt:Ser/Plas:Ord",
                        "clonazePAM [Presence] in Serum or Plasma",
                        "clonazePAM:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ],
                    "UMLS:C0366420": [
                        "clonazePAM Dose",
                        "clonazePAM (Dose) [Mass]",
                        "clonazePAM [Mass] of Dose",
                        "clonazePAM:Mass:Pt:Dose:Qn",
                        "clonazePAM:Mass:To identify measures at a point in time:Dose:Quantitative"
                    ],
                    "UMLS:C0985017": [
                        "clonazepam 1 MG",
                        "clonazePAM 1 MG"
                    ]
                }
            },
            {
                "label": "is",
                "id": {
                    "UBERON:0002872": [
                        "IS",
                        "inferior salivary nucleus",
                        "Nucleus salivarius inferior",
                        "nucleus salivarius inferior",
                        "Inferior salivatory nucleus",
                        "inferior salivatary nucleus",
                        "inferior salivatory nucleus",
                        "Nucleus salivatorius inferior",
                        "nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior",
                        "Nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior nervi glossopharyngei",
                        "Nucleus salivatorius inferior nervi glossopharyngei"
                    ],
                    "OMIM:146850": [
                        "IS",
                        "ISCW",
                        "ISSCW",
                        "IMMUNE SUPPRESSION",
                        "STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO"
                    ],
                    "FB:FBgn0001274": [
                        "Is"
                    ],
                    "PUBCHEM.COMPOUND:7021816": [
                        "IS",
                        "isoleucylserine",
                        "Isoleucyl-Serine",
                        "L-isoleucyl-L-serine",
                        "Ile-Ser",
                        "L-Ile-L-Ser",
                        "CHEMBL56803"
                    ],
                    "UMLS:C0021632": [
                        "IS",
                        "INSTRUM",
                        "instrumentation",
                        "instrumentation aspects"
                    ]
                }
            },
            {
                "label": "useful in the treatment of myoclonic seizures",
                "id": {}
            }
        ]
    ],
    "Clonazepam is indicated for the treatment of panic disorder, with or without agoraphobia, as defined in DSM-IV": [
        [
            {
                "label": "Clonazepam",
                "id": {
                    "PUBCHEM.COMPOUND:2802": [
                        "CLONAZEPAM",
                        "clonazepam",
                        "clonazepam",
                        "Clonazepam",
                        "ClonazePAM",
                        "clonazePAM",
                        "Clonazepamum",
                        "Clonazepamum",
                        "clonazepamum",
                        "Clonazepam tablets",
                        "Clonazepam (substance)",
                        "clonazepam (medication)",
                        "Clonazepam fine granules",
                        "Clonazepam-containing product",
                        "Product containing clonazepam (medicinal product)",
                        "Rivotril",
                        "Klonopin",
                        "Antelepsin",
                        "Chlonazepam",
                        "5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one",
                        "5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one",
                        "5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one",
                        "1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one",
                        "5-(2-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "1,3-dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one",
                        "5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "1,3-dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one",
                        "2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-",
                        "5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one",
                        "5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one",
                        "5-(2-chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one"
                    ],
                    "PUBCHEM.COMPOUND:45358948": [
                        "Clonazepam-d4"
                    ],
                    "UMLS:C0796741": [
                        "clonazePAM Ql",
                        "clonazePAM SerPl Ql",
                        "clonazePAM:PrThr:Pt:Ser/Plas:Ord",
                        "clonazePAM [Presence] in Serum or Plasma",
                        "clonazePAM:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ],
                    "UMLS:C0366420": [
                        "clonazePAM Dose",
                        "clonazePAM (Dose) [Mass]",
                        "clonazePAM [Mass] of Dose",
                        "clonazePAM:Mass:Pt:Dose:Qn",
                        "clonazePAM:Mass:To identify measures at a point in time:Dose:Quantitative"
                    ],
                    "UMLS:C0985017": [
                        "clonazepam 1 MG",
                        "clonazePAM 1 MG"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of panic disorder",
                "id": {}
            }
        ],
        [
            {
                "label": "Clonazepam",
                "id": {
                    "PUBCHEM.COMPOUND:2802": [
                        "CLONAZEPAM",
                        "clonazepam",
                        "clonazepam",
                        "Clonazepam",
                        "ClonazePAM",
                        "clonazePAM",
                        "Clonazepamum",
                        "Clonazepamum",
                        "clonazepamum",
                        "Clonazepam tablets",
                        "Clonazepam (substance)",
                        "clonazepam (medication)",
                        "Clonazepam fine granules",
                        "Clonazepam-containing product",
                        "Product containing clonazepam (medicinal product)",
                        "Rivotril",
                        "Klonopin",
                        "Antelepsin",
                        "Chlonazepam",
                        "5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one",
                        "5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one",
                        "5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one",
                        "1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one",
                        "5-(2-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "1,3-dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one",
                        "5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "1,3-dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one",
                        "2H-1,4-Benzodiazepin-2-one, 5-(2-chlorophenyl)-1,3-dihydro-7-nitro-",
                        "5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one",
                        "5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one",
                        "5-(2-chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one"
                    ],
                    "PUBCHEM.COMPOUND:45358948": [
                        "Clonazepam-d4"
                    ],
                    "UMLS:C0796741": [
                        "clonazePAM Ql",
                        "clonazePAM SerPl Ql",
                        "clonazePAM:PrThr:Pt:Ser/Plas:Ord",
                        "clonazePAM [Presence] in Serum or Plasma",
                        "clonazePAM:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ],
                    "UMLS:C0366420": [
                        "clonazePAM Dose",
                        "clonazePAM (Dose) [Mass]",
                        "clonazePAM [Mass] of Dose",
                        "clonazePAM:Mass:Pt:Dose:Qn",
                        "clonazePAM:Mass:To identify measures at a point in time:Dose:Quantitative"
                    ],
                    "UMLS:C0985017": [
                        "clonazepam 1 MG",
                        "clonazePAM 1 MG"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "treatment of panic disorder with or without agoraphobia",
                "id": {}
            }
        ],
        [
            {
                "label": "panic disorder",
                "id": {
                    "MONDO:0008187": [
                        "panic disorder",
                        "PANIC DISORDER 1",
                        "panic disorder 1",
                        "panic disorder syndrome 1",
                        "panic disorder with Joint laxity",
                        "PANIC DISORDER WITH JOINT LAXITY",
                        "Panic Disorder with Joint Laxity",
                        "panic disorder, susceptibility to",
                        "PANIC DISORDER WITH BLADDER CONDITIONS",
                        "Panic Disorder with Bladder Conditions",
                        "panic disorder with bladder conditions",
                        "panic disorder susceptibility locus, chromosome 13Q-related",
                        "PANIC DISORDER SUSCEPTIBILITY LOCUS, CHROMOSOME 13q-RELATED",
                        "PAND1"
                    ],
                    "MONDO:0005383": [
                        "PANIC DISORDER",
                        "panic disorder",
                        "Disorder;panic",
                        "panic disorder",
                        "Panic disorder",
                        "Panic Disorder",
                        "panic; disorder",
                        "disorder; panic",
                        "panic disorders",
                        "Disorder, Panic",
                        "Panic Disorders",
                        "Panic disorders",
                        "Disorders, Panic",
                        "Panic disorder NOS",
                        "Panic disorder (disorder)",
                        "panic disorder (diagnosis)",
                        "Panic disorder [episodic paroxysmal anxiety]",
                        "PANIC DIS",
                        "panic anxiety syndrome",
                        "panic anxiety syndrome",
                        "Episodic paroxysml anx disord",
                        "Episodic paroxysmal anxiety disorder"
                    ],
                    "MONDO:0012384": [
                        "panic disorder 3",
                        "PANIC DISORDER 3",
                        "panic disorder type 3",
                        "panic disorder susceptibility locus, chromosome 4Q-related",
                        "PANIC DISORDER SUSCEPTIBILITY LOCUS, CHROMOSOME 4q-RELATED",
                        "Pand3",
                        "PAND3"
                    ],
                    "MONDO:0011924": [
                        "panic disorder 2",
                        "PANIC DISORDER 2",
                        "panic disorder type 2",
                        "panic disorder susceptibility locus, chromosome 9Q-related",
                        "PANIC DISORDER SUSCEPTIBILITY LOCUS, CHROMOSOME 9q-RELATED",
                        "PAND2",
                        "Pand2"
                    ],
                    "MONDO:0044144": [
                        "agoraphobia disorder panic",
                        "panic disorder agoraphobia",
                        "agoraphobia with panic disorder",
                        "Panic Disorder with Agoraphobia",
                        "Agoraphobia with panic disorder",
                        "Panic disorder with agoraphobia",
                        "panic disorder with agoraphobia",
                        "panic; disorder, with agoraphobia",
                        "disorder; panic, with agoraphobia",
                        "Panic disorder with agoraphobia, NOS",
                        "Panic disorder with agoraphobia (disorder)",
                        "panic disorder with agoraphobia (diagnosis)",
                        "panic disorder with agoraphobia and panic attacks",
                        "panic disorder with agoraphobia and panic attacks (diagnosis)",
                        "Agoraphobia w panic dis"
                    ]
                }
            },
            {
                "label": "defined in",
                "id": {
                    "UMLS:C3640643": [
                        "Institution Not Defined"
                    ],
                    "MONDO:0005426": [
                        "MRI defined brain infarct"
                    ],
                    "UMLS:C2985577": [
                        "Defined Inclusion Criterion"
                    ],
                    "UMLS:C0152519": [
                        "Ill-defined intestinal infections",
                        "ill-defined intestinal infections",
                        "Ill-defined intestinal infection, NOS",
                        "ill-defined intestinal infections (diagnosis)"
                    ],
                    "UMLS:C3846523": [
                        "Code - not defined in code system"
                    ]
                }
            },
            {
                "label": "DSM-IV",
                "id": {
                    "UMLS:C0220952": [
                        "DSM-IV",
                        "dsm iv",
                        "DSM IV",
                        "dsm-iv",
                        "dsm4",
                        "DSM-4",
                        "Diagnostic and Statistical Manual of Mental Disorders, 4th Edition"
                    ],
                    "UMLS:C3710317": [
                        "No doc of dsm-iv",
                        "Dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified"
                    ],
                    "UMLS:C0236962": [
                        "dsm-iv classification",
                        "classifications dsm iv"
                    ],
                    "UMLS:C3710316": [
                        "Doc of dsm-iv init eval",
                        "Dsm-ivtm criteria for major depressive disorder documented at the initial evaluation"
                    ],
                    "UMLS:C2199206": [
                        "DSM-IV criteria for major depressive disorder documented",
                        "DSM-IV criteria for major depressive disorder documented (treatment)"
                    ]
                }
            }
        ]
    ],
    "Venlafaxine tablets, USP are indicated for the treatment of major depressive disorder.": [
        [
            {
                "label": "Venlafaxine tablets, USP",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of major depressive disorder",
                "id": {}
            }
        ]
    ],
    "AMRIX® (cyclobenzaprine hydrochloride extended-release capsules) is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.": [
        [
            {
                "label": "AMRIX® (cyclobenzaprine hydrochloride extended-release capsules)",
                "id": {}
            },
            {
                "label": "is indicated as",
                "id": {
                    "UMLS:C4710292": [
                        "Assure that someone is oxygenating the patient and assisting with intubation, as indicated"
                    ],
                    "UMLS:C4713987": [
                        "Assure that the surgical site is marked with a permanent marker by the surgeon, as indicated"
                    ],
                    "UMLS:C4714380": [
                        "Perform targeted assessment of the system that is indicated by the history of present illness"
                    ],
                    "UMLS:C4711109": [
                        "Ensure that equipment is operational via trial run (i.e., assemble laryngoscope and check light bulb function), as indicated"
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ]
                }
            },
            {
                "label": "an adjunct to rest and physical therapy",
                "id": {}
            }
        ],
        [
            {
                "label": "an adjunct to rest and physical therapy",
                "id": {}
            },
            {
                "label": "for relief of",
                "id": {
                    "UMLS:C2066417": [
                        "bronchoscopy for relief of stenosis",
                        "bronchoscopy for relief of stenosis (treatment)"
                    ],
                    "UMLS:C0176906": [
                        "Incision of bile duct for relief of obstruction",
                        "Incision of bile duct for obstruction",
                        "Incision of bile duct for obstruction (procedure)"
                    ],
                    "UMLS:C4076552": [
                        "Palliative debulking of tumor for symptom relief",
                        "Palliative debulking of tumour for symptom relief",
                        "Palliative debulking of neoplasm for symptom relief",
                        "Palliative debulking of neoplasm for symptom relief (procedure)"
                    ],
                    "UMLS:C4273129": [
                        "bronchoscopy for relief of stenosis by cryotherapy",
                        "bronchoscopy for relief of stenosis by cryotherapy (treatment)"
                    ],
                    "UMLS:C2037641": [
                        "surgery for relief of elevated intraocular pressure",
                        "surgery for relief of elevated intraocular pressure (treatment)"
                    ]
                }
            },
            {
                "label": "muscle spasm associated with acute, painful musculoskeletal conditions",
                "id": {}
            }
        ]
    ],
    "AMRIX should be used only for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted": [
        [
            {
                "label": "AMRIX",
                "id": {
                    "UMLS:C1961958": [
                        "Amrix"
                    ],
                    "UMLS:C3228223": [
                        "Amrix Pill"
                    ],
                    "UMLS:C3228222": [
                        "Amrix Oral Product"
                    ],
                    "UMLS:C1961961": [
                        "Amrix 15mg Extended-Release Capsule",
                        "Amrix, 15 mg oral capsule, extended release",
                        "Amrix 15 MG 24HR Extended Release Oral Capsule",
                        "24 HR Amrix 15 MG Extended Release Oral Capsule",
                        "Amrix 15 MG 24 HR Extended Release Oral Capsule",
                        "Cyclobenzaprine Hydrochloride 15 MG Oral Capsule, Extended Release [AMRIX]",
                        "CYCLOBENZAPRINE HYDROCHLORIDE 15 mg ORAL CAPSULE, EXTENDED RELEASE [AMRIX]",
                        "24 HR cyclobenzaprine hydrochloride 15 MG Extended Release Oral Capsule [Amrix]"
                    ],
                    "UMLS:C1961965": [
                        "Amrix 30mg Extended-Release Capsule",
                        "Amrix, 30 mg oral capsule, extended release",
                        "Amrix 30 MG 24HR Extended Release Oral Capsule",
                        "24 HR Amrix 30 MG Extended Release Oral Capsule",
                        "Amrix 30 MG 24 HR Extended Release Oral Capsule",
                        "CYCLOBENZAPRINE HYDROCHLORIDE 30 mg ORAL CAPSULE, EXTENDED RELEASE [AMRIX]",
                        "Cyclobenzaprine Hydrochloride 30 MG Oral Capsule, Extended Release [AMRIX]",
                        "24 HR cyclobenzaprine hydrochloride 30 MG Extended Release Oral Capsule [Amrix]"
                    ]
                }
            },
            {
                "label": "should be used",
                "id": {
                    "UMLS:C4069263": [
                        "Shoulder belt only used"
                    ],
                    "UMLS:C3840837": [
                        "Shoulder and lap belt used"
                    ],
                    "UMLS:C0520010": [
                        "Acute treatment (this modifier should be used when reporting service 98940, 98941, 98942)",
                        "Acute treatment"
                    ],
                    "UMLS:C4714646": [
                        "Inform children and young people and their parents and caregivers that bedwetting is not their fault and that punitive measures should not be used"
                    ],
                    "UMLS:C0497699": [
                        "Technical component; under certain circumstances, a charge may be made for the technical component alone; under those circumstances the technical component charge is identified by adding modifier 'tc' to the usual procedure number; technical component charges are institutional charges and not billed separately by physicians; however, portable x-ray suppliers only bill for technical component and should utilize modifier tc; the charge data from portable x-ray suppliers will then be used to build customary and prevailing profiles",
                        "Technical component"
                    ]
                }
            },
            {
                "label": "only for short periods (up to two or three weeks)",
                "id": {}
            }
        ],
        [
            {
                "label": "Adequate evidence of effectiveness for more prolonged use",
                "id": {}
            },
            {
                "label": "is not",
                "id": {
                    "UMLS:C0445130": [
                        "Not isolated",
                        "Not isolated (qualifier value)"
                    ],
                    "PR:000040231": [
                        "NOTCH1/iso:1",
                        "neurogenic locus notch homolog protein 1 isoform 1"
                    ],
                    "UniProtKB:Q9SR22-2": [
                        "At-NOTUM/iso:2",
                        "pectin acetylesterase 5 isoform 2 (Arabidopsis thaliana)"
                    ],
                    "UniProtKB:Q9SR22-1": [
                        "At-NOTUM/iso:1",
                        "pectin acetylesterase 5 isoform 1 (Arabidopsis thaliana)"
                    ],
                    "PUBCHEM.COMPOUND:156583059": [
                        "Iso-notoamide B"
                    ]
                }
            },
            {
                "label": "available",
                "id": {
                    "UMLS:C0470187": [
                        "Available",
                        "available",
                        "Availability",
                        "availability",
                        "Availability of",
                        "availability of",
                        "Availability of (contextual qualifier)",
                        "Availability of (contextual qualifier) (qualifier value)"
                    ],
                    "UMLS:C0686905": [
                        "Not available",
                        "Not Available",
                        "Unavailable",
                        "unavailable",
                        "Unavailability",
                        "unavailability",
                        "Unavailability of",
                        "of unavailability",
                        "Unavailability (qualifier value)",
                        "Unavailability of (contextual qualifier)",
                        "Unavailability of (contextual qualifier) (qualifier value)"
                    ],
                    "UMLS:C0418624": [
                        "drug available",
                        "available drug",
                        "available drugs",
                        "Nonadmin necess medicine",
                        "Nonadministration of necessary drug or medicine",
                        "nonadministration of necessary drug or medicine",
                        "dosage failure nonadministration of necessary drug",
                        "Nonadministration of necessary drug or medicine (event)",
                        "nonadministration of necessary drug or medicinal substance",
                        "Nonadministration of necessary drug or medicinal substance",
                        "nonadministration of necessary drug or medicinal substance (treatment)"
                    ],
                    "UMLS:C1511733": [
                        "Date Available",
                        "Availablibility"
                    ],
                    "UMLS:C1551351": [
                        "Available Volume"
                    ]
                }
            }
        ],
        [
            {
                "label": "Muscle spasm associated with acute, painful musculoskeletal conditions",
                "id": {}
            },
            {
                "label": "is",
                "id": {
                    "UBERON:0002872": [
                        "IS",
                        "inferior salivary nucleus",
                        "Nucleus salivarius inferior",
                        "nucleus salivarius inferior",
                        "Inferior salivatory nucleus",
                        "inferior salivatary nucleus",
                        "inferior salivatory nucleus",
                        "Nucleus salivatorius inferior",
                        "nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior",
                        "Nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior nervi glossopharyngei",
                        "Nucleus salivatorius inferior nervi glossopharyngei"
                    ],
                    "OMIM:146850": [
                        "IS",
                        "ISCW",
                        "ISSCW",
                        "IMMUNE SUPPRESSION",
                        "STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO"
                    ],
                    "FB:FBgn0001274": [
                        "Is"
                    ],
                    "PUBCHEM.COMPOUND:7021816": [
                        "IS",
                        "isoleucylserine",
                        "Isoleucyl-Serine",
                        "L-isoleucyl-L-serine",
                        "Ile-Ser",
                        "L-Ile-L-Ser",
                        "CHEMBL56803"
                    ],
                    "UMLS:C0021632": [
                        "IS",
                        "INSTRUM",
                        "instrumentation",
                        "instrumentation aspects"
                    ]
                }
            },
            {
                "label": "of short duration",
                "id": {
                    "UMLS:C0566672": [
                        "duration of labor short",
                        "Short duration of labor",
                        "Short duration of labour",
                        "Short duration of labor (finding)",
                        "duration of labor short (physical finding)"
                    ],
                    "UMLS:C3164022": [
                        "Duration of medication therapy too short",
                        "Duration of medication therapy too short (finding)"
                    ],
                    "UMLS:C5551658": [
                        "Duration of shortness of breath in past 7D",
                        "Duration of shortness of breath in past 7 days"
                    ],
                    "UMLS:C1834638": [
                        "Shortened duration of motor unit potentials"
                    ],
                    "UMLS:C0429362": [
                        "Finding of polyphasic units - short duration",
                        "Finding of polyphasic units - short duration (finding)",
                        "Polyphasic units - short dur",
                        "Polyphasic units - short duration",
                        "Polyphasic units - short duration - finding"
                    ]
                }
            }
        ],
        [
            {
                "label": "Specific therapy for longer periods",
                "id": {}
            },
            {
                "label": "is",
                "id": {
                    "UBERON:0002872": [
                        "IS",
                        "inferior salivary nucleus",
                        "Nucleus salivarius inferior",
                        "nucleus salivarius inferior",
                        "Inferior salivatory nucleus",
                        "inferior salivatary nucleus",
                        "inferior salivatory nucleus",
                        "Nucleus salivatorius inferior",
                        "nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior",
                        "Nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior nervi glossopharyngei",
                        "Nucleus salivatorius inferior nervi glossopharyngei"
                    ],
                    "OMIM:146850": [
                        "IS",
                        "ISCW",
                        "ISSCW",
                        "IMMUNE SUPPRESSION",
                        "STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO"
                    ],
                    "FB:FBgn0001274": [
                        "Is"
                    ],
                    "PUBCHEM.COMPOUND:7021816": [
                        "IS",
                        "isoleucylserine",
                        "Isoleucyl-Serine",
                        "L-isoleucyl-L-serine",
                        "Ile-Ser",
                        "L-Ile-L-Ser",
                        "CHEMBL56803"
                    ],
                    "UMLS:C0021632": [
                        "IS",
                        "INSTRUM",
                        "instrumentation",
                        "instrumentation aspects"
                    ]
                }
            },
            {
                "label": "seldom warranted",
                "id": {}
            }
        ]
    ],
    "Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, and limitation of motion.": [
        [
            {
                "label": "Improvement",
                "id": {
                    "UMLS:C2986411": [
                        "Improvement"
                    ],
                    "UMLS:C3844714": [
                        "No improvement"
                    ],
                    "UMLS:C5141504": [
                        "Improvement plan"
                    ],
                    "UMLS:C5452884": [
                        "Motor improvement"
                    ],
                    "UMLS:C0680092": [
                        "sexual improvement"
                    ]
                }
            },
            {
                "label": "is manifested by",
                "id": {}
            },
            {
                "label": "relief of muscle spasm",
                "id": {}
            }
        ],
        [
            {
                "label": "relief of muscle spasm",
                "id": {}
            },
            {
                "label": "is associated with",
                "id": {
                    "UMLS:C0544684": [
                        "Deafness associated with ischemia"
                    ],
                    "NCBIGene:9798": [
                        "IST1 FACTOR ASSOCIATED WITH ESCRT-III",
                        "IST1 factor associated with ESCRT-III",
                        "IST1",
                        "CHMP8",
                        "CHMP8",
                        "KIAA0174",
                        "IST1 gene",
                        "IST1, ESCRT-III associated factor",
                        "increased sodium tolerance 1 homolog (yeast)",
                        "INCREASED SODIUM TOLERANCE 1, YEAST, HOMOLOG OF",
                        "IST1, endosomal sorting complex required for transport-III component",
                        "IST1, endosomal sorting complex required for transport-III component"
                    ],
                    "UMLS:C4019004": [
                        "Case is associated with a known outbreak"
                    ],
                    "UMLS:C4019185": [
                        "Case is associated with a known outbreak",
                        "Case is associated with a known outbreak:Find:Pt:^Event:Ord",
                        "Case is associated with a known outbreak:Finding:To identify measures at a point in time:^Event:Ordinal"
                    ],
                    "UMLS:C1883213": [
                        "Suction Issue Associated with Medical Device",
                        "Suction Problem"
                    ]
                }
            },
            {
                "label": "signs and symptoms",
                "id": {
                    "NCIT:C3367": [
                        "Symptoms and Signs",
                        "Signs and symptoms",
                        "Signs and Symptoms",
                        "finding",
                        "Finding",
                        "sign/symptom",
                        "SIGNS SYMPTOMS",
                        "sign and symptom",
                        "Clinical finding",
                        "Sign and symptom",
                        "Clinical findings",
                        "clinical findings",
                        "Observable Entity",
                        "Clinical finding (finding)"
                    ],
                    "UMLS:C0156323": [
                        "Breast signs and symptoms",
                        "signs and symptoms in breast",
                        "Signs and symptoms in breast",
                        "Breast signs and symptoms (finding)",
                        "signs and symptoms in breast (diagnosis)"
                    ],
                    "UMLS:C0851952": [
                        "Tongue signs and symptoms"
                    ],
                    "UMLS:C4716887": [
                        "Signs and symptoms of pain"
                    ],
                    "UMLS:C0478147": [
                        "General symptoms and signs",
                        "General symptoms and signs (R50-R69)"
                    ]
                }
            }
        ],
        [
            {
                "label": "signs and symptoms",
                "id": {
                    "NCIT:C3367": [
                        "Symptoms and Signs",
                        "Signs and symptoms",
                        "Signs and Symptoms",
                        "finding",
                        "Finding",
                        "sign/symptom",
                        "SIGNS SYMPTOMS",
                        "sign and symptom",
                        "Clinical finding",
                        "Sign and symptom",
                        "Clinical findings",
                        "clinical findings",
                        "Observable Entity",
                        "Clinical finding (finding)"
                    ],
                    "UMLS:C0156323": [
                        "Breast signs and symptoms",
                        "signs and symptoms in breast",
                        "Signs and symptoms in breast",
                        "Breast signs and symptoms (finding)",
                        "signs and symptoms in breast (diagnosis)"
                    ],
                    "UMLS:C0851952": [
                        "Tongue signs and symptoms"
                    ],
                    "UMLS:C4716887": [
                        "Signs and symptoms of pain"
                    ],
                    "UMLS:C0478147": [
                        "General symptoms and signs",
                        "General symptoms and signs (R50-R69)"
                    ]
                }
            },
            {
                "label": "are namely",
                "id": {}
            },
            {
                "label": "pain",
                "id": {
                    "NCIT:C53794": [
                        "PAIN",
                        "Adverse Event Associated with Pain"
                    ],
                    "NCIT:C143725": [
                        "Pain",
                        "Pain, CTCAE"
                    ],
                    "HP:0012531": [
                        "Pain",
                        "pain",
                        "PAIN",
                        "pains",
                        "painful",
                        "Painful",
                        "Pain NOS",
                        "Pain, NOS",
                        "sense of pain",
                        "Pain symptoms",
                        "TYPES OF PAIN",
                        "pain (symptom)",
                        "Pain (finding)",
                        "Pain (Various)",
                        "Unspecified pain",
                        "Unspecified Pain",
                        "Pain (b280-b289)",
                        "Pain, unspecified",
                        "Pain observations",
                        "A26-A29 TYPES OF PAIN",
                        "RNDx unspecified pain",
                        "RNDx unspecified pain (diagnosis)",
                        "Ache",
                        "Dolor",
                        "Dolour",
                        "Part hurts"
                    ],
                    "NCIT:C53837": [
                        "Pain",
                        "Pain by Anatomic Descriptor, CTCAE"
                    ],
                    "NCBIGene:37985": [
                        "pain"
                    ]
                }
            }
        ],
        [
            {
                "label": "signs and symptoms",
                "id": {
                    "NCIT:C3367": [
                        "Symptoms and Signs",
                        "Signs and symptoms",
                        "Signs and Symptoms",
                        "finding",
                        "Finding",
                        "sign/symptom",
                        "SIGNS SYMPTOMS",
                        "sign and symptom",
                        "Clinical finding",
                        "Sign and symptom",
                        "Clinical findings",
                        "clinical findings",
                        "Observable Entity",
                        "Clinical finding (finding)"
                    ],
                    "UMLS:C0156323": [
                        "Breast signs and symptoms",
                        "signs and symptoms in breast",
                        "Signs and symptoms in breast",
                        "Breast signs and symptoms (finding)",
                        "signs and symptoms in breast (diagnosis)"
                    ],
                    "UMLS:C0851952": [
                        "Tongue signs and symptoms"
                    ],
                    "UMLS:C4716887": [
                        "Signs and symptoms of pain"
                    ],
                    "UMLS:C0478147": [
                        "General symptoms and signs",
                        "General symptoms and signs (R50-R69)"
                    ]
                }
            },
            {
                "label": "are namely",
                "id": {}
            },
            {
                "label": "tenderness",
                "id": {
                    "NCIT:C50748": [
                        "TENDERNESS",
                        "Tenderness",
                        "tenderness",
                        "Tenderness NOS",
                        "TENDERNESS (NOS)",
                        "Tenderness (finding)",
                        "sore",
                        "soreness",
                        "Soreness",
                        "Sore pain",
                        "Tender pain",
                        "sore, painful",
                        "sore to touch",
                        "Sore to touch",
                        "Soreness (finding)"
                    ],
                    "UMLS:C0684239": [
                        "tenderness",
                        "emotional tenderness",
                        "Emotional tenderness"
                    ],
                    "NCIT:C78325": [
                        "gum tenderness",
                        "Tenderness of gums",
                        "Gingival tenderness",
                        "GINGIVAL TENDERNESS",
                        "Tenderness of gums (finding)",
                        "gum ache",
                        "Ache gum",
                        "PAIN GUM",
                        "GUM PAIN",
                        "sore gum",
                        "gum sore",
                        "Gum pain",
                        "Pain gum",
                        "gum pain",
                        "gums pain",
                        "sore gums",
                        "ache gums",
                        "Pain;gums",
                        "Sore gums",
                        "gums sore",
                        "aches gum",
                        "gums sores",
                        "Tender gum",
                        "Gingivalgia",
                        "gums painful",
                        "Soreness gum",
                        "gum soreness",
                        "SORENESS GUM",
                        "painful gums",
                        "Painful gums",
                        "Gingival Pain",
                        "gingival pain",
                        "GINGIVAL PAIN",
                        "Gingival pain",
                        "pain in the gums",
                        "Painful gingivae",
                        "Sore gums - symptom",
                        "Sore gums (finding)",
                        "painful gums (symptom)"
                    ],
                    "UMLS:C0239230": [
                        "EAR TENDERNESS"
                    ],
                    "UMLS:C0235634": [
                        "CVA tenderness",
                        "FLANK TENDERNESS",
                        "Flank tenderness",
                        "RENAL ANGLE TENDERNESS",
                        "Renal angle tenderness",
                        "COSTAL MARGIN TENDERNESS",
                        "COSTOVERTEBRAL ANGLE TENDERNESS",
                        "Costovertebral angle tenderness",
                        "costovertebral angle tenderness",
                        "Renal angle tenderness (finding)",
                        "costovertebral angle tenderness (physical finding)"
                    ]
                }
            }
        ],
        [
            {
                "label": "signs and symptoms",
                "id": {
                    "NCIT:C3367": [
                        "Symptoms and Signs",
                        "Signs and symptoms",
                        "Signs and Symptoms",
                        "finding",
                        "Finding",
                        "sign/symptom",
                        "SIGNS SYMPTOMS",
                        "sign and symptom",
                        "Clinical finding",
                        "Sign and symptom",
                        "Clinical findings",
                        "clinical findings",
                        "Observable Entity",
                        "Clinical finding (finding)"
                    ],
                    "UMLS:C0156323": [
                        "Breast signs and symptoms",
                        "signs and symptoms in breast",
                        "Signs and symptoms in breast",
                        "Breast signs and symptoms (finding)",
                        "signs and symptoms in breast (diagnosis)"
                    ],
                    "UMLS:C0851952": [
                        "Tongue signs and symptoms"
                    ],
                    "UMLS:C4716887": [
                        "Signs and symptoms of pain"
                    ],
                    "UMLS:C0478147": [
                        "General symptoms and signs",
                        "General symptoms and signs (R50-R69)"
                    ]
                }
            },
            {
                "label": "are namely",
                "id": {}
            },
            {
                "label": "limitation of motion",
                "id": {
                    "UMLS:C0518456": [
                        "Limitation of motion",
                        "Limited mobility",
                        "Impaired mobility",
                        "impaired mobility",
                        "MOTION LIMITATION",
                        "impaired physical mobility",
                        "impaired mobility physical",
                        "Impaired physical mobility",
                        "problem; impaired mobility",
                        "Impaired mobility (finding)",
                        "impaired; mobility, problem",
                        "Physical Mobility Impairment",
                        "Physical mobility impairment",
                        "RNDx physical mobility impairment",
                        "Impaired physical mobility (specify level)",
                        "RNDx physical mobility impairment (diagnosis)"
                    ],
                    "HP:0005986": [
                        "Limitation of neck motion",
                        "stiff neck",
                        "Neck rigid",
                        "Neck stiff",
                        "crick neck",
                        "NECK STIFF",
                        "neck crick",
                        "Stiff neck",
                        "Crick neck",
                        "NECK RIGID",
                        "cricked neck",
                        "Rigidity neck",
                        "neck rigidity",
                        "RIGIDITY NECK",
                        "Crick in neck",
                        "Neck rigidity",
                        "crick in neck",
                        "NECK RIGIDITY",
                        "Neck Stiffness",
                        "NECK STIFFNESS",
                        "Neck stiffness",
                        "neck stiffness",
                        "Stiffness;neck",
                        "Nuchal Rigidity",
                        "NUCHAL RIGIDITY",
                        "stiffness; neck",
                        "nuchal rigidity",
                        "Nuchal rigidity",
                        "neck; stiffness",
                        "Rigidity, Nuchal",
                        "Cervical rigidity",
                        "stiffness of neck",
                        "NS - Neck stiffness",
                        "Stiff neck (finding)",
                        "Limited neck mobility",
                        "Limited neck mobility",
                        "Restricted neck movement",
                        "neck stiffness (symptom)",
                        "Nuchal rigidity (finding)",
                        "Cervical rigidity (finding)",
                        "stiff neck (physical finding)"
                    ],
                    "UMLS:C0231589": [
                        "Limitation of joint motion",
                        "decreased motion range",
                        "limited range of motion",
                        "Limited range of motion",
                        "limited motion of range",
                        "Joint movement decreased",
                        "RANGE OF MOTION DECREASED",
                        "decreased range of motion",
                        "Joint movement restrained",
                        "range of motion decreased",
                        "Restricted joint movement",
                        "Decreased range of motion",
                        "Joint movement restricted",
                        "Decrease in range of motion",
                        "Restriction of joint motion",
                        "Limitation of joint movement",
                        "Range joint movement reduced",
                        "Range of joint movement reduced",
                        "Limitation of joint movement (finding)",
                        "range of motion decreased (physical finding)"
                    ],
                    "UMLS:C1717848": [
                        "Functional limitation in range of motion"
                    ],
                    "UMLS:C1976699": [
                        "Other limitation or loss - range of motion"
                    ]
                }
            }
        ]
    ],
    "Amphetamine sulfate tablets, USP 5 mg and 10 mg are indicated for: Narcolepsy": [
        [
            {
                "label": "Amphetamine sulfate tablets, USP 5 mg and 10 mg",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "Narcolepsy",
                "id": {
                    "MONDO:0021107": [
                        "narcolepsy",
                        "NARCOLEPSY",
                        "Narcolepsy",
                        "narcolepsy",
                        "Narcolepsy NOS",
                        "narcolepsy disorder",
                        "Narcolepsy (disorder)",
                        "narcolepsy (diagnosis)",
                        "Narcolepsy, without cataplexy",
                        "narcolepsy, without cataplexy",
                        "Narcolepsy with or without cataplexy",
                        "narcolepsies",
                        "paroxysmal sleep",
                        "Paroxysmal sleep",
                        "PAROXYSMAL SLEEP",
                        "paroxysmal sleep",
                        "Paroxysmal Sleep",
                        "Gelineau Syndrome",
                        "GELINEAU SYNDROME",
                        "SLEEP, PAROXYSMAL",
                        "Sleep, Paroxysmal",
                        "gelineau syndrome",
                        "Syndrome, Gelineau",
                        "Gelineaus Syndrome",
                        "gelineau's syndrome",
                        "Gelineau's Syndrome",
                        "Gelineau's syndrome",
                        "gélineau's syndrome",
                        "Narcoleptic syndrome",
                        "narcoleptic syndrome",
                        "Narcoleptic Syndrome",
                        "Gelineau's Syndromes",
                        "Syndrome, Gelineau's",
                        "Syndromes, Gelineau's",
                        "Syndrome, Narcoleptic",
                        "Narcoleptic Syndromes",
                        "Syndromes, Narcoleptic",
                        "excessive uncontrollable daytime sleepiness"
                    ],
                    "MONDO:0011607": [
                        "narcolepsy 2",
                        "narcolepsy 2, susceptibility to",
                        "NARCOLEPSY 2, SUSCEPTIBILITY TO",
                        "NRCLP2"
                    ],
                    "MONDO:0012898": [
                        "narcolepsy 4",
                        "NARCOLEPSY 4, SUSCEPTIBILITY TO",
                        "narcolepsy 4, susceptibility to",
                        "NRCLP4"
                    ],
                    "MONDO:0012179": [
                        "narcolepsy 3",
                        "NARCOLEPSY 3",
                        "NRCLP3"
                    ],
                    "MONDO:0008062": [
                        "narcolepsy 1",
                        "Narcolepsy 1",
                        "NARCOLEPSY 1",
                        "HCRT narcolepsy",
                        "narcolepsy type 1",
                        "narcolepsy caused by mutation in HCRT",
                        "NRCLP1",
                        "NRCLP1",
                        "CATAPLEXY",
                        "cataplexy",
                        "cataplexy",
                        "Cataplexy",
                        "Cataleptic Attack",
                        "Henneberg Syndrome",
                        "Attack, Cataleptic",
                        "Cataleptic Attacks",
                        "Syndrome, Henneberg",
                        "Attacks, Cataleptic",
                        "Cataplexy (disorder)",
                        "Tonelessness Syndrome",
                        "Cataplexy (diagnosis)",
                        "Syndrome, Tonelessness",
                        "NARCOLEPTIC SYNDROME 1",
                        "narcoleptic syndrome 1",
                        "Narcoleptic Syndrome 1",
                        "Tonelessness Syndromes",
                        "Syndromes, Tonelessness",
                        "disorder of brain cataplexy"
                    ]
                }
            }
        ]
    ],
    "Amphetamine sulfate tablets, USP 5 mg and 10 mg are indicated for: Attention Deficit Disorder with Hyperactivity as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.": [
        [
            {
                "label": "Amphetamine sulfate tablets, USP 5 mg and 10 mg",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "Attention Deficit Disorder with Hyperactivity",
                "id": {
                    "MONDO:0005302": [
                        "Attention deficit disorder with hyperactivity",
                        "attention deficit disorder with hyperactivity",
                        "Attention Deficit Disorder with Hyperactivity",
                        "Attention Deficit Disorders with Hyperactivity",
                        "attention deficit disorder; with hyperactivity",
                        "Attention deficit disorder without hyperactivity",
                        "attention deficit disorder without hyperactivity",
                        "attention deficit disorder; without hyperactivity",
                        "ADD - Attention deficit disorder with hyperactivity",
                        "ADHD - Attention deficit disorder with hyperactivity",
                        "ADD - Attention deficit disorder without hyperactivity",
                        "Attention deficit disorder with hyperactivity syndrome",
                        "disorder; attention deficit, with hyperactivity (ADHD)",
                        "Attention deficit disorder without hyperactivity syndrome",
                        "Attention deficit disorder of childhood with hyperactivity",
                        "Attention deficit disorder without mention of hyperactivity",
                        "attention deficit disorder without hyperactivity (diagnosis)",
                        "Attention deficit disorder of childhood without mention of hyperactivity",
                        "ADD",
                        "ADHD",
                        "ADDH",
                        "ADHD",
                        "addh",
                        "MBD syndrome",
                        "Attention deficit",
                        "Attention-deficit",
                        "deficit; attention",
                        "Attention deficits",
                        "child; hyperactivity",
                        "hyperactivity; child",
                        "Hyperkinetic Syndrome",
                        "hyperkinetic disorder",
                        "SYNDROME HYPERKINETIC",
                        "Hyperkinetic disorder",
                        "Syndrome hyperkinetic",
                        "ATTENTION DEFICIT DIS",
                        "Hyperkinetic synd NOS",
                        "HYPERKINETIC SYNDROME",
                        "Hyperkinetic syndrome",
                        "hyperkinetic disorder",
                        "hyperkinetic syndrome",
                        "hyperkinetic; syndrome",
                        "disorder hyperactivity",
                        "syndrome; hyperkinetic",
                        "hyperactivity disorder",
                        "hyperkinetic; disorder",
                        "Attn defic nonhyperact",
                        "Hyperkinetic disorders",
                        "disorder; hyperkinetic",
                        "disorder; hyperactivity",
                        "Minimal Brain Disorders",
                        "Attn deficit w hyperact",
                        "Syndromes, Hyperkinetic",
                        "hyperactivity; disorder",
                        "Hyperkinetic syndrome NOS",
                        "Minimal brain dysfunction",
                        "Minimal Brain Dysfunction",
                        "MINIMAL BRAIN DYSFUNCTION",
                        "Overactive child syndrome",
                        "minimal brain dysfunction",
                        "Brain Dysfunction, Minimal",
                        "attention deficit disorder",
                        "Hyperactivity Disorder NOS",
                        "Hyperactive child syndrome",
                        "Attention Deficit Disorder",
                        "Attention-deficit disorder",
                        "attention deficit disorder",
                        "attention-deficit disorder",
                        "HYPERACTIVITY OF CHILDHOOD",
                        "ATTENTION DEFICIT DISORDER",
                        "Dysfunction, Minimal Brain",
                        "hyperactive child syndrome",
                        "Attention deficit disorder",
                        "Attention Deficit Disorders",
                        "Deficit Disorder, Attention",
                        "Disorder, Attention Deficit",
                        "disorder; attention deficit",
                        "attention deficit disorders",
                        "Deficit Disorders, Attention",
                        "Disorders, Attention Deficit",
                        "Childhood hyperkinetic syndr.",
                        "MBD - Minimal brain dysfunctn",
                        "Minimal brain damage syndrome",
                        "Att deficit hyperactivity dis",
                        "ADD - Attention deficit disord",
                        "attention deficit disorder add",
                        "Attntn defic dis w/out hypract",
                        "Disorder;attent deficit(hyper)",
                        "Attention-Deficit Disorder NOS",
                        "ADD-Attn def dis with hyperact",
                        "ADD-Attn defic dis w/t hypract",
                        "add attention deficit disorder",
                        "Attentn deficit hyperkin disor",
                        "Attention deficit-not hyperact",
                        "Childhood hyperkinetic syndrome",
                        "childhood hyperkinetic syndrome",
                        "MBD - Minimal brain dysfunction",
                        "attention deficit hyper disorder",
                        "ADD - Attention deficit disorder",
                        "attention deficit(hyper) disorder",
                        "attention deficits disorder hyper",
                        "Unspecified hyperkinetic syndrome",
                        "Hyperkinetic syndrome of childhood",
                        "Minimal brain dysfunction syndrome",
                        "Hyperkinetic disorder, unspecified",
                        "ATTENTION DEFICIT HYPERACTIVITY DIS",
                        "ADHD, predominantly inattentive type",
                        "Attention deficit without hyperactivity",
                        "Attention deficit hyperkinetic disorder",
                        "Attention Deficit Hyperactivity Disorder",
                        "Attention-deficit hyperactivity disorder",
                        "attention deficit hyperactivity disorder",
                        "attention-deficit hyperactivity disorder",
                        "Attention deficit-hyperactivity disorder",
                        "attention deficit hyperactivity disorder",
                        "Attention deficit/hyperactivity disorder",
                        "ATTENTION DEFICIT DIS WITH HYPERACTIVITY",
                        "Attention-deficit/hyperactivity disorder",
                        "Attention deficit hyperactivity disorder",
                        "ATTENTION DEFICIT-HYPERACTIVITY DISORDER",
                        "Attention Deficit-Hyperactivity Disorder",
                        "ATTENTION DEFICIT HYPERACTIVITY DISORDER",
                        "Attention Deficit Hyperactivity Disorders",
                        "Attention Deficit-Hyperactivity Disorders",
                        "Disorder, Attention Deficit-Hyperactivity",
                        "Attention-deficit hyperactivity disorders",
                        "Deficit-Hyperactivity Disorder, Attention",
                        "Deficit-Hyperactivity Disorders, Attention",
                        "Disorders, Attention Deficit-Hyperactivity",
                        "Attention-deficit hyperactivity disorder NOS",
                        "Attention deficit/hyperactivity disorder NOS",
                        "attention deficit syndrome with hyperactivity",
                        "unspecified hyperkinetic syndrome of childhood",
                        "Unspecified hyperkinetic syndrome of childhood",
                        "ADHD, predominantly hyperactive-impulsive type",
                        "attention deficit hyperactivity disorder (ADHD)",
                        "Attention deficit hyperactivity disorder (ADHD)",
                        "Attention-deficit/hyperactivity disorder (ADHD)",
                        "ADHD (attention deficit hyperactivity disorder)",
                        "Attention deficit-hyperactivity disorder (ADHD)",
                        "Attention-deficit hyperactivity disorder (ADHD)",
                        "ADHD (attention-deficit hyperactivity disorder)",
                        "ADHD, predominantly inattentive type (diagnosis)",
                        "Childhood attention deficit/hyperactivity disorder",
                        "Attention deficit hyperactivity disorder (disorder)",
                        "attention-deficit hyperactivity disorder (diagnosis)",
                        "attention-deficit disorder predominantly inattentive type",
                        "unspecified hyperkinetic syndrome of childhood (diagnosis)",
                        "Attention-Deficit Disorder, Predominantly Inattentive Type",
                        "attention deficit hyperactivity disorder, inattentive type",
                        "Attn-defct hyperactivity disorder, predom inattentive type",
                        "Attention Deficit Hyperactivity Disorder, Inattentive Type",
                        "Hyperactivity Disorder, Predominantly Hyperactive-Impulsive Type",
                        "Attention deficit hyperactivity disorder, hyperactive impulsive type",
                        "Attention-Deficit Disorder, Predominantly Hyperactive-Impulsive Type",
                        "Attention Deficit Hyperactivity Disorder, Inattentive/Distractible Type",
                        "attention deficit hyperactivity disorder, inattentive/distractible type",
                        "attention-deficit hyperactivity disorder predominantly inattentive type",
                        "attention deficit hyperactivity disorder, predominantly inattentive type",
                        "Attention Deficit Hyperactivity Disorder, Predominantly Inattentive Type",
                        "Attention deficit hyperactivity disorder, predominantly inattentive type",
                        "Attention-deficit hyperactivity disorder, predominantly inattentive type",
                        "Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type",
                        "Attention deficit hyperactivity disorder, predominantly hyperactive impulsive type",
                        "Attention deficit hyperactivity disorder, predominantly inattentive type (disorder)",
                        "Attention deficit hyperactivity disorder, predominantly hyperactive impulsive type (disorder)"
                    ],
                    "UMLS:C3695185": [
                        "attention-deficit hyperactivity disorder with residual state",
                        "attention-deficit hyperactivity disorder with residual state (diagnosis)"
                    ],
                    "UMLS:C4016488": [
                        "AARSKOG-SCOTT SYNDROME WITH ATTENTION DEFICIT-HYPERACTIVITY DISORDER"
                    ],
                    "MONDO:0010589": [
                        "FACIOGENITAL DYSPLASIA WITH ATTENTION DEFICIT-HYPERACTIVITY DISORDER",
                        "Faciogenital Dysplasia with Attention Deficit-Hyperactivity Disorder",
                        "faciogenital dysplasia with attention Deficit-hyperactivity disorder",
                        "FGD",
                        "AAS",
                        "FGD",
                        "AAS",
                        "FGDY",
                        "FGDY",
                        "MRXS16",
                        "Aarskog",
                        "Greig syndrome",
                        "greig syndrome",
                        "greigs syndrome",
                        "Aarskog disease",
                        "Aarskog Disease",
                        "Aarskog syndrome",
                        "MRXS16, included",
                        "aarskog syndrome",
                        "Aarskog Syndrome",
                        "Aarskog syndrome",
                        "aarskogs syndrome",
                        "Aarskog's syndrome",
                        "aarskog's syndrome",
                        "Aarskog-like syndrome",
                        "FACIOGENITAL DYSPLASIA",
                        "faciogenital dysplasia",
                        "Aarskog-Scott syndrome",
                        "Scott Aarskog Syndrome",
                        "aarskog-scott syndrome",
                        "Aarskog-Scott Syndrome",
                        "faciogenital dysplasia",
                        "Aarskog-Scott syndrome",
                        "Aarskog Scott syndrome",
                        "Scott Aarskog syndrome",
                        "Faciogenital Dysplasia",
                        "AARSKOG-SCOTT SYNDROME",
                        "Faciogenital dysplasia",
                        "shawl scrotum syndrome",
                        "facio-genital dysplasia",
                        "AARSKOG SYNDROME, X-LINKED",
                        "Aarskog syndrome, X-linked",
                        "FACIODIGITOGENITAL SYNDROME",
                        "Aarskog syndrome (disorder)",
                        "Faciodigitogenital Syndrome",
                        "Faciodigitogenital syndrome",
                        "faciodigitogenital syndrome",
                        "Aarskog-Scott syndrome (ASS)",
                        "facio-digito-genital syndrome",
                        "Facio-Digito-Genital Dysplasia",
                        "facio-digito-genital dysplasia",
                        "facial-digital-genital syndrome",
                        "Aarskog-Scott syndrome, X-linked",
                        "Aarskog-Scott syndrome (diagnosis)",
                        "faciodigitogenital syndrome, recessive",
                        "MENTAL RETARDATION, X-LINKED, SYNDROMIC 16",
                        "Aarskog-Scott syndrome, X-linked recessive",
                        "mental retardation, X-linked, syndromic 16",
                        "mental retardation, X-linked, syndromic 16, included",
                        "INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 16",
                        "mental retardation, X-linked syndromic 16, X-linked recessive"
                    ],
                    "UMLS:C3864054": [
                        "attention deficit disorder without hyperactivity, predominantly inattentive type",
                        "attention deficit disorder without hyperactivity, predominantly inattentive type (diagnosis)"
                    ]
                }
            }
        ],
        [
            {
                "label": "a total treatment program",
                "id": {}
            },
            {
                "label": "typically includes",
                "id": {
                    "UMLS:C4291820": [
                        "Occupational therapy evaluation, low complexity, requiring these components: An occupational profile and medical and therapy history, which includes a brief history including review of medical and/or therapy records relating to the presenting problem; An assessment(s) that identifies 1-3 performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; and Clinical decision making of low complexity, which includes an analysis of the occupational profile, analysis of data from problem-focused assessment(s), and consideration of a limited number of treatment options. Patient presents with no comorbidities that affect occupational performance. Modification of tasks or assistance (eg, physical or verbal) with assessment(s) is not necessary to enable completion of evaluation component. Typically, 30 minutes are spent face-to-face with the patient and/or family.",
                        "OT EVAL LOW COMPLEX 30 MIN",
                        "Ot eval low complex 30 min",
                        "OCCUPATIONAL THERAPY EVAL LOW COMPLEX 30 MINS"
                    ],
                    "UMLS:C4291822": [
                        "Occupational therapy evaluation, high complexity, requiring these components: An occupational profile and medical and therapy history, which includes review of medical and/or therapy records and extensive additional review of physical, cognitive, or psychosocial history related to current functional performance; An assessment(s) that identifies 5 or more performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; and Clinical decision making of high analytic complexity, which includes an analysis of the patient profile, analysis of data from comprehensive assessment(s), and consideration of multiple treatment options. Patient presents with comorbidities that affect occupational performance. Significant modification of tasks or assistance (eg, physical or verbal) with assessment(s) is necessary to enable patient to complete evaluation component. Typically, 60 minutes are spent face-to-face with the patient and/or family.",
                        "OT EVAL HIGH COMPLEX 60 MIN",
                        "Ot eval high complex 60 min",
                        "OCCUPATIONAL THERAPY EVAL HIGH COMPLEX 60 MINS"
                    ],
                    "UMLS:C4291821": [
                        "Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or psychosocial history related to current functional performance; An assessment(s) that identifies 3-5 performance deficits (ie, relating to physical, cognitive, or psychosocial skills) that result in activity limitations and/or participation restrictions; and Clinical decision making of moderate analytic complexity, which includes an analysis of the occupational profile, analysis of data from detailed assessment(s), and consideration of several treatment options. Patient may present with comorbidities that affect occupational performance. Minimal to moderate modification of tasks or assistance (eg, physical or verbal) with assessment(s) is necessary to enable patient to complete evaluation component. Typically, 45 minutes are spent face-to-face with the patient and/or family.",
                        "OT EVAL MOD COMPLEX 45 MIN",
                        "Ot eval mod complex 45 min",
                        "OCCUPATIONAL THERAPY EVAL MOD COMPLEX 45 MINS"
                    ]
                }
            },
            {
                "label": "other remedial measures (psychological, educational, social)",
                "id": {}
            }
        ],
        [
            {
                "label": "a total treatment program",
                "id": {}
            },
            {
                "label": "is for",
                "id": {
                    "CHEBI:140821": [
                        "iso-Forssman",
                        "i-Forssman",
                        "isogloboside iGb5Cer",
                        "alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer",
                        "N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide"
                    ],
                    "UMLS:C1552560": [
                        "is backup for"
                    ],
                    "PUBCHEM.COMPOUND:8052": [
                        "Isoamyl formate",
                        "Isoamyl formate",
                        "isoamyl formate",
                        "ISOAMYL FORMATE",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formic acid",
                        "Formate, isopentyl ester",
                        "Isopentyl alcohol, formate",
                        "Formic acid, isopentyl ester",
                        "Formic acid, isopentyl ester",
                        "Isoamyl methanoate",
                        "Isoamyl methanoate",
                        "Isopentyl methanoate",
                        "Isopentyl methanoate",
                        "3-methylbutyl formate",
                        "3-Methylbutyl formate",
                        "Isoamyl methanoic acid",
                        "Isopentyl methanoic acid",
                        "3-Methyl-1-butyl formate",
                        "3-Methylbutyl formic acid",
                        "1-Butanol, 3-methyl-, formate",
                        "3-Methyl-2-butenyl formic acid",
                        "1-Butanol, 3-methyl-, 1-formate"
                    ],
                    "UMLS:C2346508": [
                        "ISS for Myeloma",
                        "International Staging System for Myeloma"
                    ],
                    "UMLS:C1562189": [
                        "Is etiology for",
                        "is etiology for",
                        "Is aetiology for",
                        "Is etiology for (link assertion)"
                    ]
                }
            },
            {
                "label": "a stabilizing effect in children with behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity",
                "id": {}
            }
        ]
    ],
    "The diagnosis of the syndrome should not be made with finality when these symptoms are only of comparatively recent origin. Nonlocalizing (soft) neurological signs, learning disability, and abnormal EEG may or may not be present, and a diagnosis of central nervous system dysfunction may or not be warranted.": [
        [
            {
                "label": "The diagnosis of the syndrome",
                "id": {
                    "UMLS:C2243026": [
                        "complex regional pain syndrome type I of the knee (diagnosis)",
                        "complex regional pain syndrome type I of the knee"
                    ],
                    "UMLS:C0343267": [
                        "complex regional pain syndrome type I of the hand (diagnosis)",
                        "Algodystrophy of hand",
                        "HAND REFLEX SYMPATHETIC DYSTROPHY",
                        "Reflex sympathetic dystrophy of hand",
                        "Complex regional pain syndrome of hand",
                        "complex regional pain syndrome type I of the hand",
                        "Complex regional pain syndrome of hand (disorder)"
                    ],
                    "UMLS:C2169886": [
                        "complex regional pain syndrome type I of the wrist (diagnosis)",
                        "complex regional pain syndrome type I of the wrist"
                    ],
                    "UMLS:C2169882": [
                        "complex regional pain syndrome type I of the ankle (diagnosis)",
                        "complex regional pain syndrome type I of the ankle"
                    ],
                    "UMLS:C2169884": [
                        "complex regional pain syndrome type I of the elbow (diagnosis)",
                        "complex regional pain syndrome type I of the elbow"
                    ]
                }
            },
            {
                "label": "should not be made",
                "id": {
                    "UMLS:C0497699": [
                        "Technical component; under certain circumstances, a charge may be made for the technical component alone; under those circumstances the technical component charge is identified by adding modifier 'tc' to the usual procedure number; technical component charges are institutional charges and not billed separately by physicians; however, portable x-ray suppliers only bill for technical component and should utilize modifier tc; the charge data from portable x-ray suppliers will then be used to build customary and prevailing profiles",
                        "Technical component"
                    ]
                }
            },
            {
                "label": "with finality when these symptoms are only of comparatively recent origin",
                "id": {}
            }
        ],
        [
            {
                "label": "Nonlocalizing (soft) neurological signs, learning disability, and abnormal EEG",
                "id": {}
            },
            {
                "label": "may or may not be",
                "id": {
                    "UMLS:C2674041": [
                        "Rash may or may not be pruritic"
                    ],
                    "UMLS:C1834241": [
                        "Freckling may or may not be present"
                    ],
                    "UMLS:C3279967": [
                        "Bilirubin may or may not be increased"
                    ],
                    "UMLS:C1834239": [
                        "Neurofibromas may or may not be present"
                    ],
                    "UMLS:C1834240": [
                        "Cafe-au-lait spots may or may not be present"
                    ]
                }
            },
            {
                "label": "present",
                "id": {
                    "NCIT:C159277": [
                        "Present",
                        "Macroscopic Satellite Nodule is Present"
                    ],
                    "NCIT:C158920": [
                        "Present",
                        "MLH1 Promoter Hypermethylation",
                        "COCA2 Promoter Hypermethylation",
                        "HNPCC2 Promoter Hypermethylation",
                        "MLH1 Gene Promoter Hypermethylation",
                        "MutL Homolog 1 Promoter Hypermethylation",
                        "MutL, E. coli, Homolog of, 1 Promoter Hypermethylation"
                    ],
                    "NCIT:C159241": [
                        "Present",
                        "Myometrial invasion",
                        "Myometrial Invasion"
                    ],
                    "NCIT:C160836": [
                        "Present",
                        "regression",
                        "Decreasing",
                        "Tumor regression",
                        "Tumor Regression",
                        "Tumor Decreasing"
                    ],
                    "NCIT:C153562": [
                        "Present",
                        "Positive",
                        "Methylated MGMT",
                        "MGMT Methylation",
                        "MGMT Gene Methylation",
                        "Methylated MGMT Promoter",
                        "Methylated MGMT Gene Promoter",
                        "MGMT Gene Promoter Methylation",
                        "Methylguanine-DNA Methyltransferase Gene Promoter Methylation",
                        "O-6-Methylguanine-DNA Methyltransferase Gene Promoter Methylation"
                    ]
                }
            }
        ],
        [
            {
                "label": "a diagnosis of central nervous system dysfunction",
                "id": {}
            },
            {
                "label": "may or not be",
                "id": {
                    "UMLS:C2674041": [
                        "Rash may or may not be pruritic"
                    ],
                    "UMLS:C1834241": [
                        "Freckling may or may not be present"
                    ],
                    "UMLS:C3279967": [
                        "Bilirubin may or may not be increased"
                    ],
                    "UMLS:C1834239": [
                        "Neurofibromas may or may not be present"
                    ],
                    "UMLS:C1834240": [
                        "Cafe-au-lait spots may or may not be present"
                    ]
                }
            },
            {
                "label": "warranted",
                "id": {
                    "UMLS:C1553502": [
                        "warranted product",
                        "RoleClassWarrantedProduct"
                    ],
                    "UMLS:C3244071": [
                        "WarrantedProductRoleType"
                    ],
                    "UMLS:C4711244": [
                        "Assist family to resolve unrealistic feelings of guilt or responsibility, as warranted"
                    ]
                }
            }
        ]
    ],
    "Methylphenidate Hydrochloride is indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity": [
        [
            {
                "label": "Methylphenidate Hydrochloride",
                "id": {
                    "UNII:4B3SC438HI": [
                        "METHYLPHENIDATE HYDROCHLORIDE"
                    ],
                    "UMLS:C0700545": [
                        "Methylphenidate Hydrochloride",
                        "Methylphenidate hydrochloride",
                        "METHYLPHENIDATE HYDROCHLORIDE",
                        "methylphenidate hydrochloride",
                        "Hydrochloride, Methylphenidate",
                        "Methylphenidate hydrochloride (substance)",
                        "methylphenidate hydrochloride (medication)",
                        "methylphenidate HCl",
                        "methylphenidate hcl",
                        "Methylphenidylacetate hydrochloride",
                        "alpha-Phenyl-2-piperidineacetic Acid Methyl Ester Hydrochloride",
                        "alpha-phenyl-2-piperidineacetic acid methyl ester hydrochloride"
                    ],
                    "CHEMBL.COMPOUND:CHEMBL1722": [
                        "METHYLPHENIDATE HYDROCHLORIDE",
                        "methylphenidate hydrochloride",
                        "Ritalin",
                        "Metadate",
                        "Concerta",
                        "Centedrin",
                        "methylphenidate HCl",
                        "methylphenidylacetate hydrochloride",
                        "2-(2-methoxy-2-oxo-1-phenylethyl)piperidinium chloride"
                    ],
                    "PUBCHEM.COMPOUND:10945497": [
                        "Methylphenidate hydrochloride",
                        "Concerta",
                        "Daytrana",
                        "metilfenidato",
                        "methylphenidan",
                        "methylphenidate",
                        "methylphenidate",
                        "methylphenidatum",
                        "dl-threo-methylphenidate",
                        "threo-(+-)-methylphenidate",
                        "methyl rac-threo-phenidylacetate",
                        "rac-methyl (2R)-phenyl[(2R)-piperidin-2-yl]acetate",
                        "rac-threo-methyl alpha-phenyl-alpha-(2-piperidyl)acetate",
                        "methyl rac-threo-alpha-phenyl-alpha-2-piperidinylacetate",
                        "rac-threo-alpha-phenyl-2-piperidineacetic acid methyl ester"
                    ],
                    "PUBCHEM.COMPOUND:4158": [
                        "Methylphenidate hydrochloride",
                        "Hydrochloride, methylphenidate",
                        "Celltech brand OF methylphenidate hydrochloride",
                        "Cephalon brand OF methylphenidate hydrochloride",
                        "Novartis brand 1 OF methylphenidate hydrochloride",
                        "Novartis brand 2 OF methylphenidate hydrochloride",
                        "Mallinckrodt brand OF methylphenidate hydrochloride",
                        "MPH",
                        "Equasym",
                        "Ritalin",
                        "Methylin",
                        "Ritaline",
                        "Daytrana",
                        "Concerta",
                        "Metadate",
                        "Centedrin",
                        "Ritalin-SR",
                        "Ritalin SR",
                        "Tsentedrin",
                        "Phenidylate",
                        "Metilfenidato",
                        "methylphenidan",
                        "Methylphenidan",
                        "Methylphenidan",
                        "methylphenidate",
                        "Methylphenidate",
                        "Methylphenidate",
                        "METHYLPHENIDATE",
                        "Methylphenidatum",
                        "d-methylphenidate",
                        "Methylphenidate HCL",
                        "Methylphenidic acid",
                        "D-Methylphenidate HCL",
                        "Methyl phenidylacetate",
                        "Methyl phenidylacetate",
                        "methyl phenidylacetate",
                        "Methyl phenidyl acetate",
                        "Methyl phenidylacetic acid",
                        "Metilfenidat hydrochloride",
                        "Methylphenidate (substance)",
                        "methylphenidate (medication)",
                        "CNS stimulants methylphenidate",
                        "Methylphenidate-containing product",
                        "Methylphenidylacetate hydrochloride",
                        "methyl phenyl(piperidin-2-yl)acetate",
                        "methyl α-phenyl-α-2-piperidinylacetate",
                        "Methyl α-phenyl-α-2-piperidinylacetate",
                        "Methyl a-phenyl-a-2-piperidinylacetate",
                        "Methyl α-phenyl-α-(2-piperidyl)acetate",
                        "methyl α-phenyl-α-(2-piperidyl)acetate",
                        "Methyl a-phenyl-a-(2-piperidyl)acetate",
                        "Methyl phenyl(piperidin-2-yl)acetic acid",
                        "Α-phenyl-2-piperidineacetate methyl ester",
                        "a-Phenyl-2-piperidineacetate methyl ester",
                        "Methyl α-phenyl-α-2-piperidinylacetic acid",
                        "Methyl α-phenyl-α-(2-piperidyl)acetic acid",
                        "Methyl a-phenyl-a-(2-piperidyl)acetic acid",
                        "Methyl a-phenyl-a-2-piperidinylacetic acid",
                        "alpha-Phenyl-2-piperidineacetate methyl ester",
                        "a-Phenyl-2-piperidineacetic acid methyl ester",
                        "α-phenyl-2-piperidineacetic acid methyl ester",
                        "Α-phenyl-2-piperidineacetic acid methyl ester",
                        "Methyl alpha-phenyl-alpha-2-piperidinylacetate",
                        "methyl alpha-phenyl-alpha-2-piperidinylacetate",
                        "Methyl alpha-phenyl-alpha-(2-piperidyl)acetate",
                        "methyl alpha-phenyl-alpha-(2-piperidyl)acetate",
                        "alpha-phenyl-2-piperidineacetic acid methyl ester",
                        "alpha-Phenyl-2-piperidineacetic acid methyl ester",
                        "alpha-Phenyl-2-piperidineacetic Acid Methyl Ester",
                        "Methyl alpha-phenyl-alpha-(2-piperidyl)acetic acid",
                        "Methyl alpha-phenyl-alpha-2-piperidinylacetic acid",
                        "2-Piperidineacetic acid, alpha-phenyl-, methyl ester",
                        "Product containing methylphenidate (medicinal product)"
                    ]
                }
            },
            {
                "label": "is indicated as",
                "id": {
                    "UMLS:C4710292": [
                        "Assure that someone is oxygenating the patient and assisting with intubation, as indicated"
                    ],
                    "UMLS:C4713987": [
                        "Assure that the surgical site is marked with a permanent marker by the surgeon, as indicated"
                    ],
                    "UMLS:C4714380": [
                        "Perform targeted assessment of the system that is indicated by the history of present illness"
                    ],
                    "UMLS:C4711109": [
                        "Ensure that equipment is operational via trial run (i.e., assemble laryngoscope and check light bulb function), as indicated"
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ]
                }
            },
            {
                "label": "an integral part of a total treatment program",
                "id": {}
            }
        ],
        [
            {
                "label": "total treatment program",
                "id": {}
            },
            {
                "label": "includes",
                "id": {
                    "UMLS:C0332257": [
                        "Includes",
                        "includes",
                        "include",
                        "Has part",
                        "included",
                        "has part",
                        "Inclusive",
                        "inclusive",
                        "including",
                        "Including",
                        "Including (qualifier)",
                        "Including (qualifier value)"
                    ],
                    "UMLS:C4065484": [
                        "diet includes",
                        "diet includes (history)"
                    ],
                    "UMLS:C4065481": [
                        "diet includes fruit",
                        "diet includes fruit (history)"
                    ],
                    "UMLS:C4065478": [
                        "diet includes peanuts",
                        "diet includes peanuts (history)"
                    ],
                    "UMLS:C3687491": [
                        "Includes sub-specimen",
                        "Includes sub-specimen (attribute)"
                    ]
                }
            },
            {
                "label": "other remedial measures (psychological, educational, social)",
                "id": {}
            }
        ],
        [
            {
                "label": "remedial measures",
                "id": {}
            },
            {
                "label": "is for",
                "id": {
                    "CHEBI:140821": [
                        "iso-Forssman",
                        "i-Forssman",
                        "isogloboside iGb5Cer",
                        "alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer",
                        "N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide"
                    ],
                    "UMLS:C1552560": [
                        "is backup for"
                    ],
                    "PUBCHEM.COMPOUND:8052": [
                        "Isoamyl formate",
                        "Isoamyl formate",
                        "isoamyl formate",
                        "ISOAMYL FORMATE",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formic acid",
                        "Formate, isopentyl ester",
                        "Isopentyl alcohol, formate",
                        "Formic acid, isopentyl ester",
                        "Formic acid, isopentyl ester",
                        "Isoamyl methanoate",
                        "Isoamyl methanoate",
                        "Isopentyl methanoate",
                        "Isopentyl methanoate",
                        "3-methylbutyl formate",
                        "3-Methylbutyl formate",
                        "Isoamyl methanoic acid",
                        "Isopentyl methanoic acid",
                        "3-Methyl-1-butyl formate",
                        "3-Methylbutyl formic acid",
                        "1-Butanol, 3-methyl-, formate",
                        "3-Methyl-2-butenyl formic acid",
                        "1-Butanol, 3-methyl-, 1-formate"
                    ],
                    "UMLS:C2346508": [
                        "ISS for Myeloma",
                        "International Staging System for Myeloma"
                    ],
                    "UMLS:C1562189": [
                        "Is etiology for",
                        "is etiology for",
                        "Is aetiology for",
                        "Is etiology for (link assertion)"
                    ]
                }
            },
            {
                "label": "a stabilizing effect in children",
                "id": {}
            }
        ],
        [
            {
                "label": "children",
                "id": {
                    "UMLS:C0008059": [
                        "Children",
                        "CHILDREN",
                        "children",
                        "Children (0-21)",
                        "Child",
                        "CHILD",
                        "child",
                        "Child, NOS",
                        "Child Youth",
                        "0-11 years old",
                        "Child (person)",
                        "Childhood age person",
                        "Childhood age person (person)"
                    ],
                    "UMLS:C0680063": [
                        "Children",
                        "kid",
                        "kids",
                        "Child",
                        "child",
                        "Progeny",
                        "progeny",
                        "Child of",
                        "of child",
                        "child of",
                        "offspring",
                        "Offspring",
                        "offsprings",
                        "child find",
                        "Human, Child",
                        "RoleClassChild",
                        "Biological Child",
                        "Child of (finding)",
                        "child (family member)"
                    ],
                    "UMLS:C3715932": [
                        "Childrena",
                        "Childrena Hemming, 1943"
                    ],
                    "UMLS:C5452958": [
                        "My children"
                    ],
                    "UMLS:C0029039": [
                        "only children",
                        "Only Children",
                        "children only",
                        "Children, Only",
                        "only child",
                        "Only child",
                        "Only Child",
                        "Child, Only",
                        "Is an only child",
                        "Is an only child (finding)"
                    ]
                }
            },
            {
                "label": "have",
                "id": {
                    "UMLS:C3154893": [
                        "Have",
                        "Possess"
                    ],
                    "UMLS:C3539897": [
                        "Have",
                        "Had",
                        "Has"
                    ],
                    "UniProtKB:Q9NQS1": [
                        "hAVEN",
                        "AVEN",
                        "cell death regulator Aven (human)"
                    ],
                    "UMLS:C1226488": [
                        "Havetia"
                    ],
                    "UMLS:C2984058": [
                        "Have Pain",
                        "Have Any Pain",
                        "Had Pain"
                    ]
                }
            },
            {
                "label": "a behavioral syndrome",
                "id": {
                    "UMLS:C4505414": [
                        "Behavioral Assessment of Dysexecutive Syndrome"
                    ],
                    "GO:0051867": [
                        "general adaptation syndrome, behavioral process",
                        "general adaptation syndrome, behavioral response",
                        "behavioral process during general adaptation syndrome",
                        "behavioral response during general adaptation syndrome",
                        "general adaptation syndrome, behavioural process",
                        "general adaptation syndrome, behavioural response",
                        "behavioural process during general adaptation syndrome",
                        "behavioural response during general adaptation syndrome"
                    ],
                    "UMLS:C1816439": [
                        "general adaptation syndrome, behavioral process",
                        "general adaptation syndrome, behavioral response",
                        "behavioral process during general adaptation syndrome",
                        "behavioral response during general adaptation syndrome",
                        "general adaptation syndrome, behavioural process",
                        "general adaptation syndrome, behavioural response",
                        "behavioural process during general adaptation syndrome",
                        "behavioural response during general adaptation syndrome"
                    ],
                    "UMLS:C2959822": [
                        "Behavioral assessment of the dysexecutive syndrome score",
                        "Behavioral assessment of the dysexecutive syndrome score (observable entity)",
                        "Behavioural assessment of the dysexecutive syndrome score"
                    ],
                    "UMLS:C2960671": [
                        "Assessment using behavioral assessment of the dysexecutive syndrome",
                        "Assessment using behavioral assessment of the dysexecutive syndrome (procedure)",
                        "Assessment using behavioural assessment of the dysexecutive syndrome"
                    ]
                }
            }
        ],
        [
            {
                "label": "behavioral syndrome",
                "id": {
                    "UMLS:C0349251": [
                        "Behavioral syndrome",
                        "syndrome behavioral",
                        "behavioral syndrome",
                        "Behavioral syndrome associated with physiological disturbance and physical factors",
                        "Behavioral syndromes associated with physiological disturbances and physical factors",
                        "Behavioral syndrome associated with physiological disturbance and physical factors (disorder)",
                        "Behavioral syndromes associated with physiological disturbances and physical factors (F50-F59)",
                        "Unspecified behavioral syndromes associated with physiological disturbances and physical factors",
                        "Behavioural syndrome",
                        "Behav synd assoc phys factor",
                        "Unsp behavrl synd assoc w physiol disturb and physcl factors",
                        "Behavr synd assoc with physiological disturb and phys factor",
                        "Behavioural syndrome associated with physiological disturbance and physical factors",
                        "Behavioural syndromes associated with physiological disturbances and physical factors",
                        "Unspecified behavioural syndromes associated with physiological disturbances and physical factors"
                    ],
                    "UMLS:C3495811": [
                        "Neonatal behavioral syndrome",
                        "Neonatal behavioural syndrome"
                    ],
                    "UMLS:C4760954": [
                        "Behavioral induced insufficient sleep syndrome",
                        "Behavioural induced insufficient sleep syndrome"
                    ],
                    "UMLS:C4505414": [
                        "Behavioral Assessment of Dysexecutive Syndrome"
                    ],
                    "GO:0051867": [
                        "general adaptation syndrome, behavioral process",
                        "general adaptation syndrome, behavioral response",
                        "behavioral process during general adaptation syndrome",
                        "behavioral response during general adaptation syndrome",
                        "general adaptation syndrome, behavioural process",
                        "general adaptation syndrome, behavioural response",
                        "behavioural process during general adaptation syndrome",
                        "behavioural response during general adaptation syndrome"
                    ]
                }
            },
            {
                "label": "is characterized by",
                "id": {
                    "MONDO:0100015": [
                        "an adult-onset, focal or segmental, isolated dystonia that is characterized by cervical or cranial dystonia that often begins in the fourth decade (range 7-54 years).",
                        "DYT-GNAL",
                        "adult-onset segmental dystonia"
                    ],
                    "MONDO:0100016": [
                        "A generalized isolated dystonia characterized by early-onset, which may be clinically indistinguishable from DYT-TOR1A and may be the most common cause of early-onset generalized dystonia, at least outside the Askenazi Jewish population.",
                        "DYT-KMT2B",
                        "early-onset generalized dystonia",
                        "early-onset generalized isolated dystonia",
                        "early-onset, generalized dystonia with mild syndromic features"
                    ]
                }
            },
            {
                "label": "developmentally inappropriate symptoms",
                "id": {}
            }
        ],
        [
            {
                "label": "developmentally inappropriate symptoms",
                "id": {}
            },
            {
                "label": "include",
                "id": {
                    "UMLS:C0332257": [
                        "include",
                        "Includes",
                        "included",
                        "includes",
                        "Has part",
                        "has part",
                        "Inclusive",
                        "inclusive",
                        "including",
                        "Including",
                        "Including (qualifier)",
                        "Including (qualifier value)"
                    ],
                    "UMLS:C1552866": [
                        "include",
                        "include - SetOperator"
                    ],
                    "UMLS:C2700399": [
                        "Include",
                        "Include (action)",
                        "Inclusion"
                    ],
                    "UMLS:C4065484": [
                        "diet includes",
                        "diet includes (history)"
                    ],
                    "MONDO:0007508": [
                        "OFC8, included",
                        "RHS",
                        "RHS",
                        "RHS",
                        "orofacial cleft 8",
                        "Rapp-Hodgkin syndrome",
                        "RAPP-HODGKIN SYNDROME",
                        "Rapp-Hodgkin syndrome",
                        "Anhidrotic ectodermal dyspl",
                        "Rapp-Hodgkin ectoderm dysplas",
                        "Anhidrotic ectodermal dysplasia",
                        "Anhidrotic Ectodermal Dysplasia",
                        "Anhydrotic Ectodermal Dysplasia",
                        "Ectodermal Dysplasia Anhidrotic",
                        "Dysplasia, Anhidrotic Ectodermal",
                        "Ectodermal dysplasia, anhidrotic",
                        "Anhidrotic Ectodermal Dysplasias",
                        "Dysplasia, Anhydrotic Ectodermal",
                        "Anhidrotic, Ectodermal Dysplasia",
                        "Anhydrotic Ectodermal Dysplasias",
                        "Dysplasia Anhidrotic, Ectodermal",
                        "Ectodermal Dysplasia, Anhidrotic",
                        "Ectodermal Dysplasia, Anhydrotic",
                        "Anhidrotics, Ectodermal Dysplasia",
                        "Ectodermal Dysplasias, Anhidrotic",
                        "Dysplasias, Anhydrotic Ectodermal",
                        "Ectodermal dysplasia (anhidrotic)",
                        "Dysplasias, Anhidrotic Ectodermal",
                        "Dysplasia Anhidrotics, Ectodermal",
                        "Ectodermal Dysplasias, Anhydrotic",
                        "ectodermal dysplasia, Rapp-Hodgkin type",
                        "Anhidrotic ectodermal dysplasia syndrome",
                        "Rapp-Hodgkin type of ectodermal dysplasia",
                        "Rapp-Hodgkin ectodermal dysplasia syndrome",
                        "Rapp-Hodgkin ectodermal dysplasia syndrome",
                        "ectodermal dysplasia syndrome, Rapp-Hodgkin type",
                        "anhidrotic ectodermal dysplasia with cleft lip/palate",
                        "anhidrotic ectodermal dysplasia with cleft lip/palate",
                        "Ectodermal dysplasia, anhidrotic, with cleft lip-palate",
                        "ectodermal dysplasia, anhidrotic, with cleft Lip/palate",
                        "cleft lip with or without cleft palate, nonsyndromic, 8",
                        "ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATE",
                        "ectodermal dysplasia, anhidrotic, with cleft lip-palate",
                        "autosomal dominant hypohidrotic ectodermal dysplasia syndrome",
                        "Autosomal dominant hypohidrotic ectodermal dysplasia syndrome",
                        "Hypohidrotic ectodermal dysplasia syndrome, autosomal dominant type",
                        "Autosomal dominant hypohidrotic ectodermal dysplasia syndrome (disorder)",
                        "autosomal dominant hypohidrotic ectodermal dysplasia syndrome (diagnosis)"
                    ]
                }
            },
            {
                "label": "moderate-to-severe distractibility",
                "id": {}
            }
        ],
        [
            {
                "label": "developmentally inappropriate symptoms",
                "id": {}
            },
            {
                "label": "include",
                "id": {
                    "UMLS:C0332257": [
                        "include",
                        "Includes",
                        "included",
                        "includes",
                        "Has part",
                        "has part",
                        "Inclusive",
                        "inclusive",
                        "including",
                        "Including",
                        "Including (qualifier)",
                        "Including (qualifier value)"
                    ],
                    "UMLS:C1552866": [
                        "include",
                        "include - SetOperator"
                    ],
                    "UMLS:C2700399": [
                        "Include",
                        "Include (action)",
                        "Inclusion"
                    ],
                    "UMLS:C4065484": [
                        "diet includes",
                        "diet includes (history)"
                    ],
                    "MONDO:0007508": [
                        "OFC8, included",
                        "RHS",
                        "RHS",
                        "RHS",
                        "orofacial cleft 8",
                        "Rapp-Hodgkin syndrome",
                        "RAPP-HODGKIN SYNDROME",
                        "Rapp-Hodgkin syndrome",
                        "Anhidrotic ectodermal dyspl",
                        "Rapp-Hodgkin ectoderm dysplas",
                        "Anhidrotic ectodermal dysplasia",
                        "Anhidrotic Ectodermal Dysplasia",
                        "Anhydrotic Ectodermal Dysplasia",
                        "Ectodermal Dysplasia Anhidrotic",
                        "Dysplasia, Anhidrotic Ectodermal",
                        "Ectodermal dysplasia, anhidrotic",
                        "Anhidrotic Ectodermal Dysplasias",
                        "Dysplasia, Anhydrotic Ectodermal",
                        "Anhidrotic, Ectodermal Dysplasia",
                        "Anhydrotic Ectodermal Dysplasias",
                        "Dysplasia Anhidrotic, Ectodermal",
                        "Ectodermal Dysplasia, Anhidrotic",
                        "Ectodermal Dysplasia, Anhydrotic",
                        "Anhidrotics, Ectodermal Dysplasia",
                        "Ectodermal Dysplasias, Anhidrotic",
                        "Dysplasias, Anhydrotic Ectodermal",
                        "Ectodermal dysplasia (anhidrotic)",
                        "Dysplasias, Anhidrotic Ectodermal",
                        "Dysplasia Anhidrotics, Ectodermal",
                        "Ectodermal Dysplasias, Anhydrotic",
                        "ectodermal dysplasia, Rapp-Hodgkin type",
                        "Anhidrotic ectodermal dysplasia syndrome",
                        "Rapp-Hodgkin type of ectodermal dysplasia",
                        "Rapp-Hodgkin ectodermal dysplasia syndrome",
                        "Rapp-Hodgkin ectodermal dysplasia syndrome",
                        "ectodermal dysplasia syndrome, Rapp-Hodgkin type",
                        "anhidrotic ectodermal dysplasia with cleft lip/palate",
                        "anhidrotic ectodermal dysplasia with cleft lip/palate",
                        "Ectodermal dysplasia, anhidrotic, with cleft lip-palate",
                        "ectodermal dysplasia, anhidrotic, with cleft Lip/palate",
                        "cleft lip with or without cleft palate, nonsyndromic, 8",
                        "ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATE",
                        "ectodermal dysplasia, anhidrotic, with cleft lip-palate",
                        "autosomal dominant hypohidrotic ectodermal dysplasia syndrome",
                        "Autosomal dominant hypohidrotic ectodermal dysplasia syndrome",
                        "Hypohidrotic ectodermal dysplasia syndrome, autosomal dominant type",
                        "Autosomal dominant hypohidrotic ectodermal dysplasia syndrome (disorder)",
                        "autosomal dominant hypohidrotic ectodermal dysplasia syndrome (diagnosis)"
                    ]
                }
            },
            {
                "label": "short attention span",
                "id": {
                    "HP:0000736": [
                        "Short;attention span",
                        "Short attention span",
                        "short attention span",
                        "SHORT ATTENTION SPAN",
                        "Distracts easily",
                        "easily distracted",
                        "Easily distracted",
                        "Easily distracted",
                        "Poor attention span",
                        "Reduced attention span",
                        "Poor attention control",
                        "Short concentration span",
                        "Problem paying attention",
                        "Reduced concentration span",
                        "easily distracted (symptom)",
                        "Easily distracted (finding)",
                        "Reduced concentration span (finding)"
                    ]
                }
            }
        ],
        [
            {
                "label": "developmentally inappropriate symptoms",
                "id": {}
            },
            {
                "label": "include",
                "id": {
                    "UMLS:C0332257": [
                        "include",
                        "Includes",
                        "included",
                        "includes",
                        "Has part",
                        "has part",
                        "Inclusive",
                        "inclusive",
                        "including",
                        "Including",
                        "Including (qualifier)",
                        "Including (qualifier value)"
                    ],
                    "UMLS:C1552866": [
                        "include",
                        "include - SetOperator"
                    ],
                    "UMLS:C2700399": [
                        "Include",
                        "Include (action)",
                        "Inclusion"
                    ],
                    "UMLS:C4065484": [
                        "diet includes",
                        "diet includes (history)"
                    ],
                    "MONDO:0007508": [
                        "OFC8, included",
                        "RHS",
                        "RHS",
                        "RHS",
                        "orofacial cleft 8",
                        "Rapp-Hodgkin syndrome",
                        "RAPP-HODGKIN SYNDROME",
                        "Rapp-Hodgkin syndrome",
                        "Anhidrotic ectodermal dyspl",
                        "Rapp-Hodgkin ectoderm dysplas",
                        "Anhidrotic ectodermal dysplasia",
                        "Anhidrotic Ectodermal Dysplasia",
                        "Anhydrotic Ectodermal Dysplasia",
                        "Ectodermal Dysplasia Anhidrotic",
                        "Dysplasia, Anhidrotic Ectodermal",
                        "Ectodermal dysplasia, anhidrotic",
                        "Anhidrotic Ectodermal Dysplasias",
                        "Dysplasia, Anhydrotic Ectodermal",
                        "Anhidrotic, Ectodermal Dysplasia",
                        "Anhydrotic Ectodermal Dysplasias",
                        "Dysplasia Anhidrotic, Ectodermal",
                        "Ectodermal Dysplasia, Anhidrotic",
                        "Ectodermal Dysplasia, Anhydrotic",
                        "Anhidrotics, Ectodermal Dysplasia",
                        "Ectodermal Dysplasias, Anhidrotic",
                        "Dysplasias, Anhydrotic Ectodermal",
                        "Ectodermal dysplasia (anhidrotic)",
                        "Dysplasias, Anhidrotic Ectodermal",
                        "Dysplasia Anhidrotics, Ectodermal",
                        "Ectodermal Dysplasias, Anhydrotic",
                        "ectodermal dysplasia, Rapp-Hodgkin type",
                        "Anhidrotic ectodermal dysplasia syndrome",
                        "Rapp-Hodgkin type of ectodermal dysplasia",
                        "Rapp-Hodgkin ectodermal dysplasia syndrome",
                        "Rapp-Hodgkin ectodermal dysplasia syndrome",
                        "ectodermal dysplasia syndrome, Rapp-Hodgkin type",
                        "anhidrotic ectodermal dysplasia with cleft lip/palate",
                        "anhidrotic ectodermal dysplasia with cleft lip/palate",
                        "Ectodermal dysplasia, anhidrotic, with cleft lip-palate",
                        "ectodermal dysplasia, anhidrotic, with cleft Lip/palate",
                        "cleft lip with or without cleft palate, nonsyndromic, 8",
                        "ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATE",
                        "ectodermal dysplasia, anhidrotic, with cleft lip-palate",
                        "autosomal dominant hypohidrotic ectodermal dysplasia syndrome",
                        "Autosomal dominant hypohidrotic ectodermal dysplasia syndrome",
                        "Hypohidrotic ectodermal dysplasia syndrome, autosomal dominant type",
                        "Autosomal dominant hypohidrotic ectodermal dysplasia syndrome (disorder)",
                        "autosomal dominant hypohidrotic ectodermal dysplasia syndrome (diagnosis)"
                    ]
                }
            },
            {
                "label": "hyperactivity",
                "id": {
                    "HP:0000752": [
                        "Hyperactivity",
                        "hyperactivity",
                        "HYPERACTIVITY",
                        "Hyperactivity, NOS",
                        "HA - Hyperactivity",
                        "motor hyperactivity",
                        "hyperactivity (behavior)",
                        "HYPER",
                        "Hyperactive",
                        "hyperactive",
                        "HYPERACTIVE",
                        "hyperkinesis",
                        "Hyperkinesis",
                        "hyperactivities",
                        "Hyperkinesis, NOS",
                        "hyperactive behavior",
                        "Hyperactive behavior",
                        "BEHAVIOR HYPERACTIVE",
                        "Behavior hyperactive",
                        "BEHAVIOUR HYPERACTIVE",
                        "Behaviour hyperactive",
                        "Hyperactive behaviour",
                        "hyperkinetic movement",
                        "behavior; overactivity",
                        "overactivity; behavior",
                        "More active than typical",
                        "hyperactive behavior (symptom)",
                        "Hyperactive behavior (finding)",
                        "Increased purposeful goal-directed activity",
                        "Increased purposeful goal-directed activity, NOS"
                    ],
                    "UMLS:C1321018": [
                        "Hyperactivity Level",
                        "Hyperactivity level",
                        "Hyperactivity level (observable entity)"
                    ],
                    "HP:0002487": [
                        "Motor Hyperactivity",
                        "MOTOR HYPERACTIVITY",
                        "Hyperactivity, Motor",
                        "spasm",
                        "SPASM",
                        "Spasm",
                        "Spasms",
                        "spasms",
                        "SPASMS",
                        "Spasms NOS",
                        "Spasm, NOS",
                        "hyperkinesia",
                        "Hyperkinesia",
                        "HYPERKINESIA",
                        "MUSCLE SPASM",
                        "muscle spasm",
                        "Muscle Spasm",
                        "Hyperkinesis",
                        "Spasm muscle",
                        "Muscle spasm",
                        "SPASM MUSCLE",
                        "Muscle cramps",
                        "Muscle spasms",
                        "Muscle Spasms",
                        "hyperkinesias",
                        "muscle spasms",
                        "Spasm, Muscle",
                        "Muscular spasm",
                        "Spasms, Muscle",
                        "muscular spasm",
                        "Muscular Spasm",
                        "Spasm, Muscular",
                        "Spasm (finding)",
                        "Spasm of muscle",
                        "Spasm;muscle(s)",
                        "muscular spasms",
                        "Muscular Spasms",
                        "Spasms, Muscular",
                        "Hyperkinesia, NOS",
                        "spasms (diagnosis)",
                        "Hyperkinetic Movement",
                        "reported muscle spasms",
                        "Movement, Hyperkinetic",
                        "Muscle spasm (finding)",
                        "Hyperkinetic Movements",
                        "Hyperkinetic movements",
                        "Movements, Hyperkinetic",
                        "muscle spasm (diagnosis)",
                        "reported muscle spasms (symptom)",
                        "muscle spasms (physical finding)"
                    ],
                    "UMLS:C4049602": [
                        "Hyperactivity Scale",
                        "Hyperactivity Scale (BASC-2)"
                    ],
                    "MONDO:0005302": [
                        "child; hyperactivity",
                        "hyperactivity; child",
                        "disorder hyperactivity",
                        "hyperactivity disorder",
                        "disorder; hyperactivity",
                        "hyperactivity; disorder",
                        "Hyperactivity Disorder NOS",
                        "HYPERACTIVITY OF CHILDHOOD",
                        "Att deficit hyperactivity dis",
                        "ATTENTION DEFICIT HYPERACTIVITY DIS",
                        "Attention deficit without hyperactivity",
                        "Attention Deficit Hyperactivity Disorder",
                        "Attention-deficit hyperactivity disorder",
                        "attention deficit hyperactivity disorder",
                        "attention-deficit hyperactivity disorder",
                        "Attention deficit-hyperactivity disorder",
                        "attention deficit hyperactivity disorder",
                        "Attention deficit/hyperactivity disorder",
                        "ATTENTION DEFICIT DIS WITH HYPERACTIVITY",
                        "Attention-deficit/hyperactivity disorder",
                        "Attention deficit hyperactivity disorder",
                        "ATTENTION DEFICIT-HYPERACTIVITY DISORDER",
                        "Attention Deficit-Hyperactivity Disorder",
                        "ATTENTION DEFICIT HYPERACTIVITY DISORDER",
                        "Attention Deficit Hyperactivity Disorders",
                        "Attention Deficit-Hyperactivity Disorders",
                        "Disorder, Attention Deficit-Hyperactivity",
                        "Attention-deficit hyperactivity disorders",
                        "Deficit-Hyperactivity Disorder, Attention",
                        "Deficit-Hyperactivity Disorders, Attention",
                        "Disorders, Attention Deficit-Hyperactivity",
                        "Attention-deficit hyperactivity disorder NOS",
                        "Attention deficit/hyperactivity disorder NOS",
                        "Attention deficit disorder with hyperactivity",
                        "attention deficit disorder with hyperactivity",
                        "Attention Deficit Disorder with Hyperactivity",
                        "attention deficit syndrome with hyperactivity",
                        "Attention Deficit Disorders with Hyperactivity",
                        "attention deficit disorder; with hyperactivity",
                        "attention deficit hyperactivity disorder (ADHD)",
                        "Attention deficit hyperactivity disorder (ADHD)",
                        "Attention-deficit/hyperactivity disorder (ADHD)",
                        "ADHD (attention deficit hyperactivity disorder)",
                        "Attention deficit-hyperactivity disorder (ADHD)",
                        "Attention-deficit hyperactivity disorder (ADHD)",
                        "ADHD (attention-deficit hyperactivity disorder)",
                        "Attention deficit disorder without hyperactivity",
                        "attention deficit disorder without hyperactivity",
                        "attention deficit disorder; without hyperactivity",
                        "Childhood attention deficit/hyperactivity disorder",
                        "ADD - Attention deficit disorder with hyperactivity",
                        "Attention deficit hyperactivity disorder (disorder)",
                        "ADHD - Attention deficit disorder with hyperactivity",
                        "attention-deficit hyperactivity disorder (diagnosis)",
                        "ADD - Attention deficit disorder without hyperactivity",
                        "Attention deficit disorder with hyperactivity syndrome",
                        "disorder; attention deficit, with hyperactivity (ADHD)",
                        "Attention deficit disorder without hyperactivity syndrome",
                        "Attention deficit disorder of childhood with hyperactivity",
                        "attention deficit hyperactivity disorder, inattentive type",
                        "Attn-defct hyperactivity disorder, predom inattentive type",
                        "Attention Deficit Hyperactivity Disorder, Inattentive Type",
                        "Attention deficit disorder without mention of hyperactivity",
                        "attention deficit disorder without hyperactivity (diagnosis)",
                        "Hyperactivity Disorder, Predominantly Hyperactive-Impulsive Type",
                        "Attention deficit hyperactivity disorder, hyperactive impulsive type",
                        "Attention Deficit Hyperactivity Disorder, Inattentive/Distractible Type",
                        "attention deficit hyperactivity disorder, inattentive/distractible type",
                        "attention-deficit hyperactivity disorder predominantly inattentive type",
                        "attention deficit hyperactivity disorder, predominantly inattentive type",
                        "Attention Deficit Hyperactivity Disorder, Predominantly Inattentive Type",
                        "Attention deficit disorder of childhood without mention of hyperactivity",
                        "Attention deficit hyperactivity disorder, predominantly inattentive type",
                        "Attention-deficit hyperactivity disorder, predominantly inattentive type",
                        "Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type",
                        "Attention deficit hyperactivity disorder, predominantly hyperactive impulsive type",
                        "Attention deficit hyperactivity disorder, predominantly inattentive type (disorder)",
                        "Attention deficit hyperactivity disorder, predominantly hyperactive impulsive type (disorder)",
                        "ADD",
                        "ADHD",
                        "ADDH",
                        "ADHD",
                        "addh",
                        "MBD syndrome",
                        "Attention deficit",
                        "Attention-deficit",
                        "deficit; attention",
                        "Attention deficits",
                        "Hyperkinetic Syndrome",
                        "hyperkinetic disorder",
                        "SYNDROME HYPERKINETIC",
                        "Hyperkinetic disorder",
                        "Syndrome hyperkinetic",
                        "ATTENTION DEFICIT DIS",
                        "Hyperkinetic synd NOS",
                        "HYPERKINETIC SYNDROME",
                        "Hyperkinetic syndrome",
                        "hyperkinetic disorder",
                        "hyperkinetic syndrome",
                        "hyperkinetic; syndrome",
                        "syndrome; hyperkinetic",
                        "hyperkinetic; disorder",
                        "Attn defic nonhyperact",
                        "Hyperkinetic disorders",
                        "disorder; hyperkinetic",
                        "Minimal Brain Disorders",
                        "Attn deficit w hyperact",
                        "Syndromes, Hyperkinetic",
                        "Hyperkinetic syndrome NOS",
                        "Minimal brain dysfunction",
                        "Minimal Brain Dysfunction",
                        "MINIMAL BRAIN DYSFUNCTION",
                        "Overactive child syndrome",
                        "minimal brain dysfunction",
                        "Brain Dysfunction, Minimal",
                        "attention deficit disorder",
                        "Hyperactive child syndrome",
                        "Attention Deficit Disorder",
                        "Attention-deficit disorder",
                        "attention deficit disorder",
                        "attention-deficit disorder",
                        "ATTENTION DEFICIT DISORDER",
                        "Dysfunction, Minimal Brain",
                        "hyperactive child syndrome",
                        "Attention deficit disorder",
                        "Attention Deficit Disorders",
                        "Deficit Disorder, Attention",
                        "Disorder, Attention Deficit",
                        "disorder; attention deficit",
                        "attention deficit disorders",
                        "Deficit Disorders, Attention",
                        "Disorders, Attention Deficit",
                        "Childhood hyperkinetic syndr.",
                        "MBD - Minimal brain dysfunctn",
                        "Minimal brain damage syndrome",
                        "ADD - Attention deficit disord",
                        "attention deficit disorder add",
                        "Attntn defic dis w/out hypract",
                        "Disorder;attent deficit(hyper)",
                        "Attention-Deficit Disorder NOS",
                        "ADD-Attn def dis with hyperact",
                        "ADD-Attn defic dis w/t hypract",
                        "add attention deficit disorder",
                        "Attentn deficit hyperkin disor",
                        "Attention deficit-not hyperact",
                        "Childhood hyperkinetic syndrome",
                        "childhood hyperkinetic syndrome",
                        "MBD - Minimal brain dysfunction",
                        "attention deficit hyper disorder",
                        "ADD - Attention deficit disorder",
                        "attention deficit(hyper) disorder",
                        "attention deficits disorder hyper",
                        "Unspecified hyperkinetic syndrome",
                        "Hyperkinetic syndrome of childhood",
                        "Minimal brain dysfunction syndrome",
                        "Hyperkinetic disorder, unspecified",
                        "ADHD, predominantly inattentive type",
                        "Attention deficit hyperkinetic disorder",
                        "unspecified hyperkinetic syndrome of childhood",
                        "Unspecified hyperkinetic syndrome of childhood",
                        "ADHD, predominantly hyperactive-impulsive type",
                        "ADHD, predominantly inattentive type (diagnosis)",
                        "attention-deficit disorder predominantly inattentive type",
                        "unspecified hyperkinetic syndrome of childhood (diagnosis)",
                        "Attention-Deficit Disorder, Predominantly Inattentive Type",
                        "Attention-Deficit Disorder, Predominantly Hyperactive-Impulsive Type"
                    ]
                }
            }
        ],
        [
            {
                "label": "developmentally inappropriate symptoms",
                "id": {}
            },
            {
                "label": "include",
                "id": {
                    "UMLS:C0332257": [
                        "include",
                        "Includes",
                        "included",
                        "includes",
                        "Has part",
                        "has part",
                        "Inclusive",
                        "inclusive",
                        "including",
                        "Including",
                        "Including (qualifier)",
                        "Including (qualifier value)"
                    ],
                    "UMLS:C1552866": [
                        "include",
                        "include - SetOperator"
                    ],
                    "UMLS:C2700399": [
                        "Include",
                        "Include (action)",
                        "Inclusion"
                    ],
                    "UMLS:C4065484": [
                        "diet includes",
                        "diet includes (history)"
                    ],
                    "MONDO:0007508": [
                        "OFC8, included",
                        "RHS",
                        "RHS",
                        "RHS",
                        "orofacial cleft 8",
                        "Rapp-Hodgkin syndrome",
                        "RAPP-HODGKIN SYNDROME",
                        "Rapp-Hodgkin syndrome",
                        "Anhidrotic ectodermal dyspl",
                        "Rapp-Hodgkin ectoderm dysplas",
                        "Anhidrotic ectodermal dysplasia",
                        "Anhidrotic Ectodermal Dysplasia",
                        "Anhydrotic Ectodermal Dysplasia",
                        "Ectodermal Dysplasia Anhidrotic",
                        "Dysplasia, Anhidrotic Ectodermal",
                        "Ectodermal dysplasia, anhidrotic",
                        "Anhidrotic Ectodermal Dysplasias",
                        "Dysplasia, Anhydrotic Ectodermal",
                        "Anhidrotic, Ectodermal Dysplasia",
                        "Anhydrotic Ectodermal Dysplasias",
                        "Dysplasia Anhidrotic, Ectodermal",
                        "Ectodermal Dysplasia, Anhidrotic",
                        "Ectodermal Dysplasia, Anhydrotic",
                        "Anhidrotics, Ectodermal Dysplasia",
                        "Ectodermal Dysplasias, Anhidrotic",
                        "Dysplasias, Anhydrotic Ectodermal",
                        "Ectodermal dysplasia (anhidrotic)",
                        "Dysplasias, Anhidrotic Ectodermal",
                        "Dysplasia Anhidrotics, Ectodermal",
                        "Ectodermal Dysplasias, Anhydrotic",
                        "ectodermal dysplasia, Rapp-Hodgkin type",
                        "Anhidrotic ectodermal dysplasia syndrome",
                        "Rapp-Hodgkin type of ectodermal dysplasia",
                        "Rapp-Hodgkin ectodermal dysplasia syndrome",
                        "Rapp-Hodgkin ectodermal dysplasia syndrome",
                        "ectodermal dysplasia syndrome, Rapp-Hodgkin type",
                        "anhidrotic ectodermal dysplasia with cleft lip/palate",
                        "anhidrotic ectodermal dysplasia with cleft lip/palate",
                        "Ectodermal dysplasia, anhidrotic, with cleft lip-palate",
                        "ectodermal dysplasia, anhidrotic, with cleft Lip/palate",
                        "cleft lip with or without cleft palate, nonsyndromic, 8",
                        "ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATE",
                        "ectodermal dysplasia, anhidrotic, with cleft lip-palate",
                        "autosomal dominant hypohidrotic ectodermal dysplasia syndrome",
                        "Autosomal dominant hypohidrotic ectodermal dysplasia syndrome",
                        "Hypohidrotic ectodermal dysplasia syndrome, autosomal dominant type",
                        "Autosomal dominant hypohidrotic ectodermal dysplasia syndrome (disorder)",
                        "autosomal dominant hypohidrotic ectodermal dysplasia syndrome (diagnosis)"
                    ]
                }
            },
            {
                "label": "emotional lability",
                "id": {
                    "HP:0000712": [
                        "Emotional Lability",
                        "Emotional lability",
                        "Lability emotional",
                        "EMOTIONAL LABILITY",
                        "emotional lability",
                        "LABILITY EMOTIONAL",
                        "emotional lability (symptom)",
                        "Mood swing",
                        "Mood Swing",
                        "mood swing",
                        "mood swings",
                        "MOOD CHANGE",
                        "Mood swings",
                        "Labile mood",
                        "MOOD SWINGS",
                        "MOOD LABILE",
                        "labile mood",
                        "Mood change",
                        "mood labile",
                        "mood change",
                        "MOOD ALTERED",
                        "ALTERED MOOD",
                        "Mood altered",
                        "Mood changes",
                        "Altered mood",
                        "MOOD VARIABLE",
                        "Mood Lability",
                        "altered moods",
                        "Mood variable",
                        "Unstable mood",
                        "Variable mood",
                        "mood lability",
                        "Mood lability",
                        "Labile in mood",
                        "Change in mood",
                        "Changeable mood",
                        "Mood alterations",
                        "emotionally labile",
                        "Emotionally labile",
                        "Emotional instability",
                        "EMOTIONAL INSTABILITY",
                        "Mood swings (finding)",
                        "INSTABILITY EMOTIONAL",
                        "Emotional Instability",
                        "emotional instability",
                        "Instability emotional",
                        "emotional; instability",
                        "instability; emotional",
                        "Instability (Emotional)",
                        "labile mood (physical finding)"
                    ],
                    "UMLS:C3279458": [
                        "Emotional lability (variable)"
                    ],
                    "UMLS:C1850428": [
                        "Emotional lability in 50% of patients"
                    ],
                    "UMLS:C2216324": [
                        "emotional lability prior to menstruation (3-10 days)",
                        "emotional lability prior to menstruation (3-10 days) (symptom)"
                    ]
                }
            }
        ],
        [
            {
                "label": "developmentally inappropriate symptoms",
                "id": {}
            },
            {
                "label": "include",
                "id": {
                    "UMLS:C0332257": [
                        "include",
                        "Includes",
                        "included",
                        "includes",
                        "Has part",
                        "has part",
                        "Inclusive",
                        "inclusive",
                        "including",
                        "Including",
                        "Including (qualifier)",
                        "Including (qualifier value)"
                    ],
                    "UMLS:C1552866": [
                        "include",
                        "include - SetOperator"
                    ],
                    "UMLS:C2700399": [
                        "Include",
                        "Include (action)",
                        "Inclusion"
                    ],
                    "UMLS:C4065484": [
                        "diet includes",
                        "diet includes (history)"
                    ],
                    "MONDO:0007508": [
                        "OFC8, included",
                        "RHS",
                        "RHS",
                        "RHS",
                        "orofacial cleft 8",
                        "Rapp-Hodgkin syndrome",
                        "RAPP-HODGKIN SYNDROME",
                        "Rapp-Hodgkin syndrome",
                        "Anhidrotic ectodermal dyspl",
                        "Rapp-Hodgkin ectoderm dysplas",
                        "Anhidrotic ectodermal dysplasia",
                        "Anhidrotic Ectodermal Dysplasia",
                        "Anhydrotic Ectodermal Dysplasia",
                        "Ectodermal Dysplasia Anhidrotic",
                        "Dysplasia, Anhidrotic Ectodermal",
                        "Ectodermal dysplasia, anhidrotic",
                        "Anhidrotic Ectodermal Dysplasias",
                        "Dysplasia, Anhydrotic Ectodermal",
                        "Anhidrotic, Ectodermal Dysplasia",
                        "Anhydrotic Ectodermal Dysplasias",
                        "Dysplasia Anhidrotic, Ectodermal",
                        "Ectodermal Dysplasia, Anhidrotic",
                        "Ectodermal Dysplasia, Anhydrotic",
                        "Anhidrotics, Ectodermal Dysplasia",
                        "Ectodermal Dysplasias, Anhidrotic",
                        "Dysplasias, Anhydrotic Ectodermal",
                        "Ectodermal dysplasia (anhidrotic)",
                        "Dysplasias, Anhidrotic Ectodermal",
                        "Dysplasia Anhidrotics, Ectodermal",
                        "Ectodermal Dysplasias, Anhydrotic",
                        "ectodermal dysplasia, Rapp-Hodgkin type",
                        "Anhidrotic ectodermal dysplasia syndrome",
                        "Rapp-Hodgkin type of ectodermal dysplasia",
                        "Rapp-Hodgkin ectodermal dysplasia syndrome",
                        "Rapp-Hodgkin ectodermal dysplasia syndrome",
                        "ectodermal dysplasia syndrome, Rapp-Hodgkin type",
                        "anhidrotic ectodermal dysplasia with cleft lip/palate",
                        "anhidrotic ectodermal dysplasia with cleft lip/palate",
                        "Ectodermal dysplasia, anhidrotic, with cleft lip-palate",
                        "ectodermal dysplasia, anhidrotic, with cleft Lip/palate",
                        "cleft lip with or without cleft palate, nonsyndromic, 8",
                        "ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATE",
                        "ectodermal dysplasia, anhidrotic, with cleft lip-palate",
                        "autosomal dominant hypohidrotic ectodermal dysplasia syndrome",
                        "Autosomal dominant hypohidrotic ectodermal dysplasia syndrome",
                        "Hypohidrotic ectodermal dysplasia syndrome, autosomal dominant type",
                        "Autosomal dominant hypohidrotic ectodermal dysplasia syndrome (disorder)",
                        "autosomal dominant hypohidrotic ectodermal dysplasia syndrome (diagnosis)"
                    ]
                }
            },
            {
                "label": "impulsivity",
                "id": {
                    "HP:0100710": [
                        "Impulsivity",
                        "impulsivity",
                        "Impulsive",
                        "Impulsivities",
                        "IMPULSIVE BEHAVIOR",
                        "Impulsive Behavior",
                        "Impulsive behavior",
                        "impulsive behavior",
                        "IMPULSIVE BEHAVIOUR",
                        "impulsive behaviour",
                        "Impulsive Behaviors",
                        "Impulsive behaviour",
                        "Behavior, Impulsive",
                        "Behaviors, Impulsive",
                        "poor impulse control",
                        "Poor impulse control",
                        "Impulsive behavior NOS",
                        "Impulsive behaviour NOS",
                        "impulsive behavior (symptom)"
                    ],
                    "UMLS:C4715862": [
                        "Exhibits impulsivity"
                    ],
                    "UMLS:C0233461": [
                        "Emotional impulsivity",
                        "Emotional impulsivity (finding)"
                    ],
                    "UMLS:C5214605": [
                        "Hyperactivity-impulsivity"
                    ],
                    "UMLS:C4065833": [
                        "CPT-II impulsivity measures",
                        "CPT-II impulsivity measures (procedure)"
                    ]
                }
            }
        ]
    ],
    "Indications and Usage: Attention Deficit Disorders, Narcolepsy": [],
    "Lamotrigine tablets are indicated as adjunctive therapy for the following seizure types in patients aged 2 years and older": [
        [
            {
                "label": "Lamotrigine tablets",
                "id": {
                    "UMLS:C1246625": [
                        "Lamotrigine Tablets",
                        "lamoTRIgine Oral Tablet",
                        "lamotrigine Oral Tablet"
                    ],
                    "UMLS:C2700653": [
                        "Lamotrigine Extended-Release Tablets",
                        "lamoTRIgine Extended Release Oral Tablet",
                        "lamotrigine Extended Release Oral Tablet"
                    ],
                    "UMLS:C1246624": [
                        "Lamotrigine Orally Disintegrating Tablets",
                        "lamotrigine Disintegrating Oral Tablet",
                        "lamoTRIgine Disintegrating Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated",
                "id": {
                    "UMLS:C1548408": [
                        "The indicated time slot(s) is(are) blocked"
                    ],
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C0514907": [
                        "Provide input in areas of strength and development needs, as indicated"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4714006": [
                        "Activate the rapid response team if indicated by presence of trigger areas, per agency protocol"
                    ]
                }
            },
            {
                "label": "as adjunctive therapy",
                "id": {
                    "UMLS:C0846961": [
                        "Adjunctive dental physical therapy for temporomandibular joint and associated structures"
                    ]
                }
            }
        ],
        [
            {
                "label": "Lamotrigine tablets",
                "id": {
                    "UMLS:C1246625": [
                        "Lamotrigine Tablets",
                        "lamoTRIgine Oral Tablet",
                        "lamotrigine Oral Tablet"
                    ],
                    "UMLS:C2700653": [
                        "Lamotrigine Extended-Release Tablets",
                        "lamoTRIgine Extended Release Oral Tablet",
                        "lamotrigine Extended Release Oral Tablet"
                    ],
                    "UMLS:C1246624": [
                        "Lamotrigine Orally Disintegrating Tablets",
                        "lamotrigine Disintegrating Oral Tablet",
                        "lamoTRIgine Disintegrating Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the following seizure types",
                "id": {}
            }
        ],
        [
            {
                "label": "Lamotrigine tablets",
                "id": {
                    "UMLS:C1246625": [
                        "Lamotrigine Tablets",
                        "lamoTRIgine Oral Tablet",
                        "lamotrigine Oral Tablet"
                    ],
                    "UMLS:C2700653": [
                        "Lamotrigine Extended-Release Tablets",
                        "lamoTRIgine Extended Release Oral Tablet",
                        "lamotrigine Extended Release Oral Tablet"
                    ],
                    "UMLS:C1246624": [
                        "Lamotrigine Orally Disintegrating Tablets",
                        "lamotrigine Disintegrating Oral Tablet",
                        "lamoTRIgine Disintegrating Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated",
                "id": {
                    "UMLS:C1548408": [
                        "The indicated time slot(s) is(are) blocked"
                    ],
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C0514907": [
                        "Provide input in areas of strength and development needs, as indicated"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4714006": [
                        "Activate the rapid response team if indicated by presence of trigger areas, per agency protocol"
                    ]
                }
            },
            {
                "label": "in patients aged 2 years and older",
                "id": {}
            }
        ]
    ],
    "Lamotrigine tablets are indicated for conversion to monotherapy in adults (aged 16 years and older) with partial-onset seizures who are receiving treatment with carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug (AED).": [
        [
            {
                "label": "Lamotrigine tablets",
                "id": {
                    "UMLS:C1246625": [
                        "Lamotrigine Tablets",
                        "lamoTRIgine Oral Tablet",
                        "lamotrigine Oral Tablet"
                    ],
                    "UMLS:C2700653": [
                        "Lamotrigine Extended-Release Tablets",
                        "lamoTRIgine Extended Release Oral Tablet",
                        "lamotrigine Extended Release Oral Tablet"
                    ],
                    "UMLS:C1246624": [
                        "Lamotrigine Orally Disintegrating Tablets",
                        "lamotrigine Disintegrating Oral Tablet",
                        "lamoTRIgine Disintegrating Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "conversion to monotherapy in adults with partial-onset seizures",
                "id": {}
            }
        ],
        [
            {
                "label": "adults with partial-onset seizures",
                "id": {}
            },
            {
                "label": "are receiving treatment with",
                "id": {
                    "UMLS:C4290509": [
                        "Categories Z40-Z53 are intended for use to indicate a reason for care. They may be used for patients who have already been treated for a disease or injury, but who are receiving aftercare or prophylactic care, or care to consolidate the treatment, or to deal with a residual state"
                    ]
                }
            },
            {
                "label": "carbamazepine, phenytoin, phenobarbital, primidone, or valproate as the single antiepileptic drug (AED)",
                "id": {}
            }
        ]
    ],
    "Lamotrigine tablets are indicated for the maintenance treatment of bipolar I disorder to delay the time to occurrence of mood episodes (depression, mania, hypomania, mixed episodes) in patients treated for acute mood episodes with standard therapy": [
        [
            {
                "label": "Lamotrigine tablets",
                "id": {
                    "UMLS:C1246625": [
                        "Lamotrigine Tablets",
                        "lamoTRIgine Oral Tablet",
                        "lamotrigine Oral Tablet"
                    ],
                    "UMLS:C2700653": [
                        "Lamotrigine Extended-Release Tablets",
                        "lamoTRIgine Extended Release Oral Tablet",
                        "lamotrigine Extended Release Oral Tablet"
                    ],
                    "UMLS:C1246624": [
                        "Lamotrigine Orally Disintegrating Tablets",
                        "lamotrigine Disintegrating Oral Tablet",
                        "lamoTRIgine Disintegrating Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the maintenance treatment of bipolar I disorder",
                "id": {}
            }
        ],
        [
            {
                "label": "Lamotrigine tablets",
                "id": {
                    "UMLS:C1246625": [
                        "Lamotrigine Tablets",
                        "lamoTRIgine Oral Tablet",
                        "lamotrigine Oral Tablet"
                    ],
                    "UMLS:C2700653": [
                        "Lamotrigine Extended-Release Tablets",
                        "lamoTRIgine Extended Release Oral Tablet",
                        "lamotrigine Extended Release Oral Tablet"
                    ],
                    "UMLS:C1246624": [
                        "Lamotrigine Orally Disintegrating Tablets",
                        "lamotrigine Disintegrating Oral Tablet",
                        "lamoTRIgine Disintegrating Oral Tablet"
                    ]
                }
            },
            {
                "label": "to delay",
                "id": {
                    "UMLS:C0678775": [
                        "delayed toxicity"
                    ],
                    "HP:0025336": [
                        "Delayed ability to sit"
                    ],
                    "HP:0000684": [
                        "tooth delayed eruption",
                        "Delayed tooth eruption",
                        "delayed tooth eruption",
                        "delayed; tooth eruption",
                        "tooth eruption; delayed",
                        "Delayed eruption of tooth",
                        "DENTITION DELAY",
                        "Delayed eruption",
                        "Eruption, delayed",
                        "Delayed dentition",
                        "late tooth eruption",
                        "Late tooth eruption",
                        "Tooth eruption, late",
                        "Late eruption of teeth",
                        "Delayed teeth eruption",
                        "Delayed dental eruption",
                        "Delayed eruption of teeth",
                        "Delayed dental development",
                        "Late tooth eruption (disorder)",
                        "late tooth eruption (diagnosis)"
                    ],
                    "UMLS:C0424873": [
                        "Delayed toilet training",
                        "Delayed toilet training (finding)"
                    ],
                    "HP:0031936": [
                        "Delayed ability to walk",
                        "Walking delay",
                        "WALKING DELAY",
                        "delays walking",
                        "Delayed walking",
                        "delayed walking"
                    ]
                }
            },
            {
                "label": "the time to occurrence of mood episodes",
                "id": {}
            }
        ],
        [
            {
                "label": "patients",
                "id": {
                    "UMLS:C0030705": [
                        "Patients",
                        "patients",
                        "PT",
                        "patient",
                        "Patient",
                        "PATIENT",
                        "^Patient",
                        "*^patient",
                        "Patient (person)"
                    ],
                    "UMLS:C0029921": [
                        "out-patients",
                        "Out-patients",
                        "Out patients",
                        "outpatient",
                        "Outpatient",
                        "Outpatients",
                        "out-patient",
                        "outpatients",
                        "Out-patient",
                        "Outpatient (person)"
                    ],
                    "UMLS:C0150831": [
                        "patients sex",
                        "patient sex",
                        "Patient sex",
                        "Patient's Sex",
                        "Patient sex (observable entity)"
                    ],
                    "UMLS:C0030690": [
                        "fall patients",
                        "falls patients",
                        "patient fall",
                        "PATIENT FALL",
                        "falls patient"
                    ],
                    "UMLS:C0150904": [
                        "male patients",
                        "male patient",
                        "patient is male",
                        "Patient is male"
                    ]
                }
            },
            {
                "label": "treated for",
                "id": {
                    "UMLS:C0332154": [
                        "Treated for",
                        "RP",
                        "Received therapy or drug for",
                        "RP - received therapy or drug for",
                        "Received therapy or drug for (contextual qualifier)",
                        "Received therapy or drug for (contextual qualifier) (qualifier value)"
                    ],
                    "UMLS:C0332155": [
                        "Not treated for",
                        "NG",
                        "untreated",
                        "did not receive therapy or drug for",
                        "Did not receive therapy or drug for",
                        "NG - did not receive therapy or drug for",
                        "Did not receive therapy or drug for (contextual qualifier)",
                        "Did not receive therapy or drug for (contextual qualifier) (qualifier value)"
                    ],
                    "UMLS:C3533168": [
                        "Treated for syphillis"
                    ],
                    "UMLS:C5400857": [
                        "Patient treated for high BP",
                        "Patient is being treated for high blood pressure",
                        "Patient is being treated for high blood pressure:Find:Pt:^Patient:Ord",
                        "Patient is being treated for high blood pressure:Finding:Point in time:^Patient:Ordinal",
                        "Patient is being treated for high blood pressure:Finding:To identify measures at a point in time:^Patient:Ordinal"
                    ],
                    "UMLS:C3533838": [
                        "Treated for syphillis [RHEA]",
                        "Treated for syphillis:Find:Pt:^Patient:Ord:RHEA",
                        "Treated for syphillis:Finding:To identify measures at a point in time:^Patient:Ordinal:RHEA"
                    ]
                }
            },
            {
                "label": "acute mood episodes with standard therapy",
                "id": {}
            }
        ]
    ],
    "Topiramate tablets and topiramate capsules are indicated as initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older": [
        [
            {
                "label": "Topiramate tablets and topiramate capsules",
                "id": {}
            },
            {
                "label": "are indicated as",
                "id": {
                    "UMLS:C0514907": [
                        "Provide input in areas of strength and development needs, as indicated"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4712573": [
                        "Assist physician with the provision of electroconvulsive therapy (ECT) treatments when they are indicated"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures",
                "id": {}
            }
        ],
        [
            {
                "label": "Topiramate tablets and topiramate capsules",
                "id": {}
            },
            {
                "label": "are for",
                "id": {
                    "UMLS:C0086312": [
                        "Forested Area",
                        "Forested Areas",
                        "Area, Forested",
                        "Areas, Forested",
                        "forest",
                        "Forest",
                        "Forests",
                        "forests",
                        "Woodland",
                        "Woodlands",
                        "Forestland",
                        "Forestlands",
                        "Forest (environment)"
                    ],
                    "UMLS:C5268462": [
                        "Arenaria forrestii",
                        "Arenaria forrestii Diels"
                    ],
                    "UMLS:C2331620": [
                        "basal forebrain area",
                        "Basal Forebrain Area",
                        "Area, Basal Forebrain",
                        "Forebrain Area, Basal",
                        "Basal Forebrain Areas",
                        "Areas, Basal Forebrain",
                        "Forebrain Areas, Basal",
                        "basal forebrain",
                        "Basal Forebrain",
                        "Basal forebrain",
                        "Basal Forebrains",
                        "Forebrain, Basal",
                        "Forebrains, Basal",
                        "Pars Basalis Telencephali",
                        "Pars basalis telencephali",
                        "Telencephali, Pars Basalis",
                        "Basalis Telencephali, Pars",
                        "Pars Basalis Telencephalus",
                        "Telencephalus, Pars Basalis",
                        "Basalis Telencephalus, Pars"
                    ],
                    "UBERON:0002743": [
                        "basal forebrain area",
                        "basal forebrain",
                        "pars basalis telencephali"
                    ],
                    "PUBCHEM.COMPOUND:2230": [
                        "arecoline in any form",
                        "Arekolin",
                        "arecolin",
                        "Arecolin",
                        "Arecolin",
                        "arekolin",
                        "Arecaline",
                        "arecoline",
                        "ARECOLINE",
                        "Arecaline",
                        "arecaline",
                        "Arecholin",
                        "Arecholin",
                        "arecholin",
                        "arecaline",
                        "Arecoline",
                        "Arecholine",
                        "Arecholine",
                        "arecholine",
                        "arecholine",
                        "Arecoline base",
                        "Methylarecaiden",
                        "methylarecaidin",
                        "methylarecaidin",
                        "methylarecaiden",
                        "Methylarecaidin",
                        "Methylarecaidin",
                        "Arecoline (substance)",
                        "Arecoline hydrobromide",
                        "arecaidine methyl ester",
                        "Arecaidine methyl ester",
                        "Methyl N-methyltetrahydronicotinate",
                        "N-Methyl-beta -carboxylic acid methyl ester",
                        "Methyl 1,2,5,6-tetrahydro-1-methylnicotinate",
                        "Methyl N-methyl-1,2,5,6-tetrahydronicotinate",
                        "Methyl N-methyl-1,2,5, 6-tetrahydronicotinate",
                        "Methyl 1,2,5, 6-tetrahydro-1-methylnicotinate",
                        "N-Methyltetrahydronicotinic acid, methyl ester",
                        "Methyl 1-methyl-5,6-dihydro-2H-pyridine-3-carboxylate",
                        "1,2,5,6-Tetrahydro-1-methylnicotinic acid, methyl ester",
                        "methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate",
                        "Methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate",
                        "Methyl 1-methyl-1,2,5,6-tetrahydro-3-pyridinecarboxylate",
                        "Nicotinic acid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester",
                        "3-Pyridinecarboxylic acid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester"
                    ]
                }
            },
            {
                "label": "patients 2 years of age and older",
                "id": {
                    "UMLS:C3702276": [
                        "End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older"
                    ],
                    "UMLS:C2366714": [
                        "End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older",
                        "ESRD HOME PT SERV P MO 20+",
                        "Esrd home pt serv p mo 20+",
                        "ESRD SVC HOME DIALYSIS FULL MONTH 20 YR OLD"
                    ],
                    "UMLS:C2366718": [
                        "End-stage renal disease (ESRD) related services for dialysis less than a full month of service, per day; for patients 20 years of age and older",
                        "ESRD SVC PR DAY PT 20+",
                        "Esrd svc pr day pt 20+",
                        "ESRD RELATED SVC <FULL MONTH 20/>YR OLD"
                    ],
                    "UMLS:C2366710": [
                        "End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month",
                        "ESRD SERV 1 VISIT P MO 20+",
                        "Esrd serv 1 visit p mo 20+",
                        "ESRD RELATED SVC MONTHLY 20&/>YR OLD 1 VISIT"
                    ],
                    "UMLS:C2366709": [
                        "End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month",
                        "ESRD SRV 2-3 VSTS P MO 20+",
                        "Esrd srv 2-3 vsts p mo 20+",
                        "ESRD RELATED SVC MONTHLY 20/>YR OLD 2/3 VISITS"
                    ]
                }
            }
        ]
    ],
    "Topiramate tablets and topiramate capsules are indicated as adjunctive therapy for for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older": [
        [
            {
                "label": "Topiramate tablets and topiramate capsules",
                "id": {}
            },
            {
                "label": "are indicated as",
                "id": {
                    "UMLS:C0514907": [
                        "Provide input in areas of strength and development needs, as indicated"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4712573": [
                        "Assist physician with the provision of electroconvulsive therapy (ECT) treatments when they are indicated"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "adjunctive therapy",
                "id": {
                    "UMLS:C1292783": [
                        "Adjunctive care (regime/therapy)",
                        "Adjunctive care",
                        "Adjunctive care procedure"
                    ],
                    "UMLS:C1138792": [
                        "LAMP, NON-HEATING, FOR ADJUNCTIVE USE IN PAIN THERAPY"
                    ],
                    "UMLS:C0846961": [
                        "Adjunctive dental physical therapy for temporomandibular joint and associated structures"
                    ]
                }
            }
        ],
        [
            {
                "label": "Topiramate tablets and topiramate capsules",
                "id": {}
            },
            {
                "label": "used for the treatment of",
                "id": {
                    "UMLS:C1579373": [
                        "Drugs used for the treatment of acute migraine",
                        "Drugs used for acute migraine"
                    ],
                    "UMLS:C1145363": [
                        "Personal care services, per diem, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant)",
                        "Personal care ser per diem"
                    ],
                    "UMLS:C1145362": [
                        "Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant)",
                        "Personal care ser per 15 min"
                    ],
                    "SMPDB:SMP0000744": [
                        "Rilpivirine Action Pathway,Drug Action,Rilpivirine is non-nucleoside reverse transcriptase inhibitor (NNRTI) which is used for the treatment of HIV-1 infections in treatment-naive patients. It binds to reverse transcriptase which results in a block in RNA and DNA- dependent DNA polymerase activities. One such activity is HIV-1 replication. Intracellular phosphorylation is not necessary for its antiviral activity."
                    ]
                }
            },
            {
                "label": "partial-onset seizures",
                "id": {
                    "UMLS:C0270836": [
                        "Complex partial seizures with impaired consciousness at onset",
                        "Complex part seiz+imp cons ons",
                        "Complex partial seizure + impairment consciousness at onset",
                        "Complex partial seizure with impairment of consciousness at onset",
                        "Complex partial seizure + impairment consciousness at onset (disorder)"
                    ],
                    "UMLS:C0270835": [
                        "Simple partial onset seizures followed by impaired consciousness",
                        "Simp part onset seiz-imp consc",
                        "Simple partial onset seizure followed by impairm consciousn",
                        "Simple partial onset seizure followed by impaired consciousness",
                        "Simple partial onset of seizure followed by impairment of consciousness",
                        "Simple partial onset seizure followed by impaired consciousness (disorder)"
                    ],
                    "UMLS:C3554196": [
                        "Seizures, partial with secondary generalization, focal at onset, usually motor"
                    ],
                    "UMLS:C0475521": [
                        "Localisation-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset",
                        "Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset",
                        "Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset",
                        "Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset NOS",
                        "Local-rel (focal) idio epilepsy w seizures of loc onset"
                    ],
                    "UMLS:C2875078": [
                        "Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable",
                        "Local-rel (focal) idio epi w seizures of loc onset, ntrct"
                    ]
                }
            }
        ],
        [
            {
                "label": "Topiramate tablets and topiramate capsules",
                "id": {}
            },
            {
                "label": "used for the treatment of",
                "id": {
                    "UMLS:C1579373": [
                        "Drugs used for the treatment of acute migraine",
                        "Drugs used for acute migraine"
                    ],
                    "UMLS:C1145363": [
                        "Personal care services, per diem, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant)",
                        "Personal care ser per diem"
                    ],
                    "UMLS:C1145362": [
                        "Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant)",
                        "Personal care ser per 15 min"
                    ],
                    "SMPDB:SMP0000744": [
                        "Rilpivirine Action Pathway,Drug Action,Rilpivirine is non-nucleoside reverse transcriptase inhibitor (NNRTI) which is used for the treatment of HIV-1 infections in treatment-naive patients. It binds to reverse transcriptase which results in a block in RNA and DNA- dependent DNA polymerase activities. One such activity is HIV-1 replication. Intracellular phosphorylation is not necessary for its antiviral activity."
                    ]
                }
            },
            {
                "label": "primary generalized tonic-clonic seizures",
                "id": {
                    "HP:0025190": [
                        "Primary generalized tonic-clonic seizures",
                        "Generalized-onset tonic-clonic seizure",
                        "Generalised-onset tonic-clonic seizure",
                        "Primary generalised tonic-clonic seizure",
                        "Primary generalized tonic-clonic seizure",
                        "Primary generalised tonic-clonic seizures",
                        "Primarily generalised tonic-clonic seizures",
                        "Primarily generalized tonic-clonic seizures",
                        "Generalised tonic-clonic seizure without focal onset",
                        "Generalized tonic-clonic seizure without focal onset",
                        "Bilateral tonic-clonic seizure with generalized onset",
                        "Bilateral tonic-clonic seizure with generalised onset",
                        "Generalised tonic-clonic seizures without focal onset",
                        "Generalized tonic-clonic seizures without focal onset",
                        "Generalised tonic-clonic seizure without partial onset",
                        "Generalized tonic-clonic seizure without partial onset"
                    ]
                }
            }
        ],
        [
            {
                "label": "Topiramate tablets and topiramate capsules",
                "id": {}
            },
            {
                "label": "used for the treatment of",
                "id": {
                    "UMLS:C1579373": [
                        "Drugs used for the treatment of acute migraine",
                        "Drugs used for acute migraine"
                    ],
                    "UMLS:C1145363": [
                        "Personal care services, per diem, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant)",
                        "Personal care ser per diem"
                    ],
                    "UMLS:C1145362": [
                        "Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant)",
                        "Personal care ser per 15 min"
                    ],
                    "SMPDB:SMP0000744": [
                        "Rilpivirine Action Pathway,Drug Action,Rilpivirine is non-nucleoside reverse transcriptase inhibitor (NNRTI) which is used for the treatment of HIV-1 infections in treatment-naive patients. It binds to reverse transcriptase which results in a block in RNA and DNA- dependent DNA polymerase activities. One such activity is HIV-1 replication. Intracellular phosphorylation is not necessary for its antiviral activity."
                    ]
                }
            },
            {
                "label": "seizures associated with Lennox-Gastaut syndrome",
                "id": {}
            }
        ],
        [
            {
                "label": "Topiramate tablets and topiramate capsules",
                "id": {}
            },
            {
                "label": "are for",
                "id": {
                    "UMLS:C0086312": [
                        "Forested Area",
                        "Forested Areas",
                        "Area, Forested",
                        "Areas, Forested",
                        "forest",
                        "Forest",
                        "Forests",
                        "forests",
                        "Woodland",
                        "Woodlands",
                        "Forestland",
                        "Forestlands",
                        "Forest (environment)"
                    ],
                    "UMLS:C5268462": [
                        "Arenaria forrestii",
                        "Arenaria forrestii Diels"
                    ],
                    "UMLS:C2331620": [
                        "basal forebrain area",
                        "Basal Forebrain Area",
                        "Area, Basal Forebrain",
                        "Forebrain Area, Basal",
                        "Basal Forebrain Areas",
                        "Areas, Basal Forebrain",
                        "Forebrain Areas, Basal",
                        "basal forebrain",
                        "Basal Forebrain",
                        "Basal forebrain",
                        "Basal Forebrains",
                        "Forebrain, Basal",
                        "Forebrains, Basal",
                        "Pars Basalis Telencephali",
                        "Pars basalis telencephali",
                        "Telencephali, Pars Basalis",
                        "Basalis Telencephali, Pars",
                        "Pars Basalis Telencephalus",
                        "Telencephalus, Pars Basalis",
                        "Basalis Telencephalus, Pars"
                    ],
                    "UBERON:0002743": [
                        "basal forebrain area",
                        "basal forebrain",
                        "pars basalis telencephali"
                    ],
                    "PUBCHEM.COMPOUND:2230": [
                        "arecoline in any form",
                        "Arekolin",
                        "arecolin",
                        "Arecolin",
                        "Arecolin",
                        "arekolin",
                        "Arecaline",
                        "arecoline",
                        "ARECOLINE",
                        "Arecaline",
                        "arecaline",
                        "Arecholin",
                        "Arecholin",
                        "arecholin",
                        "arecaline",
                        "Arecoline",
                        "Arecholine",
                        "Arecholine",
                        "arecholine",
                        "arecholine",
                        "Arecoline base",
                        "Methylarecaiden",
                        "methylarecaidin",
                        "methylarecaidin",
                        "methylarecaiden",
                        "Methylarecaidin",
                        "Methylarecaidin",
                        "Arecoline (substance)",
                        "Arecoline hydrobromide",
                        "arecaidine methyl ester",
                        "Arecaidine methyl ester",
                        "Methyl N-methyltetrahydronicotinate",
                        "N-Methyl-beta -carboxylic acid methyl ester",
                        "Methyl 1,2,5,6-tetrahydro-1-methylnicotinate",
                        "Methyl N-methyl-1,2,5,6-tetrahydronicotinate",
                        "Methyl N-methyl-1,2,5, 6-tetrahydronicotinate",
                        "Methyl 1,2,5, 6-tetrahydro-1-methylnicotinate",
                        "N-Methyltetrahydronicotinic acid, methyl ester",
                        "Methyl 1-methyl-5,6-dihydro-2H-pyridine-3-carboxylate",
                        "1,2,5,6-Tetrahydro-1-methylnicotinic acid, methyl ester",
                        "methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate",
                        "Methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate",
                        "Methyl 1-methyl-1,2,5,6-tetrahydro-3-pyridinecarboxylate",
                        "Nicotinic acid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester",
                        "3-Pyridinecarboxylic acid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester"
                    ]
                }
            },
            {
                "label": "patients 2 years of age and older",
                "id": {
                    "UMLS:C3702276": [
                        "End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older"
                    ],
                    "UMLS:C2366714": [
                        "End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older",
                        "ESRD HOME PT SERV P MO 20+",
                        "Esrd home pt serv p mo 20+",
                        "ESRD SVC HOME DIALYSIS FULL MONTH 20 YR OLD"
                    ],
                    "UMLS:C2366718": [
                        "End-stage renal disease (ESRD) related services for dialysis less than a full month of service, per day; for patients 20 years of age and older",
                        "ESRD SVC PR DAY PT 20+",
                        "Esrd svc pr day pt 20+",
                        "ESRD RELATED SVC <FULL MONTH 20/>YR OLD"
                    ],
                    "UMLS:C2366710": [
                        "End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 1 face-to-face visit by a physician or other qualified health care professional per month",
                        "ESRD SERV 1 VISIT P MO 20+",
                        "Esrd serv 1 visit p mo 20+",
                        "ESRD RELATED SVC MONTHLY 20&/>YR OLD 1 VISIT"
                    ],
                    "UMLS:C2366709": [
                        "End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month",
                        "ESRD SRV 2-3 VSTS P MO 20+",
                        "Esrd srv 2-3 vsts p mo 20+",
                        "ESRD RELATED SVC MONTHLY 20/>YR OLD 2/3 VISITS"
                    ]
                }
            }
        ]
    ],
    "Topiramate tablets and topiramate capsules are indicated for the preventive treatment of migraine in patients 12 years of age and older": [
        [
            {
                "label": "Topiramate tablets and topiramate capsules",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the preventive treatment of migraine in patients 12 years of age and older",
                "id": {}
            }
        ]
    ],
    "Quetiapine tablets are indicated for the treatment of schizophrenia.": [
        [
            {
                "label": "Quetiapine tablets",
                "id": {
                    "UMLS:C1248733": [
                        "Quetiapine Tablets",
                        "QUEtiapine Oral Tablet",
                        "quetiapine Oral Tablet"
                    ],
                    "UMLS:C1949279": [
                        "Quetiapine Extended-Release Tablets",
                        "QUEtiapine Extended Release Oral Tablet",
                        "quetiapine Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of schizophrenia",
                "id": {}
            }
        ]
    ],
    "Quetiapine tablets are indicated for the acute treatment of manic episodes associated with bipolar I disorder, both as monotherapy and as an adjunct to lithium or divalproex": [
        [
            {
                "label": "Quetiapine tablets",
                "id": {
                    "UMLS:C1248733": [
                        "Quetiapine Tablets",
                        "QUEtiapine Oral Tablet",
                        "quetiapine Oral Tablet"
                    ],
                    "UMLS:C1949279": [
                        "Quetiapine Extended-Release Tablets",
                        "QUEtiapine Extended Release Oral Tablet",
                        "quetiapine Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the acute treatment of manic episodes associated with bipolar I disorder",
                "id": {}
            }
        ],
        [
            {
                "label": "Quetiapine tablets",
                "id": {
                    "UMLS:C1248733": [
                        "Quetiapine Tablets",
                        "QUEtiapine Oral Tablet",
                        "quetiapine Oral Tablet"
                    ],
                    "UMLS:C1949279": [
                        "Quetiapine Extended-Release Tablets",
                        "QUEtiapine Extended Release Oral Tablet",
                        "quetiapine Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "apply as",
                "id": {
                    "UMLS:C1879723": [
                        "Apply As Directed"
                    ],
                    "UMLS:C0547911": [
                        "Apply ice packs as ordered."
                    ],
                    "UMLS:C0508525": [
                        "Apply oxygen, as appropriate"
                    ],
                    "UMLS:C4713783": [
                        "Apply a sling, as appropriate"
                    ],
                    "UMLS:C0508448": [
                        "Apply dressing, as appropriate",
                        "Apply dressings, as appropriate",
                        "Apply a dressing, as appropriate"
                    ]
                }
            },
            {
                "label": "monotherapy",
                "id": {
                    "UMLS:C4763675": [
                        "Monotherapy",
                        "Single Agent Therapy",
                        "Single Agent Treatment"
                    ],
                    "UMLS:C0591698": [
                        "Lamictal Monotherapy"
                    ],
                    "UMLS:C0361859": [
                        "Lamictal Monotherapy pack",
                        "Lamictal Monotherapy 25mg starter pack"
                    ],
                    "UMLS:C4054901": [
                        "Genomically Directed Monotherapy",
                        "Genomically-Directed Monotherapy"
                    ]
                }
            }
        ],
        [
            {
                "label": "Quetiapine tablets",
                "id": {
                    "UMLS:C1248733": [
                        "Quetiapine Tablets",
                        "QUEtiapine Oral Tablet",
                        "quetiapine Oral Tablet"
                    ],
                    "UMLS:C1949279": [
                        "Quetiapine Extended-Release Tablets",
                        "QUEtiapine Extended Release Oral Tablet",
                        "quetiapine Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "are used as an adjunct to",
                "id": {}
            },
            {
                "label": "lithium or divalproex",
                "id": {}
            }
        ]
    ],
    "Quetiapine tablets are indicated as monotherapy for the acute treatment of depressive episodes associated with bipolar disorder.": [
        [
            {
                "label": "Quetiapine tablets",
                "id": {
                    "UMLS:C1248733": [
                        "Quetiapine Tablets",
                        "QUEtiapine Oral Tablet",
                        "quetiapine Oral Tablet"
                    ],
                    "UMLS:C1949279": [
                        "Quetiapine Extended-Release Tablets",
                        "QUEtiapine Extended Release Oral Tablet",
                        "quetiapine Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated as",
                "id": {
                    "UMLS:C0514907": [
                        "Provide input in areas of strength and development needs, as indicated"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4712573": [
                        "Assist physician with the provision of electroconvulsive therapy (ECT) treatments when they are indicated"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "monotherapy for the acute treatment of depressive episodes associated with bipolar disorder",
                "id": {}
            }
        ]
    ],
    "Alprazolam extended-release tablets are indicated for the treatment of panic disorder, with or without agoraphobia.": [
        [
            {
                "label": "Alprazolam extended-release tablets",
                "id": {
                    "UMLS:C1244845": [
                        "Alprazolam Extended-Release Tablets",
                        "alprazolam Extended Release Oral Tablet",
                        "ALPRAZolam Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of panic disorder",
                "id": {}
            }
        ],
        [
            {
                "label": "Alprazolam extended-release tablets",
                "id": {
                    "UMLS:C1244845": [
                        "Alprazolam Extended-Release Tablets",
                        "alprazolam Extended Release Oral Tablet",
                        "ALPRAZolam Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of agoraphobia",
                "id": {}
            }
        ]
    ],
    "Tizanidine hydrochloride capsules are central alpha-2-adrenergic agonist indicated for the management of spasticity.": [
        [
            {
                "label": "Tizanidine hydrochloride capsules",
                "id": {}
            },
            {
                "label": "are",
                "id": {
                    "NCIT:C13662": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1515984": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1551058": [
                        "Are",
                        "are unit of measure"
                    ],
                    "MONDO:0044742": [
                        "AREI",
                        "autosomal recessive epidermolytic ichthyosis"
                    ],
                    "MONDO:0017339": [
                        "AREI",
                        "Ichthyosis exfoliativa",
                        "ICHTHYOSIS EXFOLIATIVA",
                        "ichthyosis exfoliativa",
                        "Exfoliative ichthyosis",
                        "Ichthyosis Exfoliativa",
                        "exfoliative ichthyosis",
                        "ICHTHYOSIS BULLOSA OF SIEMENS-LIKE",
                        "autosomal recessive exfoliative ichthyosis",
                        "Autosomal recessive exfoliative ichthyosis",
                        "ICHTHYOSIS, EXFOLIATIVE, AUTOSOMAL RECESSIVE",
                        "ichthyosis congenital autosomal recessive exfoliative",
                        "Autosomal recessive exfoliative ichthyosis (disorder)",
                        "Autosomal recessive exfoliative ichthyosis (diagnosis)"
                    ]
                }
            },
            {
                "label": "central alpha-2-adrenergic agonist",
                "id": {
                    "UMLS:C2267005": [
                        "Central alpha-2 Adrenergic Agonist",
                        "Central alpha-2 Adrenergic Agonist [EPC]",
                        "Selective alpha2-Agonist",
                        "alpha-2 Adrenergic Agonist",
                        "Central a-2 Adrenergic Agonist"
                    ],
                    "UMLS:C5203510": [
                        "Central alpha-2 adrenergic receptor agonist",
                        "Central alpha-2 adrenergic receptor agonist (disposition)"
                    ],
                    "UMLS:C5203511": [
                        "Central alpha-2 adrenergic receptor agonist",
                        "Central alpha-2 adrenergic receptor agonist-containing product",
                        "Product containing central alpha-2 adrenergic receptor agonist (product)",
                        "Substance with central alpha-2 adrenergic receptor agonist mechanism of action (substance)"
                    ],
                    "UMLS:C5230443": [
                        "Central alpha-2 adrenergic receptor agonist overdose",
                        "Central alpha-2 adrenergic receptor agonist overdose (disorder)"
                    ],
                    "UMLS:C5230442": [
                        "Central alpha-2 adrenergic receptor agonist poisoning",
                        "Central alpha-2 adrenergic receptor agonist poisoning (disorder)"
                    ]
                }
            }
        ],
        [
            {
                "label": "Tizanidine hydrochloride capsules",
                "id": {}
            },
            {
                "label": "indicated for",
                "id": {
                    "UMLS:C3872862": [
                        "Testing for Ebola virus indicated",
                        "Testing for Ebola virus indicated (situation)"
                    ],
                    "UMLS:C3872863": [
                        "Testing for Ebola virus not indicated",
                        "Testing for Ebola virus not indicated (situation)"
                    ],
                    "UMLS:C0515329": [
                        "Refer for family therapy, as indicated",
                        "Refer for family therapy, as appropriate"
                    ],
                    "UMLS:C4714387": [
                        "Prepare for thrombolytic therapy, if indicated"
                    ],
                    "UMLS:C5681217": [
                        "Rare disorder potentially indicated for transplant"
                    ]
                }
            },
            {
                "label": "the management of spasticity",
                "id": {}
            }
        ]
    ],
    "Uses: temporarily reduces pains and aches due to headache, toothache, backache, menstrual cramps, the common cold, muscular aches, minor pains of arthritis, temporarily reduces fever": [
        [
            {
                "label": "Uses",
                "id": {
                    "UMLS:C0457083": [
                        "uses",
                        "Use",
                        "Usage",
                        "usage",
                        "Employ",
                        "usages",
                        "Usage (attribute)"
                    ],
                    "UMLS:C1522726": [
                        "iv uses",
                        "intravenous uses",
                        "IV",
                        "IV use",
                        "iv route",
                        "IV route",
                        "Intravenous",
                        "Intravenous use",
                        "intravenous use",
                        "IntravenousRoute",
                        "Intravenous route",
                        "IV - Intravenous route",
                        "Intravenous route (qualifier value)",
                        "route of administration intravenous",
                        "Intravenous Route of Administration",
                        "route of administration: intravenous",
                        "Intravenous Route of Drug Administration",
                        "route of administration: intravenous (treatment)"
                    ],
                    "UMLS:C0578310": [
                        "Uses lift",
                        "Does use lift",
                        "Does use lift (finding)"
                    ],
                    "UMLS:C4083280": [
                        "ECig Uses",
                        "E-Cig Uses",
                        "Ecigarette Uses",
                        "E-Cigarette Uses",
                        "Uses, Ecigarette",
                        "Vape",
                        "Vapes",
                        "Vaping",
                        "ECig Use",
                        "E Cig Use",
                        "E-Cig Use",
                        "Use, ECig",
                        "THC Vaping",
                        "Use, E-Cig",
                        "Vaping, THC",
                        "THC Vapings",
                        "Vapings, THC",
                        "Vaping (event)",
                        "Ecigarette Use",
                        "E Cigarette Use",
                        "E-Cigarette Use",
                        "Use, Ecigarette",
                        "Nicotine Vaping",
                        "Vaping, Nicotine",
                        "Use, E-Cigarette",
                        "Nicotine Vapings",
                        "Vapings, Nicotine"
                    ],
                    "UMLS:C0565721": [
                        "Uses a key",
                        "Does use a key",
                        "Does use a key (finding)"
                    ]
                }
            },
            {
                "label": "temporarily reduces",
                "id": {}
            },
            {
                "label": "pains and aches due to headache",
                "id": {}
            }
        ],
        [
            {
                "label": "Uses",
                "id": {
                    "UMLS:C0457083": [
                        "uses",
                        "Use",
                        "Usage",
                        "usage",
                        "Employ",
                        "usages",
                        "Usage (attribute)"
                    ],
                    "UMLS:C1522726": [
                        "iv uses",
                        "intravenous uses",
                        "IV",
                        "IV use",
                        "iv route",
                        "IV route",
                        "Intravenous",
                        "Intravenous use",
                        "intravenous use",
                        "IntravenousRoute",
                        "Intravenous route",
                        "IV - Intravenous route",
                        "Intravenous route (qualifier value)",
                        "route of administration intravenous",
                        "Intravenous Route of Administration",
                        "route of administration: intravenous",
                        "Intravenous Route of Drug Administration",
                        "route of administration: intravenous (treatment)"
                    ],
                    "UMLS:C0578310": [
                        "Uses lift",
                        "Does use lift",
                        "Does use lift (finding)"
                    ],
                    "UMLS:C4083280": [
                        "ECig Uses",
                        "E-Cig Uses",
                        "Ecigarette Uses",
                        "E-Cigarette Uses",
                        "Uses, Ecigarette",
                        "Vape",
                        "Vapes",
                        "Vaping",
                        "ECig Use",
                        "E Cig Use",
                        "E-Cig Use",
                        "Use, ECig",
                        "THC Vaping",
                        "Use, E-Cig",
                        "Vaping, THC",
                        "THC Vapings",
                        "Vapings, THC",
                        "Vaping (event)",
                        "Ecigarette Use",
                        "E Cigarette Use",
                        "E-Cigarette Use",
                        "Use, Ecigarette",
                        "Nicotine Vaping",
                        "Vaping, Nicotine",
                        "Use, E-Cigarette",
                        "Nicotine Vapings",
                        "Vapings, Nicotine"
                    ],
                    "UMLS:C0565721": [
                        "Uses a key",
                        "Does use a key",
                        "Does use a key (finding)"
                    ]
                }
            },
            {
                "label": "temporarily reduces",
                "id": {}
            },
            {
                "label": "pains and aches due to toothache",
                "id": {}
            }
        ],
        [
            {
                "label": "Uses",
                "id": {
                    "UMLS:C0457083": [
                        "uses",
                        "Use",
                        "Usage",
                        "usage",
                        "Employ",
                        "usages",
                        "Usage (attribute)"
                    ],
                    "UMLS:C1522726": [
                        "iv uses",
                        "intravenous uses",
                        "IV",
                        "IV use",
                        "iv route",
                        "IV route",
                        "Intravenous",
                        "Intravenous use",
                        "intravenous use",
                        "IntravenousRoute",
                        "Intravenous route",
                        "IV - Intravenous route",
                        "Intravenous route (qualifier value)",
                        "route of administration intravenous",
                        "Intravenous Route of Administration",
                        "route of administration: intravenous",
                        "Intravenous Route of Drug Administration",
                        "route of administration: intravenous (treatment)"
                    ],
                    "UMLS:C0578310": [
                        "Uses lift",
                        "Does use lift",
                        "Does use lift (finding)"
                    ],
                    "UMLS:C4083280": [
                        "ECig Uses",
                        "E-Cig Uses",
                        "Ecigarette Uses",
                        "E-Cigarette Uses",
                        "Uses, Ecigarette",
                        "Vape",
                        "Vapes",
                        "Vaping",
                        "ECig Use",
                        "E Cig Use",
                        "E-Cig Use",
                        "Use, ECig",
                        "THC Vaping",
                        "Use, E-Cig",
                        "Vaping, THC",
                        "THC Vapings",
                        "Vapings, THC",
                        "Vaping (event)",
                        "Ecigarette Use",
                        "E Cigarette Use",
                        "E-Cigarette Use",
                        "Use, Ecigarette",
                        "Nicotine Vaping",
                        "Vaping, Nicotine",
                        "Use, E-Cigarette",
                        "Nicotine Vapings",
                        "Vapings, Nicotine"
                    ],
                    "UMLS:C0565721": [
                        "Uses a key",
                        "Does use a key",
                        "Does use a key (finding)"
                    ]
                }
            },
            {
                "label": "temporarily reduces",
                "id": {}
            },
            {
                "label": "pains and aches due to backache",
                "id": {}
            }
        ],
        [
            {
                "label": "Uses",
                "id": {
                    "UMLS:C0457083": [
                        "uses",
                        "Use",
                        "Usage",
                        "usage",
                        "Employ",
                        "usages",
                        "Usage (attribute)"
                    ],
                    "UMLS:C1522726": [
                        "iv uses",
                        "intravenous uses",
                        "IV",
                        "IV use",
                        "iv route",
                        "IV route",
                        "Intravenous",
                        "Intravenous use",
                        "intravenous use",
                        "IntravenousRoute",
                        "Intravenous route",
                        "IV - Intravenous route",
                        "Intravenous route (qualifier value)",
                        "route of administration intravenous",
                        "Intravenous Route of Administration",
                        "route of administration: intravenous",
                        "Intravenous Route of Drug Administration",
                        "route of administration: intravenous (treatment)"
                    ],
                    "UMLS:C0578310": [
                        "Uses lift",
                        "Does use lift",
                        "Does use lift (finding)"
                    ],
                    "UMLS:C4083280": [
                        "ECig Uses",
                        "E-Cig Uses",
                        "Ecigarette Uses",
                        "E-Cigarette Uses",
                        "Uses, Ecigarette",
                        "Vape",
                        "Vapes",
                        "Vaping",
                        "ECig Use",
                        "E Cig Use",
                        "E-Cig Use",
                        "Use, ECig",
                        "THC Vaping",
                        "Use, E-Cig",
                        "Vaping, THC",
                        "THC Vapings",
                        "Vapings, THC",
                        "Vaping (event)",
                        "Ecigarette Use",
                        "E Cigarette Use",
                        "E-Cigarette Use",
                        "Use, Ecigarette",
                        "Nicotine Vaping",
                        "Vaping, Nicotine",
                        "Use, E-Cigarette",
                        "Nicotine Vapings",
                        "Vapings, Nicotine"
                    ],
                    "UMLS:C0565721": [
                        "Uses a key",
                        "Does use a key",
                        "Does use a key (finding)"
                    ]
                }
            },
            {
                "label": "temporarily reduces",
                "id": {}
            },
            {
                "label": "pains and aches due to menstrual cramps",
                "id": {}
            }
        ],
        [
            {
                "label": "Uses",
                "id": {
                    "UMLS:C0457083": [
                        "uses",
                        "Use",
                        "Usage",
                        "usage",
                        "Employ",
                        "usages",
                        "Usage (attribute)"
                    ],
                    "UMLS:C1522726": [
                        "iv uses",
                        "intravenous uses",
                        "IV",
                        "IV use",
                        "iv route",
                        "IV route",
                        "Intravenous",
                        "Intravenous use",
                        "intravenous use",
                        "IntravenousRoute",
                        "Intravenous route",
                        "IV - Intravenous route",
                        "Intravenous route (qualifier value)",
                        "route of administration intravenous",
                        "Intravenous Route of Administration",
                        "route of administration: intravenous",
                        "Intravenous Route of Drug Administration",
                        "route of administration: intravenous (treatment)"
                    ],
                    "UMLS:C0578310": [
                        "Uses lift",
                        "Does use lift",
                        "Does use lift (finding)"
                    ],
                    "UMLS:C4083280": [
                        "ECig Uses",
                        "E-Cig Uses",
                        "Ecigarette Uses",
                        "E-Cigarette Uses",
                        "Uses, Ecigarette",
                        "Vape",
                        "Vapes",
                        "Vaping",
                        "ECig Use",
                        "E Cig Use",
                        "E-Cig Use",
                        "Use, ECig",
                        "THC Vaping",
                        "Use, E-Cig",
                        "Vaping, THC",
                        "THC Vapings",
                        "Vapings, THC",
                        "Vaping (event)",
                        "Ecigarette Use",
                        "E Cigarette Use",
                        "E-Cigarette Use",
                        "Use, Ecigarette",
                        "Nicotine Vaping",
                        "Vaping, Nicotine",
                        "Use, E-Cigarette",
                        "Nicotine Vapings",
                        "Vapings, Nicotine"
                    ],
                    "UMLS:C0565721": [
                        "Uses a key",
                        "Does use a key",
                        "Does use a key (finding)"
                    ]
                }
            },
            {
                "label": "temporarily reduces",
                "id": {}
            },
            {
                "label": "pains and aches due to the common cold",
                "id": {}
            }
        ],
        [
            {
                "label": "Uses",
                "id": {
                    "UMLS:C0457083": [
                        "uses",
                        "Use",
                        "Usage",
                        "usage",
                        "Employ",
                        "usages",
                        "Usage (attribute)"
                    ],
                    "UMLS:C1522726": [
                        "iv uses",
                        "intravenous uses",
                        "IV",
                        "IV use",
                        "iv route",
                        "IV route",
                        "Intravenous",
                        "Intravenous use",
                        "intravenous use",
                        "IntravenousRoute",
                        "Intravenous route",
                        "IV - Intravenous route",
                        "Intravenous route (qualifier value)",
                        "route of administration intravenous",
                        "Intravenous Route of Administration",
                        "route of administration: intravenous",
                        "Intravenous Route of Drug Administration",
                        "route of administration: intravenous (treatment)"
                    ],
                    "UMLS:C0578310": [
                        "Uses lift",
                        "Does use lift",
                        "Does use lift (finding)"
                    ],
                    "UMLS:C4083280": [
                        "ECig Uses",
                        "E-Cig Uses",
                        "Ecigarette Uses",
                        "E-Cigarette Uses",
                        "Uses, Ecigarette",
                        "Vape",
                        "Vapes",
                        "Vaping",
                        "ECig Use",
                        "E Cig Use",
                        "E-Cig Use",
                        "Use, ECig",
                        "THC Vaping",
                        "Use, E-Cig",
                        "Vaping, THC",
                        "THC Vapings",
                        "Vapings, THC",
                        "Vaping (event)",
                        "Ecigarette Use",
                        "E Cigarette Use",
                        "E-Cigarette Use",
                        "Use, Ecigarette",
                        "Nicotine Vaping",
                        "Vaping, Nicotine",
                        "Use, E-Cigarette",
                        "Nicotine Vapings",
                        "Vapings, Nicotine"
                    ],
                    "UMLS:C0565721": [
                        "Uses a key",
                        "Does use a key",
                        "Does use a key (finding)"
                    ]
                }
            },
            {
                "label": "temporarily reduces",
                "id": {}
            },
            {
                "label": "pains and aches due to muscular aches",
                "id": {}
            }
        ],
        [
            {
                "label": "Uses",
                "id": {
                    "UMLS:C0457083": [
                        "uses",
                        "Use",
                        "Usage",
                        "usage",
                        "Employ",
                        "usages",
                        "Usage (attribute)"
                    ],
                    "UMLS:C1522726": [
                        "iv uses",
                        "intravenous uses",
                        "IV",
                        "IV use",
                        "iv route",
                        "IV route",
                        "Intravenous",
                        "Intravenous use",
                        "intravenous use",
                        "IntravenousRoute",
                        "Intravenous route",
                        "IV - Intravenous route",
                        "Intravenous route (qualifier value)",
                        "route of administration intravenous",
                        "Intravenous Route of Administration",
                        "route of administration: intravenous",
                        "Intravenous Route of Drug Administration",
                        "route of administration: intravenous (treatment)"
                    ],
                    "UMLS:C0578310": [
                        "Uses lift",
                        "Does use lift",
                        "Does use lift (finding)"
                    ],
                    "UMLS:C4083280": [
                        "ECig Uses",
                        "E-Cig Uses",
                        "Ecigarette Uses",
                        "E-Cigarette Uses",
                        "Uses, Ecigarette",
                        "Vape",
                        "Vapes",
                        "Vaping",
                        "ECig Use",
                        "E Cig Use",
                        "E-Cig Use",
                        "Use, ECig",
                        "THC Vaping",
                        "Use, E-Cig",
                        "Vaping, THC",
                        "THC Vapings",
                        "Vapings, THC",
                        "Vaping (event)",
                        "Ecigarette Use",
                        "E Cigarette Use",
                        "E-Cigarette Use",
                        "Use, Ecigarette",
                        "Nicotine Vaping",
                        "Vaping, Nicotine",
                        "Use, E-Cigarette",
                        "Nicotine Vapings",
                        "Vapings, Nicotine"
                    ],
                    "UMLS:C0565721": [
                        "Uses a key",
                        "Does use a key",
                        "Does use a key (finding)"
                    ]
                }
            },
            {
                "label": "temporarily reduces",
                "id": {}
            },
            {
                "label": "pains and aches due to minor pains of arthritis",
                "id": {}
            }
        ],
        [
            {
                "label": "Uses",
                "id": {
                    "UMLS:C0457083": [
                        "uses",
                        "Use",
                        "Usage",
                        "usage",
                        "Employ",
                        "usages",
                        "Usage (attribute)"
                    ],
                    "UMLS:C1522726": [
                        "iv uses",
                        "intravenous uses",
                        "IV",
                        "IV use",
                        "iv route",
                        "IV route",
                        "Intravenous",
                        "Intravenous use",
                        "intravenous use",
                        "IntravenousRoute",
                        "Intravenous route",
                        "IV - Intravenous route",
                        "Intravenous route (qualifier value)",
                        "route of administration intravenous",
                        "Intravenous Route of Administration",
                        "route of administration: intravenous",
                        "Intravenous Route of Drug Administration",
                        "route of administration: intravenous (treatment)"
                    ],
                    "UMLS:C0578310": [
                        "Uses lift",
                        "Does use lift",
                        "Does use lift (finding)"
                    ],
                    "UMLS:C4083280": [
                        "ECig Uses",
                        "E-Cig Uses",
                        "Ecigarette Uses",
                        "E-Cigarette Uses",
                        "Uses, Ecigarette",
                        "Vape",
                        "Vapes",
                        "Vaping",
                        "ECig Use",
                        "E Cig Use",
                        "E-Cig Use",
                        "Use, ECig",
                        "THC Vaping",
                        "Use, E-Cig",
                        "Vaping, THC",
                        "THC Vapings",
                        "Vapings, THC",
                        "Vaping (event)",
                        "Ecigarette Use",
                        "E Cigarette Use",
                        "E-Cigarette Use",
                        "Use, Ecigarette",
                        "Nicotine Vaping",
                        "Vaping, Nicotine",
                        "Use, E-Cigarette",
                        "Nicotine Vapings",
                        "Vapings, Nicotine"
                    ],
                    "UMLS:C0565721": [
                        "Uses a key",
                        "Does use a key",
                        "Does use a key (finding)"
                    ]
                }
            },
            {
                "label": "temporarily reduces",
                "id": {}
            },
            {
                "label": "fever",
                "id": {
                    "UMLS:C0424755": [
                        "Fever",
                        "fever",
                        "fever symptom",
                        "fever symptoms",
                        "symptoms fever",
                        "fever as symptom",
                        "fever symptom (symptom)",
                        "Fever symptoms (finding)"
                    ],
                    "NCIT:C143485": [
                        "Fever",
                        "Fever, CTCAE"
                    ],
                    "HP:0001945": [
                        "Fever",
                        "FEVER",
                        "fever",
                        "Fevers",
                        "fevers",
                        "fevered",
                        "feverish",
                        "Feverish",
                        "Fever NOS",
                        "Fever (finding)",
                        "Fever, unspecified",
                        "fever (physical finding)",
                        "Alteration in body temperature: hyperthermia, fever",
                        "febris",
                        "febrile",
                        "Febrile",
                        "PYREXIA",
                        "pyrexia",
                        "Pyrexia",
                        "Pyrexias",
                        "Pyrexial",
                        "pyrexial",
                        "Pyrexia NOS",
                        "Hyperthermia",
                        "HYPERTHERMIA",
                        "Hyperthermic",
                        "hyperthermic",
                        "hyperthermia",
                        "high temperature",
                        "Temperature;high",
                        "High temperature",
                        "temperature; high",
                        "Has a temperature",
                        "high; temperature",
                        "Temperature raised",
                        "raised temperature",
                        "pyrexia (diagnosis)",
                        "elevated temperature",
                        "TEMPERATURE INCREASE",
                        "Temperature elevated",
                        "increase temperature",
                        "temperature increase",
                        "TEMPERATURE ELEVATION",
                        "temperature elevation",
                        "High body temperature",
                        "high body temperature",
                        "Temperature elevation",
                        "increases temperature",
                        "BODY TEMPERATURE INCREASED",
                        "Body temperature increased",
                        "increased body temperature",
                        "Increased body temperature",
                        "increased; body temperature",
                        "Body temperature, increased",
                        "body temperature; increased",
                        "Increase in body temperature",
                        "Body temperature above normal",
                        "Body temperature above reference range",
                        "Body temperature above reference range (finding)"
                    ],
                    "UMLS:C0872996": [
                        "Q fever",
                        "Q fever vaccine",
                        "Q fever vaccine (medication)"
                    ],
                    "MONDO:0019186": [
                        "Q-fever",
                        "fever q",
                        "q fever",
                        "Q fever",
                        "Q Fever",
                        "q-fever",
                        "Q fever",
                        "Q FEVER",
                        "fever; Q",
                        "Fever, Q",
                        "Q; fever",
                        "Q Fevers",
                        "Fevers, Q",
                        "query fever",
                        "fever query",
                        "Query Fever",
                        "Query fever",
                        "Fever, Query",
                        "Query Fevers",
                        "E-217 Q FEVER",
                        "Fevers, Query",
                        "Abattoir fever",
                        "nine Mile fever",
                        "Nine Mile fever",
                        "Nine-mile fever",
                        "FEVER, NINE MILE",
                        "fever; nine Mile",
                        "nine Mile; fever",
                        "Q fever pneumonia",
                        "Q fever (disorder)",
                        "Q-fever (diagnosis)",
                        "quadrilateral fever",
                        "Quadrilateral fever",
                        "quadrilateral; fever",
                        "fever; quadrilateral",
                        "Coxiella burnetii Fever",
                        "Coxiella burnetii fever",
                        "Fever, Coxiella burnetii",
                        "Coxiella burnetii Fevers",
                        "Fevers, Coxiella burnetii",
                        "Coxiellosis",
                        "BALKAN GRIPPE",
                        "Balkan grippe",
                        "Balkan influenza",
                        "Balkan; influenza",
                        "influenza; Balkan",
                        "DERRICK-BURNET DISEASE",
                        "Coxiella burnetii infection",
                        "infection; Coxiella burnetii",
                        "Coxiella burnetii; infection",
                        "BRONCHOPNEUMONIA, HIBERNO-VERNAL",
                        "Infection due to Coxiella burnetii",
                        "infection due to Coxiella burnetii",
                        "Infection due to Coxiella burnetii",
                        "Coxiella burnetii infectious disease",
                        "Coxiella burnetii disease or disorder",
                        "Coxiella burnetii caused disease or disorder"
                    ]
                }
            }
        ]
    ],
    "Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in thetreatment of partial onset seizures in adults with epilepsy.": [
        [
            {
                "label": "Levetiracetam in Sodium Chloride Injection",
                "id": {
                    "UMLS:C4238001": [
                        "Levetiracetam 5mg/1mL, Sodium Chloride 0.82% Solution for injection",
                        "Levetiracetam 5 MG/1 ML Intravenous Solution"
                    ],
                    "UMLS:C3247936": [
                        "Levetiracetam 10mg/1mL, Sodium Chloride 0.75% Solution for injection",
                        "Levetiracetam 10 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam in Sodium Chloride]",
                        "100 ML levetiracetam 10 MG/ML Injection",
                        "100 ML levETIRAcetam 10 MG/ML Injection",
                        "LEVETIRACETAM 10MG/ML/NACL INJ BAG 100ML",
                        "LEVETIRACETAM 10MG/ML/NACL INJ,BAG,100ML",
                        "levETIRAcetam 1000 MG in 100 ML Injection",
                        "levETIRAcetam 1000 MG per 100 ML Injection",
                        "levetiracetam 1000 MG per 100 ML Injection",
                        "Levetiracetam 10 MG/1 ML Intravenous Solution",
                        "LEVETIRACETAM 10 mg in 1 mL INTRAVENOUS INJECTION",
                        "LEVETIRACETAM 10 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "levETIRAcetam 1000 mg/100 mL-NaCl 0.75% intravenous solution",
                        "LevETIRAcetam, 1000 mg/100 mL-NaCl 0.75% intravenous solution",
                        "Levetiracetam 10 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam]",
                        "Levetiracetam/Sodium Chloride 1000 MG/100 ML-0.75% Intravenous Solution",
                        "LEVETIRACETAM 1000 mg in 100 mL INTRAVENOUS INJECTION, SOLUTION [Levetiracetam]",
                        "levetiracetam in NaCl (iso-os) 1,000 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic@1,000 mg/100 mL@INTRAVEN@INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic 1,000 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "Levetiracetam/Sodium Chloride 1000 MG/100 ML-0.75% Intravenous Solution [LEVETIRACETAM-SODIUM CHLORIDE NOVAPLUS]"
                    ],
                    "UMLS:C3247938": [
                        "Levetiracetam 15mg/1mL, Sodium Chloride 0.54% Solution for injection",
                        "Levetiracetam 15 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam in Sodium Chloride]",
                        "100 ML levetiracetam 15 MG/ML Injection",
                        "100 ML levETIRAcetam 15 MG/ML Injection",
                        "LEVETIRACETAM 15MG/ML/NACL INJ BAG 100ML",
                        "LEVETIRACETAM 15MG/ML/NACL INJ,BAG,100ML",
                        "levETIRAcetam 1500 MG in 100 ML Injection",
                        "levETIRAcetam 1500 MG per 100 ML Injection",
                        "levetiracetam 1500 MG per 100 ML Injection",
                        "Levetiracetam 15 MG/1 ML Intravenous Solution",
                        "LEVETIRACETAM 15 mg in 1 mL INTRAVENOUS INJECTION",
                        "LEVETIRACETAM 15 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "levETIRAcetam 1500 mg/100 mL-NaCl 0.54% intravenous solution",
                        "LevETIRAcetam, 1500 mg/100 mL-NaCl 0.54% intravenous solution",
                        "Levetiracetam 15 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam]",
                        "Levetiracetam/Sodium Chloride 1500 MG/100 ML-0.54% Intravenous Solution",
                        "LEVETIRACETAM 1500 mg in 100 mL INTRAVENOUS INJECTION, SOLUTION [Levetiracetam]",
                        "levetiracetam in NaCl (iso-os) 1,500 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic 1,500 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic@1,500 mg/100 mL@INTRAVEN@INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "Levetiracetam/Sodium Chloride 1500 MG/100 ML-0.54% Intravenous Solution [LEVETIRACETAM-SODIUM CHLORIDE NOVPALUS]"
                    ],
                    "UMLS:C3247940": [
                        "Levetiracetam 5mg/1mL, Sodium Chloride 0.82% Solution for injection_#1",
                        "Levetiracetam 5 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam in Sodium Chloride]",
                        "100 ML levETIRAcetam 5 MG/ML Injection",
                        "100 ML levetiracetam 5 MG/ML Injection",
                        "LEVETIRACETAM 5MG/ML/NACL INJ,BAG,100ML",
                        "LEVETIRACETAM 5MG/ML/NACL INJ BAG 100ML",
                        "levETIRAcetam 500 MG in 100 ML Injection",
                        "levETIRAcetam 500 MG per 100 ML Injection",
                        "levetiracetam 500 MG per 100 ML Injection",
                        "Levetiracetam 5 MG/1 ML Intravenous Solution_#1",
                        "LEVETIRACETAM 5 mg in 1 mL INTRAVENOUS INJECTION",
                        "LEVETIRACETAM 5 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "levETIRAcetam 500 mg/100 mL-NaCl 0.82% intravenous solution",
                        "LevETIRAcetam, 500 mg/100 mL-NaCl 0.82% intravenous solution",
                        "Levetiracetam 5 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam]",
                        "Levetiracetam/Sodium Chloride 500 MG/100 ML-0.82% Intravenous Solution",
                        "LEVETIRACETAM 500 mg in 100 mL INTRAVENOUS INJECTION, SOLUTION [Levetiracetam]",
                        "levetiracetam in NaCl (iso-os) 500 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic 500 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic@500 mg/100 mL@INTRAVEN@INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "Levetiracetam/Sodium Chloride 500 MG/100 ML-0.82% Intravenous Solution [LEVETIRACETAM-SODIUM CHLORIDE NOVAPLUS]"
                    ],
                    "UMLS:C5551354": [
                        "Levetiracetam 5mg/1mL, Sodium Chloride 0.82% Solution for injection_#2",
                        "50 ML levetiracetam 5 MG/ML Injection",
                        "50 ML levETIRAcetam 5 MG/ML Injection",
                        "LEVETIRACETAM 5MG/ML/NACL INJ BAG 50ML",
                        "LEVETIRACETAM 5MG/ML/NACL INJ,BAG,50ML",
                        "levETIRAcetam 250 MG in 50 ML Injection",
                        "levetiracetam 250 MG per 50 ML Injection",
                        "levETIRAcetam 250 MG per 50 ML Injection",
                        "levetiracetam 5 MG/ML per 50 ML Injection",
                        "levETIRAcetam 5 MG/ML per 50 ML Injection",
                        "Levetiracetam 5 MG/1 ML Intravenous Solution_#2",
                        "LEVETIRACETAM 5 mg in 1 mL INTRAVENOUS INJECTION",
                        "levetiracetam in NaCl (iso-os) 250 mg/50 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic@250 mg/50 mL@INTRAVEN@INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic 250 mg/50 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)"
                    ]
                }
            },
            {
                "label": "is indicated as",
                "id": {
                    "UMLS:C4710292": [
                        "Assure that someone is oxygenating the patient and assisting with intubation, as indicated"
                    ],
                    "UMLS:C4713987": [
                        "Assure that the surgical site is marked with a permanent marker by the surgeon, as indicated"
                    ],
                    "UMLS:C4714380": [
                        "Perform targeted assessment of the system that is indicated by the history of present illness"
                    ],
                    "UMLS:C4711109": [
                        "Ensure that equipment is operational via trial run (i.e., assemble laryngoscope and check light bulb function), as indicated"
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ]
                }
            },
            {
                "label": "adjunctive therapy in thetreatment of partial onset seizures in adults with epilepsy",
                "id": {}
            }
        ]
    ],
    "Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adult patients (16 years and older) when oral administration is temporarily not feasible": [
        [
            {
                "label": "Levetiracetam in Sodium Chloride Injection",
                "id": {
                    "UMLS:C4238001": [
                        "Levetiracetam 5mg/1mL, Sodium Chloride 0.82% Solution for injection",
                        "Levetiracetam 5 MG/1 ML Intravenous Solution"
                    ],
                    "UMLS:C3247936": [
                        "Levetiracetam 10mg/1mL, Sodium Chloride 0.75% Solution for injection",
                        "Levetiracetam 10 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam in Sodium Chloride]",
                        "100 ML levetiracetam 10 MG/ML Injection",
                        "100 ML levETIRAcetam 10 MG/ML Injection",
                        "LEVETIRACETAM 10MG/ML/NACL INJ BAG 100ML",
                        "LEVETIRACETAM 10MG/ML/NACL INJ,BAG,100ML",
                        "levETIRAcetam 1000 MG in 100 ML Injection",
                        "levETIRAcetam 1000 MG per 100 ML Injection",
                        "levetiracetam 1000 MG per 100 ML Injection",
                        "Levetiracetam 10 MG/1 ML Intravenous Solution",
                        "LEVETIRACETAM 10 mg in 1 mL INTRAVENOUS INJECTION",
                        "LEVETIRACETAM 10 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "levETIRAcetam 1000 mg/100 mL-NaCl 0.75% intravenous solution",
                        "LevETIRAcetam, 1000 mg/100 mL-NaCl 0.75% intravenous solution",
                        "Levetiracetam 10 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam]",
                        "Levetiracetam/Sodium Chloride 1000 MG/100 ML-0.75% Intravenous Solution",
                        "LEVETIRACETAM 1000 mg in 100 mL INTRAVENOUS INJECTION, SOLUTION [Levetiracetam]",
                        "levetiracetam in NaCl (iso-os) 1,000 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic@1,000 mg/100 mL@INTRAVEN@INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic 1,000 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "Levetiracetam/Sodium Chloride 1000 MG/100 ML-0.75% Intravenous Solution [LEVETIRACETAM-SODIUM CHLORIDE NOVAPLUS]"
                    ],
                    "UMLS:C3247938": [
                        "Levetiracetam 15mg/1mL, Sodium Chloride 0.54% Solution for injection",
                        "Levetiracetam 15 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam in Sodium Chloride]",
                        "100 ML levetiracetam 15 MG/ML Injection",
                        "100 ML levETIRAcetam 15 MG/ML Injection",
                        "LEVETIRACETAM 15MG/ML/NACL INJ BAG 100ML",
                        "LEVETIRACETAM 15MG/ML/NACL INJ,BAG,100ML",
                        "levETIRAcetam 1500 MG in 100 ML Injection",
                        "levETIRAcetam 1500 MG per 100 ML Injection",
                        "levetiracetam 1500 MG per 100 ML Injection",
                        "Levetiracetam 15 MG/1 ML Intravenous Solution",
                        "LEVETIRACETAM 15 mg in 1 mL INTRAVENOUS INJECTION",
                        "LEVETIRACETAM 15 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "levETIRAcetam 1500 mg/100 mL-NaCl 0.54% intravenous solution",
                        "LevETIRAcetam, 1500 mg/100 mL-NaCl 0.54% intravenous solution",
                        "Levetiracetam 15 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam]",
                        "Levetiracetam/Sodium Chloride 1500 MG/100 ML-0.54% Intravenous Solution",
                        "LEVETIRACETAM 1500 mg in 100 mL INTRAVENOUS INJECTION, SOLUTION [Levetiracetam]",
                        "levetiracetam in NaCl (iso-os) 1,500 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic 1,500 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic@1,500 mg/100 mL@INTRAVEN@INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "Levetiracetam/Sodium Chloride 1500 MG/100 ML-0.54% Intravenous Solution [LEVETIRACETAM-SODIUM CHLORIDE NOVPALUS]"
                    ],
                    "UMLS:C3247940": [
                        "Levetiracetam 5mg/1mL, Sodium Chloride 0.82% Solution for injection_#1",
                        "Levetiracetam 5 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam in Sodium Chloride]",
                        "100 ML levETIRAcetam 5 MG/ML Injection",
                        "100 ML levetiracetam 5 MG/ML Injection",
                        "LEVETIRACETAM 5MG/ML/NACL INJ,BAG,100ML",
                        "LEVETIRACETAM 5MG/ML/NACL INJ BAG 100ML",
                        "levETIRAcetam 500 MG in 100 ML Injection",
                        "levETIRAcetam 500 MG per 100 ML Injection",
                        "levetiracetam 500 MG per 100 ML Injection",
                        "Levetiracetam 5 MG/1 ML Intravenous Solution_#1",
                        "LEVETIRACETAM 5 mg in 1 mL INTRAVENOUS INJECTION",
                        "LEVETIRACETAM 5 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "levETIRAcetam 500 mg/100 mL-NaCl 0.82% intravenous solution",
                        "LevETIRAcetam, 500 mg/100 mL-NaCl 0.82% intravenous solution",
                        "Levetiracetam 5 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam]",
                        "Levetiracetam/Sodium Chloride 500 MG/100 ML-0.82% Intravenous Solution",
                        "LEVETIRACETAM 500 mg in 100 mL INTRAVENOUS INJECTION, SOLUTION [Levetiracetam]",
                        "levetiracetam in NaCl (iso-os) 500 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic 500 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic@500 mg/100 mL@INTRAVEN@INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "Levetiracetam/Sodium Chloride 500 MG/100 ML-0.82% Intravenous Solution [LEVETIRACETAM-SODIUM CHLORIDE NOVAPLUS]"
                    ],
                    "UMLS:C5551354": [
                        "Levetiracetam 5mg/1mL, Sodium Chloride 0.82% Solution for injection_#2",
                        "50 ML levetiracetam 5 MG/ML Injection",
                        "50 ML levETIRAcetam 5 MG/ML Injection",
                        "LEVETIRACETAM 5MG/ML/NACL INJ BAG 50ML",
                        "LEVETIRACETAM 5MG/ML/NACL INJ,BAG,50ML",
                        "levETIRAcetam 250 MG in 50 ML Injection",
                        "levetiracetam 250 MG per 50 ML Injection",
                        "levETIRAcetam 250 MG per 50 ML Injection",
                        "levetiracetam 5 MG/ML per 50 ML Injection",
                        "levETIRAcetam 5 MG/ML per 50 ML Injection",
                        "Levetiracetam 5 MG/1 ML Intravenous Solution_#2",
                        "LEVETIRACETAM 5 mg in 1 mL INTRAVENOUS INJECTION",
                        "levetiracetam in NaCl (iso-os) 250 mg/50 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic@250 mg/50 mL@INTRAVEN@INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic 250 mg/50 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)"
                    ]
                }
            },
            {
                "label": "is",
                "id": {
                    "UBERON:0002872": [
                        "IS",
                        "inferior salivary nucleus",
                        "Nucleus salivarius inferior",
                        "nucleus salivarius inferior",
                        "Inferior salivatory nucleus",
                        "inferior salivatary nucleus",
                        "inferior salivatory nucleus",
                        "Nucleus salivatorius inferior",
                        "nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior",
                        "Nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior nervi glossopharyngei",
                        "Nucleus salivatorius inferior nervi glossopharyngei"
                    ],
                    "OMIM:146850": [
                        "IS",
                        "ISCW",
                        "ISSCW",
                        "IMMUNE SUPPRESSION",
                        "STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO"
                    ],
                    "FB:FBgn0001274": [
                        "Is"
                    ],
                    "PUBCHEM.COMPOUND:7021816": [
                        "IS",
                        "isoleucylserine",
                        "Isoleucyl-Serine",
                        "L-isoleucyl-L-serine",
                        "Ile-Ser",
                        "L-Ile-L-Ser",
                        "CHEMBL56803"
                    ],
                    "UMLS:C0021632": [
                        "IS",
                        "INSTRUM",
                        "instrumentation",
                        "instrumentation aspects"
                    ]
                }
            },
            {
                "label": "an antiepileptic drug",
                "id": {
                    "UMLS:C0003299": [
                        "Antiepileptic Drug",
                        "antiepileptic drug",
                        "Antiepileptic Drugs",
                        "antiepileptic drugs",
                        "Drug, Antiepileptic",
                        "antiepileptics drugs",
                        "Drugs, Antiepileptic",
                        "Antiepileptic",
                        "antiepileptic",
                        "Anti-epileptic",
                        "antiepileptics",
                        "Antiepileptics",
                        "ANTIEPILEPTICS",
                        "Antiepileptic Agent",
                        "Anti-epileptic Agent",
                        "Antiepileptic Agents",
                        "Agent, Antiepileptic",
                        "Agents, Antiepileptic",
                        "Anti-epileptic Agent [TC]"
                    ],
                    "UMLS:C0572841": [
                        "Overdose of antiepileptic drug",
                        "OD, anticonvulsant drug",
                        "Overdose of anticonvulsant drug",
                        "Overdose of anticonvulsant drug (disorder)"
                    ],
                    "UMLS:C3863687": [
                        "drug screen for antiepileptics",
                        "drug screen for antiepileptics (lab test)"
                    ],
                    "MONDO:0018262": [
                        "Fetal antiepileptic drug syndrome",
                        "fetal antiepileptic drug syndrome",
                        "FACS",
                        "fetal AEDS",
                        "Fetal AEDS",
                        "Fetal anticonvulsant syndrome",
                        "fetal anticonvulsant syndrome",
                        "Foetal anticonvulsant syndrome",
                        "Fetus affected by placental transfer of anticonvulsant",
                        "Foetus affected by placental transfer of anticonvulsant",
                        "Fetus affected by placental transfer of anticonvulsant (disorder)"
                    ],
                    "UMLS:C5400808": [
                        "Enzyme-inducing Antiepileptic Drug",
                        "EIAED",
                        "Enzyme-inducing AED"
                    ]
                }
            }
        ],
        [
            {
                "label": "an antiepileptic drug",
                "id": {
                    "UMLS:C0003299": [
                        "Antiepileptic Drug",
                        "antiepileptic drug",
                        "Antiepileptic Drugs",
                        "antiepileptic drugs",
                        "Drug, Antiepileptic",
                        "antiepileptics drugs",
                        "Drugs, Antiepileptic",
                        "Antiepileptic",
                        "antiepileptic",
                        "Anti-epileptic",
                        "antiepileptics",
                        "Antiepileptics",
                        "ANTIEPILEPTICS",
                        "Antiepileptic Agent",
                        "Anti-epileptic Agent",
                        "Antiepileptic Agents",
                        "Agent, Antiepileptic",
                        "Agents, Antiepileptic",
                        "Anti-epileptic Agent [TC]"
                    ],
                    "UMLS:C0572841": [
                        "Overdose of antiepileptic drug",
                        "OD, anticonvulsant drug",
                        "Overdose of anticonvulsant drug",
                        "Overdose of anticonvulsant drug (disorder)"
                    ],
                    "UMLS:C3863687": [
                        "drug screen for antiepileptics",
                        "drug screen for antiepileptics (lab test)"
                    ],
                    "MONDO:0018262": [
                        "Fetal antiepileptic drug syndrome",
                        "fetal antiepileptic drug syndrome",
                        "FACS",
                        "fetal AEDS",
                        "Fetal AEDS",
                        "Fetal anticonvulsant syndrome",
                        "fetal anticonvulsant syndrome",
                        "Foetal anticonvulsant syndrome",
                        "Fetus affected by placental transfer of anticonvulsant",
                        "Foetus affected by placental transfer of anticonvulsant",
                        "Fetus affected by placental transfer of anticonvulsant (disorder)"
                    ],
                    "UMLS:C5400808": [
                        "Enzyme-inducing Antiepileptic Drug",
                        "EIAED",
                        "Enzyme-inducing AED"
                    ]
                }
            },
            {
                "label": "indicated for",
                "id": {
                    "UMLS:C3872862": [
                        "Testing for Ebola virus indicated",
                        "Testing for Ebola virus indicated (situation)"
                    ],
                    "UMLS:C3872863": [
                        "Testing for Ebola virus not indicated",
                        "Testing for Ebola virus not indicated (situation)"
                    ],
                    "UMLS:C0515329": [
                        "Refer for family therapy, as indicated",
                        "Refer for family therapy, as appropriate"
                    ],
                    "UMLS:C4714387": [
                        "Prepare for thrombolytic therapy, if indicated"
                    ],
                    "UMLS:C5681217": [
                        "Rare disorder potentially indicated for transplant"
                    ]
                }
            },
            {
                "label": "adult patients (16 years and older)",
                "id": {}
            }
        ],
        [
            {
                "label": "oral administration",
                "id": {
                    "UMLS:C0001563": [
                        "oral administration",
                        "Oral Administration",
                        "administration oral",
                        "Oral Administrations",
                        "Administration, Oral",
                        "Administrations, Oral",
                        "Oral Drug Administration",
                        "Drug Administration, Oral",
                        "Oral Drug Administrations",
                        "Administration, Oral Drug",
                        "Drug Administrations, Oral",
                        "Administrations, Oral Drug",
                        "oral enteral administration",
                        "oral medication administration",
                        "Medication administration: oral",
                        "Medication Administration: Oral",
                        "Oral medication administration each treatment",
                        "Administration of drug or medicament via oral route",
                        "Administration of drug or medicament via oral route (procedure)",
                        "ORAL ADMIN",
                        "ADMIN ORAL",
                        "DRUG ADMIN ORAL",
                        "ADMIN ORAL DRUG",
                        "ORAL DRUG ADMIN",
                        "PO administration",
                        "orl meds admin.ea.Tx",
                        "per os administration"
                    ],
                    "UMLS:C0182055": [
                        "SET, ORAL ADMINISTRATION",
                        "Oral Administration Sets"
                    ],
                    "UMLS:C0678821": [
                        "oral mucosal administration"
                    ],
                    "UMLS:C1527415": [
                        "Oral Route of Administration",
                        "route of administration oral",
                        "route of administration: oral",
                        "Oral Route of Drug administration",
                        "route of administration: oral (treatment)",
                        "PO",
                        "Oral",
                        "per os",
                        "Orally",
                        "Per Os",
                        "Per os",
                        "By mouth",
                        "Oral use",
                        "use oral",
                        "oral use",
                        "per oral",
                        "Per oral",
                        "by mouth",
                        "OralRoute",
                        "oral route",
                        "Oral route",
                        "PO - Per os",
                        "Peroral route",
                        "PO - Per oral",
                        "Per oral route",
                        "Oral route (qualifier value)"
                    ],
                    "UMLS:C1504152": [
                        "RP THERAPY ORAL ADMINISTRATION",
                        "Radiopharmaceutical therapy, by oral administration",
                        "NUCLEAR RX ORAL ADMIN",
                        "Nuclear rx oral admin"
                    ]
                }
            },
            {
                "label": "is temporarily not",
                "id": {}
            },
            {
                "label": "feasible",
                "id": {
                    "UMLS:C0515203": [
                        "Read aloud, if needed or feasible"
                    ],
                    "UMLS:C3844381": [
                        "Discharge to community determined to be feasible"
                    ],
                    "UMLS:C3844380": [
                        "Discharge to community determined to be not feasible"
                    ],
                    "UMLS:C4711645": [
                        "Provide one-to-one teaching or counseling whenever feasible"
                    ],
                    "UMLS:C4711184": [
                        "Follow up to assure that plans were feasible and carried out"
                    ]
                }
            }
        ]
    ],
    "Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults with juvenile myoclonic epilepsy.": [
        [
            {
                "label": "Levetiracetam in Sodium Chloride Injection",
                "id": {
                    "UMLS:C4238001": [
                        "Levetiracetam 5mg/1mL, Sodium Chloride 0.82% Solution for injection",
                        "Levetiracetam 5 MG/1 ML Intravenous Solution"
                    ],
                    "UMLS:C3247936": [
                        "Levetiracetam 10mg/1mL, Sodium Chloride 0.75% Solution for injection",
                        "Levetiracetam 10 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam in Sodium Chloride]",
                        "100 ML levetiracetam 10 MG/ML Injection",
                        "100 ML levETIRAcetam 10 MG/ML Injection",
                        "LEVETIRACETAM 10MG/ML/NACL INJ BAG 100ML",
                        "LEVETIRACETAM 10MG/ML/NACL INJ,BAG,100ML",
                        "levETIRAcetam 1000 MG in 100 ML Injection",
                        "levETIRAcetam 1000 MG per 100 ML Injection",
                        "levetiracetam 1000 MG per 100 ML Injection",
                        "Levetiracetam 10 MG/1 ML Intravenous Solution",
                        "LEVETIRACETAM 10 mg in 1 mL INTRAVENOUS INJECTION",
                        "LEVETIRACETAM 10 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "levETIRAcetam 1000 mg/100 mL-NaCl 0.75% intravenous solution",
                        "LevETIRAcetam, 1000 mg/100 mL-NaCl 0.75% intravenous solution",
                        "Levetiracetam 10 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam]",
                        "Levetiracetam/Sodium Chloride 1000 MG/100 ML-0.75% Intravenous Solution",
                        "LEVETIRACETAM 1000 mg in 100 mL INTRAVENOUS INJECTION, SOLUTION [Levetiracetam]",
                        "levetiracetam in NaCl (iso-os) 1,000 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic@1,000 mg/100 mL@INTRAVEN@INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic 1,000 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "Levetiracetam/Sodium Chloride 1000 MG/100 ML-0.75% Intravenous Solution [LEVETIRACETAM-SODIUM CHLORIDE NOVAPLUS]"
                    ],
                    "UMLS:C3247938": [
                        "Levetiracetam 15mg/1mL, Sodium Chloride 0.54% Solution for injection",
                        "Levetiracetam 15 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam in Sodium Chloride]",
                        "100 ML levetiracetam 15 MG/ML Injection",
                        "100 ML levETIRAcetam 15 MG/ML Injection",
                        "LEVETIRACETAM 15MG/ML/NACL INJ BAG 100ML",
                        "LEVETIRACETAM 15MG/ML/NACL INJ,BAG,100ML",
                        "levETIRAcetam 1500 MG in 100 ML Injection",
                        "levETIRAcetam 1500 MG per 100 ML Injection",
                        "levetiracetam 1500 MG per 100 ML Injection",
                        "Levetiracetam 15 MG/1 ML Intravenous Solution",
                        "LEVETIRACETAM 15 mg in 1 mL INTRAVENOUS INJECTION",
                        "LEVETIRACETAM 15 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "levETIRAcetam 1500 mg/100 mL-NaCl 0.54% intravenous solution",
                        "LevETIRAcetam, 1500 mg/100 mL-NaCl 0.54% intravenous solution",
                        "Levetiracetam 15 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam]",
                        "Levetiracetam/Sodium Chloride 1500 MG/100 ML-0.54% Intravenous Solution",
                        "LEVETIRACETAM 1500 mg in 100 mL INTRAVENOUS INJECTION, SOLUTION [Levetiracetam]",
                        "levetiracetam in NaCl (iso-os) 1,500 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic 1,500 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic@1,500 mg/100 mL@INTRAVEN@INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "Levetiracetam/Sodium Chloride 1500 MG/100 ML-0.54% Intravenous Solution [LEVETIRACETAM-SODIUM CHLORIDE NOVPALUS]"
                    ],
                    "UMLS:C3247940": [
                        "Levetiracetam 5mg/1mL, Sodium Chloride 0.82% Solution for injection_#1",
                        "Levetiracetam 5 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam in Sodium Chloride]",
                        "100 ML levETIRAcetam 5 MG/ML Injection",
                        "100 ML levetiracetam 5 MG/ML Injection",
                        "LEVETIRACETAM 5MG/ML/NACL INJ,BAG,100ML",
                        "LEVETIRACETAM 5MG/ML/NACL INJ BAG 100ML",
                        "levETIRAcetam 500 MG in 100 ML Injection",
                        "levETIRAcetam 500 MG per 100 ML Injection",
                        "levetiracetam 500 MG per 100 ML Injection",
                        "Levetiracetam 5 MG/1 ML Intravenous Solution_#1",
                        "LEVETIRACETAM 5 mg in 1 mL INTRAVENOUS INJECTION",
                        "LEVETIRACETAM 5 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "levETIRAcetam 500 mg/100 mL-NaCl 0.82% intravenous solution",
                        "LevETIRAcetam, 500 mg/100 mL-NaCl 0.82% intravenous solution",
                        "Levetiracetam 5 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam]",
                        "Levetiracetam/Sodium Chloride 500 MG/100 ML-0.82% Intravenous Solution",
                        "LEVETIRACETAM 500 mg in 100 mL INTRAVENOUS INJECTION, SOLUTION [Levetiracetam]",
                        "levetiracetam in NaCl (iso-os) 500 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic 500 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic@500 mg/100 mL@INTRAVEN@INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "Levetiracetam/Sodium Chloride 500 MG/100 ML-0.82% Intravenous Solution [LEVETIRACETAM-SODIUM CHLORIDE NOVAPLUS]"
                    ],
                    "UMLS:C5551354": [
                        "Levetiracetam 5mg/1mL, Sodium Chloride 0.82% Solution for injection_#2",
                        "50 ML levetiracetam 5 MG/ML Injection",
                        "50 ML levETIRAcetam 5 MG/ML Injection",
                        "LEVETIRACETAM 5MG/ML/NACL INJ BAG 50ML",
                        "LEVETIRACETAM 5MG/ML/NACL INJ,BAG,50ML",
                        "levETIRAcetam 250 MG in 50 ML Injection",
                        "levetiracetam 250 MG per 50 ML Injection",
                        "levETIRAcetam 250 MG per 50 ML Injection",
                        "levetiracetam 5 MG/ML per 50 ML Injection",
                        "levETIRAcetam 5 MG/ML per 50 ML Injection",
                        "Levetiracetam 5 MG/1 ML Intravenous Solution_#2",
                        "LEVETIRACETAM 5 mg in 1 mL INTRAVENOUS INJECTION",
                        "levetiracetam in NaCl (iso-os) 250 mg/50 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic@250 mg/50 mL@INTRAVEN@INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic 250 mg/50 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)"
                    ]
                }
            },
            {
                "label": "is indicated as",
                "id": {
                    "UMLS:C4710292": [
                        "Assure that someone is oxygenating the patient and assisting with intubation, as indicated"
                    ],
                    "UMLS:C4713987": [
                        "Assure that the surgical site is marked with a permanent marker by the surgeon, as indicated"
                    ],
                    "UMLS:C4714380": [
                        "Perform targeted assessment of the system that is indicated by the history of present illness"
                    ],
                    "UMLS:C4711109": [
                        "Ensure that equipment is operational via trial run (i.e., assemble laryngoscope and check light bulb function), as indicated"
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ]
                }
            },
            {
                "label": "adjunctive therapy",
                "id": {
                    "UMLS:C1292783": [
                        "Adjunctive care (regime/therapy)",
                        "Adjunctive care",
                        "Adjunctive care procedure"
                    ],
                    "UMLS:C1138792": [
                        "LAMP, NON-HEATING, FOR ADJUNCTIVE USE IN PAIN THERAPY"
                    ],
                    "UMLS:C0846961": [
                        "Adjunctive dental physical therapy for temporomandibular joint and associated structures"
                    ]
                }
            }
        ],
        [
            {
                "label": "adjunctive therapy",
                "id": {
                    "UMLS:C1292783": [
                        "Adjunctive care (regime/therapy)",
                        "Adjunctive care",
                        "Adjunctive care procedure"
                    ],
                    "UMLS:C1138792": [
                        "LAMP, NON-HEATING, FOR ADJUNCTIVE USE IN PAIN THERAPY"
                    ],
                    "UMLS:C0846961": [
                        "Adjunctive dental physical therapy for temporomandibular joint and associated structures"
                    ]
                }
            },
            {
                "label": "in the treatment of",
                "id": {
                    "UMLS:C0018100": [
                        "Drugs in the treatment of gout",
                        "drug gout",
                        "gout drug",
                        "drugs gout",
                        "antigout agent",
                        "ANTIGOUT AGENTS",
                        "Antigout Agents",
                        "Agents, Antigout",
                        "Gout suppressants",
                        "gout suppressants",
                        "Gout Suppressants",
                        "suppressants gout",
                        "Suppressants, Gout",
                        "drugs gout treatment",
                        "ANTIGOUT PREPARATIONS",
                        "Drugs for the treatment of gout"
                    ],
                    "UMLS:C0850210": [
                        "treatment of fract/disloc of the interphalan",
                        "Treat;fract/disloc;interphalan"
                    ],
                    "UMLS:C2460327": [
                        "Therapeutic Exercise Treatment of Integu Body",
                        "Therapeutic Exercise Treatment of Integumentary System - Whole Body",
                        "Physical Rehabilitation and Diagnostic Audiology @ Rehabilitation @ Motor Treatment @ Integumentary System - Whole Body @ Therapeutic Exercise @ None @ None"
                    ],
                    "UMLS:C0361272": [
                        "Corticosteroids used in the treatment of asthma",
                        "corticosteroids used in the treatment of asthma",
                        "Corticosteroids used in asthma",
                        "asthma corticosteroid treatment",
                        "asthma corticosteroids treatment"
                    ],
                    "UMLS:C4718640": [
                        "Use of probiotics in the treatment of infection"
                    ]
                }
            },
            {
                "label": "myoclonic seizures in adults with juvenile myoclonic epilepsy",
                "id": {}
            }
        ]
    ],
    "Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults with idiopathic generalized epilepsy.": [
        [
            {
                "label": "Levetiracetam in Sodium Chloride Injection",
                "id": {
                    "UMLS:C4238001": [
                        "Levetiracetam 5mg/1mL, Sodium Chloride 0.82% Solution for injection",
                        "Levetiracetam 5 MG/1 ML Intravenous Solution"
                    ],
                    "UMLS:C3247936": [
                        "Levetiracetam 10mg/1mL, Sodium Chloride 0.75% Solution for injection",
                        "Levetiracetam 10 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam in Sodium Chloride]",
                        "100 ML levetiracetam 10 MG/ML Injection",
                        "100 ML levETIRAcetam 10 MG/ML Injection",
                        "LEVETIRACETAM 10MG/ML/NACL INJ BAG 100ML",
                        "LEVETIRACETAM 10MG/ML/NACL INJ,BAG,100ML",
                        "levETIRAcetam 1000 MG in 100 ML Injection",
                        "levETIRAcetam 1000 MG per 100 ML Injection",
                        "levetiracetam 1000 MG per 100 ML Injection",
                        "Levetiracetam 10 MG/1 ML Intravenous Solution",
                        "LEVETIRACETAM 10 mg in 1 mL INTRAVENOUS INJECTION",
                        "LEVETIRACETAM 10 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "levETIRAcetam 1000 mg/100 mL-NaCl 0.75% intravenous solution",
                        "LevETIRAcetam, 1000 mg/100 mL-NaCl 0.75% intravenous solution",
                        "Levetiracetam 10 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam]",
                        "Levetiracetam/Sodium Chloride 1000 MG/100 ML-0.75% Intravenous Solution",
                        "LEVETIRACETAM 1000 mg in 100 mL INTRAVENOUS INJECTION, SOLUTION [Levetiracetam]",
                        "levetiracetam in NaCl (iso-os) 1,000 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic@1,000 mg/100 mL@INTRAVEN@INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic 1,000 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "Levetiracetam/Sodium Chloride 1000 MG/100 ML-0.75% Intravenous Solution [LEVETIRACETAM-SODIUM CHLORIDE NOVAPLUS]"
                    ],
                    "UMLS:C3247938": [
                        "Levetiracetam 15mg/1mL, Sodium Chloride 0.54% Solution for injection",
                        "Levetiracetam 15 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam in Sodium Chloride]",
                        "100 ML levetiracetam 15 MG/ML Injection",
                        "100 ML levETIRAcetam 15 MG/ML Injection",
                        "LEVETIRACETAM 15MG/ML/NACL INJ BAG 100ML",
                        "LEVETIRACETAM 15MG/ML/NACL INJ,BAG,100ML",
                        "levETIRAcetam 1500 MG in 100 ML Injection",
                        "levETIRAcetam 1500 MG per 100 ML Injection",
                        "levetiracetam 1500 MG per 100 ML Injection",
                        "Levetiracetam 15 MG/1 ML Intravenous Solution",
                        "LEVETIRACETAM 15 mg in 1 mL INTRAVENOUS INJECTION",
                        "LEVETIRACETAM 15 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "levETIRAcetam 1500 mg/100 mL-NaCl 0.54% intravenous solution",
                        "LevETIRAcetam, 1500 mg/100 mL-NaCl 0.54% intravenous solution",
                        "Levetiracetam 15 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam]",
                        "Levetiracetam/Sodium Chloride 1500 MG/100 ML-0.54% Intravenous Solution",
                        "LEVETIRACETAM 1500 mg in 100 mL INTRAVENOUS INJECTION, SOLUTION [Levetiracetam]",
                        "levetiracetam in NaCl (iso-os) 1,500 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic 1,500 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic@1,500 mg/100 mL@INTRAVEN@INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "Levetiracetam/Sodium Chloride 1500 MG/100 ML-0.54% Intravenous Solution [LEVETIRACETAM-SODIUM CHLORIDE NOVPALUS]"
                    ],
                    "UMLS:C3247940": [
                        "Levetiracetam 5mg/1mL, Sodium Chloride 0.82% Solution for injection_#1",
                        "Levetiracetam 5 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam in Sodium Chloride]",
                        "100 ML levETIRAcetam 5 MG/ML Injection",
                        "100 ML levetiracetam 5 MG/ML Injection",
                        "LEVETIRACETAM 5MG/ML/NACL INJ,BAG,100ML",
                        "LEVETIRACETAM 5MG/ML/NACL INJ BAG 100ML",
                        "levETIRAcetam 500 MG in 100 ML Injection",
                        "levETIRAcetam 500 MG per 100 ML Injection",
                        "levetiracetam 500 MG per 100 ML Injection",
                        "Levetiracetam 5 MG/1 ML Intravenous Solution_#1",
                        "LEVETIRACETAM 5 mg in 1 mL INTRAVENOUS INJECTION",
                        "LEVETIRACETAM 5 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "levETIRAcetam 500 mg/100 mL-NaCl 0.82% intravenous solution",
                        "LevETIRAcetam, 500 mg/100 mL-NaCl 0.82% intravenous solution",
                        "Levetiracetam 5 mg in 1 mL INTRAVENOUS INJECTION [Levetiracetam]",
                        "Levetiracetam/Sodium Chloride 500 MG/100 ML-0.82% Intravenous Solution",
                        "LEVETIRACETAM 500 mg in 100 mL INTRAVENOUS INJECTION, SOLUTION [Levetiracetam]",
                        "levetiracetam in NaCl (iso-os) 500 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic 500 mg/100 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic@500 mg/100 mL@INTRAVEN@INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "Levetiracetam/Sodium Chloride 500 MG/100 ML-0.82% Intravenous Solution [LEVETIRACETAM-SODIUM CHLORIDE NOVAPLUS]"
                    ],
                    "UMLS:C5551354": [
                        "Levetiracetam 5mg/1mL, Sodium Chloride 0.82% Solution for injection_#2",
                        "50 ML levetiracetam 5 MG/ML Injection",
                        "50 ML levETIRAcetam 5 MG/ML Injection",
                        "LEVETIRACETAM 5MG/ML/NACL INJ BAG 50ML",
                        "LEVETIRACETAM 5MG/ML/NACL INJ,BAG,50ML",
                        "levETIRAcetam 250 MG in 50 ML Injection",
                        "levetiracetam 250 MG per 50 ML Injection",
                        "levETIRAcetam 250 MG per 50 ML Injection",
                        "levetiracetam 5 MG/ML per 50 ML Injection",
                        "levETIRAcetam 5 MG/ML per 50 ML Injection",
                        "Levetiracetam 5 MG/1 ML Intravenous Solution_#2",
                        "LEVETIRACETAM 5 mg in 1 mL INTRAVENOUS INJECTION",
                        "levetiracetam in NaCl (iso-os) 250 mg/50 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic@250 mg/50 mL@INTRAVEN@INTRAVENOUS SOLUTION, PIGGYBACK (ML)",
                        "levetiracetam in sodium chloride, iso-osmotic 250 mg/50 mL INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML)"
                    ]
                }
            },
            {
                "label": "is indicated as",
                "id": {
                    "UMLS:C4710292": [
                        "Assure that someone is oxygenating the patient and assisting with intubation, as indicated"
                    ],
                    "UMLS:C4713987": [
                        "Assure that the surgical site is marked with a permanent marker by the surgeon, as indicated"
                    ],
                    "UMLS:C4714380": [
                        "Perform targeted assessment of the system that is indicated by the history of present illness"
                    ],
                    "UMLS:C4711109": [
                        "Ensure that equipment is operational via trial run (i.e., assemble laryngoscope and check light bulb function), as indicated"
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ]
                }
            },
            {
                "label": "adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults with idiopathic generalized epilepsy",
                "id": {}
            }
        ]
    ],
    "Divalproex sodium delayed-release capsules are indicated as monotherapy and adjunctive therapy in the treatment of adult patients and pediatric patients down to the age of 10 years with complex partial seizures that occur either in isolation or in association with other types of seizures.": [
        [
            {
                "label": "Divalproex sodium delayed-release capsules",
                "id": {
                    "UMLS:C4719920": [
                        "Divalproex Sodium Delayed-Release Capsules"
                    ]
                }
            },
            {
                "label": "are indicated as",
                "id": {
                    "UMLS:C0514907": [
                        "Provide input in areas of strength and development needs, as indicated"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4712573": [
                        "Assist physician with the provision of electroconvulsive therapy (ECT) treatments when they are indicated"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "monotherapy",
                "id": {
                    "UMLS:C4763675": [
                        "Monotherapy",
                        "Single Agent Therapy",
                        "Single Agent Treatment"
                    ],
                    "UMLS:C0591698": [
                        "Lamictal Monotherapy"
                    ],
                    "UMLS:C0361859": [
                        "Lamictal Monotherapy pack",
                        "Lamictal Monotherapy 25mg starter pack"
                    ],
                    "UMLS:C4054901": [
                        "Genomically Directed Monotherapy",
                        "Genomically-Directed Monotherapy"
                    ]
                }
            }
        ],
        [
            {
                "label": "Divalproex sodium delayed-release capsules",
                "id": {
                    "UMLS:C4719920": [
                        "Divalproex Sodium Delayed-Release Capsules"
                    ]
                }
            },
            {
                "label": "are indicated as",
                "id": {
                    "UMLS:C0514907": [
                        "Provide input in areas of strength and development needs, as indicated"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4712573": [
                        "Assist physician with the provision of electroconvulsive therapy (ECT) treatments when they are indicated"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "adjunctive therapy",
                "id": {
                    "UMLS:C1292783": [
                        "Adjunctive care (regime/therapy)",
                        "Adjunctive care",
                        "Adjunctive care procedure"
                    ],
                    "UMLS:C1138792": [
                        "LAMP, NON-HEATING, FOR ADJUNCTIVE USE IN PAIN THERAPY"
                    ],
                    "UMLS:C0846961": [
                        "Adjunctive dental physical therapy for temporomandibular joint and associated structures"
                    ]
                }
            }
        ],
        [
            {
                "label": "adjunctive therapy",
                "id": {
                    "UMLS:C1292783": [
                        "Adjunctive care (regime/therapy)",
                        "Adjunctive care",
                        "Adjunctive care procedure"
                    ],
                    "UMLS:C1138792": [
                        "LAMP, NON-HEATING, FOR ADJUNCTIVE USE IN PAIN THERAPY"
                    ],
                    "UMLS:C0846961": [
                        "Adjunctive dental physical therapy for temporomandibular joint and associated structures"
                    ]
                }
            },
            {
                "label": "in the treatment of",
                "id": {
                    "UMLS:C0018100": [
                        "Drugs in the treatment of gout",
                        "drug gout",
                        "gout drug",
                        "drugs gout",
                        "antigout agent",
                        "ANTIGOUT AGENTS",
                        "Antigout Agents",
                        "Agents, Antigout",
                        "Gout suppressants",
                        "gout suppressants",
                        "Gout Suppressants",
                        "suppressants gout",
                        "Suppressants, Gout",
                        "drugs gout treatment",
                        "ANTIGOUT PREPARATIONS",
                        "Drugs for the treatment of gout"
                    ],
                    "UMLS:C0850210": [
                        "treatment of fract/disloc of the interphalan",
                        "Treat;fract/disloc;interphalan"
                    ],
                    "UMLS:C2460327": [
                        "Therapeutic Exercise Treatment of Integu Body",
                        "Therapeutic Exercise Treatment of Integumentary System - Whole Body",
                        "Physical Rehabilitation and Diagnostic Audiology @ Rehabilitation @ Motor Treatment @ Integumentary System - Whole Body @ Therapeutic Exercise @ None @ None"
                    ],
                    "UMLS:C0361272": [
                        "Corticosteroids used in the treatment of asthma",
                        "corticosteroids used in the treatment of asthma",
                        "Corticosteroids used in asthma",
                        "asthma corticosteroid treatment",
                        "asthma corticosteroids treatment"
                    ],
                    "UMLS:C4718640": [
                        "Use of probiotics in the treatment of infection"
                    ]
                }
            },
            {
                "label": "adult patients",
                "id": {
                    "UMLS:C1855413": [
                        "Nystagmus in adult patients"
                    ],
                    "UMLS:C1855412": [
                        "Impaired smooth pursuit in adult patients"
                    ],
                    "UMLS:C1855411": [
                        "Retinal degeneration in adult patients, progressive"
                    ],
                    "UMLS:C4746352": [
                        "Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5",
                        "Adit mdd dys rem 12 mnths"
                    ],
                    "UMLS:C5229138": [
                        "Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq- 9 or phq-9m score was not assessed or is greater than or equal to 5",
                        "Remis12m not phq-9 score <5"
                    ]
                }
            }
        ],
        [
            {
                "label": "adjunctive therapy",
                "id": {
                    "UMLS:C1292783": [
                        "Adjunctive care (regime/therapy)",
                        "Adjunctive care",
                        "Adjunctive care procedure"
                    ],
                    "UMLS:C1138792": [
                        "LAMP, NON-HEATING, FOR ADJUNCTIVE USE IN PAIN THERAPY"
                    ],
                    "UMLS:C0846961": [
                        "Adjunctive dental physical therapy for temporomandibular joint and associated structures"
                    ]
                }
            },
            {
                "label": "in the treatment of",
                "id": {
                    "UMLS:C0018100": [
                        "Drugs in the treatment of gout",
                        "drug gout",
                        "gout drug",
                        "drugs gout",
                        "antigout agent",
                        "ANTIGOUT AGENTS",
                        "Antigout Agents",
                        "Agents, Antigout",
                        "Gout suppressants",
                        "gout suppressants",
                        "Gout Suppressants",
                        "suppressants gout",
                        "Suppressants, Gout",
                        "drugs gout treatment",
                        "ANTIGOUT PREPARATIONS",
                        "Drugs for the treatment of gout"
                    ],
                    "UMLS:C0850210": [
                        "treatment of fract/disloc of the interphalan",
                        "Treat;fract/disloc;interphalan"
                    ],
                    "UMLS:C2460327": [
                        "Therapeutic Exercise Treatment of Integu Body",
                        "Therapeutic Exercise Treatment of Integumentary System - Whole Body",
                        "Physical Rehabilitation and Diagnostic Audiology @ Rehabilitation @ Motor Treatment @ Integumentary System - Whole Body @ Therapeutic Exercise @ None @ None"
                    ],
                    "UMLS:C0361272": [
                        "Corticosteroids used in the treatment of asthma",
                        "corticosteroids used in the treatment of asthma",
                        "Corticosteroids used in asthma",
                        "asthma corticosteroid treatment",
                        "asthma corticosteroids treatment"
                    ],
                    "UMLS:C4718640": [
                        "Use of probiotics in the treatment of infection"
                    ]
                }
            },
            {
                "label": "pediatric patients down to the age of 10 years",
                "id": {}
            }
        ],
        [
            {
                "label": "pediatric patients down to the age of 10 years",
                "id": {}
            },
            {
                "label": "with",
                "id": {
                    "FB:FBgn0004015": [
                        "with"
                    ],
                    "UMLS:C0332287": [
                        "With",
                        "With (attribute)",
                        "c",
                        "W",
                        "PL",
                        "Cum",
                        "Plus",
                        "Addition",
                        "In addition to"
                    ],
                    "UMLS:C1705690": [
                        "With",
                        "With - dosing instruction fragment",
                        "With - dosing instruction fragment (qualifier value)"
                    ],
                    "UMLS:C0332285": [
                        "Within",
                        "Of",
                        "In",
                        "in",
                        "Inside",
                        "Found in",
                        "Located in",
                        "Has setting",
                        "Has location",
                        "Arising from",
                        "In (attribute)"
                    ],
                    "UBERON:0017749": [
                        "withers"
                    ]
                }
            },
            {
                "label": "complex partial seizures",
                "id": {
                    "HP:0002384": [
                        "Complex Partial Seizures",
                        "Complex partial seizures",
                        "Partial complex seizures",
                        "seizures partial complex",
                        "COMPLEX PARTIAL SEIZURES",
                        "complex partial seizures",
                        "partial complex seizures",
                        "Partial seizures, complex",
                        "Partial Seizures, Complex",
                        "Seizures, partial complex",
                        "Seizures, complex partial",
                        "Complex partial seizures with consciousness impaired",
                        "cps",
                        "Psychomotor fit",
                        "Dyscognitive seizures",
                        "SEIZURE FOCAL COMPLEX",
                        "Complex focal seizures",
                        "complex partial seizure",
                        "partial complex seizure",
                        "PARTIAL-COMPLEX SEIZURE",
                        "Complex partial seizure",
                        "Complex Partial Seizure",
                        "Seizure, Complex Partial",
                        "Partial Seizure, Complex",
                        "Focal dyscognitive seizure",
                        "Partial dyscognitive seizure",
                        "Localized dyscognitive seizure",
                        "Complex part seiz,impair consc",
                        "Localised dyscognitive seizure",
                        "seizure partial (focal) complex",
                        "Focal impaired awareness seizure",
                        "Focal Impaired Awareness Seizure",
                        "Focal impaired-awareness seizures",
                        "Focal impaired awareness seizures",
                        "partial complex seizure (diagnosis)",
                        "Focal seizure with loss of awareness",
                        "Partial seizure with loss of awareness",
                        "Localized seizure with loss of awareness",
                        "Localised seizure with loss of awareness",
                        "Localized seizure with impaired awareness",
                        "Localised seizure with impaired awareness",
                        "Focal seizure with impairment of awareness",
                        "complex partial seizure (physical finding)",
                        "Partial seizure with impairment of awareness",
                        "partial complex seizure with impairment of consciousness",
                        "Complex partial seizure with impairment of consciousness",
                        "Focal seizures with impairment of consciousness or awareness",
                        "Complex partial seizure with impairment of consciousness (disorder)",
                        "partial complex seizure with impairment of consciousness (diagnosis)"
                    ],
                    "MONDO:0006710": [
                        "DIS COMPLEX PARTIAL SEIZURES",
                        "Disorder, Complex Partial Seizures",
                        "epilepsy; complex partial seizures",
                        "complex partial seizures; epileptic",
                        "epilepsy; syndrome, complex partial seizures",
                        "epilepsy; syndrome, with complex partial seizures",
                        "syndrome; epileptic, with complex partial seizures",
                        "psychomotor epilepsy",
                        "Psychomotor epilepsy",
                        "Psychomotor Epilepsy",
                        "PSYCHOMOTOR EPILEPSY",
                        "psychomotor epilepsy",
                        "epilepsy psychomotor",
                        "Epilepsy, Psychomotor",
                        "epilepsy, psychomotor",
                        "EPILEPSY, PSYCHOMOTOR",
                        "epilepsy, psychomotor",
                        "Epilepsy, psychomotor",
                        "epilepsy; psychomotor",
                        "PARTIAL COMPLEX EPILEPSY",
                        "complex partial epilepsy",
                        "Complex Partial Epilepsy",
                        "partial complex epilepsy",
                        "complex partial epilepsy",
                        "Partial Epilepsy, Complex",
                        "Epilepsy, Complex Partial",
                        "SEIZURE DIS COMPLEX PARTIAL",
                        "COMPLEX PARTIAL SEIZURE DIS",
                        "Psychic Equivalent Epilepsy",
                        "Epilepsy, Psychic Equivalent",
                        "Psychomotor epilepsy (disorder)",
                        "partial complex seizure disorder",
                        "complex partial seizure disorder",
                        "Complex Partial Seizure Disorder",
                        "Psychomotor epilepsy (diagnosis)",
                        "Complex partial epileptic seizure",
                        "Seizure Disorder, Complex Partial",
                        "Complex partial epileptic seizure",
                        "partial complex psychomotor seizure",
                        "seizure; epileptic, complex, partial",
                        "epilepsy localization-related psychomotor",
                        "Complex partial epileptic seizure (disorder)",
                        "partial complex psychomotor seizure (diagnosis)"
                    ],
                    "UMLS:C0858254": [
                        "Complex partial seizures increased",
                        "Complex partial seizures exacerbated"
                    ],
                    "UMLS:C3150523": [
                        "Seizures, complex partial, episodic"
                    ],
                    "UMLS:C3280735": [
                        "Partial seizures, simple and complex"
                    ]
                }
            }
        ],
        [
            {
                "label": "complex partial seizures",
                "id": {
                    "HP:0002384": [
                        "Complex Partial Seizures",
                        "Complex partial seizures",
                        "Partial complex seizures",
                        "seizures partial complex",
                        "COMPLEX PARTIAL SEIZURES",
                        "complex partial seizures",
                        "partial complex seizures",
                        "Partial seizures, complex",
                        "Partial Seizures, Complex",
                        "Seizures, partial complex",
                        "Seizures, complex partial",
                        "Complex partial seizures with consciousness impaired",
                        "cps",
                        "Psychomotor fit",
                        "Dyscognitive seizures",
                        "SEIZURE FOCAL COMPLEX",
                        "Complex focal seizures",
                        "complex partial seizure",
                        "partial complex seizure",
                        "PARTIAL-COMPLEX SEIZURE",
                        "Complex partial seizure",
                        "Complex Partial Seizure",
                        "Seizure, Complex Partial",
                        "Partial Seizure, Complex",
                        "Focal dyscognitive seizure",
                        "Partial dyscognitive seizure",
                        "Localized dyscognitive seizure",
                        "Complex part seiz,impair consc",
                        "Localised dyscognitive seizure",
                        "seizure partial (focal) complex",
                        "Focal impaired awareness seizure",
                        "Focal Impaired Awareness Seizure",
                        "Focal impaired-awareness seizures",
                        "Focal impaired awareness seizures",
                        "partial complex seizure (diagnosis)",
                        "Focal seizure with loss of awareness",
                        "Partial seizure with loss of awareness",
                        "Localized seizure with loss of awareness",
                        "Localised seizure with loss of awareness",
                        "Localized seizure with impaired awareness",
                        "Localised seizure with impaired awareness",
                        "Focal seizure with impairment of awareness",
                        "complex partial seizure (physical finding)",
                        "Partial seizure with impairment of awareness",
                        "partial complex seizure with impairment of consciousness",
                        "Complex partial seizure with impairment of consciousness",
                        "Focal seizures with impairment of consciousness or awareness",
                        "Complex partial seizure with impairment of consciousness (disorder)",
                        "partial complex seizure with impairment of consciousness (diagnosis)"
                    ],
                    "MONDO:0006710": [
                        "DIS COMPLEX PARTIAL SEIZURES",
                        "Disorder, Complex Partial Seizures",
                        "epilepsy; complex partial seizures",
                        "complex partial seizures; epileptic",
                        "epilepsy; syndrome, complex partial seizures",
                        "epilepsy; syndrome, with complex partial seizures",
                        "syndrome; epileptic, with complex partial seizures",
                        "psychomotor epilepsy",
                        "Psychomotor epilepsy",
                        "Psychomotor Epilepsy",
                        "PSYCHOMOTOR EPILEPSY",
                        "psychomotor epilepsy",
                        "epilepsy psychomotor",
                        "Epilepsy, Psychomotor",
                        "epilepsy, psychomotor",
                        "EPILEPSY, PSYCHOMOTOR",
                        "epilepsy, psychomotor",
                        "Epilepsy, psychomotor",
                        "epilepsy; psychomotor",
                        "PARTIAL COMPLEX EPILEPSY",
                        "complex partial epilepsy",
                        "Complex Partial Epilepsy",
                        "partial complex epilepsy",
                        "complex partial epilepsy",
                        "Partial Epilepsy, Complex",
                        "Epilepsy, Complex Partial",
                        "SEIZURE DIS COMPLEX PARTIAL",
                        "COMPLEX PARTIAL SEIZURE DIS",
                        "Psychic Equivalent Epilepsy",
                        "Epilepsy, Psychic Equivalent",
                        "Psychomotor epilepsy (disorder)",
                        "partial complex seizure disorder",
                        "complex partial seizure disorder",
                        "Complex Partial Seizure Disorder",
                        "Psychomotor epilepsy (diagnosis)",
                        "Complex partial epileptic seizure",
                        "Seizure Disorder, Complex Partial",
                        "Complex partial epileptic seizure",
                        "partial complex psychomotor seizure",
                        "seizure; epileptic, complex, partial",
                        "epilepsy localization-related psychomotor",
                        "Complex partial epileptic seizure (disorder)",
                        "partial complex psychomotor seizure (diagnosis)"
                    ],
                    "UMLS:C0858254": [
                        "Complex partial seizures increased",
                        "Complex partial seizures exacerbated"
                    ],
                    "UMLS:C3150523": [
                        "Seizures, complex partial, episodic"
                    ],
                    "UMLS:C3280735": [
                        "Partial seizures, simple and complex"
                    ]
                }
            },
            {
                "label": "occur either in",
                "id": {
                    "UMLS:C1145125": [
                        "Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequently than once a week; billing units of service include 4 tests",
                        "Md inr test revie inter mgmt"
                    ],
                    "UMLS:C1145124": [
                        "Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests",
                        "Provide inr test mater/equip"
                    ]
                }
            },
            {
                "label": "isolation",
                "id": {
                    "UMLS:C0260397": [
                        "Isolation",
                        "isolation",
                        "Need for isolation",
                        "Prophylactic isolation"
                    ],
                    "UMLS:C0204727": [
                        "isolation",
                        "Isolation",
                        "isolations",
                        "Isolation technique",
                        "Isolation procedure",
                        "isolation technique",
                        "isolation procedure",
                        "Isolation procedures",
                        "isolation procedures",
                        "isolation techniques",
                        "Isolation precautions",
                        "Isolation procedure (procedure)",
                        "Isolation procedure (technique)",
                        "Other Procedures @ Physiological Systems and Anatomical Regions @ Other Procedures @ None @ External @ Other Method @ Isolation"
                    ],
                    "UMLS:C0205409": [
                        "Isolation",
                        "Isolated",
                        "isolated",
                        "Isolated (qualifier value)"
                    ],
                    "UMLS:C0220862": [
                        "isolation",
                        "isolation aspects"
                    ],
                    "UMLS:C1547129": [
                        "Isolation",
                        "Accommodation - Isolation"
                    ]
                }
            }
        ],
        [
            {
                "label": "complex partial seizures",
                "id": {
                    "HP:0002384": [
                        "Complex Partial Seizures",
                        "Complex partial seizures",
                        "Partial complex seizures",
                        "seizures partial complex",
                        "COMPLEX PARTIAL SEIZURES",
                        "complex partial seizures",
                        "partial complex seizures",
                        "Partial seizures, complex",
                        "Partial Seizures, Complex",
                        "Seizures, partial complex",
                        "Seizures, complex partial",
                        "Complex partial seizures with consciousness impaired",
                        "cps",
                        "Psychomotor fit",
                        "Dyscognitive seizures",
                        "SEIZURE FOCAL COMPLEX",
                        "Complex focal seizures",
                        "complex partial seizure",
                        "partial complex seizure",
                        "PARTIAL-COMPLEX SEIZURE",
                        "Complex partial seizure",
                        "Complex Partial Seizure",
                        "Seizure, Complex Partial",
                        "Partial Seizure, Complex",
                        "Focal dyscognitive seizure",
                        "Partial dyscognitive seizure",
                        "Localized dyscognitive seizure",
                        "Complex part seiz,impair consc",
                        "Localised dyscognitive seizure",
                        "seizure partial (focal) complex",
                        "Focal impaired awareness seizure",
                        "Focal Impaired Awareness Seizure",
                        "Focal impaired-awareness seizures",
                        "Focal impaired awareness seizures",
                        "partial complex seizure (diagnosis)",
                        "Focal seizure with loss of awareness",
                        "Partial seizure with loss of awareness",
                        "Localized seizure with loss of awareness",
                        "Localised seizure with loss of awareness",
                        "Localized seizure with impaired awareness",
                        "Localised seizure with impaired awareness",
                        "Focal seizure with impairment of awareness",
                        "complex partial seizure (physical finding)",
                        "Partial seizure with impairment of awareness",
                        "partial complex seizure with impairment of consciousness",
                        "Complex partial seizure with impairment of consciousness",
                        "Focal seizures with impairment of consciousness or awareness",
                        "Complex partial seizure with impairment of consciousness (disorder)",
                        "partial complex seizure with impairment of consciousness (diagnosis)"
                    ],
                    "MONDO:0006710": [
                        "DIS COMPLEX PARTIAL SEIZURES",
                        "Disorder, Complex Partial Seizures",
                        "epilepsy; complex partial seizures",
                        "complex partial seizures; epileptic",
                        "epilepsy; syndrome, complex partial seizures",
                        "epilepsy; syndrome, with complex partial seizures",
                        "syndrome; epileptic, with complex partial seizures",
                        "psychomotor epilepsy",
                        "Psychomotor epilepsy",
                        "Psychomotor Epilepsy",
                        "PSYCHOMOTOR EPILEPSY",
                        "psychomotor epilepsy",
                        "epilepsy psychomotor",
                        "Epilepsy, Psychomotor",
                        "epilepsy, psychomotor",
                        "EPILEPSY, PSYCHOMOTOR",
                        "epilepsy, psychomotor",
                        "Epilepsy, psychomotor",
                        "epilepsy; psychomotor",
                        "PARTIAL COMPLEX EPILEPSY",
                        "complex partial epilepsy",
                        "Complex Partial Epilepsy",
                        "partial complex epilepsy",
                        "complex partial epilepsy",
                        "Partial Epilepsy, Complex",
                        "Epilepsy, Complex Partial",
                        "SEIZURE DIS COMPLEX PARTIAL",
                        "COMPLEX PARTIAL SEIZURE DIS",
                        "Psychic Equivalent Epilepsy",
                        "Epilepsy, Psychic Equivalent",
                        "Psychomotor epilepsy (disorder)",
                        "partial complex seizure disorder",
                        "complex partial seizure disorder",
                        "Complex Partial Seizure Disorder",
                        "Psychomotor epilepsy (diagnosis)",
                        "Complex partial epileptic seizure",
                        "Seizure Disorder, Complex Partial",
                        "Complex partial epileptic seizure",
                        "partial complex psychomotor seizure",
                        "seizure; epileptic, complex, partial",
                        "epilepsy localization-related psychomotor",
                        "Complex partial epileptic seizure (disorder)",
                        "partial complex psychomotor seizure (diagnosis)"
                    ],
                    "UMLS:C0858254": [
                        "Complex partial seizures increased",
                        "Complex partial seizures exacerbated"
                    ],
                    "UMLS:C3150523": [
                        "Seizures, complex partial, episodic"
                    ],
                    "UMLS:C3280735": [
                        "Partial seizures, simple and complex"
                    ]
                }
            },
            {
                "label": "occur",
                "id": {
                    "UMLS:C1709305": [
                        "Occur",
                        "Occurred",
                        "Occur (action)",
                        "Happen",
                        "Happened",
                        "Took Place",
                        "Take Place"
                    ],
                    "UMLS:C0243132": [
                        "occurrence",
                        "occurrence characteristics"
                    ],
                    "UMLS:C2745955": [
                        "Occurrence",
                        "Occurrences",
                        "Occurrence (attribute)",
                        "Occurrences (qualifier value)"
                    ],
                    "UMLS:C1554210": [
                        "occurrence",
                        "is occurrence of",
                        "Act Relationship Type - occurrence"
                    ],
                    "UMLS:C3242296": [
                        "occurs during"
                    ]
                }
            },
            {
                "label": "in association with other types of seizures",
                "id": {}
            }
        ]
    ],
    "Uses - temporarily relieves minor aches and pains due to: minor pain of arthritis, backache, headache, muscular aches, menstrual cramps, toothache, common cold, temporarily reduces fever": [
        [
            {
                "label": "Uses",
                "id": {
                    "UMLS:C0457083": [
                        "uses",
                        "Use",
                        "Usage",
                        "usage",
                        "Employ",
                        "usages",
                        "Usage (attribute)"
                    ],
                    "UMLS:C1522726": [
                        "iv uses",
                        "intravenous uses",
                        "IV",
                        "IV use",
                        "iv route",
                        "IV route",
                        "Intravenous",
                        "Intravenous use",
                        "intravenous use",
                        "IntravenousRoute",
                        "Intravenous route",
                        "IV - Intravenous route",
                        "Intravenous route (qualifier value)",
                        "route of administration intravenous",
                        "Intravenous Route of Administration",
                        "route of administration: intravenous",
                        "Intravenous Route of Drug Administration",
                        "route of administration: intravenous (treatment)"
                    ],
                    "UMLS:C0578310": [
                        "Uses lift",
                        "Does use lift",
                        "Does use lift (finding)"
                    ],
                    "UMLS:C4083280": [
                        "ECig Uses",
                        "E-Cig Uses",
                        "Ecigarette Uses",
                        "E-Cigarette Uses",
                        "Uses, Ecigarette",
                        "Vape",
                        "Vapes",
                        "Vaping",
                        "ECig Use",
                        "E Cig Use",
                        "E-Cig Use",
                        "Use, ECig",
                        "THC Vaping",
                        "Use, E-Cig",
                        "Vaping, THC",
                        "THC Vapings",
                        "Vapings, THC",
                        "Vaping (event)",
                        "Ecigarette Use",
                        "E Cigarette Use",
                        "E-Cigarette Use",
                        "Use, Ecigarette",
                        "Nicotine Vaping",
                        "Vaping, Nicotine",
                        "Use, E-Cigarette",
                        "Nicotine Vapings",
                        "Vapings, Nicotine"
                    ],
                    "UMLS:C0565721": [
                        "Uses a key",
                        "Does use a key",
                        "Does use a key (finding)"
                    ]
                }
            },
            {
                "label": "temporarily relieves",
                "id": {}
            },
            {
                "label": "minor aches and pains due to minor pain of arthritis",
                "id": {}
            }
        ],
        [
            {
                "label": "Uses",
                "id": {
                    "UMLS:C0457083": [
                        "uses",
                        "Use",
                        "Usage",
                        "usage",
                        "Employ",
                        "usages",
                        "Usage (attribute)"
                    ],
                    "UMLS:C1522726": [
                        "iv uses",
                        "intravenous uses",
                        "IV",
                        "IV use",
                        "iv route",
                        "IV route",
                        "Intravenous",
                        "Intravenous use",
                        "intravenous use",
                        "IntravenousRoute",
                        "Intravenous route",
                        "IV - Intravenous route",
                        "Intravenous route (qualifier value)",
                        "route of administration intravenous",
                        "Intravenous Route of Administration",
                        "route of administration: intravenous",
                        "Intravenous Route of Drug Administration",
                        "route of administration: intravenous (treatment)"
                    ],
                    "UMLS:C0578310": [
                        "Uses lift",
                        "Does use lift",
                        "Does use lift (finding)"
                    ],
                    "UMLS:C4083280": [
                        "ECig Uses",
                        "E-Cig Uses",
                        "Ecigarette Uses",
                        "E-Cigarette Uses",
                        "Uses, Ecigarette",
                        "Vape",
                        "Vapes",
                        "Vaping",
                        "ECig Use",
                        "E Cig Use",
                        "E-Cig Use",
                        "Use, ECig",
                        "THC Vaping",
                        "Use, E-Cig",
                        "Vaping, THC",
                        "THC Vapings",
                        "Vapings, THC",
                        "Vaping (event)",
                        "Ecigarette Use",
                        "E Cigarette Use",
                        "E-Cigarette Use",
                        "Use, Ecigarette",
                        "Nicotine Vaping",
                        "Vaping, Nicotine",
                        "Use, E-Cigarette",
                        "Nicotine Vapings",
                        "Vapings, Nicotine"
                    ],
                    "UMLS:C0565721": [
                        "Uses a key",
                        "Does use a key",
                        "Does use a key (finding)"
                    ]
                }
            },
            {
                "label": "temporarily relieves",
                "id": {}
            },
            {
                "label": "backache",
                "id": {
                    "HP:0003418": [
                        "BACKACHE",
                        "Backache",
                        "backache",
                        "Backaches",
                        "backaches",
                        "Backache NOS",
                        "Backache, NOS",
                        "backache symptom",
                        "backache symptoms",
                        "Backache (finding)",
                        "Backache; unspecified",
                        "Backache, unspecified",
                        "backpain",
                        "BACKPAIN",
                        "notalgia",
                        "Notalgia",
                        "dorsalgia",
                        "PAIN BACK",
                        "Pain back",
                        "BACK PAIN",
                        "BACK ACHE",
                        "back ache",
                        "Back Pain",
                        "Back ache",
                        "Pain;back",
                        "Back pain",
                        "Dorsalgia",
                        "back pain",
                        "ache back",
                        "Back Ache",
                        "back pains",
                        "Back Aches",
                        "pain; back",
                        "Ache, Back",
                        "Pain, Back",
                        "back; pain",
                        "backs pain",
                        "aches back",
                        "Dorsodynia",
                        "Back Pains",
                        "back aches",
                        "dorsodynia",
                        "DORSAL PAIN",
                        "Dorsal pain",
                        "Aches, Back",
                        "Pains, Back",
                        "dorsal pain",
                        "PAIN DORSAL",
                        "Pain dorsal",
                        "back pain in",
                        "back paining",
                        "Pain in back",
                        "pain in back",
                        "Back pain NOS",
                        "and back pain",
                        "back pain over",
                        "back over pain",
                        "dorsal back pain",
                        "DORSAL BACK PAIN",
                        "Pain over the back",
                        "pain over the back",
                        "back pain (symptom)",
                        "dorsopathy dorsalgia",
                        "back ache (diagnosis)",
                        "Dorsalgia (diagnosis)",
                        "Unspecified dorsalgia",
                        "dorsalgia unspecified",
                        "unspecified back pain",
                        "Dorsalgia, unspecified"
                    ],
                    "UMLS:C0423680": [
                        "No backache",
                        "No backache (situation)"
                    ],
                    "HP:0003419": [
                        "Low Backache",
                        "low backache",
                        "Low Backaches",
                        "low; backache",
                        "backache; low",
                        "Backache, Low",
                        "lower backache",
                        "Backaches, Low",
                        "backache lower",
                        "lower backache (diagnosis)",
                        "lbp",
                        "LUMBAGO",
                        "Lumbago",
                        "lumbago",
                        "lumbalgia",
                        "Lumbalgia",
                        "Lumbago NOS",
                        "Lumbar pain",
                        "LUMBAR PAIN",
                        "lumbar pain",
                        "lumbar pains",
                        "Low back pain",
                        "Low back ache",
                        "Low Back Ache",
                        "Low Back Pain",
                        "low back pain",
                        "LOW BACK PAIN",
                        "Pain;back low",
                        "low back pains",
                        "Pain, Low Back",
                        "pain; low back",
                        "low back; pain",
                        "Back Pain, Low",
                        "Back Ache, Low",
                        "Low Back Pains",
                        "Ache, Low Back",
                        "Low Back Aches",
                        "pain; back, low",
                        "Back Pains, Low",
                        "Lower Back Pain",
                        "Back Aches, Low",
                        "lower back pain",
                        "Lower back pain",
                        "back; pain, low",
                        "Aches, Low Back",
                        "Pains, Low Back",
                        "lumbar back pain",
                        "Lumbago syndrome",
                        "BACK PAIN LUMBAR",
                        "Back Pain, Lower",
                        "Pain;back;lumbar",
                        "lower back pains",
                        "Pain, Lower Back",
                        "Lower Back Pains",
                        "BACK PAIN, LOWER",
                        "Pains, Lower Back",
                        "Low back syndrome",
                        "Back Pains, Lower",
                        "syndrome; low back",
                        "LBP - Low back pain",
                        "lumbago (diagnosis)",
                        "BACK PAIN LOWER BACK",
                        "low back pain (symptom)",
                        "Low back pain (finding)",
                        "dorsopathy low back pain",
                        "low back pain (diagnosis)",
                        "Low back derangement syndrome",
                        "Nonspecific pain lumbar region",
                        "Nonspecific pain in the lumbar region"
                    ],
                    "UMLS:C0423683": [
                        "backache renal",
                        "renal backache",
                        "renal backache (diagnosis)",
                        "Lumbar ache - renal",
                        "Lumbar ache - renal (finding)"
                    ],
                    "UMLS:C0730669": [
                        "Doans Backache"
                    ]
                }
            }
        ],
        [
            {
                "label": "Uses",
                "id": {
                    "UMLS:C0457083": [
                        "uses",
                        "Use",
                        "Usage",
                        "usage",
                        "Employ",
                        "usages",
                        "Usage (attribute)"
                    ],
                    "UMLS:C1522726": [
                        "iv uses",
                        "intravenous uses",
                        "IV",
                        "IV use",
                        "iv route",
                        "IV route",
                        "Intravenous",
                        "Intravenous use",
                        "intravenous use",
                        "IntravenousRoute",
                        "Intravenous route",
                        "IV - Intravenous route",
                        "Intravenous route (qualifier value)",
                        "route of administration intravenous",
                        "Intravenous Route of Administration",
                        "route of administration: intravenous",
                        "Intravenous Route of Drug Administration",
                        "route of administration: intravenous (treatment)"
                    ],
                    "UMLS:C0578310": [
                        "Uses lift",
                        "Does use lift",
                        "Does use lift (finding)"
                    ],
                    "UMLS:C4083280": [
                        "ECig Uses",
                        "E-Cig Uses",
                        "Ecigarette Uses",
                        "E-Cigarette Uses",
                        "Uses, Ecigarette",
                        "Vape",
                        "Vapes",
                        "Vaping",
                        "ECig Use",
                        "E Cig Use",
                        "E-Cig Use",
                        "Use, ECig",
                        "THC Vaping",
                        "Use, E-Cig",
                        "Vaping, THC",
                        "THC Vapings",
                        "Vapings, THC",
                        "Vaping (event)",
                        "Ecigarette Use",
                        "E Cigarette Use",
                        "E-Cigarette Use",
                        "Use, Ecigarette",
                        "Nicotine Vaping",
                        "Vaping, Nicotine",
                        "Use, E-Cigarette",
                        "Nicotine Vapings",
                        "Vapings, Nicotine"
                    ],
                    "UMLS:C0565721": [
                        "Uses a key",
                        "Does use a key",
                        "Does use a key (finding)"
                    ]
                }
            },
            {
                "label": "temporarily relieves",
                "id": {}
            },
            {
                "label": "headache",
                "id": {
                    "NCIT:C143527": [
                        "Headache",
                        "Headache, CTCAE"
                    ],
                    "HP:0002315": [
                        "Headache",
                        "headache",
                        "HEADACHE",
                        "Headaches",
                        "headaches",
                        "Headache NOS",
                        "Headache, NOS",
                        "HA - Headache",
                        "Have headaches",
                        "headache (symptom)",
                        "Headache (finding)",
                        "Headache, unspecified",
                        "headache, cephalalgia",
                        "Headache (excl N02 N89 R09)",
                        "Headache (excluding N02 N89 R09)",
                        "ha",
                        "HA",
                        "Pain head",
                        "HEAD PAIN",
                        "Head Pain",
                        "ache head",
                        "Cephalgia",
                        "PAIN HEAD",
                        "Pain;head",
                        "Head pain",
                        "cephalgia",
                        "head ache",
                        "head pain",
                        "CEPHALGIA",
                        "HEAD ACHE",
                        "head pains",
                        "pain; head",
                        "Cephalgias",
                        "cephalgias",
                        "head; pain",
                        "Head Pains",
                        "Pain, Head",
                        "cephalalgia",
                        "head pained",
                        "CEPHALALGIA",
                        "Pains, Head",
                        "Cephalalgia",
                        "Pain in head",
                        "cranial pain",
                        "Cephalalgias",
                        "cephalodynia",
                        "Cranial Pain",
                        "pain in head",
                        "Cephalodynia",
                        "Cephalodynias",
                        "Cranial Pains",
                        "Pain, Cranial",
                        "Pains, Cranial",
                        "Pain in head NOS",
                        "HEAD PAIN CEPHALGIA"
                    ],
                    "UMLS:C2732092": [
                        "BC Headache"
                    ],
                    "UMLS:C0423624": [
                        "No headache",
                        "No headache (situation)"
                    ],
                    "MONDO:0021146": [
                        "HEADACHE DIS",
                        "chronic headache",
                        "headache disorder",
                        "headache, chronic",
                        "Headache Syndrome",
                        "Headache disorder",
                        "HEADACHE DISORDER",
                        "headache syndrome",
                        "headache syndrome",
                        "chronic headaches",
                        "Headache Disorder",
                        "headache syndromes",
                        "Syndrome, Headache",
                        "headache; syndrome",
                        "headache disorders",
                        "headaches syndrome",
                        "disorders headache",
                        "syndrome; headache",
                        "syndrome, headache",
                        "Headache Syndromes",
                        "Headache Disorders",
                        "headaches, chronic",
                        "headache syndromes",
                        "headaches syndromes",
                        "disorders headaches",
                        "intractable headache",
                        "intractable headaches",
                        "headache, intractable",
                        "headaches, intractable",
                        "chronic daily headache",
                        "headache, chronic daily",
                        "daily headache, chronic",
                        "chronic daily headaches",
                        "headaches, chronic daily",
                        "daily headaches, chronic",
                        "Headache disorder (disorder)",
                        "headache syndromes (diagnosis)",
                        "cephalgia syndrome",
                        "Cephalgia Syndrome",
                        "Cephalgia Syndromes",
                        "cephalgia syndromes"
                    ]
                }
            }
        ],
        [
            {
                "label": "Uses",
                "id": {
                    "UMLS:C0457083": [
                        "uses",
                        "Use",
                        "Usage",
                        "usage",
                        "Employ",
                        "usages",
                        "Usage (attribute)"
                    ],
                    "UMLS:C1522726": [
                        "iv uses",
                        "intravenous uses",
                        "IV",
                        "IV use",
                        "iv route",
                        "IV route",
                        "Intravenous",
                        "Intravenous use",
                        "intravenous use",
                        "IntravenousRoute",
                        "Intravenous route",
                        "IV - Intravenous route",
                        "Intravenous route (qualifier value)",
                        "route of administration intravenous",
                        "Intravenous Route of Administration",
                        "route of administration: intravenous",
                        "Intravenous Route of Drug Administration",
                        "route of administration: intravenous (treatment)"
                    ],
                    "UMLS:C0578310": [
                        "Uses lift",
                        "Does use lift",
                        "Does use lift (finding)"
                    ],
                    "UMLS:C4083280": [
                        "ECig Uses",
                        "E-Cig Uses",
                        "Ecigarette Uses",
                        "E-Cigarette Uses",
                        "Uses, Ecigarette",
                        "Vape",
                        "Vapes",
                        "Vaping",
                        "ECig Use",
                        "E Cig Use",
                        "E-Cig Use",
                        "Use, ECig",
                        "THC Vaping",
                        "Use, E-Cig",
                        "Vaping, THC",
                        "THC Vapings",
                        "Vapings, THC",
                        "Vaping (event)",
                        "Ecigarette Use",
                        "E Cigarette Use",
                        "E-Cigarette Use",
                        "Use, Ecigarette",
                        "Nicotine Vaping",
                        "Vaping, Nicotine",
                        "Use, E-Cigarette",
                        "Nicotine Vapings",
                        "Vapings, Nicotine"
                    ],
                    "UMLS:C0565721": [
                        "Uses a key",
                        "Does use a key",
                        "Does use a key (finding)"
                    ]
                }
            },
            {
                "label": "temporarily relieves",
                "id": {}
            },
            {
                "label": "muscular aches",
                "id": {}
            }
        ],
        [
            {
                "label": "Uses",
                "id": {
                    "UMLS:C0457083": [
                        "uses",
                        "Use",
                        "Usage",
                        "usage",
                        "Employ",
                        "usages",
                        "Usage (attribute)"
                    ],
                    "UMLS:C1522726": [
                        "iv uses",
                        "intravenous uses",
                        "IV",
                        "IV use",
                        "iv route",
                        "IV route",
                        "Intravenous",
                        "Intravenous use",
                        "intravenous use",
                        "IntravenousRoute",
                        "Intravenous route",
                        "IV - Intravenous route",
                        "Intravenous route (qualifier value)",
                        "route of administration intravenous",
                        "Intravenous Route of Administration",
                        "route of administration: intravenous",
                        "Intravenous Route of Drug Administration",
                        "route of administration: intravenous (treatment)"
                    ],
                    "UMLS:C0578310": [
                        "Uses lift",
                        "Does use lift",
                        "Does use lift (finding)"
                    ],
                    "UMLS:C4083280": [
                        "ECig Uses",
                        "E-Cig Uses",
                        "Ecigarette Uses",
                        "E-Cigarette Uses",
                        "Uses, Ecigarette",
                        "Vape",
                        "Vapes",
                        "Vaping",
                        "ECig Use",
                        "E Cig Use",
                        "E-Cig Use",
                        "Use, ECig",
                        "THC Vaping",
                        "Use, E-Cig",
                        "Vaping, THC",
                        "THC Vapings",
                        "Vapings, THC",
                        "Vaping (event)",
                        "Ecigarette Use",
                        "E Cigarette Use",
                        "E-Cigarette Use",
                        "Use, Ecigarette",
                        "Nicotine Vaping",
                        "Vaping, Nicotine",
                        "Use, E-Cigarette",
                        "Nicotine Vapings",
                        "Vapings, Nicotine"
                    ],
                    "UMLS:C0565721": [
                        "Uses a key",
                        "Does use a key",
                        "Does use a key (finding)"
                    ]
                }
            },
            {
                "label": "temporarily relieves",
                "id": {}
            },
            {
                "label": "menstrual cramps",
                "id": {
                    "HP:0100607": [
                        "Menstrual cramps",
                        "MENSTRUAL CRAMPS",
                        "Cramps menstrual",
                        "menstrual cramps",
                        "CRAMPS MENSTRUAL",
                        "Period pain",
                        "Period Pain",
                        "dysmenorrhea",
                        "DYSMENORRHEA",
                        "Period pains",
                        "Dysmenorrhea",
                        "menorrhalgia",
                        "Menorrhalgia",
                        "Dysmenorrheas",
                        "dysmenorrhoea",
                        "Dysmenorrhoea",
                        "DYSMENORRHOEA",
                        "MENSES PAINFUL",
                        "menstrual pain",
                        "Menses painful",
                        "PAIN MENSTRUAL",
                        "painful period",
                        "Menstrual Pain",
                        "painful menses",
                        "MENSTRUAL PAIN",
                        "Menstrual pain",
                        "PAINFUL MENSES",
                        "Pain menstrual",
                        "painful periods",
                        "MENSTRUAL CRAMP",
                        "menstrual cramp",
                        "Pain, Menstrual",
                        "Menstrual cramp",
                        "Menstrual Pains",
                        "Painful periods",
                        "menstrual pains",
                        "Pains, Menstrual",
                        "Pain;menstruation",
                        "menstruation pain",
                        "Dysmenorrhea, NOS",
                        "menstruation; pain",
                        "pain; menstruation",
                        "Cramp(s);menstrual",
                        "Dysmenorrhoea, NOS",
                        "Period pain present",
                        "Painful menstruation",
                        "painful menstruation",
                        "Painful Menstruation",
                        "Painful Menstruations",
                        "Menstruation, Painful",
                        "severe menstrual pain",
                        "painful; menstruation",
                        "Menstruations, Painful",
                        "Dysmenorrhea (disorder)",
                        "dysmenorrhea (diagnosis)",
                        "Dysmenorrhea, unspecified",
                        "Menstrual cramp (finding)",
                        "Dysmenorrhoea, unspecified",
                        "Period pain present (finding)",
                        "severe menstrual pain (symptom)",
                        "severe menstrual pain (dysmenorrhea)"
                    ],
                    "UMLS:C3500047": [
                        "Homeopathic Substance Sublingual Tablet [HYLAND'S MENSTRUAL CRAMPS]",
                        "MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 12 [hp_X] / CITRULLUS COLOCYNTHIS FRUIT PULP 12 [hp_X] / BLACK COHOSH 12 [hp_X] / PULSATILLA VULGARIS 6 [hp_X] ORAL TABLET, SOLUBLE [Menstrual Cramps]"
                    ],
                    "UMLS:C3487527": [
                        "MAGNESIUM CATION 30 [hp_C] in 1 mL ORAL PELLET [Menstrual Muscle Cramps]"
                    ],
                    "UMLS:C3263427": [
                        "Bothered by menstrual cramps or other problems with your period in last 4W",
                        "Bothered by menstrual cramps or other problems with your period in last 4 weeks"
                    ],
                    "UMLS:C3263426": [
                        "Bothered by menstrual cramps or other problems with your period in last 4 weeks [Reported.PHQ]",
                        "Bothered by menstrual cramps or other problems with your period in last 4W:Find:4W:^Patient:Ord:Reported.PHQ",
                        "Bothered by menstrual cramps or other problems with your period in last 4W:Finding:4 weeks:^Patient:Ordinal:Reported.PHQ"
                    ]
                }
            }
        ],
        [
            {
                "label": "Uses",
                "id": {
                    "UMLS:C0457083": [
                        "uses",
                        "Use",
                        "Usage",
                        "usage",
                        "Employ",
                        "usages",
                        "Usage (attribute)"
                    ],
                    "UMLS:C1522726": [
                        "iv uses",
                        "intravenous uses",
                        "IV",
                        "IV use",
                        "iv route",
                        "IV route",
                        "Intravenous",
                        "Intravenous use",
                        "intravenous use",
                        "IntravenousRoute",
                        "Intravenous route",
                        "IV - Intravenous route",
                        "Intravenous route (qualifier value)",
                        "route of administration intravenous",
                        "Intravenous Route of Administration",
                        "route of administration: intravenous",
                        "Intravenous Route of Drug Administration",
                        "route of administration: intravenous (treatment)"
                    ],
                    "UMLS:C0578310": [
                        "Uses lift",
                        "Does use lift",
                        "Does use lift (finding)"
                    ],
                    "UMLS:C4083280": [
                        "ECig Uses",
                        "E-Cig Uses",
                        "Ecigarette Uses",
                        "E-Cigarette Uses",
                        "Uses, Ecigarette",
                        "Vape",
                        "Vapes",
                        "Vaping",
                        "ECig Use",
                        "E Cig Use",
                        "E-Cig Use",
                        "Use, ECig",
                        "THC Vaping",
                        "Use, E-Cig",
                        "Vaping, THC",
                        "THC Vapings",
                        "Vapings, THC",
                        "Vaping (event)",
                        "Ecigarette Use",
                        "E Cigarette Use",
                        "E-Cigarette Use",
                        "Use, Ecigarette",
                        "Nicotine Vaping",
                        "Vaping, Nicotine",
                        "Use, E-Cigarette",
                        "Nicotine Vapings",
                        "Vapings, Nicotine"
                    ],
                    "UMLS:C0565721": [
                        "Uses a key",
                        "Does use a key",
                        "Does use a key (finding)"
                    ]
                }
            },
            {
                "label": "temporarily relieves",
                "id": {}
            },
            {
                "label": "toothache",
                "id": {
                    "NCIT:C78640": [
                        "TOOTHACHE",
                        "toothache",
                        "Toothache",
                        "Toothaches",
                        "toothaches",
                        "Toothache NOS",
                        "Toothache (finding)",
                        "Dentagra",
                        "dentalgia",
                        "Dentalgia",
                        "TOOTH ACHE",
                        "tooth ache",
                        "odontalgia",
                        "tooth pain",
                        "Odontalgia",
                        "Tooth ache",
                        "Tooth pain",
                        "TOOTH PAIN",
                        "dental pain",
                        "pain; tooth",
                        "Odontalgias",
                        "DENTAL PAIN",
                        "tooth; pain",
                        "pain; dental",
                        "Pain in tooth",
                        "tooth/teeth pain",
                        "Pain;tooth/teeth",
                        "tooth pain (symptom)"
                    ],
                    "NCIT:C143879": [
                        "Toothache",
                        "Toothache, CTCAE"
                    ],
                    "UMLS:C0727671": [
                        "Toothache",
                        "Red Cross Toothache Drops"
                    ],
                    "UMLS:C1907725": [
                        "toothache-tree",
                        "northern prickly-ash",
                        "Zanthoxylum americanum",
                        "Zanthoxylum americanum Mill."
                    ],
                    "UMLS:C2348238": [
                        "toothache plant",
                        "Brazilian cress",
                        "Acmella oleracea",
                        "jambu <eudicots>",
                        "Spilanthes oleracea",
                        "Spilanthes oleracea L., 1767",
                        "Acmella oleracea (L.) R.K.Jansen, 1985"
                    ]
                }
            }
        ],
        [
            {
                "label": "Uses",
                "id": {
                    "UMLS:C0457083": [
                        "uses",
                        "Use",
                        "Usage",
                        "usage",
                        "Employ",
                        "usages",
                        "Usage (attribute)"
                    ],
                    "UMLS:C1522726": [
                        "iv uses",
                        "intravenous uses",
                        "IV",
                        "IV use",
                        "iv route",
                        "IV route",
                        "Intravenous",
                        "Intravenous use",
                        "intravenous use",
                        "IntravenousRoute",
                        "Intravenous route",
                        "IV - Intravenous route",
                        "Intravenous route (qualifier value)",
                        "route of administration intravenous",
                        "Intravenous Route of Administration",
                        "route of administration: intravenous",
                        "Intravenous Route of Drug Administration",
                        "route of administration: intravenous (treatment)"
                    ],
                    "UMLS:C0578310": [
                        "Uses lift",
                        "Does use lift",
                        "Does use lift (finding)"
                    ],
                    "UMLS:C4083280": [
                        "ECig Uses",
                        "E-Cig Uses",
                        "Ecigarette Uses",
                        "E-Cigarette Uses",
                        "Uses, Ecigarette",
                        "Vape",
                        "Vapes",
                        "Vaping",
                        "ECig Use",
                        "E Cig Use",
                        "E-Cig Use",
                        "Use, ECig",
                        "THC Vaping",
                        "Use, E-Cig",
                        "Vaping, THC",
                        "THC Vapings",
                        "Vapings, THC",
                        "Vaping (event)",
                        "Ecigarette Use",
                        "E Cigarette Use",
                        "E-Cigarette Use",
                        "Use, Ecigarette",
                        "Nicotine Vaping",
                        "Vaping, Nicotine",
                        "Use, E-Cigarette",
                        "Nicotine Vapings",
                        "Vapings, Nicotine"
                    ],
                    "UMLS:C0565721": [
                        "Uses a key",
                        "Does use a key",
                        "Does use a key (finding)"
                    ]
                }
            },
            {
                "label": "temporarily relieves",
                "id": {}
            },
            {
                "label": "common cold",
                "id": {
                    "MONDO:0005709": [
                        "COMMON COLD",
                        "Common Cold",
                        "common cold",
                        "Common cold",
                        "common cold",
                        "Cold, Common",
                        "common; cold",
                        "Common Colds",
                        "Cold, common",
                        "cold; common",
                        "common colds",
                        "Colds, Common",
                        "Common cold syndrome",
                        "Common cold (disorder)",
                        "common cold (diagnosis)",
                        "Acute nasopharyngitis [common cold]",
                        "acute nasopharyngitis [common cold]",
                        "Acute nasopharyngitis (common cold)",
                        "Cold",
                        "COLD",
                        "cold",
                        "colds",
                        "Coryza",
                        "CORYZA",
                        "Head cold",
                        "head cold",
                        "acute coryza",
                        "acute coryza",
                        "Acute coryza",
                        "Coryza, acute",
                        "Head cold, NOS",
                        "rhinitis acute",
                        "Rhinitis;acute",
                        "acute rhinitis",
                        "Coryza (acute)",
                        "RHINITIS ACUTE",
                        "acute rhinitis",
                        "Cold (Disease)",
                        "Acute rhinitis",
                        "URI (head cold)",
                        "rhinitis; acute",
                        "rhino-sinusitis",
                        "Rhinitis, acute",
                        "RHINITIS, ACUTE",
                        "rhino-sinusitis",
                        "acute; rhinitis",
                        "Rhinitis infective",
                        "Infective rhinitis",
                        "rhinitis; infective",
                        "Acute nasal catarrh",
                        "infective; rhinitis",
                        "Infectious Rhinitis",
                        "Rhinitis, infective",
                        "RHINITIS INFECTIOUS",
                        "Rhinitis (infective)",
                        "Nasal catarrh, acute",
                        "Acute Nasopharyngitis",
                        "acute nasopharyngitis",
                        "nasal; catarrh, acute",
                        "Nasopharyngitis;acute",
                        "catarrh; nasal, acute",
                        "Non-Allergic Rhinitis",
                        "acute nasopharyngitis",
                        "Acute nasopharyngitis",
                        "Nasopharyngitis, acute",
                        "Nasopharyngitis, acute",
                        "nasopharyngitis, acute",
                        "nasopharyngitis - acute",
                        "Nasopharyngitis - acute",
                        "Acute infective rhinitis",
                        "Infective nasopharyngitis",
                        "Acute rhinitis (disorder)",
                        "acute rhinitis (diagnosis)",
                        "Acute nasopharyngitis, NOS",
                        "Acute viral rhinopharyngitis",
                        "acute viral rhinopharyngitis",
                        "Infective nasopharyngitis NOS",
                        "Infective rhinitis (diagnosis)",
                        "catarrh; nasopharyngeal, acute",
                        "nasopharyngeal; catarrh, acute",
                        "Infective nasopharyngitis, NOS",
                        "viral upper respiratory infection",
                        "UPPER RESPIRATORY INFECTION VIRAL",
                        "upper respiratory infection viral",
                        "VIRAL UPPER RESPIRATORY INFECTION",
                        "Upper respiratory infection acute",
                        "acute nasopharyngitis (diagnosis)",
                        "viral upper respiratory infection (diagnosis)"
                    ],
                    "UMLS:C0205939": [
                        "Common Cold Virus",
                        "cold common virus",
                        "common cold virus",
                        "Common cold virus",
                        "virus common cold",
                        "Cold Virus, Common",
                        "Common Cold Viruses",
                        "Cold Viruses, Common"
                    ],
                    "UMLS:C0260380": [
                        "Vaccin for common cold",
                        "Need for prophylactic vaccination and inoculation against common cold"
                    ],
                    "UMLS:C0161636": [
                        "Anti-common-cold drugs",
                        "Anti-common cold drug poison.",
                        "Anti-common cold drug poisoning",
                        "Poisoning by anti-common cold drugs",
                        "Poisoning by anti-common-cold drugs",
                        "anti-common cold medication toxicity",
                        "Poisoning by anti-common cold drug, NOS",
                        "toxicity from anti-common cold medications",
                        "anti-common cold medication toxicity (diagnosis)",
                        "Pois-anti-cold drugs"
                    ],
                    "UMLS:C0414040": [
                        "Anti-common-cold drugs",
                        "Adv eff anti-common cold",
                        "Common cold drug adv eff",
                        "[X]Common cold drug adv eff",
                        "adverse reaction to common cold medications",
                        "adverse effect of anti-common cold medications",
                        "Anti-common-cold drugs caus adverse eff in therapeut use",
                        "adverse effect of anti-common cold medications (diagnosis)",
                        "[X]Anti-common-cold drugs caus adverse eff in therapeut use",
                        "Adverse effects in the therapeutic use of anti-common-cold drugs",
                        "Anti-common cold drugs causing adverse effects in therapeutic use",
                        "Anti-common-cold drugs causing adverse effects in therapeutic use",
                        "[X]Anti-common-cold drugs causing adverse effects in therapeutic use"
                    ]
                }
            }
        ],
        [
            {
                "label": "Uses",
                "id": {
                    "UMLS:C0457083": [
                        "uses",
                        "Use",
                        "Usage",
                        "usage",
                        "Employ",
                        "usages",
                        "Usage (attribute)"
                    ],
                    "UMLS:C1522726": [
                        "iv uses",
                        "intravenous uses",
                        "IV",
                        "IV use",
                        "iv route",
                        "IV route",
                        "Intravenous",
                        "Intravenous use",
                        "intravenous use",
                        "IntravenousRoute",
                        "Intravenous route",
                        "IV - Intravenous route",
                        "Intravenous route (qualifier value)",
                        "route of administration intravenous",
                        "Intravenous Route of Administration",
                        "route of administration: intravenous",
                        "Intravenous Route of Drug Administration",
                        "route of administration: intravenous (treatment)"
                    ],
                    "UMLS:C0578310": [
                        "Uses lift",
                        "Does use lift",
                        "Does use lift (finding)"
                    ],
                    "UMLS:C4083280": [
                        "ECig Uses",
                        "E-Cig Uses",
                        "Ecigarette Uses",
                        "E-Cigarette Uses",
                        "Uses, Ecigarette",
                        "Vape",
                        "Vapes",
                        "Vaping",
                        "ECig Use",
                        "E Cig Use",
                        "E-Cig Use",
                        "Use, ECig",
                        "THC Vaping",
                        "Use, E-Cig",
                        "Vaping, THC",
                        "THC Vapings",
                        "Vapings, THC",
                        "Vaping (event)",
                        "Ecigarette Use",
                        "E Cigarette Use",
                        "E-Cigarette Use",
                        "Use, Ecigarette",
                        "Nicotine Vaping",
                        "Vaping, Nicotine",
                        "Use, E-Cigarette",
                        "Nicotine Vapings",
                        "Vapings, Nicotine"
                    ],
                    "UMLS:C0565721": [
                        "Uses a key",
                        "Does use a key",
                        "Does use a key (finding)"
                    ]
                }
            },
            {
                "label": "temporarily reduces",
                "id": {}
            },
            {
                "label": "fever",
                "id": {
                    "UMLS:C0424755": [
                        "Fever",
                        "fever",
                        "fever symptom",
                        "fever symptoms",
                        "symptoms fever",
                        "fever as symptom",
                        "fever symptom (symptom)",
                        "Fever symptoms (finding)"
                    ],
                    "NCIT:C143485": [
                        "Fever",
                        "Fever, CTCAE"
                    ],
                    "HP:0001945": [
                        "Fever",
                        "FEVER",
                        "fever",
                        "Fevers",
                        "fevers",
                        "fevered",
                        "feverish",
                        "Feverish",
                        "Fever NOS",
                        "Fever (finding)",
                        "Fever, unspecified",
                        "fever (physical finding)",
                        "Alteration in body temperature: hyperthermia, fever",
                        "febris",
                        "febrile",
                        "Febrile",
                        "PYREXIA",
                        "pyrexia",
                        "Pyrexia",
                        "Pyrexias",
                        "Pyrexial",
                        "pyrexial",
                        "Pyrexia NOS",
                        "Hyperthermia",
                        "HYPERTHERMIA",
                        "Hyperthermic",
                        "hyperthermic",
                        "hyperthermia",
                        "high temperature",
                        "Temperature;high",
                        "High temperature",
                        "temperature; high",
                        "Has a temperature",
                        "high; temperature",
                        "Temperature raised",
                        "raised temperature",
                        "pyrexia (diagnosis)",
                        "elevated temperature",
                        "TEMPERATURE INCREASE",
                        "Temperature elevated",
                        "increase temperature",
                        "temperature increase",
                        "TEMPERATURE ELEVATION",
                        "temperature elevation",
                        "High body temperature",
                        "high body temperature",
                        "Temperature elevation",
                        "increases temperature",
                        "BODY TEMPERATURE INCREASED",
                        "Body temperature increased",
                        "increased body temperature",
                        "Increased body temperature",
                        "increased; body temperature",
                        "Body temperature, increased",
                        "body temperature; increased",
                        "Increase in body temperature",
                        "Body temperature above normal",
                        "Body temperature above reference range",
                        "Body temperature above reference range (finding)"
                    ],
                    "UMLS:C0872996": [
                        "Q fever",
                        "Q fever vaccine",
                        "Q fever vaccine (medication)"
                    ],
                    "MONDO:0019186": [
                        "Q-fever",
                        "fever q",
                        "q fever",
                        "Q fever",
                        "Q Fever",
                        "q-fever",
                        "Q fever",
                        "Q FEVER",
                        "fever; Q",
                        "Fever, Q",
                        "Q; fever",
                        "Q Fevers",
                        "Fevers, Q",
                        "query fever",
                        "fever query",
                        "Query Fever",
                        "Query fever",
                        "Fever, Query",
                        "Query Fevers",
                        "E-217 Q FEVER",
                        "Fevers, Query",
                        "Abattoir fever",
                        "nine Mile fever",
                        "Nine Mile fever",
                        "Nine-mile fever",
                        "FEVER, NINE MILE",
                        "fever; nine Mile",
                        "nine Mile; fever",
                        "Q fever pneumonia",
                        "Q fever (disorder)",
                        "Q-fever (diagnosis)",
                        "quadrilateral fever",
                        "Quadrilateral fever",
                        "quadrilateral; fever",
                        "fever; quadrilateral",
                        "Coxiella burnetii Fever",
                        "Coxiella burnetii fever",
                        "Fever, Coxiella burnetii",
                        "Coxiella burnetii Fevers",
                        "Fevers, Coxiella burnetii",
                        "Coxiellosis",
                        "BALKAN GRIPPE",
                        "Balkan grippe",
                        "Balkan influenza",
                        "Balkan; influenza",
                        "influenza; Balkan",
                        "DERRICK-BURNET DISEASE",
                        "Coxiella burnetii infection",
                        "infection; Coxiella burnetii",
                        "Coxiella burnetii; infection",
                        "BRONCHOPNEUMONIA, HIBERNO-VERNAL",
                        "Infection due to Coxiella burnetii",
                        "infection due to Coxiella burnetii",
                        "Infection due to Coxiella burnetii",
                        "Coxiella burnetii infectious disease",
                        "Coxiella burnetii disease or disorder",
                        "Coxiella burnetii caused disease or disorder"
                    ]
                }
            }
        ]
    ],
    "Baclofen is useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.": [
        [
            {
                "label": "Baclofen",
                "id": {
                    "UMLS:C0004609": [
                        "baclofen",
                        "Baclofen",
                        "BACLOFEN",
                        "Baclofeno",
                        "Baclofenum",
                        "Baclofen (substance)",
                        "baclofen (medication)",
                        "Baclofen-containing product",
                        "Product containing baclofen (medicinal product)",
                        "Ba34647",
                        "BA34647",
                        "Liorésal",
                        "Ba-34647",
                        "PCP-GABA",
                        "lioresal",
                        "Lioresal",
                        "Ba34,647",
                        "Ba-34,647",
                        "baclophen",
                        "Baclofène",
                        "Baclophen",
                        "CIBA34,647BA",
                        "CIBA-34,647-BA",
                        "Chlorophenyl GABA",
                        "GABA, Chlorophenyl",
                        "beta-(4-Chlorophenyl)gaba",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "4-Amino-3-(4-chlorophenyl)-butanoic Acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric Acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-"
                    ],
                    "PUBCHEM.COMPOUND:2284": [
                        "baclofen",
                        "baclofen",
                        "Baclofen",
                        "BACLOFEN",
                        "baclofene",
                        "Baclofeno",
                        "Baclofene",
                        "baclofeno",
                        "Baclofeno",
                        "Baclofenum",
                        "Baclofenum",
                        "baclofenum",
                        "DL-Baclofen",
                        "DL-Baclofen",
                        "apo-Baclofen",
                        "Baclofen awd",
                        "apo Baclofen",
                        "Gen-baclofen",
                        "Gen baclofen",
                        "PMS Baclofen",
                        "PMS-Baclofen",
                        "(+-)-Baclofen",
                        "(+-)-Baclofen",
                        "AWD, baclofen",
                        "baclofen zwitterion",
                        "Baclofen isis brand",
                        "Baclofen irex brand",
                        "Baclofen zwitterion",
                        "Baclofen (substance)",
                        "Baclofen athena brand",
                        "Baclofen apotex brand",
                        "baclofen (medication)",
                        "Isis brand OF baclofen",
                        "Irex brand OF baclofen",
                        "Baclofen nu-pharm brand",
                        "Baclofen novartis brand",
                        "Athena brand OF baclofen",
                        "Baclofen medtronic brand",
                        "Baclofen ashbourne brand",
                        "Apotex brand OF baclofen",
                        "Baclofen ciba-geigy brand",
                        "Baclofen alphapharm brand",
                        "Nu pharm brand OF baclofen",
                        "Novartis brand OF baclofen",
                        "Nu-pharm brand OF baclofen",
                        "Baclofen-containing product",
                        "Medtronic brand OF baclofen",
                        "Ashbourne brand OF baclofen",
                        "Ciba-geigy brand OF baclofen",
                        "Alphapharm brand OF baclofen",
                        "Baclofen pharmascience brand",
                        "Ciba geigy brand OF baclofen",
                        "ASTA medica brand OF baclofen",
                        "Pharmascience brand OF baclofen",
                        "Product containing baclofen (medicinal product)",
                        "Lebic",
                        "Clofen",
                        "Kemstro",
                        "Atrofen",
                        "NuBaclo",
                        "PCP-GABA",
                        "Nu baclo",
                        "Nu-baclo",
                        "Genpharm",
                        "PCP-GABA",
                        "Lioresal",
                        "baclophen",
                        "Baclofène",
                        "Baclophen",
                        "Baclophen",
                        "Baclospas",
                        "GenBaclofen",
                        "ApoBaclofen",
                        "PMSBaclofen",
                        "CIBA34,647ba",
                        "BaclofèneIrex",
                        "CIBA-34,647-ba",
                        "Baclofène-irex",
                        "Baclofène irex",
                        "Chlorophenyl gaba",
                        "Chlorophenyl GABA",
                        "GABA, Chlorophenyl",
                        "GABA, chlorophenyl",
                        "Β-(4-chlorophenyl)gaba",
                        "b-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "g-Amino-b-(p-chlorophenyl)butyrate",
                        "b-(p-Chlorophenyl)-g-aminobutyrate",
                        "4-Amino-3-(4-chlorophenyl)butyrate",
                        "Γ-amino-β-(p-chlorophenyl)butyrate",
                        "Β-(p-chlorophenyl)-γ-aminobutyrate",
                        "DL-4-Amino-3-p-chlorophenylbutanoate",
                        "b-(Aminomethyl)-p-chlorohydrocinnamate",
                        "g-Amino-b-(p-chlorophenyl)butyric acid",
                        "Γ-amino-β-(p-chlorophenyl)butyric acid",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "Β-(aminomethyl)-p-chlorohydrocinnamate",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "b-(p-Chlorophenyl)-g-aminobutyric acid",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "Β-(p-chlorophenyl)-γ-aminobutyric acid",
                        "4-amino-3-(4-chlorophenyl)butanoic acid",
                        "DL-4-Amino-3-p-chlorophenylbutanoic acid",
                        "4-Amino-3-(4-chlorophenyl)-butanoic Acid",
                        "DL-4-Amino-3-p-chlorophenylbutanoic acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyrate",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamate",
                        "gamma-Amino-beta-(p-chlorophenyl)butyrate",
                        "Β-(aminomethyl)-4-chlorobenzenepropanoate",
                        "b-(Aminomethyl)-4-chlorobenzenepropanoate",
                        "b-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "Β-(aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoate",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "b-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Β-(aminomethyl)-4-chlorobenzenepropanoic acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric Acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-"
                    ],
                    "UNII:3OHN4989XM": [
                        "L-Baclofen",
                        "(S)-Baclofen",
                        "BACLOFEN, (S)-",
                        "Baclofen, (S)-",
                        "CHEMBL302213",
                        "(S) 4-Amino-3-(4-Chlorophenyl)Butanoic Acid"
                    ],
                    "PUBCHEM.COMPOUND:44602": [
                        "d-Baclofen",
                        "Baclofen R-",
                        "(-)-baclofen",
                        "(R)-Baclofen",
                        "(R)-(-)-Baclofen",
                        "[<sup>3</sup>H](R)-(-)-baclofen",
                        "ARBACLOFEN",
                        "Arbaclofen",
                        "CID 6918881",
                        "(R)-4-Amino-3-(4-chlorophenyl)butanoic Acid",
                        "(R) 4-Amino-3-(4-Chlorophenyl)Butanoic Acid",
                        "(R)-4-amino-3-(4-chlorophenyl)butan-oic acid"
                    ],
                    "PUBCHEM.COMPOUND:45038188": [
                        "Baclofen-d4"
                    ]
                }
            },
            {
                "label": "is useful for",
                "id": {}
            },
            {
                "label": "the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis",
                "id": {}
            }
        ],
        [
            {
                "label": "Baclofen",
                "id": {
                    "UMLS:C0004609": [
                        "baclofen",
                        "Baclofen",
                        "BACLOFEN",
                        "Baclofeno",
                        "Baclofenum",
                        "Baclofen (substance)",
                        "baclofen (medication)",
                        "Baclofen-containing product",
                        "Product containing baclofen (medicinal product)",
                        "Ba34647",
                        "BA34647",
                        "Liorésal",
                        "Ba-34647",
                        "PCP-GABA",
                        "lioresal",
                        "Lioresal",
                        "Ba34,647",
                        "Ba-34,647",
                        "baclophen",
                        "Baclofène",
                        "Baclophen",
                        "CIBA34,647BA",
                        "CIBA-34,647-BA",
                        "Chlorophenyl GABA",
                        "GABA, Chlorophenyl",
                        "beta-(4-Chlorophenyl)gaba",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "4-Amino-3-(4-chlorophenyl)-butanoic Acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric Acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-"
                    ],
                    "PUBCHEM.COMPOUND:2284": [
                        "baclofen",
                        "baclofen",
                        "Baclofen",
                        "BACLOFEN",
                        "baclofene",
                        "Baclofeno",
                        "Baclofene",
                        "baclofeno",
                        "Baclofeno",
                        "Baclofenum",
                        "Baclofenum",
                        "baclofenum",
                        "DL-Baclofen",
                        "DL-Baclofen",
                        "apo-Baclofen",
                        "Baclofen awd",
                        "apo Baclofen",
                        "Gen-baclofen",
                        "Gen baclofen",
                        "PMS Baclofen",
                        "PMS-Baclofen",
                        "(+-)-Baclofen",
                        "(+-)-Baclofen",
                        "AWD, baclofen",
                        "baclofen zwitterion",
                        "Baclofen isis brand",
                        "Baclofen irex brand",
                        "Baclofen zwitterion",
                        "Baclofen (substance)",
                        "Baclofen athena brand",
                        "Baclofen apotex brand",
                        "baclofen (medication)",
                        "Isis brand OF baclofen",
                        "Irex brand OF baclofen",
                        "Baclofen nu-pharm brand",
                        "Baclofen novartis brand",
                        "Athena brand OF baclofen",
                        "Baclofen medtronic brand",
                        "Baclofen ashbourne brand",
                        "Apotex brand OF baclofen",
                        "Baclofen ciba-geigy brand",
                        "Baclofen alphapharm brand",
                        "Nu pharm brand OF baclofen",
                        "Novartis brand OF baclofen",
                        "Nu-pharm brand OF baclofen",
                        "Baclofen-containing product",
                        "Medtronic brand OF baclofen",
                        "Ashbourne brand OF baclofen",
                        "Ciba-geigy brand OF baclofen",
                        "Alphapharm brand OF baclofen",
                        "Baclofen pharmascience brand",
                        "Ciba geigy brand OF baclofen",
                        "ASTA medica brand OF baclofen",
                        "Pharmascience brand OF baclofen",
                        "Product containing baclofen (medicinal product)",
                        "Lebic",
                        "Clofen",
                        "Kemstro",
                        "Atrofen",
                        "NuBaclo",
                        "PCP-GABA",
                        "Nu baclo",
                        "Nu-baclo",
                        "Genpharm",
                        "PCP-GABA",
                        "Lioresal",
                        "baclophen",
                        "Baclofène",
                        "Baclophen",
                        "Baclophen",
                        "Baclospas",
                        "GenBaclofen",
                        "ApoBaclofen",
                        "PMSBaclofen",
                        "CIBA34,647ba",
                        "BaclofèneIrex",
                        "CIBA-34,647-ba",
                        "Baclofène-irex",
                        "Baclofène irex",
                        "Chlorophenyl gaba",
                        "Chlorophenyl GABA",
                        "GABA, Chlorophenyl",
                        "GABA, chlorophenyl",
                        "Β-(4-chlorophenyl)gaba",
                        "b-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "g-Amino-b-(p-chlorophenyl)butyrate",
                        "b-(p-Chlorophenyl)-g-aminobutyrate",
                        "4-Amino-3-(4-chlorophenyl)butyrate",
                        "Γ-amino-β-(p-chlorophenyl)butyrate",
                        "Β-(p-chlorophenyl)-γ-aminobutyrate",
                        "DL-4-Amino-3-p-chlorophenylbutanoate",
                        "b-(Aminomethyl)-p-chlorohydrocinnamate",
                        "g-Amino-b-(p-chlorophenyl)butyric acid",
                        "Γ-amino-β-(p-chlorophenyl)butyric acid",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "Β-(aminomethyl)-p-chlorohydrocinnamate",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "b-(p-Chlorophenyl)-g-aminobutyric acid",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "Β-(p-chlorophenyl)-γ-aminobutyric acid",
                        "4-amino-3-(4-chlorophenyl)butanoic acid",
                        "DL-4-Amino-3-p-chlorophenylbutanoic acid",
                        "4-Amino-3-(4-chlorophenyl)-butanoic Acid",
                        "DL-4-Amino-3-p-chlorophenylbutanoic acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyrate",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamate",
                        "gamma-Amino-beta-(p-chlorophenyl)butyrate",
                        "Β-(aminomethyl)-4-chlorobenzenepropanoate",
                        "b-(Aminomethyl)-4-chlorobenzenepropanoate",
                        "b-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "Β-(aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoate",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "b-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Β-(aminomethyl)-4-chlorobenzenepropanoic acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric Acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-"
                    ],
                    "UNII:3OHN4989XM": [
                        "L-Baclofen",
                        "(S)-Baclofen",
                        "BACLOFEN, (S)-",
                        "Baclofen, (S)-",
                        "CHEMBL302213",
                        "(S) 4-Amino-3-(4-Chlorophenyl)Butanoic Acid"
                    ],
                    "PUBCHEM.COMPOUND:44602": [
                        "d-Baclofen",
                        "Baclofen R-",
                        "(-)-baclofen",
                        "(R)-Baclofen",
                        "(R)-(-)-Baclofen",
                        "[<sup>3</sup>H](R)-(-)-baclofen",
                        "ARBACLOFEN",
                        "Arbaclofen",
                        "CID 6918881",
                        "(R)-4-Amino-3-(4-chlorophenyl)butanoic Acid",
                        "(R) 4-Amino-3-(4-Chlorophenyl)Butanoic Acid",
                        "(R)-4-amino-3-(4-chlorophenyl)butan-oic acid"
                    ],
                    "PUBCHEM.COMPOUND:45038188": [
                        "Baclofen-d4"
                    ]
                }
            },
            {
                "label": "is useful for",
                "id": {}
            },
            {
                "label": "the relief of flexor spasms",
                "id": {}
            }
        ],
        [
            {
                "label": "Baclofen",
                "id": {
                    "UMLS:C0004609": [
                        "baclofen",
                        "Baclofen",
                        "BACLOFEN",
                        "Baclofeno",
                        "Baclofenum",
                        "Baclofen (substance)",
                        "baclofen (medication)",
                        "Baclofen-containing product",
                        "Product containing baclofen (medicinal product)",
                        "Ba34647",
                        "BA34647",
                        "Liorésal",
                        "Ba-34647",
                        "PCP-GABA",
                        "lioresal",
                        "Lioresal",
                        "Ba34,647",
                        "Ba-34,647",
                        "baclophen",
                        "Baclofène",
                        "Baclophen",
                        "CIBA34,647BA",
                        "CIBA-34,647-BA",
                        "Chlorophenyl GABA",
                        "GABA, Chlorophenyl",
                        "beta-(4-Chlorophenyl)gaba",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "4-Amino-3-(4-chlorophenyl)-butanoic Acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric Acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-"
                    ],
                    "PUBCHEM.COMPOUND:2284": [
                        "baclofen",
                        "baclofen",
                        "Baclofen",
                        "BACLOFEN",
                        "baclofene",
                        "Baclofeno",
                        "Baclofene",
                        "baclofeno",
                        "Baclofeno",
                        "Baclofenum",
                        "Baclofenum",
                        "baclofenum",
                        "DL-Baclofen",
                        "DL-Baclofen",
                        "apo-Baclofen",
                        "Baclofen awd",
                        "apo Baclofen",
                        "Gen-baclofen",
                        "Gen baclofen",
                        "PMS Baclofen",
                        "PMS-Baclofen",
                        "(+-)-Baclofen",
                        "(+-)-Baclofen",
                        "AWD, baclofen",
                        "baclofen zwitterion",
                        "Baclofen isis brand",
                        "Baclofen irex brand",
                        "Baclofen zwitterion",
                        "Baclofen (substance)",
                        "Baclofen athena brand",
                        "Baclofen apotex brand",
                        "baclofen (medication)",
                        "Isis brand OF baclofen",
                        "Irex brand OF baclofen",
                        "Baclofen nu-pharm brand",
                        "Baclofen novartis brand",
                        "Athena brand OF baclofen",
                        "Baclofen medtronic brand",
                        "Baclofen ashbourne brand",
                        "Apotex brand OF baclofen",
                        "Baclofen ciba-geigy brand",
                        "Baclofen alphapharm brand",
                        "Nu pharm brand OF baclofen",
                        "Novartis brand OF baclofen",
                        "Nu-pharm brand OF baclofen",
                        "Baclofen-containing product",
                        "Medtronic brand OF baclofen",
                        "Ashbourne brand OF baclofen",
                        "Ciba-geigy brand OF baclofen",
                        "Alphapharm brand OF baclofen",
                        "Baclofen pharmascience brand",
                        "Ciba geigy brand OF baclofen",
                        "ASTA medica brand OF baclofen",
                        "Pharmascience brand OF baclofen",
                        "Product containing baclofen (medicinal product)",
                        "Lebic",
                        "Clofen",
                        "Kemstro",
                        "Atrofen",
                        "NuBaclo",
                        "PCP-GABA",
                        "Nu baclo",
                        "Nu-baclo",
                        "Genpharm",
                        "PCP-GABA",
                        "Lioresal",
                        "baclophen",
                        "Baclofène",
                        "Baclophen",
                        "Baclophen",
                        "Baclospas",
                        "GenBaclofen",
                        "ApoBaclofen",
                        "PMSBaclofen",
                        "CIBA34,647ba",
                        "BaclofèneIrex",
                        "CIBA-34,647-ba",
                        "Baclofène-irex",
                        "Baclofène irex",
                        "Chlorophenyl gaba",
                        "Chlorophenyl GABA",
                        "GABA, Chlorophenyl",
                        "GABA, chlorophenyl",
                        "Β-(4-chlorophenyl)gaba",
                        "b-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "g-Amino-b-(p-chlorophenyl)butyrate",
                        "b-(p-Chlorophenyl)-g-aminobutyrate",
                        "4-Amino-3-(4-chlorophenyl)butyrate",
                        "Γ-amino-β-(p-chlorophenyl)butyrate",
                        "Β-(p-chlorophenyl)-γ-aminobutyrate",
                        "DL-4-Amino-3-p-chlorophenylbutanoate",
                        "b-(Aminomethyl)-p-chlorohydrocinnamate",
                        "g-Amino-b-(p-chlorophenyl)butyric acid",
                        "Γ-amino-β-(p-chlorophenyl)butyric acid",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "Β-(aminomethyl)-p-chlorohydrocinnamate",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "b-(p-Chlorophenyl)-g-aminobutyric acid",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "Β-(p-chlorophenyl)-γ-aminobutyric acid",
                        "4-amino-3-(4-chlorophenyl)butanoic acid",
                        "DL-4-Amino-3-p-chlorophenylbutanoic acid",
                        "4-Amino-3-(4-chlorophenyl)-butanoic Acid",
                        "DL-4-Amino-3-p-chlorophenylbutanoic acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyrate",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamate",
                        "gamma-Amino-beta-(p-chlorophenyl)butyrate",
                        "Β-(aminomethyl)-4-chlorobenzenepropanoate",
                        "b-(Aminomethyl)-4-chlorobenzenepropanoate",
                        "b-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "Β-(aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoate",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "b-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Β-(aminomethyl)-4-chlorobenzenepropanoic acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric Acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-"
                    ],
                    "UNII:3OHN4989XM": [
                        "L-Baclofen",
                        "(S)-Baclofen",
                        "BACLOFEN, (S)-",
                        "Baclofen, (S)-",
                        "CHEMBL302213",
                        "(S) 4-Amino-3-(4-Chlorophenyl)Butanoic Acid"
                    ],
                    "PUBCHEM.COMPOUND:44602": [
                        "d-Baclofen",
                        "Baclofen R-",
                        "(-)-baclofen",
                        "(R)-Baclofen",
                        "(R)-(-)-Baclofen",
                        "[<sup>3</sup>H](R)-(-)-baclofen",
                        "ARBACLOFEN",
                        "Arbaclofen",
                        "CID 6918881",
                        "(R)-4-Amino-3-(4-chlorophenyl)butanoic Acid",
                        "(R) 4-Amino-3-(4-Chlorophenyl)Butanoic Acid",
                        "(R)-4-amino-3-(4-chlorophenyl)butan-oic acid"
                    ],
                    "PUBCHEM.COMPOUND:45038188": [
                        "Baclofen-d4"
                    ]
                }
            },
            {
                "label": "is useful for",
                "id": {}
            },
            {
                "label": "the relief of concomitant pain",
                "id": {}
            }
        ],
        [
            {
                "label": "Baclofen",
                "id": {
                    "UMLS:C0004609": [
                        "baclofen",
                        "Baclofen",
                        "BACLOFEN",
                        "Baclofeno",
                        "Baclofenum",
                        "Baclofen (substance)",
                        "baclofen (medication)",
                        "Baclofen-containing product",
                        "Product containing baclofen (medicinal product)",
                        "Ba34647",
                        "BA34647",
                        "Liorésal",
                        "Ba-34647",
                        "PCP-GABA",
                        "lioresal",
                        "Lioresal",
                        "Ba34,647",
                        "Ba-34,647",
                        "baclophen",
                        "Baclofène",
                        "Baclophen",
                        "CIBA34,647BA",
                        "CIBA-34,647-BA",
                        "Chlorophenyl GABA",
                        "GABA, Chlorophenyl",
                        "beta-(4-Chlorophenyl)gaba",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "4-Amino-3-(4-chlorophenyl)-butanoic Acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric Acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-"
                    ],
                    "PUBCHEM.COMPOUND:2284": [
                        "baclofen",
                        "baclofen",
                        "Baclofen",
                        "BACLOFEN",
                        "baclofene",
                        "Baclofeno",
                        "Baclofene",
                        "baclofeno",
                        "Baclofeno",
                        "Baclofenum",
                        "Baclofenum",
                        "baclofenum",
                        "DL-Baclofen",
                        "DL-Baclofen",
                        "apo-Baclofen",
                        "Baclofen awd",
                        "apo Baclofen",
                        "Gen-baclofen",
                        "Gen baclofen",
                        "PMS Baclofen",
                        "PMS-Baclofen",
                        "(+-)-Baclofen",
                        "(+-)-Baclofen",
                        "AWD, baclofen",
                        "baclofen zwitterion",
                        "Baclofen isis brand",
                        "Baclofen irex brand",
                        "Baclofen zwitterion",
                        "Baclofen (substance)",
                        "Baclofen athena brand",
                        "Baclofen apotex brand",
                        "baclofen (medication)",
                        "Isis brand OF baclofen",
                        "Irex brand OF baclofen",
                        "Baclofen nu-pharm brand",
                        "Baclofen novartis brand",
                        "Athena brand OF baclofen",
                        "Baclofen medtronic brand",
                        "Baclofen ashbourne brand",
                        "Apotex brand OF baclofen",
                        "Baclofen ciba-geigy brand",
                        "Baclofen alphapharm brand",
                        "Nu pharm brand OF baclofen",
                        "Novartis brand OF baclofen",
                        "Nu-pharm brand OF baclofen",
                        "Baclofen-containing product",
                        "Medtronic brand OF baclofen",
                        "Ashbourne brand OF baclofen",
                        "Ciba-geigy brand OF baclofen",
                        "Alphapharm brand OF baclofen",
                        "Baclofen pharmascience brand",
                        "Ciba geigy brand OF baclofen",
                        "ASTA medica brand OF baclofen",
                        "Pharmascience brand OF baclofen",
                        "Product containing baclofen (medicinal product)",
                        "Lebic",
                        "Clofen",
                        "Kemstro",
                        "Atrofen",
                        "NuBaclo",
                        "PCP-GABA",
                        "Nu baclo",
                        "Nu-baclo",
                        "Genpharm",
                        "PCP-GABA",
                        "Lioresal",
                        "baclophen",
                        "Baclofène",
                        "Baclophen",
                        "Baclophen",
                        "Baclospas",
                        "GenBaclofen",
                        "ApoBaclofen",
                        "PMSBaclofen",
                        "CIBA34,647ba",
                        "BaclofèneIrex",
                        "CIBA-34,647-ba",
                        "Baclofène-irex",
                        "Baclofène irex",
                        "Chlorophenyl gaba",
                        "Chlorophenyl GABA",
                        "GABA, Chlorophenyl",
                        "GABA, chlorophenyl",
                        "Β-(4-chlorophenyl)gaba",
                        "b-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "g-Amino-b-(p-chlorophenyl)butyrate",
                        "b-(p-Chlorophenyl)-g-aminobutyrate",
                        "4-Amino-3-(4-chlorophenyl)butyrate",
                        "Γ-amino-β-(p-chlorophenyl)butyrate",
                        "Β-(p-chlorophenyl)-γ-aminobutyrate",
                        "DL-4-Amino-3-p-chlorophenylbutanoate",
                        "b-(Aminomethyl)-p-chlorohydrocinnamate",
                        "g-Amino-b-(p-chlorophenyl)butyric acid",
                        "Γ-amino-β-(p-chlorophenyl)butyric acid",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "Β-(aminomethyl)-p-chlorohydrocinnamate",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "b-(p-Chlorophenyl)-g-aminobutyric acid",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "Β-(p-chlorophenyl)-γ-aminobutyric acid",
                        "4-amino-3-(4-chlorophenyl)butanoic acid",
                        "DL-4-Amino-3-p-chlorophenylbutanoic acid",
                        "4-Amino-3-(4-chlorophenyl)-butanoic Acid",
                        "DL-4-Amino-3-p-chlorophenylbutanoic acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyrate",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamate",
                        "gamma-Amino-beta-(p-chlorophenyl)butyrate",
                        "Β-(aminomethyl)-4-chlorobenzenepropanoate",
                        "b-(Aminomethyl)-4-chlorobenzenepropanoate",
                        "b-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "Β-(aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoate",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "b-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Β-(aminomethyl)-4-chlorobenzenepropanoic acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric Acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-"
                    ],
                    "UNII:3OHN4989XM": [
                        "L-Baclofen",
                        "(S)-Baclofen",
                        "BACLOFEN, (S)-",
                        "Baclofen, (S)-",
                        "CHEMBL302213",
                        "(S) 4-Amino-3-(4-Chlorophenyl)Butanoic Acid"
                    ],
                    "PUBCHEM.COMPOUND:44602": [
                        "d-Baclofen",
                        "Baclofen R-",
                        "(-)-baclofen",
                        "(R)-Baclofen",
                        "(R)-(-)-Baclofen",
                        "[<sup>3</sup>H](R)-(-)-baclofen",
                        "ARBACLOFEN",
                        "Arbaclofen",
                        "CID 6918881",
                        "(R)-4-Amino-3-(4-chlorophenyl)butanoic Acid",
                        "(R) 4-Amino-3-(4-Chlorophenyl)Butanoic Acid",
                        "(R)-4-amino-3-(4-chlorophenyl)butan-oic acid"
                    ],
                    "PUBCHEM.COMPOUND:45038188": [
                        "Baclofen-d4"
                    ]
                }
            },
            {
                "label": "is useful for",
                "id": {}
            },
            {
                "label": "the relief of clonus",
                "id": {}
            }
        ],
        [
            {
                "label": "Baclofen",
                "id": {
                    "UMLS:C0004609": [
                        "baclofen",
                        "Baclofen",
                        "BACLOFEN",
                        "Baclofeno",
                        "Baclofenum",
                        "Baclofen (substance)",
                        "baclofen (medication)",
                        "Baclofen-containing product",
                        "Product containing baclofen (medicinal product)",
                        "Ba34647",
                        "BA34647",
                        "Liorésal",
                        "Ba-34647",
                        "PCP-GABA",
                        "lioresal",
                        "Lioresal",
                        "Ba34,647",
                        "Ba-34,647",
                        "baclophen",
                        "Baclofène",
                        "Baclophen",
                        "CIBA34,647BA",
                        "CIBA-34,647-BA",
                        "Chlorophenyl GABA",
                        "GABA, Chlorophenyl",
                        "beta-(4-Chlorophenyl)gaba",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "4-Amino-3-(4-chlorophenyl)-butanoic Acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric Acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-"
                    ],
                    "PUBCHEM.COMPOUND:2284": [
                        "baclofen",
                        "baclofen",
                        "Baclofen",
                        "BACLOFEN",
                        "baclofene",
                        "Baclofeno",
                        "Baclofene",
                        "baclofeno",
                        "Baclofeno",
                        "Baclofenum",
                        "Baclofenum",
                        "baclofenum",
                        "DL-Baclofen",
                        "DL-Baclofen",
                        "apo-Baclofen",
                        "Baclofen awd",
                        "apo Baclofen",
                        "Gen-baclofen",
                        "Gen baclofen",
                        "PMS Baclofen",
                        "PMS-Baclofen",
                        "(+-)-Baclofen",
                        "(+-)-Baclofen",
                        "AWD, baclofen",
                        "baclofen zwitterion",
                        "Baclofen isis brand",
                        "Baclofen irex brand",
                        "Baclofen zwitterion",
                        "Baclofen (substance)",
                        "Baclofen athena brand",
                        "Baclofen apotex brand",
                        "baclofen (medication)",
                        "Isis brand OF baclofen",
                        "Irex brand OF baclofen",
                        "Baclofen nu-pharm brand",
                        "Baclofen novartis brand",
                        "Athena brand OF baclofen",
                        "Baclofen medtronic brand",
                        "Baclofen ashbourne brand",
                        "Apotex brand OF baclofen",
                        "Baclofen ciba-geigy brand",
                        "Baclofen alphapharm brand",
                        "Nu pharm brand OF baclofen",
                        "Novartis brand OF baclofen",
                        "Nu-pharm brand OF baclofen",
                        "Baclofen-containing product",
                        "Medtronic brand OF baclofen",
                        "Ashbourne brand OF baclofen",
                        "Ciba-geigy brand OF baclofen",
                        "Alphapharm brand OF baclofen",
                        "Baclofen pharmascience brand",
                        "Ciba geigy brand OF baclofen",
                        "ASTA medica brand OF baclofen",
                        "Pharmascience brand OF baclofen",
                        "Product containing baclofen (medicinal product)",
                        "Lebic",
                        "Clofen",
                        "Kemstro",
                        "Atrofen",
                        "NuBaclo",
                        "PCP-GABA",
                        "Nu baclo",
                        "Nu-baclo",
                        "Genpharm",
                        "PCP-GABA",
                        "Lioresal",
                        "baclophen",
                        "Baclofène",
                        "Baclophen",
                        "Baclophen",
                        "Baclospas",
                        "GenBaclofen",
                        "ApoBaclofen",
                        "PMSBaclofen",
                        "CIBA34,647ba",
                        "BaclofèneIrex",
                        "CIBA-34,647-ba",
                        "Baclofène-irex",
                        "Baclofène irex",
                        "Chlorophenyl gaba",
                        "Chlorophenyl GABA",
                        "GABA, Chlorophenyl",
                        "GABA, chlorophenyl",
                        "Β-(4-chlorophenyl)gaba",
                        "b-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "g-Amino-b-(p-chlorophenyl)butyrate",
                        "b-(p-Chlorophenyl)-g-aminobutyrate",
                        "4-Amino-3-(4-chlorophenyl)butyrate",
                        "Γ-amino-β-(p-chlorophenyl)butyrate",
                        "Β-(p-chlorophenyl)-γ-aminobutyrate",
                        "DL-4-Amino-3-p-chlorophenylbutanoate",
                        "b-(Aminomethyl)-p-chlorohydrocinnamate",
                        "g-Amino-b-(p-chlorophenyl)butyric acid",
                        "Γ-amino-β-(p-chlorophenyl)butyric acid",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "Β-(aminomethyl)-p-chlorohydrocinnamate",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "b-(p-Chlorophenyl)-g-aminobutyric acid",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "Β-(p-chlorophenyl)-γ-aminobutyric acid",
                        "4-amino-3-(4-chlorophenyl)butanoic acid",
                        "DL-4-Amino-3-p-chlorophenylbutanoic acid",
                        "4-Amino-3-(4-chlorophenyl)-butanoic Acid",
                        "DL-4-Amino-3-p-chlorophenylbutanoic acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyrate",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamate",
                        "gamma-Amino-beta-(p-chlorophenyl)butyrate",
                        "Β-(aminomethyl)-4-chlorobenzenepropanoate",
                        "b-(Aminomethyl)-4-chlorobenzenepropanoate",
                        "b-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "Β-(aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoate",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "b-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Β-(aminomethyl)-4-chlorobenzenepropanoic acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric Acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-"
                    ],
                    "UNII:3OHN4989XM": [
                        "L-Baclofen",
                        "(S)-Baclofen",
                        "BACLOFEN, (S)-",
                        "Baclofen, (S)-",
                        "CHEMBL302213",
                        "(S) 4-Amino-3-(4-Chlorophenyl)Butanoic Acid"
                    ],
                    "PUBCHEM.COMPOUND:44602": [
                        "d-Baclofen",
                        "Baclofen R-",
                        "(-)-baclofen",
                        "(R)-Baclofen",
                        "(R)-(-)-Baclofen",
                        "[<sup>3</sup>H](R)-(-)-baclofen",
                        "ARBACLOFEN",
                        "Arbaclofen",
                        "CID 6918881",
                        "(R)-4-Amino-3-(4-chlorophenyl)butanoic Acid",
                        "(R) 4-Amino-3-(4-Chlorophenyl)Butanoic Acid",
                        "(R)-4-amino-3-(4-chlorophenyl)butan-oic acid"
                    ],
                    "PUBCHEM.COMPOUND:45038188": [
                        "Baclofen-d4"
                    ]
                }
            },
            {
                "label": "is useful for",
                "id": {}
            },
            {
                "label": "the relief of muscular rigidity",
                "id": {}
            }
        ]
    ],
    "Diclofenac potassium tablets are indicated:For relief of mild to moderate pain": [
        [
            {
                "label": "Diclofenac potassium tablets",
                "id": {
                    "UMLS:C4719822": [
                        "Diclofenac Potassium Tablets"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "relief of mild to moderate pain",
                "id": {}
            }
        ]
    ],
    "Baclofen may also be of some value in patients with spinal cord injuries and other spinal cord diseases.": [
        [
            {
                "label": "Baclofen",
                "id": {
                    "UMLS:C0004609": [
                        "baclofen",
                        "Baclofen",
                        "BACLOFEN",
                        "Baclofeno",
                        "Baclofenum",
                        "Baclofen (substance)",
                        "baclofen (medication)",
                        "Baclofen-containing product",
                        "Product containing baclofen (medicinal product)",
                        "Ba34647",
                        "BA34647",
                        "Liorésal",
                        "Ba-34647",
                        "PCP-GABA",
                        "lioresal",
                        "Lioresal",
                        "Ba34,647",
                        "Ba-34,647",
                        "baclophen",
                        "Baclofène",
                        "Baclophen",
                        "CIBA34,647BA",
                        "CIBA-34,647-BA",
                        "Chlorophenyl GABA",
                        "GABA, Chlorophenyl",
                        "beta-(4-Chlorophenyl)gaba",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "4-Amino-3-(4-chlorophenyl)-butanoic Acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric Acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-"
                    ],
                    "PUBCHEM.COMPOUND:2284": [
                        "baclofen",
                        "baclofen",
                        "Baclofen",
                        "BACLOFEN",
                        "baclofene",
                        "Baclofeno",
                        "Baclofene",
                        "baclofeno",
                        "Baclofeno",
                        "Baclofenum",
                        "Baclofenum",
                        "baclofenum",
                        "DL-Baclofen",
                        "DL-Baclofen",
                        "apo-Baclofen",
                        "Baclofen awd",
                        "apo Baclofen",
                        "Gen-baclofen",
                        "Gen baclofen",
                        "PMS Baclofen",
                        "PMS-Baclofen",
                        "(+-)-Baclofen",
                        "(+-)-Baclofen",
                        "AWD, baclofen",
                        "baclofen zwitterion",
                        "Baclofen isis brand",
                        "Baclofen irex brand",
                        "Baclofen zwitterion",
                        "Baclofen (substance)",
                        "Baclofen athena brand",
                        "Baclofen apotex brand",
                        "baclofen (medication)",
                        "Isis brand OF baclofen",
                        "Irex brand OF baclofen",
                        "Baclofen nu-pharm brand",
                        "Baclofen novartis brand",
                        "Athena brand OF baclofen",
                        "Baclofen medtronic brand",
                        "Baclofen ashbourne brand",
                        "Apotex brand OF baclofen",
                        "Baclofen ciba-geigy brand",
                        "Baclofen alphapharm brand",
                        "Nu pharm brand OF baclofen",
                        "Novartis brand OF baclofen",
                        "Nu-pharm brand OF baclofen",
                        "Baclofen-containing product",
                        "Medtronic brand OF baclofen",
                        "Ashbourne brand OF baclofen",
                        "Ciba-geigy brand OF baclofen",
                        "Alphapharm brand OF baclofen",
                        "Baclofen pharmascience brand",
                        "Ciba geigy brand OF baclofen",
                        "ASTA medica brand OF baclofen",
                        "Pharmascience brand OF baclofen",
                        "Product containing baclofen (medicinal product)",
                        "Lebic",
                        "Clofen",
                        "Kemstro",
                        "Atrofen",
                        "NuBaclo",
                        "PCP-GABA",
                        "Nu baclo",
                        "Nu-baclo",
                        "Genpharm",
                        "PCP-GABA",
                        "Lioresal",
                        "baclophen",
                        "Baclofène",
                        "Baclophen",
                        "Baclophen",
                        "Baclospas",
                        "GenBaclofen",
                        "ApoBaclofen",
                        "PMSBaclofen",
                        "CIBA34,647ba",
                        "BaclofèneIrex",
                        "CIBA-34,647-ba",
                        "Baclofène-irex",
                        "Baclofène irex",
                        "Chlorophenyl gaba",
                        "Chlorophenyl GABA",
                        "GABA, Chlorophenyl",
                        "GABA, chlorophenyl",
                        "Β-(4-chlorophenyl)gaba",
                        "b-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "g-Amino-b-(p-chlorophenyl)butyrate",
                        "b-(p-Chlorophenyl)-g-aminobutyrate",
                        "4-Amino-3-(4-chlorophenyl)butyrate",
                        "Γ-amino-β-(p-chlorophenyl)butyrate",
                        "Β-(p-chlorophenyl)-γ-aminobutyrate",
                        "DL-4-Amino-3-p-chlorophenylbutanoate",
                        "b-(Aminomethyl)-p-chlorohydrocinnamate",
                        "g-Amino-b-(p-chlorophenyl)butyric acid",
                        "Γ-amino-β-(p-chlorophenyl)butyric acid",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "Β-(aminomethyl)-p-chlorohydrocinnamate",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "b-(p-Chlorophenyl)-g-aminobutyric acid",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "Β-(p-chlorophenyl)-γ-aminobutyric acid",
                        "4-amino-3-(4-chlorophenyl)butanoic acid",
                        "DL-4-Amino-3-p-chlorophenylbutanoic acid",
                        "4-Amino-3-(4-chlorophenyl)-butanoic Acid",
                        "DL-4-Amino-3-p-chlorophenylbutanoic acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyrate",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamate",
                        "gamma-Amino-beta-(p-chlorophenyl)butyrate",
                        "Β-(aminomethyl)-4-chlorobenzenepropanoate",
                        "b-(Aminomethyl)-4-chlorobenzenepropanoate",
                        "b-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "Β-(aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoate",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "b-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Β-(aminomethyl)-4-chlorobenzenepropanoic acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric Acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-"
                    ],
                    "UNII:3OHN4989XM": [
                        "L-Baclofen",
                        "(S)-Baclofen",
                        "BACLOFEN, (S)-",
                        "Baclofen, (S)-",
                        "CHEMBL302213",
                        "(S) 4-Amino-3-(4-Chlorophenyl)Butanoic Acid"
                    ],
                    "PUBCHEM.COMPOUND:44602": [
                        "d-Baclofen",
                        "Baclofen R-",
                        "(-)-baclofen",
                        "(R)-Baclofen",
                        "(R)-(-)-Baclofen",
                        "[<sup>3</sup>H](R)-(-)-baclofen",
                        "ARBACLOFEN",
                        "Arbaclofen",
                        "CID 6918881",
                        "(R)-4-Amino-3-(4-chlorophenyl)butanoic Acid",
                        "(R) 4-Amino-3-(4-Chlorophenyl)Butanoic Acid",
                        "(R)-4-amino-3-(4-chlorophenyl)butan-oic acid"
                    ],
                    "PUBCHEM.COMPOUND:45038188": [
                        "Baclofen-d4"
                    ]
                }
            },
            {
                "label": "may also be of some value in",
                "id": {}
            },
            {
                "label": "patients with spinal cord injuries",
                "id": {
                    "UMLS:C4710844": [
                        "Monitor trends in serum levels of calcium (e.g., ionized calcium) in at risk populations (e.g., patients with malignancies, hyperparathyroidism, prolonged immobilization in severe or multiple fractures or spinal cord injuries)"
                    ]
                }
            }
        ],
        [
            {
                "label": "Baclofen",
                "id": {
                    "UMLS:C0004609": [
                        "baclofen",
                        "Baclofen",
                        "BACLOFEN",
                        "Baclofeno",
                        "Baclofenum",
                        "Baclofen (substance)",
                        "baclofen (medication)",
                        "Baclofen-containing product",
                        "Product containing baclofen (medicinal product)",
                        "Ba34647",
                        "BA34647",
                        "Liorésal",
                        "Ba-34647",
                        "PCP-GABA",
                        "lioresal",
                        "Lioresal",
                        "Ba34,647",
                        "Ba-34,647",
                        "baclophen",
                        "Baclofène",
                        "Baclophen",
                        "CIBA34,647BA",
                        "CIBA-34,647-BA",
                        "Chlorophenyl GABA",
                        "GABA, Chlorophenyl",
                        "beta-(4-Chlorophenyl)gaba",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "4-Amino-3-(4-chlorophenyl)-butanoic Acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric Acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-"
                    ],
                    "PUBCHEM.COMPOUND:2284": [
                        "baclofen",
                        "baclofen",
                        "Baclofen",
                        "BACLOFEN",
                        "baclofene",
                        "Baclofeno",
                        "Baclofene",
                        "baclofeno",
                        "Baclofeno",
                        "Baclofenum",
                        "Baclofenum",
                        "baclofenum",
                        "DL-Baclofen",
                        "DL-Baclofen",
                        "apo-Baclofen",
                        "Baclofen awd",
                        "apo Baclofen",
                        "Gen-baclofen",
                        "Gen baclofen",
                        "PMS Baclofen",
                        "PMS-Baclofen",
                        "(+-)-Baclofen",
                        "(+-)-Baclofen",
                        "AWD, baclofen",
                        "baclofen zwitterion",
                        "Baclofen isis brand",
                        "Baclofen irex brand",
                        "Baclofen zwitterion",
                        "Baclofen (substance)",
                        "Baclofen athena brand",
                        "Baclofen apotex brand",
                        "baclofen (medication)",
                        "Isis brand OF baclofen",
                        "Irex brand OF baclofen",
                        "Baclofen nu-pharm brand",
                        "Baclofen novartis brand",
                        "Athena brand OF baclofen",
                        "Baclofen medtronic brand",
                        "Baclofen ashbourne brand",
                        "Apotex brand OF baclofen",
                        "Baclofen ciba-geigy brand",
                        "Baclofen alphapharm brand",
                        "Nu pharm brand OF baclofen",
                        "Novartis brand OF baclofen",
                        "Nu-pharm brand OF baclofen",
                        "Baclofen-containing product",
                        "Medtronic brand OF baclofen",
                        "Ashbourne brand OF baclofen",
                        "Ciba-geigy brand OF baclofen",
                        "Alphapharm brand OF baclofen",
                        "Baclofen pharmascience brand",
                        "Ciba geigy brand OF baclofen",
                        "ASTA medica brand OF baclofen",
                        "Pharmascience brand OF baclofen",
                        "Product containing baclofen (medicinal product)",
                        "Lebic",
                        "Clofen",
                        "Kemstro",
                        "Atrofen",
                        "NuBaclo",
                        "PCP-GABA",
                        "Nu baclo",
                        "Nu-baclo",
                        "Genpharm",
                        "PCP-GABA",
                        "Lioresal",
                        "baclophen",
                        "Baclofène",
                        "Baclophen",
                        "Baclophen",
                        "Baclospas",
                        "GenBaclofen",
                        "ApoBaclofen",
                        "PMSBaclofen",
                        "CIBA34,647ba",
                        "BaclofèneIrex",
                        "CIBA-34,647-ba",
                        "Baclofène-irex",
                        "Baclofène irex",
                        "Chlorophenyl gaba",
                        "Chlorophenyl GABA",
                        "GABA, Chlorophenyl",
                        "GABA, chlorophenyl",
                        "Β-(4-chlorophenyl)gaba",
                        "b-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "beta-(4-Chlorophenyl)gaba",
                        "g-Amino-b-(p-chlorophenyl)butyrate",
                        "b-(p-Chlorophenyl)-g-aminobutyrate",
                        "4-Amino-3-(4-chlorophenyl)butyrate",
                        "Γ-amino-β-(p-chlorophenyl)butyrate",
                        "Β-(p-chlorophenyl)-γ-aminobutyrate",
                        "DL-4-Amino-3-p-chlorophenylbutanoate",
                        "b-(Aminomethyl)-p-chlorohydrocinnamate",
                        "g-Amino-b-(p-chlorophenyl)butyric acid",
                        "Γ-amino-β-(p-chlorophenyl)butyric acid",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "Β-(aminomethyl)-p-chlorohydrocinnamate",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "b-(p-Chlorophenyl)-g-aminobutyric acid",
                        "4-Amino-3-(4-chlorophenyl)butyric acid",
                        "Β-(p-chlorophenyl)-γ-aminobutyric acid",
                        "4-amino-3-(4-chlorophenyl)butanoic acid",
                        "DL-4-Amino-3-p-chlorophenylbutanoic acid",
                        "4-Amino-3-(4-chlorophenyl)-butanoic Acid",
                        "DL-4-Amino-3-p-chlorophenylbutanoic acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyrate",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamate",
                        "gamma-Amino-beta-(p-chlorophenyl)butyrate",
                        "Β-(aminomethyl)-4-chlorobenzenepropanoate",
                        "b-(Aminomethyl)-4-chlorobenzenepropanoate",
                        "b-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "Β-(aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoate",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "b-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Β-(aminomethyl)-4-chlorobenzenepropanoic acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(p-Chlorophenyl)-gamma-aminobutyric Acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "gamma-Amino-beta-(p-chlorophenyl)butyric acid",
                        "beta-(Aminomethyl)-p-chlorohydrocinnamic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic Acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "beta-(Aminomethyl)-4-chlorobenzenepropanoic acid",
                        "Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-"
                    ],
                    "UNII:3OHN4989XM": [
                        "L-Baclofen",
                        "(S)-Baclofen",
                        "BACLOFEN, (S)-",
                        "Baclofen, (S)-",
                        "CHEMBL302213",
                        "(S) 4-Amino-3-(4-Chlorophenyl)Butanoic Acid"
                    ],
                    "PUBCHEM.COMPOUND:44602": [
                        "d-Baclofen",
                        "Baclofen R-",
                        "(-)-baclofen",
                        "(R)-Baclofen",
                        "(R)-(-)-Baclofen",
                        "[<sup>3</sup>H](R)-(-)-baclofen",
                        "ARBACLOFEN",
                        "Arbaclofen",
                        "CID 6918881",
                        "(R)-4-Amino-3-(4-chlorophenyl)butanoic Acid",
                        "(R) 4-Amino-3-(4-Chlorophenyl)Butanoic Acid",
                        "(R)-4-amino-3-(4-chlorophenyl)butan-oic acid"
                    ],
                    "PUBCHEM.COMPOUND:45038188": [
                        "Baclofen-d4"
                    ]
                }
            },
            {
                "label": "may also be of some value in",
                "id": {}
            },
            {
                "label": "patients with other spinal cord diseases",
                "id": {}
            }
        ]
    ],
    "Mirtazapine tablets, USP are indicated for the treatment of major depressive disorder.": [
        [
            {
                "label": "Mirtazapine tablets, USP",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of major depressive disorder",
                "id": {}
            }
        ]
    ],
    "Hydrocodone Bitartrate Extended-Release Capsules are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.": [
        [
            {
                "label": "Hydrocodone Bitartrate Extended-Release Capsules",
                "id": {
                    "UMLS:C4720065": [
                        "Hydrocodone Bitartrate Extended-Release Capsules"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment",
                "id": {}
            }
        ],
        [
            {
                "label": "Hydrocodone Bitartrate Extended-Release Capsules",
                "id": {
                    "UMLS:C4720065": [
                        "Hydrocodone Bitartrate Extended-Release Capsules"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "which alternative treatment options are inadequate",
                "id": {}
            }
        ]
    ],
    "Carisoprodol Tablets are indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults.": [
        [
            {
                "label": "Carisoprodol Tablets",
                "id": {
                    "UMLS:C1245329": [
                        "Carisoprodol Tablets",
                        "carisoprodol Oral Tablet"
                    ],
                    "UMLS:C1248524": [
                        "Carisoprodol and Aspirin Tablets",
                        "aspirin / carisoprodol Oral Tablet"
                    ],
                    "UMLS:C4719799": [
                        "Carisoprodol, Aspirin, and Codeine Phosphate Tablets"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the relief of discomfort associated with acute, painful musculoskeletal conditions in adults",
                "id": {}
            }
        ]
    ],
    "Ropinirole tablets are indicated for the treatment of Parkinson’s disease": [
        [
            {
                "label": "Ropinirole tablets",
                "id": {
                    "UMLS:C1247870": [
                        "Ropinirole Tablets",
                        "rOPINIRole Oral Tablet",
                        "ropinirole Oral Tablet"
                    ],
                    "UMLS:C2344623": [
                        "Ropinirole Extended-Release Tablets",
                        "ropinirole Extended Release Oral Tablet",
                        "rOPINIRole Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of Parkinson’s disease",
                "id": {}
            }
        ]
    ],
    "Ropinirole tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).": [
        [
            {
                "label": "Ropinirole tablets",
                "id": {
                    "UMLS:C1247870": [
                        "Ropinirole Tablets",
                        "rOPINIRole Oral Tablet",
                        "ropinirole Oral Tablet"
                    ],
                    "UMLS:C2344623": [
                        "Ropinirole Extended-Release Tablets",
                        "ropinirole Extended Release Oral Tablet",
                        "rOPINIRole Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS)",
                "id": {}
            }
        ]
    ],
    "Methocarbamol tablets, USP are indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions.": [
        [
            {
                "label": "Methocarbamol tablets, USP",
                "id": {
                    "UMLS:C0689533": [
                        "METHOCARBAMOL 500 mg ORAL TABLET, FILM COATED [Methocarbamol Tablets, USP, 500 mg]",
                        "Methocarb 500-EZS KIT",
                        "METHOCARBAMOL 500MG TAB",
                        "Methocarbamol 500mg Oral tablet",
                        "methocarbamol 500 MG Oral Tablet",
                        "methocarbamol 500 mg oral tablet",
                        "METHOCARBAMOL 500 mg ORAL TABLET",
                        "Methocarbamol 500 mg oral tablet",
                        "methocarbamol@500 mg@ORAL@TABLET",
                        "Methocarbamol 500 MG Oral Tablet",
                        "methocarbamol 500 mg ORAL TABLET",
                        "Methocarbamol, 500 mg oral tablet",
                        "METHOCARBAMOL 500 mg ORAL TABLET, COATED",
                        "METHOCARBAMOL 500 mg ORAL TABLET, FILM COATED",
                        "Methocarbamol 500 mg ORAL TABLET, FILM COATED",
                        "METHOCARBAMOL 500 mg ORAL TABLET [Methocarbamol]",
                        "Methocarbamol 500 mg ORAL TABLET [Methocarbamol]",
                        "METHOCARBAMOL 500 mg ORAL TABLET, COATED [Methocarbamol]",
                        "Product containing precisely methocarbamol 500 milligram/1 each conventional release oral tablet (clinical drug)"
                    ],
                    "UMLS:C0689534": [
                        "METHOCARBAMOL 750 mg ORAL TABLET, FILM COATED [Methocarbamol Tablets, USP, 750 mg]",
                        "METHOCARBAMOL 750MG TAB",
                        "Methocarbamol 750mg tablet",
                        "Methocarbamol 750mg Oral tablet",
                        "Methocarbamol 750 MG Oral Tablet",
                        "methocarbamol 750 mg oral tablet",
                        "methocarbamol@750 mg@ORAL@TABLET",
                        "methocarbamol 750 mg ORAL TABLET",
                        "methocarbamol 750 MG Oral Tablet",
                        "METHOCARBAMOL 750 mg ORAL TABLET",
                        "Methocarbamol 750 mg oral tablet",
                        "Methocarbamol, 750 mg oral tablet",
                        "METHOCARBAMOL 750 mg ORAL TABLET, COATED",
                        "Methocarbamol 750 mg ORAL TABLET, FILM COATED",
                        "METHOCARBAMOL 750 mg ORAL TABLET, FILM COATED",
                        "METHOCARBAMOL 750 mg ORAL TABLET [Methocarbamol]",
                        "Methocarbamol 750 mg ORAL TABLET [Methocarbamol]",
                        "METHOCARBAMOL 750 mg ORAL TABLET, COATED [Methocarbamol]",
                        "Product containing precisely methocarbamol 750 milligram/1 each conventional release oral tablet (clinical drug)"
                    ]
                }
            },
            {
                "label": "are indicated",
                "id": {
                    "UMLS:C1548408": [
                        "The indicated time slot(s) is(are) blocked"
                    ],
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C0514907": [
                        "Provide input in areas of strength and development needs, as indicated"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4714006": [
                        "Activate the rapid response team if indicated by presence of trigger areas, per agency protocol"
                    ]
                }
            },
            {
                "label": "as an adjunct to rest",
                "id": {}
            }
        ],
        [
            {
                "label": "Methocarbamol tablets, USP",
                "id": {
                    "UMLS:C0689533": [
                        "METHOCARBAMOL 500 mg ORAL TABLET, FILM COATED [Methocarbamol Tablets, USP, 500 mg]",
                        "Methocarb 500-EZS KIT",
                        "METHOCARBAMOL 500MG TAB",
                        "Methocarbamol 500mg Oral tablet",
                        "methocarbamol 500 MG Oral Tablet",
                        "methocarbamol 500 mg oral tablet",
                        "METHOCARBAMOL 500 mg ORAL TABLET",
                        "Methocarbamol 500 mg oral tablet",
                        "methocarbamol@500 mg@ORAL@TABLET",
                        "Methocarbamol 500 MG Oral Tablet",
                        "methocarbamol 500 mg ORAL TABLET",
                        "Methocarbamol, 500 mg oral tablet",
                        "METHOCARBAMOL 500 mg ORAL TABLET, COATED",
                        "METHOCARBAMOL 500 mg ORAL TABLET, FILM COATED",
                        "Methocarbamol 500 mg ORAL TABLET, FILM COATED",
                        "METHOCARBAMOL 500 mg ORAL TABLET [Methocarbamol]",
                        "Methocarbamol 500 mg ORAL TABLET [Methocarbamol]",
                        "METHOCARBAMOL 500 mg ORAL TABLET, COATED [Methocarbamol]",
                        "Product containing precisely methocarbamol 500 milligram/1 each conventional release oral tablet (clinical drug)"
                    ],
                    "UMLS:C0689534": [
                        "METHOCARBAMOL 750 mg ORAL TABLET, FILM COATED [Methocarbamol Tablets, USP, 750 mg]",
                        "METHOCARBAMOL 750MG TAB",
                        "Methocarbamol 750mg tablet",
                        "Methocarbamol 750mg Oral tablet",
                        "Methocarbamol 750 MG Oral Tablet",
                        "methocarbamol 750 mg oral tablet",
                        "methocarbamol@750 mg@ORAL@TABLET",
                        "methocarbamol 750 mg ORAL TABLET",
                        "methocarbamol 750 MG Oral Tablet",
                        "METHOCARBAMOL 750 mg ORAL TABLET",
                        "Methocarbamol 750 mg oral tablet",
                        "Methocarbamol, 750 mg oral tablet",
                        "METHOCARBAMOL 750 mg ORAL TABLET, COATED",
                        "Methocarbamol 750 mg ORAL TABLET, FILM COATED",
                        "METHOCARBAMOL 750 mg ORAL TABLET, FILM COATED",
                        "METHOCARBAMOL 750 mg ORAL TABLET [Methocarbamol]",
                        "Methocarbamol 750 mg ORAL TABLET [Methocarbamol]",
                        "METHOCARBAMOL 750 mg ORAL TABLET, COATED [Methocarbamol]",
                        "Product containing precisely methocarbamol 750 milligram/1 each conventional release oral tablet (clinical drug)"
                    ]
                }
            },
            {
                "label": "are an adjunct to",
                "id": {}
            },
            {
                "label": "physical therapy",
                "id": {
                    "UMLS:C0949766": [
                        "Physical Therapy",
                        "Therapy;physical",
                        "Physical therapy",
                        "PHYSICAL THERAPY",
                        "physical therapy",
                        "therapy physical",
                        "physical; therapy",
                        "therapy; physical",
                        "Therapy, Physical",
                        "Physical Therapy Service",
                        "procedure physical therapy",
                        "Physical therapy procedure",
                        "physical technique therapy",
                        "Physical therapy treatment",
                        "Physical Therapy Procedure",
                        "physical therapy treatment",
                        "treatment physical therapy",
                        "physical procedures therapy",
                        "physical therapy techniques",
                        "physical therapy treatments",
                        "Physical therapy procedure, NOS",
                        "Physical Therapy - Physiotherapy",
                        "Physical Therapy Service (treatment)",
                        "RNAx perform physical therapy service",
                        "Physical therapy procedure (regime/therapy)",
                        "RNAx perform physical therapy service (treatment)",
                        "PT",
                        "Physiotherapy",
                        "physiotherapy",
                        "physiotherapies",
                        "PT - Physiotherapy",
                        "Physical Therapies",
                        "physical therapies",
                        "Physiotherapy, NOS",
                        "Physiatric Procedure",
                        "Physical Therapeutics",
                        "Physiotherapy Procedure",
                        "Physiotherapy procedure",
                        "physiotherapy techniques",
                        "Physical Therapist Service",
                        "Physical Medicine Procedure",
                        "Physiotherapy procedure, NOS",
                        "RNIx physical therapist service",
                        "Physical medicine - physiatric service",
                        "Physical medicine - physiatric procedure",
                        "RNIx physical therapist service (treatment)"
                    ],
                    "UMLS:C1547999": [
                        "Physical Therapy",
                        "Diagnostic Service Section ID - Physical Therapy"
                    ],
                    "UMLS:C0007235": [
                        "Physical therapy NEC",
                        "Physical therapy NEC in ICD9CM_2014",
                        "Care involving other physical therapy"
                    ],
                    "UMLS:C0553651": [
                        "Physical therapy NEC",
                        "Other physical therapy",
                        "PHYSICAL THERAPY NEC in ICD9CM"
                    ],
                    "UMLS:C3669033": [
                        "Physical Therapy Mud",
                        "Mud"
                    ]
                }
            }
        ],
        [
            {
                "label": "Methocarbamol tablets, USP",
                "id": {
                    "UMLS:C0689533": [
                        "METHOCARBAMOL 500 mg ORAL TABLET, FILM COATED [Methocarbamol Tablets, USP, 500 mg]",
                        "Methocarb 500-EZS KIT",
                        "METHOCARBAMOL 500MG TAB",
                        "Methocarbamol 500mg Oral tablet",
                        "methocarbamol 500 MG Oral Tablet",
                        "methocarbamol 500 mg oral tablet",
                        "METHOCARBAMOL 500 mg ORAL TABLET",
                        "Methocarbamol 500 mg oral tablet",
                        "methocarbamol@500 mg@ORAL@TABLET",
                        "Methocarbamol 500 MG Oral Tablet",
                        "methocarbamol 500 mg ORAL TABLET",
                        "Methocarbamol, 500 mg oral tablet",
                        "METHOCARBAMOL 500 mg ORAL TABLET, COATED",
                        "METHOCARBAMOL 500 mg ORAL TABLET, FILM COATED",
                        "Methocarbamol 500 mg ORAL TABLET, FILM COATED",
                        "METHOCARBAMOL 500 mg ORAL TABLET [Methocarbamol]",
                        "Methocarbamol 500 mg ORAL TABLET [Methocarbamol]",
                        "METHOCARBAMOL 500 mg ORAL TABLET, COATED [Methocarbamol]",
                        "Product containing precisely methocarbamol 500 milligram/1 each conventional release oral tablet (clinical drug)"
                    ],
                    "UMLS:C0689534": [
                        "METHOCARBAMOL 750 mg ORAL TABLET, FILM COATED [Methocarbamol Tablets, USP, 750 mg]",
                        "METHOCARBAMOL 750MG TAB",
                        "Methocarbamol 750mg tablet",
                        "Methocarbamol 750mg Oral tablet",
                        "Methocarbamol 750 MG Oral Tablet",
                        "methocarbamol 750 mg oral tablet",
                        "methocarbamol@750 mg@ORAL@TABLET",
                        "methocarbamol 750 mg ORAL TABLET",
                        "methocarbamol 750 MG Oral Tablet",
                        "METHOCARBAMOL 750 mg ORAL TABLET",
                        "Methocarbamol 750 mg oral tablet",
                        "Methocarbamol, 750 mg oral tablet",
                        "METHOCARBAMOL 750 mg ORAL TABLET, COATED",
                        "Methocarbamol 750 mg ORAL TABLET, FILM COATED",
                        "METHOCARBAMOL 750 mg ORAL TABLET, FILM COATED",
                        "METHOCARBAMOL 750 mg ORAL TABLET [Methocarbamol]",
                        "Methocarbamol 750 mg ORAL TABLET [Methocarbamol]",
                        "METHOCARBAMOL 750 mg ORAL TABLET, COATED [Methocarbamol]",
                        "Product containing precisely methocarbamol 750 milligram/1 each conventional release oral tablet (clinical drug)"
                    ]
                }
            },
            {
                "label": "are an adjunct to",
                "id": {}
            },
            {
                "label": "other measures",
                "id": {
                    "UMLS:C0496637": [
                        "Need for other prophylactic measures"
                    ],
                    "UMLS:C0481565": [
                        "Other specified prophylactic measures"
                    ],
                    "UMLS:C4270761": [
                        "Encounter for other prophylactic measures"
                    ],
                    "UMLS:C4062932": [
                        "Infant unresponsive to other comfort measures"
                    ],
                    "UMLS:C0841577": [
                        "Other diagnostic tests, measures or investigations"
                    ]
                }
            }
        ],
        [
            {
                "label": "other measures",
                "id": {
                    "UMLS:C0496637": [
                        "Need for other prophylactic measures"
                    ],
                    "UMLS:C0481565": [
                        "Other specified prophylactic measures"
                    ],
                    "UMLS:C4270761": [
                        "Encounter for other prophylactic measures"
                    ],
                    "UMLS:C4062932": [
                        "Infant unresponsive to other comfort measures"
                    ],
                    "UMLS:C0841577": [
                        "Other diagnostic tests, measures or investigations"
                    ]
                }
            },
            {
                "label": "for the relief of",
                "id": {
                    "UMLS:C2224814": [
                        "bronchoscopy for relief of stenosis by stent placement in the trachea",
                        "bronchoscopy for relief of stenosis by stent in trachea",
                        "bronchoscopy for relief of stenosis by stent in trachea (treatment)"
                    ],
                    "UMLS:C2224815": [
                        "bronchoscopy for relief of stenosis by stent placement in the bronchus",
                        "bronchoscopy for relief of stenosis by stent in bronchus",
                        "bronchoscopy for relief of stenosis by stent in bronchus (treatment)"
                    ],
                    "UMLS:C1609560": [
                        "Use of anti-inflammatory or analgesic over-the-counter (otc) medications for symptom relief assessed (oa)",
                        "Use of anti-inflammatory or analgesic over-the-counter (OTC) medications for symptom relief assessed (OA)",
                        "ANTI-INFLM/ANLGSC OTC ASSESS",
                        "Anti-inflm/anlgsc otc assess",
                        "ANTI-INFLAMMATORY/ANALGESIC SYMPTOM RELIEF ASSES"
                    ],
                    "UMLS:C4709643": [
                        "Instruct patient and family about the use of analgesics, strategies to decrease side effects, and expectations for involvement in decisions about pain relief"
                    ]
                }
            },
            {
                "label": "discomfort",
                "id": {
                    "NCIT:C50535": [
                        "Discomfort",
                        "DISCOMFORT",
                        "discomfort",
                        "discomforts",
                        "Discomfort NOS",
                        "body discomfort",
                        "Discomfort, NOS",
                        "sensory discomfort",
                        "Discomfort (finding)"
                    ],
                    "UMLS:C0859235": [
                        "leg discomfort",
                        "Leg discomfort",
                        "discomfort leg",
                        "Lower extremities discomfort",
                        "Lower extremities ill feeling of"
                    ],
                    "UMLS:C0948595": [
                        "Eye discomfort",
                        "Ocular discomfort"
                    ],
                    "UMLS:C0877610": [
                        "arm discomfort",
                        "Arm discomfort"
                    ],
                    "UMLS:C0948296": [
                        "ear discomfort",
                        "discomfort ear",
                        "Ear discomfort",
                        "discomfort ears"
                    ]
                }
            }
        ],
        [
            {
                "label": "discomfort",
                "id": {
                    "NCIT:C50535": [
                        "Discomfort",
                        "DISCOMFORT",
                        "discomfort",
                        "discomforts",
                        "Discomfort NOS",
                        "body discomfort",
                        "Discomfort, NOS",
                        "sensory discomfort",
                        "Discomfort (finding)"
                    ],
                    "UMLS:C0859235": [
                        "leg discomfort",
                        "Leg discomfort",
                        "discomfort leg",
                        "Lower extremities discomfort",
                        "Lower extremities ill feeling of"
                    ],
                    "UMLS:C0948595": [
                        "Eye discomfort",
                        "Ocular discomfort"
                    ],
                    "UMLS:C0877610": [
                        "arm discomfort",
                        "Arm discomfort"
                    ],
                    "UMLS:C0948296": [
                        "ear discomfort",
                        "discomfort ear",
                        "Ear discomfort",
                        "discomfort ears"
                    ]
                }
            },
            {
                "label": "associated with",
                "id": {
                    "UMLS:C0332281": [
                        "associated with",
                        "ASSOCIATED WITH",
                        "Associated with",
                        "Associated with (attribute)",
                        "AW",
                        "ASSOC",
                        "associated",
                        "Associated",
                        "associating"
                    ],
                    "UMLS:C1608982": [
                        "Associated with (APAH)"
                    ],
                    "UMLS:C2029691": [
                        "headache associated with",
                        "headache associated",
                        "headache associated factor",
                        "headache associated factor (symptom)"
                    ],
                    "HP:0033705": [
                        "Crying associated with mood",
                        "Crying associated with emotion",
                        "Crying associated with mood (finding)",
                        "weep",
                        "Weepy",
                        "Weeps",
                        "weepy",
                        "weeping",
                        "tearful",
                        "WEEPING",
                        "Weeping",
                        "Tearful",
                        "Weepiness",
                        "weepiness",
                        "Tearfulness",
                        "affect tearful",
                        "tearful (physical finding)"
                    ],
                    "NCBIGene:23077": [
                        "PROTEIN ASSOCIATED WITH MYC",
                        "PAM",
                        "PAM",
                        "PHR1",
                        "PHR1",
                        "MYCBP2",
                        "FLJ10106",
                        "KIAA0916",
                        "FLJ10106",
                        "KIAA0916",
                        "MYCBP2 gene",
                        "MYCBP2 Gene",
                        "MYC-BINDING PROTEIN 2",
                        "MYC binding protein 2",
                        "MYC Binding Protein 2 Gene",
                        "PAM/Highwire/RPM-1 protein 1",
                        "PAM/Highwire/RPM-1 protein 1",
                        "MYC binding protein 2, E3 ubiquitin protein ligase"
                    ]
                }
            },
            {
                "label": "acute, painful musculoskeletal conditions",
                "id": {}
            }
        ]
    ],
    "Oxcarbazepine oral suspension is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures": [
        [
            {
                "label": "Oxcarbazepine oral suspension",
                "id": {
                    "UMLS:C1249301": [
                        "Oxcarbazepine Oral Suspension",
                        "OXcarbazepine Oral Suspension",
                        "oxcarbazepine Oral Suspension"
                    ],
                    "UMLS:C0937594": [
                        "oxcarbazepine 60 MG/ML Oral Suspension",
                        "OXcarbazepine 60 MG/ML Oral Suspension",
                        "Oxcarbazepine 60 mg/mL oral suspension",
                        "Oxcarbazepine 300mg/5mL Oral suspension",
                        "Oxcarbazepine 300 MG/5 ML Oral Suspension",
                        "OXcarbazepine 300 mg/5 mL oral suspension",
                        "Oxcarbazepine, 300 mg/5 mL oral suspension",
                        "Oxcarbazepine 300 mg in 5 mL ORAL SUSPENSION",
                        "OXCARBAZEPINE 300 mg in 5 mL ORAL SUSPENSION",
                        "OXCARBAZEPINE 60 mg in 1 mL ORAL SUSPENSION [Oxcarbazepine]",
                        "OXCARBAZEPINE 300 mg in 5 mL ORAL SUSPENSION [Oxcarbazepine]",
                        "oxcarbazepine 300 mg/5 mL (60 mg/mL) ORAL SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "oxcarbazepine@300 mg/5 mL (60 mg/mL)@ORAL@SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "Product containing precisely oxcarbazepine 60 milligram/1 milliliter conventional release oral suspension (clinical drug)",
                        "OXCARBAZEPINE 300MG/5ML SUSP",
                        "oxacarbazepine 300 MG in 5 mL Oral Suspension",
                        "oxacarbazepine 300 MG per 5 ML Oral Suspension"
                    ],
                    "UMLS:C1239822": [
                        "OXcarbazepine Oral Suspension [Trileptal]",
                        "oxcarbazepine Oral Suspension [Trileptal]"
                    ],
                    "UMLS:C1169605": [
                        "oxcarbazepine 60 MG/ML Oral Suspension [Trileptal]",
                        "OXcarbazepine 60 MG/ML Oral Suspension [Trileptal]",
                        "Oxcarbazepine 300 MG/5 ML Oral Suspension [TRILEPTAL]",
                        "OXCARBAZEPINE 60 mg in 1 mL ORAL SUSPENSION [Trileptal]",
                        "Trileptal 300mg/5ml Suspension",
                        "Trileptal 60 MG/ML Oral Suspension",
                        "Trileptal, 300 mg/5 mL oral suspension",
                        "Trileptal 300 MG in 5 mL Oral Suspension",
                        "Trileptal 300 MG per 5 ML Oral Suspension"
                    ]
                }
            },
            {
                "label": "is indicated for use as",
                "id": {
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "monotherapy in the treatment of partial-onset seizures in adults",
                "id": {}
            }
        ],
        [
            {
                "label": "Oxcarbazepine oral suspension",
                "id": {
                    "UMLS:C1249301": [
                        "Oxcarbazepine Oral Suspension",
                        "OXcarbazepine Oral Suspension",
                        "oxcarbazepine Oral Suspension"
                    ],
                    "UMLS:C0937594": [
                        "oxcarbazepine 60 MG/ML Oral Suspension",
                        "OXcarbazepine 60 MG/ML Oral Suspension",
                        "Oxcarbazepine 60 mg/mL oral suspension",
                        "Oxcarbazepine 300mg/5mL Oral suspension",
                        "Oxcarbazepine 300 MG/5 ML Oral Suspension",
                        "OXcarbazepine 300 mg/5 mL oral suspension",
                        "Oxcarbazepine, 300 mg/5 mL oral suspension",
                        "Oxcarbazepine 300 mg in 5 mL ORAL SUSPENSION",
                        "OXCARBAZEPINE 300 mg in 5 mL ORAL SUSPENSION",
                        "OXCARBAZEPINE 60 mg in 1 mL ORAL SUSPENSION [Oxcarbazepine]",
                        "OXCARBAZEPINE 300 mg in 5 mL ORAL SUSPENSION [Oxcarbazepine]",
                        "oxcarbazepine 300 mg/5 mL (60 mg/mL) ORAL SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "oxcarbazepine@300 mg/5 mL (60 mg/mL)@ORAL@SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "Product containing precisely oxcarbazepine 60 milligram/1 milliliter conventional release oral suspension (clinical drug)",
                        "OXCARBAZEPINE 300MG/5ML SUSP",
                        "oxacarbazepine 300 MG in 5 mL Oral Suspension",
                        "oxacarbazepine 300 MG per 5 ML Oral Suspension"
                    ],
                    "UMLS:C1239822": [
                        "OXcarbazepine Oral Suspension [Trileptal]",
                        "oxcarbazepine Oral Suspension [Trileptal]"
                    ],
                    "UMLS:C1169605": [
                        "oxcarbazepine 60 MG/ML Oral Suspension [Trileptal]",
                        "OXcarbazepine 60 MG/ML Oral Suspension [Trileptal]",
                        "Oxcarbazepine 300 MG/5 ML Oral Suspension [TRILEPTAL]",
                        "OXCARBAZEPINE 60 mg in 1 mL ORAL SUSPENSION [Trileptal]",
                        "Trileptal 300mg/5ml Suspension",
                        "Trileptal 60 MG/ML Oral Suspension",
                        "Trileptal, 300 mg/5 mL oral suspension",
                        "Trileptal 300 MG in 5 mL Oral Suspension",
                        "Trileptal 300 MG per 5 ML Oral Suspension"
                    ]
                }
            },
            {
                "label": "is indicated for use as",
                "id": {
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "adjunctive therapy in the treatment of partial-onset seizures in adults",
                "id": {}
            }
        ],
        [
            {
                "label": "Oxcarbazepine oral suspension",
                "id": {
                    "UMLS:C1249301": [
                        "Oxcarbazepine Oral Suspension",
                        "OXcarbazepine Oral Suspension",
                        "oxcarbazepine Oral Suspension"
                    ],
                    "UMLS:C0937594": [
                        "oxcarbazepine 60 MG/ML Oral Suspension",
                        "OXcarbazepine 60 MG/ML Oral Suspension",
                        "Oxcarbazepine 60 mg/mL oral suspension",
                        "Oxcarbazepine 300mg/5mL Oral suspension",
                        "Oxcarbazepine 300 MG/5 ML Oral Suspension",
                        "OXcarbazepine 300 mg/5 mL oral suspension",
                        "Oxcarbazepine, 300 mg/5 mL oral suspension",
                        "Oxcarbazepine 300 mg in 5 mL ORAL SUSPENSION",
                        "OXCARBAZEPINE 300 mg in 5 mL ORAL SUSPENSION",
                        "OXCARBAZEPINE 60 mg in 1 mL ORAL SUSPENSION [Oxcarbazepine]",
                        "OXCARBAZEPINE 300 mg in 5 mL ORAL SUSPENSION [Oxcarbazepine]",
                        "oxcarbazepine 300 mg/5 mL (60 mg/mL) ORAL SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "oxcarbazepine@300 mg/5 mL (60 mg/mL)@ORAL@SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "Product containing precisely oxcarbazepine 60 milligram/1 milliliter conventional release oral suspension (clinical drug)",
                        "OXCARBAZEPINE 300MG/5ML SUSP",
                        "oxacarbazepine 300 MG in 5 mL Oral Suspension",
                        "oxacarbazepine 300 MG per 5 ML Oral Suspension"
                    ],
                    "UMLS:C1239822": [
                        "OXcarbazepine Oral Suspension [Trileptal]",
                        "oxcarbazepine Oral Suspension [Trileptal]"
                    ],
                    "UMLS:C1169605": [
                        "oxcarbazepine 60 MG/ML Oral Suspension [Trileptal]",
                        "OXcarbazepine 60 MG/ML Oral Suspension [Trileptal]",
                        "Oxcarbazepine 300 MG/5 ML Oral Suspension [TRILEPTAL]",
                        "OXCARBAZEPINE 60 mg in 1 mL ORAL SUSPENSION [Trileptal]",
                        "Trileptal 300mg/5ml Suspension",
                        "Trileptal 60 MG/ML Oral Suspension",
                        "Trileptal, 300 mg/5 mL oral suspension",
                        "Trileptal 300 MG in 5 mL Oral Suspension",
                        "Trileptal 300 MG per 5 ML Oral Suspension"
                    ]
                }
            },
            {
                "label": "is indicated for use as",
                "id": {
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above",
                "id": {}
            }
        ],
        [
            {
                "label": "Oxcarbazepine oral suspension",
                "id": {
                    "UMLS:C1249301": [
                        "Oxcarbazepine Oral Suspension",
                        "OXcarbazepine Oral Suspension",
                        "oxcarbazepine Oral Suspension"
                    ],
                    "UMLS:C0937594": [
                        "oxcarbazepine 60 MG/ML Oral Suspension",
                        "OXcarbazepine 60 MG/ML Oral Suspension",
                        "Oxcarbazepine 60 mg/mL oral suspension",
                        "Oxcarbazepine 300mg/5mL Oral suspension",
                        "Oxcarbazepine 300 MG/5 ML Oral Suspension",
                        "OXcarbazepine 300 mg/5 mL oral suspension",
                        "Oxcarbazepine, 300 mg/5 mL oral suspension",
                        "Oxcarbazepine 300 mg in 5 mL ORAL SUSPENSION",
                        "OXCARBAZEPINE 300 mg in 5 mL ORAL SUSPENSION",
                        "OXCARBAZEPINE 60 mg in 1 mL ORAL SUSPENSION [Oxcarbazepine]",
                        "OXCARBAZEPINE 300 mg in 5 mL ORAL SUSPENSION [Oxcarbazepine]",
                        "oxcarbazepine 300 mg/5 mL (60 mg/mL) ORAL SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "oxcarbazepine@300 mg/5 mL (60 mg/mL)@ORAL@SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "Product containing precisely oxcarbazepine 60 milligram/1 milliliter conventional release oral suspension (clinical drug)",
                        "OXCARBAZEPINE 300MG/5ML SUSP",
                        "oxacarbazepine 300 MG in 5 mL Oral Suspension",
                        "oxacarbazepine 300 MG per 5 ML Oral Suspension"
                    ],
                    "UMLS:C1239822": [
                        "OXcarbazepine Oral Suspension [Trileptal]",
                        "oxcarbazepine Oral Suspension [Trileptal]"
                    ],
                    "UMLS:C1169605": [
                        "oxcarbazepine 60 MG/ML Oral Suspension [Trileptal]",
                        "OXcarbazepine 60 MG/ML Oral Suspension [Trileptal]",
                        "Oxcarbazepine 300 MG/5 ML Oral Suspension [TRILEPTAL]",
                        "OXCARBAZEPINE 60 mg in 1 mL ORAL SUSPENSION [Trileptal]",
                        "Trileptal 300mg/5ml Suspension",
                        "Trileptal 60 MG/ML Oral Suspension",
                        "Trileptal, 300 mg/5 mL oral suspension",
                        "Trileptal 300 MG in 5 mL Oral Suspension",
                        "Trileptal 300 MG per 5 ML Oral Suspension"
                    ]
                }
            },
            {
                "label": "is indicated for use as",
                "id": {
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures",
                "id": {}
            }
        ]
    ],
    "Pramipexole dihydrochloride tablets are indicated for the treatment of Parkinson’s disease.": [
        [
            {
                "label": "Pramipexole dihydrochloride tablets",
                "id": {
                    "UMLS:C4720056": [
                        "Pramipexole Dihydrochloride Extended-Release Tablets"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of Parkinson’s disease",
                "id": {}
            }
        ]
    ],
    "Pramipexole dihydrochloride tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).": [
        [
            {
                "label": "Pramipexole dihydrochloride tablets",
                "id": {
                    "UMLS:C4720056": [
                        "Pramipexole Dihydrochloride Extended-Release Tablets"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS)",
                "id": {}
            }
        ]
    ],
    "Atomoxetine capsules are indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).": [
        [
            {
                "label": "Atomoxetine capsules",
                "id": {
                    "UMLS:C1577882": [
                        "Atomoxetine Capsules",
                        "atomoxetine Oral Capsule"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)",
                "id": {}
            }
        ]
    ],
    "Vyvanse® is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).": [
        [
            {
                "label": "Vyvanse®",
                "id": {
                    "UMLS:C1876807": [
                        "Vyvanse"
                    ],
                    "PUBCHEM.COMPOUND:11597698": [
                        "Vyvanse",
                        "vyvanse",
                        "NRP104",
                        "Elvanse",
                        "NRP 104",
                        "NRP-104",
                        "lisdexamfetamine",
                        "LISDEXAMFETAMINE",
                        "Lisdexamfetamine",
                        "lisdexamphetamine",
                        "Lisdexamfetamine dimesylate",
                        "lisdexamfetamine dimesylate",
                        "Dimesylate, lisdexamfetamine",
                        "Lis dexamfetamine dimesylate",
                        "Lisdexamfetamine (substance)",
                        "Lis-dexamfetamine dimesylate",
                        "lisdexamfetamine (medication)",
                        "Dimesylate, lis-dexamfetamine",
                        "CNS stimulants lisdexamfetamine",
                        "Lisdexamfetamine-containing product",
                        "Product containing lisdexamfetamine (medicinal product)"
                    ],
                    "PUBCHEM.COMPOUND:42105518": [
                        "Vyvanse"
                    ],
                    "UMLS:C3241344": [
                        "Vyvanse Pill"
                    ],
                    "UMLS:C1948437": [
                        "Vyvanse 30mg Capsule",
                        "Vyvanse 30 MG Oral Capsule",
                        "Vyvanse, 30 mg oral capsule",
                        "Lisdexamfetamine Dimesylate 30 MG Oral Capsule [VYVANSE]",
                        "lisdexamfetamine dimesylate 30 MG Oral Capsule [Vyvanse]",
                        "LISDEXAMFETAMINE DIMESYLATE 30 mg ORAL CAPSULE [Vyvanse]"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of Attention Deficit Hyperactivity Disorder (ADHD)",
                "id": {}
            }
        ]
    ],
    "As an antiaggregant in antiplatelet therapy or for temporary relief of minor aches and pains.": [],
    "Trihexyphenidyl is indicated as an adjunct in the treatment of all forms of parkinsonism (postencephalitic, arteriosclerotic, and idiopathic).": [
        [
            {
                "label": "Trihexyphenidyl",
                "id": {
                    "PUBCHEM.COMPOUND:5572": [
                        "trihexyphenidyl",
                        "Trihexyphenidyl",
                        "TRIHEXYPHENIDYL",
                        "Trihexyphenidyle",
                        "Trihexyphenidylum",
                        "trihexyphenidyl HCl",
                        "Trihexyphenidyl (substance)",
                        "Trihexyphenidyl wyeth brand",
                        "trihexyphenidyl (medication)",
                        "trihexyphenidyl hydrochloride",
                        "Trihexyphenidyl hydrochloride",
                        "Wyeth brand OF trihexyphenidyl",
                        "Trihexyphenidyl-containing product",
                        "Trihexyphenidyl hydrochloride elixir",
                        "AHP brand OF trihexyphenidyl hydrochloride",
                        "Eisai brand OF trihexyphenidyl hydrochloride",
                        "Rugby brand OF trihexyphenidyl hydrochloride",
                        "Hexal brand OF trihexyphenidyl hydrochloride",
                        "Wyeth brand OF trihexyphenidyl hydrochloride",
                        "Apotex brand OF trihexyphenidyl hydrochloride",
                        "Lederle brand OF trihexyphenidyl hydrochloride",
                        "Schrein brand OF trihexyphenidyl hydrochloride",
                        "Cypress brand OF trihexyphenidyl hydrochloride",
                        "Aventis brand OF trihexyphenidyl hydrochloride",
                        "Psicofarma brand OF trihexyphenidyl hydrochloride",
                        "Liquipharm brand OF trihexyphenidyl hydrochloride",
                        "Product containing trihexyphenidyl (medicinal product)",
                        "Pharmaceutical associates brand OF trihexyphenidyl hydrochloride",
                        "Artane",
                        "Parkopan",
                        "Cyclodol",
                        "Hipokinon",
                        "Parkinane",
                        "benzhexol",
                        "Benzhexol",
                        "ApoTrihex",
                        "benzhexol",
                        "Benzhexol",
                        "Trihexane",
                        "apo Trihex",
                        "Apo-trihex",
                        "Triphenidyl",
                        "benzhexol HCl",
                        "trihexphenidyl",
                        "Trihexphenidyl",
                        "Trihexifenidilo",
                        "Trihexylphenidyl",
                        "Trihexyphénidyle",
                        "Trihexylphenizyl",
                        "Trihexylphenidyle",
                        "benzhexol hydrochloride",
                        "Trihexidyl hydrochloride",
                        "1-Piperidinepropanol, alpha-cyclohexyl-alpha-phenyl-"
                    ],
                    "PUBCHEM.COMPOUND:163322572": [
                        "Trihexyphenidyl-d5"
                    ],
                    "UMLS:C0003830": [
                        "TRIHEXYPHENIDYL HCL",
                        "trihexyphenidyl hcl",
                        "trihexyphenidyl HCl",
                        "trihexyphenidyl hydrochloride",
                        "TRIHEXYPHENIDYL HYDROCHLORIDE",
                        "Trihexyphenidyl hydrochloride",
                        "Trihexyphenidyl Hydrochloride",
                        "Trihexyphenidyl hydrochloride (substance)",
                        "trihexyphenidyl hydrochloride (medication)",
                        "Benzhexol hydrochloride",
                        "1-Piperidinepropanol, alpha-cyclohexyl-alpha-phenyl-, Hydrochloride"
                    ],
                    "PUBCHEM.COMPOUND:207843": [
                        "(R)-trihexyphenidyl",
                        "TRIHEXYPHENIDYL, (R)-",
                        "CHEMBL1356870"
                    ],
                    "PUBCHEM.COMPOUND:207845": [
                        "(s)-Trihexyphenidyl",
                        "TRIHEXYPHENIDYL, (S)-"
                    ]
                }
            },
            {
                "label": "is indicated as",
                "id": {
                    "UMLS:C4710292": [
                        "Assure that someone is oxygenating the patient and assisting with intubation, as indicated"
                    ],
                    "UMLS:C4713987": [
                        "Assure that the surgical site is marked with a permanent marker by the surgeon, as indicated"
                    ],
                    "UMLS:C4714380": [
                        "Perform targeted assessment of the system that is indicated by the history of present illness"
                    ],
                    "UMLS:C4711109": [
                        "Ensure that equipment is operational via trial run (i.e., assemble laryngoscope and check light bulb function), as indicated"
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ]
                }
            },
            {
                "label": "an adjunct in the treatment of all forms of parkinsonism (postencephalitic, arteriosclerotic, and idiopathic)",
                "id": {}
            }
        ]
    ],
    "It is often useful as adjuvant therapy when treating these forms of parkinsonism with levodopa.": [
        [
            {
                "label": "It",
                "id": {
                    "MGI:96598": [
                        "It"
                    ],
                    "PUBCHEM.COMPOUND:44298493": [
                        "IT",
                        "IT dipeptide",
                        "I-T",
                        "Ile-Thr",
                        "CHEMBL54609",
                        "I-T dipeptide",
                        "isoleucylthreonine",
                        "L-Isoleucyl-L-threonine",
                        "L-isoleucyl-L-threonine",
                        "isoleucine threonine dipeptide",
                        "(2S,3R)-2-{[(2S,3S)-2-amino-3-methylpentanoyl]amino}-3-hydroxybutanoic acid"
                    ],
                    "UMLS:C0677897": [
                        "IT",
                        "IT - Intrathecal route",
                        "intrathecal",
                        "Intrathecal",
                        "Intrathecal use",
                        "IntrathecalRoute",
                        "Intrathecal route",
                        "into the spinal space",
                        "Intrathecal route (qualifier value)",
                        "Intrathecal Route of Administration",
                        "Intrathecal Route of Drug Administration"
                    ],
                    "MONDO:0008558": [
                        "itp",
                        "ITP",
                        "ITP, NOS",
                        "ITP - Idiopat thrombocytop pur",
                        "ITP (immune thrombocytopenic purpura)",
                        "Idiopathic thrombocytopenic purpura (ITP)",
                        "ITP (idiopathic thrombocytopenic purpura)",
                        "idiopathic thrombocytopenic purpura (ITP)",
                        "ITP - Idiopathic thrombocytopenic purpura",
                        "AITP",
                        "AITP",
                        "Frank",
                        "Werlhof",
                        "WERLHOF DIS",
                        "WERLHOFS DIS",
                        "Werlhof Disease",
                        "WERLHOF DISEASE",
                        "Werlhofs Disease",
                        "Disease, Werlhof",
                        "werlhof's disease",
                        "Werlhof's Disease",
                        "Werlhof's disease",
                        "Werlhof's disease",
                        "werlhof's disease",
                        "Idiopathic purpura",
                        "Idiopathic purpura",
                        "Werlhof's syndrome",
                        "idiopathic purpura",
                        "idiopathic purpura",
                        "Disease, Werlhof's",
                        "purpura; idiopathic",
                        "idiopathic; purpura",
                        "Immune thrombocytopenia",
                        "Immune Thrombocytopenia",
                        "immune thrombocytopenia",
                        "Idiopathic purpura, NOS",
                        "Thrombocytopenia, Immune",
                        "Immune Thrombocytopenias",
                        "Immune thrombocyt purpra",
                        "Thrombocytopenias, Immune",
                        "Idiopathic Thrombocytopenia",
                        "Autoimmune Thrombocytopenia",
                        "idiopathic thrombocytopenia",
                        "Autoimmune Thrombocytopenias",
                        "Thrombocytopenia, Autoimmune",
                        "Thrombocytopenias, Autoimmune",
                        "Ideopath thrombocytopenic pur",
                        "ideopath thrombocytopenic pur",
                        "Idiopath thrombocytopen purpur",
                        "Autoimmune thrombocytopen purp",
                        "Immune thrombocytopenic purpur",
                        "Idiopath Thrombocytopenic Purp",
                        "immune purpura thrombocytopenic",
                        "thrombocytopenic purpura immune",
                        "Primary immune thrombocytopenia",
                        "Immune thrombocytopenic purpura",
                        "IMMUNE THROMBOCYTOPENIC PURPURA",
                        "immune thrombocytopenic purpura",
                        "Immune thrombocytopenic purpura",
                        "Primary Immune Thrombocytopenia",
                        "Immune Thrombocytopenic Purpura",
                        "immune thrombocytopenic purpura",
                        "primary thrombocytopenic purpura",
                        "primary thrombocytopenic purpura",
                        "Immune Thrombocytopenic Purpuras",
                        "Thrombocytopenic Purpura, Immune",
                        "Purpura, Immune Thrombocytopenic",
                        "Thrombocytopenic Purpuras, Immune",
                        "Purpuras, Immune Thrombocytopenic",
                        "IDIOPATHIC THROMBOCYTOPENIC PURPURA",
                        "idiopathic thrombocytopenic purpura",
                        "Idiopathic thrombocytopenia purpura",
                        "idiopathic thrombocytopenia purpura",
                        "Idiopathic Thrombocytopenic Purpura",
                        "autoimmune thrombocytopenic purpura",
                        "idiopathic thrombocytopenic purpura",
                        "thrombocytopenic purpura autoimmune",
                        "autoimmune thrombocytopenic purpura",
                        "Autoimmune thrombocytopenic purpura",
                        "Idiopathic Thrombocytopenia Purpura",
                        "Idiopathic thrombocytopenic purpura",
                        "Autoimmune Thrombocytopenic Purpura",
                        "THROMBOCYTOPENIC PURPURA, AUTOIMMUNE",
                        "Idiopathic Thrombocytopenic Purpuras",
                        "Autoimmune Thrombocytopenic Purpuras",
                        "Thrombocytopenic Purpura, Idiopathic",
                        "Purpura, Autoimmune Thrombocytopenic",
                        "thrombocytopenic purpura, autoimmune",
                        "Thrombocytopenic Purpura, Autoimmune",
                        "Purpura, Idiopathic Thrombocytopenic",
                        "thrombocytopenic; purpura, idiopathic",
                        "Purpuras, Autoimmune Thrombocytopenic",
                        "PURPURA, THROMBOCYTOPENIC, IDIOPATHIC",
                        "purpura; thrombocytopenic, idiopathic",
                        "Thrombocytopenic Purpuras, Idiopathic",
                        "Purpura, Thrombocytopenic, Idiopathic",
                        "Purpuras, Idiopathic Thrombocytopenic",
                        "Purpura, Thrombocytopenic, Autoimmune",
                        "Idiopathic thrombocytopenic purpura, NOS",
                        "immune thrombocytopenic purpura (diagnosis)",
                        "idiopathic thrombocytopenic purpura (diagnosis)"
                    ],
                    "MGI:3716200": [
                        "ita"
                    ]
                }
            },
            {
                "label": "is often useful as",
                "id": {}
            },
            {
                "label": "adjuvant therapy",
                "id": {
                    "UMLS:C0677850": [
                        "Adjuvant Therapy",
                        "Adjuvant therapy",
                        "adjuvant therapy"
                    ],
                    "UMLS:C5203904": [
                        "Pre-Adjuvant Therapy"
                    ],
                    "UMLS:C0085533": [
                        "Adjuvant Drug Therapy",
                        "Drug Therapy, Adjuvant",
                        "CHEMOTHER ADJUVANT",
                        "DRUG THER ADJUVANT",
                        "ADJUVANT DRUG THER",
                        "adjuvant chemotherapy",
                        "Adjuvant Chemotherapy",
                        "Chemotherapy, Adjuvant"
                    ],
                    "UMLS:C5203903": [
                        "Post-Adjuvant Therapy"
                    ],
                    "UMLS:C5239220": [
                        "Adjuvant Therapy Table"
                    ]
                }
            }
        ],
        [
            {
                "label": "It",
                "id": {
                    "MGI:96598": [
                        "It"
                    ],
                    "PUBCHEM.COMPOUND:44298493": [
                        "IT",
                        "IT dipeptide",
                        "I-T",
                        "Ile-Thr",
                        "CHEMBL54609",
                        "I-T dipeptide",
                        "isoleucylthreonine",
                        "L-Isoleucyl-L-threonine",
                        "L-isoleucyl-L-threonine",
                        "isoleucine threonine dipeptide",
                        "(2S,3R)-2-{[(2S,3S)-2-amino-3-methylpentanoyl]amino}-3-hydroxybutanoic acid"
                    ],
                    "UMLS:C0677897": [
                        "IT",
                        "IT - Intrathecal route",
                        "intrathecal",
                        "Intrathecal",
                        "Intrathecal use",
                        "IntrathecalRoute",
                        "Intrathecal route",
                        "into the spinal space",
                        "Intrathecal route (qualifier value)",
                        "Intrathecal Route of Administration",
                        "Intrathecal Route of Drug Administration"
                    ],
                    "MONDO:0008558": [
                        "itp",
                        "ITP",
                        "ITP, NOS",
                        "ITP - Idiopat thrombocytop pur",
                        "ITP (immune thrombocytopenic purpura)",
                        "Idiopathic thrombocytopenic purpura (ITP)",
                        "ITP (idiopathic thrombocytopenic purpura)",
                        "idiopathic thrombocytopenic purpura (ITP)",
                        "ITP - Idiopathic thrombocytopenic purpura",
                        "AITP",
                        "AITP",
                        "Frank",
                        "Werlhof",
                        "WERLHOF DIS",
                        "WERLHOFS DIS",
                        "Werlhof Disease",
                        "WERLHOF DISEASE",
                        "Werlhofs Disease",
                        "Disease, Werlhof",
                        "werlhof's disease",
                        "Werlhof's Disease",
                        "Werlhof's disease",
                        "Werlhof's disease",
                        "werlhof's disease",
                        "Idiopathic purpura",
                        "Idiopathic purpura",
                        "Werlhof's syndrome",
                        "idiopathic purpura",
                        "idiopathic purpura",
                        "Disease, Werlhof's",
                        "purpura; idiopathic",
                        "idiopathic; purpura",
                        "Immune thrombocytopenia",
                        "Immune Thrombocytopenia",
                        "immune thrombocytopenia",
                        "Idiopathic purpura, NOS",
                        "Thrombocytopenia, Immune",
                        "Immune Thrombocytopenias",
                        "Immune thrombocyt purpra",
                        "Thrombocytopenias, Immune",
                        "Idiopathic Thrombocytopenia",
                        "Autoimmune Thrombocytopenia",
                        "idiopathic thrombocytopenia",
                        "Autoimmune Thrombocytopenias",
                        "Thrombocytopenia, Autoimmune",
                        "Thrombocytopenias, Autoimmune",
                        "Ideopath thrombocytopenic pur",
                        "ideopath thrombocytopenic pur",
                        "Idiopath thrombocytopen purpur",
                        "Autoimmune thrombocytopen purp",
                        "Immune thrombocytopenic purpur",
                        "Idiopath Thrombocytopenic Purp",
                        "immune purpura thrombocytopenic",
                        "thrombocytopenic purpura immune",
                        "Primary immune thrombocytopenia",
                        "Immune thrombocytopenic purpura",
                        "IMMUNE THROMBOCYTOPENIC PURPURA",
                        "immune thrombocytopenic purpura",
                        "Immune thrombocytopenic purpura",
                        "Primary Immune Thrombocytopenia",
                        "Immune Thrombocytopenic Purpura",
                        "immune thrombocytopenic purpura",
                        "primary thrombocytopenic purpura",
                        "primary thrombocytopenic purpura",
                        "Immune Thrombocytopenic Purpuras",
                        "Thrombocytopenic Purpura, Immune",
                        "Purpura, Immune Thrombocytopenic",
                        "Thrombocytopenic Purpuras, Immune",
                        "Purpuras, Immune Thrombocytopenic",
                        "IDIOPATHIC THROMBOCYTOPENIC PURPURA",
                        "idiopathic thrombocytopenic purpura",
                        "Idiopathic thrombocytopenia purpura",
                        "idiopathic thrombocytopenia purpura",
                        "Idiopathic Thrombocytopenic Purpura",
                        "autoimmune thrombocytopenic purpura",
                        "idiopathic thrombocytopenic purpura",
                        "thrombocytopenic purpura autoimmune",
                        "autoimmune thrombocytopenic purpura",
                        "Autoimmune thrombocytopenic purpura",
                        "Idiopathic Thrombocytopenia Purpura",
                        "Idiopathic thrombocytopenic purpura",
                        "Autoimmune Thrombocytopenic Purpura",
                        "THROMBOCYTOPENIC PURPURA, AUTOIMMUNE",
                        "Idiopathic Thrombocytopenic Purpuras",
                        "Autoimmune Thrombocytopenic Purpuras",
                        "Thrombocytopenic Purpura, Idiopathic",
                        "Purpura, Autoimmune Thrombocytopenic",
                        "thrombocytopenic purpura, autoimmune",
                        "Thrombocytopenic Purpura, Autoimmune",
                        "Purpura, Idiopathic Thrombocytopenic",
                        "thrombocytopenic; purpura, idiopathic",
                        "Purpuras, Autoimmune Thrombocytopenic",
                        "PURPURA, THROMBOCYTOPENIC, IDIOPATHIC",
                        "purpura; thrombocytopenic, idiopathic",
                        "Thrombocytopenic Purpuras, Idiopathic",
                        "Purpura, Thrombocytopenic, Idiopathic",
                        "Purpuras, Idiopathic Thrombocytopenic",
                        "Purpura, Thrombocytopenic, Autoimmune",
                        "Idiopathic thrombocytopenic purpura, NOS",
                        "immune thrombocytopenic purpura (diagnosis)",
                        "idiopathic thrombocytopenic purpura (diagnosis)"
                    ],
                    "MGI:3716200": [
                        "ita"
                    ]
                }
            },
            {
                "label": "when treating",
                "id": {
                    "UMLS:C4086250": [
                        "Doctors are Careful to Check Everything When Treating and Examining Me"
                    ],
                    "UMLS:C0373365": [
                        "Special dosimetry (eg, TLD, microdosimetry) (specify), only when prescribed by the treating physician",
                        "SPECIAL RADIATION DOSIMETRY",
                        "Special radiation dosimetry",
                        "SPEC DOSIM ONLY PRESCRIBED TREATING PHYS"
                    ],
                    "UMLS:C2729425": [
                        "Positron emission tomography (pet) or pet/computed tomography (ct) to inform the subsequent treatment strategy of cancerous tumors when the beneficiary's treating physician determines that the pet study is needed to inform subsequent anti-tumor strategy",
                        "Pet tumor subsq tx strategy"
                    ],
                    "UMLS:C0373364": [
                        "Basic radiation dosimetry calculation, central axis depth dose calculation, TDF, NSD, gap calculation, off axis factor, tissue inhomogeneity factors, calculation of non-ionizing radiation surface and depth dose, as required during course of treatment, only when prescribed by the treating physician",
                        "Radiation therapy dose plan",
                        "RADIATION THERAPY DOSE PLAN",
                        "BASIC RADIATION DOSIMETRY CALCULATION"
                    ]
                }
            },
            {
                "label": "these forms of parkinsonism with levodopa",
                "id": {}
            }
        ]
    ],
    "Additionally, it is indicated for the control of extrapyramidal disorders caused by central nervous system drugs such as the dibenzoxazepines, phenothiazines, thioxanthenes, and butyrophenones.": [
        [
            {
                "label": "it",
                "id": {
                    "MGI:96598": [
                        "It"
                    ],
                    "PUBCHEM.COMPOUND:44298493": [
                        "IT",
                        "IT dipeptide",
                        "I-T",
                        "Ile-Thr",
                        "CHEMBL54609",
                        "I-T dipeptide",
                        "isoleucylthreonine",
                        "L-Isoleucyl-L-threonine",
                        "L-isoleucyl-L-threonine",
                        "isoleucine threonine dipeptide",
                        "(2S,3R)-2-{[(2S,3S)-2-amino-3-methylpentanoyl]amino}-3-hydroxybutanoic acid"
                    ],
                    "UMLS:C0677897": [
                        "IT",
                        "IT - Intrathecal route",
                        "intrathecal",
                        "Intrathecal",
                        "Intrathecal use",
                        "IntrathecalRoute",
                        "Intrathecal route",
                        "into the spinal space",
                        "Intrathecal route (qualifier value)",
                        "Intrathecal Route of Administration",
                        "Intrathecal Route of Drug Administration"
                    ],
                    "MONDO:0008558": [
                        "itp",
                        "ITP",
                        "ITP, NOS",
                        "ITP - Idiopat thrombocytop pur",
                        "ITP (immune thrombocytopenic purpura)",
                        "Idiopathic thrombocytopenic purpura (ITP)",
                        "ITP (idiopathic thrombocytopenic purpura)",
                        "idiopathic thrombocytopenic purpura (ITP)",
                        "ITP - Idiopathic thrombocytopenic purpura",
                        "AITP",
                        "AITP",
                        "Frank",
                        "Werlhof",
                        "WERLHOF DIS",
                        "WERLHOFS DIS",
                        "Werlhof Disease",
                        "WERLHOF DISEASE",
                        "Werlhofs Disease",
                        "Disease, Werlhof",
                        "werlhof's disease",
                        "Werlhof's Disease",
                        "Werlhof's disease",
                        "Werlhof's disease",
                        "werlhof's disease",
                        "Idiopathic purpura",
                        "Idiopathic purpura",
                        "Werlhof's syndrome",
                        "idiopathic purpura",
                        "idiopathic purpura",
                        "Disease, Werlhof's",
                        "purpura; idiopathic",
                        "idiopathic; purpura",
                        "Immune thrombocytopenia",
                        "Immune Thrombocytopenia",
                        "immune thrombocytopenia",
                        "Idiopathic purpura, NOS",
                        "Thrombocytopenia, Immune",
                        "Immune Thrombocytopenias",
                        "Immune thrombocyt purpra",
                        "Thrombocytopenias, Immune",
                        "Idiopathic Thrombocytopenia",
                        "Autoimmune Thrombocytopenia",
                        "idiopathic thrombocytopenia",
                        "Autoimmune Thrombocytopenias",
                        "Thrombocytopenia, Autoimmune",
                        "Thrombocytopenias, Autoimmune",
                        "Ideopath thrombocytopenic pur",
                        "ideopath thrombocytopenic pur",
                        "Idiopath thrombocytopen purpur",
                        "Autoimmune thrombocytopen purp",
                        "Immune thrombocytopenic purpur",
                        "Idiopath Thrombocytopenic Purp",
                        "immune purpura thrombocytopenic",
                        "thrombocytopenic purpura immune",
                        "Primary immune thrombocytopenia",
                        "Immune thrombocytopenic purpura",
                        "IMMUNE THROMBOCYTOPENIC PURPURA",
                        "immune thrombocytopenic purpura",
                        "Immune thrombocytopenic purpura",
                        "Primary Immune Thrombocytopenia",
                        "Immune Thrombocytopenic Purpura",
                        "immune thrombocytopenic purpura",
                        "primary thrombocytopenic purpura",
                        "primary thrombocytopenic purpura",
                        "Immune Thrombocytopenic Purpuras",
                        "Thrombocytopenic Purpura, Immune",
                        "Purpura, Immune Thrombocytopenic",
                        "Thrombocytopenic Purpuras, Immune",
                        "Purpuras, Immune Thrombocytopenic",
                        "IDIOPATHIC THROMBOCYTOPENIC PURPURA",
                        "idiopathic thrombocytopenic purpura",
                        "Idiopathic thrombocytopenia purpura",
                        "idiopathic thrombocytopenia purpura",
                        "Idiopathic Thrombocytopenic Purpura",
                        "autoimmune thrombocytopenic purpura",
                        "idiopathic thrombocytopenic purpura",
                        "thrombocytopenic purpura autoimmune",
                        "autoimmune thrombocytopenic purpura",
                        "Autoimmune thrombocytopenic purpura",
                        "Idiopathic Thrombocytopenia Purpura",
                        "Idiopathic thrombocytopenic purpura",
                        "Autoimmune Thrombocytopenic Purpura",
                        "THROMBOCYTOPENIC PURPURA, AUTOIMMUNE",
                        "Idiopathic Thrombocytopenic Purpuras",
                        "Autoimmune Thrombocytopenic Purpuras",
                        "Thrombocytopenic Purpura, Idiopathic",
                        "Purpura, Autoimmune Thrombocytopenic",
                        "thrombocytopenic purpura, autoimmune",
                        "Thrombocytopenic Purpura, Autoimmune",
                        "Purpura, Idiopathic Thrombocytopenic",
                        "thrombocytopenic; purpura, idiopathic",
                        "Purpuras, Autoimmune Thrombocytopenic",
                        "PURPURA, THROMBOCYTOPENIC, IDIOPATHIC",
                        "purpura; thrombocytopenic, idiopathic",
                        "Thrombocytopenic Purpuras, Idiopathic",
                        "Purpura, Thrombocytopenic, Idiopathic",
                        "Purpuras, Idiopathic Thrombocytopenic",
                        "Purpura, Thrombocytopenic, Autoimmune",
                        "Idiopathic thrombocytopenic purpura, NOS",
                        "immune thrombocytopenic purpura (diagnosis)",
                        "idiopathic thrombocytopenic purpura (diagnosis)"
                    ],
                    "MGI:3716200": [
                        "ita"
                    ]
                }
            },
            {
                "label": "is indicated for the control",
                "id": {}
            },
            {
                "label": "extrapyramidal disorders",
                "id": {
                    "HP:0002071": [
                        "extrapyramidal disorders",
                        "Extrapyramidal Disorders",
                        "extrapyramidal disorders (diagnosis)",
                        "EXTRAPYRAMIDAL DIS",
                        "extrapyramidal sign",
                        "Extrapyramidal sign",
                        "extrapyramidal signs",
                        "Extrapyramidal signs",
                        "Extrapyramidal disease",
                        "extrapyramidal disease",
                        "Extrapyramidal symptom",
                        "extrapyramidal symptom",
                        "EXTRAPYRAMIDAL DISEASE",
                        "EXTRAPYRAMIDAL SYMPTOM",
                        "SYNDROME EXTRAPYRAMIDAL",
                        "extrapyramidal disorder",
                        "EXTRAPYRAMIDAL SYNDROME",
                        "EXTRAPYRAMIDAL DISORDER",
                        "Extrapyramidal Symptoms",
                        "Extrapyramidal symptoms",
                        "Syndrome extrapyramidal",
                        "Extrapyramidal syndrome",
                        "extrapyramidal symptoms",
                        "Extrapyramidal Disorder",
                        "extrapyramidal syndrome",
                        "EXTRAPYRAMIDAL DISEASES",
                        "Extrapyramidal disorder",
                        "extrapyramidal; syndrome",
                        "extrapyramidal; disorder",
                        "extrapyramidal syndromes",
                        "Extrapyramidal sign, NOS",
                        "syndrome; extrapyramidal",
                        "Extrapyramidal tract signs",
                        "Extrapyramidal dysfunction",
                        "Extrapyramidal disease, NOS",
                        "Extrapyramidal disorder, NOS",
                        "A-21 EXTRAPYRAMIDAL DISEASES",
                        "EXTRAPYRAMIDAL DISORDER (NOS)",
                        "Extrapyramidal sign (finding)",
                        "EXTRAPYRAMIDAL SYNDROME (NOS)",
                        "Extrapyramidal disease (disorder)",
                        "Extrapyramidal disease or syndrome",
                        "disease (or disorder); extrapyramidal",
                        "Abnormality of extrapyramidal motor function"
                    ],
                    "HP:0002305": [
                        "extrapyramidal disorders athetosis",
                        "ATHETOSIS",
                        "Athetoses",
                        "Athetosis",
                        "athetosis",
                        "HAMMOND DIS",
                        "HAMMONDS DIS",
                        "Athetosis, NOS",
                        "Hammond Disease",
                        "Hammond Diseases",
                        "Hammonds Disease",
                        "hammonds disease",
                        "Disease, Hammond",
                        "Diseases, Hammond",
                        "athetoid movement",
                        "Athetoid movement",
                        "Hammond's Disease",
                        "Athetoid Movement",
                        "athetoid movements",
                        "Disease, Hammond's",
                        "Athetoid movements",
                        "Athetoid Movements",
                        "Hammond's Diseases",
                        "Movement, Athetoid",
                        "athetosis was noted",
                        "Movements, Athetoid",
                        "Diseases, Hammond's",
                        "Athetosis (disorder)",
                        "athetosis (diagnosis)",
                        "Athetoid movement (finding)",
                        "athetosis (physical finding)",
                        "Involuntary writhing movements",
                        "Involuntary writhing movements in fingers, hands, toes, and feet"
                    ],
                    "UMLS:C3825393": [
                        "Extrapyramidal disorders in children"
                    ],
                    "MONDO:0001815": [
                        "Extrapyramidal and movement disorders",
                        "Extrapyramidal and movement disorders (G20-G26)",
                        "Extrapyramidal dis NOS",
                        "extrapyramidal and movement disease",
                        "extrapyramidal and movement disease",
                        "Extrapyramidal and movement disorder, unspecified",
                        "Unspecified extrapyramidal disease and abnormal movement disorder"
                    ],
                    "UMLS:C0154678": [
                        "Other extrapyramidal and movement disorders",
                        "Other extrapyramidal disease and abnormal movement disorders",
                        "Other extrapyramidal diseases and abnormal movement disorders",
                        "Other and unspecified extrapyramidal diseases and abnormal movement disorders",
                        "Extrapyramidal dis NEC"
                    ]
                }
            }
        ],
        [
            {
                "label": "extrapyramidal disorders",
                "id": {
                    "HP:0002071": [
                        "extrapyramidal disorders",
                        "Extrapyramidal Disorders",
                        "extrapyramidal disorders (diagnosis)",
                        "EXTRAPYRAMIDAL DIS",
                        "extrapyramidal sign",
                        "Extrapyramidal sign",
                        "extrapyramidal signs",
                        "Extrapyramidal signs",
                        "Extrapyramidal disease",
                        "extrapyramidal disease",
                        "Extrapyramidal symptom",
                        "extrapyramidal symptom",
                        "EXTRAPYRAMIDAL DISEASE",
                        "EXTRAPYRAMIDAL SYMPTOM",
                        "SYNDROME EXTRAPYRAMIDAL",
                        "extrapyramidal disorder",
                        "EXTRAPYRAMIDAL SYNDROME",
                        "EXTRAPYRAMIDAL DISORDER",
                        "Extrapyramidal Symptoms",
                        "Extrapyramidal symptoms",
                        "Syndrome extrapyramidal",
                        "Extrapyramidal syndrome",
                        "extrapyramidal symptoms",
                        "Extrapyramidal Disorder",
                        "extrapyramidal syndrome",
                        "EXTRAPYRAMIDAL DISEASES",
                        "Extrapyramidal disorder",
                        "extrapyramidal; syndrome",
                        "extrapyramidal; disorder",
                        "extrapyramidal syndromes",
                        "Extrapyramidal sign, NOS",
                        "syndrome; extrapyramidal",
                        "Extrapyramidal tract signs",
                        "Extrapyramidal dysfunction",
                        "Extrapyramidal disease, NOS",
                        "Extrapyramidal disorder, NOS",
                        "A-21 EXTRAPYRAMIDAL DISEASES",
                        "EXTRAPYRAMIDAL DISORDER (NOS)",
                        "Extrapyramidal sign (finding)",
                        "EXTRAPYRAMIDAL SYNDROME (NOS)",
                        "Extrapyramidal disease (disorder)",
                        "Extrapyramidal disease or syndrome",
                        "disease (or disorder); extrapyramidal",
                        "Abnormality of extrapyramidal motor function"
                    ],
                    "HP:0002305": [
                        "extrapyramidal disorders athetosis",
                        "ATHETOSIS",
                        "Athetoses",
                        "Athetosis",
                        "athetosis",
                        "HAMMOND DIS",
                        "HAMMONDS DIS",
                        "Athetosis, NOS",
                        "Hammond Disease",
                        "Hammond Diseases",
                        "Hammonds Disease",
                        "hammonds disease",
                        "Disease, Hammond",
                        "Diseases, Hammond",
                        "athetoid movement",
                        "Athetoid movement",
                        "Hammond's Disease",
                        "Athetoid Movement",
                        "athetoid movements",
                        "Disease, Hammond's",
                        "Athetoid movements",
                        "Athetoid Movements",
                        "Hammond's Diseases",
                        "Movement, Athetoid",
                        "athetosis was noted",
                        "Movements, Athetoid",
                        "Diseases, Hammond's",
                        "Athetosis (disorder)",
                        "athetosis (diagnosis)",
                        "Athetoid movement (finding)",
                        "athetosis (physical finding)",
                        "Involuntary writhing movements",
                        "Involuntary writhing movements in fingers, hands, toes, and feet"
                    ],
                    "UMLS:C3825393": [
                        "Extrapyramidal disorders in children"
                    ],
                    "MONDO:0001815": [
                        "Extrapyramidal and movement disorders",
                        "Extrapyramidal and movement disorders (G20-G26)",
                        "Extrapyramidal dis NOS",
                        "extrapyramidal and movement disease",
                        "extrapyramidal and movement disease",
                        "Extrapyramidal and movement disorder, unspecified",
                        "Unspecified extrapyramidal disease and abnormal movement disorder"
                    ],
                    "UMLS:C0154678": [
                        "Other extrapyramidal and movement disorders",
                        "Other extrapyramidal disease and abnormal movement disorders",
                        "Other extrapyramidal diseases and abnormal movement disorders",
                        "Other and unspecified extrapyramidal diseases and abnormal movement disorders",
                        "Extrapyramidal dis NEC"
                    ]
                }
            },
            {
                "label": "caused by",
                "id": {
                    "UMLS:C0015127": [
                        "caused by",
                        "ET",
                        "cause",
                        "ETIOL",
                        "causes",
                        "etiology",
                        "aetiology",
                        "causality",
                        "etiologies",
                        "Etiology aspects"
                    ],
                    "UMLS:C1314792": [
                        "Caused by",
                        "Causes",
                        "Etiology",
                        "etiology",
                        "Causality",
                        "Aetiology",
                        "Causalities",
                        "disease cause",
                        "disease etiology",
                        "General Etiology",
                        "disorder etiology",
                        "disease causation",
                        "disorder by cause",
                        "Etiology (attribute)",
                        "disease/disorder etiology"
                    ],
                    "UMLS:C0239313": [
                        "CAUSED BY EXERCISE",
                        "exertional",
                        "EXERTIONAL",
                        "EXERCISE INDUCED",
                        "exercise induced",
                        "PRECIPITATED BY EXERCISE"
                    ],
                    "UMLS:C0338466": [
                        "Tic caused by drug",
                        "Tic caused by drug (disorder)",
                        "drug; tic",
                        "Drug-induced tic",
                        "tic; drug-induced",
                        "Drug induced tics",
                        "drug-induced tic disorder",
                        "drug-induced tic disorder (diagnosis)"
                    ],
                    "UMLS:C0409910": [
                        "Gout caused by drug",
                        "Gout caused by drug (disorder)",
                        "drug; gouty",
                        "Drug-induced gout",
                        "gout; drug-induced",
                        "Gout secondary to drug",
                        "gout secondary drug-induced",
                        "Drug-induced gout (diagnosis)",
                        "Drug-induced gout, unspecified site",
                        "Drug-induced gout, site unspecified"
                    ]
                }
            },
            {
                "label": "central nervous system drugs",
                "id": {
                    "UMLS:C0007680": [
                        "central nervous system drugs",
                        "central drugs nervous system",
                        "Central Nervous System Drugs",
                        "cns drug",
                        "cn drugs",
                        "CNS Agent",
                        "CNS agent",
                        "CNS DRUGS",
                        "cns drugs",
                        "CNS agents",
                        "CNS AGENTS",
                        "cns agents",
                        "affecting cns drugs",
                        "CNS Affecting Drugs",
                        "drugs affecting cns",
                        "centrally acting drug",
                        "centrally acting drugs",
                        "Central nervous system agent",
                        "central nervous system agent",
                        "Central Nervous System Agent",
                        "Central Nervous System Agents",
                        "CENTRAL NERVOUS SYSTEM AGENTS",
                        "Central nervous system agent, NOS",
                        "Central Nervous System Agent [TC]",
                        "central medication nervous system",
                        "central medications nervous system",
                        "CENTRAL NERVOUS SYSTEM MEDICATIONS",
                        "SECTION 6 CENTRAL NERVOUS SYSTEM AGENTS",
                        "Central nervous system agent (substance)"
                    ],
                    "UMLS:C0261413": [
                        "Accidental poisoning by other drugs acting on central and autonomic nervous system"
                    ],
                    "UMLS:C0261421": [
                        "Accidental poisoning by other specified drugs acting on central and autonomic nervous systems",
                        "Acc poison-cns drug NEC"
                    ],
                    "UMLS:C0481171": [
                        "Drugs primarily affecting the central nervous system causing adverse effects in therapeutic use",
                        "[X]Drugs primarily affecting the central nervous system causing adverse effects in therapeutic use",
                        "Drug prim affect CNS adv ef",
                        "[X]Drug prim affect CNS adv ef",
                        "Drugs prim affect the CNS caus adverse eff in therap use",
                        "[X]Drugs prim affect the CNS caus adverse eff in therap use"
                    ]
                }
            }
        ],
        [
            {
                "label": "central nervous system drugs",
                "id": {
                    "UMLS:C0007680": [
                        "central nervous system drugs",
                        "central drugs nervous system",
                        "Central Nervous System Drugs",
                        "cns drug",
                        "cn drugs",
                        "CNS Agent",
                        "CNS agent",
                        "CNS DRUGS",
                        "cns drugs",
                        "CNS agents",
                        "CNS AGENTS",
                        "cns agents",
                        "affecting cns drugs",
                        "CNS Affecting Drugs",
                        "drugs affecting cns",
                        "centrally acting drug",
                        "centrally acting drugs",
                        "Central nervous system agent",
                        "central nervous system agent",
                        "Central Nervous System Agent",
                        "Central Nervous System Agents",
                        "CENTRAL NERVOUS SYSTEM AGENTS",
                        "Central nervous system agent, NOS",
                        "Central Nervous System Agent [TC]",
                        "central medication nervous system",
                        "central medications nervous system",
                        "CENTRAL NERVOUS SYSTEM MEDICATIONS",
                        "SECTION 6 CENTRAL NERVOUS SYSTEM AGENTS",
                        "Central nervous system agent (substance)"
                    ],
                    "UMLS:C0261413": [
                        "Accidental poisoning by other drugs acting on central and autonomic nervous system"
                    ],
                    "UMLS:C0261421": [
                        "Accidental poisoning by other specified drugs acting on central and autonomic nervous systems",
                        "Acc poison-cns drug NEC"
                    ],
                    "UMLS:C0481171": [
                        "Drugs primarily affecting the central nervous system causing adverse effects in therapeutic use",
                        "[X]Drugs primarily affecting the central nervous system causing adverse effects in therapeutic use",
                        "Drug prim affect CNS adv ef",
                        "[X]Drug prim affect CNS adv ef",
                        "Drugs prim affect the CNS caus adverse eff in therap use",
                        "[X]Drugs prim affect the CNS caus adverse eff in therap use"
                    ]
                }
            },
            {
                "label": "include",
                "id": {
                    "UMLS:C0332257": [
                        "include",
                        "Includes",
                        "included",
                        "includes",
                        "Has part",
                        "has part",
                        "Inclusive",
                        "inclusive",
                        "including",
                        "Including",
                        "Including (qualifier)",
                        "Including (qualifier value)"
                    ],
                    "UMLS:C1552866": [
                        "include",
                        "include - SetOperator"
                    ],
                    "UMLS:C2700399": [
                        "Include",
                        "Include (action)",
                        "Inclusion"
                    ],
                    "UMLS:C4065484": [
                        "diet includes",
                        "diet includes (history)"
                    ],
                    "MONDO:0007508": [
                        "OFC8, included",
                        "RHS",
                        "RHS",
                        "RHS",
                        "orofacial cleft 8",
                        "Rapp-Hodgkin syndrome",
                        "RAPP-HODGKIN SYNDROME",
                        "Rapp-Hodgkin syndrome",
                        "Anhidrotic ectodermal dyspl",
                        "Rapp-Hodgkin ectoderm dysplas",
                        "Anhidrotic ectodermal dysplasia",
                        "Anhidrotic Ectodermal Dysplasia",
                        "Anhydrotic Ectodermal Dysplasia",
                        "Ectodermal Dysplasia Anhidrotic",
                        "Dysplasia, Anhidrotic Ectodermal",
                        "Ectodermal dysplasia, anhidrotic",
                        "Anhidrotic Ectodermal Dysplasias",
                        "Dysplasia, Anhydrotic Ectodermal",
                        "Anhidrotic, Ectodermal Dysplasia",
                        "Anhydrotic Ectodermal Dysplasias",
                        "Dysplasia Anhidrotic, Ectodermal",
                        "Ectodermal Dysplasia, Anhidrotic",
                        "Ectodermal Dysplasia, Anhydrotic",
                        "Anhidrotics, Ectodermal Dysplasia",
                        "Ectodermal Dysplasias, Anhidrotic",
                        "Dysplasias, Anhydrotic Ectodermal",
                        "Ectodermal dysplasia (anhidrotic)",
                        "Dysplasias, Anhidrotic Ectodermal",
                        "Dysplasia Anhidrotics, Ectodermal",
                        "Ectodermal Dysplasias, Anhydrotic",
                        "ectodermal dysplasia, Rapp-Hodgkin type",
                        "Anhidrotic ectodermal dysplasia syndrome",
                        "Rapp-Hodgkin type of ectodermal dysplasia",
                        "Rapp-Hodgkin ectodermal dysplasia syndrome",
                        "Rapp-Hodgkin ectodermal dysplasia syndrome",
                        "ectodermal dysplasia syndrome, Rapp-Hodgkin type",
                        "anhidrotic ectodermal dysplasia with cleft lip/palate",
                        "anhidrotic ectodermal dysplasia with cleft lip/palate",
                        "Ectodermal dysplasia, anhidrotic, with cleft lip-palate",
                        "ectodermal dysplasia, anhidrotic, with cleft Lip/palate",
                        "cleft lip with or without cleft palate, nonsyndromic, 8",
                        "ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATE",
                        "ectodermal dysplasia, anhidrotic, with cleft lip-palate",
                        "autosomal dominant hypohidrotic ectodermal dysplasia syndrome",
                        "Autosomal dominant hypohidrotic ectodermal dysplasia syndrome",
                        "Hypohidrotic ectodermal dysplasia syndrome, autosomal dominant type",
                        "Autosomal dominant hypohidrotic ectodermal dysplasia syndrome (disorder)",
                        "autosomal dominant hypohidrotic ectodermal dysplasia syndrome (diagnosis)"
                    ]
                }
            },
            {
                "label": "dibenzoxazepines, phenothiazines, thioxanthenes, butyrophenones",
                "id": {}
            }
        ]
    ],
    "Dextroamphetamine sulfate tablets are indicated in: Narcolepsy and Attention Deficit Disorder with Hyperactivity: As an integral part of a total treatment program that typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in pediatric patients (ages 3 years to 16 years)": [
        [
            {
                "label": "Dextroamphetamine sulfate tablets",
                "id": {
                    "UMLS:C4719803": [
                        "Dextroamphetamine Sulfate Tablets"
                    ],
                    "UMLS:C1384309": [
                        "Amphetamine Aspartate Monohydrate 5 mg / AMPHETAMINE SULFATE 5 mg / DEXTROAMPHETAMINE SACCHARATE 5 mg / DEXTROAMPHETAMINE SULFATE 5 mg ORAL TABLET [Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII]",
                        "Amphetamine Salts Oral tablet",
                        "AMPHETAMINE/DEXTROAMPHETAMINE 20MG TAB",
                        "mixed amphetamine salts 20 MG Oral Tablet",
                        "amphetamine-dextroamphetamine 20 mg oral tablet",
                        "dextroamphetamine/amphetamine 20 mg ORAL TABLET",
                        "Amphetamine-Dextroamphetamine, 20 mg oral tablet",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate 20 mg ORAL TABLET",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate@20 mg@ORAL@TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 20 MG Oral Tablet",
                        "dextroamphetamine saccharate 5 MG / amphetamine aspartate 5 MG / dextroamphetamine sulfate 5 MG / amphetamine sulfate 5 MG Oral Tablet",
                        "amphetamine aspartate 5 MG / amphetamine sulfate 5 MG / dextroamphetamine saccharate 5 MG / dextroamphetamine sulfate 5 MG Oral Tablet",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 20 MG Oral Tablet [AMPHETAMINE SALT COMBO]",
                        "DEXTROAMPHETAMINE SACCHARATE 5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg / DEXTROAMPHETAMINE SULFATE 5 mg / AMPHETAMINE SULFATE 5 mg ORAL TABLET",
                        "AMPHETAMINE SULFATE 5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg / DEXTROAMPHETAMINE SULFATE 5 mg / DEXTROAMPHETAMINE SACCHARATE 5 mg ORAL TABLET",
                        "DEXTROAMPHETAMINE SACCHARATE 5.00 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 5.00 mg / DEXTROAMPHETAMINE SULFATE 5.00 mg / AMPHETAMINE SULFATE 5.00 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 20 MG Oral Tablet [DEXTROAMPHETAMIN SACC/SULF-AMPHETAMINE ASPART/SULF]",
                        "Dextroamphetamine saccharate 5 mg / Amphetamine aspartate 5 mg / Dextroamphetamine sulfate 5 mg / Amphetamine sulfate 5 mg ORAL TABLET [Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate]",
                        "DEXTROAMPHETAMINE SACCHARATE 5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg / DEXTROAMPHETAMINE SULFATE 5 mg / AMPHETAMINE SULFATE 5 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE]",
                        "AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg / AMPHETAMINE SULFATE 5 mg / DEXTROAMPHETAMINE SULFATE 5 mg / DEXTROAMPHETAMINE SACCHARATE 5 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE]"
                    ],
                    "UMLS:C1585326": [
                        "Amphetamine Aspartate Monohydrate 7.5 mg / AMPHETAMINE SULFATE 7.5 mg / DEXTROAMPHETAMINE SACCHARATE 7.5 mg / DEXTROAMPHETAMINE SULFATE 7.5 mg ORAL TABLET [Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII]",
                        "Amphetamine Salts Oral tablet",
                        "AMPHETAMINE/DEXTROAMPHETAMINE 30MG TAB",
                        "mixed amphetamine salts 30 MG Oral Tablet",
                        "dextroamphetamine/amphetamine 30 mg ORAL TABLET",
                        "amphetamine-dextroamphetamine 30 mg oral tablet",
                        "Amphetamine-Dextroamphetamine, 30 mg oral tablet",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate@30 mg@ORAL@TABLET",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate 30 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 30 MG Oral Tablet",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 30 MG Oral Tablet [AMPHETAMINE SALT COMBO]",
                        "amphetamine aspartate 7.5 MG / amphetamine sulfate 7.5 MG / dextroamphetamine saccharate 7.5 MG / dextroamphetamine sulfate 7.5 MG Oral Tablet",
                        "dextroamphetamine saccharate 7.5 MG / amphetamine aspartate 7.5 MG / dextroamphetamine sulfate 7.5 MG / amphetamine sulfate 7.5 MG Oral Tablet",
                        "AMPHETAMINE SULFATE 7.5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg / DEXTROAMPHETAMINE SULFATE 7.5 mg / DEXTROAMPHETAMINE SACCHARATE 7.5 mg ORAL TABLET",
                        "DEXTROAMPHETAMINE SACCHARATE 7.5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg / DEXTROAMPHETAMINE SULFATE 7.5 mg / AMPHETAMINE SULFATE 7.5 mg ORAL TABLET",
                        "DEXTROAMPHETAMINE SACCHARATE 7.50 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 7.50 mg / DEXTROAMPHETAMINE SULFATE 7.50 mg / AMPHETAMINE SULFATE 7.50 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 30 MG Oral Tablet [DEXTROAMPHETAMIN SACC/SULF-AMPHETAMINE ASPART/SULF]",
                        "Dextroamphetamine saccharate 7.5 mg / Amphetamine aspartate 7.5 mg / Dextroamphetamine sulfate 7.5 mg / Amphetamine sulfate 7.5 mg ORAL TABLET [Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate]",
                        "DEXTROAMPHETAMINE SACCHARATE 7.5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg / DEXTROAMPHETAMINE SULFATE 7.5 mg / AMPHETAMINE SULFATE 7.5 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE]",
                        "AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg / AMPHETAMINE SULFATE 7.5 mg / DEXTROAMPHETAMINE SULFATE 7.5 mg / DEXTROAMPHETAMINE SACCHARATE 7.5 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE]"
                    ],
                    "UMLS:C1623081": [
                        "Amphetamine Aspartate Monohydrate 2.5 mg / AMPHETAMINE SULFATE 2.5 mg / DEXTROAMPHETAMINE SACCHARATE 2.5 mg / DEXTROAMPHETAMINE SULFATE 2.5 mg ORAL TABLET [Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII]",
                        "AMPHETAMINE/DEXTROAMPHETAMINE 10MG TAB",
                        "mixed amphetamine salts 10 MG Oral Tablet",
                        "dextroamphetamine/amphetamine 10 mg ORAL TABLET",
                        "amphetamine-dextroamphetamine 10 mg oral tablet",
                        "Amphetamine-Dextroamphetamine, 10 mg oral tablet",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate@10 mg@ORAL@TABLET",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate 10 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 10 MG Oral Tablet",
                        "Amphetamine Aspartate 2.5mg, Amphetamine Sulfate 2.5mg, Dextroamphetamine Saccharate 2.5mg, Dextroamphetamine Sulfate 2.5mg Oral tablet",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 10 MG Oral Tablet [AMPHETAMINE SALT COMBO]",
                        "dextroamphetamine saccharate 2.5 MG / amphetamine aspartate 2.5 MG / dextroamphetamine sulfate 2.5 MG / amphetamine sulfate 2.5 MG Oral Tablet",
                        "amphetamine aspartate 2.5 MG / amphetamine sulfate 2.5 MG / dextroamphetamine saccharate 2.5 MG / dextroamphetamine sulfate 2.5 MG Oral Tablet",
                        "AMPHETAMINE SULFATE 2.5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg / DEXTROAMPHETAMINE SULFATE 2.5 mg / DEXTROAMPHETAMINE SACCHARATE 2.5 mg ORAL TABLET",
                        "DEXTROAMPHETAMINE SACCHARATE 2.5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg / DEXTROAMPHETAMINE SULFATE 2.5 mg / AMPHETAMINE SULFATE 2.5 mg ORAL TABLET",
                        "DEXTROAMPHETAMINE SACCHARATE 2.50 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 2.50 mg / DEXTROAMPHETAMINE SULFATE 2.50 mg / AMPHETAMINE SULFATE 2.50 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 10 MG Oral Tablet [DEXTROAMPHETAMIN SACC/SULF-AMPHETAMINE ASPART/SULF]",
                        "DEXTROAMPHETAMINE SACCHARATE 2.5 mg / AMPHETAMINE ASPARTATE 2.5 mg / DEXTROAMPHETAMINE SULFATE 2.5 mg / AMPHETAMINE SULFATE 2.5 mg ORAL TABLET [Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate]",
                        "Dextroamphetamine saccharate 2.5 mg / Amphetamine aspartate 2.5 mg / Dextroamphetamine sulfate 2.5 mg / Amphetamine sulfate 2.5 mg ORAL TABLET [Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate]",
                        "DEXTROAMPHETAMINE SACCHARATE 2.5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg / DEXTROAMPHETAMINE SULFATE 2.5 mg / AMPHETAMINE SULFATE 2.5 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE]",
                        "AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg / AMPHETAMINE SULFATE 2.5 mg / DEXTROAMPHETAMINE SULFATE 2.5 mg / DEXTROAMPHETAMINE SACCHARATE 2.5 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE]"
                    ],
                    "UMLS:C0974358": [
                        "Amphetamine Aspartate Monohydrate 1.25 mg / AMPHETAMINE SULFATE 1.25 mg / DEXTROAMPHETAMINE SACCHARATE 1.25 mg / DEXTROAMPHETAMINE SULFATE 1.25 mg ORAL TABLET [Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII]",
                        "Amphetamine Salts Oral tablet",
                        "AMPHETAMINE/DEXTROAMPHETAMINE 5MG TAB",
                        "mixed amphetamine salts 5 MG Oral Tablet",
                        "dextroamphetamine/amphetamine 5 mg ORAL TABLET",
                        "amphetamine-dextroamphetamine 5 mg oral tablet",
                        "Amphetamine-Dextroamphetamine, 5 mg oral tablet",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate@5 mg@ORAL@TABLET",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate 5 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 5 MG Oral Tablet",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 5 MG Oral Tablet [AMPHETAMINE SALT COMBO]",
                        "amphetamine aspartate 1.25 MG / amphetamine sulfate 1.25 MG / dextroamphetamine saccharate 1.25 MG / dextroamphetamine sulfate 1.25 MG Oral Tablet",
                        "dextroamphetamine saccharate 1.25 MG / amphetamine aspartate 1.25 MG / dextroamphetamine sulfate 1.25 MG / amphetamine sulfate 1.25 MG Oral Tablet",
                        "DEXTROAMPHETAMINE SACCHARATE 1.25 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg / DEXTROAMPHETAMINE SULFATE 1.25 mg / AMPHETAMINE SULFATE 1.25 mg ORAL TABLET",
                        "AMPHETAMINE SULFATE 1.25 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg / DEXTROAMPHETAMINE SULFATE 1.25 mg / DEXTROAMPHETAMINE SACCHARATE 1.25 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 5 MG Oral Tablet [DEXTROAMPHETAMIN SACC/SULF-AMPHETAMINE ASPART/SULF]",
                        "Dextroamphetamine saccharate 1.25 mg / Amphetamine aspartate 1.25 mg / Dextroamphetamine sulfate 1.25 mg / Amphetamine sulfate 1.25 mg ORAL TABLET [Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate]",
                        "DEXTROAMPHETAMINE SACCHARATE 1.25 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg / DEXTROAMPHETAMINE SULFATE 1.25 mg / AMPHETAMINE SULFATE 1.25 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE]",
                        "AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg / AMPHETAMINE SULFATE 1.25 mg / DEXTROAMPHETAMINE SULFATE 1.25 mg / DEXTROAMPHETAMINE SACCHARATE 1.25 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE]",
                        "DEXTROAMPHETAMINE SACCHARATE 1.25 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg / DEXTROAMPHETAMINE SULFATE 1.25 mg / AMPHETAMINE SULFATE 1.25 mg ORAL TABLET [Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate]"
                    ]
                }
            },
            {
                "label": "are indicated in",
                "id": {
                    "UMLS:C1548408": [
                        "The indicated time slot(s) is(are) blocked"
                    ],
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C0514907": [
                        "Provide input in areas of strength and development needs, as indicated"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4714006": [
                        "Activate the rapid response team if indicated by presence of trigger areas, per agency protocol"
                    ]
                }
            },
            {
                "label": "Narcolepsy",
                "id": {
                    "MONDO:0021107": [
                        "narcolepsy",
                        "NARCOLEPSY",
                        "Narcolepsy",
                        "narcolepsy",
                        "Narcolepsy NOS",
                        "narcolepsy disorder",
                        "Narcolepsy (disorder)",
                        "narcolepsy (diagnosis)",
                        "Narcolepsy, without cataplexy",
                        "narcolepsy, without cataplexy",
                        "Narcolepsy with or without cataplexy",
                        "narcolepsies",
                        "paroxysmal sleep",
                        "Paroxysmal sleep",
                        "PAROXYSMAL SLEEP",
                        "paroxysmal sleep",
                        "Paroxysmal Sleep",
                        "Gelineau Syndrome",
                        "GELINEAU SYNDROME",
                        "SLEEP, PAROXYSMAL",
                        "Sleep, Paroxysmal",
                        "gelineau syndrome",
                        "Syndrome, Gelineau",
                        "Gelineaus Syndrome",
                        "gelineau's syndrome",
                        "Gelineau's Syndrome",
                        "Gelineau's syndrome",
                        "gélineau's syndrome",
                        "Narcoleptic syndrome",
                        "narcoleptic syndrome",
                        "Narcoleptic Syndrome",
                        "Gelineau's Syndromes",
                        "Syndrome, Gelineau's",
                        "Syndromes, Gelineau's",
                        "Syndrome, Narcoleptic",
                        "Narcoleptic Syndromes",
                        "Syndromes, Narcoleptic",
                        "excessive uncontrollable daytime sleepiness"
                    ],
                    "MONDO:0011607": [
                        "narcolepsy 2",
                        "narcolepsy 2, susceptibility to",
                        "NARCOLEPSY 2, SUSCEPTIBILITY TO",
                        "NRCLP2"
                    ],
                    "MONDO:0012898": [
                        "narcolepsy 4",
                        "NARCOLEPSY 4, SUSCEPTIBILITY TO",
                        "narcolepsy 4, susceptibility to",
                        "NRCLP4"
                    ],
                    "MONDO:0012179": [
                        "narcolepsy 3",
                        "NARCOLEPSY 3",
                        "NRCLP3"
                    ],
                    "MONDO:0008062": [
                        "narcolepsy 1",
                        "Narcolepsy 1",
                        "NARCOLEPSY 1",
                        "HCRT narcolepsy",
                        "narcolepsy type 1",
                        "narcolepsy caused by mutation in HCRT",
                        "NRCLP1",
                        "NRCLP1",
                        "CATAPLEXY",
                        "cataplexy",
                        "cataplexy",
                        "Cataplexy",
                        "Cataleptic Attack",
                        "Henneberg Syndrome",
                        "Attack, Cataleptic",
                        "Cataleptic Attacks",
                        "Syndrome, Henneberg",
                        "Attacks, Cataleptic",
                        "Cataplexy (disorder)",
                        "Tonelessness Syndrome",
                        "Cataplexy (diagnosis)",
                        "Syndrome, Tonelessness",
                        "NARCOLEPTIC SYNDROME 1",
                        "narcoleptic syndrome 1",
                        "Narcoleptic Syndrome 1",
                        "Tonelessness Syndromes",
                        "Syndromes, Tonelessness",
                        "disorder of brain cataplexy"
                    ]
                }
            }
        ],
        [
            {
                "label": "Dextroamphetamine sulfate tablets",
                "id": {
                    "UMLS:C4719803": [
                        "Dextroamphetamine Sulfate Tablets"
                    ],
                    "UMLS:C1384309": [
                        "Amphetamine Aspartate Monohydrate 5 mg / AMPHETAMINE SULFATE 5 mg / DEXTROAMPHETAMINE SACCHARATE 5 mg / DEXTROAMPHETAMINE SULFATE 5 mg ORAL TABLET [Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII]",
                        "Amphetamine Salts Oral tablet",
                        "AMPHETAMINE/DEXTROAMPHETAMINE 20MG TAB",
                        "mixed amphetamine salts 20 MG Oral Tablet",
                        "amphetamine-dextroamphetamine 20 mg oral tablet",
                        "dextroamphetamine/amphetamine 20 mg ORAL TABLET",
                        "Amphetamine-Dextroamphetamine, 20 mg oral tablet",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate 20 mg ORAL TABLET",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate@20 mg@ORAL@TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 20 MG Oral Tablet",
                        "dextroamphetamine saccharate 5 MG / amphetamine aspartate 5 MG / dextroamphetamine sulfate 5 MG / amphetamine sulfate 5 MG Oral Tablet",
                        "amphetamine aspartate 5 MG / amphetamine sulfate 5 MG / dextroamphetamine saccharate 5 MG / dextroamphetamine sulfate 5 MG Oral Tablet",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 20 MG Oral Tablet [AMPHETAMINE SALT COMBO]",
                        "DEXTROAMPHETAMINE SACCHARATE 5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg / DEXTROAMPHETAMINE SULFATE 5 mg / AMPHETAMINE SULFATE 5 mg ORAL TABLET",
                        "AMPHETAMINE SULFATE 5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg / DEXTROAMPHETAMINE SULFATE 5 mg / DEXTROAMPHETAMINE SACCHARATE 5 mg ORAL TABLET",
                        "DEXTROAMPHETAMINE SACCHARATE 5.00 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 5.00 mg / DEXTROAMPHETAMINE SULFATE 5.00 mg / AMPHETAMINE SULFATE 5.00 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 20 MG Oral Tablet [DEXTROAMPHETAMIN SACC/SULF-AMPHETAMINE ASPART/SULF]",
                        "Dextroamphetamine saccharate 5 mg / Amphetamine aspartate 5 mg / Dextroamphetamine sulfate 5 mg / Amphetamine sulfate 5 mg ORAL TABLET [Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate]",
                        "DEXTROAMPHETAMINE SACCHARATE 5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg / DEXTROAMPHETAMINE SULFATE 5 mg / AMPHETAMINE SULFATE 5 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE]",
                        "AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg / AMPHETAMINE SULFATE 5 mg / DEXTROAMPHETAMINE SULFATE 5 mg / DEXTROAMPHETAMINE SACCHARATE 5 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE]"
                    ],
                    "UMLS:C1585326": [
                        "Amphetamine Aspartate Monohydrate 7.5 mg / AMPHETAMINE SULFATE 7.5 mg / DEXTROAMPHETAMINE SACCHARATE 7.5 mg / DEXTROAMPHETAMINE SULFATE 7.5 mg ORAL TABLET [Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII]",
                        "Amphetamine Salts Oral tablet",
                        "AMPHETAMINE/DEXTROAMPHETAMINE 30MG TAB",
                        "mixed amphetamine salts 30 MG Oral Tablet",
                        "dextroamphetamine/amphetamine 30 mg ORAL TABLET",
                        "amphetamine-dextroamphetamine 30 mg oral tablet",
                        "Amphetamine-Dextroamphetamine, 30 mg oral tablet",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate@30 mg@ORAL@TABLET",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate 30 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 30 MG Oral Tablet",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 30 MG Oral Tablet [AMPHETAMINE SALT COMBO]",
                        "amphetamine aspartate 7.5 MG / amphetamine sulfate 7.5 MG / dextroamphetamine saccharate 7.5 MG / dextroamphetamine sulfate 7.5 MG Oral Tablet",
                        "dextroamphetamine saccharate 7.5 MG / amphetamine aspartate 7.5 MG / dextroamphetamine sulfate 7.5 MG / amphetamine sulfate 7.5 MG Oral Tablet",
                        "AMPHETAMINE SULFATE 7.5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg / DEXTROAMPHETAMINE SULFATE 7.5 mg / DEXTROAMPHETAMINE SACCHARATE 7.5 mg ORAL TABLET",
                        "DEXTROAMPHETAMINE SACCHARATE 7.5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg / DEXTROAMPHETAMINE SULFATE 7.5 mg / AMPHETAMINE SULFATE 7.5 mg ORAL TABLET",
                        "DEXTROAMPHETAMINE SACCHARATE 7.50 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 7.50 mg / DEXTROAMPHETAMINE SULFATE 7.50 mg / AMPHETAMINE SULFATE 7.50 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 30 MG Oral Tablet [DEXTROAMPHETAMIN SACC/SULF-AMPHETAMINE ASPART/SULF]",
                        "Dextroamphetamine saccharate 7.5 mg / Amphetamine aspartate 7.5 mg / Dextroamphetamine sulfate 7.5 mg / Amphetamine sulfate 7.5 mg ORAL TABLET [Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate]",
                        "DEXTROAMPHETAMINE SACCHARATE 7.5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg / DEXTROAMPHETAMINE SULFATE 7.5 mg / AMPHETAMINE SULFATE 7.5 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE]",
                        "AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg / AMPHETAMINE SULFATE 7.5 mg / DEXTROAMPHETAMINE SULFATE 7.5 mg / DEXTROAMPHETAMINE SACCHARATE 7.5 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE]"
                    ],
                    "UMLS:C1623081": [
                        "Amphetamine Aspartate Monohydrate 2.5 mg / AMPHETAMINE SULFATE 2.5 mg / DEXTROAMPHETAMINE SACCHARATE 2.5 mg / DEXTROAMPHETAMINE SULFATE 2.5 mg ORAL TABLET [Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII]",
                        "AMPHETAMINE/DEXTROAMPHETAMINE 10MG TAB",
                        "mixed amphetamine salts 10 MG Oral Tablet",
                        "dextroamphetamine/amphetamine 10 mg ORAL TABLET",
                        "amphetamine-dextroamphetamine 10 mg oral tablet",
                        "Amphetamine-Dextroamphetamine, 10 mg oral tablet",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate@10 mg@ORAL@TABLET",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate 10 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 10 MG Oral Tablet",
                        "Amphetamine Aspartate 2.5mg, Amphetamine Sulfate 2.5mg, Dextroamphetamine Saccharate 2.5mg, Dextroamphetamine Sulfate 2.5mg Oral tablet",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 10 MG Oral Tablet [AMPHETAMINE SALT COMBO]",
                        "dextroamphetamine saccharate 2.5 MG / amphetamine aspartate 2.5 MG / dextroamphetamine sulfate 2.5 MG / amphetamine sulfate 2.5 MG Oral Tablet",
                        "amphetamine aspartate 2.5 MG / amphetamine sulfate 2.5 MG / dextroamphetamine saccharate 2.5 MG / dextroamphetamine sulfate 2.5 MG Oral Tablet",
                        "AMPHETAMINE SULFATE 2.5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg / DEXTROAMPHETAMINE SULFATE 2.5 mg / DEXTROAMPHETAMINE SACCHARATE 2.5 mg ORAL TABLET",
                        "DEXTROAMPHETAMINE SACCHARATE 2.5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg / DEXTROAMPHETAMINE SULFATE 2.5 mg / AMPHETAMINE SULFATE 2.5 mg ORAL TABLET",
                        "DEXTROAMPHETAMINE SACCHARATE 2.50 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 2.50 mg / DEXTROAMPHETAMINE SULFATE 2.50 mg / AMPHETAMINE SULFATE 2.50 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 10 MG Oral Tablet [DEXTROAMPHETAMIN SACC/SULF-AMPHETAMINE ASPART/SULF]",
                        "DEXTROAMPHETAMINE SACCHARATE 2.5 mg / AMPHETAMINE ASPARTATE 2.5 mg / DEXTROAMPHETAMINE SULFATE 2.5 mg / AMPHETAMINE SULFATE 2.5 mg ORAL TABLET [Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate]",
                        "Dextroamphetamine saccharate 2.5 mg / Amphetamine aspartate 2.5 mg / Dextroamphetamine sulfate 2.5 mg / Amphetamine sulfate 2.5 mg ORAL TABLET [Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate]",
                        "DEXTROAMPHETAMINE SACCHARATE 2.5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg / DEXTROAMPHETAMINE SULFATE 2.5 mg / AMPHETAMINE SULFATE 2.5 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE]",
                        "AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg / AMPHETAMINE SULFATE 2.5 mg / DEXTROAMPHETAMINE SULFATE 2.5 mg / DEXTROAMPHETAMINE SACCHARATE 2.5 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE]"
                    ],
                    "UMLS:C0974358": [
                        "Amphetamine Aspartate Monohydrate 1.25 mg / AMPHETAMINE SULFATE 1.25 mg / DEXTROAMPHETAMINE SACCHARATE 1.25 mg / DEXTROAMPHETAMINE SULFATE 1.25 mg ORAL TABLET [Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII]",
                        "Amphetamine Salts Oral tablet",
                        "AMPHETAMINE/DEXTROAMPHETAMINE 5MG TAB",
                        "mixed amphetamine salts 5 MG Oral Tablet",
                        "dextroamphetamine/amphetamine 5 mg ORAL TABLET",
                        "amphetamine-dextroamphetamine 5 mg oral tablet",
                        "Amphetamine-Dextroamphetamine, 5 mg oral tablet",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate@5 mg@ORAL@TABLET",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate 5 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 5 MG Oral Tablet",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 5 MG Oral Tablet [AMPHETAMINE SALT COMBO]",
                        "amphetamine aspartate 1.25 MG / amphetamine sulfate 1.25 MG / dextroamphetamine saccharate 1.25 MG / dextroamphetamine sulfate 1.25 MG Oral Tablet",
                        "dextroamphetamine saccharate 1.25 MG / amphetamine aspartate 1.25 MG / dextroamphetamine sulfate 1.25 MG / amphetamine sulfate 1.25 MG Oral Tablet",
                        "DEXTROAMPHETAMINE SACCHARATE 1.25 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg / DEXTROAMPHETAMINE SULFATE 1.25 mg / AMPHETAMINE SULFATE 1.25 mg ORAL TABLET",
                        "AMPHETAMINE SULFATE 1.25 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg / DEXTROAMPHETAMINE SULFATE 1.25 mg / DEXTROAMPHETAMINE SACCHARATE 1.25 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 5 MG Oral Tablet [DEXTROAMPHETAMIN SACC/SULF-AMPHETAMINE ASPART/SULF]",
                        "Dextroamphetamine saccharate 1.25 mg / Amphetamine aspartate 1.25 mg / Dextroamphetamine sulfate 1.25 mg / Amphetamine sulfate 1.25 mg ORAL TABLET [Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate]",
                        "DEXTROAMPHETAMINE SACCHARATE 1.25 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg / DEXTROAMPHETAMINE SULFATE 1.25 mg / AMPHETAMINE SULFATE 1.25 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE]",
                        "AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg / AMPHETAMINE SULFATE 1.25 mg / DEXTROAMPHETAMINE SULFATE 1.25 mg / DEXTROAMPHETAMINE SACCHARATE 1.25 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE]",
                        "DEXTROAMPHETAMINE SACCHARATE 1.25 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg / DEXTROAMPHETAMINE SULFATE 1.25 mg / AMPHETAMINE SULFATE 1.25 mg ORAL TABLET [Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate]"
                    ]
                }
            },
            {
                "label": "are indicated in",
                "id": {
                    "UMLS:C1548408": [
                        "The indicated time slot(s) is(are) blocked"
                    ],
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C0514907": [
                        "Provide input in areas of strength and development needs, as indicated"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4714006": [
                        "Activate the rapid response team if indicated by presence of trigger areas, per agency protocol"
                    ]
                }
            },
            {
                "label": "Attention Deficit Disorder with Hyperactivity",
                "id": {
                    "MONDO:0005302": [
                        "Attention deficit disorder with hyperactivity",
                        "attention deficit disorder with hyperactivity",
                        "Attention Deficit Disorder with Hyperactivity",
                        "Attention Deficit Disorders with Hyperactivity",
                        "attention deficit disorder; with hyperactivity",
                        "Attention deficit disorder without hyperactivity",
                        "attention deficit disorder without hyperactivity",
                        "attention deficit disorder; without hyperactivity",
                        "ADD - Attention deficit disorder with hyperactivity",
                        "ADHD - Attention deficit disorder with hyperactivity",
                        "ADD - Attention deficit disorder without hyperactivity",
                        "Attention deficit disorder with hyperactivity syndrome",
                        "disorder; attention deficit, with hyperactivity (ADHD)",
                        "Attention deficit disorder without hyperactivity syndrome",
                        "Attention deficit disorder of childhood with hyperactivity",
                        "Attention deficit disorder without mention of hyperactivity",
                        "attention deficit disorder without hyperactivity (diagnosis)",
                        "Attention deficit disorder of childhood without mention of hyperactivity",
                        "ADD",
                        "ADHD",
                        "ADDH",
                        "ADHD",
                        "addh",
                        "MBD syndrome",
                        "Attention deficit",
                        "Attention-deficit",
                        "deficit; attention",
                        "Attention deficits",
                        "child; hyperactivity",
                        "hyperactivity; child",
                        "Hyperkinetic Syndrome",
                        "hyperkinetic disorder",
                        "SYNDROME HYPERKINETIC",
                        "Hyperkinetic disorder",
                        "Syndrome hyperkinetic",
                        "ATTENTION DEFICIT DIS",
                        "Hyperkinetic synd NOS",
                        "HYPERKINETIC SYNDROME",
                        "Hyperkinetic syndrome",
                        "hyperkinetic disorder",
                        "hyperkinetic syndrome",
                        "hyperkinetic; syndrome",
                        "disorder hyperactivity",
                        "syndrome; hyperkinetic",
                        "hyperactivity disorder",
                        "hyperkinetic; disorder",
                        "Attn defic nonhyperact",
                        "Hyperkinetic disorders",
                        "disorder; hyperkinetic",
                        "disorder; hyperactivity",
                        "Minimal Brain Disorders",
                        "Attn deficit w hyperact",
                        "Syndromes, Hyperkinetic",
                        "hyperactivity; disorder",
                        "Hyperkinetic syndrome NOS",
                        "Minimal brain dysfunction",
                        "Minimal Brain Dysfunction",
                        "MINIMAL BRAIN DYSFUNCTION",
                        "Overactive child syndrome",
                        "minimal brain dysfunction",
                        "Brain Dysfunction, Minimal",
                        "attention deficit disorder",
                        "Hyperactivity Disorder NOS",
                        "Hyperactive child syndrome",
                        "Attention Deficit Disorder",
                        "Attention-deficit disorder",
                        "attention deficit disorder",
                        "attention-deficit disorder",
                        "HYPERACTIVITY OF CHILDHOOD",
                        "ATTENTION DEFICIT DISORDER",
                        "Dysfunction, Minimal Brain",
                        "hyperactive child syndrome",
                        "Attention deficit disorder",
                        "Attention Deficit Disorders",
                        "Deficit Disorder, Attention",
                        "Disorder, Attention Deficit",
                        "disorder; attention deficit",
                        "attention deficit disorders",
                        "Deficit Disorders, Attention",
                        "Disorders, Attention Deficit",
                        "Childhood hyperkinetic syndr.",
                        "MBD - Minimal brain dysfunctn",
                        "Minimal brain damage syndrome",
                        "Att deficit hyperactivity dis",
                        "ADD - Attention deficit disord",
                        "attention deficit disorder add",
                        "Attntn defic dis w/out hypract",
                        "Disorder;attent deficit(hyper)",
                        "Attention-Deficit Disorder NOS",
                        "ADD-Attn def dis with hyperact",
                        "ADD-Attn defic dis w/t hypract",
                        "add attention deficit disorder",
                        "Attentn deficit hyperkin disor",
                        "Attention deficit-not hyperact",
                        "Childhood hyperkinetic syndrome",
                        "childhood hyperkinetic syndrome",
                        "MBD - Minimal brain dysfunction",
                        "attention deficit hyper disorder",
                        "ADD - Attention deficit disorder",
                        "attention deficit(hyper) disorder",
                        "attention deficits disorder hyper",
                        "Unspecified hyperkinetic syndrome",
                        "Hyperkinetic syndrome of childhood",
                        "Minimal brain dysfunction syndrome",
                        "Hyperkinetic disorder, unspecified",
                        "ATTENTION DEFICIT HYPERACTIVITY DIS",
                        "ADHD, predominantly inattentive type",
                        "Attention deficit without hyperactivity",
                        "Attention deficit hyperkinetic disorder",
                        "Attention Deficit Hyperactivity Disorder",
                        "Attention-deficit hyperactivity disorder",
                        "attention deficit hyperactivity disorder",
                        "attention-deficit hyperactivity disorder",
                        "Attention deficit-hyperactivity disorder",
                        "attention deficit hyperactivity disorder",
                        "Attention deficit/hyperactivity disorder",
                        "ATTENTION DEFICIT DIS WITH HYPERACTIVITY",
                        "Attention-deficit/hyperactivity disorder",
                        "Attention deficit hyperactivity disorder",
                        "ATTENTION DEFICIT-HYPERACTIVITY DISORDER",
                        "Attention Deficit-Hyperactivity Disorder",
                        "ATTENTION DEFICIT HYPERACTIVITY DISORDER",
                        "Attention Deficit Hyperactivity Disorders",
                        "Attention Deficit-Hyperactivity Disorders",
                        "Disorder, Attention Deficit-Hyperactivity",
                        "Attention-deficit hyperactivity disorders",
                        "Deficit-Hyperactivity Disorder, Attention",
                        "Deficit-Hyperactivity Disorders, Attention",
                        "Disorders, Attention Deficit-Hyperactivity",
                        "Attention-deficit hyperactivity disorder NOS",
                        "Attention deficit/hyperactivity disorder NOS",
                        "attention deficit syndrome with hyperactivity",
                        "unspecified hyperkinetic syndrome of childhood",
                        "Unspecified hyperkinetic syndrome of childhood",
                        "ADHD, predominantly hyperactive-impulsive type",
                        "attention deficit hyperactivity disorder (ADHD)",
                        "Attention deficit hyperactivity disorder (ADHD)",
                        "Attention-deficit/hyperactivity disorder (ADHD)",
                        "ADHD (attention deficit hyperactivity disorder)",
                        "Attention deficit-hyperactivity disorder (ADHD)",
                        "Attention-deficit hyperactivity disorder (ADHD)",
                        "ADHD (attention-deficit hyperactivity disorder)",
                        "ADHD, predominantly inattentive type (diagnosis)",
                        "Childhood attention deficit/hyperactivity disorder",
                        "Attention deficit hyperactivity disorder (disorder)",
                        "attention-deficit hyperactivity disorder (diagnosis)",
                        "attention-deficit disorder predominantly inattentive type",
                        "unspecified hyperkinetic syndrome of childhood (diagnosis)",
                        "Attention-Deficit Disorder, Predominantly Inattentive Type",
                        "attention deficit hyperactivity disorder, inattentive type",
                        "Attn-defct hyperactivity disorder, predom inattentive type",
                        "Attention Deficit Hyperactivity Disorder, Inattentive Type",
                        "Hyperactivity Disorder, Predominantly Hyperactive-Impulsive Type",
                        "Attention deficit hyperactivity disorder, hyperactive impulsive type",
                        "Attention-Deficit Disorder, Predominantly Hyperactive-Impulsive Type",
                        "Attention Deficit Hyperactivity Disorder, Inattentive/Distractible Type",
                        "attention deficit hyperactivity disorder, inattentive/distractible type",
                        "attention-deficit hyperactivity disorder predominantly inattentive type",
                        "attention deficit hyperactivity disorder, predominantly inattentive type",
                        "Attention Deficit Hyperactivity Disorder, Predominantly Inattentive Type",
                        "Attention deficit hyperactivity disorder, predominantly inattentive type",
                        "Attention-deficit hyperactivity disorder, predominantly inattentive type",
                        "Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type",
                        "Attention deficit hyperactivity disorder, predominantly hyperactive impulsive type",
                        "Attention deficit hyperactivity disorder, predominantly inattentive type (disorder)",
                        "Attention deficit hyperactivity disorder, predominantly hyperactive impulsive type (disorder)"
                    ],
                    "UMLS:C3695185": [
                        "attention-deficit hyperactivity disorder with residual state",
                        "attention-deficit hyperactivity disorder with residual state (diagnosis)"
                    ],
                    "UMLS:C4016488": [
                        "AARSKOG-SCOTT SYNDROME WITH ATTENTION DEFICIT-HYPERACTIVITY DISORDER"
                    ],
                    "MONDO:0010589": [
                        "FACIOGENITAL DYSPLASIA WITH ATTENTION DEFICIT-HYPERACTIVITY DISORDER",
                        "Faciogenital Dysplasia with Attention Deficit-Hyperactivity Disorder",
                        "faciogenital dysplasia with attention Deficit-hyperactivity disorder",
                        "FGD",
                        "AAS",
                        "FGD",
                        "AAS",
                        "FGDY",
                        "FGDY",
                        "MRXS16",
                        "Aarskog",
                        "Greig syndrome",
                        "greig syndrome",
                        "greigs syndrome",
                        "Aarskog disease",
                        "Aarskog Disease",
                        "Aarskog syndrome",
                        "MRXS16, included",
                        "aarskog syndrome",
                        "Aarskog Syndrome",
                        "Aarskog syndrome",
                        "aarskogs syndrome",
                        "Aarskog's syndrome",
                        "aarskog's syndrome",
                        "Aarskog-like syndrome",
                        "FACIOGENITAL DYSPLASIA",
                        "faciogenital dysplasia",
                        "Aarskog-Scott syndrome",
                        "Scott Aarskog Syndrome",
                        "aarskog-scott syndrome",
                        "Aarskog-Scott Syndrome",
                        "faciogenital dysplasia",
                        "Aarskog-Scott syndrome",
                        "Aarskog Scott syndrome",
                        "Scott Aarskog syndrome",
                        "Faciogenital Dysplasia",
                        "AARSKOG-SCOTT SYNDROME",
                        "Faciogenital dysplasia",
                        "shawl scrotum syndrome",
                        "facio-genital dysplasia",
                        "AARSKOG SYNDROME, X-LINKED",
                        "Aarskog syndrome, X-linked",
                        "FACIODIGITOGENITAL SYNDROME",
                        "Aarskog syndrome (disorder)",
                        "Faciodigitogenital Syndrome",
                        "Faciodigitogenital syndrome",
                        "faciodigitogenital syndrome",
                        "Aarskog-Scott syndrome (ASS)",
                        "facio-digito-genital syndrome",
                        "Facio-Digito-Genital Dysplasia",
                        "facio-digito-genital dysplasia",
                        "facial-digital-genital syndrome",
                        "Aarskog-Scott syndrome, X-linked",
                        "Aarskog-Scott syndrome (diagnosis)",
                        "faciodigitogenital syndrome, recessive",
                        "MENTAL RETARDATION, X-LINKED, SYNDROMIC 16",
                        "Aarskog-Scott syndrome, X-linked recessive",
                        "mental retardation, X-linked, syndromic 16",
                        "mental retardation, X-linked, syndromic 16, included",
                        "INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 16",
                        "mental retardation, X-linked syndromic 16, X-linked recessive"
                    ],
                    "UMLS:C3864054": [
                        "attention deficit disorder without hyperactivity, predominantly inattentive type",
                        "attention deficit disorder without hyperactivity, predominantly inattentive type (diagnosis)"
                    ]
                }
            }
        ],
        [
            {
                "label": "Dextroamphetamine sulfate tablets",
                "id": {
                    "UMLS:C4719803": [
                        "Dextroamphetamine Sulfate Tablets"
                    ],
                    "UMLS:C1384309": [
                        "Amphetamine Aspartate Monohydrate 5 mg / AMPHETAMINE SULFATE 5 mg / DEXTROAMPHETAMINE SACCHARATE 5 mg / DEXTROAMPHETAMINE SULFATE 5 mg ORAL TABLET [Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII]",
                        "Amphetamine Salts Oral tablet",
                        "AMPHETAMINE/DEXTROAMPHETAMINE 20MG TAB",
                        "mixed amphetamine salts 20 MG Oral Tablet",
                        "amphetamine-dextroamphetamine 20 mg oral tablet",
                        "dextroamphetamine/amphetamine 20 mg ORAL TABLET",
                        "Amphetamine-Dextroamphetamine, 20 mg oral tablet",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate 20 mg ORAL TABLET",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate@20 mg@ORAL@TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 20 MG Oral Tablet",
                        "dextroamphetamine saccharate 5 MG / amphetamine aspartate 5 MG / dextroamphetamine sulfate 5 MG / amphetamine sulfate 5 MG Oral Tablet",
                        "amphetamine aspartate 5 MG / amphetamine sulfate 5 MG / dextroamphetamine saccharate 5 MG / dextroamphetamine sulfate 5 MG Oral Tablet",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 20 MG Oral Tablet [AMPHETAMINE SALT COMBO]",
                        "DEXTROAMPHETAMINE SACCHARATE 5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg / DEXTROAMPHETAMINE SULFATE 5 mg / AMPHETAMINE SULFATE 5 mg ORAL TABLET",
                        "AMPHETAMINE SULFATE 5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg / DEXTROAMPHETAMINE SULFATE 5 mg / DEXTROAMPHETAMINE SACCHARATE 5 mg ORAL TABLET",
                        "DEXTROAMPHETAMINE SACCHARATE 5.00 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 5.00 mg / DEXTROAMPHETAMINE SULFATE 5.00 mg / AMPHETAMINE SULFATE 5.00 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 20 MG Oral Tablet [DEXTROAMPHETAMIN SACC/SULF-AMPHETAMINE ASPART/SULF]",
                        "Dextroamphetamine saccharate 5 mg / Amphetamine aspartate 5 mg / Dextroamphetamine sulfate 5 mg / Amphetamine sulfate 5 mg ORAL TABLET [Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate]",
                        "DEXTROAMPHETAMINE SACCHARATE 5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg / DEXTROAMPHETAMINE SULFATE 5 mg / AMPHETAMINE SULFATE 5 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE]",
                        "AMPHETAMINE ASPARTATE MONOHYDRATE 5 mg / AMPHETAMINE SULFATE 5 mg / DEXTROAMPHETAMINE SULFATE 5 mg / DEXTROAMPHETAMINE SACCHARATE 5 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE]"
                    ],
                    "UMLS:C1585326": [
                        "Amphetamine Aspartate Monohydrate 7.5 mg / AMPHETAMINE SULFATE 7.5 mg / DEXTROAMPHETAMINE SACCHARATE 7.5 mg / DEXTROAMPHETAMINE SULFATE 7.5 mg ORAL TABLET [Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII]",
                        "Amphetamine Salts Oral tablet",
                        "AMPHETAMINE/DEXTROAMPHETAMINE 30MG TAB",
                        "mixed amphetamine salts 30 MG Oral Tablet",
                        "dextroamphetamine/amphetamine 30 mg ORAL TABLET",
                        "amphetamine-dextroamphetamine 30 mg oral tablet",
                        "Amphetamine-Dextroamphetamine, 30 mg oral tablet",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate@30 mg@ORAL@TABLET",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate 30 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 30 MG Oral Tablet",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 30 MG Oral Tablet [AMPHETAMINE SALT COMBO]",
                        "amphetamine aspartate 7.5 MG / amphetamine sulfate 7.5 MG / dextroamphetamine saccharate 7.5 MG / dextroamphetamine sulfate 7.5 MG Oral Tablet",
                        "dextroamphetamine saccharate 7.5 MG / amphetamine aspartate 7.5 MG / dextroamphetamine sulfate 7.5 MG / amphetamine sulfate 7.5 MG Oral Tablet",
                        "AMPHETAMINE SULFATE 7.5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg / DEXTROAMPHETAMINE SULFATE 7.5 mg / DEXTROAMPHETAMINE SACCHARATE 7.5 mg ORAL TABLET",
                        "DEXTROAMPHETAMINE SACCHARATE 7.5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg / DEXTROAMPHETAMINE SULFATE 7.5 mg / AMPHETAMINE SULFATE 7.5 mg ORAL TABLET",
                        "DEXTROAMPHETAMINE SACCHARATE 7.50 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 7.50 mg / DEXTROAMPHETAMINE SULFATE 7.50 mg / AMPHETAMINE SULFATE 7.50 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 30 MG Oral Tablet [DEXTROAMPHETAMIN SACC/SULF-AMPHETAMINE ASPART/SULF]",
                        "Dextroamphetamine saccharate 7.5 mg / Amphetamine aspartate 7.5 mg / Dextroamphetamine sulfate 7.5 mg / Amphetamine sulfate 7.5 mg ORAL TABLET [Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate]",
                        "DEXTROAMPHETAMINE SACCHARATE 7.5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg / DEXTROAMPHETAMINE SULFATE 7.5 mg / AMPHETAMINE SULFATE 7.5 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE]",
                        "AMPHETAMINE ASPARTATE MONOHYDRATE 7.5 mg / AMPHETAMINE SULFATE 7.5 mg / DEXTROAMPHETAMINE SULFATE 7.5 mg / DEXTROAMPHETAMINE SACCHARATE 7.5 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE]"
                    ],
                    "UMLS:C1623081": [
                        "Amphetamine Aspartate Monohydrate 2.5 mg / AMPHETAMINE SULFATE 2.5 mg / DEXTROAMPHETAMINE SACCHARATE 2.5 mg / DEXTROAMPHETAMINE SULFATE 2.5 mg ORAL TABLET [Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII]",
                        "AMPHETAMINE/DEXTROAMPHETAMINE 10MG TAB",
                        "mixed amphetamine salts 10 MG Oral Tablet",
                        "dextroamphetamine/amphetamine 10 mg ORAL TABLET",
                        "amphetamine-dextroamphetamine 10 mg oral tablet",
                        "Amphetamine-Dextroamphetamine, 10 mg oral tablet",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate@10 mg@ORAL@TABLET",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate 10 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 10 MG Oral Tablet",
                        "Amphetamine Aspartate 2.5mg, Amphetamine Sulfate 2.5mg, Dextroamphetamine Saccharate 2.5mg, Dextroamphetamine Sulfate 2.5mg Oral tablet",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 10 MG Oral Tablet [AMPHETAMINE SALT COMBO]",
                        "dextroamphetamine saccharate 2.5 MG / amphetamine aspartate 2.5 MG / dextroamphetamine sulfate 2.5 MG / amphetamine sulfate 2.5 MG Oral Tablet",
                        "amphetamine aspartate 2.5 MG / amphetamine sulfate 2.5 MG / dextroamphetamine saccharate 2.5 MG / dextroamphetamine sulfate 2.5 MG Oral Tablet",
                        "AMPHETAMINE SULFATE 2.5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg / DEXTROAMPHETAMINE SULFATE 2.5 mg / DEXTROAMPHETAMINE SACCHARATE 2.5 mg ORAL TABLET",
                        "DEXTROAMPHETAMINE SACCHARATE 2.5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg / DEXTROAMPHETAMINE SULFATE 2.5 mg / AMPHETAMINE SULFATE 2.5 mg ORAL TABLET",
                        "DEXTROAMPHETAMINE SACCHARATE 2.50 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 2.50 mg / DEXTROAMPHETAMINE SULFATE 2.50 mg / AMPHETAMINE SULFATE 2.50 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 10 MG Oral Tablet [DEXTROAMPHETAMIN SACC/SULF-AMPHETAMINE ASPART/SULF]",
                        "DEXTROAMPHETAMINE SACCHARATE 2.5 mg / AMPHETAMINE ASPARTATE 2.5 mg / DEXTROAMPHETAMINE SULFATE 2.5 mg / AMPHETAMINE SULFATE 2.5 mg ORAL TABLET [Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate]",
                        "Dextroamphetamine saccharate 2.5 mg / Amphetamine aspartate 2.5 mg / Dextroamphetamine sulfate 2.5 mg / Amphetamine sulfate 2.5 mg ORAL TABLET [Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate]",
                        "DEXTROAMPHETAMINE SACCHARATE 2.5 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg / DEXTROAMPHETAMINE SULFATE 2.5 mg / AMPHETAMINE SULFATE 2.5 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE]",
                        "AMPHETAMINE ASPARTATE MONOHYDRATE 2.5 mg / AMPHETAMINE SULFATE 2.5 mg / DEXTROAMPHETAMINE SULFATE 2.5 mg / DEXTROAMPHETAMINE SACCHARATE 2.5 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE]"
                    ],
                    "UMLS:C0974358": [
                        "Amphetamine Aspartate Monohydrate 1.25 mg / AMPHETAMINE SULFATE 1.25 mg / DEXTROAMPHETAMINE SACCHARATE 1.25 mg / DEXTROAMPHETAMINE SULFATE 1.25 mg ORAL TABLET [Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Tablets,CII]",
                        "Amphetamine Salts Oral tablet",
                        "AMPHETAMINE/DEXTROAMPHETAMINE 5MG TAB",
                        "mixed amphetamine salts 5 MG Oral Tablet",
                        "dextroamphetamine/amphetamine 5 mg ORAL TABLET",
                        "amphetamine-dextroamphetamine 5 mg oral tablet",
                        "Amphetamine-Dextroamphetamine, 5 mg oral tablet",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate@5 mg@ORAL@TABLET",
                        "dextroamphetamine sulf-saccharate/amphetamine sulf-aspartate 5 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 5 MG Oral Tablet",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 5 MG Oral Tablet [AMPHETAMINE SALT COMBO]",
                        "amphetamine aspartate 1.25 MG / amphetamine sulfate 1.25 MG / dextroamphetamine saccharate 1.25 MG / dextroamphetamine sulfate 1.25 MG Oral Tablet",
                        "dextroamphetamine saccharate 1.25 MG / amphetamine aspartate 1.25 MG / dextroamphetamine sulfate 1.25 MG / amphetamine sulfate 1.25 MG Oral Tablet",
                        "DEXTROAMPHETAMINE SACCHARATE 1.25 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg / DEXTROAMPHETAMINE SULFATE 1.25 mg / AMPHETAMINE SULFATE 1.25 mg ORAL TABLET",
                        "AMPHETAMINE SULFATE 1.25 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg / DEXTROAMPHETAMINE SULFATE 1.25 mg / DEXTROAMPHETAMINE SACCHARATE 1.25 mg ORAL TABLET",
                        "Amphetamine Aspartate/Amphetamine Sulfate/Dextroamphetamine Saccharate/Dextroamphetamine Sulfate 5 MG Oral Tablet [DEXTROAMPHETAMIN SACC/SULF-AMPHETAMINE ASPART/SULF]",
                        "Dextroamphetamine saccharate 1.25 mg / Amphetamine aspartate 1.25 mg / Dextroamphetamine sulfate 1.25 mg / Amphetamine sulfate 1.25 mg ORAL TABLET [Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate]",
                        "DEXTROAMPHETAMINE SACCHARATE 1.25 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg / DEXTROAMPHETAMINE SULFATE 1.25 mg / AMPHETAMINE SULFATE 1.25 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE]",
                        "AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg / AMPHETAMINE SULFATE 1.25 mg / DEXTROAMPHETAMINE SULFATE 1.25 mg / DEXTROAMPHETAMINE SACCHARATE 1.25 mg ORAL TABLET [DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE]",
                        "DEXTROAMPHETAMINE SACCHARATE 1.25 mg / AMPHETAMINE ASPARTATE MONOHYDRATE 1.25 mg / DEXTROAMPHETAMINE SULFATE 1.25 mg / AMPHETAMINE SULFATE 1.25 mg ORAL TABLET [Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate]"
                    ]
                }
            },
            {
                "label": "are integral part of",
                "id": {}
            },
            {
                "label": "a total treatment program",
                "id": {}
            }
        ],
        [
            {
                "label": "a total treatment program",
                "id": {}
            },
            {
                "label": "includes",
                "id": {
                    "UMLS:C0332257": [
                        "Includes",
                        "includes",
                        "include",
                        "Has part",
                        "included",
                        "has part",
                        "Inclusive",
                        "inclusive",
                        "including",
                        "Including",
                        "Including (qualifier)",
                        "Including (qualifier value)"
                    ],
                    "UMLS:C4065484": [
                        "diet includes",
                        "diet includes (history)"
                    ],
                    "UMLS:C4065481": [
                        "diet includes fruit",
                        "diet includes fruit (history)"
                    ],
                    "UMLS:C4065478": [
                        "diet includes peanuts",
                        "diet includes peanuts (history)"
                    ],
                    "UMLS:C3687491": [
                        "Includes sub-specimen",
                        "Includes sub-specimen (attribute)"
                    ]
                }
            },
            {
                "label": "other remedial measures",
                "id": {}
            }
        ],
        [
            {
                "label": "other remedial measures",
                "id": {}
            },
            {
                "label": "are for",
                "id": {
                    "UMLS:C0086312": [
                        "Forested Area",
                        "Forested Areas",
                        "Area, Forested",
                        "Areas, Forested",
                        "forest",
                        "Forest",
                        "Forests",
                        "forests",
                        "Woodland",
                        "Woodlands",
                        "Forestland",
                        "Forestlands",
                        "Forest (environment)"
                    ],
                    "UMLS:C5268462": [
                        "Arenaria forrestii",
                        "Arenaria forrestii Diels"
                    ],
                    "UMLS:C2331620": [
                        "basal forebrain area",
                        "Basal Forebrain Area",
                        "Area, Basal Forebrain",
                        "Forebrain Area, Basal",
                        "Basal Forebrain Areas",
                        "Areas, Basal Forebrain",
                        "Forebrain Areas, Basal",
                        "basal forebrain",
                        "Basal Forebrain",
                        "Basal forebrain",
                        "Basal Forebrains",
                        "Forebrain, Basal",
                        "Forebrains, Basal",
                        "Pars Basalis Telencephali",
                        "Pars basalis telencephali",
                        "Telencephali, Pars Basalis",
                        "Basalis Telencephali, Pars",
                        "Pars Basalis Telencephalus",
                        "Telencephalus, Pars Basalis",
                        "Basalis Telencephalus, Pars"
                    ],
                    "UBERON:0002743": [
                        "basal forebrain area",
                        "basal forebrain",
                        "pars basalis telencephali"
                    ],
                    "PUBCHEM.COMPOUND:2230": [
                        "arecoline in any form",
                        "Arekolin",
                        "arecolin",
                        "Arecolin",
                        "Arecolin",
                        "arekolin",
                        "Arecaline",
                        "arecoline",
                        "ARECOLINE",
                        "Arecaline",
                        "arecaline",
                        "Arecholin",
                        "Arecholin",
                        "arecholin",
                        "arecaline",
                        "Arecoline",
                        "Arecholine",
                        "Arecholine",
                        "arecholine",
                        "arecholine",
                        "Arecoline base",
                        "Methylarecaiden",
                        "methylarecaidin",
                        "methylarecaidin",
                        "methylarecaiden",
                        "Methylarecaidin",
                        "Methylarecaidin",
                        "Arecoline (substance)",
                        "Arecoline hydrobromide",
                        "arecaidine methyl ester",
                        "Arecaidine methyl ester",
                        "Methyl N-methyltetrahydronicotinate",
                        "N-Methyl-beta -carboxylic acid methyl ester",
                        "Methyl 1,2,5,6-tetrahydro-1-methylnicotinate",
                        "Methyl N-methyl-1,2,5,6-tetrahydronicotinate",
                        "Methyl N-methyl-1,2,5, 6-tetrahydronicotinate",
                        "Methyl 1,2,5, 6-tetrahydro-1-methylnicotinate",
                        "N-Methyltetrahydronicotinic acid, methyl ester",
                        "Methyl 1-methyl-5,6-dihydro-2H-pyridine-3-carboxylate",
                        "1,2,5,6-Tetrahydro-1-methylnicotinic acid, methyl ester",
                        "methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate",
                        "Methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate",
                        "Methyl 1-methyl-1,2,5,6-tetrahydro-3-pyridinecarboxylate",
                        "Nicotinic acid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester",
                        "3-Pyridinecarboxylic acid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester"
                    ]
                }
            },
            {
                "label": "a stabilizing effect in pediatric patients",
                "id": {}
            }
        ]
    ],
    "Morphine sulfate is indicated for the relief of severe pain": [
        [
            {
                "label": "Morphine sulfate",
                "id": {
                    "PUBCHEM.COMPOUND:5288826": [
                        "Morphine sulfate",
                        "Sulfate, morphine",
                        "Morphine sulfate (2:1), anhydrous",
                        "Morphine sulfate (2:1), pentahydrate",
                        "Morfina",
                        "Morphia",
                        "Morphin",
                        "morfina",
                        "Morphin",
                        "Morphia",
                        "Morphine",
                        "Morphina",
                        "Morphium",
                        "morphium",
                        "morphine",
                        "MORPHINE",
                        "Morphinum",
                        "Paregoric",
                        "paregoric",
                        "PAREGORIC",
                        "morphinum",
                        "Substitol",
                        "MS Contin",
                        "Duramorph",
                        "Contin, MS",
                        "Oramorph SR",
                        "(-)-Morphine",
                        "(-)-morphine",
                        "Morfina dosa",
                        "D-(-)-Morphine",
                        "Morphine chloride",
                        "anhydrous morphine",
                        "Chloride, morphine",
                        "Anhydrous morphine",
                        "Morphine, Anhydrous",
                        "MORPHINE (ANHYDROUS)",
                        "paregoric (medication)",
                        "Camphorated opium tincture",
                        "camphorated opium tincture",
                        "Anhydrous morphine (substance)",
                        "(5a,6a)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol",
                        "(5Α,6α)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol",
                        "(5R,6S,9R,13S,14R)-4,5-epoxy-N-methyl-7-morphinen-3,6-diol",
                        "(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol",
                        "(5a,6a)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol",
                        "(5Α,6α)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol",
                        "17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol",
                        "(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol",
                        "(5alpha,6alpha)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol",
                        "(5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol",
                        "(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol",
                        "(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL",
                        "(7R,7AS,12BS)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol"
                    ],
                    "UMLS:C0066814": [
                        "MORPHINE SULFATE",
                        "Morphine Sulfate",
                        "morphine sulfate",
                        "Morphine sulfate",
                        "Sulfate, Morphine",
                        "narcotics morphine sulfate",
                        "Morphine sulfate (substance)",
                        "morphine sulfate (medication)",
                        "morphine sulphate",
                        "Morphine sulphate"
                    ],
                    "CHEMBL.COMPOUND:CHEMBL2096625": [
                        "MORPHINE SULFATE",
                        "morphine sulfate",
                        "MORPHINE SULFATE ANHYDROUS",
                        "17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6-diol sulfate (2:1)"
                    ],
                    "PUBCHEM.COMPOUND:6321225": [
                        "MORPHINE SULFATE",
                        "Morphine sulfate hydrate",
                        "morphine sulfate pentahydrate",
                        "Morphine sulfate pentahydrate",
                        "Di(morphine) dihydrogen sulfate pentahydrate",
                        "Statex",
                        "Avinza",
                        "Kadian",
                        "M-Eslon",
                        "DepoDur",
                        "Ms Contin",
                        "Oramorph SR",
                        "Morphine H.P",
                        "Duramorph PF",
                        "Astramorph PF",
                        "Morphine Forte",
                        "Morphine Extra-Forte",
                        "17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6-diol sulfate (2:1) pentahydrate"
                    ],
                    "PUBCHEM.COMPOUND:16051935": [
                        "Morphine sulfate"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the relief of severe pain",
                "id": {}
            }
        ]
    ],
    "The use of morphine for the relief of pain should be reserved for the more severe manifestations of pain, as in myocardial infarction,severe injuries, or in severe chronic pain associated with terminal cancer after all non-narcotic analgesics have failed.": [
        [
            {
                "label": "The use of morphine",
                "id": {}
            },
            {
                "label": "should be reserved for",
                "id": {}
            },
            {
                "label": "the more severe manifestations of pain",
                "id": {}
            }
        ],
        [
            {
                "label": "severe manifestations of pain",
                "id": {}
            },
            {
                "label": "as in",
                "id": {
                    "NCBIGene:109729178": [
                        "INTS9-AS1",
                        "INTS9-AS1 gene",
                        "ENST00000520055",
                        "ENST00000520055",
                        "INTS9 antisense RNA 1"
                    ],
                    "NCBIGene:285954": [
                        "INHBA-AS1",
                        "INHBA-AS1 gene",
                        "INHBA antisense RNA 1",
                        "INHBA antisense RNA 1 (non-protein coding)"
                    ],
                    "NCBIGene:100506343": [
                        "INKA2-AS1",
                        "INKA2-AS1 gene",
                        "FAM212B-AS1",
                        "INKA2 antisense RNA 1",
                        "FAM212B antisense RNA 1"
                    ],
                    "NCBIGene:100507398": [
                        "INTS6-AS1",
                        "INTS6-AS1 gene",
                        "INTS6 antisense RNA 1",
                        "INTS6 antisense RNA 1 (non-protein coding)"
                    ],
                    "NCBIGene:109729177": [
                        "INO80-AS1",
                        "INO80-AS1 gene",
                        "ENST00000560178",
                        "ENST00000560178",
                        "INO80 antisense RNA 1"
                    ]
                }
            },
            {
                "label": "myocardial infarction",
                "id": {
                    "NCIT:C101589": [
                        "Myocardial Infarction",
                        "MYOCARDIAL INFARCTION",
                        "myocardial infarction ecg",
                        "ecg infarction myocardial",
                        "ecg myocardial infarction",
                        "ecg: myocardial infarction",
                        "ECG: myocardial infarction",
                        "EKG: myocardial infarction",
                        "Myocardial Infarction by ECG Finding",
                        "Myocardial Infarction by EKG Finding",
                        "Electrocardiographic myocardial infarction",
                        "Electrocardiogram: myocardial infarction (finding)",
                        "Electrocardiographic myocardial infarction (finding)",
                        "EKG findings of infarction",
                        "Electrocardiogram finding of infarction"
                    ],
                    "NCIT:C143691": [
                        "Myocardial infarction",
                        "Myocardial Infarction",
                        "Myocardial Infarction, CTCAE"
                    ],
                    "MONDO:0005068": [
                        "Myocardial Infarction",
                        "MYOCARDIAL INFARCTION",
                        "myocardial infarction",
                        "Myocardial infarction",
                        "Infarction;myocardial",
                        "myocardial infarction",
                        "Myocardial Infarctions",
                        "Infarction, Myocardial",
                        "myocardial infarctions",
                        "infarction; myocardial",
                        "infarctions myocardial",
                        "Infarctions, Myocardial",
                        "Infarctions (Myocardial)",
                        "MI, myocardial infarction",
                        "Myocardial infarction NOS",
                        "Myocardial infarction (MI)",
                        "MI - myocardial infarction",
                        "Myocardial infarction, NOS",
                        "MI - Myocardial infarction",
                        "infarction (MI), myocardial",
                        "myocardial infarction, (MI)",
                        "syndrome myocardial infarction",
                        "disorder infarction myocardial",
                        "Myocardial infarction syndrome",
                        "myocardial infarction (disease)",
                        "Myocardial infarction (disorder)",
                        "myocardial infarction (diagnosis)",
                        "MI",
                        "mi",
                        "AMI",
                        "mies",
                        "HEART ATTACK",
                        "heart attack",
                        "Heart attack",
                        "Heart Attack",
                        "heart attack",
                        "heart attacks",
                        "Heart Attacks",
                        "attack hearts",
                        "attacks hearts",
                        "coronary attack",
                        "attacking heart",
                        "Cardiac infarct",
                        "ATTACK CORONARY",
                        "Attack coronary",
                        "heart infarction",
                        "Infarction;heart",
                        "attacks coronary",
                        "HEART INFARCTION",
                        "Heart attack, NOS",
                        "myocardial infarct",
                        "INFARCT MYOCARDIAL",
                        "Attack heart (NOS)",
                        "Myocardial infarct",
                        "Cardiac infarction",
                        "Myocardial infarct",
                        "Infarct myocardial",
                        "MYOCARDIAL INFARCT",
                        "Myocardial Infarct",
                        "ATTACK HEART (NOS)",
                        "cardiac infarction",
                        "Myocardial Infarcts",
                        "Infarction of heart",
                        "cardiac; infarction",
                        "infarcts myocardial",
                        "Infarct, Myocardial",
                        "myocardial necrosis",
                        "myocardial infarcts",
                        "Infarcts, Myocardial",
                        "Cardiovascular Stroke",
                        "Cardiovascular Strokes",
                        "Stroke, Cardiovascular",
                        "Cardiac infarction, NOS",
                        "Strokes, Cardiovascular",
                        "Infarction of heart, NOS"
                    ],
                    "UMLS:C2926063": [
                        "Myocardial infarction",
                        "Myocardial infarction:Find:Pt:^Patient:Ord",
                        "Myocardial infarction:Finding:Point in time:^Patient:Ordinal",
                        "Myocardial infarction:Finding:To identify measures at a point in time:^Patient:Ordinal"
                    ],
                    "NCIT:C102731": [
                        "New Myocardial Infarction",
                        "NEW MYOCARDIAL INFARCTION",
                        "New Myocardial Infarction by EKG Finding",
                        "New Myocardial Infarction by ECG Finding"
                    ]
                }
            }
        ],
        [
            {
                "label": "severe manifestations of pain",
                "id": {}
            },
            {
                "label": "as in",
                "id": {
                    "NCBIGene:109729178": [
                        "INTS9-AS1",
                        "INTS9-AS1 gene",
                        "ENST00000520055",
                        "ENST00000520055",
                        "INTS9 antisense RNA 1"
                    ],
                    "NCBIGene:285954": [
                        "INHBA-AS1",
                        "INHBA-AS1 gene",
                        "INHBA antisense RNA 1",
                        "INHBA antisense RNA 1 (non-protein coding)"
                    ],
                    "NCBIGene:100506343": [
                        "INKA2-AS1",
                        "INKA2-AS1 gene",
                        "FAM212B-AS1",
                        "INKA2 antisense RNA 1",
                        "FAM212B antisense RNA 1"
                    ],
                    "NCBIGene:100507398": [
                        "INTS6-AS1",
                        "INTS6-AS1 gene",
                        "INTS6 antisense RNA 1",
                        "INTS6 antisense RNA 1 (non-protein coding)"
                    ],
                    "NCBIGene:109729177": [
                        "INO80-AS1",
                        "INO80-AS1 gene",
                        "ENST00000560178",
                        "ENST00000560178",
                        "INO80 antisense RNA 1"
                    ]
                }
            },
            {
                "label": "severe injuries",
                "id": {
                    "UMLS:C0581290": [
                        "Severe multiple injuries",
                        "Severe multiple injuries (disorder)"
                    ],
                    "UMLS:C4710844": [
                        "Monitor trends in serum levels of calcium (e.g., ionized calcium) in at risk populations (e.g., patients with malignancies, hyperparathyroidism, prolonged immobilization in severe or multiple fractures or spinal cord injuries)"
                    ]
                }
            }
        ],
        [
            {
                "label": "severe manifestations of pain",
                "id": {}
            },
            {
                "label": "or in",
                "id": {
                    "UMLS:C5474874": [
                        "Inga ornata",
                        "Inga ornata Kunth, 1819"
                    ],
                    "UMLS:C2137071": [
                        "Oral intake",
                        "Oral intake (observable entity)",
                        "otolaryngologic surgical result of oral intake",
                        "otolaryngologic surgical result of oral intake (treatment)"
                    ],
                    "UMLS:C3891917": [
                        "Ora <insect>",
                        "Ora"
                    ],
                    "PR:000024627": [
                        "orn/InitMet-",
                        "oligoribonuclease, initiator methionine removed form"
                    ],
                    "UMLS:C0413385": [
                        "Inject organ",
                        "Inject organ for local action",
                        "Inject organ for local action (procedure)"
                    ]
                }
            },
            {
                "label": "severe chronic pain associated with terminal cancer",
                "id": {}
            }
        ],
        [
            {
                "label": "non-narcotic analgesics",
                "id": {
                    "UMLS:C0242937": [
                        "analgesics non-narcotic",
                        "Non-Narcotic Analgesics",
                        "non narcotic analgesics",
                        "non-narcotic analgesics",
                        "Analgesics Non-narcotic",
                        "Analgesics, Non Narcotic",
                        "Analgesics, Non-Narcotic",
                        "Nonopioid Analgesic",
                        "Non-opioid analgesic",
                        "Nonopioid Analgesics",
                        "Analgesic, Nonopioid",
                        "Non-Opioid Analgesic",
                        "Non Opioid Analgesic",
                        "Opioid Analgesic, Non",
                        "Analgesic, Non Opioid",
                        "Nonnarcotic Analgesic",
                        "nonnarcotic analgesic",
                        "Non-Opioid Analgesics",
                        "Analgesics, Nonopioid",
                        "non-opioid analgesics",
                        "Non Opioid Analgesics",
                        "NON-OPIOID ANALGESICS",
                        "Non-opioid analgesics",
                        "Analgesic, Non-Opioid",
                        "analgesics non opioid",
                        "Analgesics, Non-Opioid",
                        "analgesic non narcotic",
                        "Nonnarcotic Analgesics",
                        "nonnarcotic analgesics",
                        "non narcotic analgesic",
                        "Analgesics, Nonnarcotic",
                        "Analgesics.non-narcotic",
                        "Non-opioid analgesic (substance)"
                    ],
                    "UMLS:C1715315": [
                        "Analgesics Non-narcotic Ql",
                        "Analgesics Non-narcotic SerPl Ql",
                        "Analgesics Non-narcotic [Presence] in Serum or Plasma",
                        "Analgesics.non-narcotic:PrThr:Pt:Ser/Plas:Ord",
                        "Analgesics.non-narcotic:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ],
                    "UMLS:C1715316": [
                        "Analgesics Non-narcotic Ur Ql",
                        "Analgesics Non-narcotic Ql (U)",
                        "Analgesics Non-narcotic [Presence] in Urine",
                        "Analgesics.non-narcotic:PrThr:Pt:Urine:Ord",
                        "Analgesics.non-narcotic:Presence or Threshold:To identify measures at a point in time:Urine:Ordinal"
                    ],
                    "UMLS:C0567540": [
                        "toxicity from non-narcotic analgesics",
                        "Poisoning nonopioid analgesic",
                        "non-narcotic analgesic toxicity",
                        "Poisoning by nonopioid analgesic",
                        "Poisoning caused by nonopioid analgesic",
                        "non-narcotic analgesic toxicity (diagnosis)",
                        "Poisoning caused by nonopioid analgesic (disorder)"
                    ],
                    "UMLS:C0413720": [
                        "adverse effect of non-narcotic analgesics",
                        "adverse reaction to non-narcotic analgesics",
                        "adverse effect of non-narcotic analgesics (diagnosis)",
                        "adverse effect of drug therapy analgesics non-narcotic"
                    ]
                }
            },
            {
                "label": "have",
                "id": {
                    "UMLS:C3154893": [
                        "Have",
                        "Possess"
                    ],
                    "UMLS:C3539897": [
                        "Have",
                        "Had",
                        "Has"
                    ],
                    "UniProtKB:Q9NQS1": [
                        "hAVEN",
                        "AVEN",
                        "cell death regulator Aven (human)"
                    ],
                    "UMLS:C1226488": [
                        "Havetia"
                    ],
                    "UMLS:C2984058": [
                        "Have Pain",
                        "Have Any Pain",
                        "Had Pain"
                    ]
                }
            },
            {
                "label": "failed",
                "id": {
                    "UMLS:C0231175": [
                        "Failed",
                        "failed",
                        "fail",
                        "Fail",
                        "fails",
                        "failing"
                    ],
                    "UMLS:C5670421": [
                        "Assay Failed",
                        "Assay Failure"
                    ],
                    "UMLS:C0476586": [
                        "Failed exams",
                        "Failed examinations",
                        "Failed exams (finding)"
                    ],
                    "UMLS:C0851988": [
                        "Failed labor",
                        "Failed labour"
                    ],
                    "UMLS:C3842069": [
                        "Airway-failed"
                    ]
                }
            }
        ]
    ],
    "Pyridostigmine Bromide Oral Solution, USP is useful in the treatment of myasthenia gravis.": [
        [
            {
                "label": "Pyridostigmine Bromide Oral Solution, USP",
                "id": {}
            },
            {
                "label": "is",
                "id": {
                    "UBERON:0002872": [
                        "IS",
                        "inferior salivary nucleus",
                        "Nucleus salivarius inferior",
                        "nucleus salivarius inferior",
                        "Inferior salivatory nucleus",
                        "inferior salivatary nucleus",
                        "inferior salivatory nucleus",
                        "Nucleus salivatorius inferior",
                        "nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior",
                        "Nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior nervi glossopharyngei",
                        "Nucleus salivatorius inferior nervi glossopharyngei"
                    ],
                    "OMIM:146850": [
                        "IS",
                        "ISCW",
                        "ISSCW",
                        "IMMUNE SUPPRESSION",
                        "STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO"
                    ],
                    "FB:FBgn0001274": [
                        "Is"
                    ],
                    "PUBCHEM.COMPOUND:7021816": [
                        "IS",
                        "isoleucylserine",
                        "Isoleucyl-Serine",
                        "L-isoleucyl-L-serine",
                        "Ile-Ser",
                        "L-Ile-L-Ser",
                        "CHEMBL56803"
                    ],
                    "UMLS:C0021632": [
                        "IS",
                        "INSTRUM",
                        "instrumentation",
                        "instrumentation aspects"
                    ]
                }
            },
            {
                "label": "useful in the treatment of myasthenia gravis",
                "id": {}
            }
        ]
    ],
    "Buprenorphine Sublingual Tablets are indicated for the treatment of opioid dependence and are preferred for induction.": [
        [
            {
                "label": "Buprenorphine Sublingual Tablets",
                "id": {
                    "UMLS:C1245198": [
                        "Buprenorphine Sublingual Tablets",
                        "buprenorphine Sublingual Tablet"
                    ],
                    "UMLS:C1253118": [
                        "Buprenorphine and Naloxone Sublingual Tablets",
                        "buprenorphine / naloxone Sublingual Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of opioid dependence",
                "id": {}
            }
        ],
        [
            {
                "label": "Buprenorphine Sublingual Tablets",
                "id": {
                    "UMLS:C1245198": [
                        "Buprenorphine Sublingual Tablets",
                        "buprenorphine Sublingual Tablet"
                    ],
                    "UMLS:C1253118": [
                        "Buprenorphine and Naloxone Sublingual Tablets",
                        "buprenorphine / naloxone Sublingual Tablet"
                    ]
                }
            },
            {
                "label": "are",
                "id": {
                    "NCIT:C13662": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1515984": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1551058": [
                        "Are",
                        "are unit of measure"
                    ],
                    "MONDO:0044742": [
                        "AREI",
                        "autosomal recessive epidermolytic ichthyosis"
                    ],
                    "MONDO:0017339": [
                        "AREI",
                        "Ichthyosis exfoliativa",
                        "ICHTHYOSIS EXFOLIATIVA",
                        "ichthyosis exfoliativa",
                        "Exfoliative ichthyosis",
                        "Ichthyosis Exfoliativa",
                        "exfoliative ichthyosis",
                        "ICHTHYOSIS BULLOSA OF SIEMENS-LIKE",
                        "autosomal recessive exfoliative ichthyosis",
                        "Autosomal recessive exfoliative ichthyosis",
                        "ICHTHYOSIS, EXFOLIATIVE, AUTOSOMAL RECESSIVE",
                        "ichthyosis congenital autosomal recessive exfoliative",
                        "Autosomal recessive exfoliative ichthyosis (disorder)",
                        "Autosomal recessive exfoliative ichthyosis (diagnosis)"
                    ]
                }
            },
            {
                "label": "preferred for induction",
                "id": {}
            }
        ]
    ],
    "Naltrexone hydrochloride tablets USP 50 mg is indicated in the treatment of alcohol dependence": [
        [
            {
                "label": "Naltrexone hydrochloride tablets USP 50 mg",
                "id": {}
            },
            {
                "label": "is indicated in",
                "id": {
                    "UMLS:C1548409": [
                        "The indicated appointment is booked"
                    ],
                    "UMLS:C1548408": [
                        "The indicated time slot(s) is(are) blocked"
                    ],
                    "UMLS:C4489688": [
                        "No, and walking goal is clinically indicated"
                    ],
                    "UMLS:C4489223": [
                        "No, and walking goal is not clinically indicated"
                    ],
                    "UMLS:C1548417": [
                        "The indicated appointment has begun and is currently in progress"
                    ]
                }
            },
            {
                "label": "the treatment of alcohol dependence",
                "id": {}
            }
        ]
    ],
    "RADICAVA is indicated for the treatment of amyotrophic lateral sclerosis (ALS).": [
        [
            {
                "label": "RADICAVA",
                "id": {
                    "UMLS:C4475575": [
                        "Radicava"
                    ],
                    "HMDB:HMDB0251697": [
                        "Radicava",
                        "Radicut",
                        "MCI-186",
                        "MCI 186",
                        "Edaravone",
                        "Edarabone",
                        "Developer Z",
                        "Norphenazone",
                        "Norantipyrine",
                        "C.I. developer 1",
                        "Phenylmethylpyrazolone",
                        "Methylphenylpyrazolone",
                        "Phenyl methyl pyrazolone",
                        "3-Methyl-1-phenyl-5-pyrazolone",
                        "1-Phenyl-3-methyl-5-pyrazolone",
                        "3-Methyl-1-phenylpyrazol-5-one",
                        "1 Phenyl 3 methyl 5 pyrazolone",
                        "3 Methyl 1 phenyl 2 pyrazolin 5 one",
                        "3-Methyl-1-phenyl-2-pyrazolin-5-one",
                        "1-Phenyl-3-methyl-5-oxo-2-pyrazoline",
                        "2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one"
                    ],
                    "UMLS:C5678710": [
                        "Radicava ORS"
                    ],
                    "UMLS:C5673217": [
                        "RADICAVA ORS KIT",
                        "Radicava ORS 21 MG/ML Oral Suspension",
                        "Radicava ORS, 105 mg/5 mL oral suspension",
                        "Radicava ORS 105mg/5mL Oral Suspension (Kit)",
                        "edaravone 21 MG/ML Oral Suspension [Radicava]",
                        "Radicava ORS 735 MG per 35 ML Oral Suspension",
                        "Radicava ORS 1050 MG per 50 ML Oral Suspension",
                        "Radicava ORS 105mg/5mL Oral Suspension (Starter Kit)",
                        "Edaravone 105 MG/5 ML Oral Suspension [RADICAVA ORS]",
                        "EDARAVONE 735 mg in 35 mL ORAL SUSPENSION [RADICAVA ORS]",
                        "EDARAVONE 1050 mg in 50 mL ORAL SUSPENSION [RADICAVA ORS]"
                    ],
                    "UMLS:C5673214": [
                        "Radicava Oral Product"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of amyotrophic lateral sclerosis (ALS)",
                "id": {}
            }
        ]
    ],
    "Tetrabenazine tablets are indicated for the treatment of chorea associated with Huntington's disease.": [
        [
            {
                "label": "Tetrabenazine tablets",
                "id": {
                    "UMLS:C1249423": [
                        "Tetrabenazine Tablets",
                        "tetrabenazine Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of chorea associated with Huntington's disease",
                "id": {}
            }
        ]
    ],
    "Riluzole is indicated for the treatment of amyotrophic lateral sclerosis(ALS).": [
        [
            {
                "label": "Riluzole",
                "id": {
                    "PUBCHEM.COMPOUND:5070": [
                        "RILUZOLE",
                        "Riluzole",
                        "riluzole",
                        "riluzole HCl",
                        "Riluzole (substance)",
                        "Riluzole impax brand",
                        "riluzole (medication)",
                        "Riluzole aventis brand",
                        "riluzole hydrochloride",
                        "Impax brand OF riluzole",
                        "Aventis brand OF riluzole",
                        "Riluzole-containing product",
                        "Aventis behring brand OF riluzole",
                        "Rhone-poulenc rorer brand OF riluzole",
                        "Rhone poulenc rorer brand OF riluzole",
                        "Product containing riluzole (medicinal product)",
                        "Riluzol",
                        "Rilutek",
                        "RP54274",
                        "rilutek",
                        "rilutor",
                        "RP-54274",
                        "Riluzolum",
                        "2-Amino-6-trifluoromethoxybenzothiazole",
                        "2 Amino 6 trifluoromethoxybenzothiazole",
                        "2 Amino 6 trifluoromethoxybenzothiazole",
                        "2-Amino-6-trifluoromethoxybenzothiazole",
                        "6-Trifluoromethoxybenzothiazol-2-ylamine",
                        "2-Amino-6-(trifluoromethoxy)benzothiazole",
                        "2-amino-6-(trifluoromethoxy)benzothiazole"
                    ],
                    "UMLS:C3219724": [
                        "riluzole Pill"
                    ],
                    "UMLS:C0992886": [
                        "riluzole 50 MG"
                    ],
                    "UMLS:C1247857": [
                        "Riluzole Tablets",
                        "riluzole Oral Tablet"
                    ],
                    "UMLS:C4731258": [
                        "riluzole 5 MG/ML"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of amyotrophic lateral sclerosis(ALS)",
                "id": {}
            }
        ]
    ],
    "RUZURGI is indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age.": [
        [
            {
                "label": "RUZURGI",
                "id": {
                    "UMLS:C5187562": [
                        "Ruzurgi"
                    ],
                    "HMDB:HMDB0246022": [
                        "Ruzurgi",
                        "Firdapse",
                        "Amifampridine",
                        "3,4 Diaminopyridine",
                        "3,4-Diaminopyridine",
                        "3,4-Diaminopyridine",
                        "Amifampridine phosphate"
                    ],
                    "UMLS:C5187566": [
                        "Ruzurgi Pill"
                    ],
                    "UMLS:C5187567": [
                        "Ruzurgi 10mg Tablet",
                        "Ruzurgi 10 MG Oral Tablet",
                        "amifampridine 10 MG Oral Tablet [Ruzurgi]",
                        "Amifampridine 10 mg ORAL TABLET [Ruzurgi]"
                    ],
                    "UMLS:C5187565": [
                        "Ruzurgi Oral Product"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age",
                "id": {}
            }
        ]
    ],
    "USES: For the temporary relief of discomfort and pain associated with - minor burns and skin irritations, minor cuts and scrapes, itching.": [
        [
            {
                "label": "USES",
                "id": {
                    "UMLS:C0457083": [
                        "uses",
                        "Use",
                        "Usage",
                        "usage",
                        "Employ",
                        "usages",
                        "Usage (attribute)"
                    ],
                    "UMLS:C1522726": [
                        "iv uses",
                        "intravenous uses",
                        "IV",
                        "IV use",
                        "iv route",
                        "IV route",
                        "Intravenous",
                        "Intravenous use",
                        "intravenous use",
                        "IntravenousRoute",
                        "Intravenous route",
                        "IV - Intravenous route",
                        "Intravenous route (qualifier value)",
                        "route of administration intravenous",
                        "Intravenous Route of Administration",
                        "route of administration: intravenous",
                        "Intravenous Route of Drug Administration",
                        "route of administration: intravenous (treatment)"
                    ],
                    "UMLS:C0578310": [
                        "Uses lift",
                        "Does use lift",
                        "Does use lift (finding)"
                    ],
                    "UMLS:C4083280": [
                        "ECig Uses",
                        "E-Cig Uses",
                        "Ecigarette Uses",
                        "E-Cigarette Uses",
                        "Uses, Ecigarette",
                        "Vape",
                        "Vapes",
                        "Vaping",
                        "ECig Use",
                        "E Cig Use",
                        "E-Cig Use",
                        "Use, ECig",
                        "THC Vaping",
                        "Use, E-Cig",
                        "Vaping, THC",
                        "THC Vapings",
                        "Vapings, THC",
                        "Vaping (event)",
                        "Ecigarette Use",
                        "E Cigarette Use",
                        "E-Cigarette Use",
                        "Use, Ecigarette",
                        "Nicotine Vaping",
                        "Vaping, Nicotine",
                        "Use, E-Cigarette",
                        "Nicotine Vapings",
                        "Vapings, Nicotine"
                    ],
                    "UMLS:C0565721": [
                        "Uses a key",
                        "Does use a key",
                        "Does use a key (finding)"
                    ]
                }
            },
            {
                "label": "is for",
                "id": {
                    "CHEBI:140821": [
                        "iso-Forssman",
                        "i-Forssman",
                        "isogloboside iGb5Cer",
                        "alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer",
                        "N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide"
                    ],
                    "UMLS:C1552560": [
                        "is backup for"
                    ],
                    "PUBCHEM.COMPOUND:8052": [
                        "Isoamyl formate",
                        "Isoamyl formate",
                        "isoamyl formate",
                        "ISOAMYL FORMATE",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formic acid",
                        "Formate, isopentyl ester",
                        "Isopentyl alcohol, formate",
                        "Formic acid, isopentyl ester",
                        "Formic acid, isopentyl ester",
                        "Isoamyl methanoate",
                        "Isoamyl methanoate",
                        "Isopentyl methanoate",
                        "Isopentyl methanoate",
                        "3-methylbutyl formate",
                        "3-Methylbutyl formate",
                        "Isoamyl methanoic acid",
                        "Isopentyl methanoic acid",
                        "3-Methyl-1-butyl formate",
                        "3-Methylbutyl formic acid",
                        "1-Butanol, 3-methyl-, formate",
                        "3-Methyl-2-butenyl formic acid",
                        "1-Butanol, 3-methyl-, 1-formate"
                    ],
                    "UMLS:C2346508": [
                        "ISS for Myeloma",
                        "International Staging System for Myeloma"
                    ],
                    "UMLS:C1562189": [
                        "Is etiology for",
                        "is etiology for",
                        "Is aetiology for",
                        "Is etiology for (link assertion)"
                    ]
                }
            },
            {
                "label": "temporary relief of discomfort and pain",
                "id": {}
            }
        ],
        [
            {
                "label": "temporary relief of discomfort and pain",
                "id": {}
            },
            {
                "label": "is associated with",
                "id": {
                    "UMLS:C0544684": [
                        "Deafness associated with ischemia"
                    ],
                    "NCBIGene:9798": [
                        "IST1 FACTOR ASSOCIATED WITH ESCRT-III",
                        "IST1 factor associated with ESCRT-III",
                        "IST1",
                        "CHMP8",
                        "CHMP8",
                        "KIAA0174",
                        "IST1 gene",
                        "IST1, ESCRT-III associated factor",
                        "increased sodium tolerance 1 homolog (yeast)",
                        "INCREASED SODIUM TOLERANCE 1, YEAST, HOMOLOG OF",
                        "IST1, endosomal sorting complex required for transport-III component",
                        "IST1, endosomal sorting complex required for transport-III component"
                    ],
                    "UMLS:C4019004": [
                        "Case is associated with a known outbreak"
                    ],
                    "UMLS:C4019185": [
                        "Case is associated with a known outbreak",
                        "Case is associated with a known outbreak:Find:Pt:^Event:Ord",
                        "Case is associated with a known outbreak:Finding:To identify measures at a point in time:^Event:Ordinal"
                    ],
                    "UMLS:C1883213": [
                        "Suction Issue Associated with Medical Device",
                        "Suction Problem"
                    ]
                }
            },
            {
                "label": "minor burns and skin irritations",
                "id": {}
            }
        ],
        [
            {
                "label": "temporary relief of discomfort and pain",
                "id": {}
            },
            {
                "label": "is associated with",
                "id": {
                    "UMLS:C0544684": [
                        "Deafness associated with ischemia"
                    ],
                    "NCBIGene:9798": [
                        "IST1 FACTOR ASSOCIATED WITH ESCRT-III",
                        "IST1 factor associated with ESCRT-III",
                        "IST1",
                        "CHMP8",
                        "CHMP8",
                        "KIAA0174",
                        "IST1 gene",
                        "IST1, ESCRT-III associated factor",
                        "increased sodium tolerance 1 homolog (yeast)",
                        "INCREASED SODIUM TOLERANCE 1, YEAST, HOMOLOG OF",
                        "IST1, endosomal sorting complex required for transport-III component",
                        "IST1, endosomal sorting complex required for transport-III component"
                    ],
                    "UMLS:C4019004": [
                        "Case is associated with a known outbreak"
                    ],
                    "UMLS:C4019185": [
                        "Case is associated with a known outbreak",
                        "Case is associated with a known outbreak:Find:Pt:^Event:Ord",
                        "Case is associated with a known outbreak:Finding:To identify measures at a point in time:^Event:Ordinal"
                    ],
                    "UMLS:C1883213": [
                        "Suction Issue Associated with Medical Device",
                        "Suction Problem"
                    ]
                }
            },
            {
                "label": "minor cuts and scrapes",
                "id": {}
            }
        ],
        [
            {
                "label": "temporary relief of discomfort and pain",
                "id": {}
            },
            {
                "label": "is associated with",
                "id": {
                    "UMLS:C0544684": [
                        "Deafness associated with ischemia"
                    ],
                    "NCBIGene:9798": [
                        "IST1 FACTOR ASSOCIATED WITH ESCRT-III",
                        "IST1 factor associated with ESCRT-III",
                        "IST1",
                        "CHMP8",
                        "CHMP8",
                        "KIAA0174",
                        "IST1 gene",
                        "IST1, ESCRT-III associated factor",
                        "increased sodium tolerance 1 homolog (yeast)",
                        "INCREASED SODIUM TOLERANCE 1, YEAST, HOMOLOG OF",
                        "IST1, endosomal sorting complex required for transport-III component",
                        "IST1, endosomal sorting complex required for transport-III component"
                    ],
                    "UMLS:C4019004": [
                        "Case is associated with a known outbreak"
                    ],
                    "UMLS:C4019185": [
                        "Case is associated with a known outbreak",
                        "Case is associated with a known outbreak:Find:Pt:^Event:Ord",
                        "Case is associated with a known outbreak:Finding:To identify measures at a point in time:^Event:Ordinal"
                    ],
                    "UMLS:C1883213": [
                        "Suction Issue Associated with Medical Device",
                        "Suction Problem"
                    ]
                }
            },
            {
                "label": "itching",
                "id": {
                    "HP:0000989": [
                        "itching",
                        "ITCHING",
                        "Itching",
                        "skin itching",
                        "Skin itching",
                        "Itching;skin",
                        "itching skin",
                        "Itching of skin",
                        "Itching Sensation",
                        "Itching (finding)",
                        "Itching (pruritus)",
                        "itching (pruritus)",
                        "Itching of skin (finding)",
                        "Itch",
                        "itch",
                        "itchy",
                        "Itchy",
                        "PRURITUS",
                        "pruritus",
                        "PRURITIS",
                        "Itch NOS",
                        "pruritis",
                        "Pruritis",
                        "Pruritus",
                        "itch skin",
                        "skin itch",
                        "itchy skin",
                        "Itchy skin",
                        "Pruritus NOS",
                        "Itch of skin",
                        "Skin Pruritus",
                        "Pruritus, NOS",
                        "Pruritus;skin",
                        "Scratching skin",
                        "pruritis of skin",
                        "Pruritus of skin",
                        "PRURITIC DISORDER",
                        "Pruritic Disorder",
                        "Pruritic disorder",
                        "Itch of skin, NOS",
                        "pruritus (symptom)",
                        "Pruritic disorders",
                        "Pruritus cutaneous",
                        "pruritic dermatitis",
                        "Pruritus - disorder",
                        "Pruritic dermatitis",
                        "Irritating sensation",
                        "Excessive scratching",
                        "pruritus (diagnosis)",
                        "Pruritus, unspecified",
                        "Pruritic disorder NOS",
                        "Pruritus of skin, NOS",
                        "Irritation - sensation",
                        "Pruritis (excl D05 X16)",
                        "Pruritic dermatitis, NOS",
                        "Pruritic disorder (disorder)",
                        "Pruritis (excluding D05 X16)",
                        "Unspecified pruritic disorder",
                        "Itch of skin (observable entity)"
                    ],
                    "UMLS:C0877202": [
                        "Itching gum",
                        "gums itching",
                        "gums itch",
                        "gingival pruritus",
                        "Gingival pruritus"
                    ],
                    "HP:0033841": [
                        "Itching;eye",
                        "Eye itching",
                        "itching eye",
                        "eye itching",
                        "eyes itching",
                        "itching eyes",
                        "Itching eyes",
                        "Ocular itching",
                        "Itching of eye",
                        "Itching of eye (finding)",
                        "eye itch",
                        "eyes itch",
                        "itch; eye",
                        "itchy eye",
                        "itchy eyes",
                        "eye; itchy",
                        "Itchy eyes",
                        "eyes itchy",
                        "Ocular itch",
                        "EYE PRURITUS",
                        "Eye pruritus",
                        "pruritus of eye",
                        "ocular pruritus",
                        "Ocular pruritus",
                        "pruritus of eye (symptom)"
                    ],
                    "UMLS:C1276050": [
                        "Not itching",
                        "No sensation of itching",
                        "Not itching (qualifier value)",
                        "No itch",
                        "no itch",
                        "No itch (situation)"
                    ],
                    "UMLS:C0849907": [
                        "ear itching",
                        "Itching;ear",
                        "itching ear",
                        "ears itching",
                        "Itching of ear",
                        "itching of ears",
                        "Itching of ear (finding)",
                        "itching of ears (symptom)",
                        "ear itch",
                        "itch ear",
                        "EAR ITCHY",
                        "ears itch",
                        "itchy ear",
                        "ears itchy",
                        "itchy ears",
                        "EAR PRURITUS",
                        "Ear pruritus",
                        "ear pruritus"
                    ]
                }
            }
        ]
    ],
    "Adults and children 12 years of age and older: Apply to affected area not more than 3-4 times daily.": [
        [
            {
                "label": "Adults and children 12 years of age and older",
                "id": {}
            },
            {
                "label": "Apply to",
                "id": {
                    "UMLS:C0585702": [
                        "Able to apply make-up",
                        "Able to apply own make-up",
                        "Able to apply own make-up (finding)"
                    ],
                    "UMLS:C4709973": [
                        "Apply ice to perineum"
                    ],
                    "UMLS:C0585703": [
                        "Unable to apply make-up",
                        "Unable to apply own make-up",
                        "Unable to apply own make-up (finding)"
                    ],
                    "UMLS:C0548265": [
                        "Apply puff pack to bed."
                    ],
                    "UMLS:C0548267": [
                        "Apply egg crate to bed."
                    ]
                }
            },
            {
                "label": "affected area",
                "id": {
                    "UMLS:C1879646": [
                        "Affected Area",
                        "Affected Body Area"
                    ],
                    "UMLS:C4319771": [
                        "Affected area",
                        "Affected area of body",
                        "Affected area of body (body structure)",
                        "Affected site"
                    ],
                    "UMLS:C4717257": [
                        "Rubbing affected area"
                    ],
                    "UMLS:C4717131": [
                        "Edema of affected area"
                    ],
                    "UMLS:C4717133": [
                        "Aching of affected area"
                    ]
                }
            }
        ],
        [
            {
                "label": "Adults and children 12 years of age and older",
                "id": {}
            },
            {
                "label": "Apply not more than",
                "id": {}
            },
            {
                "label": "3-4 times daily",
                "id": {}
            }
        ]
    ],
    "Cevimeline hydrochloride capsules are indicated for the treatment of symptoms of dry mouth in patients with Sjögren’s Syndrome.": [
        [
            {
                "label": "Cevimeline hydrochloride capsules",
                "id": {
                    "UMLS:C4720247": [
                        "Cevimeline Hydrochloride Capsules"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of symptoms of dry mouth in patients with Sjögren’s Syndrome",
                "id": {}
            }
        ]
    ],
    "temporarily relieves minor aches and pains due to:•the common cold•headache•backache•minor pain of arthritis•toothache•muscular aches•premenstrual and menstrual cramps•temporarily reduces fever": [
        [
            {
                "label": "",
                "id": {}
            },
            {
                "label": "temporarily relieves minor aches and pains due",
                "id": {}
            },
            {
                "label": "the common cold",
                "id": {
                    "UMLS:C0199822": [
                        "Prophylactic vaccination against the common cold",
                        "Common cold vaccination"
                    ],
                    "UMLS:C0414040": [
                        "Anti-common-cold drugs caus adverse eff in therapeut use",
                        "[X]Anti-common-cold drugs caus adverse eff in therapeut use",
                        "Adverse effects in the therapeutic use of anti-common-cold drugs",
                        "Anti-common cold drugs causing adverse effects in therapeutic use",
                        "Anti-common-cold drugs causing adverse effects in therapeutic use",
                        "[X]Anti-common-cold drugs causing adverse effects in therapeutic use",
                        "Anti-common-cold drugs",
                        "Adv eff anti-common cold",
                        "Common cold drug adv eff",
                        "[X]Common cold drug adv eff",
                        "adverse reaction to common cold medications",
                        "adverse effect of anti-common cold medications",
                        "adverse effect of anti-common cold medications (diagnosis)"
                    ]
                }
            }
        ],
        [
            {
                "label": "",
                "id": {}
            },
            {
                "label": "temporarily relieves minor aches and pains due",
                "id": {}
            },
            {
                "label": "headache",
                "id": {
                    "NCIT:C143527": [
                        "Headache",
                        "Headache, CTCAE"
                    ],
                    "HP:0002315": [
                        "Headache",
                        "headache",
                        "HEADACHE",
                        "Headaches",
                        "headaches",
                        "Headache NOS",
                        "Headache, NOS",
                        "HA - Headache",
                        "Have headaches",
                        "headache (symptom)",
                        "Headache (finding)",
                        "Headache, unspecified",
                        "headache, cephalalgia",
                        "Headache (excl N02 N89 R09)",
                        "Headache (excluding N02 N89 R09)",
                        "ha",
                        "HA",
                        "Pain head",
                        "HEAD PAIN",
                        "Head Pain",
                        "ache head",
                        "Cephalgia",
                        "PAIN HEAD",
                        "Pain;head",
                        "Head pain",
                        "cephalgia",
                        "head ache",
                        "head pain",
                        "CEPHALGIA",
                        "HEAD ACHE",
                        "head pains",
                        "pain; head",
                        "Cephalgias",
                        "cephalgias",
                        "head; pain",
                        "Head Pains",
                        "Pain, Head",
                        "cephalalgia",
                        "head pained",
                        "CEPHALALGIA",
                        "Pains, Head",
                        "Cephalalgia",
                        "Pain in head",
                        "cranial pain",
                        "Cephalalgias",
                        "cephalodynia",
                        "Cranial Pain",
                        "pain in head",
                        "Cephalodynia",
                        "Cephalodynias",
                        "Cranial Pains",
                        "Pain, Cranial",
                        "Pains, Cranial",
                        "Pain in head NOS",
                        "HEAD PAIN CEPHALGIA"
                    ],
                    "UMLS:C2732092": [
                        "BC Headache"
                    ],
                    "UMLS:C0423624": [
                        "No headache",
                        "No headache (situation)"
                    ],
                    "MONDO:0021146": [
                        "HEADACHE DIS",
                        "chronic headache",
                        "headache disorder",
                        "headache, chronic",
                        "Headache Syndrome",
                        "Headache disorder",
                        "HEADACHE DISORDER",
                        "headache syndrome",
                        "headache syndrome",
                        "chronic headaches",
                        "Headache Disorder",
                        "headache syndromes",
                        "Syndrome, Headache",
                        "headache; syndrome",
                        "headache disorders",
                        "headaches syndrome",
                        "disorders headache",
                        "syndrome; headache",
                        "syndrome, headache",
                        "Headache Syndromes",
                        "Headache Disorders",
                        "headaches, chronic",
                        "headache syndromes",
                        "headaches syndromes",
                        "disorders headaches",
                        "intractable headache",
                        "intractable headaches",
                        "headache, intractable",
                        "headaches, intractable",
                        "chronic daily headache",
                        "headache, chronic daily",
                        "daily headache, chronic",
                        "chronic daily headaches",
                        "headaches, chronic daily",
                        "daily headaches, chronic",
                        "Headache disorder (disorder)",
                        "headache syndromes (diagnosis)",
                        "cephalgia syndrome",
                        "Cephalgia Syndrome",
                        "Cephalgia Syndromes",
                        "cephalgia syndromes"
                    ]
                }
            }
        ],
        [
            {
                "label": "",
                "id": {}
            },
            {
                "label": "temporarily relieves minor aches and pains due",
                "id": {}
            },
            {
                "label": "backache",
                "id": {
                    "HP:0003418": [
                        "BACKACHE",
                        "Backache",
                        "backache",
                        "Backaches",
                        "backaches",
                        "Backache NOS",
                        "Backache, NOS",
                        "backache symptom",
                        "backache symptoms",
                        "Backache (finding)",
                        "Backache; unspecified",
                        "Backache, unspecified",
                        "backpain",
                        "BACKPAIN",
                        "notalgia",
                        "Notalgia",
                        "dorsalgia",
                        "PAIN BACK",
                        "Pain back",
                        "BACK PAIN",
                        "BACK ACHE",
                        "back ache",
                        "Back Pain",
                        "Back ache",
                        "Pain;back",
                        "Back pain",
                        "Dorsalgia",
                        "back pain",
                        "ache back",
                        "Back Ache",
                        "back pains",
                        "Back Aches",
                        "pain; back",
                        "Ache, Back",
                        "Pain, Back",
                        "back; pain",
                        "backs pain",
                        "aches back",
                        "Dorsodynia",
                        "Back Pains",
                        "back aches",
                        "dorsodynia",
                        "DORSAL PAIN",
                        "Dorsal pain",
                        "Aches, Back",
                        "Pains, Back",
                        "dorsal pain",
                        "PAIN DORSAL",
                        "Pain dorsal",
                        "back pain in",
                        "back paining",
                        "Pain in back",
                        "pain in back",
                        "Back pain NOS",
                        "and back pain",
                        "back pain over",
                        "back over pain",
                        "dorsal back pain",
                        "DORSAL BACK PAIN",
                        "Pain over the back",
                        "pain over the back",
                        "back pain (symptom)",
                        "dorsopathy dorsalgia",
                        "back ache (diagnosis)",
                        "Dorsalgia (diagnosis)",
                        "Unspecified dorsalgia",
                        "dorsalgia unspecified",
                        "unspecified back pain",
                        "Dorsalgia, unspecified"
                    ],
                    "UMLS:C0423680": [
                        "No backache",
                        "No backache (situation)"
                    ],
                    "HP:0003419": [
                        "Low Backache",
                        "low backache",
                        "Low Backaches",
                        "low; backache",
                        "backache; low",
                        "Backache, Low",
                        "lower backache",
                        "Backaches, Low",
                        "backache lower",
                        "lower backache (diagnosis)",
                        "lbp",
                        "LUMBAGO",
                        "Lumbago",
                        "lumbago",
                        "lumbalgia",
                        "Lumbalgia",
                        "Lumbago NOS",
                        "Lumbar pain",
                        "LUMBAR PAIN",
                        "lumbar pain",
                        "lumbar pains",
                        "Low back pain",
                        "Low back ache",
                        "Low Back Ache",
                        "Low Back Pain",
                        "low back pain",
                        "LOW BACK PAIN",
                        "Pain;back low",
                        "low back pains",
                        "Pain, Low Back",
                        "pain; low back",
                        "low back; pain",
                        "Back Pain, Low",
                        "Back Ache, Low",
                        "Low Back Pains",
                        "Ache, Low Back",
                        "Low Back Aches",
                        "pain; back, low",
                        "Back Pains, Low",
                        "Lower Back Pain",
                        "Back Aches, Low",
                        "lower back pain",
                        "Lower back pain",
                        "back; pain, low",
                        "Aches, Low Back",
                        "Pains, Low Back",
                        "lumbar back pain",
                        "Lumbago syndrome",
                        "BACK PAIN LUMBAR",
                        "Back Pain, Lower",
                        "Pain;back;lumbar",
                        "lower back pains",
                        "Pain, Lower Back",
                        "Lower Back Pains",
                        "BACK PAIN, LOWER",
                        "Pains, Lower Back",
                        "Low back syndrome",
                        "Back Pains, Lower",
                        "syndrome; low back",
                        "LBP - Low back pain",
                        "lumbago (diagnosis)",
                        "BACK PAIN LOWER BACK",
                        "low back pain (symptom)",
                        "Low back pain (finding)",
                        "dorsopathy low back pain",
                        "low back pain (diagnosis)",
                        "Low back derangement syndrome",
                        "Nonspecific pain lumbar region",
                        "Nonspecific pain in the lumbar region"
                    ],
                    "UMLS:C0423683": [
                        "backache renal",
                        "renal backache",
                        "renal backache (diagnosis)",
                        "Lumbar ache - renal",
                        "Lumbar ache - renal (finding)"
                    ],
                    "UMLS:C0730669": [
                        "Doans Backache"
                    ]
                }
            }
        ],
        [
            {
                "label": "",
                "id": {}
            },
            {
                "label": "temporarily relieves minor aches and pains due",
                "id": {}
            },
            {
                "label": "minor pain of arthritis",
                "id": {}
            }
        ],
        [
            {
                "label": "",
                "id": {}
            },
            {
                "label": "temporarily relieves minor aches and pains due",
                "id": {}
            },
            {
                "label": "toothache",
                "id": {
                    "NCIT:C78640": [
                        "TOOTHACHE",
                        "toothache",
                        "Toothache",
                        "Toothaches",
                        "toothaches",
                        "Toothache NOS",
                        "Toothache (finding)",
                        "Dentagra",
                        "dentalgia",
                        "Dentalgia",
                        "TOOTH ACHE",
                        "tooth ache",
                        "odontalgia",
                        "tooth pain",
                        "Odontalgia",
                        "Tooth ache",
                        "Tooth pain",
                        "TOOTH PAIN",
                        "dental pain",
                        "pain; tooth",
                        "Odontalgias",
                        "DENTAL PAIN",
                        "tooth; pain",
                        "pain; dental",
                        "Pain in tooth",
                        "tooth/teeth pain",
                        "Pain;tooth/teeth",
                        "tooth pain (symptom)"
                    ],
                    "NCIT:C143879": [
                        "Toothache",
                        "Toothache, CTCAE"
                    ],
                    "UMLS:C0727671": [
                        "Toothache",
                        "Red Cross Toothache Drops"
                    ],
                    "UMLS:C1907725": [
                        "toothache-tree",
                        "northern prickly-ash",
                        "Zanthoxylum americanum",
                        "Zanthoxylum americanum Mill."
                    ],
                    "UMLS:C2348238": [
                        "toothache plant",
                        "Brazilian cress",
                        "Acmella oleracea",
                        "jambu <eudicots>",
                        "Spilanthes oleracea",
                        "Spilanthes oleracea L., 1767",
                        "Acmella oleracea (L.) R.K.Jansen, 1985"
                    ]
                }
            }
        ],
        [
            {
                "label": "",
                "id": {}
            },
            {
                "label": "temporarily relieves minor aches and pains due",
                "id": {}
            },
            {
                "label": "muscular aches",
                "id": {}
            }
        ],
        [
            {
                "label": "",
                "id": {}
            },
            {
                "label": "temporarily relieves minor aches and pains due",
                "id": {}
            },
            {
                "label": "premenstrual and menstrual cramps",
                "id": {}
            }
        ],
        [
            {
                "label": "",
                "id": {}
            },
            {
                "label": "temporarily reduces",
                "id": {}
            },
            {
                "label": "fever",
                "id": {
                    "UMLS:C0424755": [
                        "Fever",
                        "fever",
                        "fever symptom",
                        "fever symptoms",
                        "symptoms fever",
                        "fever as symptom",
                        "fever symptom (symptom)",
                        "Fever symptoms (finding)"
                    ],
                    "NCIT:C143485": [
                        "Fever",
                        "Fever, CTCAE"
                    ],
                    "HP:0001945": [
                        "Fever",
                        "FEVER",
                        "fever",
                        "Fevers",
                        "fevers",
                        "fevered",
                        "feverish",
                        "Feverish",
                        "Fever NOS",
                        "Fever (finding)",
                        "Fever, unspecified",
                        "fever (physical finding)",
                        "Alteration in body temperature: hyperthermia, fever",
                        "febris",
                        "febrile",
                        "Febrile",
                        "PYREXIA",
                        "pyrexia",
                        "Pyrexia",
                        "Pyrexias",
                        "Pyrexial",
                        "pyrexial",
                        "Pyrexia NOS",
                        "Hyperthermia",
                        "HYPERTHERMIA",
                        "Hyperthermic",
                        "hyperthermic",
                        "hyperthermia",
                        "high temperature",
                        "Temperature;high",
                        "High temperature",
                        "temperature; high",
                        "Has a temperature",
                        "high; temperature",
                        "Temperature raised",
                        "raised temperature",
                        "pyrexia (diagnosis)",
                        "elevated temperature",
                        "TEMPERATURE INCREASE",
                        "Temperature elevated",
                        "increase temperature",
                        "temperature increase",
                        "TEMPERATURE ELEVATION",
                        "temperature elevation",
                        "High body temperature",
                        "high body temperature",
                        "Temperature elevation",
                        "increases temperature",
                        "BODY TEMPERATURE INCREASED",
                        "Body temperature increased",
                        "increased body temperature",
                        "Increased body temperature",
                        "increased; body temperature",
                        "Body temperature, increased",
                        "body temperature; increased",
                        "Increase in body temperature",
                        "Body temperature above normal",
                        "Body temperature above reference range",
                        "Body temperature above reference range (finding)"
                    ],
                    "UMLS:C0872996": [
                        "Q fever",
                        "Q fever vaccine",
                        "Q fever vaccine (medication)"
                    ],
                    "MONDO:0019186": [
                        "Q-fever",
                        "fever q",
                        "q fever",
                        "Q fever",
                        "Q Fever",
                        "q-fever",
                        "Q fever",
                        "Q FEVER",
                        "fever; Q",
                        "Fever, Q",
                        "Q; fever",
                        "Q Fevers",
                        "Fevers, Q",
                        "query fever",
                        "fever query",
                        "Query Fever",
                        "Query fever",
                        "Fever, Query",
                        "Query Fevers",
                        "E-217 Q FEVER",
                        "Fevers, Query",
                        "Abattoir fever",
                        "nine Mile fever",
                        "Nine Mile fever",
                        "Nine-mile fever",
                        "FEVER, NINE MILE",
                        "fever; nine Mile",
                        "nine Mile; fever",
                        "Q fever pneumonia",
                        "Q fever (disorder)",
                        "Q-fever (diagnosis)",
                        "quadrilateral fever",
                        "Quadrilateral fever",
                        "quadrilateral; fever",
                        "fever; quadrilateral",
                        "Coxiella burnetii Fever",
                        "Coxiella burnetii fever",
                        "Fever, Coxiella burnetii",
                        "Coxiella burnetii Fevers",
                        "Fevers, Coxiella burnetii",
                        "Coxiellosis",
                        "BALKAN GRIPPE",
                        "Balkan grippe",
                        "Balkan influenza",
                        "Balkan; influenza",
                        "influenza; Balkan",
                        "DERRICK-BURNET DISEASE",
                        "Coxiella burnetii infection",
                        "infection; Coxiella burnetii",
                        "Coxiella burnetii; infection",
                        "BRONCHOPNEUMONIA, HIBERNO-VERNAL",
                        "Infection due to Coxiella burnetii",
                        "infection due to Coxiella burnetii",
                        "Infection due to Coxiella burnetii",
                        "Coxiella burnetii infectious disease",
                        "Coxiella burnetii disease or disorder",
                        "Coxiella burnetii caused disease or disorder"
                    ]
                }
            }
        ]
    ],
    "Diazepam is a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology (such as inflammation of the muscles or joints, or secondary to trauma), spasticity caused by upper motor neuron disorders (such as cerebral palsy and paraplegia); athetosis; stiff man syndrome; and tetanus.": [
        [
            {
                "label": "Diazepam",
                "id": {
                    "PUBCHEM.COMPOUND:3016": [
                        "Diazepam",
                        "DiazePAM",
                        "diazepam",
                        "DIAZEPAM",
                        "diazePAM",
                        "Diazepam product",
                        "Diazepam (substance)",
                        "diazepam (medication)",
                        "Diazepam-containing product",
                        "Product containing diazepam (medicinal product)",
                        "Valium",
                        "Valium",
                        "Seduxen",
                        "Faustan",
                        "Apaurin",
                        "Diastat",
                        "Sibazon",
                        "Relanium",
                        "Stesolid",
                        "Diazemuls",
                        "Methyldiazepinone",
                        "Methyl diazepinone",
                        "Methyl diazepinone",
                        "methyl diazepinone",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-"
                    ],
                    "PUBCHEM.COMPOUND:129818764": [
                        "Diazepamon"
                    ],
                    "PUBCHEM.COMPOUND:12205124": [
                        "Diazepam-d3"
                    ],
                    "PUBCHEM.COMPOUND:45358967": [
                        "Diazepam-d5"
                    ],
                    "PUBCHEM.COMPOUND:165361942": [
                        "Diazepam-d8"
                    ]
                }
            },
            {
                "label": "is",
                "id": {
                    "UBERON:0002872": [
                        "IS",
                        "inferior salivary nucleus",
                        "Nucleus salivarius inferior",
                        "nucleus salivarius inferior",
                        "Inferior salivatory nucleus",
                        "inferior salivatary nucleus",
                        "inferior salivatory nucleus",
                        "Nucleus salivatorius inferior",
                        "nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior",
                        "Nucleus salivatorius caudalis",
                        "nucleus salivatorius inferior nervi glossopharyngei",
                        "Nucleus salivatorius inferior nervi glossopharyngei"
                    ],
                    "OMIM:146850": [
                        "IS",
                        "ISCW",
                        "ISSCW",
                        "IMMUNE SUPPRESSION",
                        "STREPTOCOCCAL CELL WALL ANTIGEN, SUPPRESSION OF IMMUNE RESPONSE TO"
                    ],
                    "FB:FBgn0001274": [
                        "Is"
                    ],
                    "PUBCHEM.COMPOUND:7021816": [
                        "IS",
                        "isoleucylserine",
                        "Isoleucyl-Serine",
                        "L-isoleucyl-L-serine",
                        "Ile-Ser",
                        "L-Ile-L-Ser",
                        "CHEMBL56803"
                    ],
                    "UMLS:C0021632": [
                        "IS",
                        "INSTRUM",
                        "instrumentation",
                        "instrumentation aspects"
                    ]
                }
            },
            {
                "label": "a useful adjunct for the relief of skeletal muscle spasm",
                "id": {}
            }
        ],
        [
            {
                "label": "skeletal muscle spasm",
                "id": {
                    "UMLS:C2919378": [
                        "Spasm of skeletal muscle of thorax",
                        "Spasm of skeletal muscle of thorax (finding)",
                        "Thoracic muscle spasm"
                    ],
                    "MONDO:0010922": [
                        "muscle spasms, intermittent with alopecia, diarrhea and skeletal abnormalities",
                        "Muscle spasms, intermittent with alopecia, diarrhea, and skeletal abnormalities",
                        "muscle spasms, intermittent, with alopecia, diarrhea, and skeletal abnormalities",
                        "MUSCLE SPASMS, INTERMITTENT, WITH ALOPECIA, DIARRHEA, AND SKELETAL ABNORMALITIES",
                        "Muscle Spasms, Intermittent, With Alopecia, Diarrhea, And Skeletal Abnormalities",
                        "Satoyoshi syndrome",
                        "SATOYOSHI SYNDROME",
                        "KOMURAGAERI DISEASE",
                        "Komuragaeri disease",
                        "Komuragaeri Disease",
                        "Satoyoshi syndrome (disorder)",
                        "Satoyoshi syndrome (diagnosis)",
                        "autoimmune disease satoyoshi syndrome"
                    ]
                }
            },
            {
                "label": "due to",
                "id": {
                    "UMLS:C0678226": [
                        "Due To",
                        "due to",
                        "Due to",
                        "Due to (attribute)",
                        "DT",
                        "due",
                        "resulting",
                        "Resulting from",
                        "resulting from"
                    ],
                    "MONDO:0012994": [
                        "DRD due to SRD",
                        "DRD due to SRD",
                        "dopa-responsive dystonia due to sepiapterin reductase deficiency",
                        "Dopa-Responsive Dystonia Due To Sepiapterin Reductase Deficiency",
                        "dopa-responsive dystonia due to sepiapterin reductase deficiency",
                        "Dopa-responsive dystonia due to sepiapterin reductase deficiency",
                        "Dopa responsive dystonia due to sepiapterin reductase deficiency",
                        "Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency",
                        "DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY",
                        "dystonia, DOPA-responsive, due to sepiapterin reductase deficiency",
                        "Dopa responsive dystonia due to sepiapterin reductase deficiency (disorder)",
                        "SRD",
                        "SRD",
                        "DYT-SPR",
                        "Spr Deficiency",
                        "SPR DEFICIENCY",
                        "SPR deficiency",
                        "SPR deficiency",
                        "Biopterin deficiency",
                        "Sepiapterin reductase defic",
                        "sepiapterin reductase deficiency",
                        "Sepiapterin Reductase Deficiency",
                        "sepiapterin reductase deficiency",
                        "Sepiapterin reductase deficiency",
                        "SEPIAPTERIN REDUCTASE DEFICIENCY",
                        "7,8-Dihydrobiopterin synthetase deficiency",
                        "Sepiapterin reductase deficiency (disorder)",
                        "autosomal recessive sepiapterin reductase-deficient DRD",
                        "Autosomal recessive sepiapterin reductase-deficient DRD"
                    ],
                    "UMLS:C1456116": [
                        "Due to cat hair"
                    ],
                    "UMLS:C1456117": [
                        "Due to dog hair"
                    ],
                    "MONDO:0100097": [
                        "CAD due to TBX4",
                        "congenital alveolar dysplasia due to TBX4"
                    ]
                }
            },
            {
                "label": "reflex spasm to local pathology",
                "id": {}
            }
        ],
        [
            {
                "label": "local pathology",
                "id": {
                    "UMLS:C4288812": [
                        "Local Pathology Review",
                        "LPR"
                    ],
                    "UMLS:C5201859": [
                        "Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT) with concurrently acquired computed tomography (CT) transmission scan for anatomical review, localization and determination/detection of pathology, single area (eg, head, neck, chest, pelvis), single day imaging",
                        "Rp loclzj tum spect w/ct 1",
                        "RP LOCLZJ TUM SPECT W/CT 1",
                        "RP LOCLZJ TUM SPECT W/CT 1 AREA 1 DAY IMAGING"
                    ],
                    "UMLS:C5201927": [
                        "Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT) with concurrently acquired computed tomography (CT) transmission scan for anatomical review, localization and determination/detection of pathology, minimum 2 areas (eg, pelvis and knees, abdomen and pelvis), single day imaging, or single area imaging over 2 or more days",
                        "RP LOCLZJ TUM SPECT W/CT 2",
                        "Rp loclzj tum spect w/ct 2",
                        "RP LOCLZJ TUM SPECT CT 2AREA 1D IMG/1 AR IMG>2+D"
                    ]
                }
            },
            {
                "label": "such as",
                "id": {
                    "UMLS:C1881351": [
                        "Label as Such",
                        "L.A.S."
                    ],
                    "UMLS:C3843727": [
                        "Prescription pill such as Zyban®"
                    ],
                    "UMLS:C5452792": [
                        "Pests such as bugs, ants, or mice"
                    ],
                    "UMLS:C4534416": [
                        "Being around animals such as pets"
                    ],
                    "UMLS:C3641919": [
                        "Drinks Alcohol Such as Beer or Wine"
                    ]
                }
            },
            {
                "label": "inflammation of the muscles or joints",
                "id": {}
            }
        ],
        [
            {
                "label": "local pathology",
                "id": {
                    "UMLS:C4288812": [
                        "Local Pathology Review",
                        "LPR"
                    ],
                    "UMLS:C5201859": [
                        "Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT) with concurrently acquired computed tomography (CT) transmission scan for anatomical review, localization and determination/detection of pathology, single area (eg, head, neck, chest, pelvis), single day imaging",
                        "Rp loclzj tum spect w/ct 1",
                        "RP LOCLZJ TUM SPECT W/CT 1",
                        "RP LOCLZJ TUM SPECT W/CT 1 AREA 1 DAY IMAGING"
                    ],
                    "UMLS:C5201927": [
                        "Radiopharmaceutical localization of tumor, inflammatory process or distribution of radiopharmaceutical agent(s) (includes vascular flow and blood pool imaging, when performed); tomographic (SPECT) with concurrently acquired computed tomography (CT) transmission scan for anatomical review, localization and determination/detection of pathology, minimum 2 areas (eg, pelvis and knees, abdomen and pelvis), single day imaging, or single area imaging over 2 or more days",
                        "RP LOCLZJ TUM SPECT W/CT 2",
                        "Rp loclzj tum spect w/ct 2",
                        "RP LOCLZJ TUM SPECT CT 2AREA 1D IMG/1 AR IMG>2+D"
                    ]
                }
            },
            {
                "label": "resulting from",
                "id": {
                    "UMLS:C0678226": [
                        "Resulting from",
                        "resulting from",
                        "DT",
                        "due",
                        "Due To",
                        "due to",
                        "Due to",
                        "resulting",
                        "Due to (attribute)"
                    ],
                    "UMLS:C0342172": [
                        "Hypothyroidism resulting from PAS",
                        "Hypothyroidism resulting from P-aminosalicylic acid",
                        "Hypothyroidism resulting from para-aminosalicylic acid",
                        "Hypothyroidism resulting from para-aminosalicylic acid (disorder)"
                    ],
                    "UMLS:C1399695": [
                        "herpes; resulting from HIV disease",
                        "HIV disease; herpes",
                        "HIV disease; resulting in, herpesviral infection",
                        "HIV disease; resulting in, infection, herpesvirus"
                    ],
                    "UMLS:C4041061": [
                        "Facial fracture resulting from MVA",
                        "Facial fracture due to motor vehicle accident",
                        "Facial fracture due to motor vehicle accident (disorder)",
                        "Facial fracture due to motor vehicle accident (diagnosis)"
                    ],
                    "UMLS:C0348206": [
                        "mycosis; resulting from HIV disease",
                        "fungus; infection, resulting from HIV disease",
                        "infection; fungus, resulting from HIV disease",
                        "mycotic; infection, resulting from HIV disease",
                        "infection; mycotic, resulting from HIV disease",
                        "HIV disease; mycosis",
                        "HIV disease; resulting in, mycosis",
                        "HIV disease resulting in other mycoses",
                        "HIV disease; resulting in, infection, fungus",
                        "HIV disease; resulting in, infection, mycotic"
                    ]
                }
            },
            {
                "label": "secondary to trauma",
                "id": {
                    "UMLS:C0546413": [
                        "Atrophy secondary to trauma",
                        "Posttraumatic atrophy"
                    ],
                    "UMLS:C0152086": [
                        "Arthritis secondary to trauma",
                        "Traumatic arthritis",
                        "TRAUMATIC ARTHRITIS",
                        "Arthritis;traumatic",
                        "traumatic arthritis",
                        "ARTHRITIS TRAUMATIC",
                        "Traumatic Arthritis",
                        "arthritis; traumatic",
                        "traumatic; arthritis",
                        "traumatic arthropathy",
                        "Traumatic Arthropathy",
                        "Traumatic arthropathy",
                        "traumatic; arthropathy",
                        "arthropathy; traumatic",
                        "Traum arthropathy-unspec",
                        "Posttraumatic arthropathy",
                        "ARTHRITIS, TRAUMATIC, PRIMARY",
                        "traumatic arthritis (diagnosis)",
                        "Traumatic arthropathy (disorder)",
                        "traumatic arthropathy (diagnosis)",
                        "Traumatic arthropathy, site unspecified",
                        "Traumatic arthropathy, unspecified site"
                    ],
                    "UMLS:C0494532": [
                        "Glaucoma secondary to eye trauma",
                        "glaucoma; eye trauma (i.e. caused by eye trauma)"
                    ],
                    "UMLS:C2229336": [
                        "secondary hypersomnia due to trauma",
                        "secondary hypersomnia due to trauma (diagnosis)",
                        "secondary hypersomnia post-traumatic",
                        "post-traumatic secondary hypersomnia"
                    ],
                    "UMLS:C0522277": [
                        "Immunodeficiency secondary to trauma",
                        "immunodeficiency secondary to trauma",
                        "Immunodeficiency secondary to trauma (disorder)",
                        "immunodeficiency secondary to trauma (diagnosis)"
                    ]
                }
            }
        ],
        [
            {
                "label": "spasticity",
                "id": {
                    "NCIT:C143854": [
                        "Spasticity",
                        "Spasticity, CTCAE"
                    ],
                    "HP:0001257": [
                        "spasticity",
                        "Spasticity",
                        "SPASTICITY",
                        "Muscle Spasticity",
                        "Spasticity muscle",
                        "Muscle spasticity",
                        "SPASTICITY MUSCLE",
                        "MUSCLE SPASTICITY",
                        "muscle spasticity",
                        "Spasticity, Muscle",
                        "muscles spasticity",
                        "Muscular spasticity",
                        "Spasticity, muscular",
                        "Spasticity (finding)",
                        "spasticity was noted",
                        "Spasticity (qualifier value)",
                        "spasticity (physical finding)",
                        "Spastic",
                        "Muscle spasm - tone",
                        "Involuntary muscle stiffness, contraction, or spasm"
                    ],
                    "HP:0002061": [
                        "Leg spasticity",
                        "leg spasticity",
                        "legs spasticity",
                        "Lower limb spasticity",
                        "limb lower spasticity",
                        "lower limb spasticity",
                        "Spasticity of lower limbs",
                        "LOWER EXTREMITY SPASTICITY",
                        "Lower extremity spasticity",
                        "extremities lower spasticity",
                        "Spasticity of the lower limbs",
                        "Spasticity of lower extremities",
                        "Lower limb spasticity (finding)"
                    ],
                    "UMLS:C4230622": [
                        "Jaw spasticity"
                    ],
                    "UMLS:C0877408": [
                        "Arm spasticity"
                    ]
                }
            },
            {
                "label": "caused by",
                "id": {
                    "UMLS:C0015127": [
                        "caused by",
                        "ET",
                        "cause",
                        "ETIOL",
                        "causes",
                        "etiology",
                        "aetiology",
                        "causality",
                        "etiologies",
                        "Etiology aspects"
                    ],
                    "UMLS:C1314792": [
                        "Caused by",
                        "Causes",
                        "Etiology",
                        "etiology",
                        "Causality",
                        "Aetiology",
                        "Causalities",
                        "disease cause",
                        "disease etiology",
                        "General Etiology",
                        "disorder etiology",
                        "disease causation",
                        "disorder by cause",
                        "Etiology (attribute)",
                        "disease/disorder etiology"
                    ],
                    "UMLS:C0239313": [
                        "CAUSED BY EXERCISE",
                        "exertional",
                        "EXERTIONAL",
                        "EXERCISE INDUCED",
                        "exercise induced",
                        "PRECIPITATED BY EXERCISE"
                    ],
                    "UMLS:C0338466": [
                        "Tic caused by drug",
                        "Tic caused by drug (disorder)",
                        "drug; tic",
                        "Drug-induced tic",
                        "tic; drug-induced",
                        "Drug induced tics",
                        "drug-induced tic disorder",
                        "drug-induced tic disorder (diagnosis)"
                    ],
                    "UMLS:C0409910": [
                        "Gout caused by drug",
                        "Gout caused by drug (disorder)",
                        "drug; gouty",
                        "Drug-induced gout",
                        "gout; drug-induced",
                        "Gout secondary to drug",
                        "gout secondary drug-induced",
                        "Drug-induced gout (diagnosis)",
                        "Drug-induced gout, unspecified site",
                        "Drug-induced gout, site unspecified"
                    ]
                }
            },
            {
                "label": "upper motor neuron disorders",
                "id": {}
            }
        ],
        [
            {
                "label": "upper motor neuron disorders",
                "id": {}
            },
            {
                "label": "such as",
                "id": {
                    "UMLS:C1881351": [
                        "Label as Such",
                        "L.A.S."
                    ],
                    "UMLS:C3843727": [
                        "Prescription pill such as Zyban®"
                    ],
                    "UMLS:C5452792": [
                        "Pests such as bugs, ants, or mice"
                    ],
                    "UMLS:C4534416": [
                        "Being around animals such as pets"
                    ],
                    "UMLS:C3641919": [
                        "Drinks Alcohol Such as Beer or Wine"
                    ]
                }
            },
            {
                "label": "cerebral palsy and paraplegia",
                "id": {}
            }
        ],
        [
            {
                "label": "Diazepam",
                "id": {
                    "PUBCHEM.COMPOUND:3016": [
                        "Diazepam",
                        "DiazePAM",
                        "diazepam",
                        "DIAZEPAM",
                        "diazePAM",
                        "Diazepam product",
                        "Diazepam (substance)",
                        "diazepam (medication)",
                        "Diazepam-containing product",
                        "Product containing diazepam (medicinal product)",
                        "Valium",
                        "Valium",
                        "Seduxen",
                        "Faustan",
                        "Apaurin",
                        "Diastat",
                        "Sibazon",
                        "Relanium",
                        "Stesolid",
                        "Diazemuls",
                        "Methyldiazepinone",
                        "Methyl diazepinone",
                        "Methyl diazepinone",
                        "methyl diazepinone",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-"
                    ],
                    "PUBCHEM.COMPOUND:129818764": [
                        "Diazepamon"
                    ],
                    "PUBCHEM.COMPOUND:12205124": [
                        "Diazepam-d3"
                    ],
                    "PUBCHEM.COMPOUND:45358967": [
                        "Diazepam-d5"
                    ],
                    "PUBCHEM.COMPOUND:165361942": [
                        "Diazepam-d8"
                    ]
                }
            },
            {
                "label": "used for",
                "id": {
                    "UMLS:C3687613": [
                        "Used for rodeo",
                        "Used for rodeo (animal life circumstance)"
                    ],
                    "UMLS:C4527560": [
                        "Used Paper Form"
                    ],
                    "UMLS:C4255476": [
                        "Method used for RMR",
                        "Method used to measure RMR",
                        "Method used to measure RMR:Type:Pt:^Patient:Nom",
                        "Method used to measure RMR:Type:Point in time:^Patient:Nominal",
                        "Method used to measure RMR:Type:To identify measures at a point in time:^Patient:Nominal"
                    ],
                    "UMLS:C5569543": [
                        "Lens used for testing"
                    ],
                    "UMLS:C1964155": [
                        "Int mam art used for cabg",
                        "INT MAM ART USED FOR CABG",
                        "LIMA GRAFT USED IN 1ST ISOLATED CABG PXD",
                        "Internal mammary artery graft performed for primary, isolated coronary artery bypass graft procedure (CABG)",
                        "Internal mammary artery graft performed for primary, isolated coronary artery bypass graft procedure (cabg)"
                    ]
                }
            },
            {
                "label": "athetosis",
                "id": {
                    "HP:0002305": [
                        "ATHETOSIS",
                        "Athetosis",
                        "athetosis",
                        "Athetosis, NOS",
                        "athetosis was noted",
                        "Athetosis (disorder)",
                        "athetosis (diagnosis)",
                        "athetosis (physical finding)",
                        "extrapyramidal disorders athetosis",
                        "Athetoses",
                        "HAMMOND DIS",
                        "HAMMONDS DIS",
                        "Hammond Disease",
                        "Hammond Diseases",
                        "Hammonds Disease",
                        "hammonds disease",
                        "Disease, Hammond",
                        "Diseases, Hammond",
                        "athetoid movement",
                        "Athetoid movement",
                        "Hammond's Disease",
                        "Athetoid Movement",
                        "athetoid movements",
                        "Disease, Hammond's",
                        "Athetoid movements",
                        "Athetoid Movements",
                        "Hammond's Diseases",
                        "Movement, Athetoid",
                        "Movements, Athetoid",
                        "Diseases, Hammond's",
                        "Athetoid movement (finding)",
                        "Involuntary writhing movements",
                        "Involuntary writhing movements in fingers, hands, toes, and feet"
                    ],
                    "UMLS:C3809613": [
                        "Athetosis, mild"
                    ],
                    "UMLS:C0270743": [
                        "Double athetosis",
                        "Double athetosis syndrome",
                        "Double athetosis (disorder)",
                        "Double athetosis (syndrome)",
                        "congenital choreoathetosis",
                        "congenital choreoathetosis (diagnosis)"
                    ],
                    "UMLS:C1850372": [
                        "Athetosis (later)"
                    ],
                    "UMLS:C0271140": [
                        "Pupillary athetosis",
                        "Pupillary athetosis (diagnosis)",
                        "anomalies of pupillary function athetosis",
                        "Hippus",
                        "hippus",
                        "Hippus (disorder)",
                        "hippus was observed",
                        "hippus (physical finding)"
                    ]
                }
            }
        ],
        [
            {
                "label": "Diazepam",
                "id": {
                    "PUBCHEM.COMPOUND:3016": [
                        "Diazepam",
                        "DiazePAM",
                        "diazepam",
                        "DIAZEPAM",
                        "diazePAM",
                        "Diazepam product",
                        "Diazepam (substance)",
                        "diazepam (medication)",
                        "Diazepam-containing product",
                        "Product containing diazepam (medicinal product)",
                        "Valium",
                        "Valium",
                        "Seduxen",
                        "Faustan",
                        "Apaurin",
                        "Diastat",
                        "Sibazon",
                        "Relanium",
                        "Stesolid",
                        "Diazemuls",
                        "Methyldiazepinone",
                        "Methyl diazepinone",
                        "Methyl diazepinone",
                        "methyl diazepinone",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-"
                    ],
                    "PUBCHEM.COMPOUND:129818764": [
                        "Diazepamon"
                    ],
                    "PUBCHEM.COMPOUND:12205124": [
                        "Diazepam-d3"
                    ],
                    "PUBCHEM.COMPOUND:45358967": [
                        "Diazepam-d5"
                    ],
                    "PUBCHEM.COMPOUND:165361942": [
                        "Diazepam-d8"
                    ]
                }
            },
            {
                "label": "used for",
                "id": {
                    "UMLS:C3687613": [
                        "Used for rodeo",
                        "Used for rodeo (animal life circumstance)"
                    ],
                    "UMLS:C4527560": [
                        "Used Paper Form"
                    ],
                    "UMLS:C4255476": [
                        "Method used for RMR",
                        "Method used to measure RMR",
                        "Method used to measure RMR:Type:Pt:^Patient:Nom",
                        "Method used to measure RMR:Type:Point in time:^Patient:Nominal",
                        "Method used to measure RMR:Type:To identify measures at a point in time:^Patient:Nominal"
                    ],
                    "UMLS:C5569543": [
                        "Lens used for testing"
                    ],
                    "UMLS:C1964155": [
                        "Int mam art used for cabg",
                        "INT MAM ART USED FOR CABG",
                        "LIMA GRAFT USED IN 1ST ISOLATED CABG PXD",
                        "Internal mammary artery graft performed for primary, isolated coronary artery bypass graft procedure (CABG)",
                        "Internal mammary artery graft performed for primary, isolated coronary artery bypass graft procedure (cabg)"
                    ]
                }
            },
            {
                "label": "stiff man syndrome",
                "id": {
                    "MONDO:0008491": [
                        "stiff man syndrome",
                        "STIFF-MAN SYNDROME",
                        "Stiff man syndrome",
                        "stiff-man syndrome",
                        "Stiff-man syndrome",
                        "Stiff Man Syndrome",
                        "Stiff-Man Syndrome",
                        "Stiff-man syndrome",
                        "stiff man syndrome",
                        "Stiff-Man syndrome",
                        "Syndrome, Stiff-Man",
                        "mans stiff syndrome",
                        "syndrome; stiff man",
                        "stiff mans syndrome",
                        "Congenital Stiff Man Syndrome",
                        "Congenital Stiff-Man Syndrome",
                        "Congenital Stiff-Man Syndromes",
                        "stiff man syndrome (diagnosis)",
                        "Syndrome, Congenital Stiff-Man",
                        "Stiff-Man Syndrome, Congenital",
                        "Syndromes, Congenital Stiff-Man",
                        "Stiff-Man Syndromes, Congenital",
                        "SMS",
                        "SMS",
                        "SPS",
                        "SPS",
                        "Startle Syndrome",
                        "stiffman syndrome",
                        "Startle Syndromes",
                        "Stiffman Syndrome",
                        "Syndrome, Startle",
                        "Syndromes, Startle",
                        "Syndrome, Stiffman",
                        "Stiff-Baby Syndrome",
                        "Stiff-trunk syndrome",
                        "STIFF-TRUNK SYNDROME",
                        "Stiff-Baby Syndromes",
                        "Stiff Trunk Syndrome",
                        "Stiff-Trunk Syndrome",
                        "Syndrome, Stiff-Baby",
                        "Stiff person syndrome",
                        "person stiff syndrome",
                        "Stiff-Trunk Syndromes",
                        "Stiff-person syndrome",
                        "Stiff Person Syndrome",
                        "stiff-person syndrome",
                        "STIFF-PERSON syndrome",
                        "STIFF-PERSON SYNDROME",
                        "Stiff-Person syndrome",
                        "stiff person syndrome",
                        "Stiff-Person Syndrome",
                        "Stiff-Person syndrome",
                        "Stiff Person syndrome",
                        "Syndromes, Stiff-Baby",
                        "Syndrome, Stiff-Trunk",
                        "Syndromes, Stiff-Trunk",
                        "persons stiff syndrome",
                        "Syndrome, Stiff-Person",
                        "Morsch Woltman syndrome",
                        "moersch woltman syndrome",
                        "Moersch-Woltman syndrome",
                        "moersch-woltman syndrome",
                        "Moersch-Woltmann Syndrome",
                        "moersch-woltmann syndrome",
                        "Moersch Woltmann Syndrome",
                        "Moersch-Woltmann syndrome",
                        "Syndrome, Moersch-Woltmann",
                        "Stiff person spectrum disorder",
                        "Congenital Stiff-Person Syndrome",
                        "Congenital Stiff-Person Syndromes",
                        "Stiff-Person Syndrome, Congenital",
                        "Syndrome, Congenital Stiff-Person",
                        "Stiff-Person Syndromes, Congenital",
                        "Gamma neuron overactivity syndrome",
                        "Syndromes, Congenital Stiff-Person",
                        "Subacute myoclonic spinal neuronitis",
                        "MUSCULAR RIGIDITY AND SPASM, PROGRESSIVE",
                        "Stiff person spectrum disorder (disorder)",
                        "Stiff person syndrome and related disorders",
                        "progressive encephalomyelitis with rigidity",
                        "Progressive encephalomyelitis with rigidity"
                    ],
                    "MONDO:0021022": [
                        "Congenital stiff man syndrome",
                        "congenital stiff man syndrome",
                        "congenital stiff man syndrome",
                        "STIFF-MAN SYNDROME, CONGENITAL",
                        "STHE",
                        "Kok disease",
                        "KOK DISEASE",
                        "Kok disease",
                        "hyperekplexia",
                        "hyperekplexia",
                        "hyperekplexia",
                        "startle disease",
                        "startle disease",
                        "STIFF-BABY SYNDROME",
                        "Stiff baby syndrome",
                        "hereditary hyperexplexia",
                        "Hereditary hyperekplexia",
                        "Hereditary hyperexplexia",
                        "hereditary hyperekplexia",
                        "hyperexplexia hereditary",
                        "familial startle disease",
                        "Hyperexplexia hereditary",
                        "Familial startle disease",
                        "Hereditary Hyperexplexia",
                        "familial startle disease",
                        "hereditary hyperekplexia",
                        "STARTLE DISEASE, FAMILIAL",
                        "Exagerrated startle reflex",
                        "EXAGGERATED STARTLE REACTION",
                        "STARTLE REACTION, EXAGGERATED",
                        "Congenital stiff person syndrome",
                        "STIFF-PERSON SYNDROME, CONGENITAL",
                        "Hereditary hyperekplexia (disorder)"
                    ],
                    "MONDO:0007868": [
                        "Stiff-Man syndrome, congenital",
                        "Sthe",
                        "HKPX1",
                        "HKPX1",
                        "Kok disease",
                        "HYPEREKPLEXIA 1",
                        "hyperekplexia 1",
                        "hyperekplexia 1",
                        "Stiff-baby syndrome",
                        "hyperekplexia type 1",
                        "startle disease, familial",
                        "hyperekplexia, hereditary 1",
                        "exaggerated startle reaction",
                        "startle reaction, exaggerated",
                        "hyperekplexia, hereditary type 1",
                        "Stiff-Person syndrome, congenital"
                    ],
                    "UniProtKB:P49418": [
                        "Stiff-Mann Syndrome with Breast Cancer 128kD Autoantigen",
                        "Amp",
                        "AMPH",
                        "AMPH",
                        "hAMPH",
                        "AMPH1",
                        "Amphiphysin",
                        "amphiphysin (human)",
                        "AMPH protein, human"
                    ],
                    "NCBIGene:273": [
                        "amphiphysin (Stiff-Man syndrome with breast cancer 128kDa autoantigen)",
                        "amphiphysin (Stiff-Mann syndrome with breast cancer 128kD autoantigen)",
                        "Amphiphysin (Stiff-Man Syndrome with Breast Cancer 128kDa Autoantigen) Gene",
                        "AMPH",
                        "AMPH Gene",
                        "AMPH gene",
                        "AMPHIPHYSIN",
                        "amphiphysin",
                        "AMPHIPHYSIN I"
                    ]
                }
            }
        ],
        [
            {
                "label": "Diazepam",
                "id": {
                    "PUBCHEM.COMPOUND:3016": [
                        "Diazepam",
                        "DiazePAM",
                        "diazepam",
                        "DIAZEPAM",
                        "diazePAM",
                        "Diazepam product",
                        "Diazepam (substance)",
                        "diazepam (medication)",
                        "Diazepam-containing product",
                        "Product containing diazepam (medicinal product)",
                        "Valium",
                        "Valium",
                        "Seduxen",
                        "Faustan",
                        "Apaurin",
                        "Diastat",
                        "Sibazon",
                        "Relanium",
                        "Stesolid",
                        "Diazemuls",
                        "Methyldiazepinone",
                        "Methyl diazepinone",
                        "Methyl diazepinone",
                        "methyl diazepinone",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one",
                        "2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-"
                    ],
                    "PUBCHEM.COMPOUND:129818764": [
                        "Diazepamon"
                    ],
                    "PUBCHEM.COMPOUND:12205124": [
                        "Diazepam-d3"
                    ],
                    "PUBCHEM.COMPOUND:45358967": [
                        "Diazepam-d5"
                    ],
                    "PUBCHEM.COMPOUND:165361942": [
                        "Diazepam-d8"
                    ]
                }
            },
            {
                "label": "used for",
                "id": {
                    "UMLS:C3687613": [
                        "Used for rodeo",
                        "Used for rodeo (animal life circumstance)"
                    ],
                    "UMLS:C4527560": [
                        "Used Paper Form"
                    ],
                    "UMLS:C4255476": [
                        "Method used for RMR",
                        "Method used to measure RMR",
                        "Method used to measure RMR:Type:Pt:^Patient:Nom",
                        "Method used to measure RMR:Type:Point in time:^Patient:Nominal",
                        "Method used to measure RMR:Type:To identify measures at a point in time:^Patient:Nominal"
                    ],
                    "UMLS:C5569543": [
                        "Lens used for testing"
                    ],
                    "UMLS:C1964155": [
                        "Int mam art used for cabg",
                        "INT MAM ART USED FOR CABG",
                        "LIMA GRAFT USED IN 1ST ISOLATED CABG PXD",
                        "Internal mammary artery graft performed for primary, isolated coronary artery bypass graft procedure (CABG)",
                        "Internal mammary artery graft performed for primary, isolated coronary artery bypass graft procedure (cabg)"
                    ]
                }
            },
            {
                "label": "tetanus",
                "id": {
                    "MESH:D013745": [
                        "tetanus",
                        "Tetanus",
                        "Tetanus toxoid",
                        "TETANUS TOXOID",
                        "tetanus toxoid",
                        "Tetanus Toxoid",
                        "Toxoid, Tetanus",
                        "tetanus vaccine",
                        "tetanus toxoids",
                        "Tetanus toxoids",
                        "Tetanus Toxoid Vaccine",
                        "TETANUS TOXOID ADSORBED",
                        "Tetanus Toxoid Adsorbed",
                        "Tetanus toxoid adsorbed",
                        "tetanus toxoid, adsorbed",
                        "tetanus toxoid (medication)",
                        "tetanus toxoid vaccine, inactivated",
                        "TETTOX",
                        "CLOSTRIDIUM TETANI",
                        "Clostridium tetani",
                        "Bacillus tetani whole",
                        "Clostridium tetani whole",
                        "Clostridium tetani Toxoid Antigen, A",
                        "CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)",
                        "Clostridium tetani Toxoid Antigen (Formaldehyde Inactivated)",
                        "Clostridium Tetani Toxoid antigen (Formaldehyde inactivated)",
                        "Clostridium tetani toxoid antigen (formaldehyde inactivated)"
                    ],
                    "UMLS:C0305062": [
                        "Tetanus",
                        "tetanus",
                        "tetanus toxoid",
                        "Tetanus Toxoid",
                        "TETANUS TOXOID",
                        "Tetanus toxoid",
                        "Tetanus toxoids",
                        "Toxoid, Tetanus",
                        "tetanus vaccine",
                        "tetanus toxoids",
                        "Tetanus Toxoid Vaccine",
                        "Tetanus toxoid adsorbed",
                        "Tetanus Toxoid Adsorbed",
                        "TETANUS TOXOID ADSORBED",
                        "tetanus toxoid, adsorbed",
                        "tetanus toxoid (medication)",
                        "tetanus toxoid vaccine, inactivated",
                        "TETTOX",
                        "CLOSTRIDIUM TETANI",
                        "Clostridium tetani",
                        "Bacillus tetani whole",
                        "Clostridium tetani Toxoid Antigen, A",
                        "CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)",
                        "Clostridium tetani Toxoid Antigen (Formaldehyde Inactivated)",
                        "Clostridium tetani toxoid antigen (formaldehyde inactivated)",
                        "Clostridium Tetani Toxoid antigen (Formaldehyde inactivated)"
                    ],
                    "MONDO:0005526": [
                        "TETANUS",
                        "tetanus",
                        "tetanus",
                        "Tetanus",
                        "Tetanus NOS",
                        "E-146 TETANUS",
                        "Tetanus (disorder)",
                        "clostridial tetanus",
                        "tetanus (diagnosis)",
                        "clostridial tetanus",
                        "lockjaw",
                        "Clostridium tetani Infection",
                        "Clostridium tetani infection",
                        "Infection, Clostridium tetani",
                        "Clostridium tetani Infections",
                        "Infections, Clostridium tetani",
                        "Infection due to Clostridium tetani",
                        "Infection due to Clostridium tetani",
                        "infection due to Clostridium tetani",
                        "Infection caused by Clostridium tetani",
                        "Infection caused by Clostridium tetani (disorder)",
                        "Clostridium tetani infectious disease of the nervous system",
                        "Clostridium tetani caused infectious disease of the nervous system"
                    ],
                    "PUBCHEM.COMPOUND:16129962": [
                        "Tetanus-cmv"
                    ],
                    "UMLS:C0235069": [
                        "TETANUS-LIKE",
                        "TETANUS LIKE",
                        "Tetanus-like"
                    ]
                }
            }
        ]
    ],
    "Clozapine is indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment": [
        [
            {
                "label": "Clozapine",
                "id": {
                    "PUBCHEM.COMPOUND:135398737": [
                        "clozapine",
                        "Clozapine",
                        "CloZAPine",
                        "CLOZAPINE",
                        "cloZAPine",
                        "clozapine",
                        "CLOZAPINE (SUN)",
                        "CLOZAPINE (MAYNE)",
                        "CLOZAPINE (SANDOZ)",
                        "Clozapine (substance)",
                        "clozapine (medication)",
                        "CLOZAPINE (GOLDEN STATE)",
                        "Clozapine-containing product",
                        "Product containing clozapine (medicinal product)",
                        "Leponex",
                        "Clozaril",
                        "Clozapin",
                        "Clozapin",
                        "Clozapin",
                        "Clozapina",
                        "Clozapina",
                        "clozapina",
                        "Clozapinum",
                        "clozapinum",
                        "Clozapinum",
                        "8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine",
                        "8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine",
                        "5H-Dibenzo(b,e)(1,4)diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)-"
                    ],
                    "UMLS:C3666182": [
                        "Clozapine",
                        "DRUG ASSAY CLOZAPINE",
                        "Drug assay clozapine",
                        "DRUG SCREEN QUANTITATIVE CLOZAPINE"
                    ],
                    "PUBCHEM.COMPOUND:135858214": [
                        "Clozapine-d8"
                    ],
                    "PUBCHEM.COMPOUND:136951475": [
                        "Clozapine-D4"
                    ],
                    "UMLS:C0796743": [
                        "cloZAPine Ql",
                        "cloZAPine SerPl Ql",
                        "cloZAPine:PrThr:Pt:Ser/Plas:Ord",
                        "cloZAPine [Presence] in Serum or Plasma",
                        "cloZAPine:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment",
                "id": {}
            }
        ]
    ],
    "Clonidine hydrochloride injection is indicated in combination with opiates for the treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone": [
        [
            {
                "label": "Clonidine hydrochloride injection",
                "id": {
                    "UMLS:C5222414": [
                        "Clonidine Hydrochloride Injection"
                    ],
                    "UMLS:C0520138": [
                        "Injection, clonidine hydrochloride, 1 mg",
                        "INJECTION, CLONIDINE HYDROCHLORIDE, 1 MG ADMINISTERED",
                        "Clonidine hydrochloride"
                    ],
                    "UMLS:C0872744": [
                        "10 ML clonidine hydrochloride 0.5 MG/ML Injection",
                        "10 ML cloNIDine hydrochloride 0.5 MG/ML Injection",
                        "Clonidine Hydrochloride 500mcg/1mL Solution for injection",
                        "CLONIDINE HYDROCHLORIDE 500 ug in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 0.5 mg in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 500 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "CLONIDINE HCL 500MCG/ML INJ",
                        "cloNIDine 500 mcg/mL injectable solution",
                        "cloNIDine HCl 5000 MCG in 10 ML Injection",
                        "cloNIDine HCl 5000 MCG per 10 ML Injection",
                        "clonidine HCl 5000 MCG per 10 ML Injection",
                        "clonidine HCl/PF@5,000 mcg/10 mL@EPIDURAL@VIAL (ML)",
                        "clonidine HCl/PF 5,000 mcg/10 mL EPIDURAL VIAL (ML)",
                        "Clonidine Hydrochloride 0.5 MG/1 ML Epidural Solution",
                        "CloNIDine Hydrochloride, 500 mcg/mL injectable solution"
                    ],
                    "UMLS:C0975738": [
                        "10 ML cloNIDine hydrochloride 0.1 MG/ML Injection",
                        "10 ML clonidine hydrochloride 0.1 MG/ML Injection",
                        "Clonidine Hydrochloride 100mcg/1mL Solution for injection",
                        "CLONIDINE HYDROCHLORIDE 100 ug in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 0.1 mg in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 100 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "CLONIDINE HCL 100MCG/ML INJ",
                        "cloNIDine 100 mcg/mL injectable solution",
                        "cloNIDine HCl 1000 MCG in 10 ML Injection",
                        "clonidine HCl 1000 MCG per 10 ML Injection",
                        "cloNIDine HCl 1000 MCG per 10 ML Injection",
                        "Clonidine Hydrochloride 0.1 MG/1 ML Epidural Solution",
                        "CloNIDine Hydrochloride, 100 mcg/mL injectable solution",
                        "clonidine HCl/PF@1,000 mcg/10 mL (100 mcg/mL)@EPIDURAL@VIAL (ML)",
                        "clonidine HCl/PF 1,000 mcg/10 mL (100 mcg/mL) EPIDURAL VIAL (ML)"
                    ],
                    "UMLS:C0787088": [
                        "Clonidine hydrochloride 150micrograms/1mL injection",
                        "Clonidine hydrochloride 150 microgram/mL solution for injection",
                        "Product containing precisely clonidine hydrochloride 150 microgram/1 milliliter conventional release solution for injection (clinical drug)",
                        "Clonidine HCl 150mcg/1mL inj",
                        "clonidine hydrochloride 0.015 % Injectable Solution",
                        "cloNIDine hydrochloride 0.015 % Injectable Solution",
                        "cloNIDine hydrochloride 0.15 MG/ML Injectable Solution",
                        "clonidine hydrochloride 0.15 MG/ML Injectable Solution"
                    ]
                }
            },
            {
                "label": "is indicated in combination with",
                "id": {}
            },
            {
                "label": "opiates",
                "id": {
                    "UMLS:C0376196": [
                        "Opiates",
                        "opiates",
                        "opiate",
                        "Opiate",
                        "Opium Derivatives",
                        "opium derivatives",
                        "Opioid receptor agonist-containing product",
                        "Product containing opioid receptor agonist (product)"
                    ],
                    "MESH:D053610": [
                        "Opiates",
                        "Alkaloid Opiates",
                        "Opiates, Alkaloid",
                        "Opiate",
                        "Opium alkaloid",
                        "opiate alkaloid",
                        "opium alkaloids",
                        "Opium Alkaloids",
                        "alkaloids opium",
                        "alkaloids opiate",
                        "Opiate Alkaloids",
                        "Alkaloids, Opiate",
                        "Opium alkaloid (substance)",
                        "Opium alkaloid-containing product",
                        "Product containing opium alkaloid (product)"
                    ],
                    "UMLS:C0242401": [
                        "opiates",
                        "Opiates",
                        "Opiates, NOS",
                        "drug screen opiates",
                        "drug screen opiates (lab test)",
                        "Opiate Assay",
                        "Opiate Measurement",
                        "Measurement of opiate"
                    ],
                    "UMLS:C0366105": [
                        "Opiates Ql",
                        "Opiates SerPl Ql",
                        "Opiates:PrThr:Pt:Ser/Plas:Ord",
                        "Opiates [Presence] in Serum or Plasma",
                        "Opiates:Presence or Threshold:To identify measures at a point in time:Serum/Plasma:Ordinal"
                    ],
                    "UMLS:C0367914": [
                        "Opiates Ur",
                        "Opiates Nom (U)",
                        "Opiates:Prid:Pt:Urine:Nom",
                        "Opiates [Identifier] in Urine",
                        "Opiates:Presence or Identity:Point in time:Urine:Nominal",
                        "Opiates:Presence or Identity:To identify measures at a point in time:Urine:Nominal"
                    ]
                }
            }
        ],
        [
            {
                "label": "Clonidine hydrochloride injection",
                "id": {
                    "UMLS:C5222414": [
                        "Clonidine Hydrochloride Injection"
                    ],
                    "UMLS:C0520138": [
                        "Injection, clonidine hydrochloride, 1 mg",
                        "INJECTION, CLONIDINE HYDROCHLORIDE, 1 MG ADMINISTERED",
                        "Clonidine hydrochloride"
                    ],
                    "UMLS:C0872744": [
                        "10 ML clonidine hydrochloride 0.5 MG/ML Injection",
                        "10 ML cloNIDine hydrochloride 0.5 MG/ML Injection",
                        "Clonidine Hydrochloride 500mcg/1mL Solution for injection",
                        "CLONIDINE HYDROCHLORIDE 500 ug in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 0.5 mg in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 500 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "CLONIDINE HCL 500MCG/ML INJ",
                        "cloNIDine 500 mcg/mL injectable solution",
                        "cloNIDine HCl 5000 MCG in 10 ML Injection",
                        "cloNIDine HCl 5000 MCG per 10 ML Injection",
                        "clonidine HCl 5000 MCG per 10 ML Injection",
                        "clonidine HCl/PF@5,000 mcg/10 mL@EPIDURAL@VIAL (ML)",
                        "clonidine HCl/PF 5,000 mcg/10 mL EPIDURAL VIAL (ML)",
                        "Clonidine Hydrochloride 0.5 MG/1 ML Epidural Solution",
                        "CloNIDine Hydrochloride, 500 mcg/mL injectable solution"
                    ],
                    "UMLS:C0975738": [
                        "10 ML cloNIDine hydrochloride 0.1 MG/ML Injection",
                        "10 ML clonidine hydrochloride 0.1 MG/ML Injection",
                        "Clonidine Hydrochloride 100mcg/1mL Solution for injection",
                        "CLONIDINE HYDROCHLORIDE 100 ug in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 0.1 mg in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 100 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION",
                        "CLONIDINE HCL 100MCG/ML INJ",
                        "cloNIDine 100 mcg/mL injectable solution",
                        "cloNIDine HCl 1000 MCG in 10 ML Injection",
                        "clonidine HCl 1000 MCG per 10 ML Injection",
                        "cloNIDine HCl 1000 MCG per 10 ML Injection",
                        "Clonidine Hydrochloride 0.1 MG/1 ML Epidural Solution",
                        "CloNIDine Hydrochloride, 100 mcg/mL injectable solution",
                        "clonidine HCl/PF@1,000 mcg/10 mL (100 mcg/mL)@EPIDURAL@VIAL (ML)",
                        "clonidine HCl/PF 1,000 mcg/10 mL (100 mcg/mL) EPIDURAL VIAL (ML)"
                    ],
                    "UMLS:C0787088": [
                        "Clonidine hydrochloride 150micrograms/1mL injection",
                        "Clonidine hydrochloride 150 microgram/mL solution for injection",
                        "Product containing precisely clonidine hydrochloride 150 microgram/1 milliliter conventional release solution for injection (clinical drug)",
                        "Clonidine HCl 150mcg/1mL inj",
                        "clonidine hydrochloride 0.015 % Injectable Solution",
                        "cloNIDine hydrochloride 0.015 % Injectable Solution",
                        "cloNIDine hydrochloride 0.15 MG/ML Injectable Solution",
                        "clonidine hydrochloride 0.15 MG/ML Injectable Solution"
                    ]
                }
            },
            {
                "label": "is for the treatment of",
                "id": {
                    "UMLS:C2051447": [
                        "patient counseling for issues related to effects of therapy (treatment)",
                        "patient counseling for issues related to effects of therapy"
                    ],
                    "UMLS:C2959335": [
                        "Item or service furnished to an esrd patient that is not for the treatment of esrd",
                        "Item/service not for esrd tx"
                    ],
                    "UMLS:C2164216": [
                        "day of procedure surgical checklist: verified a blood products consent form is in the chart (treatment)",
                        "day of procedure surgical checklist: verified a blood products consent form is in the chart"
                    ],
                    "UMLS:C2164198": [
                        "day of procedure surgical checklist: verified the signed consent form for sedation is in the chart (treatment)",
                        "day of procedure surgical checklist: verified the signed consent form for sedation is in the chart"
                    ],
                    "UMLS:C2164196": [
                        "day of procedure surgical checklist: verified the signed consent form for anesthesia is in the chart (treatment)",
                        "day of procedure surgical checklist: verified the signed consent form for anesthesia is in the chart"
                    ]
                }
            },
            {
                "label": "severe pain in cancer patients",
                "id": {}
            }
        ],
        [
            {
                "label": "severe pain in cancer patients",
                "id": {}
            },
            {
                "label": "is not adequately relieved by",
                "id": {}
            },
            {
                "label": "opioid analgesics alone",
                "id": {}
            }
        ]
    ],
    "As adjunctive treatment to levodopa (alone or with a peripheral decarboxylase inhibitor), bromocriptine mesylate therapy may provide additional therapeutic benefits in those patients who are currently maintained on optimal dosages of levodopa, those who are beginning to deteriorate (develop tolerance) to levodopa therapy, and those who are experiencing 'end of dose failure' on levodopa therapy.": [
        [
            {
                "label": "bromocriptine mesylate therapy",
                "id": {}
            },
            {
                "label": "may provide",
                "id": {
                    "UMLS:C4713411": [
                        "Provide undisturbed time because patient may fall asleep"
                    ],
                    "UMLS:C4711171": [
                        "Provide head phones for private listening when music may disturb others"
                    ],
                    "UMLS:C0514768": [
                        "Provide factual information about sexual myths and misinformation that patient may verbalize"
                    ],
                    "UMLS:C4711326": [
                        "Provide opportunities for family to apply coping strategies that may work in the current situation"
                    ],
                    "UMLS:C5448054": [
                        "Comfortable Calling Healthcare Provider About Symptom that May be Related to Return of Breast Cancer"
                    ]
                }
            },
            {
                "label": "additional therapeutic benefits in those patients who are currently maintained on optimal dosages of levodopa",
                "id": {}
            }
        ],
        [
            {
                "label": "those who are beginning to deteriorate",
                "id": {}
            },
            {
                "label": "develop",
                "id": {
                    "UMLS:C4472596": [
                        "Developea"
                    ],
                    "UMLS:C2363670": [
                        "developer",
                        "developers",
                        "Developers, X-Ray Film"
                    ],
                    "GO:0032502": [
                        "development",
                        "developmental process",
                        "single-organism developmental process"
                    ],
                    "HMDB:HMDB0251697": [
                        "Developer Z",
                        "C.I. developer 1",
                        "Radicut",
                        "MCI-186",
                        "MCI 186",
                        "Radicava",
                        "Edaravone",
                        "Edarabone",
                        "Norphenazone",
                        "Norantipyrine",
                        "Phenylmethylpyrazolone",
                        "Methylphenylpyrazolone",
                        "Phenyl methyl pyrazolone",
                        "3-Methyl-1-phenyl-5-pyrazolone",
                        "1-Phenyl-3-methyl-5-pyrazolone",
                        "3-Methyl-1-phenylpyrazol-5-one",
                        "1 Phenyl 3 methyl 5 pyrazolone",
                        "3 Methyl 1 phenyl 2 pyrazolin 5 one",
                        "3-Methyl-1-phenyl-2-pyrazolin-5-one",
                        "1-Phenyl-3-methyl-5-oxo-2-pyrazoline",
                        "2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one"
                    ],
                    "PUBCHEM.COMPOUND:4021": [
                        "developer Z",
                        "C.I. developer 1",
                        "Radicut",
                        "EDARAVONE",
                        "Edarabone",
                        "Edaravone",
                        "edaravone",
                        "norphenazone",
                        "Norphenazone",
                        "Norantipyrine",
                        "Edaravone (substance)",
                        "antioxidants edaravone",
                        "edaravone (medication)",
                        "Phenylmethylpyrazolone",
                        "methylphenylpyrazolone",
                        "phenylmethylpyrazolone",
                        "Methylphenylpyrazolone",
                        "Phenyl methyl pyrazolone",
                        "phenyl methyl pyrazolone",
                        "Edaravone-containing product",
                        "3-methyl-1-phenyl-5-pyrazolone",
                        "1-Phenyl-3-methyl-5-pyrazolone",
                        "3-methyl-1-phenylpyrazol-5-one",
                        "1 Phenyl 3 methyl 5 pyrazolone",
                        "3-methyl-1-phenyl-5-pyrazolone",
                        "3-methyl-1-phenylpyrazol-5-one",
                        "3 Methyl 1 phenyl 2 pyrazolin 5 one",
                        "3-Methyl-1-phenyl-2-pyrazolin-5-one",
                        "3-methyl-1-phenyl-2-pyrazolin-5-one",
                        "3-methyl-1-phenyl-2-pyrazolin-5-one",
                        "1-phenyl-3-methyl-5-oxo-2-pyrazoline",
                        "1-phenyl-3-methyl-5-oxo-2-pyrazoline",
                        "2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one",
                        "2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one",
                        "5-methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one",
                        "3H-pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl-",
                        "Product containing edaravone (medicinal product)"
                    ]
                }
            },
            {
                "label": "tolerance to levodopa therapy",
                "id": {}
            }
        ],
        [
            {
                "label": "those who are experiencing 'end of dose failure'",
                "id": {}
            },
            {
                "label": "on",
                "id": {
                    "PR:000015475": [
                        "ON",
                        "SPARC",
                        "BM-40",
                        "osteonectin",
                        "SPARC protein",
                        "basement-membrane protein 40",
                        "secreted protein acidic and rich in cysteine"
                    ],
                    "NCBIGene:6678": [
                        "ON",
                        "ONT",
                        "ONT",
                        "BM40",
                        "SPARC",
                        "BM-40",
                        "BM-40",
                        "SPARC Gene",
                        "SPARC gene",
                        "OSTEONECTIN",
                        "osteonectin",
                        "cysteine-rich protein",
                        "cysteine-rich protein",
                        "SECRETED PROTEIN, ACIDIC, CYSTEINE-RICH",
                        "secreted protein acidic and cysteine rich",
                        "secreted protein acidic and rich in cysteine",
                        "secreted protein acidic and rich in cysteine",
                        "Secreted Protein, Acidic, Cysteine-Rich (Osteonectin) Gene"
                    ],
                    "FB:FBgn0003000": [
                        "On"
                    ],
                    "UMLS:C1720176": [
                        "On",
                        "Upon",
                        "Upon - dosing instruction fragment",
                        "Upon - dosing instruction fragment (qualifier value)"
                    ],
                    "UMLS:C1720294": [
                        "On",
                        "On (qualifier value)"
                    ]
                }
            },
            {
                "label": "levodopa therapy",
                "id": {
                    "UMLS:C0569534": [
                        "adverse effect of drug therapy levodopa",
                        "Levodopa adverse reaction",
                        "adverse effect of levodopa",
                        "adverse reaction to levodopa",
                        "Adverse reaction to levodopa, L-dopa",
                        "Levodopa adverse reaction (disorder)",
                        "adverse effect of levodopa (diagnosis)"
                    ],
                    "UMLS:C1846869": [
                        "Secondary motor complications develop in 50% of those on levodopa therapy"
                    ]
                }
            }
        ]
    ],
    "Bromocriptine mesylate therapy may permit a reduction of the maintenance dose of levodopa and, thus may ameliorate the occurrence and/or severity of adverse reactions associated with long-term levodopa therapy such as abnormal involuntary movements (e.g., dyskinesias) and the marked swings in motor function ('on-off' phenomenon).": [
        [
            {
                "label": "Bromocriptine mesylate therapy",
                "id": {}
            },
            {
                "label": "may permit",
                "id": {
                    "UMLS:C3628586": [
                        "Mayamaea permitis",
                        "Mayamaea atomus var. permitis",
                        "Mayamaea permitis (Hustedt) K.Bruder & L.K.Medlin 2008",
                        "Navicula permitis",
                        "Navicula atomus var. permitis",
                        "Navicula permitis Hustedt 1945"
                    ]
                }
            },
            {
                "label": "a reduction of the maintenance dose of levodopa",
                "id": {}
            }
        ],
        [
            {
                "label": "Bromocriptine mesylate therapy",
                "id": {}
            },
            {
                "label": "may ameliorate",
                "id": {}
            },
            {
                "label": "the occurrence and/or severity of adverse reactions associated with long-term levodopa therapy such as abnormal involuntary movements (e.g., dyskinesias) and the marked swings in motor function ('on-off' phenomenon)",
                "id": {}
            }
        ]
    ],
    "Aripiprazole oral solution is indicated for the treatment of: Schizophrenia": [
        [
            {
                "label": "Aripiprazole oral solution",
                "id": {
                    "UMLS:C1577202": [
                        "aripiprazole Oral Solution",
                        "Aripiprazole Oral Solution",
                        "ARIPiprazole Oral Solution"
                    ],
                    "UMLS:C1576511": [
                        "aripiprazole 1 MG/ML Oral Solution",
                        "ARIPiprazole 1 MG/ML Oral Solution",
                        "ARIPiprazole 1 mg/mL oral solution",
                        "Aripiprazole 1mg/1mL Oral solution",
                        "Aripiprazole 1 mg/mL oral solution",
                        "Aripiprazole, 1 mg/mL oral solution",
                        "Aripiprazole 1 MG/1 ML Oral Solution",
                        "ARIPIPRAZOLE 1 mg in 1 mL ORAL SOLUTION",
                        "ARIPiprazole 1 MG in 1 mL Oral Solution",
                        "aripiprazole 1 mg/mL ORAL SOLUTION, ORAL",
                        "ARIPiprazole 1 MG per 1 ML Oral Solution",
                        "aripiprazole@1 mg/mL@ORAL@SOLUTION, ORAL",
                        "aripiprazole 1 MG per 1 ML Oral Solution",
                        "Product containing precisely aripiprazole 1 milligram/1 milliliter conventional release oral solution (clinical drug)",
                        "ARIPIPRAZOLE 1MG/ML SOLN,ORAL",
                        "ARIPIPRAZOLE 1MG/ML ORAL SOLN"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of: Schizophrenia",
                "id": {}
            }
        ]
    ],
    "Aripiprazole oral solution is indicated for the treatment of: acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder": [
        [
            {
                "label": "Aripiprazole oral solution",
                "id": {
                    "UMLS:C1577202": [
                        "aripiprazole Oral Solution",
                        "Aripiprazole Oral Solution",
                        "ARIPiprazole Oral Solution"
                    ],
                    "UMLS:C1576511": [
                        "aripiprazole 1 MG/ML Oral Solution",
                        "ARIPiprazole 1 MG/ML Oral Solution",
                        "ARIPiprazole 1 mg/mL oral solution",
                        "Aripiprazole 1mg/1mL Oral solution",
                        "Aripiprazole 1 mg/mL oral solution",
                        "Aripiprazole, 1 mg/mL oral solution",
                        "Aripiprazole 1 MG/1 ML Oral Solution",
                        "ARIPIPRAZOLE 1 mg in 1 mL ORAL SOLUTION",
                        "ARIPiprazole 1 MG in 1 mL Oral Solution",
                        "aripiprazole 1 mg/mL ORAL SOLUTION, ORAL",
                        "ARIPiprazole 1 MG per 1 ML Oral Solution",
                        "aripiprazole@1 mg/mL@ORAL@SOLUTION, ORAL",
                        "aripiprazole 1 MG per 1 ML Oral Solution",
                        "Product containing precisely aripiprazole 1 milligram/1 milliliter conventional release oral solution (clinical drug)",
                        "ARIPIPRAZOLE 1MG/ML SOLN,ORAL",
                        "ARIPIPRAZOLE 1MG/ML ORAL SOLN"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of: acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder",
                "id": {}
            }
        ]
    ],
    "Aripiprazole oral solution is indicated for the treatment of: Irritability Associated with Autistic Disorder": [
        [
            {
                "label": "Aripiprazole oral solution",
                "id": {
                    "UMLS:C1577202": [
                        "aripiprazole Oral Solution",
                        "Aripiprazole Oral Solution",
                        "ARIPiprazole Oral Solution"
                    ],
                    "UMLS:C1576511": [
                        "aripiprazole 1 MG/ML Oral Solution",
                        "ARIPiprazole 1 MG/ML Oral Solution",
                        "ARIPiprazole 1 mg/mL oral solution",
                        "Aripiprazole 1mg/1mL Oral solution",
                        "Aripiprazole 1 mg/mL oral solution",
                        "Aripiprazole, 1 mg/mL oral solution",
                        "Aripiprazole 1 MG/1 ML Oral Solution",
                        "ARIPIPRAZOLE 1 mg in 1 mL ORAL SOLUTION",
                        "ARIPiprazole 1 MG in 1 mL Oral Solution",
                        "aripiprazole 1 mg/mL ORAL SOLUTION, ORAL",
                        "ARIPiprazole 1 MG per 1 ML Oral Solution",
                        "aripiprazole@1 mg/mL@ORAL@SOLUTION, ORAL",
                        "aripiprazole 1 MG per 1 ML Oral Solution",
                        "Product containing precisely aripiprazole 1 milligram/1 milliliter conventional release oral solution (clinical drug)",
                        "ARIPIPRAZOLE 1MG/ML SOLN,ORAL",
                        "ARIPIPRAZOLE 1MG/ML ORAL SOLN"
                    ]
                }
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the treatment of: Irritability Associated with Autistic Disorder",
                "id": {}
            }
        ]
    ],
    "Combination Therapy - Adults: The combination of risperidone with lithium or valproate is indicated for the short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder": [
        [
            {
                "label": "The combination of risperidone with lithium or valproate",
                "id": {}
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the short-term treatment of acute manic or mixed episodes",
                "id": {}
            }
        ],
        [
            {
                "label": "The short-term treatment of acute manic or mixed episodes",
                "id": {}
            },
            {
                "label": "associated with",
                "id": {
                    "UMLS:C0332281": [
                        "associated with",
                        "ASSOCIATED WITH",
                        "Associated with",
                        "Associated with (attribute)",
                        "AW",
                        "ASSOC",
                        "associated",
                        "Associated",
                        "associating"
                    ],
                    "UMLS:C1608982": [
                        "Associated with (APAH)"
                    ],
                    "UMLS:C2029691": [
                        "headache associated with",
                        "headache associated",
                        "headache associated factor",
                        "headache associated factor (symptom)"
                    ],
                    "HP:0033705": [
                        "Crying associated with mood",
                        "Crying associated with emotion",
                        "Crying associated with mood (finding)",
                        "weep",
                        "Weepy",
                        "Weeps",
                        "weepy",
                        "weeping",
                        "tearful",
                        "WEEPING",
                        "Weeping",
                        "Tearful",
                        "Weepiness",
                        "weepiness",
                        "Tearfulness",
                        "affect tearful",
                        "tearful (physical finding)"
                    ],
                    "NCBIGene:23077": [
                        "PROTEIN ASSOCIATED WITH MYC",
                        "PAM",
                        "PAM",
                        "PHR1",
                        "PHR1",
                        "MYCBP2",
                        "FLJ10106",
                        "KIAA0916",
                        "FLJ10106",
                        "KIAA0916",
                        "MYCBP2 gene",
                        "MYCBP2 Gene",
                        "MYC-BINDING PROTEIN 2",
                        "MYC binding protein 2",
                        "MYC Binding Protein 2 Gene",
                        "PAM/Highwire/RPM-1 protein 1",
                        "PAM/Highwire/RPM-1 protein 1",
                        "MYC binding protein 2, E3 ubiquitin protein ligase"
                    ]
                }
            },
            {
                "label": "Bipolar I Disorder",
                "id": {
                    "MONDO:0001866": [
                        "bipolar I disorder",
                        "Bipolar I disorder",
                        "bipolar I disorder",
                        "bipolar i disorder",
                        "bipolar; disorder, I",
                        "disorder; bipolar, I",
                        "bipolar type I disorder",
                        "Depressed bipolar I disorder",
                        "Bipolar I disorder (disorder)",
                        "Bipolar I disorder (diagnosis)",
                        "Depressed bipolar I disorder, NOS",
                        "Depressed bipolar I disorder (disorder)",
                        "Bipolar I disorder, most recent episode depressed",
                        "bipolar I disorder, most recent episode, depressed",
                        "bipolar I disorder, most recent episode, depressed (diagnosis)",
                        "Bipolar I disorder, Current or most recent episode depressed, Unspecified",
                        "Bipolar I disorder, most recent episode (or current) depressed, unspecified",
                        "Bipolar 1 disorder",
                        "bipolar 1 disorder",
                        "Bipol I cur depres NOS",
                        "Manic-depressive illness, depressive type",
                        "Manic-depressive psychosis, depressed type",
                        "Bipolar affective disorder, depressed, unspecified degree"
                    ],
                    "MONDO:0000693": [
                        "Bipolar II disorder",
                        "bipolar ii disorder",
                        "bipolar disorder ii",
                        "bipolar II disorder",
                        "disorder; bipolar, II",
                        "bipolar; disorder, II",
                        "Bipolar II disorder, NOS",
                        "Bipolar II disorder (disorder)",
                        "bipolar II disorder (diagnosis)",
                        "bipolar 2 disorder",
                        "Bipolar 2 disorder",
                        "bipolar ll disorder",
                        "bipolar ll disorder",
                        "bipolar ll disorder",
                        "Bipolar Disorder Type 2",
                        "Type 2 Bipolar Disorder",
                        "Bipolar disorder, type 2",
                        "Bipolar disorder, Type 2"
                    ],
                    "MONDO:0024612": [
                        "Manic bipolar I disorder",
                        "Manic bipolar I disorder, NOS",
                        "Manic bipolar I disorder (disorder)",
                        "Bipolar I disorder, most recent episode manic",
                        "bipolar I disorder, most recent episode, manic",
                        "disorder; bipolar, I, most recent episode, manic",
                        "Bipolar I disorder, most recent episode manic (disorder)",
                        "bipolar I disorder, most recent episode, manic (diagnosis)",
                        "Bipolar I disorder, Current or most recent episode manic, Unspecified",
                        "Bipolar I disorder, most recent episode (or current) manic, unspecified",
                        "MANIC DIS",
                        "Manic Disorder",
                        "manic disorder",
                        "MANIC DISORDER",
                        "disorder; manic",
                        "manic disorders",
                        "Manic Disorders",
                        "manic; disorder",
                        "monopolar mania",
                        "Disorder, Manic",
                        "BIPOLAR DISEASE, MANIC",
                        "bipolar disorder manic",
                        "BIPOLAR DISORDER, MANIC",
                        "Bipol I currnt manic NOS",
                        "CYCLOTHYMIC DISORDER, MANIC",
                        "bipolar disorder manic phase",
                        "Manic-depressive - now manic",
                        "manic-depressive - now manic",
                        "Bipolar affective - now manic",
                        "bipolar depression manic phase",
                        "manic bipolar affective disorder",
                        "Manic Bipolar Affective Disorder",
                        "Bipolar affective disorder, manic",
                        "BIPOLAR DISORDER MANIC UNSPECIFIED",
                        "MANIC DEPRESSIVE DISEASE MANIC PHASE",
                        "MANIC DEPRESSIVE DISEASE, MANIC PHASE",
                        "bipolar disorder affective, current episode manic",
                        "bipolar affective disorder, current episode manic",
                        "Bipolar affective disorder, current episode manic",
                        "disorder; bipolar, affective, current episode, manic",
                        "Bipolar affective disorder, manic, unspecified degree",
                        "Bipolar affective disorder, current episode manic (disorder)",
                        "Bipolar affective disorder, current episode manic (diagnosis)"
                    ],
                    "MONDO:0004985": [
                        "Manic bipolar I disorder",
                        "Mixed bipolar I disorder",
                        "manic bipolar I disorder",
                        "Mixed bipolar I disorder, NOS",
                        "Mixed bipolar I disorder (disorder)",
                        "Bipolar I disorder, most recent episode mixed",
                        "bipolar I disorder, most recent episode, mixed",
                        "disorder; bipolar, I, most recent episode, mixed",
                        "bipolar I disorder, most recent episode, mixed (diagnosis)",
                        "Bipolar I disorder, most recent episode (or current) mixed, unspecified",
                        "MAFD",
                        "BPAD",
                        "BIPOLAR DIS",
                        "manic disorder",
                        "manic disorder",
                        "bipolar illness",
                        "Bipolar disorder",
                        "Manic Depression",
                        "manic depressive",
                        "BIPOLAR DISORDER",
                        "Bipolar Disorder",
                        "Manic depressive",
                        "manic depression",
                        "Manic depression",
                        "bipolar disorder",
                        "manic-depression",
                        "manic depression",
                        "Manic-Depression",
                        "Disorder;bipolar",
                        "bipolar disorder",
                        "Depression;manic",
                        "manic depression",
                        "Bipolar Disorders",
                        "bipolar; disorder",
                        "Disorder, Bipolar",
                        "Bi-polar Disorder",
                        "Bipolar disorders",
                        "bipolar disorders",
                        "BIPOLAR DISORDERS",
                        "manic depressions",
                        "disorder; bipolar",
                        "bipolar depression",
                        "bipolar depression",
                        "bipolar disorder NOS",
                        "bipolar disorder nos",
                        "Bipolar disorder NOS",
                        "Bipolar Mood Disorder",
                        "Bipolar disorder, NOS",
                        "bipolar mood disorder",
                        "Disorder, Bipolar Mood",
                        "Mood Disorder, Bipolar",
                        "Bipolar Mood Disorders",
                        "mixed bipolar disorder",
                        "mixed bipolar disorder",
                        "9-51 BIPOLAR DISORDERS",
                        "depressive-manic psych.",
                        "Depressive-manic psych.",
                        "manic-depressive illness",
                        "Manic depressive illness",
                        "major affective disorder",
                        "Manic-depressive illness",
                        "Bipol I currnt mixed NOS",
                        "Manic-Depressive Illness",
                        "manic depressive illness",
                        "MANIC DEPRESSIVE ILLNESS",
                        "manic-depressive illness",
                        "Reaction manic-depressive",
                        "manic depressive disorder",
                        "Manic depressive reaction",
                        "REACTION MANIC-DEPRESSIVE",
                        "MANIC DEPRESSIVE REACTION",
                        "manic-depressive reaction",
                        "Manic Depressive disorder",
                        "manic depressive disorder",
                        "Manic Depressive Disorder",
                        "affective bipolar disorder",
                        "Manic-depressive psychosis",
                        "manic-depressive; syndrome",
                        "bipolar affective disorder",
                        "BIPOLAR AFFECTIVE DISORDER",
                        "bipolar affective disorder",
                        "Manic-Depressive Psychosis",
                        "PSYCHOSIS MANIC-DEPRESSIVE",
                        "manic depressive psychosis",
                        "Psychosis manic-depressive",
                        "Bipolar affective disorder",
                        "manic-depressive; disorder",
                        "manic-depressive disorders",
                        "Manic depressive psychosis",
                        "manic-depressive psychosis",
                        "Psychosis;manic depressive",
                        "Manic Depressive Psychosis",
                        "manic-depressive psychosis",
                        "Bipolar Affective Disorder",
                        "syndrome; manic-depressive",
                        "Psychosis, Manic-Depressive",
                        "Psychoses, Manic-Depressive",
                        "Psychosis, Manic Depressive",
                        "manic-depressive; psychosis",
                        "psychosis; manic-depressive",
                        "bipolar affective psychosis",
                        "Psychoses, Manic Depressive",
                        "Bipolar Affective Psychosis",
                        "Bipolar disorder (disorder)",
                        "affective bipolar disorders",
                        "disorder; bipolar, affective",
                        "bipolar disorder manic phase",
                        "Psychoses, Bipolar Affective",
                        "bipolar; disorder, affective",
                        "Psychosis, Bipolar Affective",
                        "Affective Psychosis, Bipolar",
                        "bipolar disorder manic phase",
                        "Bipolar disorder, unspecified",
                        "Manic-depressive reaction NOS",
                        "Manic-depressive syndrome NOS",
                        "MDI - Manic-depressive illness",
                        "Manic Bipolar Affective disorder",
                        "bipolar disorder NOS (diagnosis)",
                        "major bipolar affective disorder",
                        "manic bipolar affective disorder",
                        "Bipolar affective disorder, unspecified",
                        "Bipolar affective disorder, mixed, unspecified degree"
                    ],
                    "UMLS:C1276786": [
                        "Severe bipolar I disorder",
                        "Severe bipolar I disorder (disorder)",
                        "Severe bipolar I disorder (diagnosis)"
                    ]
                }
            }
        ]
    ],
    "Escitalopram oral solution, USP is indicated for the acute treatment of Generalized Anxiety Disorder (GAD) in adults": [
        [
            {
                "label": "Escitalopram oral solution, USP",
                "id": {}
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "the acute treatment of Generalized Anxiety Disorder (GAD) in adults",
                "id": {}
            }
        ]
    ],
    "Quetiapine tablets are indicated for the treatment of schizophrenia": [
        [
            {
                "label": "Quetiapine tablets",
                "id": {
                    "UMLS:C1248733": [
                        "Quetiapine Tablets",
                        "QUEtiapine Oral Tablet",
                        "quetiapine Oral Tablet"
                    ],
                    "UMLS:C1949279": [
                        "Quetiapine Extended-Release Tablets",
                        "QUEtiapine Extended Release Oral Tablet",
                        "quetiapine Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of schizophrenia",
                "id": {}
            }
        ]
    ],
    "Oxcarbazepine oral suspension is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures.": [
        [
            {
                "label": "Oxcarbazepine oral suspension",
                "id": {
                    "UMLS:C1249301": [
                        "Oxcarbazepine Oral Suspension",
                        "OXcarbazepine Oral Suspension",
                        "oxcarbazepine Oral Suspension"
                    ],
                    "UMLS:C0937594": [
                        "oxcarbazepine 60 MG/ML Oral Suspension",
                        "OXcarbazepine 60 MG/ML Oral Suspension",
                        "Oxcarbazepine 60 mg/mL oral suspension",
                        "Oxcarbazepine 300mg/5mL Oral suspension",
                        "Oxcarbazepine 300 MG/5 ML Oral Suspension",
                        "OXcarbazepine 300 mg/5 mL oral suspension",
                        "Oxcarbazepine, 300 mg/5 mL oral suspension",
                        "Oxcarbazepine 300 mg in 5 mL ORAL SUSPENSION",
                        "OXCARBAZEPINE 300 mg in 5 mL ORAL SUSPENSION",
                        "OXCARBAZEPINE 60 mg in 1 mL ORAL SUSPENSION [Oxcarbazepine]",
                        "OXCARBAZEPINE 300 mg in 5 mL ORAL SUSPENSION [Oxcarbazepine]",
                        "oxcarbazepine 300 mg/5 mL (60 mg/mL) ORAL SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "oxcarbazepine@300 mg/5 mL (60 mg/mL)@ORAL@SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "Product containing precisely oxcarbazepine 60 milligram/1 milliliter conventional release oral suspension (clinical drug)",
                        "OXCARBAZEPINE 300MG/5ML SUSP",
                        "oxacarbazepine 300 MG in 5 mL Oral Suspension",
                        "oxacarbazepine 300 MG per 5 ML Oral Suspension"
                    ],
                    "UMLS:C1239822": [
                        "OXcarbazepine Oral Suspension [Trileptal]",
                        "oxcarbazepine Oral Suspension [Trileptal]"
                    ],
                    "UMLS:C1169605": [
                        "oxcarbazepine 60 MG/ML Oral Suspension [Trileptal]",
                        "OXcarbazepine 60 MG/ML Oral Suspension [Trileptal]",
                        "Oxcarbazepine 300 MG/5 ML Oral Suspension [TRILEPTAL]",
                        "OXCARBAZEPINE 60 mg in 1 mL ORAL SUSPENSION [Trileptal]",
                        "Trileptal 300mg/5ml Suspension",
                        "Trileptal 60 MG/ML Oral Suspension",
                        "Trileptal, 300 mg/5 mL oral suspension",
                        "Trileptal 300 MG in 5 mL Oral Suspension",
                        "Trileptal 300 MG per 5 ML Oral Suspension"
                    ]
                }
            },
            {
                "label": "is indicated for use as monotherapy or adjunctive therapy in",
                "id": {}
            },
            {
                "label": "the treatment of partial-onset seizures in adults",
                "id": {}
            }
        ],
        [
            {
                "label": "Oxcarbazepine oral suspension",
                "id": {
                    "UMLS:C1249301": [
                        "Oxcarbazepine Oral Suspension",
                        "OXcarbazepine Oral Suspension",
                        "oxcarbazepine Oral Suspension"
                    ],
                    "UMLS:C0937594": [
                        "oxcarbazepine 60 MG/ML Oral Suspension",
                        "OXcarbazepine 60 MG/ML Oral Suspension",
                        "Oxcarbazepine 60 mg/mL oral suspension",
                        "Oxcarbazepine 300mg/5mL Oral suspension",
                        "Oxcarbazepine 300 MG/5 ML Oral Suspension",
                        "OXcarbazepine 300 mg/5 mL oral suspension",
                        "Oxcarbazepine, 300 mg/5 mL oral suspension",
                        "Oxcarbazepine 300 mg in 5 mL ORAL SUSPENSION",
                        "OXCARBAZEPINE 300 mg in 5 mL ORAL SUSPENSION",
                        "OXCARBAZEPINE 60 mg in 1 mL ORAL SUSPENSION [Oxcarbazepine]",
                        "OXCARBAZEPINE 300 mg in 5 mL ORAL SUSPENSION [Oxcarbazepine]",
                        "oxcarbazepine 300 mg/5 mL (60 mg/mL) ORAL SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "oxcarbazepine@300 mg/5 mL (60 mg/mL)@ORAL@SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "Product containing precisely oxcarbazepine 60 milligram/1 milliliter conventional release oral suspension (clinical drug)",
                        "OXCARBAZEPINE 300MG/5ML SUSP",
                        "oxacarbazepine 300 MG in 5 mL Oral Suspension",
                        "oxacarbazepine 300 MG per 5 ML Oral Suspension"
                    ],
                    "UMLS:C1239822": [
                        "OXcarbazepine Oral Suspension [Trileptal]",
                        "oxcarbazepine Oral Suspension [Trileptal]"
                    ],
                    "UMLS:C1169605": [
                        "oxcarbazepine 60 MG/ML Oral Suspension [Trileptal]",
                        "OXcarbazepine 60 MG/ML Oral Suspension [Trileptal]",
                        "Oxcarbazepine 300 MG/5 ML Oral Suspension [TRILEPTAL]",
                        "OXCARBAZEPINE 60 mg in 1 mL ORAL SUSPENSION [Trileptal]",
                        "Trileptal 300mg/5ml Suspension",
                        "Trileptal 60 MG/ML Oral Suspension",
                        "Trileptal, 300 mg/5 mL oral suspension",
                        "Trileptal 300 MG in 5 mL Oral Suspension",
                        "Trileptal 300 MG per 5 ML Oral Suspension"
                    ]
                }
            },
            {
                "label": "is indicated for use as monotherapy in",
                "id": {}
            },
            {
                "label": "the treatment of partial-onset seizures in pediatric patients aged 4 years and above",
                "id": {}
            }
        ],
        [
            {
                "label": "Oxcarbazepine oral suspension",
                "id": {
                    "UMLS:C1249301": [
                        "Oxcarbazepine Oral Suspension",
                        "OXcarbazepine Oral Suspension",
                        "oxcarbazepine Oral Suspension"
                    ],
                    "UMLS:C0937594": [
                        "oxcarbazepine 60 MG/ML Oral Suspension",
                        "OXcarbazepine 60 MG/ML Oral Suspension",
                        "Oxcarbazepine 60 mg/mL oral suspension",
                        "Oxcarbazepine 300mg/5mL Oral suspension",
                        "Oxcarbazepine 300 MG/5 ML Oral Suspension",
                        "OXcarbazepine 300 mg/5 mL oral suspension",
                        "Oxcarbazepine, 300 mg/5 mL oral suspension",
                        "Oxcarbazepine 300 mg in 5 mL ORAL SUSPENSION",
                        "OXCARBAZEPINE 300 mg in 5 mL ORAL SUSPENSION",
                        "OXCARBAZEPINE 60 mg in 1 mL ORAL SUSPENSION [Oxcarbazepine]",
                        "OXCARBAZEPINE 300 mg in 5 mL ORAL SUSPENSION [Oxcarbazepine]",
                        "oxcarbazepine 300 mg/5 mL (60 mg/mL) ORAL SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "oxcarbazepine@300 mg/5 mL (60 mg/mL)@ORAL@SUSPENSION, ORAL (FINAL DOSE FORM)",
                        "Product containing precisely oxcarbazepine 60 milligram/1 milliliter conventional release oral suspension (clinical drug)",
                        "OXCARBAZEPINE 300MG/5ML SUSP",
                        "oxacarbazepine 300 MG in 5 mL Oral Suspension",
                        "oxacarbazepine 300 MG per 5 ML Oral Suspension"
                    ],
                    "UMLS:C1239822": [
                        "OXcarbazepine Oral Suspension [Trileptal]",
                        "oxcarbazepine Oral Suspension [Trileptal]"
                    ],
                    "UMLS:C1169605": [
                        "oxcarbazepine 60 MG/ML Oral Suspension [Trileptal]",
                        "OXcarbazepine 60 MG/ML Oral Suspension [Trileptal]",
                        "Oxcarbazepine 300 MG/5 ML Oral Suspension [TRILEPTAL]",
                        "OXCARBAZEPINE 60 mg in 1 mL ORAL SUSPENSION [Trileptal]",
                        "Trileptal 300mg/5ml Suspension",
                        "Trileptal 60 MG/ML Oral Suspension",
                        "Trileptal, 300 mg/5 mL oral suspension",
                        "Trileptal 300 MG in 5 mL Oral Suspension",
                        "Trileptal 300 MG per 5 ML Oral Suspension"
                    ]
                }
            },
            {
                "label": "is indicated for use as adjunctive therapy in",
                "id": {}
            },
            {
                "label": "pediatric patients aged 2 years and above with partial-onset seizures",
                "id": {}
            }
        ]
    ],
    "Buprenorphine Sublingual Tablets are indicated for the treatment of opioid dependence and are preferred for induction": [
        [
            {
                "label": "Buprenorphine Sublingual Tablets",
                "id": {
                    "UMLS:C1245198": [
                        "Buprenorphine Sublingual Tablets",
                        "buprenorphine Sublingual Tablet"
                    ],
                    "UMLS:C1253118": [
                        "Buprenorphine and Naloxone Sublingual Tablets",
                        "buprenorphine / naloxone Sublingual Tablet"
                    ]
                }
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the treatment of opioid dependence",
                "id": {}
            }
        ],
        [
            {
                "label": "Buprenorphine Sublingual Tablets",
                "id": {
                    "UMLS:C1245198": [
                        "Buprenorphine Sublingual Tablets",
                        "buprenorphine Sublingual Tablet"
                    ],
                    "UMLS:C1253118": [
                        "Buprenorphine and Naloxone Sublingual Tablets",
                        "buprenorphine / naloxone Sublingual Tablet"
                    ]
                }
            },
            {
                "label": "are",
                "id": {
                    "NCIT:C13662": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1515984": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1551058": [
                        "Are",
                        "are unit of measure"
                    ],
                    "MONDO:0044742": [
                        "AREI",
                        "autosomal recessive epidermolytic ichthyosis"
                    ],
                    "MONDO:0017339": [
                        "AREI",
                        "Ichthyosis exfoliativa",
                        "ICHTHYOSIS EXFOLIATIVA",
                        "ichthyosis exfoliativa",
                        "Exfoliative ichthyosis",
                        "Ichthyosis Exfoliativa",
                        "exfoliative ichthyosis",
                        "ICHTHYOSIS BULLOSA OF SIEMENS-LIKE",
                        "autosomal recessive exfoliative ichthyosis",
                        "Autosomal recessive exfoliative ichthyosis",
                        "ICHTHYOSIS, EXFOLIATIVE, AUTOSOMAL RECESSIVE",
                        "ichthyosis congenital autosomal recessive exfoliative",
                        "Autosomal recessive exfoliative ichthyosis (disorder)",
                        "Autosomal recessive exfoliative ichthyosis (diagnosis)"
                    ]
                }
            },
            {
                "label": "preferred for induction",
                "id": {}
            }
        ]
    ],
    "USES: For the temporary relief of discomfort and pain associated with - minor burns and skin irritations, minor cuts and scrapes, itching": [
        [
            {
                "label": "USES",
                "id": {
                    "UMLS:C0457083": [
                        "uses",
                        "Use",
                        "Usage",
                        "usage",
                        "Employ",
                        "usages",
                        "Usage (attribute)"
                    ],
                    "UMLS:C1522726": [
                        "iv uses",
                        "intravenous uses",
                        "IV",
                        "IV use",
                        "iv route",
                        "IV route",
                        "Intravenous",
                        "Intravenous use",
                        "intravenous use",
                        "IntravenousRoute",
                        "Intravenous route",
                        "IV - Intravenous route",
                        "Intravenous route (qualifier value)",
                        "route of administration intravenous",
                        "Intravenous Route of Administration",
                        "route of administration: intravenous",
                        "Intravenous Route of Drug Administration",
                        "route of administration: intravenous (treatment)"
                    ],
                    "UMLS:C0578310": [
                        "Uses lift",
                        "Does use lift",
                        "Does use lift (finding)"
                    ],
                    "UMLS:C4083280": [
                        "ECig Uses",
                        "E-Cig Uses",
                        "Ecigarette Uses",
                        "E-Cigarette Uses",
                        "Uses, Ecigarette",
                        "Vape",
                        "Vapes",
                        "Vaping",
                        "ECig Use",
                        "E Cig Use",
                        "E-Cig Use",
                        "Use, ECig",
                        "THC Vaping",
                        "Use, E-Cig",
                        "Vaping, THC",
                        "THC Vapings",
                        "Vapings, THC",
                        "Vaping (event)",
                        "Ecigarette Use",
                        "E Cigarette Use",
                        "E-Cigarette Use",
                        "Use, Ecigarette",
                        "Nicotine Vaping",
                        "Vaping, Nicotine",
                        "Use, E-Cigarette",
                        "Nicotine Vapings",
                        "Vapings, Nicotine"
                    ],
                    "UMLS:C0565721": [
                        "Uses a key",
                        "Does use a key",
                        "Does use a key (finding)"
                    ]
                }
            },
            {
                "label": "For the temporary relief of",
                "id": {}
            },
            {
                "label": "discomfort and pain",
                "id": {
                    "UMLS:C4744595": [
                        "Pain and Discomfort"
                    ],
                    "UMLS:C1112117": [
                        "Pain and discomfort NEC"
                    ],
                    "UMLS:C4744623": [
                        "Free of Pain and Discomfort"
                    ],
                    "UMLS:C2609238": [
                        "Musculoskeletal and connective tissue pain and discomfort"
                    ],
                    "UMLS:C4712209": [
                        "Monitor breast engorgement and associated discomfort or pain"
                    ]
                }
            }
        ],
        [
            {
                "label": "discomfort and pain",
                "id": {
                    "UMLS:C4744595": [
                        "Pain and Discomfort"
                    ],
                    "UMLS:C1112117": [
                        "Pain and discomfort NEC"
                    ],
                    "UMLS:C4744623": [
                        "Free of Pain and Discomfort"
                    ],
                    "UMLS:C2609238": [
                        "Musculoskeletal and connective tissue pain and discomfort"
                    ],
                    "UMLS:C4712209": [
                        "Monitor breast engorgement and associated discomfort or pain"
                    ]
                }
            },
            {
                "label": "associated with",
                "id": {
                    "UMLS:C0332281": [
                        "associated with",
                        "ASSOCIATED WITH",
                        "Associated with",
                        "Associated with (attribute)",
                        "AW",
                        "ASSOC",
                        "associated",
                        "Associated",
                        "associating"
                    ],
                    "UMLS:C1608982": [
                        "Associated with (APAH)"
                    ],
                    "UMLS:C2029691": [
                        "headache associated with",
                        "headache associated",
                        "headache associated factor",
                        "headache associated factor (symptom)"
                    ],
                    "HP:0033705": [
                        "Crying associated with mood",
                        "Crying associated with emotion",
                        "Crying associated with mood (finding)",
                        "weep",
                        "Weepy",
                        "Weeps",
                        "weepy",
                        "weeping",
                        "tearful",
                        "WEEPING",
                        "Weeping",
                        "Tearful",
                        "Weepiness",
                        "weepiness",
                        "Tearfulness",
                        "affect tearful",
                        "tearful (physical finding)"
                    ],
                    "NCBIGene:23077": [
                        "PROTEIN ASSOCIATED WITH MYC",
                        "PAM",
                        "PAM",
                        "PHR1",
                        "PHR1",
                        "MYCBP2",
                        "FLJ10106",
                        "KIAA0916",
                        "FLJ10106",
                        "KIAA0916",
                        "MYCBP2 gene",
                        "MYCBP2 Gene",
                        "MYC-BINDING PROTEIN 2",
                        "MYC binding protein 2",
                        "MYC Binding Protein 2 Gene",
                        "PAM/Highwire/RPM-1 protein 1",
                        "PAM/Highwire/RPM-1 protein 1",
                        "MYC binding protein 2, E3 ubiquitin protein ligase"
                    ]
                }
            },
            {
                "label": "minor burns and skin irritations",
                "id": {}
            }
        ],
        [
            {
                "label": "discomfort and pain",
                "id": {
                    "UMLS:C4744595": [
                        "Pain and Discomfort"
                    ],
                    "UMLS:C1112117": [
                        "Pain and discomfort NEC"
                    ],
                    "UMLS:C4744623": [
                        "Free of Pain and Discomfort"
                    ],
                    "UMLS:C2609238": [
                        "Musculoskeletal and connective tissue pain and discomfort"
                    ],
                    "UMLS:C4712209": [
                        "Monitor breast engorgement and associated discomfort or pain"
                    ]
                }
            },
            {
                "label": "associated with",
                "id": {
                    "UMLS:C0332281": [
                        "associated with",
                        "ASSOCIATED WITH",
                        "Associated with",
                        "Associated with (attribute)",
                        "AW",
                        "ASSOC",
                        "associated",
                        "Associated",
                        "associating"
                    ],
                    "UMLS:C1608982": [
                        "Associated with (APAH)"
                    ],
                    "UMLS:C2029691": [
                        "headache associated with",
                        "headache associated",
                        "headache associated factor",
                        "headache associated factor (symptom)"
                    ],
                    "HP:0033705": [
                        "Crying associated with mood",
                        "Crying associated with emotion",
                        "Crying associated with mood (finding)",
                        "weep",
                        "Weepy",
                        "Weeps",
                        "weepy",
                        "weeping",
                        "tearful",
                        "WEEPING",
                        "Weeping",
                        "Tearful",
                        "Weepiness",
                        "weepiness",
                        "Tearfulness",
                        "affect tearful",
                        "tearful (physical finding)"
                    ],
                    "NCBIGene:23077": [
                        "PROTEIN ASSOCIATED WITH MYC",
                        "PAM",
                        "PAM",
                        "PHR1",
                        "PHR1",
                        "MYCBP2",
                        "FLJ10106",
                        "KIAA0916",
                        "FLJ10106",
                        "KIAA0916",
                        "MYCBP2 gene",
                        "MYCBP2 Gene",
                        "MYC-BINDING PROTEIN 2",
                        "MYC binding protein 2",
                        "MYC Binding Protein 2 Gene",
                        "PAM/Highwire/RPM-1 protein 1",
                        "PAM/Highwire/RPM-1 protein 1",
                        "MYC binding protein 2, E3 ubiquitin protein ligase"
                    ]
                }
            },
            {
                "label": "minor cuts and scrapes",
                "id": {}
            }
        ],
        [
            {
                "label": "discomfort and pain",
                "id": {
                    "UMLS:C4744595": [
                        "Pain and Discomfort"
                    ],
                    "UMLS:C1112117": [
                        "Pain and discomfort NEC"
                    ],
                    "UMLS:C4744623": [
                        "Free of Pain and Discomfort"
                    ],
                    "UMLS:C2609238": [
                        "Musculoskeletal and connective tissue pain and discomfort"
                    ],
                    "UMLS:C4712209": [
                        "Monitor breast engorgement and associated discomfort or pain"
                    ]
                }
            },
            {
                "label": "associated with",
                "id": {
                    "UMLS:C0332281": [
                        "associated with",
                        "ASSOCIATED WITH",
                        "Associated with",
                        "Associated with (attribute)",
                        "AW",
                        "ASSOC",
                        "associated",
                        "Associated",
                        "associating"
                    ],
                    "UMLS:C1608982": [
                        "Associated with (APAH)"
                    ],
                    "UMLS:C2029691": [
                        "headache associated with",
                        "headache associated",
                        "headache associated factor",
                        "headache associated factor (symptom)"
                    ],
                    "HP:0033705": [
                        "Crying associated with mood",
                        "Crying associated with emotion",
                        "Crying associated with mood (finding)",
                        "weep",
                        "Weepy",
                        "Weeps",
                        "weepy",
                        "weeping",
                        "tearful",
                        "WEEPING",
                        "Weeping",
                        "Tearful",
                        "Weepiness",
                        "weepiness",
                        "Tearfulness",
                        "affect tearful",
                        "tearful (physical finding)"
                    ],
                    "NCBIGene:23077": [
                        "PROTEIN ASSOCIATED WITH MYC",
                        "PAM",
                        "PAM",
                        "PHR1",
                        "PHR1",
                        "MYCBP2",
                        "FLJ10106",
                        "KIAA0916",
                        "FLJ10106",
                        "KIAA0916",
                        "MYCBP2 gene",
                        "MYCBP2 Gene",
                        "MYC-BINDING PROTEIN 2",
                        "MYC binding protein 2",
                        "MYC Binding Protein 2 Gene",
                        "PAM/Highwire/RPM-1 protein 1",
                        "PAM/Highwire/RPM-1 protein 1",
                        "MYC binding protein 2, E3 ubiquitin protein ligase"
                    ]
                }
            },
            {
                "label": "itching",
                "id": {
                    "HP:0000989": [
                        "itching",
                        "ITCHING",
                        "Itching",
                        "skin itching",
                        "Skin itching",
                        "Itching;skin",
                        "itching skin",
                        "Itching of skin",
                        "Itching Sensation",
                        "Itching (finding)",
                        "Itching (pruritus)",
                        "itching (pruritus)",
                        "Itching of skin (finding)",
                        "Itch",
                        "itch",
                        "itchy",
                        "Itchy",
                        "PRURITUS",
                        "pruritus",
                        "PRURITIS",
                        "Itch NOS",
                        "pruritis",
                        "Pruritis",
                        "Pruritus",
                        "itch skin",
                        "skin itch",
                        "itchy skin",
                        "Itchy skin",
                        "Pruritus NOS",
                        "Itch of skin",
                        "Skin Pruritus",
                        "Pruritus, NOS",
                        "Pruritus;skin",
                        "Scratching skin",
                        "pruritis of skin",
                        "Pruritus of skin",
                        "PRURITIC DISORDER",
                        "Pruritic Disorder",
                        "Pruritic disorder",
                        "Itch of skin, NOS",
                        "pruritus (symptom)",
                        "Pruritic disorders",
                        "Pruritus cutaneous",
                        "pruritic dermatitis",
                        "Pruritus - disorder",
                        "Pruritic dermatitis",
                        "Irritating sensation",
                        "Excessive scratching",
                        "pruritus (diagnosis)",
                        "Pruritus, unspecified",
                        "Pruritic disorder NOS",
                        "Pruritus of skin, NOS",
                        "Irritation - sensation",
                        "Pruritis (excl D05 X16)",
                        "Pruritic dermatitis, NOS",
                        "Pruritic disorder (disorder)",
                        "Pruritis (excluding D05 X16)",
                        "Unspecified pruritic disorder",
                        "Itch of skin (observable entity)"
                    ],
                    "UMLS:C0877202": [
                        "Itching gum",
                        "gums itching",
                        "gums itch",
                        "gingival pruritus",
                        "Gingival pruritus"
                    ],
                    "HP:0033841": [
                        "Itching;eye",
                        "Eye itching",
                        "itching eye",
                        "eye itching",
                        "eyes itching",
                        "itching eyes",
                        "Itching eyes",
                        "Ocular itching",
                        "Itching of eye",
                        "Itching of eye (finding)",
                        "eye itch",
                        "eyes itch",
                        "itch; eye",
                        "itchy eye",
                        "itchy eyes",
                        "eye; itchy",
                        "Itchy eyes",
                        "eyes itchy",
                        "Ocular itch",
                        "EYE PRURITUS",
                        "Eye pruritus",
                        "pruritus of eye",
                        "ocular pruritus",
                        "Ocular pruritus",
                        "pruritus of eye (symptom)"
                    ],
                    "UMLS:C1276050": [
                        "Not itching",
                        "No sensation of itching",
                        "Not itching (qualifier value)",
                        "No itch",
                        "no itch",
                        "No itch (situation)"
                    ],
                    "UMLS:C0849907": [
                        "ear itching",
                        "Itching;ear",
                        "itching ear",
                        "ears itching",
                        "Itching of ear",
                        "itching of ears",
                        "Itching of ear (finding)",
                        "itching of ears (symptom)",
                        "ear itch",
                        "itch ear",
                        "EAR ITCHY",
                        "ears itch",
                        "itchy ear",
                        "ears itchy",
                        "itchy ears",
                        "EAR PRURITUS",
                        "Ear pruritus",
                        "ear pruritus"
                    ]
                }
            }
        ]
    ],
    "Epidural clonidine is more likely to be effective in patients with neuropathic pain than somatic or visceral pain": [
        [
            {
                "label": "Epidural clonidine",
                "id": {
                    "UMLS:C0872744": [
                        "clonidine HCl/PF@5,000 mcg/10 mL@EPIDURAL@VIAL (ML)",
                        "clonidine HCl/PF 5,000 mcg/10 mL EPIDURAL VIAL (ML)",
                        "Clonidine Hydrochloride 0.5 MG/1 ML Epidural Solution",
                        "CLONIDINE HYDROCHLORIDE 500 ug in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 0.5 mg in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HCL 500MCG/ML INJ",
                        "cloNIDine 500 mcg/mL injectable solution",
                        "cloNIDine HCl 5000 MCG in 10 ML Injection",
                        "cloNIDine HCl 5000 MCG per 10 ML Injection",
                        "clonidine HCl 5000 MCG per 10 ML Injection",
                        "10 ML clonidine hydrochloride 0.5 MG/ML Injection",
                        "10 ML cloNIDine hydrochloride 0.5 MG/ML Injection",
                        "CloNIDine Hydrochloride, 500 mcg/mL injectable solution",
                        "Clonidine Hydrochloride 500mcg/1mL Solution for injection",
                        "CLONIDINE HYDROCHLORIDE 500 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION"
                    ],
                    "UMLS:C0975738": [
                        "Clonidine Hydrochloride 0.1 MG/1 ML Epidural Solution",
                        "clonidine HCl/PF@1,000 mcg/10 mL (100 mcg/mL)@EPIDURAL@VIAL (ML)",
                        "clonidine HCl/PF 1,000 mcg/10 mL (100 mcg/mL) EPIDURAL VIAL (ML)",
                        "CLONIDINE HYDROCHLORIDE 100 ug in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 0.1 mg in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HCL 100MCG/ML INJ",
                        "cloNIDine 100 mcg/mL injectable solution",
                        "cloNIDine HCl 1000 MCG in 10 ML Injection",
                        "clonidine HCl 1000 MCG per 10 ML Injection",
                        "cloNIDine HCl 1000 MCG per 10 ML Injection",
                        "10 ML cloNIDine hydrochloride 0.1 MG/ML Injection",
                        "10 ML clonidine hydrochloride 0.1 MG/ML Injection",
                        "CloNIDine Hydrochloride, 100 mcg/mL injectable solution",
                        "Clonidine Hydrochloride 100mcg/1mL Solution for injection",
                        "CLONIDINE HYDROCHLORIDE 100 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION"
                    ],
                    "UMLS:C0875858": [
                        "Clonidine Hydrochloride 0.5 MG/1 ML Epidural Solution [DURACLON]",
                        "10 ML Duraclon 0.5 MG/ML Injection",
                        "Duraclon 5000 MCG in 10 ML Injection",
                        "Duraclon 5000 MCG per 10 ML Injection",
                        "Duraclon 5000mcg/10mL Solution for Injection",
                        "10 ML cloNIDine hydrochloride 0.5 MG/ML Injection [Duraclon]",
                        "10 ML clonidine hydrochloride 0.5 MG/ML Injection [Duraclon]"
                    ],
                    "UMLS:C0714612": [
                        "Clonidine Hydrochloride 0.1 MG/1 ML Epidural Solution [DURACLON]",
                        "CLONIDINE HYDROCHLORIDE 0.1 mg in 1 mL EPIDURAL INJECTION, SOLUTION [Duraclon]",
                        "10 ML Duraclon 0.1 MG/ML Injection",
                        "Duraclon 1000 MCG in 10 ML Injection",
                        "Duraclon 1000 MCG per 10 ML Injection",
                        "Duraclon, 100 mcg/mL injectable solution",
                        "Duraclon 1000mcg/10mL Solution for Injection",
                        "10 ML clonidine hydrochloride 0.1 MG/ML Injection [Duraclon]",
                        "10 ML cloNIDine hydrochloride 0.1 MG/ML Injection [Duraclon]"
                    ]
                }
            },
            {
                "label": "is more likely to be effective in",
                "id": {}
            },
            {
                "label": "patients with neuropathic pain",
                "id": {}
            }
        ],
        [
            {
                "label": "Epidural clonidine",
                "id": {
                    "UMLS:C0872744": [
                        "clonidine HCl/PF@5,000 mcg/10 mL@EPIDURAL@VIAL (ML)",
                        "clonidine HCl/PF 5,000 mcg/10 mL EPIDURAL VIAL (ML)",
                        "Clonidine Hydrochloride 0.5 MG/1 ML Epidural Solution",
                        "CLONIDINE HYDROCHLORIDE 500 ug in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 0.5 mg in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HCL 500MCG/ML INJ",
                        "cloNIDine 500 mcg/mL injectable solution",
                        "cloNIDine HCl 5000 MCG in 10 ML Injection",
                        "cloNIDine HCl 5000 MCG per 10 ML Injection",
                        "clonidine HCl 5000 MCG per 10 ML Injection",
                        "10 ML clonidine hydrochloride 0.5 MG/ML Injection",
                        "10 ML cloNIDine hydrochloride 0.5 MG/ML Injection",
                        "CloNIDine Hydrochloride, 500 mcg/mL injectable solution",
                        "Clonidine Hydrochloride 500mcg/1mL Solution for injection",
                        "CLONIDINE HYDROCHLORIDE 500 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION"
                    ],
                    "UMLS:C0975738": [
                        "Clonidine Hydrochloride 0.1 MG/1 ML Epidural Solution",
                        "clonidine HCl/PF@1,000 mcg/10 mL (100 mcg/mL)@EPIDURAL@VIAL (ML)",
                        "clonidine HCl/PF 1,000 mcg/10 mL (100 mcg/mL) EPIDURAL VIAL (ML)",
                        "CLONIDINE HYDROCHLORIDE 100 ug in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HYDROCHLORIDE 0.1 mg in 1 mL EPIDURAL INJECTION, SOLUTION",
                        "CLONIDINE HCL 100MCG/ML INJ",
                        "cloNIDine 100 mcg/mL injectable solution",
                        "cloNIDine HCl 1000 MCG in 10 ML Injection",
                        "clonidine HCl 1000 MCG per 10 ML Injection",
                        "cloNIDine HCl 1000 MCG per 10 ML Injection",
                        "10 ML cloNIDine hydrochloride 0.1 MG/ML Injection",
                        "10 ML clonidine hydrochloride 0.1 MG/ML Injection",
                        "CloNIDine Hydrochloride, 100 mcg/mL injectable solution",
                        "Clonidine Hydrochloride 100mcg/1mL Solution for injection",
                        "CLONIDINE HYDROCHLORIDE 100 ug in 1 mL INTRAVENOUS INJECTION, SOLUTION"
                    ],
                    "UMLS:C0875858": [
                        "Clonidine Hydrochloride 0.5 MG/1 ML Epidural Solution [DURACLON]",
                        "10 ML Duraclon 0.5 MG/ML Injection",
                        "Duraclon 5000 MCG in 10 ML Injection",
                        "Duraclon 5000 MCG per 10 ML Injection",
                        "Duraclon 5000mcg/10mL Solution for Injection",
                        "10 ML cloNIDine hydrochloride 0.5 MG/ML Injection [Duraclon]",
                        "10 ML clonidine hydrochloride 0.5 MG/ML Injection [Duraclon]"
                    ],
                    "UMLS:C0714612": [
                        "Clonidine Hydrochloride 0.1 MG/1 ML Epidural Solution [DURACLON]",
                        "CLONIDINE HYDROCHLORIDE 0.1 mg in 1 mL EPIDURAL INJECTION, SOLUTION [Duraclon]",
                        "10 ML Duraclon 0.1 MG/ML Injection",
                        "Duraclon 1000 MCG in 10 ML Injection",
                        "Duraclon 1000 MCG per 10 ML Injection",
                        "Duraclon, 100 mcg/mL injectable solution",
                        "Duraclon 1000mcg/10mL Solution for Injection",
                        "10 ML clonidine hydrochloride 0.1 MG/ML Injection [Duraclon]",
                        "10 ML cloNIDine hydrochloride 0.1 MG/ML Injection [Duraclon]"
                    ]
                }
            },
            {
                "label": "is more likely to be effective than",
                "id": {}
            },
            {
                "label": "somatic or visceral pain",
                "id": {}
            }
        ]
    ],
    "Paroxetine tablets have not been studied in children or adolescents with social phobia.": [
        [
            {
                "label": "Paroxetine tablets",
                "id": {
                    "UMLS:C1253294": [
                        "Paroxetine Tablets",
                        "PARoxetine Oral Tablet",
                        "paroxetine Oral Tablet"
                    ],
                    "UMLS:C4720193": [
                        "Paroxetine Mesylate Tablets"
                    ],
                    "UMLS:C1591733": [
                        "Paroxetine Extended-Release Tablets",
                        "paroxetine Extended Release Oral Tablet",
                        "PARoxetine Extended Release Oral Tablet"
                    ]
                }
            },
            {
                "label": "have not been studied in",
                "id": {}
            },
            {
                "label": "children or adolescents with social phobia",
                "id": {}
            }
        ]
    ],
    "Tizanidine hydrochloride capsules are central alpha-2-adrenergic agonist indicated for the management of spasticity": [
        [
            {
                "label": "Tizanidine hydrochloride capsules",
                "id": {}
            },
            {
                "label": "are",
                "id": {
                    "NCIT:C13662": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1515984": [
                        "ARE",
                        "Androgen Response Element"
                    ],
                    "UMLS:C1551058": [
                        "Are",
                        "are unit of measure"
                    ],
                    "MONDO:0044742": [
                        "AREI",
                        "autosomal recessive epidermolytic ichthyosis"
                    ],
                    "MONDO:0017339": [
                        "AREI",
                        "Ichthyosis exfoliativa",
                        "ICHTHYOSIS EXFOLIATIVA",
                        "ichthyosis exfoliativa",
                        "Exfoliative ichthyosis",
                        "Ichthyosis Exfoliativa",
                        "exfoliative ichthyosis",
                        "ICHTHYOSIS BULLOSA OF SIEMENS-LIKE",
                        "autosomal recessive exfoliative ichthyosis",
                        "Autosomal recessive exfoliative ichthyosis",
                        "ICHTHYOSIS, EXFOLIATIVE, AUTOSOMAL RECESSIVE",
                        "ichthyosis congenital autosomal recessive exfoliative",
                        "Autosomal recessive exfoliative ichthyosis (disorder)",
                        "Autosomal recessive exfoliative ichthyosis (diagnosis)"
                    ]
                }
            },
            {
                "label": "central alpha-2-adrenergic agonist",
                "id": {
                    "UMLS:C2267005": [
                        "Central alpha-2 Adrenergic Agonist",
                        "Central alpha-2 Adrenergic Agonist [EPC]",
                        "Selective alpha2-Agonist",
                        "alpha-2 Adrenergic Agonist",
                        "Central a-2 Adrenergic Agonist"
                    ],
                    "UMLS:C5203510": [
                        "Central alpha-2 adrenergic receptor agonist",
                        "Central alpha-2 adrenergic receptor agonist (disposition)"
                    ],
                    "UMLS:C5203511": [
                        "Central alpha-2 adrenergic receptor agonist",
                        "Central alpha-2 adrenergic receptor agonist-containing product",
                        "Product containing central alpha-2 adrenergic receptor agonist (product)",
                        "Substance with central alpha-2 adrenergic receptor agonist mechanism of action (substance)"
                    ],
                    "UMLS:C5230443": [
                        "Central alpha-2 adrenergic receptor agonist overdose",
                        "Central alpha-2 adrenergic receptor agonist overdose (disorder)"
                    ],
                    "UMLS:C5230442": [
                        "Central alpha-2 adrenergic receptor agonist poisoning",
                        "Central alpha-2 adrenergic receptor agonist poisoning (disorder)"
                    ]
                }
            }
        ],
        [
            {
                "label": "Tizanidine hydrochloride capsules",
                "id": {}
            },
            {
                "label": "are indicated for",
                "id": {
                    "UMLS:C0511688": [
                        "Identify medications that are indicated for current problems"
                    ],
                    "UMLS:C4712023": [
                        "Shave and prep the area, as indicated in preparation for invasive procedures and/or surgery"
                    ],
                    "UMLS:C4713273": [
                        "Identify nonpharmacological treatments (e.g., exercise, diet, physical therapy, occupational therapy, heat and cold treatment) that are indicated for current health problems"
                    ],
                    "UMLS:C4316266": [
                        "Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: tracking patient follow-up and progress using the registry, with appropriate documentation, participation in weekly caseload consultation with the psychiatric consultant, ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers, additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant, provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies, monitoring of patient outcomes using validated rating scales, and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatment.",
                        "SBSQ PSYC COLLAB CARE MGMT",
                        "Sbsq psyc collab care mgmt",
                        "SBSQ PSYCHIATRIC COLLAB CARE MGMT 1ST 60 MINS"
                    ]
                }
            },
            {
                "label": "the management of spasticity",
                "id": {}
            }
        ]
    ],
    "It is most useful in those patients who are anxious about their surgical procedure and who would prefer to have diminished recall of the events of the day of surgery.": [
        [
            {
                "label": "It",
                "id": {
                    "MGI:96598": [
                        "It"
                    ],
                    "PUBCHEM.COMPOUND:44298493": [
                        "IT",
                        "IT dipeptide",
                        "I-T",
                        "Ile-Thr",
                        "CHEMBL54609",
                        "I-T dipeptide",
                        "isoleucylthreonine",
                        "L-Isoleucyl-L-threonine",
                        "L-isoleucyl-L-threonine",
                        "isoleucine threonine dipeptide",
                        "(2S,3R)-2-{[(2S,3S)-2-amino-3-methylpentanoyl]amino}-3-hydroxybutanoic acid"
                    ],
                    "UMLS:C0677897": [
                        "IT",
                        "IT - Intrathecal route",
                        "intrathecal",
                        "Intrathecal",
                        "Intrathecal use",
                        "IntrathecalRoute",
                        "Intrathecal route",
                        "into the spinal space",
                        "Intrathecal route (qualifier value)",
                        "Intrathecal Route of Administration",
                        "Intrathecal Route of Drug Administration"
                    ],
                    "MONDO:0008558": [
                        "itp",
                        "ITP",
                        "ITP, NOS",
                        "ITP - Idiopat thrombocytop pur",
                        "ITP (immune thrombocytopenic purpura)",
                        "Idiopathic thrombocytopenic purpura (ITP)",
                        "ITP (idiopathic thrombocytopenic purpura)",
                        "idiopathic thrombocytopenic purpura (ITP)",
                        "ITP - Idiopathic thrombocytopenic purpura",
                        "AITP",
                        "AITP",
                        "Frank",
                        "Werlhof",
                        "WERLHOF DIS",
                        "WERLHOFS DIS",
                        "Werlhof Disease",
                        "WERLHOF DISEASE",
                        "Werlhofs Disease",
                        "Disease, Werlhof",
                        "werlhof's disease",
                        "Werlhof's Disease",
                        "Werlhof's disease",
                        "Werlhof's disease",
                        "werlhof's disease",
                        "Idiopathic purpura",
                        "Idiopathic purpura",
                        "Werlhof's syndrome",
                        "idiopathic purpura",
                        "idiopathic purpura",
                        "Disease, Werlhof's",
                        "purpura; idiopathic",
                        "idiopathic; purpura",
                        "Immune thrombocytopenia",
                        "Immune Thrombocytopenia",
                        "immune thrombocytopenia",
                        "Idiopathic purpura, NOS",
                        "Thrombocytopenia, Immune",
                        "Immune Thrombocytopenias",
                        "Immune thrombocyt purpra",
                        "Thrombocytopenias, Immune",
                        "Idiopathic Thrombocytopenia",
                        "Autoimmune Thrombocytopenia",
                        "idiopathic thrombocytopenia",
                        "Autoimmune Thrombocytopenias",
                        "Thrombocytopenia, Autoimmune",
                        "Thrombocytopenias, Autoimmune",
                        "Ideopath thrombocytopenic pur",
                        "ideopath thrombocytopenic pur",
                        "Idiopath thrombocytopen purpur",
                        "Autoimmune thrombocytopen purp",
                        "Immune thrombocytopenic purpur",
                        "Idiopath Thrombocytopenic Purp",
                        "immune purpura thrombocytopenic",
                        "thrombocytopenic purpura immune",
                        "Primary immune thrombocytopenia",
                        "Immune thrombocytopenic purpura",
                        "IMMUNE THROMBOCYTOPENIC PURPURA",
                        "immune thrombocytopenic purpura",
                        "Immune thrombocytopenic purpura",
                        "Primary Immune Thrombocytopenia",
                        "Immune Thrombocytopenic Purpura",
                        "immune thrombocytopenic purpura",
                        "primary thrombocytopenic purpura",
                        "primary thrombocytopenic purpura",
                        "Immune Thrombocytopenic Purpuras",
                        "Thrombocytopenic Purpura, Immune",
                        "Purpura, Immune Thrombocytopenic",
                        "Thrombocytopenic Purpuras, Immune",
                        "Purpuras, Immune Thrombocytopenic",
                        "IDIOPATHIC THROMBOCYTOPENIC PURPURA",
                        "idiopathic thrombocytopenic purpura",
                        "Idiopathic thrombocytopenia purpura",
                        "idiopathic thrombocytopenia purpura",
                        "Idiopathic Thrombocytopenic Purpura",
                        "autoimmune thrombocytopenic purpura",
                        "idiopathic thrombocytopenic purpura",
                        "thrombocytopenic purpura autoimmune",
                        "autoimmune thrombocytopenic purpura",
                        "Autoimmune thrombocytopenic purpura",
                        "Idiopathic Thrombocytopenia Purpura",
                        "Idiopathic thrombocytopenic purpura",
                        "Autoimmune Thrombocytopenic Purpura",
                        "THROMBOCYTOPENIC PURPURA, AUTOIMMUNE",
                        "Idiopathic Thrombocytopenic Purpuras",
                        "Autoimmune Thrombocytopenic Purpuras",
                        "Thrombocytopenic Purpura, Idiopathic",
                        "Purpura, Autoimmune Thrombocytopenic",
                        "thrombocytopenic purpura, autoimmune",
                        "Thrombocytopenic Purpura, Autoimmune",
                        "Purpura, Idiopathic Thrombocytopenic",
                        "thrombocytopenic; purpura, idiopathic",
                        "Purpuras, Autoimmune Thrombocytopenic",
                        "PURPURA, THROMBOCYTOPENIC, IDIOPATHIC",
                        "purpura; thrombocytopenic, idiopathic",
                        "Thrombocytopenic Purpuras, Idiopathic",
                        "Purpura, Thrombocytopenic, Idiopathic",
                        "Purpuras, Idiopathic Thrombocytopenic",
                        "Purpura, Thrombocytopenic, Autoimmune",
                        "Idiopathic thrombocytopenic purpura, NOS",
                        "immune thrombocytopenic purpura (diagnosis)",
                        "idiopathic thrombocytopenic purpura (diagnosis)"
                    ],
                    "MGI:3716200": [
                        "ita"
                    ]
                }
            },
            {
                "label": "is most useful in",
                "id": {}
            },
            {
                "label": "those patients",
                "id": {
                    "UMLS:C4713117": [
                        "Use a slide board to assist transfer to a chair or wheel chair for those patients with fair balance"
                    ],
                    "UMLS:C4710824": [
                        "Obtain a fasting blood glucose reading preprocedure and postprocedure for those patients who have insulin-dependent diabetes"
                    ],
                    "UMLS:C0547608": [
                        "Avoid exposing patient to persons with infectious diseases, including upper respiratory infections; or to those recently exposed or vaccinated; or to staff caring for infected patients."
                    ],
                    "UMLS:C4710266": [
                        "Target at risk patients (e.g., diabetics, smokers, elderly, hypertensive patients and those with elevated cholesterols levels) for comprehensive peripheral assessments and modification of risk factors"
                    ],
                    "UMLS:C5574463": [
                        "On date of encounter, patient is not able to participate in assessment or screening, including non-verbal patients, delirious, severely aphasic, severely developmentally delayed, severe visual or hearing impairment and for those patients, no knowledgeable informant available",
                        "Pt not able to participate"
                    ]
                }
            }
        ],
        [
            {
                "label": "It",
                "id": {
                    "MGI:96598": [
                        "It"
                    ],
                    "PUBCHEM.COMPOUND:44298493": [
                        "IT",
                        "IT dipeptide",
                        "I-T",
                        "Ile-Thr",
                        "CHEMBL54609",
                        "I-T dipeptide",
                        "isoleucylthreonine",
                        "L-Isoleucyl-L-threonine",
                        "L-isoleucyl-L-threonine",
                        "isoleucine threonine dipeptide",
                        "(2S,3R)-2-{[(2S,3S)-2-amino-3-methylpentanoyl]amino}-3-hydroxybutanoic acid"
                    ],
                    "UMLS:C0677897": [
                        "IT",
                        "IT - Intrathecal route",
                        "intrathecal",
                        "Intrathecal",
                        "Intrathecal use",
                        "IntrathecalRoute",
                        "Intrathecal route",
                        "into the spinal space",
                        "Intrathecal route (qualifier value)",
                        "Intrathecal Route of Administration",
                        "Intrathecal Route of Drug Administration"
                    ],
                    "MONDO:0008558": [
                        "itp",
                        "ITP",
                        "ITP, NOS",
                        "ITP - Idiopat thrombocytop pur",
                        "ITP (immune thrombocytopenic purpura)",
                        "Idiopathic thrombocytopenic purpura (ITP)",
                        "ITP (idiopathic thrombocytopenic purpura)",
                        "idiopathic thrombocytopenic purpura (ITP)",
                        "ITP - Idiopathic thrombocytopenic purpura",
                        "AITP",
                        "AITP",
                        "Frank",
                        "Werlhof",
                        "WERLHOF DIS",
                        "WERLHOFS DIS",
                        "Werlhof Disease",
                        "WERLHOF DISEASE",
                        "Werlhofs Disease",
                        "Disease, Werlhof",
                        "werlhof's disease",
                        "Werlhof's Disease",
                        "Werlhof's disease",
                        "Werlhof's disease",
                        "werlhof's disease",
                        "Idiopathic purpura",
                        "Idiopathic purpura",
                        "Werlhof's syndrome",
                        "idiopathic purpura",
                        "idiopathic purpura",
                        "Disease, Werlhof's",
                        "purpura; idiopathic",
                        "idiopathic; purpura",
                        "Immune thrombocytopenia",
                        "Immune Thrombocytopenia",
                        "immune thrombocytopenia",
                        "Idiopathic purpura, NOS",
                        "Thrombocytopenia, Immune",
                        "Immune Thrombocytopenias",
                        "Immune thrombocyt purpra",
                        "Thrombocytopenias, Immune",
                        "Idiopathic Thrombocytopenia",
                        "Autoimmune Thrombocytopenia",
                        "idiopathic thrombocytopenia",
                        "Autoimmune Thrombocytopenias",
                        "Thrombocytopenia, Autoimmune",
                        "Thrombocytopenias, Autoimmune",
                        "Ideopath thrombocytopenic pur",
                        "ideopath thrombocytopenic pur",
                        "Idiopath thrombocytopen purpur",
                        "Autoimmune thrombocytopen purp",
                        "Immune thrombocytopenic purpur",
                        "Idiopath Thrombocytopenic Purp",
                        "immune purpura thrombocytopenic",
                        "thrombocytopenic purpura immune",
                        "Primary immune thrombocytopenia",
                        "Immune thrombocytopenic purpura",
                        "IMMUNE THROMBOCYTOPENIC PURPURA",
                        "immune thrombocytopenic purpura",
                        "Immune thrombocytopenic purpura",
                        "Primary Immune Thrombocytopenia",
                        "Immune Thrombocytopenic Purpura",
                        "immune thrombocytopenic purpura",
                        "primary thrombocytopenic purpura",
                        "primary thrombocytopenic purpura",
                        "Immune Thrombocytopenic Purpuras",
                        "Thrombocytopenic Purpura, Immune",
                        "Purpura, Immune Thrombocytopenic",
                        "Thrombocytopenic Purpuras, Immune",
                        "Purpuras, Immune Thrombocytopenic",
                        "IDIOPATHIC THROMBOCYTOPENIC PURPURA",
                        "idiopathic thrombocytopenic purpura",
                        "Idiopathic thrombocytopenia purpura",
                        "idiopathic thrombocytopenia purpura",
                        "Idiopathic Thrombocytopenic Purpura",
                        "autoimmune thrombocytopenic purpura",
                        "idiopathic thrombocytopenic purpura",
                        "thrombocytopenic purpura autoimmune",
                        "autoimmune thrombocytopenic purpura",
                        "Autoimmune thrombocytopenic purpura",
                        "Idiopathic Thrombocytopenia Purpura",
                        "Idiopathic thrombocytopenic purpura",
                        "Autoimmune Thrombocytopenic Purpura",
                        "THROMBOCYTOPENIC PURPURA, AUTOIMMUNE",
                        "Idiopathic Thrombocytopenic Purpuras",
                        "Autoimmune Thrombocytopenic Purpuras",
                        "Thrombocytopenic Purpura, Idiopathic",
                        "Purpura, Autoimmune Thrombocytopenic",
                        "thrombocytopenic purpura, autoimmune",
                        "Thrombocytopenic Purpura, Autoimmune",
                        "Purpura, Idiopathic Thrombocytopenic",
                        "thrombocytopenic; purpura, idiopathic",
                        "Purpuras, Autoimmune Thrombocytopenic",
                        "PURPURA, THROMBOCYTOPENIC, IDIOPATHIC",
                        "purpura; thrombocytopenic, idiopathic",
                        "Thrombocytopenic Purpuras, Idiopathic",
                        "Purpura, Thrombocytopenic, Idiopathic",
                        "Purpuras, Idiopathic Thrombocytopenic",
                        "Purpura, Thrombocytopenic, Autoimmune",
                        "Idiopathic thrombocytopenic purpura, NOS",
                        "immune thrombocytopenic purpura (diagnosis)",
                        "idiopathic thrombocytopenic purpura (diagnosis)"
                    ],
                    "MGI:3716200": [
                        "ita"
                    ]
                }
            },
            {
                "label": "is for",
                "id": {
                    "CHEBI:140821": [
                        "iso-Forssman",
                        "i-Forssman",
                        "isogloboside iGb5Cer",
                        "alpha-D-GalNAc-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer",
                        "N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide"
                    ],
                    "UMLS:C1552560": [
                        "is backup for"
                    ],
                    "PUBCHEM.COMPOUND:8052": [
                        "Isoamyl formate",
                        "Isoamyl formate",
                        "isoamyl formate",
                        "ISOAMYL FORMATE",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formate",
                        "Isopentyl formic acid",
                        "Formate, isopentyl ester",
                        "Isopentyl alcohol, formate",
                        "Formic acid, isopentyl ester",
                        "Formic acid, isopentyl ester",
                        "Isoamyl methanoate",
                        "Isoamyl methanoate",
                        "Isopentyl methanoate",
                        "Isopentyl methanoate",
                        "3-methylbutyl formate",
                        "3-Methylbutyl formate",
                        "Isoamyl methanoic acid",
                        "Isopentyl methanoic acid",
                        "3-Methyl-1-butyl formate",
                        "3-Methylbutyl formic acid",
                        "1-Butanol, 3-methyl-, formate",
                        "3-Methyl-2-butenyl formic acid",
                        "1-Butanol, 3-methyl-, 1-formate"
                    ],
                    "UMLS:C2346508": [
                        "ISS for Myeloma",
                        "International Staging System for Myeloma"
                    ],
                    "UMLS:C1562189": [
                        "Is etiology for",
                        "is etiology for",
                        "Is aetiology for",
                        "Is etiology for (link assertion)"
                    ]
                }
            },
            {
                "label": "patients who are anxious about their surgical procedure",
                "id": {}
            }
        ],
        [
            {
                "label": "they",
                "id": {
                    "UMLS:C3166712": [
                        "When were they cleaned"
                    ],
                    "UMLS:C3173010": [
                        "When were they cleaned RIOPA",
                        "When were they cleaned [RIOPA]",
                        "When were they cleaned:Find:Pt:^Patient:Nom:RIOPA",
                        "When were they cleaned:Finding:To identify measures at a point in time:^Patient:Nominal:RIOPA"
                    ],
                    "UMLS:C3827301": [
                        "Able to Read Like They Used To"
                    ],
                    "UMLS:C1820621": [
                        "Members ask how they may assist"
                    ],
                    "UMLS:C3259919": [
                        "How often do they criticize you"
                    ]
                }
            },
            {
                "label": "would prefer",
                "id": {
                    "UMLS:C3641478": [
                        "OAB-q - Stay Home More Often Than You Would Prefer"
                    ]
                }
            },
            {
                "label": "to have diminished recall of the events of the day of surgery",
                "id": {}
            }
        ]
    ],
    "Pregbalin is indicated for:Management of neuropathic pain associated with diabetic peripheral neuropathy, Management of postherpetic neuralgia, Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older, Management of fibromyalgia, Management of neuropathic pain associated with spinal cord injury": [
        [
            {
                "label": "Pregbalin",
                "id": {}
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "Management of neuropathic pain associated with diabetic peripheral neuropathy",
                "id": {}
            }
        ],
        [
            {
                "label": "Pregbalin",
                "id": {}
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "Management of postherpetic neuralgia",
                "id": {}
            }
        ],
        [
            {
                "label": "Pregbalin",
                "id": {}
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older",
                "id": {}
            }
        ],
        [
            {
                "label": "Pregbalin",
                "id": {}
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "Management of fibromyalgia",
                "id": {}
            }
        ],
        [
            {
                "label": "Pregbalin",
                "id": {}
            },
            {
                "label": "is indicated for",
                "id": {
                    "UMLS:C4698270": [
                        "NA-Patient has no pressure ulcers OR has no pressure ulcers for which moist wound healing is indicated."
                    ],
                    "UMLS:C0811369": [
                        "Incorporate biofeedback or electrical stimulation for selected individuals when assistance is indicated to identify correct muscles to contract and/or to elicit desired strength of muscle contraction"
                    ],
                    "UMLS:C4712812": [
                        "Prepare the chosen pacemaker for use, per facility protocol (i.e., ensure battery is fresh, identify atrial and ventricular wire sets, identify positive and negative leads for each pair of wires, identification labels, as indicated/preferred)"
                    ]
                }
            },
            {
                "label": "Management of neuropathic pain associated with spinal cord injury",
                "id": {}
            }
        ]
    ]
}